Citrus Sinensis ID: 047701
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | 2.2.26 [Sep-21-2011] | |||||||
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.814 | 0.350 | 0.486 | 9e-70 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.845 | 0.345 | 0.467 | 1e-68 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.848 | 0.364 | 0.453 | 2e-68 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.867 | 0.383 | 0.437 | 5e-68 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.842 | 0.365 | 0.443 | 7e-68 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.890 | 0.389 | 0.402 | 2e-66 | |
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.853 | 0.340 | 0.396 | 9e-66 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.786 | 0.351 | 0.452 | 2e-61 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.808 | 0.278 | 0.433 | 2e-58 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.808 | 0.279 | 0.427 | 7e-58 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 264 bits (674), Expect = 9e-70, Method: Compositional matrix adjust.
Identities = 146/300 (48%), Positives = 192/300 (64%), Gaps = 10/300 (3%)
Query: 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI 75
F+ +L N T N+S +LG GGFG V+KG P+ IAVK L + + + E+QF EV TI
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQ-GEKQFRTEVVTI 540
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF----GKKRALEWEKLHEIAIGT 131
G H+NLVRL GFC + LVY+YM NGSLD +LF +K L W+ +IA+GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A+GL YLH+EC+ IIH DIKPEN+LLD+ F PKVADFGLAKL R+ S V ++ +GT
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTR 659
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251
GY APE++SG IT K DVYS+GM+ FE+V RRN +E + +FP + K
Sbjct: 660 GYLAPEWISG-VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718
Query: 252 LGAMILACGIEEK--DKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKP 309
++ +E D E+ + C VA WC+QD + RP MS VV++LEGV+EV PPP P
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (664), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 145/310 (46%), Positives = 193/310 (62%), Gaps = 9/310 (2%)
Query: 11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMA 70
+ PV FT L N T+N+S LG GGFG VYKG +AVK L++ L E +F+
Sbjct: 515 DSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSH-GEREFIT 573
Query: 71 EVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---LEWEKLHEI 127
EV TIG +H+NLVRL G+C + LVYEYM NGSLD ++F ++ L+W EI
Sbjct: 574 EVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEI 633
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
A+ TA+G+ Y HE+C+ RIIH DIKPEN+LLD NF PKV+DFGLAK+ R SHV ++
Sbjct: 634 AVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMI 692
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
+GT GY APE++S N PIT K DVYS+GM+ EIVG RRN + ++P + ++E
Sbjct: 693 RGTRGYLAPEWVS-NRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKEL 751
Query: 248 EK-SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV-EVLP 305
+ L A+ +++E K L VA WC+QD + RP M VVK+LEG E+
Sbjct: 752 TNGTSLKAVDKRLQGVAEEEEVVKAL-KVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINL 810
Query: 306 PPKPFRYLDL 315
PP P L+L
Sbjct: 811 PPMPQTILEL 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (663), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 140/309 (45%), Positives = 187/309 (60%), Gaps = 7/309 (2%)
Query: 5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIA 64
L E PV+FT +L T ++ +LG GGFG VY+G N +AVK L +
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGI--EQG 520
Query: 65 EEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--LEWE 122
E+QF EV TI T+H+NLVRL GFC LVYE+M NGSLD +LF A L WE
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
IA+GTAKG+ YLHEEC+ I+H DIKPEN+L+D NF+ KV+DFGLAKL + +
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242
+S +GT GY APE+L+ N PIT K DVYS+GMV E+V +RN V + F +
Sbjct: 641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699
Query: 243 VWEEYEKSELGAMILACGIEEK--DKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
+EE+EK A++ E++ D E+ ++ + WC+Q+ P RP M VV+MLEG+
Sbjct: 700 AYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGI 759
Query: 301 VEVLPPPKP 309
E+ P P
Sbjct: 760 TEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 140/320 (43%), Positives = 206/320 (64%), Gaps = 11/320 (3%)
Query: 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI 75
+T +L T ++S +G GGFG VY G NG K+AVKVL K+L K + E F+ EV ++
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVL-KDL-KGSAEDFINEVASM 545
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGTAKG 134
+T H+N+V L GFC + A+VYE++ENGSLD ++ K + L+ IA+G A+G
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
L YLH C+ RI+H+DIKP+N+LLD N PKV+DFGLAKLC++ S +++ +GT GY
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665
Query: 195 APEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAI---VGASESLDWFPKYVWEEYEKS 250
APE S Y ++HK DVYSFGM+ +++G R I V ++ S +FP +++++ E
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725
Query: 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PPKP 309
E I I +++KE AK++ +V LWC+Q P+DRP M+ VV+M+EG ++ L PPKP
Sbjct: 726 E-QTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784
Query: 310 FRYLDLNKMTGLRSLESSDG 329
++ +T SL SDG
Sbjct: 785 SMHISTEVITESSSL--SDG 802
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 138/311 (44%), Positives = 201/311 (64%), Gaps = 11/311 (3%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG 61
+ FL+ + P+RF L + T+N+S +LG GGFG VY+G P+G ++AVK L + +G
Sbjct: 470 DNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKL-EGIG 527
Query: 62 KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--- 118
+ +++F AEV IG +H++LVRL GFC + L YE++ GSL+ ++F KK
Sbjct: 528 Q-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
L+W+ IA+GTAKGL YLHE+C RI+H DIKPEN+LLD NF+ KV+DFGLAKL R
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW 238
+SHV + +GT GY APE+++ NY I+ K DVYS+GMV E++G R+N +
Sbjct: 647 QSHV-FTTMRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704
Query: 239 FPKYVWEEYEKSELGAMILACGIEEKD--KEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
FP + +++ E+ +L I+ ++ D E+ ++ ALWC+Q+ RP MS VV+M
Sbjct: 705 FPSFAFKKMEEGKL-MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763
Query: 297 LEGVVEVLPPP 307
LEGV V+ PP
Sbjct: 764 LEGVFPVVQPP 774
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (645), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 132/328 (40%), Positives = 207/328 (63%), Gaps = 11/328 (3%)
Query: 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY 79
+L T ++S +G GGFG VY+G NG +AVKVL G + F+ EV ++ +T
Sbjct: 490 ELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGN--GDDFINEVTSMSQTS 547
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRAL--EWEKLHEIAIGTAKGLVY 137
H+N+V L GFC++ A++ E++E+GSLD ++ + ++L L+ IA+G A+GL Y
Sbjct: 548 HVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI-SRNKSLTPNVTTLYGIALGIARGLEY 606
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
LH C+ RI+H+DIKP+N+LLD NF PKVADFGLAKLC++ S +++ +GT GY APE
Sbjct: 607 LHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPE 666
Query: 198 FLSGNY-PITHKCDVYSFGMVSFEIVGRRRNA-IVGASESLDWFPKYVWEEYEKSELGAM 255
+S Y I+HK DVYS+GM+ +++G R + S +FP +++++ E +
Sbjct: 667 VVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGD-QTW 725
Query: 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PPKPFRYLD 314
I+ I E+D + K++ +V+LWC++ P+DRPPM+ VV+M+EG ++ L PPKP R++
Sbjct: 726 IIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPKPSRHIS 785
Query: 315 LNKMTGLRSLESSDGSNSSNQSRWYKET 342
+ L S SDG + Q++ T
Sbjct: 786 TELV--LESSSLSDGQEAEKQTQTLDST 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 251 bits (640), Expect = 9e-66, Method: Compositional matrix adjust.
Identities = 127/320 (39%), Positives = 207/320 (64%), Gaps = 16/320 (5%)
Query: 5 LQEIGREKPVR-FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI 63
LQ++ P++ +T ++ T +++ +G GGFG VY G + +AVKVL + G
Sbjct: 534 LQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTD 593
Query: 64 AEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWE 122
E+ F+ EV ++ +T H+N+V L GFC + A++YE++ NGSLD ++ K L+ +
Sbjct: 594 GED-FINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDLK 652
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
L+ IA+G A+GL YLH C+ RI+H+DIKP+NVLLD N PKV+DFGLAKLC++ S +
Sbjct: 653 TLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESIL 712
Query: 183 TISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD---- 237
++ +GT GY APE +S Y ++HK DVYS+GM+ E++G R+ + D
Sbjct: 713 SLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSI 772
Query: 238 WFPKYVWEEYEKSELGAM-------ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM 290
+FP++++++ EK+ + + ++ GI +++E A+++ +V LWC+Q SP+DRPPM
Sbjct: 773 YFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPM 832
Query: 291 SAVVKMLEGVVEVLP-PPKP 309
+ VV+M+EG ++ L PP+P
Sbjct: 833 NKVVEMMEGSLDALEVPPRP 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 133/294 (45%), Positives = 182/294 (61%), Gaps = 14/294 (4%)
Query: 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGT 74
F+ +L + T+ +S ++G GGFG V+KG P + +AVK L + E +F AEV T
Sbjct: 451 FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERP--GSGESEFRAEVCT 508
Query: 75 IGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGTAK 133
IG H+NLVRL GFC + LVY+YM GSL YL + L WE IA+GTAK
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAK 568
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
G+ YLHE C+ IIH DIKPEN+LLD++++ KV+DFGLAKL R+ S V ++ +GT GY
Sbjct: 569 GIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRV-LATMRGTWGY 627
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGA-------SESLDW-FPKYVWE 245
APE++SG PIT K DVYSFGM E++G RRN IV + +E W FP +
Sbjct: 628 VAPEWISG-LPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAR 686
Query: 246 EYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299
E + + +++ + E + E+ ++ VA+WC+QD+ RP M VVKMLEG
Sbjct: 687 EIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (577), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 128/295 (43%), Positives = 184/295 (62%), Gaps = 7/295 (2%)
Query: 12 KPVRFTSLQLNNFTSNY--STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFM 69
KP FT +L + T ++ S +LG GGFG VYKG+ +G ++AVK+L+ + + QF+
Sbjct: 677 KPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVG-SRQGKGQFV 735
Query: 70 AEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIA 128
AE+ I H NLV+L+G C++ LVYEY+ NGSLD LFG+K L+W +EI
Sbjct: 736 AEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEIC 795
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
+G A+GLVYLHEE + RI+H D+K N+LLD+ PKV+DFGLAKL D ++H++ +
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVA 854
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248
GT GY APE+ + +T K DVY+FG+V+ E+V R N+ + + ++ W +E
Sbjct: 855 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHE 913
Query: 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303
K +I + E + E+ K++ +AL C Q S A RPPMS VV ML G VEV
Sbjct: 914 KGREVELI-DHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEV 967
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 224 bits (572), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 126/295 (42%), Positives = 181/295 (61%), Gaps = 7/295 (2%)
Query: 12 KPVRFTSLQLNNFTSNY--STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFM 69
KP FT +L + T ++ S +LG GGFG VYKG +G +AVK+L+ + + QF+
Sbjct: 678 KPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVG-SRQGKGQFV 736
Query: 70 AEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIA 128
AE+ I H NLV+L+G C + LVYEY+ NGSLD LFG K L+W +EI
Sbjct: 737 AEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEIC 796
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
+G A+GLVYLHEE RI+H D+K N+LLD+ P+++DFGLAKL D ++H++ +
Sbjct: 797 LGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIS-TRVA 855
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248
GT GY APE+ + +T K DVY+FG+V+ E+V R N+ E + ++ W +E
Sbjct: 856 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHE 914
Query: 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303
KS ++ + + + E+AK++ +AL C Q S A RPPMS VV ML G VE+
Sbjct: 915 KSR-DIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEI 968
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | ||||||
| 225429784 | 361 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.980 | 0.720 | 1e-155 | |
| 296081766 | 543 | unnamed protein product [Vitis vinifera] | 0.997 | 0.653 | 0.719 | 1e-154 | |
| 359476316 | 361 | PREDICTED: G-type lectin S-receptor-like | 0.997 | 0.983 | 0.719 | 1e-154 | |
| 449532913 | 358 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.988 | 0.692 | 1e-145 | |
| 449437068 | 436 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.811 | 0.689 | 1e-145 | |
| 449437352 | 452 | PREDICTED: G-type lectin S-receptor-like | 0.997 | 0.785 | 0.657 | 1e-139 | |
| 449437350 | 363 | PREDICTED: G-type lectin S-receptor-like | 0.997 | 0.977 | 0.646 | 1e-137 | |
| 449528245 | 486 | PREDICTED: G-type lectin S-receptor-like | 0.977 | 0.716 | 0.659 | 1e-135 | |
| 449437348 | 452 | PREDICTED: probable receptor-like protei | 0.963 | 0.758 | 0.611 | 1e-124 | |
| 225454761 | 491 | PREDICTED: G-type lectin S-receptor-like | 0.994 | 0.720 | 0.579 | 1e-116 |
| >gi|225429784|ref|XP_002282725.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-155, Method: Compositional matrix adjust.
Identities = 260/361 (72%), Positives = 305/361 (84%), Gaps = 7/361 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+F QE+ REKPVRFT+ QL +FT NY+T LG GGFG VYKGQFPNGVKIAVKVLN++
Sbjct: 1 MEKFFQELAREKPVRFTAQQLCSFTDNYTTTLGSGGFGMVYKGQFPNGVKIAVKVLNRSP 60
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
+ AEEQFMAEVGTIGRTYHINLVRL+GFC+DQ M+ALVYEY+ENGSLD YLF + + +E
Sbjct: 61 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQFMSALVYEYLENGSLDKYLFSEAQEVE 120
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
WEKLH IA+GTAKG+ YLHEEC +RIIHYDIKP N+LLDANF PKVADFGLAKLC+R+ +
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVERIIHYDIKPGNILLDANFFPKVADFGLAKLCNRDGT 180
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H+T+SGY+GTPGYSAPEFL N+PITHKCDVYSFGM+ FEIVGRRRNA VG++ES+DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKVGSNESMDWFP 240
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
K+ WEEYEK +L AM +ACGIEEKD+EKA+++ MVALWCVQDSP RPPMSAVVKMLEG
Sbjct: 241 KHTWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPPMSAVVKMLEGG 300
Query: 301 VEVLPPPKPFRYLDLNKMTGLRSLESSDGSNSS------NQSRWYKETTPIMARHEIQIA 354
VEV+PPPKPF YL M + + G+NSS S WYKETTPIMA++EIQ+A
Sbjct: 301 VEVMPPPKPFHYLYSVGMNVFQQANET-GTNSSYATSEETSSIWYKETTPIMAKYEIQVA 359
Query: 355 T 355
+
Sbjct: 360 S 360
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081766|emb|CBI20771.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1422), Expect = e-154, Method: Compositional matrix adjust.
Identities = 259/360 (71%), Positives = 303/360 (84%), Gaps = 5/360 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
MERF QEI +EKPVRFT+ QL +FT+NYST LG GGFG VYKGQF NGVKIAVKVLN++
Sbjct: 59 MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 118
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
+ A EQFMAEVGTIGRTYH+NLVRL+GFCHDQ M+ALVYEY+ENGSLD YLF + R +E
Sbjct: 119 DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 178
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
WEKLH IA+GTAKG+ YLHEEC QRIIHYDIKP NVLLDANF PKVADFGLAKLC+R+ +
Sbjct: 179 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 238
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H+T+SGY+GTPGYSAPEFL N+PITHKCDVYSFGM+ FEIVGRRRNA +G++ES+DWFP
Sbjct: 239 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 298
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
K+VWEEYEK +L AM +ACGIEEKD+EKA+++ MVALWCVQDSP RP MSAVVKMLEG
Sbjct: 299 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 358
Query: 301 VEVLPPPKPFRYL-----DLNKMTGLRSLESSDGSNSSNQSRWYKETTPIMARHEIQIAT 355
VEV+PPPKPF YL ++ + SS ++ S WYKETTPIMA++EIQ+A+
Sbjct: 359 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETNSIWYKETTPIMAKYEIQVAS 418
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476316|ref|XP_003631817.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1421), Expect = e-154, Method: Compositional matrix adjust.
Identities = 259/360 (71%), Positives = 303/360 (84%), Gaps = 5/360 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
MERF QEI +EKPVRFT+ QL +FT+NYST LG GGFG VYKGQF NGVKIAVKVLN++
Sbjct: 1 MERFFQEIAKEKPVRFTAQQLCSFTANYSTTLGSGGFGVVYKGQFLNGVKIAVKVLNRSP 60
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
+ A EQFMAEVGTIGRTYH+NLVRL+GFCHDQ M+ALVYEY+ENGSLD YLF + R +E
Sbjct: 61 DRQAGEQFMAEVGTIGRTYHMNLVRLYGFCHDQFMSALVYEYLENGSLDKYLFSEAREIE 120
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
WEKLH IA+GTAKG+ YLHEEC QRIIHYDIKP NVLLDANF PKVADFGLAKLC+R+ +
Sbjct: 121 WEKLHHIAVGTAKGIAYLHEECVQRIIHYDIKPGNVLLDANFFPKVADFGLAKLCNRDNT 180
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H+T+SGY+GTPGYSAPEFL N+PITHKCDVYSFGM+ FEIVGRRRNA +G++ES+DWFP
Sbjct: 181 HLTVSGYRGTPGYSAPEFLLKNHPITHKCDVYSFGMLLFEIVGRRRNAKIGSNESMDWFP 240
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
K+VWEEYEK +L AM +ACGIEEKD+EKA+++ MVALWCVQDSP RP MSAVVKMLEG
Sbjct: 241 KHVWEEYEKGDLAAMTVACGIEEKDREKAERMSMVALWCVQDSPDSRPLMSAVVKMLEGG 300
Query: 301 VEVLPPPKPFRYL-----DLNKMTGLRSLESSDGSNSSNQSRWYKETTPIMARHEIQIAT 355
VEV+PPPKPF YL ++ + SS ++ S WYKETTPIMA++EIQ+A+
Sbjct: 301 VEVMPPPKPFHYLYSVGINVLQQANETGTSSSYATSKETNSIWYKETTPIMAKYEIQVAS 360
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449532913|ref|XP_004173422.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 522 bits (1344), Expect = e-145, Method: Compositional matrix adjust.
Identities = 248/358 (69%), Positives = 296/358 (82%), Gaps = 4/358 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+F++E+ E+PVRFT QL FTSNYST LG GGFG VYKGQFPNGVKIAVKVL +N
Sbjct: 1 MEKFIREMAEERPVRFTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 60
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
+ AEEQFMAEVGTIGRTYHINLVRL+GFC+DQ+M ALV+EYMENGSLD YLFGK + ++
Sbjct: 61 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 120
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
W KLH++AIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ +
Sbjct: 121 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 180
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H++++GY+GTPGYSAPEFL NYPITHKCDVYSFGMV FEIVGR+RNA V S + DW P
Sbjct: 181 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 240
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
++VW+ YEK +L + L CGIEE +KE+A ++C VALWCVQDSP +RPPMS VV+MLEG
Sbjct: 241 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 300
Query: 301 VEVLPPPKPFRYLDLN-KMTGLRSLESSDGSNSSNQSR--WYKETTPIMARHEIQIAT 355
VE++PPPKPF YL K ++ SSD S S+ +S WYK+ TPIM ++EIQIA+
Sbjct: 301 VEIMPPPKPFLYLQSTAKRNAQQTSNSSDYSTSNEESGSVWYKD-TPIMKKYEIQIAS 357
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437068|ref|XP_004136314.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1342), Expect = e-145, Method: Compositional matrix adjust.
Identities = 247/358 (68%), Positives = 295/358 (82%), Gaps = 4/358 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+F++E+ E+PVR T QL FTSNYST LG GGFG VYKGQFPNGVKIAVKVL +N
Sbjct: 79 MEKFIREMAEERPVRLTPQQLYCFTSNYSTPLGSGGFGSVYKGQFPNGVKIAVKVLKRNA 138
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
+ AEEQFMAEVGTIGRTYHINLVRL+GFC+DQ+M ALV+EYMENGSLD YLFGK + ++
Sbjct: 139 DRQAEEQFMAEVGTIGRTYHINLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDID 198
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
W KLH++AIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ +
Sbjct: 199 WRKLHDVAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDIT 258
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H++++GY+GTPGYSAPEFL NYPITHKCDVYSFGMV FEIVGR+RNA V S + DW P
Sbjct: 259 HMSLTGYRGTPGYSAPEFLFFNYPITHKCDVYSFGMVLFEIVGRKRNAGVTDSGNPDWLP 318
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
++VW+ YEK +L + L CGIEE +KE+A ++C VALWCVQDSP +RPPMS VV+MLEG
Sbjct: 319 QHVWDNYEKGKLEELTLMCGIEEDNKERANRMCEVALWCVQDSPDNRPPMSTVVRMLEGG 378
Query: 301 VEVLPPPKPFRYL-DLNKMTGLRSLESSDGSNSSNQSR--WYKETTPIMARHEIQIAT 355
VE++PPPKPF YL K ++ SSD S S+ +S WYK+ TPIM ++EIQIA+
Sbjct: 379 VEIMPPPKPFLYLQSTAKRNAQQTSNSSDYSTSNEESGSVWYKD-TPIMKKYEIQIAS 435
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437352|ref|XP_004136456.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1285), Expect = e-139, Method: Compositional matrix adjust.
Identities = 238/362 (65%), Positives = 293/362 (80%), Gaps = 7/362 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+F+QE+ +EKP+RFT+ QL FT NYST LG G F VYKG+FPNGVKIAVKVLN+N
Sbjct: 90 MEKFIQELAKEKPIRFTAQQLYIFTRNYSTILGAGAFSTVYKGEFPNGVKIAVKVLNRNS 149
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
K AE+QFMAEVGTIG+TYH +LVRL+GFC+DQ+M ALV+EYMENGSLD YLFGK + ++
Sbjct: 150 DKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDVD 209
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
W KLH++AIGTAKGL YLHEECQ+RIIHYDIKP N+LLDANFSPKV DFGLAKLC R+R+
Sbjct: 210 WGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDANFSPKVCDFGLAKLCHRDRT 269
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H++++GY+GTPGYSAPEF NYPITHKCDVYSFGM+ FEIVGR++NA V S +LDWFP
Sbjct: 270 HISLTGYRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEIVGRKKNATVTPSGNLDWFP 329
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
++VW++Y+K EL + CGIEEKDKE ++C VALWC+QDSP +RPPMS VVKMLEG
Sbjct: 330 RHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQDSPDERPPMSVVVKMLEGD 389
Query: 301 VEVLPPPKPFRYLDL-----NKMTGLRSLESSDGSNSSNQ--SRWYKETTPIMARHEIQI 353
VE++ P PF++ + NK L+S SS+ S SS + S WYK+ TPIM ++EI I
Sbjct: 390 VEIMAPSNPFKFSNPTPVGNNKPNLLQSSSSSNYSTSSEEIHSSWYKKATPIMKKYEIHI 449
Query: 354 AT 355
+
Sbjct: 450 GS 451
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437350|ref|XP_004136455.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1270), Expect = e-137, Method: Compositional matrix adjust.
Identities = 234/362 (64%), Positives = 285/362 (78%), Gaps = 7/362 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+F ++I EKPVRFT+ QL FTSNYSTRLG GGFG+VYKG+FPNGV IAVKVL +
Sbjct: 1 MEKFFRKIAEEKPVRFTADQLYTFTSNYSTRLGSGGFGEVYKGKFPNGVNIAVKVLKRGS 60
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
K AEEQFMAEVG+I RTYHINLVRL+GFC+D M+ALV+EY+ NGSLD YLFGK++ +E
Sbjct: 61 DKRAEEQFMAEVGSICRTYHINLVRLYGFCYDHFMSALVFEYLVNGSLDKYLFGKRKEIE 120
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
W KLH+IAIGTAKGL YLHEECQQRIIHYDIKP N+LLDANFSPKV DFGLAKLC+R+ +
Sbjct: 121 WRKLHDIAIGTAKGLAYLHEECQQRIIHYDIKPANILLDANFSPKVGDFGLAKLCNRDST 180
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H++ SGY+GTPGYSAPEFL NYP+THKCDVYSFGMV FEI+GR+ NA S + DWFP
Sbjct: 181 HISFSGYRGTPGYSAPEFLLVNYPLTHKCDVYSFGMVLFEIIGRKSNAGTTVSGNPDWFP 240
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
++VW+ YE +L +I+ CGI E+D+E A + C VALWCVQDSP RP MS VV+MLEG
Sbjct: 241 QHVWDAYENGKLEELIIGCGIGEEDREMASRACEVALWCVQDSPDGRPTMSVVVRMLEGG 300
Query: 301 VEVLPPPKPFRYLD-------LNKMTGLRSLESSDGSNSSNQSRWYKETTPIMARHEIQI 353
VE++PP KPF+YL+ S S ++ + S+WYK+TT IM ++EIQ+
Sbjct: 301 VEIMPPAKPFQYLNPIRTGNSSTSSQQTGSNSSGSSTSRDSNSQWYKKTTTIMRKYEIQM 360
Query: 354 AT 355
A+
Sbjct: 361 AS 362
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449528245|ref|XP_004171116.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like, partial [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 234/355 (65%), Positives = 287/355 (80%), Gaps = 7/355 (1%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+F+QE+ +EKP+RFT+ QL FT NYST LG G F VYKG+FPNGVKIAVKVLN+N
Sbjct: 90 MEKFIQELAKEKPMRFTAQQLYIFTRNYSTILGAGAFSTVYKGEFPNGVKIAVKVLNRNS 149
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
K AE+QFMAEVGTIG+TYH +LVRL+GFC+DQ+M ALV+EYMENGSLD YLFGK + ++
Sbjct: 150 DKQAEQQFMAEVGTIGKTYHRHLVRLYGFCYDQYMGALVFEYMENGSLDKYLFGKNQDVD 209
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
W KLH++AIGTAKGL YLHEECQ+RIIHYDIKP N+LLDANFSPKV DFGLAKLC R+R+
Sbjct: 210 WGKLHDVAIGTAKGLTYLHEECQERIIHYDIKPANILLDANFSPKVCDFGLAKLCHRDRT 269
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
H++++G +GTPGYSAPEF NYPITHKCDVYSFGM+ FEIVGR++NA V S +LDWFP
Sbjct: 270 HISLTGCRGTPGYSAPEFFLNNYPITHKCDVYSFGMLLFEIVGRKKNATVTPSGNLDWFP 329
Query: 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
++VW++Y+K EL + CGIEEKDKE ++C VALWC+QDSP +RPPMS VVKMLEG
Sbjct: 330 RHVWDKYKKRELEEISQICGIEEKDKESVSRMCKVALWCIQDSPDERPPMSVVVKMLEGD 389
Query: 301 VEVLPPPKPFRY-----LDLNKMTGLRSLESSDGSNSSNQ--SRWYKETTPIMAR 348
VE++ P PF++ + NK L+S SS+ S SS + S WYK+ TPIM +
Sbjct: 390 VEIMAPSNPFKFSNPTPVGNNKPNLLQSSSSSNYSTSSEEIHSSWYKKATPIMKK 444
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437348|ref|XP_004136454.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 219/358 (61%), Positives = 275/358 (76%), Gaps = 15/358 (4%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME+ L+ I E P+RFT+LQLN FTSNYSTRLG GGFG VYKGQFPNG+KIAVK+L KN
Sbjct: 93 MEKILRGIAEESPIRFTALQLNAFTSNYSTRLGSGGFGDVYKGQFPNGLKIAVKILKKNS 152
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK-KRAL 119
K AE QFMAE+ TIGRT H NL+RL+GFC+D+ M+ALV E+MENGSLD +L+GK K L
Sbjct: 153 NKKAENQFMAEIETIGRTRHRNLLRLYGFCYDETMSALVLEFMENGSLDRFLYGKTKNEL 212
Query: 120 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
+WEKL EIAIGT +G+ Y+HEEC+++IIHYDIKP N+LLD NFSPK+ DFGLA LC+++
Sbjct: 213 DWEKLLEIAIGTGRGIAYMHEECERKIIHYDIKPANILLDENFSPKIGDFGLANLCNKDN 272
Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF 239
+H +++ Y+GTPGYSAPE L N+P+T+KCDVYSFGMV FE+VGRR+NA V S+DWF
Sbjct: 273 THDSLTEYRGTPGYSAPELLRFNFPVTYKCDVYSFGMVLFEMVGRRKNAAVSPLGSIDWF 332
Query: 240 PKYVWEEYEKSELGAMILACGIEEKDKEKAK--QLCMVALWCVQDSPADRPPMSAVVKML 297
P VWE +EK EL M +EE + K K ++C+VALWCVQDSP DRPPMSAVV+ML
Sbjct: 333 PIQVWERFEKGELVNMSGDYDVEEDGERKMKVDRMCVVALWCVQDSPEDRPPMSAVVRML 392
Query: 298 EGVVEVLPPPKPFRYL-----DLNKMT-GLRSLESSDGSNSS-NQSR-----WYKETT 343
EG VE++PPPKPF+Y+ D + +T + S + S GS SS + S+ WYK +
Sbjct: 393 EGSVEIMPPPKPFQYMFPIPTDSSTVTVAMDSEQMSFGSTSSYSMSKGTLPIWYKAAS 450
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225454761|ref|XP_002272528.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 207/357 (57%), Positives = 258/357 (72%), Gaps = 3/357 (0%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL 60
ME FL E+ REKP RF+ QL FTS++S LG GGFG VYKG+FPNG+ +AVKV+N N
Sbjct: 136 MEIFLSEMEREKPTRFSPQQLARFTSDFSMVLGSGGFGVVYKGEFPNGLPVAVKVINSNS 195
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRAL- 119
K EQFMAEV +IGRTYHINLVRL+GFC D M ALVYEY+ENGSLD LFG+ +A
Sbjct: 196 EKKVAEQFMAEVASIGRTYHINLVRLYGFCFDPTMRALVYEYVENGSLDRLLFGENKATN 255
Query: 120 -EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
+W K EIA+GTAKG+ YLHEEC+QRIIHYDIKP NVLLDA FSPK+ADFGLAKLC+R+
Sbjct: 256 DQWGKFEEIAVGTAKGIAYLHEECRQRIIHYDIKPANVLLDAVFSPKLADFGLAKLCNRD 315
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW 238
+ V ++G++GTPGY+APE L YP+T KCDVYSFGM+ FE+VGRRRN SE+ W
Sbjct: 316 STQVPVTGFRGTPGYAAPE-LWKPYPVTCKCDVYSFGMLLFEMVGRRRNHDASLSETRQW 374
Query: 239 FPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
P++ WE +EK+EL M+ CGI+E + EKA ++CMVA+WCVQ P RP M VVKMLE
Sbjct: 375 LPRWTWEMFEKNELPEMLSLCGIKETNIEKAGRMCMVAMWCVQYLPEARPTMGKVVKMLE 434
Query: 299 GVVEVLPPPKPFRYLDLNKMTGLRSLESSDGSNSSNQSRWYKETTPIMARHEIQIAT 355
G E+ PPP PF+ N ++ + E +D S S+ ++ P EI+I +
Sbjct: 435 GETEIPPPPYPFQRSMPNLVSSSGNSEDTDPSESTRETSEPSYAAPGEGVLEIEIVS 491
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 356 | ||||||
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.823 | 0.366 | 0.443 | 7.2e-68 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.828 | 0.443 | 0.426 | 9.2e-68 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.831 | 0.439 | 0.439 | 1.9e-67 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.825 | 0.441 | 0.434 | 3.6e-66 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.814 | 0.350 | 0.483 | 3.6e-66 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.842 | 0.365 | 0.440 | 9.4e-66 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.845 | 0.352 | 0.422 | 2.5e-65 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.820 | 0.457 | 0.448 | 4.1e-65 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.845 | 0.363 | 0.454 | 8.5e-65 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.845 | 0.373 | 0.435 | 1.1e-64 |
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 689 (247.6 bits), Expect = 7.2e-68, P = 7.2e-68
Identities = 134/302 (44%), Positives = 201/302 (66%)
Query: 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVK-IAVKVLNKNLGKIAEEQFMAEVG 73
RF+ +Q+ T ++ LG GGFG VYKG+ P+G + +AVK+L K + E+ F+ E+
Sbjct: 448 RFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKIL-KESNEDGED-FINEIA 505
Query: 74 TIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTA 132
++ RT H N+V L GFC++ A++YE M NGSLD ++ A +EW+ L+ IA+G +
Sbjct: 506 SMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISKNMSAKMEWKTLYNIAVGVS 565
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
GL YLH C RI+H+DIKP+N+L+D + PK++DFGLAKLC N S +++ +GT G
Sbjct: 566 HGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIG 625
Query: 193 YSAPEFLSGNYP-ITHKCDVYSFGMVSFEIVGRR---RNAIVGASESLDWFPKYVWEEYE 248
Y APE S N+ ++HK DVYS+GMV E++G R R G+S + +FP +++++ E
Sbjct: 626 YIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSMYFPDWIYKDLE 685
Query: 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PP 307
K E+ + + EE+D++ K++ +V LWC+Q +P DRPPMS VV+MLEG +E L PP
Sbjct: 686 KGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEALQIPP 745
Query: 308 KP 309
KP
Sbjct: 746 KP 747
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
Identities = 130/305 (42%), Positives = 207/305 (67%)
Query: 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVG 73
R++ ++ T++++ LG GGFG VYKG+ + G +AVK+L + G E+F+ EV
Sbjct: 320 RYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGN--GEEFINEVA 377
Query: 74 TIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTA 132
++ RT H+N+V L GFC++++ A++YE+M NGSLD Y+ +EWE+L+++A+G +
Sbjct: 378 SMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGIS 437
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
+GL YLH C RI+H+DIKP+N+L+D N PK++DFGLAKLC S +++ +GT G
Sbjct: 438 RGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFG 497
Query: 193 YSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIV---GASESLDWFPKYVWEEYE 248
Y APE S N+ ++HK DVYS+GMV E++G + V G++ +FP++V++++E
Sbjct: 498 YIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFE 557
Query: 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PP 307
K E+ I I +++++ AK+L +VALWC+Q +P+DRPPM V++MLEG +E L PP
Sbjct: 558 KGEI-TRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPP 616
Query: 308 KPFRY 312
P +
Sbjct: 617 NPLLF 621
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
Identities = 134/305 (43%), Positives = 211/305 (69%)
Query: 13 PVR-FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAE 71
P++ +T Q+ T +++ +G GGFG VY+G +G +AVKVL ++ G +E+ F+ E
Sbjct: 332 PLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSED-FINE 390
Query: 72 VGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIG 130
V ++ +T H+N+V L GFC + A++YE++ENGSLD ++ K L+ L+ IA+G
Sbjct: 391 VSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLTALYGIALG 450
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
A+GL YLH C+ RI+H+DIKP+NVLLD N SPKV+DFGLAKLC++ S +++ +GT
Sbjct: 451 VARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGT 510
Query: 191 PGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVG---ASESLDWFPKYVWEE 246
GY APE +S Y ++HK DVYS+GM+ FE++G R+ G A+ S +FP++++++
Sbjct: 511 IGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKD 570
Query: 247 YEKSELGAMI-LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305
EK++ G + + GI +++E AK++ +V LWC+Q SP+DRPPM+ VV+M+EG ++ L
Sbjct: 571 LEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALE 630
Query: 306 -PPKP 309
PP+P
Sbjct: 631 VPPRP 635
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 673 (242.0 bits), Expect = 3.6e-66, P = 3.6e-66
Identities = 132/304 (43%), Positives = 203/304 (66%)
Query: 13 PVR-FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAE 71
P++ ++ Q+ + T +++ +G GGFG VY+G +G +AVKVL ++ G E F+ E
Sbjct: 334 PLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGN--GEDFINE 391
Query: 72 VGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIG 130
V ++ +T H+N+V L GFC + + A++YE+MENGSLD ++ KK + ++W +L+ IA+G
Sbjct: 392 VASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSSTMDWRELYGIALG 451
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
A+GL YLH C+ RI+H+DIKP+NVLLD N SPKV+DFGLAKLC+R S +++ +GT
Sbjct: 452 VARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGT 511
Query: 191 PGYSAPEFLSGNYP-ITHKCDVYSFGMVSFEIVGRRRNAIVG---ASESLDWFPKYVWEE 246
GY APE S Y ++HK DVYS+GM+ +I+G R +S S +FP++++ +
Sbjct: 512 IGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRD 571
Query: 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP- 305
EK+ G I I ++ E AK++ +V LWC+Q P DRP M+ VV+M+EG ++ L
Sbjct: 572 LEKAHNGKSI-ETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDALEV 630
Query: 306 PPKP 309
PP+P
Sbjct: 631 PPRP 634
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 673 (242.0 bits), Expect = 3.6e-66, P = 3.6e-66
Identities = 145/300 (48%), Positives = 194/300 (64%)
Query: 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI 75
F+ +L N T N+S +LG GGFG V+KG P+ IAVK L + + + E+QF EV TI
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQ-GEKQFRTEVVTI 540
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF----GKKRALEWEKLHEIAIGT 131
G H+NLVRL GFC + LVY+YM NGSLD +LF +K L W+ +IA+GT
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGT 600
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A+GL YLH+EC+ IIH DIKPEN+LLD+ F PKVADFGLAKL R+ S V ++ +GT
Sbjct: 601 ARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTR 659
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS- 250
GY APE++SG IT K DVYS+GM+ FE+V RRN +E + +FP + K
Sbjct: 660 GYLAPEWISG-VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718
Query: 251 ELGAMI-LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKP 309
++ +++ + D E+ + C VA WC+QD + RP MS VV++LEGV+EV PPP P
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
Identities = 137/311 (44%), Positives = 201/311 (64%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG 61
+ FL+ + P+RF L + T+N+S +LG GGFG VY+G P+G ++AVK L + +G
Sbjct: 470 DNFLENLSG-MPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKL-EGIG 527
Query: 62 KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--- 118
+ +++F AEV IG +H++LVRL GFC + L YE++ GSL+ ++F KK
Sbjct: 528 Q-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
L+W+ IA+GTAKGL YLHE+C RI+H DIKPEN+LLD NF+ KV+DFGLAKL R
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW 238
+SHV + +GT GY APE+++ NY I+ K DVYS+GMV E++G R+N +
Sbjct: 647 QSHV-FTTMRGTRGYLAPEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCH 704
Query: 239 FPKYVWEEYEKSELGAMI--LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
FP + +++ E+ +L ++ ++ D E+ ++ ALWC+Q+ RP MS VV+M
Sbjct: 705 FPSFAFKKMEEGKLMDIVDGKMKNVDVTD-ERVQRAMKTALWCIQEDMQTRPSMSKVVQM 763
Query: 297 LEGVVEVLPPP 307
LEGV V+ PP
Sbjct: 764 LEGVFPVVQPP 774
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
Identities = 133/315 (42%), Positives = 209/315 (66%)
Query: 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN--GVKIAVKVLNKNLGKIAEEQFMAEV 72
R++ ++ T+++ +G GGFG VYKG+ P+ G IA+K+L ++ G E+F+ E+
Sbjct: 508 RYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGN--GEEFINEL 565
Query: 73 GTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGT 131
++ R H+N+V L GFC++ A++YE+M NGSLD ++ +EW+ L+ IA+G
Sbjct: 566 VSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFISENMSTKIEWKTLYNIAVGV 625
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A+GL YLH C +I+H+DIKP+N+L+D + PK++DFGLAKLC + S +++ +GT
Sbjct: 626 ARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTV 685
Query: 192 GYSAPEFLSGNYP-ITHKCDVYSFGMVSFEIVG--RRRNAIVGASE-SLDWFPKYVWEEY 247
GY APE S NY ++HK DVYS+GMV E++G +R A++ S +FP +V+E+
Sbjct: 686 GYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDL 745
Query: 248 EKSELGAMILACGIEEKDKEK-AKQLCMVALWCVQDSPADRPPMSAVVKMLEGV-VEVLP 305
E+ E ++ IEE+++EK K++ +V LWC+Q +P+DRPPM VV+MLEG +E L
Sbjct: 746 ERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQ 805
Query: 306 -PPKPFRYLDLNKMT 319
PPKP L+L+ +T
Sbjct: 806 VPPKPL--LNLHVVT 818
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 4.1e-65, P = 4.1e-65
Identities = 135/301 (44%), Positives = 197/301 (65%)
Query: 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGT 74
+++ ++ T +S LG GGFG VY G +G K+AVK+L K+ K E F+ EV +
Sbjct: 310 QYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKIL-KDF-KSNGEDFINEVAS 367
Query: 75 IGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAK 133
+ +T H+N+V L GFC++ A+VYE++ENGSLD +L KK L+ L+ IA+G A+
Sbjct: 368 MSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLNLDVSTLYRIALGVAR 427
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
GL YLH C+ RI+H+DIKP+N+LLD F PKV+DFGLAKLC++ S +++ +GT GY
Sbjct: 428 GLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGY 487
Query: 194 SAPEFLSGNYP-ITHKCDVYSFGMVSFEIVGRRRNAI--VGASESLD-WFPKYVWEEYEK 249
APE SG Y ++HK DVYS+GM+ E++G + I AS S +FP ++++ E
Sbjct: 488 IAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPDWIYKNLEN 547
Query: 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PPK 308
E I +DKE AK++ +V LWC+Q SP +RPPM+ +V+M+EG ++VL PPK
Sbjct: 548 GE-DTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPK 606
Query: 309 P 309
P
Sbjct: 607 P 607
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 8.5e-65, P = 8.5e-65
Identities = 141/310 (45%), Positives = 190/310 (61%)
Query: 5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIA 64
L E PV+FT +L T ++ +LG GGFG VY+G N +AVK L + + +
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL-EGIEQ-G 520
Query: 65 EEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA--LEWE 122
E+QF EV TI T+H+NLVRL GFC LVYE+M NGSLD +LF A L WE
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
IA+GTAKG+ YLHEEC+ I+H DIKPEN+L+D NF+ KV+DFGLAKL + +
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242
+S +GT GY APE+L+ N PIT K DVYS+GMV E+V +RN V + F +
Sbjct: 641 NMSSVRGTRGYLAPEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIW 699
Query: 243 VWEEYEKSELGAMILACGIEEK--DKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
+EE+EK A++ E++ D E+ ++ + WC+Q+ P RP M VV+MLEG+
Sbjct: 700 AYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGI 759
Query: 301 VEVLPP--PK 308
E+ P PK
Sbjct: 760 TEIKNPLCPK 769
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
Identities = 135/310 (43%), Positives = 201/310 (64%)
Query: 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI 75
+T +L T ++S +G GGFG VY G NG K+AVKVL K+L K + E F+ EV ++
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVL-KDL-KGSAEDFINEVASM 545
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGTAKG 134
+T H+N+V L GFC + A+VYE++ENGSLD ++ K + L+ IA+G A+G
Sbjct: 546 SQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTLYGIALGIARG 605
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
L YLH C+ RI+H+DIKP+N+LLD N PKV+DFGLAKLC++ S +++ +GT GY
Sbjct: 606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665
Query: 195 APEFLSGNYP-ITHKCDVYSFGMVSFEIVGRRRNAIV---GASESLDWFPKYVWEEYEKS 250
APE S Y ++HK DVYSFGM+ +++G R IV ++ S +FP +++++ E
Sbjct: 666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725
Query: 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PPKP 309
E I I +++KE AK++ +V LWC+Q P+DRP M+ VV+M+EG ++ L PPKP
Sbjct: 726 EQ-TWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP 784
Query: 310 FRYLDLNKMT 319
++ +T
Sbjct: 785 SMHISTEVIT 794
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 356 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 6e-53
Identities = 72/192 (37%), Positives = 108/192 (56%), Gaps = 7/192 (3%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG GGFG VY + G K+A+K++ K E+ + E+ + + H N+V+L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
D++ LV EY E GSL L + L +++ I + +GL YLH IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 151 IKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
+KPEN+LLD+ N K+ADFGL+KL ++S + GTP Y APE L G + K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 210 DVYSFGMVSFEI 221
D++S G++ +E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-46
Identities = 76/197 (38%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+LG G FG VYK + G +AVK+L K + ++ E+ + R H N+VRL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
D+ LV EY E G L YL + L ++ +IA+ +GL YLH IIH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHS---NGIIH 121
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+KPEN+LLD N K+ADFGLAK ++ S +T + GTP Y APE L G K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT--TFVGTPWYMAPEVLLGGNGYGPK 179
Query: 209 CDVYSFGMVSFEIVGRR 225
DV+S G++ +E++ +
Sbjct: 180 VDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 32 LGFGGFGQVYKGQ-----FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+VYKG+ V++AVK L ++ + E+F+ E + + H N+V+L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C ++ +V EYME G L YL + L L A+ A+G+ YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES---KNF 123
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG---YKGTPGYSAPE-FLSGN 202
IH D+ N L+ N K++DFGL++ + + G + + APE G
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKEGK 179
Query: 203 YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262
+ T K DV+SFG++ +EI G P + E+ +
Sbjct: 180 F--TSKSDVWSFGVLLWEIFTL------GEQ------P---YPGMSNEEVLEYLKNGYRL 222
Query: 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
+ +L + L C + P DRP S +V++L
Sbjct: 223 PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 77/276 (27%), Positives = 123/276 (44%), Gaps = 34/276 (12%)
Query: 32 LGFGGFGQVYKGQ-----FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+VYKG V++AVK L ++ + E+F+ E + + H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
G C ++ +V EYM G L YL + + L L A+ A+G+ YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KN 123
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG---YKGTPGYSAPE-FLSG 201
IH D+ N L+ N K++DFGL++ + + G + + APE G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEG 179
Query: 202 NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
+ T K DV+SFG++ +EI G P + +E+ +
Sbjct: 180 KF--TSKSDVWSFGVLLWEIFTL------GEE------P---YPGMSNAEVLEYLKKGYR 222
Query: 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
K +L + L C + P DRP S +V++L
Sbjct: 223 LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 5e-43
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G FG+VY + G +A+KV+ K K E+ + E+ + + H N+VRL+
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
D+ LV EY E G L L K+ L ++ L YLH + I+H D
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVHRD 122
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
+KPEN+LLD + K+ADFGLA+ D T + GTP Y APE L G D
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLGK-GYGKAVD 178
Query: 211 VYSFGMVSFEIV 222
++S G++ +E++
Sbjct: 179 IWSLGVILYELL 190
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 8e-39
Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 32 LGFGGFGQVYKG-----QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+VYKG K+AVK L + + E+F+ E + + H N+VRL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C +V EYM G L +L L + L ++A+ AKG+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNF 123
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+ N L+ N K++DFGL++ + + G K + APE L + T
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK-DGKFT 182
Query: 207 HKCDVYSFGMVSFEI 221
K DV+SFG++ +EI
Sbjct: 183 SKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 83/285 (29%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 32 LGFGGFGQVYKGQF----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
LG G FG+VYKG+ ++AVK L ++ + + F+ E + + H N+VRL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 88 GFCHDQHMTALVYEYMENGSLDGYL--------FGKKRALEWEKLHEIAIGTAKGLVYLH 139
G C ++ LV EYME G L YL +K L + L AI AKG+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS----- 194
++ +H D+ N L+ + K++DFGL++ + + K T G
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLPIRWM 174
Query: 195 APE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253
APE G + T K DV+SFG++ +EI +L P + E+
Sbjct: 175 APESLKDGIF--TSKSDVWSFGVLLWEIF------------TLGATP---YPGLSNEEVL 217
Query: 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ K + +L + L C Q P DRP S +V+ LE
Sbjct: 218 EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-31
Identities = 74/218 (33%), Positives = 113/218 (51%), Gaps = 23/218 (10%)
Query: 7 EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEE 66
EI RE SL+L +LG G FG+V+ G + K+AVK L G ++ E
Sbjct: 2 EIPRE------SLKLER-------KLGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPE 46
Query: 67 QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLH 125
F+ E + + H LV+L+ C ++ +V EYM GSL +L G+ + L +L
Sbjct: 47 AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV 106
Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
++A A+G+ YL + IH D+ N+L+ N K+ADFGLA+L + + +
Sbjct: 107 DMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTARE 162
Query: 186 GYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
G K ++APE G + I K DV+SFG++ EIV
Sbjct: 163 GAKFPIKWTAPEAANYGRFTI--KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 72/214 (33%), Positives = 105/214 (49%), Gaps = 14/214 (6%)
Query: 32 LGFGGFGQVYKGQF-PNG--VKI--AVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG VYKG + P G VKI A+KVL + A ++ + E + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + L+ + M G L Y+ K + + L + AKG+ YL E +R+
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
+H D+ NVL+ K+ DFGLAKL D + G K + A E L Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY-- 188
Query: 206 THKCDVYSFGMVSFEIV--GRRRNAIVGASESLD 237
THK DV+S+G+ +E++ G + + A E D
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 28 YSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG V+ G + K+A+K + + G ++EE F+ E + + H LV+L+
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G C ++ LV+E+ME+G L YL ++ E L + + +G+ YL +I
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPIT 206
H D+ N L+ N KV+DFG+ + + + + +G K +S+PE S Y +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKY--S 179
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
K DV+SFG++ +E+ SE K +E SE+ I A K +
Sbjct: 180 SKSDVWSFGVLMWEVF----------SEG-----KTPYENRSNSEVVETINAGFRLYKPR 224
Query: 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
++ + + C ++ P DRP S ++ L
Sbjct: 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 64/200 (32%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRLHGF 89
LG G FG VY G +AVK + + E E E+ + H N+VR +G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 90 CHD-QHMTALVY-EYMENGSLDGYL--FGKKRALEWEKLHEIAIGT-----AKGLVYLHE 140
D + T ++ EY+ GSL L FGK L E I +GL YLH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--------LPEPVIRKYTRQILEGLAYLHS 119
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
I+H DIK N+L+D++ K+ADFG AK + +GTP + APE +
Sbjct: 120 ---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 201 GNYPITHKCDVYSFGMVSFE 220
G D++S G E
Sbjct: 177 GE-EYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (287), Expect = 5e-29
Identities = 84/277 (30%), Positives = 124/277 (44%), Gaps = 23/277 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI--AEEQFMAEVGTIGRTYH-INLVRLHG 88
LG G FG+VY + + +A+KVL K L E+F+ E+ + H N+V+L+
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 89 FCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
F D+ LV EY++ GSL+ L G+K L + I L YLH + I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 147 IHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTI----SGYKGTPGYSAPEFLSG 201
IH DIKPEN+LLD + K+ DFGLAKL S +I S GTPGY APE L G
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 202 NY--PITHKCDVYSFGMVSFEIV-GRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258
+ D++S G+ +E++ G S + K + E S +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL--- 239
Query: 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+ +K + + P +R S+ +
Sbjct: 240 --SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
LG G G VYK + P G A+K ++ + + +Q + E+ T+ +V+ +G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ + ++V EYM+ GSL L K + L IA KGL YLH ++ IIH
Sbjct: 67 AFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIH 123
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITH 207
DIKP N+L+++ K+ADFG++K+ + N + + GT Y +PE +Y +
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNT-FVGTVTYMSPERIQGESYS--Y 179
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVG-----ASESLDWF---------PKYVWEEYEKSELG 253
D++S G+ E +G +F P E S
Sbjct: 180 AADIWSLGLTLLEC-------ALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 254 AMILACGI--EEKDKEKAKQL 272
++ + + K + A +L
Sbjct: 233 RDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 65/191 (34%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91
+G G FG V G + G K+AVK L K+ A+ F+AE + H NLV+L G
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 92 DQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
+ +V EYM GSL YL + RA + + A+ +G+ YL E + +H D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
+ NVL+ + KV+DFGLAK + K ++APE L + K D
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREK-KFSTKSD 181
Query: 211 VYSFGMVSFEI 221
V+SFG++ +EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
++G GGFG+VYK + G ++A+KV+ K +E+ + E+ + + H N+V+ +G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLE-SKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 89 -FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
D+ +V E+ GSL L + L ++ + KGL YLH II
Sbjct: 66 YLKKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGII 120
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H DIK N+LL ++ K+ DFGL+ ++ T+ GTP + APE ++G P +
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK-PYDY 176
Query: 208 KCDVYSFGMVSFE 220
K D++S G+ + E
Sbjct: 177 KADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 64/194 (32%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQ---FMAEVGTIGRTYHINLVRLH 87
+G G FG VYKG G +A+K ++ KI EE M E+ + H N+V+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLE--KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHE--IAIGTA---KGLVYLHEEC 142
G ++ EY ENGSL + KK + E +A+ +GL YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KK----FGPFPESLVAVYVYQVLQGLAYLHE-- 117
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
Q +IH DIK N+L + K+ADFG+A KL N + GTP + APE +
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPYWMAPEVIEM 173
Query: 202 NYPITHKCDVYSFG 215
+ + D++S G
Sbjct: 174 S-GASTASDIWSLG 186
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 12/197 (6%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V++G + N V++A+K+L K+ + ++ F EV + R H +L+ L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ E ME GSL +L + + L L ++A A+G+ YL E Q IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITH 207
D+ N+L+ + KVADFGLA+L + V +S K P ++APE S G + +
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIPYKWTAPEAASHGTF--ST 183
Query: 208 KCDVYSFGMVSFEIVGR 224
K DV+SFG++ +E+
Sbjct: 184 KSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 69/199 (34%), Positives = 103/199 (51%), Gaps = 20/199 (10%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V++G + N +AVK L G + + F+AE + + H L++L+ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ +V E M+ GSL YL G RAL+ +L ++A A G+ YL Q IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLSGNY 203
D+ NVL+ N KVADFGLA++ + Y+ G ++APE N
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI-------YEAREGAKFPIKWTAPEAALYN- 179
Query: 204 PITHKCDVYSFGMVSFEIV 222
+ K DV+SFG++ EIV
Sbjct: 180 RFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91
LG G FG V+ G++ + +A+K++ + G ++E+ F+ E + + H NLV+L+G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 92 DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
Q +V EYM NG L YL +K L E L ++ + + YL IH D+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
N L+ + KV+DFGLA+ L D+ S G K ++ PE F + + K
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ---GTKFPVKWAPPEVFDYSRF--SSK 181
Query: 209 CDVYSFGMVSFEI 221
DV+SFG++ +E+
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 28 YSTRLGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN 82
+ +LG G FG+V ++ G ++AVK LN + + F E+ + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 83 LVRLHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
+V+ G C + L+ EY+ +GSL YL + + ++L + KG+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-YSAPEFL 199
QR IH D+ N+L+++ K++DFGLAK+ ++ + + +P + APE L
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 200 SGNYPITHKCDVYSFGMVSFEI 221
+ DV+SFG+ +E+
Sbjct: 185 R-TSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 32 LGFGGFGQVYKG--QFPNG--VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG+V +G + P + +A+K L F+ E +G+ H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G ++ EYMENGSLD +L +L + G A G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YV 128
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-T 206
H D+ N+L+++N KV+DFGL++ + + + T G K ++APE ++ Y T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YRKFT 186
Query: 207 HKCDVYSFGMVSFEI 221
DV+SFG+V +E+
Sbjct: 187 SASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGF 89
++G G FG VYKG ++AVK L + +F+ E I + Y H N+V+L G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQE-AEILKQYDHPNIVKLIGV 60
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
C + +V E + GSL +L KK L +KL ++++ A G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITH 207
D+ N L+ N K++DFG+++ + V+ G K P ++APE L+ G Y T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEALNYGRY--TS 174
Query: 208 KCDVYSFGMVSFEI 221
+ DV+S+G++ +E
Sbjct: 175 ESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 69/196 (35%), Positives = 109/196 (55%), Gaps = 15/196 (7%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + K+A+K L + G ++ E F+AE + + H LVRL+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 91 HDQHMTALVYEYMENGSLDGYL---FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
Q ++ EYMENGSL +L G K L KL ++A A+G+ ++ ++ I
Sbjct: 71 -TQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPIT 206
H D++ N+L+ K+ADFGLA+L + N + G K ++APE ++ G + I
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTI- 182
Query: 207 HKCDVYSFGMVSFEIV 222
K DV+SFG++ EIV
Sbjct: 183 -KSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 69/204 (33%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLH- 87
LG G FG+V + + G A+KVL K + + E + E + R H +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 88 GFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
F + LV EY G L +L F ++RA + EI + L YLH
Sbjct: 61 AF-QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLA----LEYLHS-- 111
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSG 201
II+ D+KPEN+LLDA+ K+ DFGLAK L + + GTP Y APE L G
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLG 167
Query: 202 NYPITHKCDVYSFGMVSFE-IVGR 224
D +S G++ +E + G+
Sbjct: 168 K-GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G G V K P G +AVK + + + ++Q + E+ + + +V +G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEW---EKLHEIAIGTAKGLVYLHEECQQRII 147
++ ++ EYM+ GSLD L K L +IA+ KGL YLHE + +II
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123
Query: 148 HYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISG-YKGTPGYSAPEFLSGN-YP 204
H D+KP N+L+++ K+ DFG++ +L + +++ + GT Y APE + GN Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVN------SLAKTFVGTSSYMAPERIQGNDYS 177
Query: 205 ITHKCDVYSFGMVSFEI-VGR 224
+ K D++S G+ E+ GR
Sbjct: 178 V--KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 31 RLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
RLG G G V K + N I A+K + + ++Q + E+ +V+ +G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 90 CHDQH--MTALVYEYMENGSLDGYLFGKKRALEW---EK-LHEIAIGTAKGLVYLHEECQ 143
D+ + EY E GSLD ++ K + EK L +IA KGL YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAPEFL 199
++IIH DIKP N+LL G KLCD S ++ + GT Y APE +
Sbjct: 124 RKIIHRDIKPSNILLTRK--------GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERI 175
Query: 200 SG-NYPITHKCDVYSFGMVSFEIVGRR 225
G Y IT DV+S G+ E+ R
Sbjct: 176 QGKPYSIT--SDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-23
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 9/196 (4%)
Query: 32 LGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG+V++G V +A+K L + + F++E +G+ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G ++ EYMENG+LD YL +L + G A G+ YL + +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
H D+ N+L+++N KV+DFGL++ L D T SG K ++APE ++ T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFT 188
Query: 207 HKCDVYSFGMVSFEIV 222
DV+SFG+V +E++
Sbjct: 189 SASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + K+AVK L G ++ E F+ E + + H LV+L+
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 91 HDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ + +V EYM GSL +L G+ RAL+ L ++A A G+ Y+ + IH
Sbjct: 71 SEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
D++ N+L+ K+ADFGLA+L + N + G K ++APE L G + I K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183
Query: 209 CDVYSFGMVSFEIVGRRR 226
DV+SFG++ E+V + R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 63/194 (32%), Positives = 106/194 (54%), Gaps = 10/194 (5%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + N K+AVK L G ++ + F+ E + H LVRL+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ ++ EYM GSL +L + + KL + + A+G+ Y+ ++ IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPITHK 208
D++ NVL+ + K+ADFGLA++ + N + G K ++APE ++ G++ I K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTI--K 184
Query: 209 CDVYSFGMVSFEIV 222
DV+SFG++ +EIV
Sbjct: 185 SDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 74/267 (27%), Positives = 127/267 (47%), Gaps = 24/267 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91
LG G FG V+ G++ +K+A+K +N+ G ++EE F+ E + + H LV+L+G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 92 DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
Q +V E+MENG L YL ++ L + L + +G+ YL + IH D+
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126
Query: 152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCD 210
N L+ + KV+DFG+ + + + + SG K +S PE F Y + K D
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY--SSKSD 183
Query: 211 VYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAK 270
V+SFG++ +E+ +E K +E+ E+ MI + K +
Sbjct: 184 VWSFGVLMWEVF----------TEG-----KMPFEKKSNYEVVEMISRGFRLYRPKLASM 228
Query: 271 QLCMVALWCVQDSPADRPPMSAVVKML 297
+ V C + P RP + +++ +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 32 LGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V+ G+ + +AVK L + A + F E + H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFG-------------KKRALEWEKLHEIAIGTA 132
+G C + +V+EYME+G L+ +L L +L +IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKG 189
G+VYL Q +H D+ N L+ + K+ DFG+++ D R + G+
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----VGGHTM 185
Query: 190 TP-GYSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
P + PE + + T + DV+SFG+V +EI + K W
Sbjct: 186 LPIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFT---------------YGKQPWYGL 228
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
E+ I + ++ + ++ + L C + P R + + + L+
Sbjct: 229 SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-22
Identities = 76/272 (27%), Positives = 131/272 (48%), Gaps = 30/272 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ + K+AVK + G ++ E F+AE + H LV+LH
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 91 HDQHMTALVYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
+ + ++ E+M GSL +L G K+ L KL + + A+G+ ++ Q+ I
Sbjct: 71 TKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYI 124
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PIT 206
H D++ N+L+ A+ K+ADFGLA++ + N + G K ++APE + N+ T
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFT 181
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
K DV+SFG++ EIV R G S E E G + + +
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNP---------EVIRALERGYRM------PRPE 226
Query: 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
++L + + C ++ P +RP + +L+
Sbjct: 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-21
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 25/201 (12%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLN-KNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
+G G FG+VY + +G +K ++ N+ + E + EV + + H N+++ +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIG-----TAKGLVYLHEECQ 143
F + +V EY + G L + KK+ E + E I L YLH
Sbjct: 68 FEEKGKL-CIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHS--- 121
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNRSHVTISGYKGTPGYSAPEFL 199
++I+H DIKP+N+ L +N K+ DFG++K+ D ++ V GTP Y +PE
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV------GTPYYLSPELC 175
Query: 200 SGNYPITHKCDVYSFGMVSFE 220
N P +K D++S G V +E
Sbjct: 176 Q-NKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 31/276 (11%)
Query: 31 RLGFGGFGQVYKGQF--PNG--VKIAVKVL-NKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
+LG G FG V +G++ G + +AVK L + L I ++ F+ E + H NL+R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIR 60
Query: 86 LHGFCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
L+G + +V E GSL D L + A+ A G+ YL +
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
R IH D+ N+LL ++ K+ DFGL + +N H + + P + APE L
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR-TR 175
Query: 204 PITHKCDVYSFGMVSFEIVGRRRNAIVG--ASESLDWFPKYVWEEYEKSELGAMILACGI 261
+H DV+ FG+ +E+ G S+ L K + +E E+
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL----KKIDKEGERL----------- 220
Query: 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
E+ + + + V L C +PADRP +A+ + L
Sbjct: 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 11/192 (5%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91
LG G FG V G++ +A+K++ + G ++E++F+ E + + H LV+L+G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 92 DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
Q +V EYM NG L YL + + +L E+ +G+ YL E +Q IH D+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL--ESKQ-FIHRDL 126
Query: 152 KPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
N L+D KV+DFGL++ L D S V G K +S PE L + K
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLL-YSKFSSKS 182
Query: 210 DVYSFGMVSFEI 221
DV++FG++ +E+
Sbjct: 183 DVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVLN------KNLGKIAEEQFMAEVGTIGRTYHINLV 84
+G G FG+VY G +AVK + K + +IA+E + + H NLV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE-----MKVLELLKHPNLV 62
Query: 85 RLHGF-CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ +G H + + + EY G+L+ L R L+ + + +GL YLH
Sbjct: 63 KYYGVEVHREKVY-IFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS--- 117
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTISGYKGTPGYSAPEFLSG 201
I+H DIKP N+ LD N K+ DFG A N + GTP Y APE ++G
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 202 NYPITH--KCDVYSFGMVSFEIV-GRR 225
H D++S G V E+ G+R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR------TYHINLV 84
+G G F V + + A+K+L+K + +E+ + V I + H ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQ--LIKEKKVKYV-KIEKEVLTRLNGHPGII 65
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEK-----LHEIAIGTAKGLVYLH 139
+L+ D+ V EY NG L Y+ +K EK EI + L YLH
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA----LEYLH 119
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG------------- 186
+ IIH D+KPEN+LLD + K+ DFG AK+ D N S + G
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 187 -----YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+ GT Y +PE L+ P D+++ G + ++++
Sbjct: 177 RRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-21
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 32 LGFGGFGQVYKGQF-PNGVK---IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG+V +G+ G + +A+K L + F++E +G+ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G ++ E+MENG+LD +L +L + G A G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYV 128
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
H D+ N+L+++N KV+DFGL++ + + S T + G K ++APE ++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-K 187
Query: 205 ITHKCDVYSFGMVSFEIV 222
T DV+S+G+V +E++
Sbjct: 188 FTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 6e-21
Identities = 65/196 (33%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 32 LGFGGFGQVYKGQF-PNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG VYKG + P G + +A+K+LN+ G A +FM E + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + LV + M +G L Y+ K + + L + AKG++YL E +R+
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+ NVL+ + K+ DFGLA+L + + G K + A E + T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFT 189
Query: 207 HKCDVYSFGMVSFEIV 222
H+ DV+S+G+ +E++
Sbjct: 190 HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 9e-21
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G +G VYK G +A+KV+ + + K E + + +V+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK--EISILKQ------CDSPYIVK 62
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+G +V EY GS+ + + L E++ I T KGL YLH +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
IH DIK N+LL+ K+ADFG++ +L D T+ GTP + APE +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPEVIQEI-G 175
Query: 205 ITHKCDVYSFGMVSFEI 221
+K D++S G+ + E+
Sbjct: 176 YNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLN-KNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G +G VYK + + A+K ++ ++ + E + E+ + H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 90 CHDQHMTALVYEYMENGSLDGYL---FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
D + +V EY G L + K++ + +++ I I +GL LHE Q+I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKI 124
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+K N+LL AN K+ D G++K+ +N + I GTP Y APE G P +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR-PYS 179
Query: 207 HKCDVYSFGMVSFEI 221
+K D++S G + +E+
Sbjct: 180 YKSDIWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-20
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + ++A+K L G ++ E F+ E + + H LV+L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 91 HDQHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ + +V EYM GSL +L G+ + L +L ++A A G+ Y+ + +H
Sbjct: 71 SEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
D++ N+L+ N KVADFGLA+L + N + G K ++APE L G + I K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183
Query: 209 CDVYSFGMVSFEIVGRRR 226
DV+SFG++ E+ + R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-20
Identities = 65/198 (32%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + K+A+K L G + E F+ E + + H LV L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 91 HDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ + +V E+M GSL +L G + L+ +L ++A A G+ Y+ + IH
Sbjct: 71 SEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHK 208
D++ N+L+ N K+ADFGLA+L + N + G K ++APE L G + I K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI--K 183
Query: 209 CDVYSFGMVSFEIVGRRR 226
DV+SFG++ E+V + R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 30 TRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G G+VYK G ++A+K + L K +E + E+ + H N+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+V EYM+ GSL + + ++ + +GL YLH Q +IH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITH 207
DIK +N+LL + S K+ADFG A + +S ++ GTP + APE +
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVIKRK-DYGP 195
Query: 208 KCDVYSFGMVSFEIV 222
K D++S G++ E+
Sbjct: 196 KVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQ---FMAEVGTIGRTYHINLVRLH 87
LG G FG+VYK Q G+ A K++ +EE+ FM E+ + H N+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 88 -GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ ++ + L+ E+ + G+LD + +R L ++ + + L +LH ++
Sbjct: 69 EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKV 124
Query: 147 IHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFL----SG 201
IH D+K N+LL + K+ADFG+ AK + T + GTP + APE +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFK 181
Query: 202 NYPITHKCDVYSFGMVSFEIVGRR 225
+ P +K D++S G+ E+
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-20
Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 32 LGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG+V G+ + +A+K L + F++E +G+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G +V EYMENGSLD +L +L + G A G+ YL + +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYV 128
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
H D+ N+L+++N KV+DFGL++ L D + T G K ++APE ++ T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFT 187
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
DV+S+G+V +E+ + + + WE + + A IEE +
Sbjct: 188 SASDVWSYGIVMWEV--------------MSYGERPYWEMSNQDVIKA------IEEGYR 227
Query: 267 EKAKQLCMVALW-----CVQDSPADRPPMSAVVKMLEGVV 301
A C AL C Q +RP +V +L+ ++
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-20
Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 9/191 (4%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91
LG G FG+V+KG + +AVK ++L + + +F++E + + H N+V+L G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 92 DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI 151
+ +V E + G +L KK L+ ++L + A+ A G+ YL + IH D+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDL 119
Query: 152 KPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITHKC 209
N L+ N K++DFG+++ + + SG K P ++APE L+ G Y + +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRY--SSES 175
Query: 210 DVYSFGMVSFE 220
DV+S+G++ +E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 12/196 (6%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVK----VLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG VY+G +G AVK + G+ A +Q E+ + + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G ++ + E + GSL L K + + GL YLH+ +
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNT 123
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H DIK N+L+D N K+ADFG+AK +KG+P + APE ++
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 207 HKCDVYSFGMVSFEIV 222
D++S G E+
Sbjct: 181 LAADIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 38/282 (13%)
Query: 32 LGFGGFGQVYKGQFPNGVK--IAVK---VLNKNLGKIAEEQ------FMAEVGTIGRT-Y 79
LG G FG VYK + N + +A+K V N GK E+ ++EV I
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFG----KKRALEWEKLHEIAIGTAKGL 135
H N+VR + + +V + +E L G F KK+ E++ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
YLH+E +RI+H D+ P N++L + + DFGLAK ++ GT YS
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSC 181
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255
PE + N P K DV++FG + +++ ++ L K V YE
Sbjct: 182 PEIVK-NEPYGEKADVWAFGCILYQMC--TLQPPFYSTNMLSLATKIVEAVYEPL----- 233
Query: 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
+ ++ + V C+ RP + V M+
Sbjct: 234 --------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-19
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHG 88
+LG G FG VY + G +A+K + K E + EV ++ + H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ V+EYME K + + I +GL ++H + H
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFH 122
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL--SGNY--P 204
D+KPEN+L+ K+ADFGLA+ R+R T Y T Y APE L S +Y P
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYT--DYVSTRWYRAPEILLRSTSYSSP 179
Query: 205 ITHKCDVYSFGMVSFEIV 222
+ D+++ G + E+
Sbjct: 180 V----DIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 75/277 (27%), Positives = 118/277 (42%), Gaps = 35/277 (12%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G VY PN K+A+K ++ + + ++ EV + + H N+V+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTA-----KGLVYLHEECQQR 145
LV Y+ GSL + K + L E I T KGL YLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNRSHVTISGYKGTPGYSAPEFLSGNY 203
IH DIK N+LL + S K+ADFG+ A L D +R+ + GTP + APE + +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 204 PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP-----KYVWEEYEKSELGAMILA 258
K D++SFG+ + E+ GA+ + P + + E GA
Sbjct: 183 GYDFKADIWSFGITAIEL-------ATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235
Query: 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+ M++L C+Q P+ RP ++K
Sbjct: 236 YSKSFRK--------MISL-CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAV-KVLNKNLGKIAE---EQFMAEVGTIGRTYHINLVRL 86
+G G FG V K + + KI V K ++ G + E +Q ++EV + H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 87 HGFCHD--QHMTALVYEYMENGSLDGYLFGKKRA----LEWEKLHEIAIGTAKGLVYLH- 139
+ D +V EY E G L L K + +E E + I L H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 140 -EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
+ ++H D+KP N+ LDAN + K+ DFGLAK+ + S Y GTP Y +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQ 181
Query: 199 LSGNYPITHKCDVYSFGMVSFEI 221
L+ K D++S G + +E+
Sbjct: 182 LNHM-SYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 31 RLGFGGFGQVYKG--QFPNG--VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG V KG +G V++AVK L + +++F+ E + + H +VRL
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + + LV E G L YL K+R + L E+A A G+ YL +
Sbjct: 62 IGVCKGEPLM-LVMELAPLGPLLKYLK-KRREIPVSDLKELAHQVAMGMAYLES---KHF 116
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS 200
+H D+ NVLL K++DFG+++ + Y+ T + APE
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-----YRATTAGRWPLKWYAPE--C 169
Query: 201 GNYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259
NY + K DV+S+G+ +E GA Y E + +E+ AM+ +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSY------GA-------KPY--GEMKGAEVIAMLESG 214
Query: 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
+ +E +++ + L C + P DRP S +
Sbjct: 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVK-VLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G +G VYK + G +A+K + + + + + E+ + H N+++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ LV+E+M+ L + ++R L + +GL + H I+H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+KPEN+L++ K+ADFGLA+ + Y T Y APE L G+ +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFG--SPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 209 CDVYSFGMVSFEIVGRR 225
D++S G + E++ RR
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-19
Identities = 60/193 (31%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G +G+VY+G + + +AVK L ++ + E+F+ E + H NLV+L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + ++ E+M G+L YL R + L +A + + YL ++ IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+ N L+ N KVADFGL++L ++ +G K ++APE L+ N + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIK 185
Query: 209 CDVYSFGMVSFEI 221
DV++FG++ +EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 25/271 (9%)
Query: 35 GGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93
G G YKG+ NG++ VK +N + I +E+ +G+ H N+V+L G C +
Sbjct: 701 GKKGASYKGKSIKNGMQFVVKEIND-VNSIPS----SEIADMGKLQHPNIVKLIGLCRSE 755
Query: 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
L++EY+E +L L R L WE+ +IAIG AK L +LH C ++ ++ P
Sbjct: 756 KGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811
Query: 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
E +++D P + LC + + + Y APE IT K D+Y
Sbjct: 812 EKIIIDGKDEPHLRLSLPGLLCTDTKCFI-------SSAYVAPE-TRETKDITEKSDIYG 863
Query: 214 FGMVSFEIVGRR--RNAIVGASESLDWFPKYVWEE-YEKSELGAMILA-CGIEEKDKEKA 269
FG++ E++ + +A G S+ + +Y + + + + I + + + +
Sbjct: 864 FGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV 923
Query: 270 KQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
L AL C P RP + V+K LE
Sbjct: 924 MNL---ALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 32 LGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+VY+G + +++AVK L ++ + E F+ E + + H N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYL------FGKKRALEWEKLHEIAIGTAKGLVYLH 139
L G ++ ++ E M G L +L + +L + L A AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTISGYKGTP-GYS 194
E IH DI N LL P K+ADFG+A+ R S+ G P +
Sbjct: 134 E---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRA-SYYRKGGRAMLPIKWM 188
Query: 195 APE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253
PE FL G + T K DV+SFG++ +EI SL + P + E+
Sbjct: 189 PPEAFLDGIF--TSKTDVWSFGVLLWEIF------------SLGYMP---YPGRTNQEVM 231
Query: 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ G + K + + C Q +P DRP + +++ ++
Sbjct: 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL-HGF 89
LG G FG+VYK Q GV A KV++ + E +M E+ + H N+V+L F
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ ++ L+ E+ G++D + +R L ++ + T + L YLHE +IIH
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNYPI 205
D+K N+L + K+ADFG++ R+ + GTP + APE + S + P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 206 THKCDVYSFGMVSFEI 221
+K DV+S G+ E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G + VYKG+ G +A+K ++ + + + E+ + H N+VRLH
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 90 CHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
H ++ LV+EYM+ L Y+ G + AL+ + KG+ + HE R++
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVL 122
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H D+KP+N+L++ K+ADFGLA+ + T S T Y AP+ L G+ +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 208 KCDVYSFGMVSFEIV 222
D++S G + E++
Sbjct: 181 SIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
R+G G +G VYK + G +A+KV+ G E E+ + H N+V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ +V EY GSL + L ++ + T KGL YLH + IH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK---GTPGYSAPEFLS----GN 202
DIK N+LL + K+ADFG++ TI+ K GTP + APE + G
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 203 YPITHKCDVYSFGMVSFE 220
Y KCD+++ G+ + E
Sbjct: 181 Y--DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 28 YSTRLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN 82
+ +LG G FG V ++ G +AVK L + F E+ + H N
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDN 66
Query: 83 LVRLHGFCHD--QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
+V+ G C+ + LV EY+ GSL YL + L+ KL A KG+ YL
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS-----A 195
+R +H D+ N+L+++ K+ DFGL K+ +++ + + PG S A
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR----EPGESPIFWYA 179
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEI 221
PE L+ + + DV+SFG+V +E+
Sbjct: 180 PESLTES-KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-18
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 32 LGFGGFGQVYKGQFPN-------GVKIAVKVLNKNLGKIAEEQ--FMAEVGTIGRTYHIN 82
LG G FG+VY+G + +++AVK L K G +E+ F+ E + H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPN 60
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA------LEWEKLHEIAIGTAKGLV 136
+V+L G C ++ E ME G L YL + L ++L +I + AKG V
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 137 YLHEECQQRIIHYDIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
YL Q IH D+ N L+ DA+ K+ DFGLA+ ++ + G P
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-DYYRKEGEGLLP 176
Query: 192 -GYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
+ APE L G + T + DV+SFG++ +EI+
Sbjct: 177 VRWMAPESLLDGKF--TTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 71/291 (24%), Positives = 117/291 (40%), Gaps = 52/291 (17%)
Query: 32 LGFGGFGQVYKG---QFPNGV---KIAVKVLNKNLGKIAEEQFMAEVGTIGR--TYHINL 83
LG G FG VY+G G ++A+K +N+N +F+ E + +H+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-- 71
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEW---------EKLHEIAIGTAKG 134
VRL G T +V E M G L YL ++ E +K ++A A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY--KGTPG 192
+ YL ++ +H D+ N ++ + + K+ DFG+ + + + Y KG G
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD-------IYETDYYRKGGKG 181
Query: 193 -----YSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
+ APE L T K DV+SFG+V +E+ G S
Sbjct: 182 LLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN------------- 227
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
E+ ++ G + + +L + C Q +P RP +V L+
Sbjct: 228 --EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 5e-18
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF----MAEVGTIGRTYHINLVR 85
+LG G +G VYK + G +A+K + EE + E+ + H N+V+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
L H + LV+EY + L YL + L + I +GL Y H R
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHR 118
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFLSG- 201
I+H D+KP+N+L++ + K+ADFGLA+ R +H + T Y APE L G
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-----TLWYRAPEILLGS 173
Query: 202 ---NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234
+ + D++S G + E++ + G SE
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMI-TGKPLFPGDSE 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 8e-18
Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 30 TRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVR 85
+G G FG VY + +A+K ++ + GK + E++ + EV + + H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 86 LHGFCHDQHMTA-LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
G C+ + TA LV EY GS L K+ L+ ++ I G +GL YLH +
Sbjct: 80 YKG-CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----S 200
IH DIK N+LL + K+ADFG A L S V GTP + APE +
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRR 225
G Y K DV+S G+ E+ R+
Sbjct: 189 GQY--DGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 33 GFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQ----FMAEVGTIGRTYHINLVRLH 87
G G FG+V Q A+K +NK K E+ + E + H LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNK--QKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 88 -GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
F +++M LV + + G L Y +K E++ L YLH + I
Sbjct: 67 YSFQDEENMY-LVVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGI 121
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
IH DIKP+N+LLD + DF +A + + S GTPGY APE L +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQG-YS 177
Query: 207 HKCDVYSFGMVSFE-IVGRR 225
D +S G+ ++E + G+R
Sbjct: 178 VAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 9e-18
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 32 LGFGGFGQVYKGQF-PN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+V + P G +AVK L + G+ + E+ + YH N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 87 HGFCHDQ--HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
G C +Q L+ EY+ GSL YL K L +L A +G+ YLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPEFLSGNY 203
IH D+ NVLLD + K+ DFGLAK + + +P + A E L
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK-EN 185
Query: 204 PITHKCDVYSFGMVSFEIVGR 224
++ DV+SFG+ +E++
Sbjct: 186 KFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 45/210 (21%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLN-----KNLGKIAEE-QFMAEVGTIGRTYHINL 83
+G G FG+VYK +A+KV++ + I +E QF+++ R+ +I
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC----RSPYI-- 61
Query: 84 VRLHG-FCHDQHMTALVYEYMENGS-LDGYLFGKKRALEWEKLHEIAIGTA-----KGLV 136
+ +G F + ++ EY GS LD L+ KL E I GL
Sbjct: 62 TKYYGSFLKGSKL-WIIMEYCGGGSCLD--------LLKPGKLDETYIAFILREVLLGLE 112
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPG 192
YLHE + IH DIK N+LL K+ADFG L + + V GTP
Sbjct: 113 YLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPF 163
Query: 193 YSAPEFLS-GNYPITHKCDVYSFGMVSFEI 221
+ APE + Y K D++S G+ + E+
Sbjct: 164 WMAPEVIKQSGY--DEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 70/267 (26%), Positives = 120/267 (44%), Gaps = 32/267 (11%)
Query: 28 YSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
Y LG G G VYK +I AVKV+ ++ ++Q M+E+ + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+G ++ ++ E+M+ GSLD Y R + L IA+ KGL YL +I
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYL---WSLKI 116
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+KP N+L++ K+ DFG++ + Y GT Y APE +SG
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK-- 264
H DV+S G+ E+ +L FP ++ + S + +L C ++E
Sbjct: 173 HS-DVWSLGISFMEL-------------ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP 218
Query: 265 ---DKEKAKQLCMVALWCVQDSPADRP 288
+ +++ C++ P +RP
Sbjct: 219 VLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 32/270 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V +G++ G K+AVK + + + + F+ E + + +H NLVRL G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRAL-EWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ +V E M G+L +L + RAL +L + ++ A+G+ YL ++++H
Sbjct: 69 LHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D+ N+L+ + KV+DFGLA++ V S K ++APE L + K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNS--KLPVKWTAPEALKHK-KFSSKS 178
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY-EKSELGAMILACGIEEKDKEK 268
DV+S+G++ +E+ R +PK +E E E G + E +
Sbjct: 179 DVWSYGVLLWEVFSYGRAP----------YPKMSLKEVKECVEKGYRM------EPPEGC 222
Query: 269 AKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ ++ C + P RP + + LE
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
R+G G G VYK P G A+KV+ N Q E+ + H N+V+ H
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ E+M+ GSL+G ++ L ++A G+ YLH ++ I+H
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLH---RRHIVHR 192
Query: 150 DIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLS----- 200
DIKP N+L+++ + K+ADFG LA+ D S V GT Y +PE ++
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV------GTIAYMSPERINTDLNH 246
Query: 201 GNYPITHKCDVYSFGMVSFEI-VGR 224
G Y + D++S G+ E +GR
Sbjct: 247 GAYD-GYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 48/284 (16%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G F Y+ + G +AVK + + + E E+ + R H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 86 LHG-FCHDQHMTALVYEYMENGSLDGYL--FGK-KRALEWEKLHEIAIGTAKGLVYLHEE 141
+ G C D H V E+M GS+ L +G K A+ ++ +GL YLHE
Sbjct: 68 MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE- 121
Query: 142 CQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVTISG-----YKGTPGYSA 195
+IIH D+K N+L+D+ ++ADFG A R + T +G GT + A
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255
PE L G CDV+S G V E+ K W + S A+
Sbjct: 177 PEVLRGE-QYGRSCDVWSVGCVIIEMAT----------------AKPPWNAEKHSNHLAL 219
Query: 256 I--LACGIEEKD--KEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
I +A + + L V L C++ P DRPP ++K
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-17
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 32 LGFGGFGQVYKGQF-PNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG V+KG + P G + +A+K + G+ ++ + +G H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + LV + GSL ++ + +L+ ++L + AKG+ YL E R+
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRM 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
+H ++ N+LL ++ ++ADFG+A L + S +K + A E L G Y
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY-- 188
Query: 206 THKCDVYSFGMVSFEIV 222
TH+ DV+S+G+ +E++
Sbjct: 189 THQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 32 LGFGGFGQVYKGQF--PNGVKI--AVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG VY+G + P KI AVK E+F+ E + + H ++V+L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G + + +V E G L YL K +L+ L + + L YL +R +
Sbjct: 74 GVITENPVW-IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLSGN 202
H DI NVL+ + K+ DFGL++ + S YK + G + APE S N
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDE------SYYKASKGKLPIKWMAPE--SIN 181
Query: 203 Y-PITHKCDVYSFGMVSFEI 221
+ T DV+ FG+ +EI
Sbjct: 182 FRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 31 RLGFGGFGQVYKGQF------PNGVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRTY 79
LG G FGQV K + +AVK+L K+L + E M + IG+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE--MEMMKMIGK-- 74
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEK---------------L 124
H N++ L G C + +V EY +G+L +L ++ E+ L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSH 181
A A+G+ +L ++ IH D+ NVL+ + K+ADFGLA+ D R
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR-- 189
Query: 182 VTISGYKGTPG-----YSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
K T G + APE L TH+ DV+SFG++ +EI
Sbjct: 190 ------KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HINLVRLHG 88
+G G +G+VYK + G +A+K+++ + EE+ E + R Y H N+ +G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNIL-RKYSNHPNIATFYG 70
Query: 89 F--------CHDQHMTALVYEYMENGS---LDGYLFGKKRALEWEKLHEIAIGTAKGLVY 137
DQ LV E GS L L K + L+ E + I T +GL Y
Sbjct: 71 AFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTISGYKGTPGYSA 195
LHE ++IH DIK +N+LL N K+ DFG++ D R + I GTP + A
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----GTPYWMA 181
Query: 196 PEFLSGN----YPITHKCDVYSFGMVSFE 220
PE ++ + + DV+S G+ + E
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 35 GGFGQVY---KGQFPNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRL-HG 88
G +G+V+ K G A+KV+ K + K +Q + E + + +V+L +
Sbjct: 4 GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61
Query: 89 FCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
F +++ LV EY+ G L L G +L+ + L YLH I
Sbjct: 62 FQGKKNLY-LVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKL------CDRNRSHVTISGYKGTPGYSAPEFLS 200
IH D+KP+N+L+D+N K+ DFGL+K+ + N GTP Y APE +
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 201 GNYPITHKCDVYSFGMVSFE-IVG 223
G + D +S G + +E +VG
Sbjct: 175 GQ-GHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 9/207 (4%)
Query: 20 QLNNFTSNYSTRLGFGGFGQVYKG--QFPNG--VKIAVKVLNKNLGKIAEEQFMAEVGTI 75
+L+N + LG G FG++ +G + P+ + +A+ L F+AE T+
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGL 135
G+ H N+VRL G + +V EYM NG+LD +L + L +L + G A G+
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
YL E +H + VL++++ K++ F + D++ + T K ++A
Sbjct: 121 KYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAA 176
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIV 222
PE + ++ + DV+SFG+V +E++
Sbjct: 177 PEAIQYHH-FSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 32 LGFGGFGQVYKGQF--PNGVKIAVKVLNKNLGKIAE----EQFMAEVGTIGRTYHINLVR 85
LG G FG+VYKG+ PN A V K L + AE ++F E + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLF---------------GKKRALEWEKLHEIAIG 130
L G C + T +++EY+ +G L +L K +L+ IAI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
A G+ YL +H D+ N L+ + K++DFGL++ + + Y
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD-------IYSADYYRV 182
Query: 191 PGYS-------APE-FLSGNYPITHKCDVYSFGMVSFEI 221
S PE L G + T + D++SFG+V +EI
Sbjct: 183 QSKSLLPVRWMPPEAILYGKF--TTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 51/241 (21%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
LG GGFG+V + A+K + K + +E +E + H +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAI---GTAK--------GLVY 137
D+ ++ EY G L W L + + TA+ Y
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL------------WTILRDRGLFDEYTARFYIACVVLAFEY 108
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAP 196
LH + II+ D+KPEN+LLD+N K+ DFG AK L ++ GTP Y AP
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC----GTPEYVAP 161
Query: 197 EFLSGN-YPITHKCDVYSFGMVSFEI-VGR------------RRNAIVGASESLDWFPKY 242
E + Y D +S G++ +E+ GR N I+ + L+ FP Y
Sbjct: 162 EIILNKGY--DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE-FPNY 218
Query: 243 V 243
+
Sbjct: 219 I 219
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 11/194 (5%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLN-KNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G FG V+K + + A+K ++ + + E+ + E + + ++R +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
D+ +V EY ENG L L + R L +++ I GL +LH ++I+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKIL 123
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
H DIK N+ LDA + K+ D G+AK L D TI GTP Y +PE L + P
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPE-LCEDKPYN 179
Query: 207 HKCDVYSFGMVSFE 220
K DV++ G+V +E
Sbjct: 180 EKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 65/203 (32%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVK--VLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRL 86
LG G +G VY G G IAVK L+ + AE+++ EV + H+N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
G C D + ++ E++ GS+ L FG L + G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC-- 122
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS----GYKGTPGYSAPEFL- 199
++H DIK NV+L N K+ DFG A+ H T S GTP + APE +
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 200 -SGNYPITHKCDVYSFGMVSFEI 221
SG K D++S G FE+
Sbjct: 182 ESGY---GRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 32 LGFGGFGQVYKGQF----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRL 86
+G G FG VY G + AVK LN+ EQF+ E G I + + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE-GIIMKDFSHPNVLSL 61
Query: 87 HGFCHDQHMTALV-YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
G C + LV YM++G L ++ + + L + AKG+ YL ++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHV-TISGYKGTPGYSAPEFLSGNY 203
+H D+ N +LD +F+ KVADFGLA+ + D+ V +G K + A E L
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ-TQ 177
Query: 204 PITHKCDVYSFGMVSFEIVGR 224
T K DV+SFG++ +E++ R
Sbjct: 178 KFTTKSDVWSFGVLLWELMTR 198
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 32 LGFGGFGQVYKGQF-PNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG VYKG + P+G + +A+KVL +N A ++ + E + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C LV + M G L Y+ K + + L + AKG+ YL E R+
Sbjct: 75 LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+ NVL+ + K+ DFGLA+L D + + G K + A E + + T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL-HRRFT 189
Query: 207 HKCDVYSFGMVSFEIV 222
H+ DV+S+G+ +E++
Sbjct: 190 HQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 4e-16
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 35/201 (17%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQF-MAEVGTIGRT----------- 78
LG G + VYK + G +A+K KI + A+ G I T
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIK-------KIKLGERKEAKDG-INFTALREIKLLQEL 59
Query: 79 YHINLVRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVY 137
H N++ L F H ++ LV+E+ME L+ + K L + + T +GL Y
Sbjct: 60 KHPNIIGLLDVFGHKSNIN-LVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYS 194
LH I+H D+KP N+L+ ++ K+ADFGLA+ +R +H + T Y
Sbjct: 118 LHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRWYR 169
Query: 195 APEFLSGNYPITHKCDVYSFG 215
APE L G D++S G
Sbjct: 170 APELLFGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 71/299 (23%), Positives = 126/299 (42%), Gaps = 50/299 (16%)
Query: 30 TRLGFGGFGQVYKGQ------FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL 83
LG G FG+V K +AVK+L +N ++E + + H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------------------RALE 120
++L+G C L+ EY + GSL +L + RAL
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
L A ++G+ YL E +++H D+ NVL+ K++DFGL++ S
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240
+V S + + A E L ++ T + DV+SFG++ +EIV +G + P
Sbjct: 183 YVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV------TLGGNPYPGIAP 235
Query: 241 KYVWEEYEKSELGAMILACGIE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ ++ +L G E+ + ++++ + L C + P RP + + K LE
Sbjct: 236 ERLFN----------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHG 88
++G G F +V K Q G A+K + K+ + + + E+ + R + H N++RL
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 89 FCHDQHM--TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
D+ ALV+E M+ +L + G+KR L +++ K L ++H + I
Sbjct: 66 VLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGI 121
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL--SGNYP 204
H DIKPEN+L+ + K+ADFG + S + Y T Y APE L G Y
Sbjct: 122 FHRDIKPENILIKDDIL-KLADFGSCRGIY---SKPPYTEYISTRWYRAPECLLTDGYY- 176
Query: 205 ITHKCDVYSFGMVSFEIV 222
K D+++ G V FEI+
Sbjct: 177 -GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 6e-16
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIA----EEQFMAEVGTIGRTYHINLVRL 86
LG G FG+V + +G A+K+L+K KI E + E + H LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKR-ALEWEKLH--EIAIGTAKGLVYLHEECQ 143
+G D LV EY+ G L +L R + + ++ + L YLH
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLHSL-- 120
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
I++ D+KPEN+LLD++ K+ DFG AK R++ T+ GTP Y APE + +
Sbjct: 121 -DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTY-TLC---GTPEYLAPEIIL-SK 173
Query: 204 PITHKCDVYSFGMVSFEIV 222
D ++ G++ +E++
Sbjct: 174 GYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
R+G G FG+V+ G+ + +AVK + L + +F+ E + + H N+VRL G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
C + +V E ++ G +L + L+ ++L ++ A G+ YL + IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS-GNYPITH 207
D+ N L+ K++DFG+++ + + + + G K P ++APE L+ G Y +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY--SS 175
Query: 208 KCDVYSFGMVSFE 220
+ DV+SFG++ +E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+ LG G G V K Q P+G+ +A K+++ + Q + E+ + +V +G
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ ++ E+M+ GSLD L KR E E L +++I +GL YL E+ Q I+H
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSIAVLRGLAYLREKHQ--IMH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
D+KP N+L+++ K+ DFG++ +L D + + GT Y +PE L G + +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 181
Query: 208 KCDVYSFGMVSFEI-VGR 224
+ D++S G+ E+ +GR
Sbjct: 182 QSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 15/192 (7%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG-FC 90
+G G FG V G + G K+AVK + + + F+AE + + H NLV+L G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ +V EYM GSL YL + R+ L + L + ++ + + YL +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D+ NVL+ + KV+DFGL K + T K ++APE L + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR-EKKFSTKS 180
Query: 210 DVYSFGMVSFEI 221
DV+SFG++ +EI
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRTYHINLV 84
+G G +G V K + G +A+K ++++ K A + EV + + H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA----LREVKVLRQLRHENIV 63
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
L + LV+EY+E L+ L L + + + + Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
IIH DIKPEN+L+ + K+ DFG A+ L R S +T Y T Y APE L G+
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVATRWYRAPELLVGDT 177
Query: 204 PITHKCDVYSFGMVSFEI 221
DV++ G + E+
Sbjct: 178 NYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 32 LGFGGFGQVYKGQF-PNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG VYKG + P G + +A+K L + A ++ + E + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C L+ + M G L Y+ K + + L + AKG+ YL E +R+
Sbjct: 75 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRL 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPI 205
+H D+ NVL+ K+ DFGLAKL + G K + A E L Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY-- 188
Query: 206 THKCDVYSFGMVSFEIV 222
TH+ DV+S+G+ +E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 32 LGFGGFGQV----YKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+V Y + N G ++AVK L G E+ + YH N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 87 HGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
G C + L+ E++ +GSL YL K + ++ + A+ KG+ YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY-SAPE-FLSGN 202
+ +H D+ NVL+++ K+ DFGL K + ++ + T+ +P + APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 203 YPITHKCDVYSFGMVSFEIV 222
+ I DV+SFG+ +E++
Sbjct: 189 FYIA--SDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 59/194 (30%), Positives = 86/194 (44%), Gaps = 17/194 (8%)
Query: 31 RLGFGGFGQVYK-GQFPNGVKIAVK-VLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
R+G G G V+K G +A+K V + L Q + E+ + H +V+L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 89 -FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
F H LV EYM L L ++R L ++ KG+ Y+H I+
Sbjct: 67 VFPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCD----RNRSHVTISGYKGTPGYSAPEFLSGNY 203
H D+KP N+L+ A+ K+ADFGLA+L R SH T Y APE L G
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-----ATRWYRAPELLYGAR 176
Query: 204 PITHKCDVYSFGMV 217
D+++ G +
Sbjct: 177 KYDPGVDLWAVGCI 190
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLN-KNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
LG G FG+VYK + G A KV+ K+ ++ E +M E+ + H +V+L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEILATCNHPYIVKLLGA 77
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
F D + ++ E+ G++D + R L ++ I + L YLH +IIH
Sbjct: 78 FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIH 133
Query: 149 YDIKPENVLLDANFSPKVADFGLA----KLCDRNRSHVTISGYKGTPGYSAPEFL----S 200
D+K NVLL + K+ADFG++ K R S + GTP + APE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCETM 187
Query: 201 GNYPITHKCDVYSFGMVSFEI 221
+ P +K D++S G+ E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 43/291 (14%)
Query: 32 LGFGGFGQVYKGQFP-NGVKI--AVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLH 87
+G G FGQV + +G+K+ A+K+L + + F E+ + + +H N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 88 GFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRALEWEKLHEIAIGTA 132
G C ++ + EY G+L +L G L ++L + A A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
G+ YL E ++ IH D+ NVL+ N + K+ADFGL++ V + G
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181
Query: 193 YSAPEFLSGNYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251
S NY + T K DV+SFG++ +EIV G + + E YEK
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---------ELYEKLP 232
Query: 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
G + EK + ++ + C +D P +RPP + + L ++E
Sbjct: 233 QGYRM------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 29 STRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQFMA-EVGT---IGRTYHINL 83
+G G +G VYK + N + A+K + L + E+ + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 84 VRLHGFCHDQHMT-----ALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVY 137
VRL CH LV+E+++ L YL K L E + ++ +G+ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
LH RI+H D+KP+N+L+ ++ K+ADFGLA++ + ++ T Y APE
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---VTLWYRAPE 176
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIVGRR 225
L + T D++S G + E+ RR
Sbjct: 177 VLLQSSYAT-PVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 160
E+M+ GSLD L R E L +I+I +GL YL E+ + I+H D+KP N+L+++
Sbjct: 79 EHMDGGSLDQVLKKAGRIPE-NILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNS 135
Query: 161 NFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSF 219
K+ DFG++ +L D + + GT Y +PE L G + T + D++S G+
Sbjct: 136 RGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLV 189
Query: 220 EI-VGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALW 278
E+ +GR Y + EL AM G + E + V+
Sbjct: 190 EMAIGR-----------------YPIPPPDAKELEAMF---GRPVSEGEAKESHRPVS-- 227
Query: 279 CVQDSPADRPPMSAVVKMLEGVVEVLPPPK 308
P D P A+ ++L+ +V PPPK
Sbjct: 228 ---GHPPDSPRPMAIFELLDYIVNE-PPPK 253
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 60/203 (29%), Positives = 83/203 (40%), Gaps = 37/203 (18%)
Query: 35 GGFGQVYKGQ-FPNGVKIAVKVL--------NKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
G FG VY + G A+KVL N+ AE M + + + +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-----MIQGESPYVAK 61
Query: 86 LHGFCHDQHMTALVYEYMENGSLD------GYLFGKKRALEWEKLHEIAIGTAKGLVYLH 139
L+ + LV EY+ G G L +W K + G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGL-----PEDWAK--QYIAEVVLGVEDLH 114
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
Q+ IIH DIKPEN+L+D K+ DFGL++ N+ V GTP Y APE +
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI 165
Query: 200 SGNYPITHKCDVYSFGMVSFEIV 222
G D +S G V FE +
Sbjct: 166 LGV-GDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 45/292 (15%)
Query: 32 LGFGGFGQVYKGQFP-NGVKI--AVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLH 87
+G G FGQV K + +G+++ A+K + + K F E+ + + +H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE----------------KLHEIAIGT 131
G C + L EY +G+L +L K R LE + +L A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A+G+ YL + ++ IH D+ N+L+ N+ K+ADFGL++ V + G
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 192 GYSAPEFLSGNYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250
S NY + T DV+S+G++ +EIV G + + E YEK
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------ELYEKL 224
Query: 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
G + EK ++ + C ++ P +RP + ++ L ++E
Sbjct: 225 PQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 41/295 (13%)
Query: 32 LGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V+ + N + +AVK L K+ A + F E + H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 86 LHGFCHDQHMTALVYEYMENGSL---------------DGYLFGKKRALEWEKLHEIAIG 130
+G C D +V+EYM++G L DG K L ++ IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
A G+VYL Q +H D+ N L+ AN K+ DFG+++ + + + G+
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTML 187
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250
P P T + DV+SFG++ +EI + K W + +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQLSNT 232
Query: 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305
E+ I + E+ + K++ + L C Q P R + + K+L + + P
Sbjct: 233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 21/197 (10%)
Query: 32 LGFGGFGQVYK-GQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG-F 89
LG G G V K P G +A KV++ +Q + E+ + +V +G F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ ++ + E+M+ GSLD ++ K + E L +IA+ +GL YL+ RI+H
Sbjct: 73 LNENNIC-MCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAPEFL-SGNYP 204
DIKP N+L+++ G KLCD S I+ + GT Y +PE + G Y
Sbjct: 129 DIKPSNILVNSR--------GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKY- 179
Query: 205 ITHKCDVYSFGMVSFEI 221
T K DV+S G+ E+
Sbjct: 180 -TVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 27 NYSTRLGFGGFGQVY------------KGQFPNGVK-----IAVKVLNKNLGKIAEEQFM 69
N+ +LG G FG+V+ K N +AVKVL + A E F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 70 AEVGTIGRTYHINLVRLHGFC-HDQHMTALVYEYMENGSLDGYL----------FGKKRA 118
EV + R N+ RL G C D + ++ EYMENG L+ +L ++
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPL-CMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
L + L +A A G+ YL +H D+ N L+ N++ K+ADFG+ RN
Sbjct: 127 LSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGM----SRN 179
Query: 179 ---RSHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVSFEI 221
+ + G P + A E L G + T K DV++FG+ +EI
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKF--TTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 17/220 (7%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEE--QFMA--EVGTIGRTYHINLVR 85
+LG G + VYKG NG +A+KV++ EE F A E + H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMK----TEEGVPFTAIREASLLKGLKHANIVL 67
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
LH H + V+EYM L Y+ L + +GL Y+H Q
Sbjct: 68 LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQH 123
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
I+H D+KP+N+L+ K+ADFGLA+ ++ T S T Y P+ L G
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDY 181
Query: 206 THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWE 245
+ D++ G + E++ + + A G S+ + K +W
Sbjct: 182 SSALDIWGAGCIFIEML-QGQPAFPGVSDVFEQLEK-IWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 47/227 (20%)
Query: 30 TRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQ---FMAEVGTIGRTYHIN--- 82
+G G FG+V+ + + ++ A+KVL K+ I Q AE R +
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD-MIKRNQIAHVRAE-----RDILADADS 60
Query: 83 --LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
+V+L+ D+ LV EYM G L L K E A+ ++ L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDS 116
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-----------------LCDRNRSHVT 183
+ IH DIKP+N+L+DA+ K+ADFGL K L R+ V
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 184 ISGYK----------GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
+K GTP Y APE L G +CD +S G++ +E
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 32 LGFGGFGQVYKGQF---PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
LG G FG V KG + + +A+KVL K ++ M E + + + +VR+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + + LV E G L+ +L GKK + + E+ + G+ YL + +H
Sbjct: 63 VCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVH 118
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNY-PIT 206
D+ NVLL K++DFGL+K + S+ S K + APE + N+ +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NFRKFS 176
Query: 207 HKCDVYSFGMVSFE 220
+ DV+S+G+ +E
Sbjct: 177 SRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 21 LNNFTSNYSTRLGFGGFGQVYKGQ-FPNGVKIAVKVLN--KNLGKIAEEQFMAEVGTIGR 77
L NF ++G G F VYK +G +A+K + + + A + + E+ + +
Sbjct: 1 LGNFK--IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ 58
Query: 78 TYHINLVRLHGFCHDQHMTALVYEYMENGSLD---GYLFGKKRALEWEKLHEIAIGTAKG 134
H N+++ + + +V E + G L + +KR + + + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPG 192
L ++H +RI+H DIKP NV + A K+ D GL R S T + + GTP
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG----RFFSSKTTAAHSLVGTPY 171
Query: 193 YSAPEFLSGN-YPITHKCDVYSFGMVSFEI 221
Y +PE + N Y K D++S G + +E+
Sbjct: 172 YMSPERIHENGY--NFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNL--------GKIAEEQFMAEVGTIGRTYHIN 82
LG G FG+V + ++ AVKVL K++ + E++ +A G H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK-----HPF 57
Query: 83 LVRLHGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGL 135
L +LH Q L V EY+ G L ++ F + RA + EI +G L
Sbjct: 58 LTQLH--SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--EIVLG----L 109
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
+LHE + II+ D+K +NVLLD+ K+ADFG+ K VT S + GTP Y A
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIA 164
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
PE LS P D ++ G++ +E + G+
Sbjct: 165 PEILSYQ-PYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 30 TRLGFGGFGQVYK-GQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+ LG G G V+K P+G+ +A K+++ + Q + E+ + +V +G
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ ++ E+M+ GSLD L R E + L +++I KGL YL E + +I+H
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYLRE--KHKIMH 127
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
D+KP N+L+++ K+ DFG++ +L D + + GT Y +PE L G + +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTH-YSV 181
Query: 208 KCDVYSFGMVSFEI-VGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
+ D++S G+ E+ +GR A E F V + +SE + +
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP---------RPR 232
Query: 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPK 308
+ L P RPPM A+ ++L+ +V PPPK
Sbjct: 233 PPGRPLSSYG-------PDSRPPM-AIFELLDYIVNE-PPPK 265
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 62/194 (31%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 31 RLGFGGFGQVYKGQFPNGVK--IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
R+G G FG+VYKG N K +A+K+++ + E E+ + + + R +G
Sbjct: 11 RIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
++ EY+ GS L K LE + I KGL YLH E R IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIH 124
Query: 149 YDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
DIK NVLL K+ADFG+A +L D + + + + GTP + APE + +
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS-AYDF 180
Query: 208 KCDVYSFGMVSFEI 221
K D++S G+ + E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 32 LGFGGFGQVYKGQFPNGVK----IAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLV 84
+G G FG VY F V+ +A+K ++ + GK + E++ + EV + R H N +
Sbjct: 33 IGHGSFGAVY---FARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
G +H LV EY GS L K+ L+ ++ I G +GL YLH
Sbjct: 89 EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----S 200
+IH DIK N+LL K+ADFG A + S V GTP + APE +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDE 198
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRR 225
G Y K DV+S G+ E+ R+
Sbjct: 199 GQY--DGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 45/288 (15%)
Query: 32 LGFGGFGQVYKGQF--PNGV--KIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRL 86
LG G FG V +GQ +G K+AVK + ++ +E E+F++E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 87 HGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----LEWEKLHEIAIGTAKGL 135
G C + ++ +M++G L +L + L + L + + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
YL + IH D+ N +L + + VADFGL+K + K + A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255
E L+ T K DV++FG+ +EI R + G E Y+
Sbjct: 184 IESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------EIYD------- 226
Query: 256 ILACGIEEKDKEKAKQLCMVALW-----CVQDSPADRPPMSAVVKMLE 298
L G K E C+ L+ C + P DRP + + ++LE
Sbjct: 227 YLRHGNRLKQPED----CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 67/203 (33%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 32 LGFGGFGQVY--KGQFPNGVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRL 86
+G G FG VY N V +AVK ++ + GK E++ + EV + + H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEV-VAVKKMSYS-GKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G +H LV EY GS L K+ L+ ++ I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGN 202
IH DIK N+LL K+ADFG A S V GTP + APE + G
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMDEGQ 196
Query: 203 YPITHKCDVYSFGMVSFEIVGRR 225
Y K DV+S G+ E+ R+
Sbjct: 197 Y--DGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVL---------NKNLGKIAEEQFMAEVGTIGRTYHI 81
+G G +G+VY G +AVK + + + K + +E+ T+ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
N+V+ GF + ++ EY+ GS+ G E + + +GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYLH-- 125
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
+ I+H D+K +N+L+DA+ K++DFG++K D + +G+ + APE +
Sbjct: 126 -SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 202 NYP-ITHKCDVYSFGMVSFEIVGRRR 226
+ K D++S G V E+ RR
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 6e-14
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQ---FMA--EVGTIGRTYHINLV 84
+LG G + VYKG+ NG +A+KV+ ++ EE+ F A E + H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVI-----RLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
LH H + LV+EY+ L Y+ L E + +GL Y+H Q+
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QR 122
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
I+H D+KP+N+L+ K+ADFGLA+ SH T S T Y P+ L G+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH-TYSNEVVTLWYRPPDVLLGSTE 180
Query: 205 ITHKCDVYSFGMVSFEIV 222
+ D++ G + E++
Sbjct: 181 YSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 77/308 (25%), Positives = 133/308 (43%), Gaps = 47/308 (15%)
Query: 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKI--AVKVLNKNLGKIAEEQFMAEV 72
+ L+ N+ + +G G FGQV K + +G+++ A+K + + K F E+
Sbjct: 1 YPVLEWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 73 GTIGRT-YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT 131
+ + +H N++ L G C + L EY +G+L +L K R LE + IA T
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANST 117
Query: 132 A----------------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
A +G+ YL Q++ IH D+ N+L+ N+ K+ADFGL++
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-- 172
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASE 234
V + G S NY + T DV+S+G++ +EIV G +
Sbjct: 173 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229
Query: 235 SLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVV 294
+ E YEK G + EK ++ + C ++ P +RP + ++
Sbjct: 230 A---------ELYEKLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
Query: 295 KMLEGVVE 302
L ++E
Sbjct: 275 VSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 81/268 (30%), Positives = 117/268 (43%), Gaps = 40/268 (14%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQFMA--EVGTIGRTYHINLVRLHG 88
LG GGFG+V Q K+ A K L+K K + + MA E + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 89 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ LV M G L ++ F + RA+ + +I G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA--QIICG----LEHLHQR 114
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
RI++ D+KPENVLLD + + +++D GLA + + I G GTPGY APE L G
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA--VEL-KGGKKIKGRAGTPGYMAPEVLQG 168
Query: 202 NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
D ++ G +E++ R F + E+ EK EL L +
Sbjct: 169 EV-YDFSVDWFALGCTLYEMIAGRSP-----------FRQRK-EKVEKEELKRRTLEMAV 215
Query: 262 EEKDK--EKAKQLCMVALWCVQDSPADR 287
E DK +AK LC L Q P R
Sbjct: 216 EYPDKFSPEAKDLCEALL---QKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 40/211 (18%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH-INLVRLHGF 89
+G G FG V K G +AVK + + + +++ + ++ + R+ +V+ +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 90 CHDQHMTALVYEYMENGSLDG-----YLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
+ + E M+ SLD Y K E E L +IA+ T K L YL EE
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPE-EILGKIAVATVKALNYLKEEL-- 127
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY----------KGTPGYS 194
+IIH D+KP N+LLD N + K+ DFG ISG G Y
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFG-------------ISGQLVDSIAKTRDAGCRPYM 174
Query: 195 APEFLSGN----YPITHKCDVYSFGMVSFEI 221
APE + + Y + + DV+S G+ +E+
Sbjct: 175 APERIDPSARDGYDV--RSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLVRLHG 88
LG GGFG+V Q G A K LNK K + E M E + + + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK---GLVYLHEECQQR 145
+ LV M G L +++ TA+ GL +LH Q+R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
II+ D+KPENVLLD + + +++D GLA +L D GY GTPG+ APE L G
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---TKGYAGTPGFMAPELLQGE-E 173
Query: 205 ITHKCDVYSFGMVSFEIVGRR 225
D ++ G+ +E++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G +G VYK P GV +A+K + L + Q + E+ + + +V +G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEW---EKLHEIAIGTAKGLVYLHEECQQRII 147
+ + EYM+ GSLD L+ A E + L I KGL +L EE II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-- 205
H D+KP NVL++ N K+ DFG++ + + I G Y APE + P
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQN 181
Query: 206 ---THKCDVYSFGMVSFEI 221
T + DV+S G+ E+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 31 RLGFGGFGQVYK------GQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
++G G +G VYK G+ KI + + + A + E+ + H N+V
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA----IREISLLKELNHPNIV 62
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVYLH 139
+L H ++ LV+E++ + L ++ G L L ++ +GL + H
Sbjct: 63 KLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLAFCH 117
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAP 196
R++H D+KP+N+L++ + K+ADFGLA+ + R +H + T Y AP
Sbjct: 118 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAP 169
Query: 197 EFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
E L G + D++S G + E+V RR
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVLN-KNLGKIAEEQFMA---EVGTIGRTYHINLVRL 86
LG G FG+VY G ++AVK + +++ A E+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
+G D ++ EYM GS+ L +G AL + +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS---N 123
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISGYKGTPGYSAPEFLSGNY 203
I+H DIK N+L D+ + K+ DFG +K S T + GTP + +PE +SG
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE- 182
Query: 204 PITH--KCDVYSFG 215
+ K DV+S G
Sbjct: 183 --GYGRKADVWSVG 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 64/195 (32%), Positives = 89/195 (45%), Gaps = 11/195 (5%)
Query: 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRLH 87
+G G FG+V + +G AVKVL K L K + MAE + + H LV LH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
V +Y+ G L +L ++ LE + A A + YLH II
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLH---SLNII 118
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
+ D+KPEN+LLD+ + DFGL K + T S + GTP Y APE L P
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE-PYDR 175
Query: 208 KCDVYSFGMVSFEIV 222
D + G V +E++
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAE----EQFMAE---VGTIGRTYHINL 83
LG G FG+V ++ G A+K L K G I E M E T H L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKK--GDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 84 VRLHG-FCHDQHMTALVYEYMENGSLDGYL----FGKKRALEWEKLHEIAIGTAKGLVYL 138
V L F + H+ V EY G L ++ F + RA+ + A GL YL
Sbjct: 65 VNLFACFQTEDHV-CFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVLGLQYL 117
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPE 197
HE +I++ D+K +N+LLD K+ADFG LC S + GTP + APE
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 198 FLSG-NYPITHKCDVYSFGMVSFEI 221
L+ +Y T D + G++ +E+
Sbjct: 172 VLTETSY--TRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 30 TRLGFGGFGQVYKG--QFPNGVK-IAVKVL-NKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG V KG + K +AVK+L N N +++ + E + + + +VR
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+ G C + LV E E G L+ +L K + + + + E+ + G+ YL E
Sbjct: 61 MIGICEAESWM-LVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLEE---TN 115
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYP 204
+H D+ NVLL K++DFGL+K + ++ + P + APE ++ Y
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN-YYK 174
Query: 205 ITHKCDVYSFGMVSFE 220
+ K DV+SFG++ +E
Sbjct: 175 FSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 29/169 (17%)
Query: 31 RLGFGGFGQV----------YKGQFPNG-----VKIAVKVLNKNLGKIAEEQFMAEVGTI 75
+LG G FG+V + G+ V +AVK+L ++ K A F+ E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------RALEWEKL 124
R + N++RL G C ++ EYMENG L+ +L ++ ++ L
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
+A+ A G+ YL +H D+ N L+ +++ K+ADFG+++
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 49/235 (20%)
Query: 28 YSTRLGFGGFGQVY-----------KGQFPNGVK------IAVKVLNKNLGKIAEEQFMA 70
+ +LG G FG+V+ QFP V+ +AVK+L + K A F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 71 EVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF----------------- 113
EV + R N++RL G C D+ ++ EYMENG L+ +L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 114 -GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
A+ + L +A+ A G+ YL +H D+ N L+ N + K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 173 KLCDRNR---SHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
RN + I G P + A E L G + T DV++FG+ +EI+
Sbjct: 186 ----RNLYAGDYYRIQGRAVLPIRWMAWECILMGKF--TTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRLH 87
+G G FG VY + N +A+K ++ + GK + E++ + EV + + H N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G +H LV EY GS L K+ L+ ++ + G +GL YLH +I
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 137
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----SGNY 203
H D+K N+LL K+ DFG A + V GTP + APE + G Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQY 191
Query: 204 PITHKCDVYSFGMVSFEIVGRR 225
K DV+S G+ E+ R+
Sbjct: 192 --DGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 21/199 (10%)
Query: 48 GVKIAVKVLNKNLGKIAEE--QFMAEVGTIGRTYHINLVRL--HGFCHDQHMTALVYEYM 103
G ++A+K+L + + + +F E R YH N+V L G + A V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DA 160
+L L AL + + + L H Q I+H D+KP+N+++
Sbjct: 62 PGRTLREVL-AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGV 117
Query: 161 NFSPKVADFGLAKLC----DRNRSHVTISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
KV DFG+ L D + + +T + GTP Y APE L G P+T D+Y++G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE-PVTPNSDLYAWG 176
Query: 216 MVSFE-IVGRRRNAIVGAS 233
++ E + G+R + GAS
Sbjct: 177 LIFLECLTGQR--VVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 7/196 (3%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G + V+KG+ +A+K + + A + EV + H N+V LH
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
H + LV+EY+++ L YL + + +GL Y H+ ++I+H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D+KP+N+L++ K+ADFGLA+ ++ T S T Y P+ L G+ +
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 210 DVYSFGMVSFEIVGRR 225
D++ G + +E+ R
Sbjct: 186 DMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G + VYKG+ +A+K + + A + EV + H N+V LH
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
H + LV+EY++ L YL ++ + +GL Y H +++++H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D+KP+N+L++ K+ADFGLA+ ++ T S T Y P+ L G+ + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 210 DVYSFGMVSFEIVGRR 225
D++ G + +E+ R
Sbjct: 187 DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 72/225 (32%), Positives = 102/225 (45%), Gaps = 50/225 (22%)
Query: 32 LGFGGFGQVY--------KGQFPNGVKIAVKVLN-----KNLGKIAEEQFMAEVGTIGRT 78
LG G FGQV K + V +AVK+L K+L + E M ++ IG+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM--IGK- 79
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIA---------- 128
H N++ L G C ++ EY G+L YL + R E ++IA
Sbjct: 80 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDIARVPDEQMTFK 137
Query: 129 ------IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
A+G+ YL Q+ IH D+ NVL+ N K+ADFGLA+ D N
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVN---- 188
Query: 183 TISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
I YK T + APE L + TH+ DV+SFG++ +EI
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI---NLVRLH 87
+G G +G VY+G P G +A+K++N + EV + + N+ + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIG-----TAKGLVYLHEEC 142
G ++ EY E GS+ + ++ + E I L Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIAEKYISVIIREVLVALKYIH--- 118
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
+ +IH DIK N+L+ + K+ DFG+A L ++N S S + GTP + APE ++
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFVGTPYWMAPEVITEG 176
Query: 203 YPITHKCDVYSFGMVSFEIV 222
K D++S G+ +E+
Sbjct: 177 KYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 65/197 (32%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRLH 87
+G G FG+V + K AVKVL K L K ++ MAE + + H LV LH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE-KLHEIAIGTAKGLVYLHEECQQRI 146
V +Y+ G L +L ++ E + + I +A G YLH I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS---LNI 117
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPI 205
I+ D+KPEN+LLD+ + DFG LC H T S + GTP Y APE L P
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PY 173
Query: 206 THKCDVYSFGMVSFEIV 222
D + G V +E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 89/320 (27%), Positives = 137/320 (42%), Gaps = 69/320 (21%)
Query: 32 LGFGGFGQVYKG-------QFPN-GVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRT 78
LG G FGQV + P+ V +AVK+L +K+L + E + ++ IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL--IGK- 76
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEK 123
H N++ L G C + ++ EY G+L +L ++ L ++
Sbjct: 77 -HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
L A A+G+ YL +R IH D+ NVL+ + K+ADFGLA R
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA------RGVHD 186
Query: 184 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD 237
I YK T + APE L + TH+ DV+SFG++ +EI +G S
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIF------TLGGSP--- 236
Query: 238 WFPKYVWEEYEKSELGAMILACGIE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
+P EE K +L G +K +L M+ C P RP +V+
Sbjct: 237 -YPGIPVEELFK------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289
Query: 297 LEGVVEVLPPPKPFRYLDLN 316
L+ V+ + YLDL+
Sbjct: 290 LDKVLAAVSE----EYLDLS 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 44/216 (20%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKN--LGKIAEEQ--------FMAEVGTIGRTYH 80
++G G +G VYK + +V N+ L KI EQ + E+ + H
Sbjct: 9 KIGEGTYGVVYKAR--------DRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 81 INLVRLHGFCHDQHMTALVYEYME-------NGSLDGYLFGKKRALEWEKLHEIAIGTAK 133
N+VRL H + LV+EY++ + S D F K L L++I +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD---FAKNPRLIKTYLYQIL----R 113
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK---LCDRNRSHVTISGYKG 189
G+ Y H R++H D+KP+N+L+D + K+ADFGLA+ + R +H +
Sbjct: 114 GIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----- 165
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
T Y APE L G+ + D++S G + E+V ++
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 26/206 (12%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHGF 89
+G G +GQVYKG+ G A+KV++ + + EE+ E+ + + ++H N+ +G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 90 C-------HDQHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEE 141
HD + LV E+ GS+ + K AL+ + + I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH-- 138
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTISGYKGTPGYSAPEFL 199
++IH DIK +NVLL N K+ DFG++ DR R + I GTP + APE +
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMAPEVI 193
Query: 200 S----GNYPITHKCDVYSFGMVSFEI 221
+ + ++ D++S G+ + E+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 92/320 (28%), Positives = 137/320 (42%), Gaps = 68/320 (21%)
Query: 32 LGFGGFGQVY--------KGQFPNGVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRT 78
LG G FGQV K + V +AVK+L +K+L + E M ++ IG+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM--IGK- 76
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEK 123
H N++ L G C ++ EY G+L YL ++ L ++
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
L A A+G+ YL Q+ IH D+ NVL+ + K+ADFGLA R
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDVHN 186
Query: 184 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD 237
I YK T + APE L + TH+ DV+SFG++ +EI +G S
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF------TLGGSP--- 236
Query: 238 WFPKYVWEEYEKSELGAMILACGIE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
+P EE K +L G +K +L M+ C P+ RP +V+
Sbjct: 237 -YPGIPVEELFK------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
Query: 297 LEGVVEVLPPPKPFRYLDLN 316
L+ V+ V + YLDL+
Sbjct: 290 LDRVLTVTSTDE---YLDLS 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-13
Identities = 69/292 (23%), Positives = 123/292 (42%), Gaps = 38/292 (13%)
Query: 32 LGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V+ + N + +AVK L K+ A + F E + H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWE----------KLHEIAIGTAK 133
+G C + +V+EYM++G L+ +L G L E ++ IA A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
G+VYL Q +H D+ N L+ N K+ DFG+++ + + + G+ P
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIR 187
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253
P T + DV+S G+V +EI + K W + +E+
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT---------------YGKQPWYQLSNNEVI 232
Query: 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305
I + ++ + K++ + L C Q P R + + +L+ + + P
Sbjct: 233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-13
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 28 YSTRLGFGGFGQVY-------------------KGQFPNGVKIAVKVLNKNLGKIAEEQF 68
+ +LG G FG+V+ G P V +AVK+L ++ K A F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQP--VLVAVKMLREDANKNARNDF 66
Query: 69 MAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL----------FGKKRA 118
+ E+ + R N++RL C ++ EYMENG L+ +L
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
+ + L +A A G+ YL +H D+ N L+ N++ K+ADFG+++
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 179 RSHVTISGYKGTP--GYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
+ I G P S L G + T DV++FG+ +EI
Sbjct: 184 -DYYRIQGRAVLPIRWMSWESILLGKF--TTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRL-H 87
LG GGFG+V Q N G A K L+K K E+ + E + + +V L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
F H+ LV M G L +++ +R LE E++ + G+++LH I
Sbjct: 61 AFESKTHL-CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
++ D+KPENVLLD + +++D GLA + TI+ GT GY APE L P +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILK-EEPYS 172
Query: 207 HKCDVYSFGMVSFEIVGRR 225
+ D ++ G +E+V R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 71/224 (31%), Positives = 103/224 (45%), Gaps = 48/224 (21%)
Query: 32 LGFGGFGQVYKGQF-------PNGV-KIAVKVLN-----KNLGKIAEEQFMAEVGTIGRT 78
LG G FGQV + PN V K+AVK+L K+L + E M ++ IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM--IGK- 82
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEK 123
H N++ L G C ++ EY G+L YL ++ L ++
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
L A A+G+ YL ++ IH D+ NVL+ + K+ADFGLA R+ H
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHH-- 192
Query: 184 ISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
I YK T + APE L TH+ DV+SFG++ +EI
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ--------FMAEVGTIGRTYHI 81
++G G +G VYK + G +A+K KI E + E+ + H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALK-------KIRLETEDEGVPSTAIREISLLKELNHP 58
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLV 136
N+VRL H ++ LV+E++ + L Y+ G L L+++ +G+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIA 113
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGY 193
Y H R++H D+KP+N+L+D + K+ADFGLA+ + R +H + T Y
Sbjct: 114 YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWY 165
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
APE L G+ + D++S G + E+V RR
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 9e-13
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 34/208 (16%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH-INLVRLHGF 89
LG G +G V K + P G +AVK + + +++ + ++ R+ V +G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 90 CHDQHMTALVYEYMENGSLDGY---LFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ + E M+ SLD + ++ K + + L +IA+ K L YLH + +
Sbjct: 69 LFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSV 125
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY----------KGTPGYSAP 196
IH D+KP NVL++ N K+ DFG ISGY G Y AP
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFG-------------ISGYLVDSVAKTIDAGCKPYMAP 172
Query: 197 EFLSGNYPITH---KCDVYSFGMVSFEI 221
E ++ K DV+S G+ E+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 32 LGFGGFGQVY--KGQFPNGVKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRLHG 88
+G G FG++Y K + + +K ++ + E E EV + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSE-HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 89 FCHDQHMTALVYEYMENGSL-------DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ +V EY + G L G LF + + L W +I++G L ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHD- 119
Query: 142 CQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
++I+H DIK +N+ L N K+ DFG+A+ N S GTP Y +PE +
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPE-IC 174
Query: 201 GNYPITHKCDVYSFGMVSFEI 221
N P +K D++S G V +E+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 65/196 (33%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRLH 87
+G G FG+V + K AVKVL K L K E+ M+E + + H LV LH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
V +Y+ G L Y ++R + A A L YLH I+
Sbjct: 63 FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIV 118
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPIT 206
+ D+KPEN+LLD+ + DFG LC N H T S + GTP Y APE L P
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFG---LCKENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYD 174
Query: 207 HKCDVYSFGMVSFEIV 222
D + G V +E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-12
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHGF 89
+G G +GQVYKG+ G A+KV++ + EE+ E+ + + ++H N+ +G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 90 CHDQHMTA------LVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEEC 142
++ LV E+ GS+ + K L+ E + I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-- 200
Q ++IH DIK +NVLL N K+ DFG++ DR + GTP + APE ++
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 186
Query: 201 GNYPITH--KCDVYSFGMVSFEI 221
N T+ K D++S G+ + E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 32 LGFGGFGQVYKGQFPNGV---KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G FG+V G+ +G ++ VK L + + +F+ E H NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRA----LEWEKLHEIAIGTAKGLVYLHEECQQ 144
C + LV E+ G L GYL ++A + L +A A GL++LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLS--- 200
IH D+ N LL A+ + K+ D+GL+ + +VT P + APE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT-PDQLWVPLRWIAPELVDEVH 178
Query: 201 GNYPI---THKCDVYSFGMVSFEI 221
GN + T + +V+S G+ +E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 16/199 (8%)
Query: 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRTYHINL 83
+++G G +G V+K + G +A+K + + KIA + E+ + + H NL
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----LREIRMLKQLKHPNL 62
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
V L + LV+EY ++ L+ L R + + +I T + + + H +
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCH---K 118
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
IH D+KPEN+L+ K+ DFG A++ T Y T Y APE L G+
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPELLVGDT 176
Query: 204 PITHKCDVYSFGMVSFEIV 222
DV++ G V E++
Sbjct: 177 QYGPPVDVWAIGCVFAELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 32 LGFGGFGQVY--KGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH-G 88
+G G FG V+ + + + I ++ + + K E + H N++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
F D+ + +V EY G+L Y+ + +L E I + L+ LH + I+H
Sbjct: 68 FLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDED--TILHFFVQILLALHHVHTKLILH 124
Query: 149 YDIKPENVLLDAN-FSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
D+K +N+LLD + K+ DFG++K L +++++ + GTP Y +PE G P
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV----GTPCYISPELCEGK-PYN 179
Query: 207 HKCDVYSFGMVSFEIVGRRR 226
K D+++ G V +E+ +R
Sbjct: 180 QKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 40/214 (18%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIA---------EEQ-----FMAEVGTIG 76
++G G +G VYKG+ NK G+I EE+ + E+ +
Sbjct: 7 KIGEGTYGVVYKGR------------NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK 54
Query: 77 RTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKG 134
H N+V L + L++E++ L YL K + ++ E + +G
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTP 191
+++ H +R++H D+KP+N+L+D K+ADFGLA+ + R +H + T
Sbjct: 114 ILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TL 165
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE L G+ + D++S G + E+ ++
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 44/287 (15%)
Query: 32 LGFGGFGQVYKGQFPNG---VKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRLH 87
LG G FG V +GQ +K+AVK + + +E E F++E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 88 GFCHDQHMT------ALVYEYMENGSLDGYLFGKKRA-----LEWEKLHEIAIGTAKGLV 136
G C + ++ +M++G L +L + L + L + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
YL + IH D+ N +L+ N + VADFGL+K + K + A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 197 EFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256
E L+ + T K DV+SFG+ +EI R + G S E Y+
Sbjct: 184 ESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---------EIYDY------- 226
Query: 257 LACGIEEKDKEKAKQLCMVALW-----CVQDSPADRPPMSAVVKMLE 298
+ + ++ K C+ L+ C +P DRP + LE
Sbjct: 227 ----LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 12/97 (12%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVT---ISGYK 188
+GL YLH I+H DIKP N+L+++N K+ DFGLA++ + + S H+T ++ Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE L G+ T D++S G + E++GRR
Sbjct: 170 ----YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 32 LGFGGFGQVYK------GQFPNGVKIAVKVL-----NKNLGKIAEEQFMAEVGTIGRTYH 80
+G G +G V K GQ +A+K +K + KIA M E+ + + H
Sbjct: 9 VGEGSYGMVMKCKHKETGQI-----VAIKKFLESEDDKMVKKIA----MREIRMLKQLRH 59
Query: 81 INLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
NLV L + LV+E++++ LD L L+ ++ + +G+ + H
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFL 199
IIH DIKPEN+L+ + K+ DFG A+ L + + Y T Y APE L
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---TDYVATRWYRAPELL 172
Query: 200 SGNYPITHKCDVYSFGMVSFEIV 222
G+ D+++ G + E++
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 32 LGFGGFGQVYK------GQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLV 84
LG G FG+V + + +K+AVK+L E M+E+ + H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQ 143
L G C ++ EY G L +L K+ + L E L + AKG+ +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD-RNRSHVTISGYKGTP-GYSAPEFLSG 201
+ IH D+ NVLL K+ DFGLA+ D N S+ + G P + APE +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFN 217
Query: 202 NYPITHKCDVYSFGMVSFEI 221
T + DV+S+G++ +EI
Sbjct: 218 CV-YTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 55/160 (34%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH 139
H LV LH + V EY+ G L ++ ++R L E + + L YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLALNYLH 113
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
E + II+ D+K +NVLLD+ K+ D+G+ K + R T S + GTP Y APE L
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 200 SG-NYPITHKCDVYSFGMVSFEIV-GRRRNAIVGASESLD 237
G +Y + D ++ G++ FE++ GR IVG+S++ D
Sbjct: 169 RGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 35/284 (12%)
Query: 30 TRLGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL 83
T LG G FG+V+ + + + VK L K + + +F E+ + H N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKL------HEIAIGT--AKGL 135
VRL G C + ++ EY + G L +L K E K ++A+ T A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR-NRSHVTISGYKGTPGYS 194
+L R +H D+ N L+ + KV+ L+K D N + + +
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWL 185
Query: 195 APEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254
APE + + + K DV+SFG++ +E+ L F EE + L A
Sbjct: 186 APEAVQED-DFSTKSDVWSFGVLMWEVF---------TQGELP-FYGLSDEEV-LNRLQA 233
Query: 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
L + E + +L M W V +P DRP S +V L
Sbjct: 234 GKLELPVPEGCPSRLYKL-MTRCWAV--NPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNG--VKIAVKVLNKNLGKIAEEQ- 67
++P R ++ +F N+ LG G FG+V + N +A+K K+ KI +++
Sbjct: 19 KEPKRKNKMKYEDF--NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQ 74
Query: 68 ---FMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKL 124
+E + H V L+G D+ LV E++ G +L KR
Sbjct: 75 VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----- 129
Query: 125 HEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
+++ A +V + E Q I++ D+KPEN+LLD + K+ DFG AK+ D R++
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-TRTYTL 188
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
GTP Y APE L N D ++ G+ +EI+
Sbjct: 189 C----GTPEYIAPEILL-NVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 7/196 (3%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G + V+KG+ +A+K + + A + EV + H N+V LH
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
H LV+EY++ L Y+ + + +GL Y H +++++H
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D+KP+N+L++ K+ADFGLA+ ++ T S T Y P+ L G+ + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 210 DVYSFGMVSFEIVGRR 225
D++ G + FE+ R
Sbjct: 187 DMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-12
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G FG+V+KG K+ A+K+++ + E E+ + + + + +G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 90 CHDQHMTALVYEYMENGS-LDGYLFGKKRALEWEKLHEIAIGTA-----KGLVYLHEECQ 143
++ EY+ GS LD LE L E I T KGL YLH E
Sbjct: 71 YLKDTKLWIIMEYLGGGSALD--------LLEPGPLDETQIATILREILKGLDYLHSE-- 120
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
+ IH DIK NVLL + K+ADFG+A +L D + + + + GTP + APE + +
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 203 YPITHKCDVYSFGMVSFEI 221
K D++S G+ + E+
Sbjct: 177 -AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 30 TRLGFGGFG--QVYKGQFPNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVR 85
+ +G G FG QV + + + A+KV+ K+ L + F E + + + +
Sbjct: 7 SLVGRGHFGEVQVVREKATGDI-YAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
L D+ LV EY G L L + + E + + + A+ ++ +H Q
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD-EDMAQFYL--AELVLAIHSVHQMG 122
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL---SGN 202
+H DIKPENVL+D K+ADFG A N+ V GTP Y APE L +G+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 203 YPITH--KCDVYSFGMVSFEIV 222
T+ +CD +S G++++E++
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 28 YSTRLGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI 81
Y +G G FG+V++ + P + +AVK+L + + F E + H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYL---------------------FGKKRALE 120
N+V+L G C L++EYM G L+ +L L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
+ IA A G+ YL E ++ +H D+ N L+ N K+ADFGL+ R+
Sbjct: 129 CTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS------RN 179
Query: 181 HVTISGYKGTPG------YSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
+ YK + + PE + N T + DV+++G+V +EI
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEE--QFMA--EVGTIGRTYHINLVR 85
+LG G + VYKG+ G +A+K + EE F A E + H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLE----HEEGAPFTAIREASLLKDLKHANIVT 67
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT---AKGLVYLHEEC 142
LH H + LV+EY++ L Y+ L +H + + +GL Y H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGL---SMHNVRLFLFQLLRGLAYCH--- 120
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPGYSAPEFL 199
Q+R++H D+KP+N+L+ K+ADFGLA R +S V Y T Y P+ L
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLA----RAKS-VPSKTYSNEVVTLWYRPPDVL 175
Query: 200 SGNYPITHKCDVYSFGMVSFEIV 222
G+ + D++ G + +E+
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 30 TRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEE--QFMAEVGTIGRTYHINLVRL 86
T++G GG+GQV+ + + +I A+K + K+L E + E + T LV+L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 87 -HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+ F D+++ L EY+ G L L + + + LH +
Sbjct: 67 LYAFQDDEYLY-LAMEYVPGGDFRT-LLNNLGVLSEDHARFYMAEMFEAVDALH---ELG 121
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSG-NY 203
IH D+KPEN L+DA+ K+ DFGL+K + S V G+P Y APE L G Y
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVLRGKGY 175
Query: 204 PITHKCDVYSFGMVSFE-IVG 223
D +S G + +E + G
Sbjct: 176 --DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 29 STRLGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN 82
S LG G FG VY+G VK +A+K +N+ +F+ E + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE---------WEKLHEIAIGTAK 133
+VRL G T ++ E M G L YL + +E +K+ ++A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TP 191
G+ YL+ + +H D+ N ++ +F+ K+ DFG+ + D + G KG
Sbjct: 131 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 185
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
+ +PE L T+ DV+SFG+V +EI
Sbjct: 186 RWMSPESLKDGVFTTYS-DVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 24/201 (11%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGK----IAEEQFMAEVGTIGRTYHINLVR 85
R+G G +G VYK + G AVK++ G I +E FM + H N+V
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM-----VKECKHCNIVA 70
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
G + + EY GSL ++ L ++ + T +GL YLH + +
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK---GTPGYSAPEF--LS 200
+H DIK N+LL N K+ADFG+A + TI+ K GTP + APE +
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 201 GNYPITHKCDVYSFGMVSFEI 221
N CD+++ G+ + E+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 32 LGFGGFGQVYK-GQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI-GRTYHINLVRLHG- 88
+G G +G+VYK +G AVK+L+ +E+ AE + H N+V+ +G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 89 FCHDQHMTA----LVYEYMENGS----LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
F + LV E GS + G L +R L+ + I G GL +LH
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLH- 145
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNRSHVTISGYKGTPGYSAPEF 198
RIIH D+K N+LL K+ DFG+ A+L R R + ++ GTP + APE
Sbjct: 146 --NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAPEV 199
Query: 199 LSG----NYPITHKCDVYSFGMVSFEI 221
++ +Y +CDV+S G+ + E+
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVL----NKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G +G VYK + P+ G +A+K + N++ ++ + +A + + H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 87 HGFCH----DQHM-TALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHE 140
C D+ LV+E+++ L YL L E + ++ +GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
C I+H D+KPEN+L+ + K+ADFGLA++ + ++ T Y APE L
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235
+ T D++S G + E+ RR+ G SE+
Sbjct: 181 QSTYAT-PVDMWSVGCIFAEMF-RRKPLFCGNSEA 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 20/220 (9%)
Query: 32 LGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRL 86
LG G FG V + Q + K+AVK+L ++ ++ E+F+ E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 87 HGFCHDQH------MTALVYEYMENGSLDGYLFGKKRA-----LEWEKLHEIAIGTAKGL 135
G + ++ +M++G L +L + L + L I A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
YL + IH D+ N +L+ N + VADFGL+K + K + A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235
E L+ N TH DV++FG+ +EI+ R + G S
Sbjct: 184 LESLADNVYTTHS-DVWAFGVTMWEIMTRGQTPYAGVENS 222
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 37/189 (19%)
Query: 48 GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTA----LVYEY 102
G ++AVK ++ L K + + I R Y H N+V ++ ++ +V E+
Sbjct: 44 GRQVAVKKMD--LRKQQRRELLFNEVVIMRDYQHPNIVEMY----SSYLVGDELWVVMEF 97
Query: 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTA-----KGLVYLHEECQQRIIHYDIKPENVL 157
+E G+L + +++E I T K L +LH Q +IH DIK +++L
Sbjct: 98 LEGGAL-------TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSIL 147
Query: 158 LDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYS 213
L ++ K++DFG ++K R +S V GTP + APE +S P + D++S
Sbjct: 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVIS-RLPYGTEVDIWS 200
Query: 214 FGMVSFEIV 222
G++ E+V
Sbjct: 201 LGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF----MAEVGTIGRTYHINLVR 85
++G G +GQVYK + G +A+K + K E F + E+ + + H N+VR
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEK---EGFPITAIREIKLLQKLRHPNIVR 62
Query: 86 LHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK--------GL 135
L + + +V+EYM++ L G L + K GL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLD--------SPEVKFTESQIKCYMKQLLEGL 113
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVT---ISGYKGTP 191
YLH I+H DIK N+L++ + K+ADFGLA RN + T I T
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-----TL 165
Query: 192 GYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234
Y PE L G Y + D++S G + E+ + G++E
Sbjct: 166 WYRPPELLLGATRY--GPEVDMWSVGCILAELF-LGKPIFQGSTE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 32 LGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V+ + N + +AVK L K + A + F E + H ++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQHQHIVR 71
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLF-----------GKKRA---LEWEKLHEIAIGT 131
+G C + +V+EYM +G L+ +L G+ A L ++ IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A G+VYL +H D+ N L+ K+ DFG+++ + + + G P
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 187
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
P T + D++SFG+V +EI
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 31 RLGFGGFGQVYKGQFPNGVK--IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
R+G G FG+V+KG N + +A+K+++ + E E+ + + + + +G
Sbjct: 11 RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 89 FCHDQHMTALVYEYMENGS-LDGYLFGKKRALEWEKLHEIAIGTA-----KGLVYLHEEC 142
++ EY+ GS LD L E I T KGL YLH E
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD--------LLRAGPFDEFQIATMLKEILKGLDYLHSE- 120
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
+ IH DIK NVLL K+ADFG+A +L D + + + + GTP + APE +
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVIQQ 175
Query: 202 NYPITHKCDVYSFGMVSFEI 221
+ K D++S G+ + E+
Sbjct: 176 S-AYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 32 LGFGGFGQVYKGQFPNG-VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL-HGF 89
+G G FG+ Q N K A+K + A E E + + H N+V F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 90 CHDQHMTALVYEYMENGSL-------DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
D H+ +V EY + G L G LF + L+W + G+ ++HE
Sbjct: 68 EADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE-- 118
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
+R++H DIK +N+ L N K+ DFG A+L ++ Y GTP Y PE N
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWE-N 174
Query: 203 YPITHKCDVYSFGMVSFEI 221
P +K D++S G + +E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKIA---VKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G FG+V G+ G+ A VK L + + F+ EV H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAL----EWEKLHEIAIGTAKGLVYLHEECQQ 144
C + LV E+ G L YL + + + + L +A A GL++LH Q
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNY 203
IH D+ N L A+ S K+ D+GLA L + P + APE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 204 P------ITHKCDVYSFGMVSFEI 221
T K +++S G+ +E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 23/229 (10%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE--EQFMAEVGTIG-RTYHINLVRLH 87
LG G FG+V + + A+K L K++ + E M E + H L H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT--H 60
Query: 88 GFCHDQHMTAL--VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
FC Q L V EY+ G L ++ R + + A GL +LH ++
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKG 116
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
II+ D+K +NVLLD + K+ADFG+ K + N S + GTP Y APE L G
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKA-STFCGTPDYIAPEILKGQ-KY 173
Query: 206 THKCDVYSFGMVSFE-IVGRRRNAIVGASESLD-------WFPKYVWEE 246
D +SFG++ +E ++G+ E D FP+++ +E
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 59/273 (21%), Positives = 108/273 (39%), Gaps = 33/273 (12%)
Query: 32 LGFGGFGQ--VYKGQFPNGVKIAVKVLNKNLGKIAEEQ---FMAEVGTIGRTYHINLVRL 86
LG G FG+ +Y+ + + + +V NL +++E++ + E+ + H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEV---NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 87 HGFCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+ D + + EY G+L D + K + E E + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYP 204
I+H DIK N+ L K+ DFG++K+ S GTP Y +PE G Y
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGVKY- 178
Query: 205 ITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264
K D+++ G V +E++ +R ++ L I+
Sbjct: 179 -NFKSDIWALGCVLYELLTLKR----------------TFDATNPLNLVVKIVQGNYTPV 221
Query: 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
+ +L + +Q P RP V+
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 1/132 (0%)
Query: 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154
M ALV +Y G L + + + + HE + + L+ +H + +IH DIK
Sbjct: 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSF 214
N+LL +N K+ DFG +K+ S + GTP Y APE P + K D++S
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSL 231
Query: 215 GMVSFEIVGRRR 226
G++ +E++ +R
Sbjct: 232 GVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQFMAEVGTIGRTY-----HINLVR 85
+G G + +V + +I A+KV+ K L + +++ + V T + H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKEL--VNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
LH + V E++ G L + ++R L E + + L +LHE +
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL-MFHMQRQRKLPEEHARFYSAEISLALNFLHE---RG 116
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYP 204
II+ D+K +NVLLDA K+ D+G+ K + R T S + GTP Y APE L G +Y
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 205 ITHKCDVYSFGMVSFEIV-GRRRNAIVGASESLD 237
+ D ++ G++ FE++ GR IVG S++ D
Sbjct: 175 FS--VDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLVRLHG 88
LG G FG+V + G AVK L K++ I + E M E + + N H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE-NPFLTHL 61
Query: 89 FCHDQHMTAL--VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+C Q L V E++ G L ++ K R + + A GL +LH + I
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SKGI 117
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
I+ D+K +NV+LD + K+ADFG+ K + NR+ S + GTP Y APE L G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA----STFCGTPDYIAPEILQG-LK 172
Query: 205 ITHKCDVYSFGMVSFEIV 222
T D +SFG++ +E++
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 25 TSNY--STRLGFGGFGQVYKG-QFPNGVKIAVK-VLNKNLGKIAEEQF----MAEVGTIG 76
+Y +LG G FG+VYK Q G +A+K +L N ++ F + E+ +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN----EKDGFPITALREIKILK 62
Query: 77 RTYHINLVRL-------HGFCHDQHMTA-LVYEYMENGSLDGYLFGKKRALEWEKLHEIA 128
+ H N+V L + + +V YM++ L G L L ++
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
+ +G+ YLHE I+H DIK N+L+D K+ADFGLA+ D
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP---PPNPKGG 175
Query: 189 GTPG------------YSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
G G Y PE L G T D++ G V E+ RR
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--ISGYKGTP 191
GL Y+H ++H D+KP N+L++A+ K+ DFGLA+ N ++ Y T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE + T DV+S G + E++GR+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G +G VY + V+IA+K + + + + E+ H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGSD 74
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIG-----TAKGLVYLHEECQQR 145
+ + E + GSL L K L K +E I +GL YLH+ +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPL---KDNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 146 IIHYDIKPENVLLDANFSP--KVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLS-G 201
I+H DIK +NVL++ +S K++DFG +K L N T + GT Y APE + G
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTET---FTGTLQYMAPEVIDKG 184
Query: 202 NYPITHKCDVYSFGMVSFEI 221
D++S G E+
Sbjct: 185 PRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G GG G+VY P ++A+K + ++L + +++F+ E H +V ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKL-HEIAIGTAKG--LVYLHEECQ-- 143
C D Y+E +L L K + E L E+A T+ G L H+ C
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLL---KSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 144 -----QRIIHYDIKPENVLLDANFSPKV-ADFGLAKLCDRNR---------------SHV 182
+ ++H D+KP+N+LL F V D+G A S +
Sbjct: 127 EYVHSKGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 183 TISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
TI G GTP Y APE L G P + D+Y+ G++ ++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNK-NLGKIAEEQFMAEVGTIGRTYHIN-----LV 84
+G G FG+V + + +I A+K+LNK + K AE E R +N +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE----ERNVLVNGDCQWIT 64
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
LH D++ LV +Y G L L F + + + + A+ ++ +H
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIH 119
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-- 200
Q +H DIKP+NVLLD N ++ADFG +++ + V S GTP Y +PE L
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAM 178
Query: 201 ----GNYPITHKCDVYSFGMVSFEIV 222
G Y +CD +S G+ +E++
Sbjct: 179 EDGMGKY--GPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 32 LGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTI-GRTYHINLV 84
LG G FG VY+G + +K +AVK +N++ +F+ E + G T H ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE---------WEKLHEIAIGTAKGL 135
RL G T +V E M +G L YL + E +++ ++A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TPGY 193
YL+ ++ +H D+ N ++ +F+ K+ DFG+ + D + G KG +
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRW 187
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEI 221
APE L T D++SFG+V +EI
Sbjct: 188 MAPESLKDGVFTTSS-DMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRLH 87
LG G FG+V + K A+K+L K + IA+++ + E + T H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEV-IIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
V EY G L +L ++R ++ L YLH ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALGYLHS---CDVV 117
Query: 148 HYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
+ D+K EN++LD + K+ DFGL K + D T+ + GTP Y APE L N
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDN-DY 172
Query: 206 THKCDVYSFGMVSFEIV-GR 224
D + G+V +E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRLH 87
+G G FG+V + +G AVKVL K L + ++ MAE + + H LV LH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
V +++ G L +L ++R+ + A A L YLH I+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFYAAEIASALGYLH---SINIV 118
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPIT 206
+ D+KPEN+LLD+ + DFG LC + T + + GTP Y APE + P
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYD 174
Query: 207 HKCDVYSFGMVSFEIV 222
+ D + G V +E++
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNK-NLGKIAEEQFMAEVGT 74
T L++ + +G G FG+V + + ++ A+K+L+K + K ++ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 75 IGRTYHIN---LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT 131
I H N +V+LH D +V EYM G L + +W + + +
Sbjct: 96 I--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVL 153
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A L +H IH D+KP+N+LLD + K+ADFG D N V GTP
Sbjct: 154 A--LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTP 207
Query: 192 GYSAPEFL---SGNYPITHKCDVYSFGMVSFEIV 222
Y +PE L G+ +CD +S G+ +E++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIA----VKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
++G G +G V+K + +I V++ + + G + E+ + H N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--VPSSALREICLLKELKHKNIVRL 64
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ H LV+EY + L Y ++ E + KGL + H +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNV 120
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
+H D+KP+N+L++ N K+ADFGLA+ + R S + T Y P+ L G
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAK 175
Query: 204 PITHKCDVYSFGMVSFEI 221
+ D++S G + E+
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 75/256 (29%), Positives = 109/256 (42%), Gaps = 33/256 (12%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMA--EVGTIGRTYHINLVRLHG 88
LG GGFG+V Q G A K L K K + + MA E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRII 147
+ LV M G L +++ A E + A GL LH+E RI+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIV 124
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
+ D+KPEN+LLD + +++D GLA + TI G GT GY APE + N T
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVK-NERYTF 180
Query: 208 KCDVYSFGMVSFEIVG------RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
D ++ G + +E++ +R+ I E ++ K V EEY
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVQEEY-------------- 224
Query: 262 EEKDKEKAKQLCMVAL 277
EK A+ LC + L
Sbjct: 225 SEKFSPDARSLCKMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 56/201 (27%), Positives = 83/201 (41%), Gaps = 34/201 (16%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ--------FMAEVGTIGRTYHI 81
R+G G +G VY+ + +G +A+K K+ + + E+ + H
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALK-------KVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 82 NLVRLHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH 139
N+V L +H+ + LV EY E L L ++ + + +GL YLH
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YS 194
E IIH D+K N+LL K+ADFGLA R TP Y
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLA----RTYGLPAKP---MTPKVVTLWYR 175
Query: 195 APEFLSGNYPITHKCDVYSFG 215
APE L G T D+++ G
Sbjct: 176 APELLLGCTTYTTAIDMWAVG 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 49/144 (34%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
LV LH LV EY+ G L ++ ++R L E A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE-- 114
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG- 201
+ II+ D+K +NVLLDA+ K+ D+G+ K + T S + GTP Y APE L G
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 202 NYPITHKCDVYSFGMVSFEIVGRR 225
Y + D ++ G++ FE++ R
Sbjct: 172 EYGFS--VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 27 NYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAE--VGTIGRTY 79
N+ LG G FG+V + ++ A+K+L K++ I + E M E V +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV--IIQDDDVECTMVEKRVLALPGKP 60
Query: 80 HINLVRLHGFCHDQHMTAL--VYEYMENGSLDGYL--FGK-KRALEWEKLHEIAIGTAKG 134
L +LH Q M L V EY+ G L ++ GK K EIAIG
Sbjct: 61 PF-LTQLH--SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-RSHVTISGYKGTPGY 193
L +LH + II+ D+K +NV+LDA K+ADFG +C N T + GTP Y
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDY 167
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
APE ++ P D ++FG++ +E++
Sbjct: 168 IAPEIIA-YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 11 EKPVR-FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNK-NLGKIAEEQ 67
EK VR LQ+ + +G G FG+V + + K+ A+K+L+K + K ++
Sbjct: 29 EKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSA 88
Query: 68 FMAEVGTIGRTYHINLVRLHGFC--HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLH 125
F E I + V + FC D +V EYM G L + +W K +
Sbjct: 89 FFWEERDIMAFANSPWV-VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY 147
Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
TA+ ++ L +IH D+KP+N+LLD + K+ADFG D V
Sbjct: 148 -----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVRCD 201
Query: 186 GYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVSFEIV 222
GTP Y +PE L G+ +CD +S G+ FE++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVL--------NKNLGKIAEEQFMAEVGTIGRTYHIN 82
+G G FG VY G +G +AVK + +K+ + + E+ + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHE 140
+V+ G D + EY+ GS+ L +G A E + KGL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH- 123
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG----YKGTPGYSAP 196
+ IIH DIK N+L+D K++DFG++K + N +G +G+ + AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 197 EFLSGNYPITHKCDVYSFGMVSFEI 221
E + T K D++S G + E+
Sbjct: 182 EVVKQTS-YTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
+GL Y+H ++H D+KP N+LL+AN K+ DFGLA+ +T Y T
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT--EYVVTRW 173
Query: 193 YSAPEFL--SGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE L Y T DV+S G + E++GR+
Sbjct: 174 YRAPELLLNCSEY--TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTP 191
+GL YLH +IH D+KP N+L+++N K+ DFGLA+ + ++ Y T
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 192 GYSAPEFL--SGNY--PITHKCDVYSFGMVSFEIVGRR 225
Y APE L S Y I D++S G + E++ R+
Sbjct: 171 WYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 35/209 (16%)
Query: 31 RLGFGGFGQVY-----KGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
RLG G FG VY K +K+ ++ L Q E + + H +V+
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 86 LHGFCHDQHMTALVYEYMENGSLD---------GYLFGKKRALEWEKLHEIAIGTAKGLV 136
H ++ ++ EY E LD G + + EW I G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLLLGVH 120
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL----CDRNRSHVTISGYKGTPG 192
Y+H Q+RI+H D+K +N+ L N K+ DFG+++L CD + + GTP
Sbjct: 121 YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD------LATTFTGTPY 170
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
Y +PE L + K D++S G + +E+
Sbjct: 171 YMSPEALK-HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 5/95 (5%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVT-ISGYKGT 190
+GL Y+H +IH D+KP N+L++ + ++ DFG+A+ L H ++ Y T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE L T D++S G + E++GRR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 32 LGFGGFGQVY----KGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HIN--- 82
LG G +G+V+ G G A+KVL K I ++ AE R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKK--ATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 83 -LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
LV LH L+ +Y+ G L +L+ ++ E+ + A+ ++ L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF----TESEVRVYIAEIVLALDHL 121
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
Q II+ DIK EN+LLD+ + DFGL+K S + GT Y APE + G
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRG 180
Query: 202 NYPITHKC-DVYSFGMVSFEIV 222
K D +S G+++FE++
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTY-HINLVRLH 87
LG G FG+V+ + A+K L K++ + + E M E + + H L H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT--H 60
Query: 88 GFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVYLHE 140
+C Q L V EY+ G L ++ F RA + EI G L +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAA--EIICG----LQFLH- 113
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
+ I++ D+K +N+LLD + K+ADFG+ K + + GTP Y APE L
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 201 GNYPITHKCDVYSFGMVSFEIV 222
G D +SFG++ +E++
Sbjct: 170 GQ-KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 32 LGFGGFGQVYK-GQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI-GRTYHINLVRLHGF 89
+G G +G+V+K NG K AVK+L+ + I EE AE + + H N+V+ +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEE-IEAEYNILKALSDHPNVVKFYGM 83
Query: 90 CHDQHMTA-----LVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIG-----TAKGLVYL 138
+ + + LV E GS+ + G KR E++ E I GL +L
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG---ERMEEPIIAYILHEALMGLQHL 140
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-RNRSHVTISGYKGTPGYSAP 196
H + IH D+K N+LL K+ DFG+ A+L R R + ++ GTP + AP
Sbjct: 141 HV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMAP 193
Query: 197 EFLSGNYPI----THKCDVYSFGMVSFEI 221
E ++ + +CDV+S G+ + E+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 20/108 (18%)
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA-KLCD---RNR 179
L ++ + K L YL E+ +IH D+KP N+LLDA+ + K+ DFG++ +L D + R
Sbjct: 116 LGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR 173
Query: 180 SHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVSFEIV 222
S G Y APE + Y I + DV+S G+ E+
Sbjct: 174 S-------AGCAAYMAPERIDPPDPNPKYDI--RADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNL--GKIAEEQFMAEVGTIGRTYHIN---LVR 85
+G G FGQVY+ + + +I A+KVL+K K + E + RT +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVYLHE 140
L LV +YM G L +L F + RA + + E+ + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELVLA----LEHLHK 114
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEF 198
I++ D+KPEN+LLDA + DFGL+K L D T + + GT Y APE
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK----TTNTFCGTTEYLAPEV 167
Query: 199 LSGNYPITHKCDVYSFGMVSFEI 221
L T D +S G++ FE+
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 57/177 (32%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 32 LGFGGFGQVYKGQFPNGVK-IAVKVLN-KNLGKIAEEQFM-AEVGTIGRTYHINLVRLHG 88
+G G FG+V+ + A+KV+ + ++ +EQ + E + H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
HDQ ++ EY+ G L YL F L + EI L YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS--EIVCA----LEYLH---S 119
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFL 199
+ I++ D+KPEN+LLD K+ DFG AK L DR T+ GTP Y APE +
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WTLC---GTPEYLAPEVI 170
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 79/271 (29%), Positives = 110/271 (40%), Gaps = 46/271 (16%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMA--EVGTIGRTYHINLVRLHG 88
LG GGFG+V Q G A K L K K + + MA E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ LV M G L ++ F ++RA+ + EI G L LH E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA--EITCG----LEDLHRE 121
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
RI++ D+KPEN+LLD +++D GLA TI G GT GY APE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVK- 174
Query: 202 NYPITHKCDVYSFGMVSFEIVG-----RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256
N T D + G + +E++ R+R V E ++ K EEY
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERRVKEDQEEY--------- 224
Query: 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADR 287
EK E A+ +C L P R
Sbjct: 225 -----SEKFSEAARSICRQLL---TKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 9e-10
Identities = 43/129 (33%), Positives = 60/129 (46%), Gaps = 25/129 (19%)
Query: 98 LVYEYMENGSLDGYLFGKKRALEWEKLHE--IAIGTAKGLVYLHEECQQRIIHYDIKPEN 155
LV+EYME D + + LE +H+ I K L Y+H +IH D+KP N
Sbjct: 86 LVFEYMET---DLHAVIRANILE--DVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSN 137
Query: 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG---------YSAPEFLSGNYPIT 206
+LL+++ K+ADFGLA RS + P Y APE L G+ T
Sbjct: 138 ILLNSDCRVKLADFGLA------RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYT 191
Query: 207 HKCDVYSFG 215
D++S G
Sbjct: 192 KGVDMWSVG 200
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLN--KNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
++G G F +VY+ +GV +A+K + + A + E+ + + H N+++ +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 88 GFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEK-LHEIAIGTAKGLVYLHEECQQ 144
+ + +V E + G L + F K++ L EK + + + L ++H +
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SR 125
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGN 202
R++H DIKP NV + A K+ D GL + S T + + GTP Y +PE + N
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 203 YPITHKCDVYSFGMVSFEI 221
K D++S G + +E+
Sbjct: 182 -GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 27 NYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNL--------GKIAEEQFMAEVGTIGR 77
N+ LG G FG+V + ++ A+K+L K++ + E++ +A G
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 78 TYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI--AIGTAKGL 135
L +LH V EY+ G L ++ ++ +++ H + A A GL
Sbjct: 63 -----LTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGL 114
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
+LH + II+ D+K +NV+LD+ K+ADFG+ K + VT + GTP Y A
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIA 169
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVG 223
PE ++ P D ++FG++ +E++
Sbjct: 170 PEIIAYQ-PYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 32 LGFGGFGQV-YKGQFPNGVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRLH 87
LG G FG+V + +G A+K+L K + IA+++ + E + T H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEV-IIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
+ V EY+ G L +L ++R ++ L YLH +I+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVSALDYLH---SGKIV 117
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
+ D+K EN++LD + K+ DFGL K + T+ + GTP Y APE L N
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDN-DYGR 174
Query: 208 KCDVYSFGMVSFEIVGRR 225
D + G+V +E++ R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 19/181 (10%)
Query: 47 NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMEN 105
+G ++AVK+++ L K + + I R Y H N+V ++ ++ E+++
Sbjct: 45 SGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102
Query: 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
G+L + + L E++ + + L YLH Q +IH DIK +++LL + K
Sbjct: 103 GALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVK 157
Query: 166 VADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
++DFG ++K + +S V GTP + APE +S P + D++S G++ E+
Sbjct: 158 LSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEM 210
Query: 222 V 222
V
Sbjct: 211 V 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 42/211 (19%)
Query: 32 LGFGGFGQVY---KGQFPN-GVKIAVKVLNKNLGKI-------AEEQFMAEVGTIGRTYH 80
LG G FG+V+ K P+ G A+KVL K K+ E +AEV H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------H 57
Query: 81 INLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEK-----LHEIAIGTAKGL 135
+V+LH + L+ +++ G L L K + E+ L E+A+ L
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALA----L 111
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGY 193
+LH II+ D+KPEN+LLD K+ DFGL+K + +++ + GT Y
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY----SFCGTVEY 164
Query: 194 SAPEFLS--GNYPITHKCDVYSFGMVSFEIV 222
APE ++ G+ T D +SFG++ FE++
Sbjct: 165 MAPEVVNRRGH---TQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTP 191
+GL Y+H ++H D+KP N+LL+ N K+ DFGLA++ D H ++ Y T
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 192 GYSAPEFL--SGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE + S Y T D++S G + E++ R
Sbjct: 174 WYRAPEIMLNSKGY--TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 32 LGFGGFGQV-YKGQFPNGVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRLH 87
LG G FG+V + G A+K+L K + IA+++ + E + T H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
V EY G L +L ++R E+ L YLH + ++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRDVV 117
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
+ DIK EN++LD + K+ DFGL K + + T+ + GTP Y APE L N
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN-DYGR 174
Query: 208 KCDVYSFGMVSFEIVGRR 225
D + G+V +E++ R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 12/112 (10%)
Query: 110 GYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169
G L + + +EW + A L YLHE+ I+H D+K +NV L KV D
Sbjct: 96 GKLLPENQVVEW------FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDL 146
Query: 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
G+A++ + S GTP Y +PE S N P +K DV++ G +E+
Sbjct: 147 GIARVLENQCDMA--STLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 18/199 (9%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE-------EQFMAEVGTIGRTYHINL 83
+G GGFG+VY + + K+ A+K L+K K+ + E+ M + + G I +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-V 60
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ F H + + M G L Y + +++ A GL ++H
Sbjct: 61 CMTYAF-HTPDKLCFILDLMNGGDLH-YHLSQHGVFSEKEMRFYATEIILGLEHMH---N 115
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
+ +++ D+KP N+LLD + +++D GLA + + H ++ GT GY APE L
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGT 171
Query: 204 PITHKCDVYSFGMVSFEIV 222
D +S G + F+++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 19/181 (10%)
Query: 47 NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH-INLVRLHGFCHDQHMTALVYEYMEN 105
G ++AVK ++ L K + + I R YH N+V ++ +V E++E
Sbjct: 46 TGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
G+L + + + E++ + + + L YLH Q +IH DIK +++LL ++ K
Sbjct: 104 GALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 158
Query: 166 VADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
++DFG ++K + +S V GTP + APE +S P + D++S G++ E+
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEM 211
Query: 222 V 222
+
Sbjct: 212 I 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 32 LGFGGFGQV-YKGQFPNGVKIAVKVLNKNLGKIAEE--QFMAEVGTIGRTYHINLVRLHG 88
LG G FG+V + G A+K+L K + +E + E + + H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
V EY G L +L ++R ++ L YLH E + +++
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+K EN++LD + K+ DFGL K + + T+ + GTP Y APE L N
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRA 176
Query: 209 CDVYSFGMVSFEIVGRR 225
D + G+V +E++ R
Sbjct: 177 VDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRL 86
R+G G +G VYK + N G A+KV+ G E F E+ + H N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G + + E+ GSL ++ L ++ ++ T +GL YLH + +
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--- 127
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK---GTPGYSAPEFLS--- 200
+H DIK N+LL N K+ADFG++ + TI+ K GTP + APE +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA-----QITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 201 -GNYPITHKCDVYSFGMVSFEI 221
G Y CD+++ G+ + E+
Sbjct: 183 KGGY--NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLN--KNLGKIAEEQFMAEVGTIGRTYHINLVR-L 86
++G G F +VY+ + +A+K + + + A + + E+ + + H N+++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEK-LHEIAIGTAKGLVYLHEECQ 143
F D + +V E + G L + F K++ L E+ + + + + ++H
Sbjct: 69 DSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---S 124
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSG 201
+R++H DIKP NV + A K+ D GL + S T + + GTP Y +PE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERIHE 180
Query: 202 NYPITHKCDVYSFGMVSFEI 221
N K D++S G + +E+
Sbjct: 181 N-GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 16/175 (9%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAE--VGTIGRTYHINLVRL 86
LG G FG+V + ++ AVKVL K+ L E M E + ++ R H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQL 61
Query: 87 HGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
+C Q L V E++ G L + K R + + A L++LH+ +
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEITSALMFLHD---K 115
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
II+ D+K +NVLLD K+ADFG+ K + + T S + GTP Y APE L
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 19/181 (10%)
Query: 47 NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMEN 105
+G +AVK ++ L K + + I R Y H N+V ++ +V E++E
Sbjct: 44 SGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165
G+L + + + E++ + + K L LH Q +IH DIK +++LL + K
Sbjct: 102 GALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVK 156
Query: 166 VADFG----LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
++DFG ++K R +S V GTP + APE +S P + D++S G++ E+
Sbjct: 157 LSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEM 209
Query: 222 V 222
V
Sbjct: 210 V 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 31 RLGFGGFGQ-VYKGQFPNGVKIAVKVLN-KNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G FG+ + +G + +K +N + E+ EV + H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 89 FCHDQHMTALVYEYMENGSL-------DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ +V +Y E G L G LF + + L+W + L ++H+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKHVHD- 119
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
++I+H DIK +N+ L + + K+ DFG+A++ N + GTP Y +PE
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEICE- 174
Query: 202 NYPITHKCDVYSFGMVSFEI 221
N P +K D+++ G V +E+
Sbjct: 175 NRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNK-NLGKIAEEQ-FMAEVGTIGRTYHINLVRLHG 88
+G G FG+V + N K+ A+K+LNK + K AE F E + + + LH
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
D++ LV +Y G L L F + + + + A+ ++ + Q
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHY 123
Query: 147 IHYDIKPENVLLDANFSPKVADFG-LAKLCDRNRSHVTISGYKGTPGYSAPEFLS----G 201
+H DIKP+N+L+D N ++ADFG KL + +++ GTP Y +PE L G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDG 181
Query: 202 NYPITHKCDVYSFGMVSFEIV 222
+CD +S G+ +E++
Sbjct: 182 KGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 28 YSTRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ----FMAEVGTIGRTYHIN 82
+ LG FG++YKG + G+ A V K L I Q F E + +H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK----------------KRALEWEKLHE 126
+V L G + +++EY+ G L +L + K +L+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
IAI A G+ YL +H D+ N+L+ K++D GL+ R +
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLS------REIYSADY 179
Query: 187 YKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVSFEI 221
Y+ P + PE + G + + D++SFG+V +EI
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKF--SSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNK-NLGKIAEEQFMAE---VGTIGRTYHINLVRL 86
+G G FG+V + N ++ A+K+LNK + K AE E V G I L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT--NL 66
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
H D++ LV +Y G L L F + + + + A+ ++ + Q
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLAIDSVHQL 121
Query: 145 RIIHYDIKPENVLLDANFSPKVADFG--LAKLCDRN-RSHVTISGYKGTPGYSAPEFL-- 199
+H DIKP+NVLLD N ++ADFG L L D +S+V + GTP Y +PE L
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV----GTPDYISPEILQA 177
Query: 200 ----SGNYPITHKCDVYSFGMVSFEI 221
G Y +CD +S G+ +E+
Sbjct: 178 MEDGKGRY--GPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
+GL YLH QRIIH D+K EN+ ++ + D G A+ G GT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVE 221
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+APE L+ + K D++S G+V FE++
Sbjct: 222 TNAPEVLARD-KYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 6 QEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKG-QFPNGVKIAVKVLNKNL- 60
+E+ + E P R+TSL ++G G +G V G K+A+K L++
Sbjct: 4 EEVNKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ 53
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRL------HGFCHDQHMTALVYEYMENGSLDGYLFG 114
+I ++ E+ + H N++ L + LV YM+
Sbjct: 54 SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD------LQ 107
Query: 115 KKRALEW--EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
K +K+ + GL Y+H IIH D+KP N+ ++ + K+ DFGLA
Sbjct: 108 KIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+ D ++GY T Y APE + D++S G + E++
Sbjct: 165 RHAD-----AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 25 TSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNL--------GKIAEEQFMAEVGTI 75
N+ LG G FG+V + ++ A+K+L K++ + E++ +A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL---- 56
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIG 130
+ L +LH V EY+ G L ++ F + +A+ + EI++G
Sbjct: 57 -QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA--EISVG 113
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
L +LH + II+ D+K +NV+LD+ K+ADFG+ K + VT + GT
Sbjct: 114 ----LFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG 223
P Y APE ++ P D +++G++ +E++
Sbjct: 165 PDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 63/185 (34%), Positives = 84/185 (45%), Gaps = 31/185 (16%)
Query: 32 LGFGGFG---QVYKGQFPNGVKI-AVKVLNKNLGKIAEEQ-----FMAEVGTIGRTYHIN 82
LG GG+G QV K + KI A+KVL K I Q AE + H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKK--ATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVY 137
+V L L+ EY+ G L +L F + A + L EI++ L +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--LSEISLA----LEH 115
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSA 195
LH QQ II+ D+KPEN+LLDA K+ DFGL K + + +H + GT Y A
Sbjct: 116 LH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----FCGTIEYMA 168
Query: 196 PEFLS 200
PE L
Sbjct: 169 PEILM 173
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVL--NKNLGKIAEE--QFMAEVGTIGRTYHINLVRL 86
LG G FG+VY G ++AVK + + + ++E E+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 87 HGFCHD--QHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+G D + ++ E+M GS+ L +G AL + +G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH--- 123
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNRSHVTISGYKGTPGYSAPEF 198
I+H DIK N+L D+ + K+ DFG +K +C S + GTP + +PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC---LSGTGMKSVTGTPYWMSPEV 180
Query: 199 LSGNYPITHKCDVYSFGMVSFEIVGRR 225
+SG K D++S G E++ +
Sbjct: 181 ISGE-GYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 76/261 (29%), Positives = 108/261 (41%), Gaps = 43/261 (16%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMA--EVGTIGRTYHINLVRLHG 88
LG GGFG+V Q G A K L K K + + MA E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYL-------FGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ LV M G L ++ F ++RA+ + A GL L E
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY------AAELCCGLEDLQRE 121
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
RI++ D+KPEN+LLD +++D GLA T+ G GT GY APE ++
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVIN- 174
Query: 202 NYPITHKCDVYSFGMVSFEIVG-----RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256
N T D + G + +E++ R+R V E +D K EEY
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKEDQEEY--------- 224
Query: 257 LACGIEEKDKEKAKQLCMVAL 277
EK E AK +C + L
Sbjct: 225 -----SEKFSEDAKSICRMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 32 LGFGGFGQVYKGQ-FPNG--------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN 82
+G G +G+V+K + NG V++ L I E + + T H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPN 65
Query: 83 LVRLHGFC------HDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGL 135
+VRL C + +T LV+E+++ L YL + + E + ++ +GL
Sbjct: 66 VVRLFDVCTVSRTDRETKLT-LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
+LH R++H D+KP+N+L+ ++ K+ADFGLA++ + ++ T Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRA 177
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234
PE L + T D++S G + E+ RR+ G+S+
Sbjct: 178 PEVLLQSSYAT-PVDLWSVGCIFAEMF-RRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
+GL Y+H ++H D+KP N+L++ N K+ DFGLA++ D +T GY T
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMT--GYVSTRY 170
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
Y APE + + D++S G + E++
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 18/153 (11%)
Query: 35 GGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91
G FG+VY G+ N K+ AVKV+ K + K Q AE + + +V L+
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 92 DQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ LV EY+ G + L F ++ A+++ + E+A+ L YLH + I
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALA----LDYLH---RHGI 125
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
IH D+KP+N+L+ K+ DFGL+K+ NR
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKV-TLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNK-NLGKIAEEQFMAEVGTIGRTYHIN-LVRLHG 88
+G G FG+V + + K+ A+K+L+K + K ++ F E I + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
D +V EYM G L + +W + + TA+ ++ L IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIH 165
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPI 205
D+KP+N+LLD + K+ADFG ++ V GTP Y +PE L G+
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 206 THKCDVYSFGMVSFEIV 222
+CD +S G+ +E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 39/110 (35%), Positives = 55/110 (50%), Gaps = 4/110 (3%)
Query: 111 YLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170
YL + R L ++ +A + Y+H E IIH DIK ENVL++ + DFG
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG 305
Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
A + S G GT +APE L+G+ P T D++S G+V FE
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAE--VGTIGRTYHINLVRL 86
LG G FG+V + ++ A+KVL K+ L + M E + + H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-HPFLTAL 61
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
H + V EY+ G L + + R + + A L++LH + +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGV 117
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
I+ D+K +N+LLDA K+ADFG+ K + + VT + + GTP Y APE L
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ-ELEYG 174
Query: 207 HKCDVYSFGMVSFEIV 222
D ++ G++ +E++
Sbjct: 175 PSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 60/195 (30%), Positives = 84/195 (43%), Gaps = 11/195 (5%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMA--EVGTIGRTYHINLVRLHG 88
LG GGFG+V Q G A K L K K + + MA E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
+ LV M G L +++ E E+ A GL LH E +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTV 124
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
+ D+KPEN+LLD +++D GLA S I G GT GY APE L+ N T
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLN-NQRYTL 180
Query: 208 KCDVYSFGMVSFEIV 222
D + G + +E++
Sbjct: 181 SPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 35/113 (30%), Positives = 47/113 (41%), Gaps = 39/113 (34%)
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAK--------LCDRNRSHVTISGYK---------- 188
IH DIKP+N+LLDA K++DFGL R SH S +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 189 ------------------GTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
GTP Y APE FL Y +CD +S G++ +E++
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 22/201 (10%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE-------EQFMAEVGTIGRTYHINL 83
+G GGFG+VY + + K+ A+K L+K K+ + E+ M + + G I +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-V 60
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ F H + + + M G L Y + ++ A GL ++H
Sbjct: 61 CMSYAF-HTPDKLSFILDLMNGGDLH-YHLSQHGVFSEAEMRFYAAEIILGLEHMH---N 115
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD--RNRSHVTISGYKGTPGYSAPEFLSG 201
+ +++ D+KP N+LLD + +++D GLA CD + + H ++ GT GY APE L
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV----GTHGYMAPEVLQK 169
Query: 202 NYPITHKCDVYSFGMVSFEIV 222
D +S G + F+++
Sbjct: 170 GVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 40/211 (18%)
Query: 29 STRLGFGGFGQVYKGQFP-NGVKIAVK-VLNKNLGKIAEEQF----MAEVGTIGRTYHIN 82
++G G FG+V+K + +A+K VL +N +E F + E+ + H N
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN----EKEGFPITALREIKILQLLKHEN 72
Query: 83 LVRLHGFCH--------DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKG 134
+V L C + LV+E+ E+ L G L K ++ ++ G
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA------KLCDRNRSHVTISGYK 188
L Y+H + +I+H D+K N+L+ + K+ADFGLA K NR +
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR----YTNRV 184
Query: 189 GTPGYSAPEFLSG--NY--PITHKCDVYSFG 215
T Y PE L G +Y PI D++ G
Sbjct: 185 VTLWYRPPELLLGERDYGPPI----DMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 23/153 (15%)
Query: 32 LGFGGFGQVYKGQF---PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY----HINLV 84
+G G FG+V + ++ VK L N + +F+ + G Y H N++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQ----GDPYRILQHPNIL 58
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL------FGKKRALEWEKLHEIAIGTAKGLVYL 138
+ G C + LV+EY E G L YL + L L +A A G+ ++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL---LQRMACEIAAGVTHM 115
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
H + +H D+ N L ++ + KV D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQF----MAEVGTIGRTYHINLVRLH 87
+G G +GQVYK + + + L K +E F + E+ + + H N+V L
Sbjct: 15 IGEGTYGQVYKAR--DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 88 ----------GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVY 137
F D+ LV+EYM++ L G L + + +GL Y
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPGYS 194
H ++ +H DIK N+LL+ K+ADFGLA+L + S Y T Y
Sbjct: 132 CH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP----YTNKVITLWYR 184
Query: 195 APEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
PE L G DV+S G + E+ ++
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF----MAEVGTIGRTYH-INLV 84
++G G +G+VYK + G +A+K K ++ EE + E+ + I +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 85 RLHGFCHDQH-----MTALVYEYMEN---GSLDGYLFGKKRALEWEKLHEIAIGTAKGLV 136
RL H + LV+EY+++ +D G R L + + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 137 YLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKG---TPG 192
+ H + ++H D+KP+N+L+D K+AD GL R S + + Y T
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLG----RAFS-IPVKSYTHEIVTLW 176
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234
Y APE L G+ + D++S G + E+ R++ G SE
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 26/150 (17%)
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHEIAIGTAKGLVYL 138
+ N ++L+ L+ +Y+++G L D L K+ L ++ +I + L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 139 HEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAP 196
H + IIH DIK ENVL D A + D+GL K + T S Y GT Y +P
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYFSP 175
Query: 197 EFLSGNYPITHKCDVYSF-----GMVSFEI 221
E + G H D SF G++++E+
Sbjct: 176 EKIKG-----HNYD-VSFDWWAVGVLTYEL 199
|
Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 32 LGFGGFGQVY----KGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HIN--- 82
LG G +G+V+ +G A+KVL K I ++ E R HI
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK--ATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 83 -LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
LV LH L+ +Y+ G L +L ++R E E+ I + + ++ L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFL 199
+ II+ DIK EN+LLD+N + DFGL+K D + GT Y AP+ +
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC---GTIEYMAPDIV 178
Query: 200 SGNYPITHKC-DVYSFGMVSFEIV 222
G K D +S G++ +E++
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 34/234 (14%)
Query: 4 FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKG-QFPNGVKIAVKVLNKN 59
+ QE+ + E P R+ +L + +G G +G V G+++AVK L++
Sbjct: 4 YRQELNKTIWEVPERYQNL----------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 53
Query: 60 LGKIAE-EQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFG---- 114
I ++ E+ + H N++ L D A E + L +L G
Sbjct: 54 FQSIIHAKRTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLN 109
Query: 115 ---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
K + L + + + +GL Y+H IIH D+KP N+ ++ + K+ DFGL
Sbjct: 110 NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 166
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
A+ D ++GY T Y APE + D++S G + E++ R
Sbjct: 167 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
TA+ L L + +I+ D+KPEN+LLD + DFGL KL ++ + + GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGT 156
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
P Y APE L G + T D ++ G++ +E++
Sbjct: 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 57/235 (24%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNK-------NLGKI-AEEQFMAEVGTIGRTYHIN 82
+G G FG+V Q + G A+K+L K +G I AE + E ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW------ 62
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+V++ D+ L+ E++ G + L K E E IA T + +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH--- 118
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGL------------------------------- 171
Q IH DIKP+N+LLD+ K++DFGL
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 172 ---AKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
A+ RNR + S GTP Y APE F+ Y CD +S G++ +E++
Sbjct: 179 KRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 4/100 (4%)
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
I + L YLH + IIH D+K EN+ LD + + DFG A D + G
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRR 226
+ GT ++PE L+ + P K D++S G+V FE+ +
Sbjct: 247 WSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 53/229 (23%), Positives = 81/229 (35%), Gaps = 44/229 (19%)
Query: 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVG 73
R+ Q LG G +G+V K G +A+K + + VG
Sbjct: 9 RYI--QKGAH-------LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVG 59
Query: 74 TIGRTYHINLVR----LHGFCHDQHMTA-----------LVYEYMENGSLDGYLFGKKRA 118
G H +R ++ H+ M LV + M L + K R
Sbjct: 60 MCG--IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRL 116
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
E + I + GL LH + +H D+ P N+ +++ K+ADFGLA+
Sbjct: 117 TESQV-KCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
Query: 179 RSHVTISGYKG------------TPGYSAPEFLSGNYPITHKCDVYSFG 215
T+S + T Y APE L G D++S G
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G G VY G ++A+K +N + +E + E+ + + N+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 82
Query: 90 CHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
D ++ +V EY+ GSL + + ++ ++ + + L +LH +
Sbjct: 83 --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQ 135
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
+IH DIK +N+LL + S K+ DFG A++ T+ GTP + APE ++
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191
Query: 205 ITHKCDVYSFGMVSFEIV 222
K D++S G+++ E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G G VY G ++A+K +N + +E + E+ + H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYL-- 82
Query: 90 CHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
D ++ +V EY+ GSL + + ++ ++ + + L +LH +
Sbjct: 83 --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 135
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
+IH DIK +N+LL + S K+ DFG A++ T+ GTP + APE ++
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191
Query: 205 ITHKCDVYSFGMVSFEIV 222
K D++S G+++ E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 51/230 (22%)
Query: 5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKI 63
L + E P R+ +L +G G +GQV G K+A+K L+
Sbjct: 6 LNKTVWEVPDRYQNLSP----------VGSGAYGQVCSAFDTKTGRKVAIKKLS------ 49
Query: 64 AEEQFMAEVGTIGRTY----------HINLVRL-HGFCHDQHMTA-----LVYEYMENGS 107
F + + RTY H N++ L F + LV M
Sbjct: 50 --RPFQSAIHA-KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GAD 105
Query: 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167
L+ + K + L + + + +GL Y+H IIH D+KP N+ ++ + K+
Sbjct: 106 LNNIV--KCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKIL 160
Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPE--FLSGNYPITHKCDVYSFG 215
DFGLA+ D ++GY T Y APE +Y D++S G
Sbjct: 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY--NQTVDIWSVG 203
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVL--NKNLGKIAEE--QFMAEVGTIGRTYHINLVRL 86
LG G FG+VY G ++AVK + + + + ++E E+ + H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 87 HGFC---HDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+G C ++ ++ EYM GS+ L +G AL +G+ YLH
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH-- 123
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNRSHVTISGYKGTPGYSAPE 197
I+H DIK N+L D+ + K+ DFG +K +C S I GTP + +PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC---MSGTGIKSVTGTPYWMSPE 179
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIVGRR 225
+SG K DV+S E++ +
Sbjct: 180 VISGE-GYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 53/175 (30%), Positives = 74/175 (42%), Gaps = 24/175 (13%)
Query: 32 LGFGGFGQV----YKGQFPNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V +KG G A+K L K L + E + H +V
Sbjct: 26 LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQ 144
+ D++ + E++ G L +L R + K + + A YLH +
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FEYLHS---K 137
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPE 197
II+ D+KPEN+LLD KV DFG AK V + GTP Y APE
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTLCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 62 KIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
K + A I R H ++++L G T L+ + L YL K+
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAI 181
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC----- 175
+ L I + + YLHE RIIH DIK EN+ ++ + DFG A C
Sbjct: 182 CDIL-AIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDI 235
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
+ N+ + G+ GT +APE L+ + P D++S G+V FE+
Sbjct: 236 NANKYY----GWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVKVL--NKNLGKIAEE--QFMAEVGTIGRTYHINLVRL 86
LG G FG+VY G ++A K + + + ++E E+ + H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 87 HGFCHD--QHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+G D + + EYM GS+ L +G AL + +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH--- 123
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK----LCDRNRSHVTISGYKGTPGYSAPEF 198
I+H DIK N+L D+ + K+ DFG +K +C S I GTP + +PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC---MSGTGIRSVTGTPYWMSPEV 180
Query: 199 LSGNYPITHKCDVYSFGMVSFEIVGRR 225
+SG K DV+S G E++ +
Sbjct: 181 ISGE-GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 32/230 (13%)
Query: 4 FLQEIGR---EKPVRFTSLQLNNFTSNYSTRLGFGGFGQV-YKGQFPNGVKIAVKVLNKN 59
+ QE+ + E P R+ L+ ++G G +G V G K+A+K L +
Sbjct: 2 YRQEVNKTIWEVPDRYRDLK----------QVGSGAYGTVCSALDRRTGAKVAIKKLYRP 51
Query: 60 L-GKIAEEQFMAEVGTIGRTYHINLVRLHG-FCHDQHMTA-----LVYEYMENGSLDGYL 112
++ ++ E+ + H N++ L F D + LV +M G+ G L
Sbjct: 52 FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKL 109
Query: 113 FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
K L +++ + KGL Y+H IIH D+KP N+ ++ + K+ DFGLA
Sbjct: 110 M-KHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+ D ++GY T Y APE + T D++S G + E++
Sbjct: 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 49/218 (22%)
Query: 32 LGFGGFGQVYKGQF-PNG----------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH 80
LG G F +YKG V + +KVL + + + F + + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLA-FFETASLMSQLSH 60
Query: 81 INLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
+LV+L+G C +V EY++ G LD +L +K + ++A A L YL +
Sbjct: 61 KHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS------ 194
++++H ++ +N+L+ A + KL D PG
Sbjct: 120 ---KKLVHGNVCGKNILV-ARYGLNEGYVPFIKLSD--------------PGIPITVLSR 161
Query: 195 ----------APEFLSGNYP-ITHKCDVYSFGMVSFEI 221
APE + +T D +SFG EI
Sbjct: 162 EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 41/164 (25%), Positives = 64/164 (39%), Gaps = 49/164 (29%)
Query: 80 HINLVRLHG-FCHDQHMTA-LVYEYME--------------NGSLDGYLFGKKRALEWEK 123
H N+V L F + L+++Y E S+ + ++L W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV---KSLLWQI 117
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLC---- 175
L+ G+ YLH ++H D+KP N+L+ K+ D GLA+L
Sbjct: 118 LN--------GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 176 ----DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
D + VTI Y APE L G T D+++ G
Sbjct: 167 KPLADLDPVVVTI-------WYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 32 LGFGGFGQVY---KGQFPNGVKI-AVKVLNKNLGKIAEEQFMAEVGTIGRTY--HIN--- 82
LG G +G+V+ K + K+ A+KVL K + ++ E R H+
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQK--AALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 83 -LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
LV LH + L+ +Y+ G + +L+ + E E+ + + ++ L
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHL 121
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
+ I++ DIK EN+LLD+ + DFGL+K T S + GT Y APE + G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRG 180
Query: 202 NYPITHKCDVYSFGMVSFEIV 222
D +S G++ FE++
Sbjct: 181 KGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 54/231 (23%), Positives = 90/231 (38%), Gaps = 41/231 (17%)
Query: 20 QLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVG 73
++N T + LG FG+VYKG +A+K L E+F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 74 TIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRA 118
R H N+V L G + ++++ Y + L +L + K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
LE I A G+ +L ++H D+ NVL+ + K++D GL +
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----- 172
Query: 179 RSHVTISGYKGTPGYS-------APE-FLSGNYPITHKCDVYSFGMVSFEI 221
V + Y G S +PE + G + I D++S+G+V +E+
Sbjct: 173 --EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI--DSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 45/229 (19%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G FG+V Q + I A+K+L K L K AE + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
D+ L+ E++ G + L KK L E T + +H Q IH
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIH---QLGFIH 124
Query: 149 YDIKPENVLLDANFSPKVADFGL----------------------------------AKL 174
DIKP+N+LLDA K++DFGL A+
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 175 CDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
+NR + S GTP Y APE F+ Y CD +S G++ +E++
Sbjct: 185 WKKNRRQLAYSTV-GTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G G VY G ++A++ +N + +E + E+ + + N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL-- 83
Query: 90 CHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
D ++ +V EY+ GSL + + ++ ++ + + L +LH +
Sbjct: 84 --DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
+IH DIK +N+LL + S K+ DFG +S S GTP + APE ++
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVT-RKAY 193
Query: 206 THKCDVYSFGMVSFEIV 222
K D++S G+++ E++
Sbjct: 194 GPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
+GL Y+H IIH D+KP NV ++ + ++ DFGLA+ D ++GY T
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
Y APE + D++S G + E++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 40/125 (32%), Positives = 62/125 (49%), Gaps = 8/125 (6%)
Query: 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 157
LV+EY+E L+ L + EK+ K + + H + I+H DIKPEN+L
Sbjct: 77 LVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLL 132
Query: 158 LDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216
+ N K+ DFG A+ L + + ++ T Y T Y +PE L G P D++S G
Sbjct: 133 ISHNDVLKLCDFGFARNLSEGSNANYT--EYVATRWYRSPELLLGA-PYGKAVDMWSVGC 189
Query: 217 VSFEI 221
+ E+
Sbjct: 190 ILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G G V+ G ++A+K +N + +E + E+ + + N+V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFL-- 82
Query: 90 CHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
D + +V EY+ GSL + + ++ ++ + + L +LH +
Sbjct: 83 --DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQ 135
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
+IH DIK +NVLL + S K+ DFG A++ T+ GTP + APE ++
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT-RKA 191
Query: 205 ITHKCDVYSFGMVSFEIV 222
K D++S G+++ E+V
Sbjct: 192 YGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 32 LGFGGFGQVYKG---------QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN 82
LG G F +++KG + + ++ +KVL+K+ + E F + + H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGEL-HKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKH 60
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE--WEKLHEIAIGTAKGLVYLHE 140
LV +G C + +V EY++ GSLD YL K + W KL E+A A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-KL-EVAKQLAWALHFLED 118
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG---YKGTPGYSAPE 197
+ + H ++ +NVLL K + KL D S + + P + PE
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVPPE 174
Query: 198 FLSGNYPITHKCDVYSFGMVSFEI 221
+ ++ D +SFG +EI
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 32/197 (16%)
Query: 40 VYKGQFPNGVKIAVKVLNK--NLGKIAEEQFMAEVGTIGRTYHINLVRLHGF----CHDQ 93
+YKG F N ++ ++ K K+ + E+ + R N+++++GF D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
+L+ EY G L L K++ L ++ ++AI KGL L++ Y KP
Sbjct: 95 PRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYK--------YTNKP 145
Query: 154 ------ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGNY-P 204
+ L+ N+ K+ GL K+ ++ +K Y + + L+ +
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMVYFSYKMLNDIFSE 198
Query: 205 ITHKCDVYSFGMVSFEI 221
T K D+YS G+V +EI
Sbjct: 199 YTIKDDIYSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 9/84 (10%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG--TP 191
G+ +LH I+H D+K N+LL+ K+ DFGLA+ T + T
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT----QLVVTL 170
Query: 192 GYSAPEFLSGNYPITHKCDVYSFG 215
Y APE L G + D++S G
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 65/281 (23%), Positives = 112/281 (39%), Gaps = 42/281 (14%)
Query: 35 GGFGQVYKG-----QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
G FG+++ G + ++ VK + + +I + E + H N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 90 CHDQHMTALV-YEYMENGSLDGYL-------FGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
C + V Y YM G+L +L +AL ++L +AI A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-- 134
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
++ +IH DI N ++D K+ D L++ H + A E L
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 202 NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI----- 256
+ DV+SFG++ +E++ +L P + E + E+ A +
Sbjct: 194 KE-YSSASDVWSFGVLLWELM------------TLGQTP---YVEIDPFEMAAYLKDGYR 237
Query: 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
LA I D +L V C P +RP S +V+ L
Sbjct: 238 LAQPINCPD-----ELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 58/249 (23%), Positives = 95/249 (38%), Gaps = 70/249 (28%)
Query: 32 LGFGGFGQVY----KGQFPNGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINL 83
LG G G+V+ KG G A+KVL+K K+ + + E + H L
Sbjct: 9 LGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVK--RVLTEQEILATLDHPFL 63
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK--------GL 135
L+ + LV +Y G L R L+ + ++ A+ L
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELF-------RLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG--- 192
YLH I++ D+KPEN+LL + ++DF L+K D V+ + KG+
Sbjct: 117 EYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 193 ------------------------YSAPEFLSGNYPITH--KCDVYSFGMVSFEIV---- 222
Y APE +SG+ H D ++ G++ +E++
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD---GHGSAVDWWTLGILLYEMLYGTT 230
Query: 223 ---GRRRNA 228
G R+
Sbjct: 231 PFKGSNRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI--SGYKGT 190
+ L Y+H + H D+KP+N+L +A+ K+ DFGLA++ N + I + Y T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 191 PGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIV 222
Y APE L G++ T D++S G + E++
Sbjct: 170 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 15/97 (15%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKG-- 189
+GL Y+H ++H D+KP NV ++ + K+ DFGLA++ D + SH GY
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---KGYLSEG 178
Query: 190 --TPGYSAPEFL--SGNYPITHKCDVYSFGMVSFEIV 222
T Y +P L NY T D+++ G + E++
Sbjct: 179 LVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
GF ++ ++ + E E D Y K+ L E L + AKG+ +L ++ I
Sbjct: 151 GFVEEKSLSDV--EEEEAEQEDLY----KKVLTLEDLICYSFQVAKGMEFL---ASRKCI 201
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H D+ N+LL N K+ DFGLA+ ++ +V + + APE + T
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTI 260
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK-YVWEEYEKSELGAMILACGIEEKDK 266
+ DV+SFG++ +EI +GAS +P + EE+ ++E +
Sbjct: 261 QSDVWSFGVLLWEIFS------LGASP----YPGVKIDEEF----------CRRLKEGTR 300
Query: 267 EKA-----KQLCMVALWCVQDSPADRPPMSAVVKML 297
+A ++ L C P+ RP S +V+ L
Sbjct: 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 5/131 (3%)
Query: 98 LVYEYMENGSLDGYLFGKKRALEWE--KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155
L+ EY G L+ + K+R E + +E+ + + ++ L E ++++H D+K N
Sbjct: 142 LIMEYGSGGDLNKQI--KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
+ L K+ DFG +K + S S + GTP Y APE L + K D++S G
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLG 258
Query: 216 MVSFEIVGRRR 226
++ +E++ R
Sbjct: 259 VILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 61 GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV--------YEYMENGSLDGYL 112
G A Q E+ +GR H N++++ + T ++ Y +M + + D
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-- 260
Query: 113 FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
K R L + I + Y+H+ +++IH DIK EN+ L+ + + DFG A
Sbjct: 261 --KDRPLLKQT-RAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIVGR 224
++ R G+ GT ++PE L+G+ IT D++S G++ +++
Sbjct: 315 MPFEKEREAFDY-GWVGTVATNSPEILAGDGYCEIT---DIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 34/125 (27%), Positives = 63/125 (50%), Gaps = 9/125 (7%)
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
L+ E++ + G+ +LH IIH D+KP N+++ ++ + K+ DFGLA+ N
Sbjct: 120 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW 238
++ Y T Y APE + G D++S G + E+V + + I ++ +D
Sbjct: 177 ---FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELV--KGSVIFQGTDHIDQ 230
Query: 239 FPKYV 243
+ K +
Sbjct: 231 WNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
A+G+ +L ++ IH D+ N+LL N K+ DFGLA+ ++ +V +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY-VWEEYEKS 250
+ APE + T + DV+SFG++ +EI +GAS +P + EE+ +
Sbjct: 241 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS------LGASP----YPGVQINEEFCQR 289
Query: 251 ELGAMILACGIEEKDKEKAK-QLCMVALWCVQDSPADRPPMSAVVKML 297
L G + E A ++ + L C Q P +RP SA+V++L
Sbjct: 290 ------LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 35/120 (29%), Positives = 46/120 (38%), Gaps = 48/120 (40%)
Query: 147 IHYDIKPENVLLDANFSPKVADFGLA----KLCDRN------------------------ 178
IH DIKP+N+L+D K++DFGL+ K D
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 179 ------RSHVTISGYK-----------GTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFE 220
S I+ +K GTP Y APE FL Y +CD +S G + FE
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY--GQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
G+ +LH IIH D+KP N+++ ++ + K+ DFGLA+ + ++ Y T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 183
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
APE + G D++S G + E++
Sbjct: 184 RAPEVILG-MGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAK-LCDRNRSHVTISGYKGT 190
+ L Y+H + I H D+KP+N+L+D N + K+ DFG AK L RS Y +
Sbjct: 181 RALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICS 233
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
Y APE + G T D++S G + E++
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 24/141 (17%)
Query: 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 157
+V EY+E G L AL + T L YLH I+H D+KP+N+L
Sbjct: 78 MVMEYVEGGDC-ATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLL 133
Query: 158 LDANFSPKVADFGLAKLCDRNRSHVTISGYK-------------GTPGYSAPE-FLSGNY 203
+ + K+ DFGL+K+ + + G+ GTP Y APE L Y
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 204 --PITHKCDVYSFGMVSFEIV 222
P+ D ++ G++ +E +
Sbjct: 194 GKPV----DWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 15/205 (7%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG-- 88
++G G +G VYK + +G L + G E+ + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVY-----LHEECQ 143
H L+++Y E+ F + +K ++ G K L+Y +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 144 QRIIHYDIKPENVLLDANFSP-----KVADFGLAKLCDRN-RSHVTISGYKGTPGYSAPE 197
++H D+KP N+L+ P K+AD G A+L + + + T Y APE
Sbjct: 127 NWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIV 222
L G T D+++ G + E++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
L+ E++ + G+ +LH IIH D+KP N+++ ++ + K+ DFGLA+
Sbjct: 116 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 170
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+ ++ Y T Y APE + G D++S G + E+V
Sbjct: 171 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 118 ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177
AL+ E L + AKG+ +L + IH D+ N+LL K+ DFGLA+ R
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-R 265
Query: 178 NRSHVTISGYKGTP-GYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
N S+ + G P + APE + N T + DV+S+G++ +EI
Sbjct: 266 NDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 38/145 (26%), Positives = 59/145 (40%), Gaps = 18/145 (12%)
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
N+V LH + + LV ++ E G L ++ K + E + A L LH E
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFG----LAKLCDRNRSHVTISGYKGTPGYSAPE 197
I+ D+ P N+LLD ++ F + CD + Y APE
Sbjct: 105 ---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE----AVENM-----YCAPE 152
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIV 222
+ G T CD +S G + FE++
Sbjct: 153 -VGGISEETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 18/187 (9%)
Query: 116 KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
K L E L + A+G+ +L ++ IH D+ N+LL N K+ DFGLA+
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235
++ +V + + APE + T + DV+SFG++ +EI +GAS
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS------LGASP- 275
Query: 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+P +E L E E + C ++P DRP S +V+
Sbjct: 276 ---YPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD----CWHNNPEDRPTFSELVE 328
Query: 296 MLEGVVE 302
+L +++
Sbjct: 329 ILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 47/205 (22%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG-- 88
++G G +G VYK + +G L + G E+ + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVY-----LHEECQ 143
H L+++Y E+ F + +K ++ K L+Y +H
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 144 QRIIHYDIKPENVLLDANFSP-----KVADFGLAKLCDRN-RSHVTISGYKGTPGYSAPE 197
++H D+KP N+L+ P K+AD G A+L + + + T Y APE
Sbjct: 127 NWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIV 222
L G T D+++ G + E++
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 31/218 (14%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV----RLH 87
+G GGFG VY+ Q + I + + K + + E + E Y I+ + +H
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAK-IENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 88 GF----------CHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEK--LHEIAIGTA 132
C + Y ++ L K+ R K + I
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKL--VENTKEIFKRIKCKNKKLIKNIMKDML 136
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG-----Y 187
L Y+HE I H DIKPEN+++D N + D+G+A + H+ S +
Sbjct: 137 TTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLH 193
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
+GT Y+ + +G +T + D+ S G + G +
Sbjct: 194 RGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIK 230
|
Length = 294 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 29/104 (27%), Positives = 53/104 (50%), Gaps = 7/104 (6%)
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178
L+ E++ + G+ +LH IIH D+KP N+++ ++ + K+ DFGLA+
Sbjct: 123 LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+ ++ Y T Y APE + G D++S G + E++
Sbjct: 178 -TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 21/182 (11%)
Query: 49 VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108
+++ +KVL+ + IA F + + HI+L +HG C +V E++E+G L
Sbjct: 45 LRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168
D L +K + +A A L YL + + ++H ++ +N+LL A
Sbjct: 104 DVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILL--------AR 152
Query: 169 FGLA-------KLCDRNRSHVTISGYKGTP--GYSAPEFLSGNYPITHKCDVYSFGMVSF 219
GLA KL D S +S + + APE + G ++ D +SFG
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212
Query: 220 EI 221
EI
Sbjct: 213 EI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 35/122 (28%), Positives = 49/122 (40%), Gaps = 47/122 (38%)
Query: 147 IHYDIKPENVLLDANFSPKVADFGLA---------------------------------- 172
IH DIKP+N+L+D + K+ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 173 ---KLCDRN--RSHVTISGYK--GTPGYSAPEFL--SGNYPITHKCDVYSFGMVSFE-IV 222
K +R R H + GTP Y APE L +G T CD +S G++ +E +V
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY---TQLCDWWSVGVILYEMLV 239
Query: 223 GR 224
G+
Sbjct: 240 GQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 58/240 (24%), Positives = 88/240 (36%), Gaps = 55/240 (22%)
Query: 32 LGFGGFGQV-YKGQFPNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
LG G FG+V + A+K L K L + AE + + +VRL+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
D+ V +Y+ G + L + + E L I A+ + + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI--RMGIFPEDLARFYI--AELTCAVESVHKMGFIH 124
Query: 149 YDIKPENVLLDANFSPKVADFGL-----------------------------------AK 173
DIKP+N+L+D + K+ DFGL +
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 174 LCDR--------NRSHVTISGYK--GTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
DR R H + GTP Y APE L Y T CD +S G++ +E++
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 58/242 (23%), Positives = 92/242 (38%), Gaps = 59/242 (24%)
Query: 32 LGFGGFGQV-YKGQFPNGVKIAVKVLNK----NLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+V + A+K L K N ++A + AE + + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVK--AERDILAEADNEWVVKL 66
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ D+ V +Y+ G + L + + E L I A+ + + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYI--AELTLAIESVHKMGF 122
Query: 147 IHYDIKPENVLLDANFSPKVADFGL----------------------------------- 171
IH DIKP+N+L+D + K+ DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 172 AKLCDR--------NRSHVTISGYK--GTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFE 220
+ DR + H + GTP Y APE L Y T CD +S G++ FE
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY--TQLCDWWSVGVILFE 240
Query: 221 IV 222
++
Sbjct: 241 ML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 117 RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176
L+ + L + A+G+ +L + IH D+ NVLL K+ DFGLA+ D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR--D 261
Query: 177 -RNRSHVTISGYKGTP-GYSAPE-FLSGNYPITHKCDVYSFGMVSFEI 221
N S+ + G P + APE Y T + DV+S+G++ +EI
Sbjct: 262 IMNDSNYVVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 19/205 (9%)
Query: 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
T Y+ L + + + +K+ +KVL+ + I+ F + + H ++V
Sbjct: 9 TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISL-AFFETASMMRQVSHKHIV 67
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
L+G C +V E++E G LD ++ K L ++A A L YL + +
Sbjct: 68 LLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---K 124
Query: 145 RIIHYDIKPENVLL-----DANFSP--KVADFGLA-KLCDRNRSHVTISGYKGTPGYSAP 196
++H ++ +N+LL D P K++D G+ + R I + AP
Sbjct: 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP-------WIAP 177
Query: 197 EFLSGNYPITHKCDVYSFGMVSFEI 221
E + + ++ D +SFG +EI
Sbjct: 178 ECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.57 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.43 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.18 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.89 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.77 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.74 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.34 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.13 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.98 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.89 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.75 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.72 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.47 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.41 | |
| PLN02236 | 344 | choline kinase | 97.33 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.85 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.84 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.76 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.59 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.51 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.4 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.39 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.31 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 96.22 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.05 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-56 Score=402.02 Aligned_cols=285 Identities=42% Similarity=0.668 Sum_probs=246.7
Q ss_pred cceeCHHHHHHHhhccc--cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeE
Q 047701 13 PVRFTSLQLNNFTSNYS--TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90 (356)
Q Consensus 13 ~~~~~~~~~~~~~~~~~--~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 90 (356)
...|+..++..+|.+|. ++||+|+||.||+|.+.++..||||++....... ..+|..|+.++.+++|||+|+++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 44599999999999998 6899999999999999888999999887654332 45699999999999999999999999
Q ss_pred EcCC-eeeEEEEecCCCCHhHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 91 HDQH-MTALVYEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 91 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
.+.+ ..+||+|||.+|+|.++|..... .++|.++++|+.++|+||+|||+.++..|+||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 49999999999999999987666 899999999999999999999997777899999999999999999999999
Q ss_pred cCCccccCC-CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHH
Q 047701 169 FGLAKLCDR-NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247 (356)
Q Consensus 169 fGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (356)
||+|+.... ...... .. .||.+|+|||++... ..+.++||||||++++||++|+++...........+..|.+..+
T Consensus 221 FGLa~~~~~~~~~~~~-~~-~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVST-TV-MGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCcccCCccccceee-ec-CCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999976554 222111 11 799999999999875 68999999999999999999998887666555555788888888
Q ss_pred hhhchhhhHhhcCC-CchhH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 248 EKSELGAMILACGI-EEKDK-EKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 248 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.+..+.+++++... ..... .....+..++.+|++.+|.+||+|.+|++.|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 88888888888755 34343 57778999999999999999999999999996554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-54 Score=383.83 Aligned_cols=265 Identities=31% Similarity=0.454 Sum_probs=219.6
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-eeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-MTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 100 (356)
.....+.+.||+|+||+||+|.|.....||||.+.... .......|.+|+.+|.+++|||||+++|+|.+.. .+++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 33445566799999999999999443349999997542 2223678999999999999999999999999987 789999
Q ss_pred EecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eeeeccCccceEEcCCC-ceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQR-IIHYDIKPENVLLDANF-SPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~ 177 (356)
||+++|+|..++.. ....+++..++.++.|||.||+|||+ ++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999977 47899999999999999999999999 78 99999999999999997 999999999987665
Q ss_pred CCCceeecCCCCCCCCCCcccccC-CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.. ...+...||+.|||||++.+ ...++.++||||||+++|||+||+.|+...... ......+
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---------------~~~~~v~ 259 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---------------QVASAVV 259 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---------------HHHHHHH
Confidence 43 22344679999999999994 237999999999999999999999887433221 1122333
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCCC
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPP 307 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~ 307 (356)
....++..+..++..+..++.+||+.||..||++.+++..|+.+.......
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 344455556668899999999999999999999999999999887655443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-54 Score=367.30 Aligned_cols=253 Identities=27% Similarity=0.391 Sum_probs=216.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-eeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-MTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 102 (356)
..+..+.||+|.-|+||++.++ +++-+|+|++..+.......++.+|+++++..+|||||.+||.|..+. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4445678999999999999874 799999999987778888899999999999999999999999999998 49999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
|++|||++++. ..+++++..+.+++.++++||.|||+. ++||||||||+|+|++..|.+||||||.+....+.
T Consensus 160 MDgGSLd~~~k-~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK-RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred cCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999999994 447899999999999999999999952 89999999999999999999999999999987765
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
....++||..|||||.+++. .|+.++||||||++++|+..|+.|+.........+ -++...+.....+
T Consensus 233 ~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-----------~~Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-----------FELLCAIVDEPPP 300 (364)
T ss_pred hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH-----------HHHHHHHhcCCCC
Confidence 22457899999999999998 79999999999999999999999876542221111 1222333333344
Q ss_pred chhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 263 EKDKE-KAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 263 ~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+.+ +++++.+++..|+++||.+||++.+++++
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 55555 88999999999999999999999999873
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=385.12 Aligned_cols=264 Identities=27% Similarity=0.452 Sum_probs=232.9
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
..+++....+++.+.||+|-||.||.|.+....+||+|.++... ....+|.+|+++|++|+|+|||+++++|.....+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 45677778888999999999999999999777799999998642 4446789999999999999999999999998899
Q ss_pred eEEEEecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 97 ALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
|||||||..|+|.++|+. .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||||+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999986 56789999999999999999999999 99999999999999999999999999999955
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.+.... ...+.+-+..|.|||++... .++.+||||||||+||||+|-.+.+ +..+...++.+.
T Consensus 354 ~d~~Y~-~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~p---------------y~~msn~ev~~~ 416 (468)
T KOG0197|consen 354 GDDEYT-ASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVP---------------YPGMSNEEVLEL 416 (468)
T ss_pred CCCcee-ecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCC---------------CCCCCHHHHHHH
Confidence 444333 33455667889999999877 7999999999999999999954332 345566777888
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+..+.+.+.+..||.++.++|..||+.+|++||||+.+...|+.+..
T Consensus 417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 88888999999999999999999999999999999999999987754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=373.47 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=215.1
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.+|...+.||+|||+.||+++. .+|+.||+|++.+. ......+.+.+|+++.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6788899999999999999987 78999999999875 24466788999999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+|..++|..++. +.+.+++..+..++.||+.||.|||+ .+|+|||||..|+|++++.++||+|||||..+.....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999984 77899999999999999999999999 9999999999999999999999999999998875533
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.. ...+|||-|.|||++... .++..+||||+||+||-||.|++||....- .+.+...+...
T Consensus 174 rk--~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------kety~~Ik~~~------ 234 (592)
T KOG0575|consen 174 RK--KTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------KETYNKIKLNE------ 234 (592)
T ss_pred cc--ceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchH----------HHHHHHHHhcC------
Confidence 22 236799999999999977 799999999999999999999999843321 22222222111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+.++.+||..+|+.||.+|||+++|+.
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2344577888999999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-53 Score=346.77 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=214.0
Q ss_pred HHHHHHhhccccccCcCCceEEEEEE-cCCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEee-eEEcCC-
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHG-FCHDQH- 94 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~- 94 (356)
....-..|.+.++||+|.||+||++. ..+|..||.|.+.-. .......++..|+.+|++|+|||||++++ .+.++.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 44455678889999999999999995 568999999998743 34566678999999999999999999999 444444
Q ss_pred eeeEEEEecCCCCHhHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccC
Q 047701 95 MTALVYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
-++||||||.+|+|...+. +..+.+++.++|+++.|++.||.++|+.+++ -+.||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 4899999999999999884 3467899999999999999999999996644 39999999999999999999999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
|++.+...... ....+|||.||+||.+.+. +|+.+|||||+||++|||+.-..||..+.- -
T Consensus 174 L~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----------------~ 234 (375)
T KOG0591|consen 174 LGRFLSSKTTF--AHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNL----------------L 234 (375)
T ss_pred hHhHhcchhHH--HHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccH----------------H
Confidence 99988865544 3568899999999999988 799999999999999999999988854411 1
Q ss_pred chhhhHhhcCCCchh-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 251 ELGAMILACGIEEKD-KEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.+...+..+..+..+ ..++.++.+|+..|+..||..||+...++..+
T Consensus 235 ~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 235 SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 122233334344444 67889999999999999999999954444433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=354.06 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=201.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|.+.++||.|+||+||+|+++ ++..||||.+.+.. .+...+.+..|+.+|+.++|||||.+++++..++.+||||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 5677888999999999999874 58999999997653 556777889999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC------CceEEeccCCccccC
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN------FSPKVADFGLAKLCD 176 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~DfGla~~~~ 176 (356)
|+||+|.+|++.+ +.+++.++..++.||+.||++||+ ++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 91 C~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 91 CNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999544 589999999999999999999999 999999999999999654 468999999999888
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... ...+|++.|||||+++.. .|+.|+|+||+|+|+|++++|+.|+......+... .+. .
T Consensus 167 ~~~~a---~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-------~~~-------k 228 (429)
T KOG0595|consen 167 PGSMA---ETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-------YIK-------K 228 (429)
T ss_pred chhHH---HHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHh-------c
Confidence 54433 447799999999999876 79999999999999999999999985443322111 000 0
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+...+......+.+++...+..+|.+|-++.+-..
T Consensus 229 ~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 229 GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 111122333344455667777777777777766655443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=352.46 Aligned_cols=256 Identities=27% Similarity=0.343 Sum_probs=205.4
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCch------hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK------IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
.+..|-+.+.||+|+||.|-+|.. ++|+.||||++++.... .......+|+++|++|+|||||++++++....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 455677789999999999999965 57999999999754211 12234679999999999999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC---CceEEeccCC
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGL 171 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGl 171 (356)
..||||||++||.|.+++ -..+.+.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ -.+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~v-v~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV-VANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHH-HhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999998 455677888889999999999999999 999999999999999655 6799999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCC--CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
|+..+.. ......+||+.|.|||++.+.. .+..+.|+||+||+||-+++|-+||.....+. ...+....
T Consensus 326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILK 396 (475)
T ss_pred hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhc
Confidence 9987633 2345578999999999998652 34558899999999999999999984332211 00111111
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+... ..+......+.+..+||.+||..||++|||++|+++.
T Consensus 397 G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1110 1223455678899999999999999999999999973
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=386.59 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=233.5
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
++......+.+.||+|.||.||+|+.. +...||||.++.........+|.+|++++..|+|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344556677889999999999999642 35679999999887777889999999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccC---------CC----CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC
Q 047701 94 HMTALVYEYMENGSLDGYLFGK---------KR----ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 160 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~---------~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 160 (356)
+.+++|+|||..|+|..||..+ +. +++..+.+.|+.|||.||.||-+ +.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 9999999999999999999643 12 38999999999999999999999 99999999999999999
Q ss_pred CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh
Q 047701 161 NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240 (356)
Q Consensus 161 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~ 240 (356)
+..|||+||||++.....+.........-..+||+||.|... .+|.+||||||||+|||+++-..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~-------------- 703 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGK-------------- 703 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhcccc--------------
Confidence 999999999999988776665543344457799999999987 79999999999999999998442
Q ss_pred HHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.+|..+.+.++.+.+.++...+.+.++|.++++||..||+.+|++||++++|..+|......
T Consensus 704 -QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 704 -QPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -CcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 34677778888888988888889999999999999999999999999999999999987654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=373.87 Aligned_cols=267 Identities=25% Similarity=0.431 Sum_probs=237.4
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
-..|+......+.++||.|-||.|++|+++ ....||||.++...++..+.+|+.|+.||.+++||||++|.|+...
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 345666667777899999999999999874 2567999999999999999999999999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
....+||+|||++|+|+.||+.+.+.+++.++..+++.|+.||+||-+ .++|||||.++|||++.+..+|++||||+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999999999999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC-CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhh
Q 047701 173 KLCDRNR-SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 173 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
+...+.. ......+-+-..+|.|||+|... .+|.++||||||++|||.++ |.+| +=++.+.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERP----------------YWdmSNQ 841 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERP----------------YWDMSNQ 841 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCc----------------ccccchH
Confidence 9876554 33333344556799999999877 79999999999999999987 4444 2345566
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
++...+..+.+.+.+.+|+..+.+||+.||++|-.+||.|.+|+..|+++...
T Consensus 842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 77777888888889999999999999999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=341.87 Aligned_cols=257 Identities=26% Similarity=0.326 Sum_probs=207.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC--eeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH--MTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 99 (356)
..++...+.||+|+||.||++.+. +|+..|||.+....... .+.+.+|+.+|++++|||||+++|...... .++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 346778899999999999999875 48999999987652222 567899999999999999999999855444 68999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~~ 178 (356)
|||+.+|+|.+++...+..+++..+..+++||++||+|||+ +|++|+||||+|||++. ++.+||+|||++......
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999997766689999999999999999999999 99999999999999999 799999999999876641
Q ss_pred C-CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 R-SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
. .........||+.|||||++........++|||||||++.||+||.+||... ......+.....
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--------------~~~~~~~~~ig~ 237 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--------------FEEAEALLLIGR 237 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--------------cchHHHHHHHhc
Confidence 1 1122345789999999999985323345999999999999999999887321 000111111222
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
....+..+...+.+..+++.+|+..||++|||+.++++..
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 2223456667888999999999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=328.23 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=209.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|+-..++|+|+||+||+++++ +|+-||||.+..+.. +....-.++|++.|++|.|+|+|.++.+|..+...+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4566788999999999999986 599999999876543 45556679999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
|+. ++-+-|......++.+.+.+++.|++.|+.|+|+ ++++||||||+||||..+|.+||||||+|+...... .
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d 156 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--D 156 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc--c
Confidence 987 6556666778889999999999999999999999 999999999999999999999999999999887532 2
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH--------HHHhhhchhh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW--------EEYEKSELGA 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 254 (356)
..+..+-|.+|.|||.+.|...|+...||||+||++.||++|.+-|-....-.+-+...... ..+.......
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 34667789999999999998899999999999999999999997663322211111111111 1111111110
Q ss_pred hH------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MI------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
-+ .....+...+..+.-+.+++..|++.||++|++.++++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 011122233455677999999999999999999999886
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=336.38 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=209.0
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
...+.+.++||+|+||.||.++. .+++-+|+|++++.. .....+....|..+|.+++||.||.++-.|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 34567789999999999999975 469999999998652 334567889999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+||+.||.|...| ++.+.+++..+..++..|+.||.|||+ ++||||||||+|||+|.+|.++|+||||++......
T Consensus 104 ld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999999 566789999999999999999999999 999999999999999999999999999998654433
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.. +...+||+.|||||++.+. .++..+|.||||+++|||++|.+||...... ++.+.+...
T Consensus 180 ~~--t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~~I~~~ 240 (357)
T KOG0598|consen 180 DA--TRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYDKILKG 240 (357)
T ss_pred Cc--cccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHHHHhcC
Confidence 22 2347899999999999988 8999999999999999999999998544331 111222222
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRP----PMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp----s~~~v~~ 295 (356)
.....+...+.+..+++.+.+..||.+|. ++.+|.+
T Consensus 241 k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 241 KLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred cCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 22333444678899999999999999995 5555544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=356.33 Aligned_cols=275 Identities=30% Similarity=0.397 Sum_probs=228.8
Q ss_pred CCCcceeCHHHHHHHhhccccccCcCCceEEEEEEcCC--C--cE-EEEEEecc--cCchhHHHHHHHHHHHHhcCCCCC
Q 047701 10 REKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN--G--VK-IAVKVLNK--NLGKIAEEQFMAEVGTIGRTYHIN 82 (356)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~n 82 (356)
-..|+..+.|++......+.++||+|+||.||+|++.. + .. ||||.... .........++.|++++++++|||
T Consensus 143 L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~N 222 (474)
T KOG0194|consen 143 LKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPN 222 (474)
T ss_pred ecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCC
Confidence 34677788999999999999999999999999997632 2 23 89999874 356677889999999999999999
Q ss_pred eeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
||++||++.....+++|||+|+||+|.++|.+....++..+...++.+.|.||+|||+ ++++||||.++|||++.++
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCC
Confidence 9999999999999999999999999999998777789999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhH
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPK 241 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~ 241 (356)
.+||+||||++...... .......-..+|+|||.+... .++.++|||||||++||+++ |..|+
T Consensus 300 ~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py------------- 363 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPY------------- 363 (474)
T ss_pred eEEeCccccccCCccee--eccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCC-------------
Confidence 99999999987654111 111122356799999999987 79999999999999999998 55443
Q ss_pred HHHHHHhhhchhhhH-hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCC
Q 047701 242 YVWEEYEKSELGAMI-LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPP 306 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~ 306 (356)
.......+...+ .+......+...+.++..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus 364 ---~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 364 ---PGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---CCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 122222333333 44444555567788899999999999999999999999999988765443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=352.72 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=208.1
Q ss_pred HHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD 92 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 92 (356)
++...+|.+.++||+|+||.||+|.+ .+++.||||++...........+..|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 44566788999999999999999963 235789999997654445556789999999999 89999999998876
Q ss_pred C-CeeeEEEEecCCCCHhHHhccCC-------------------------------------------------------
Q 047701 93 Q-HMTALVYEYMENGSLDGYLFGKK------------------------------------------------------- 116 (356)
Q Consensus 93 ~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------------------- 116 (356)
. ...++||||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 45789999999999999985421
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCC
Q 047701 117 ------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190 (356)
Q Consensus 117 ------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt 190 (356)
..+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++...............++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 247888999999999999999999 99999999999999999999999999999865433322222334567
Q ss_pred CCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHH
Q 047701 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269 (356)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (356)
..|+|||++.+. .++.++||||||+++|||++ |..|+...... ...... +........+..++
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~---------~~~~~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQR---------LKDGTRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHH---------HhcCCCCCCCCCCC
Confidence 889999999877 68999999999999999997 87776432211 001111 11111112233456
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 270 KQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 270 ~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=345.49 Aligned_cols=267 Identities=24% Similarity=0.332 Sum_probs=212.4
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCC-eeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQH-MTAL 98 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l 98 (356)
.-.+|...++||-|.||.||+|+. .+|+.||||.+++....-..--=++|+..|++|+ ||||++++.++.++. .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 356899999999999999999975 4699999999987654333333468999999998 999999999999988 9999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||||+. +|-.++..+++.+++..+..|+.||++||+|+|. +|++|||+||+|||+.....+||+|||+|+.....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC
Confidence 9999965 9999998888999999999999999999999999 99999999999999998889999999999987755
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc-chhHHH-----HHHHhhhc-
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD-WFPKYV-----WEEYEKSE- 251 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~- 251 (356)
.. .+..+.|.+|+|||++.+...|+.+.|+|++|||++|+.+-++-| .+..+... +....+ +..+..+.
T Consensus 164 pP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF-PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 PP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF-PGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC-CCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 43 456788999999999988878999999999999999999877544 33332111 000000 11111110
Q ss_pred hh---hh----HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 252 LG---AM----ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 252 ~~---~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+. .+ +.........++.+.++.+|+.+|+..||.+|||+.+.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00 00 01111223344578899999999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=374.76 Aligned_cols=264 Identities=28% Similarity=0.406 Sum_probs=227.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC--CCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP--NGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
+...+..+.+.||+|+||.||.|... .+. .||||.+++..+.....+|++|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 44567778899999999999999763 243 499999998888888899999999999999999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 95 MTALVYEYMENGSLDGYLFGK------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
..+|++|||+||+|..||++. ...++....+.++.|||+|++||++ +++|||||.++|+|++....+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999876 6789999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 169 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
||+|+...+.+.........-...|||||.++.. .+|.++|||||||++||++|...+.+.+ ..
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~---------------~~ 909 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPS---------------RS 909 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCC---------------cc
Confidence 9999966554443322222345689999999976 7999999999999999999966544333 33
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
+.++...+..+++.+.+..|+..+.++|..||+.+|++||++..|++.+..+...
T Consensus 910 n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 910 NFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred hHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 4455555666667888999999999999999999999999999999988877543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=332.99 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=211.9
Q ss_pred HHHHhhccccccCcCCceEEEEEE-cCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+....|++.+.||.|..++||+|+ .+.++.||||++.-+......+.+.+|+..++.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 345678999999999999999996 5678999999998665556678899999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|.||.+||+.+++... ...+.+..+..|++++++||.|||. +|.||||||+.||||+.+|.+||+|||.+..+..+
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999643 4569999999999999999999999 99999999999999999999999999987765544
Q ss_pred CCcee-e-cCCCCCCCCCCccc-ccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 179 RSHVT-I-SGYKGTPGYSAPEF-LSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 179 ~~~~~-~-~~~~gt~~y~aPE~-~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
..... . ..++||++|||||+ .+....|+.|+||||||++.+||.+|..|+. .+.+.++..+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~----------------k~pPmkvLl~ 243 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS----------------KYPPMKVLLL 243 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc----------------cCChHHHHHH
Confidence 32222 2 55789999999999 5555679999999999999999999998863 2222221111
Q ss_pred HhhcC---------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACG---------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~---------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+. ..+........+.+++..|+..||.+|||++++++
T Consensus 244 tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 244 TLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111 11223345568999999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=347.52 Aligned_cols=268 Identities=25% Similarity=0.425 Sum_probs=220.2
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
..|++......+..+||+|.||+||+|+| .| .||||+++.. .+....+.|..|+.++++-+|.||+.+.|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w-hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW-HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccc-cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 66888888888999999999999999999 43 5999999854 345667889999999999999999999999999887
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.||+.+|+|.+|..++......+...+.+.|++||++||.|||. ++|||||||..||++.+++.|||+||||+..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 99999999999999998778889999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
..-..........|...|||||+++.. .+|+..+||||||+++|||++|..|+.....+.+-+.... +..
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr-------G~l- 610 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR-------GYL- 610 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc-------ccc-
Confidence 322111112224478899999998743 3799999999999999999999999875544433221110 000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.........+++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 611 ----~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 ----MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 000122345677899999999999999999999999998887765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=339.29 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=209.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
..+.|++.||.|+|++|++|+. .+++.||||++.+.. .+.-..-+.+|-.+|.+| .||.|++|+-.|.|...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 4678899999999999999975 469999999997652 222223467799999999 899999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+||+++|.|.+++. +-+.+++.....++.+|+.||+|||+ +|||||||||+|||+|++++++|.|||.|+.+....
T Consensus 153 Le~A~nGdll~~i~-K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK-KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEecCCCcHHHHHH-HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999994 44789999999999999999999999 999999999999999999999999999999875322
Q ss_pred Cc---------eee--cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 180 SH---------VTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 180 ~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
.. ... ..++||..|.+||++... ..+..+|+|+||||+|.|+.|.+||...... ..++..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFqkI- 299 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQKI- 299 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHHHH-
Confidence 21 111 458999999999999988 7899999999999999999999998544331 111111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.. ...+.+++.++.+.+|+.+.|..||.+|++..+|.++
T Consensus 300 --------~~-l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 --------QA-LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------HH-hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 0123455667889999999999999999999999873
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=329.82 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=209.9
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
+....|.+.+.||+|+||.||+|.++ .+..||+|.+...........+.+|+.++.+++||||+++++++..+...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34667889999999999999999752 36789999998765545556789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999997666789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
..... ......++..|+|||++.+. .++.++||||||+++||+++ |..|+...... .....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----------------~~~~~ 220 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------------DVIKA 220 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----------------HHHHH
Confidence 22111 11123356789999999876 78999999999999999775 88776322111 11111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
+........+..++..+.+++.+||+.+|.+||++.+|.+.|.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111122233455677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=336.34 Aligned_cols=264 Identities=24% Similarity=0.299 Sum_probs=211.1
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 98 (356)
...|+-.++||+|.||.||+|+. .+|+.||+|.+.... .+.......+|+.+|++|+||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34667778999999999999975 579999999997554 344556678999999999999999999999876 68999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|+|||+. +|..++....-.+++.++..++.|++.||+|||+ +||+|||||.+|||||.+|.+||+|||||+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999988 9999997777789999999999999999999999 99999999999999999999999999999987765
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc---------hhHHHHHHHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW---------FPKYVWEEYEK 249 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~---------~~~~~~~~~~~ 249 (356)
.... .+..+-|.+|.|||.+.|...|+.+.|+||.||||.||+.|++.+ .+..+.... .....|. .
T Consensus 272 ~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~-~G~tEveQl~kIfklcGSP~e~~W~---~ 346 (560)
T KOG0600|consen 272 GSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL-QGRTEVEQLHKIFKLCGSPTEDYWP---V 346 (560)
T ss_pred CCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc-CCccHHHHHHHHHHHhCCCChhccc---c
Confidence 4433 466677999999999999999999999999999999999998654 222221110 0000111 1
Q ss_pred hchh--hhHh-----hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SELG--AMIL-----ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~~~--~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.++. .... ...+.+.....+....+|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111 0000 01122234455678999999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=308.36 Aligned_cols=265 Identities=23% Similarity=0.290 Sum_probs=210.5
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.-.++||+|.||.||+|++ .+|+.||||.++... .........+|+..|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 566778999999999999975 579999999997542 223345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
++. +|+..+......++...+..++.++++|++|||+ +.|+||||||.|+||+.+|.+||+|||+++.+.......
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 976 9999998888899999999999999999999999 999999999999999999999999999999987654433
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch---------hHHHHHHHhhhc-h
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF---------PKYVWEEYEKSE-L 252 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~---------~~~~~~~~~~~~-~ 252 (356)
. ..+-|..|.|||.+.|...|+...|+||.|||+.||+.|.+ +..+..+..... ....|..+..-. .
T Consensus 159 ~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P-~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 159 T--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP-FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred c--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC-CCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 2 23678899999999998899999999999999999998764 444444322110 011122111110 0
Q ss_pred hhhH--hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 253 GAMI--LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 253 ~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.++. -........+.++.++.+++..++..||.+|+++.+++++
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000 0001111344566778999999999999999999999874
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=344.04 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=208.8
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
|......|.+.+.||+|+||.||+|.+. ++..||||++...........+.+|+.+++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4455667889999999999999998641 34579999997654445566788999999999 8999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhccCC-------------------------------------------------------
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGKK------------------------------------------------------- 116 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------------------- 116 (356)
.....++||||+.+|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999884321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 117 --------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 117 --------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
.++++..+++++.||+.||.|||+ ++++||||||+||++++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 247889999999999999999999 999999999999999999999999999998665433222
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
......++..|+|||++.+. .++.++||||||+++|+|++ |..|+....... ...........
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---------------~~~~~~~~~~~ 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---------------KFYKMVKRGYQ 333 (374)
T ss_pred eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccH---------------HHHHHHHcccC
Confidence 22233466789999999876 68999999999999999997 887764321110 01111111111
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
...+...+.++.+++.+||+.||.+||++.+|++.|+++.
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1122234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=344.44 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=206.9
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
++.....+.+.++||+|+||.||+|.+ .++..||||+++..........+.+|++++..+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 344456788899999999999999963 246689999997554444556788999999999 8999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhccCC-------------------------------------------------------
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGKK------------------------------------------------------- 116 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------------------- 116 (356)
++...++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999885321
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 117 -------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 117 -------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
..+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 247889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
...........++..|+|||++.+. .++.++||||||+++|||++ |..|+...... ...+. .+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~---------~~ 330 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYK---------MI 330 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHH---------HH
Confidence 4332222234456789999999877 78999999999999999998 66655322111 01111 11
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
........+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111112223456799999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=337.48 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=208.8
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc----hhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCC
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG----KIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQH 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 94 (356)
.....|.+.+.||+|+||.|+.|.. .+++.||||++.+... ......+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4456888999999999999999975 4689999998776411 123456778999999998 999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCcc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAK 173 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~ 173 (356)
..++||||+.||.|.+++.. .+++.+..+..+++|++.|++|||+ +||+||||||+|+|++.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999966 7889999999999999999999999 999999999999999999 999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCC-CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
... .........+||+.|+|||++.+.. ..+.++||||+||+||.|++|..||...... .. +..
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l-~~k------ 234 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NL-YRK------ 234 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HH-HHH------
Confidence 874 1122234578999999999999875 3468999999999999999999998542211 11 111
Q ss_pred hhhHhhcCCCchhHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILACGIEEKDKEK-AKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+..+ ....+... +.++..|+.+|+..||..|+++.+|+.
T Consensus 235 ---i~~~-~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ---IRKG-EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HhcC-CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111 12233334 788999999999999999999999995
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=336.44 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=212.2
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|+-.+.||+|.||.||+|.+ .+++.||+|++.-...+...+++.+|+.++.+++++||.++|+.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 34566678999999999999975 57999999999977777777889999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||.||++.+.+ +.+..+.+..+.-++++++.|+.|||. ++.+|||||+.|||+..+|.+||+|||.+....+....
T Consensus 92 y~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 92 YCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999999 455566888999999999999999999 99999999999999999999999999999876654333
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
. ..++||+.|||||++++. .|+.++||||||++.+||.+|.+|+..-.+ ..+.-.+-....
T Consensus 168 r--~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~P 228 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAP 228 (467)
T ss_pred c--ccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCC
Confidence 2 557899999999999976 799999999999999999999998743222 111111222222
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+.....+++.+.+++..|+..||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3334467788999999999999999999999887
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.85 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=203.9
Q ss_pred HHHhhccccccCcCCceEEEEEEcCC-----------------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPN-----------------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 84 (356)
....|.+.++||+|+||.||+|.+.+ +..||+|++...........+.+|+.++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 34578889999999999999997532 3469999998765555667899999999999999999
Q ss_pred eEeeeEEcCCeeeEEEEecCCCCHhHHhccCC------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 047701 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKK------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRI 146 (356)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 146 (356)
++++++.+....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 99999999999999999999999999884321 247889999999999999999999 999
Q ss_pred eeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC-
Q 047701 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR- 225 (356)
Q Consensus 147 vH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~- 225 (356)
+||||||+|||++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||+++.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999876544333222334568899999998876 6899999999999999998743
Q ss_pred -CccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 226 -RNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.|+....... ............. .......+..++..+.+++.+||..||.+|||+.+|++.|+
T Consensus 239 ~~p~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQ---VIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHH---HHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 3432211100 0000000000000 00011122345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=331.49 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=209.6
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
+....|+..+.||+|+||.||+|.+. +++ .||||++...........+..|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34567888999999999999999763 333 48999987654445567788999999999999999999999875 5
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++++|+.+|+|.+++......+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 679999999999999997767789999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
.............++..|+|||++.+. .++.++||||||+++|||++ |..|+...... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----------------~~~~ 222 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISS 222 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHH
Confidence 654433333334456789999999876 68999999999999999997 77776322110 0111
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..........+..++.++.+++.+||..+|++||++.+++..|..+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111111222233455678999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=333.81 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=208.0
Q ss_pred hhccccccCcCCceEEEEEE-cCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.-..+||+|+.|.||.|. ..+++.||||++..... ..++-++.|+.+|+..+|+|||.+++.+..++.+++|||||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45556789999999999996 45789999999976432 33456789999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+||+|.+.+. .-.+++.++..|++++++||+|||. ++|+|||||.+|||+..+|.+||+|||++..+......
T Consensus 353 ~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-- 425 (550)
T KOG0578|consen 353 EGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-- 425 (550)
T ss_pred CCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--
Confidence 9999999983 3349999999999999999999999 99999999999999999999999999999877655432
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc-CCC
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC-GIE 262 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 262 (356)
....+||+.|||||++... .|+.+.||||||++++||+-|++|+....+-.. +..+..++ ...
T Consensus 426 R~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---------------lyLIa~ng~P~l 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---------------LYLIATNGTPKL 489 (550)
T ss_pred cccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHH---------------HHHHhhcCCCCc
Confidence 2446799999999999988 799999999999999999999999865433211 11111111 122
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+...+.++.+++.+||..|+.+||++.|+++.
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3355678899999999999999999999999983
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=327.84 Aligned_cols=251 Identities=32% Similarity=0.493 Sum_probs=199.7
Q ss_pred ccccccCcCCceEEEEEEcC-----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 27 NYSTRLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
++.+.||.|.||.||+|.+. .+..|+||.++..........+.+|++.+++++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46788999999999999875 3678999999765555567889999999999999999999999998888999999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+|+|.+++... ...+++..++.++.||+.||.|||+ .+++|+||+++||++++++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999999999776 6789999999999999999999999 9999999999999999999999999999987743333
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
........+...|+|||.+.+. .++.++||||||+++|||++ |+.|+... ...++...+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~----------------~~~~~~~~~~~~ 221 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDY----------------DNEEIIEKLKQG 221 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTS----------------CHHHHHHHHHTT
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccccc----------------cccccccccccc
Confidence 3333445577889999999877 58999999999999999999 45553111 111222222222
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.....+..++..+.+++.+||+.||.+||++.+|++.|
T Consensus 222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23334445677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=320.86 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=210.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
...+++.+.||+|+||.||+|.+. +...||||.+...........+..|+.++++++||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 346778999999999999999874 2457999998766555666788999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
+|||+.+++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999997666789999999999999999999999 99999999999999999999999999999887633
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
..........++..|+|||.+.+. .++.++||||||+++|++++ |..|+..... ......+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~~ 222 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------------QDVIKAVE 222 (266)
T ss_pred ccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCH----------------HHHHHHHH
Confidence 322222234456789999999876 68999999999999999998 7776532111 11111111
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.....+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111222334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=324.06 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=209.1
Q ss_pred hhccccccCcCCceEEEEEEcCC------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
.+.+.+.||+|+||.||+|.... ...||+|.+...........+.+|+.++.+++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57788999999999999997532 267999998765555556778999999999999999999999999899999
Q ss_pred EEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 99 VYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
+|||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999985431 458899999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHH
Q 047701 164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~ 242 (356)
++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999866443332222334568889999998776 68999999999999999998 87776432211
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
++...+........+..++.++.+++.+||+.||.+||++.+|++.|+.
T Consensus 234 --------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 --------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1112222223333455677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=338.88 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=209.9
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 91 (356)
+......+.+.++||+|+||.||+|.+. .+..||||++...........+.+|+.+++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3444567778899999999999999752 235799999976555555678999999999995 999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhccC--------------------------------------------------------
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGK-------------------------------------------------------- 115 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------------------------------- 115 (356)
+....|||||||++|+|.+++...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999887432
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccce
Q 047701 116 ---------------------------------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156 (356)
Q Consensus 116 ---------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 156 (356)
...+++..+..++.|++.||.|||+ .+++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhE
Confidence 1247888999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCcc
Q 047701 157 LLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASES 235 (356)
Q Consensus 157 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~ 235 (356)
+++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence 9999999999999999866443322222334567889999999876 68999999999999999997 77765322110
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
...+ ..+........+..++.++.+++.+||+.||++||++.+|.+.|.++..
T Consensus 347 -----~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 -----STFY---------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -----HHHH---------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0001 1111111222334567789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=323.56 Aligned_cols=248 Identities=19% Similarity=0.239 Sum_probs=200.3
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCeeeEEEEec
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMTALVYEYM 103 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 103 (356)
..||+|++|.||+|.+ +|+.||||++..... ....+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5699999999999998 789999999975422 2224678899999999999999999999877 45778999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++|+|.+++.. .+.+++...+.++.|++.||.|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 99999999954 4578999999999999999999997 1488999999999999999999999999988654322
Q ss_pred ecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 184 ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
....|+..|+|||++.+. ..++.++||||||+++|||++|..|+...... ..... ........
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~--------i~~~~~~~ 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDL--------IINKNNSL 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHH--------HHhcCCCC
Confidence 124578999999998752 26899999999999999999999987432211 00111 11111122
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
..+..++.++.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 233356778999999999999999999999999998764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=316.23 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=200.6
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
++||+|+||.||+|.+. +++.||+|.+...........+.+|++++++++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999874 68999999987655556667899999999999999999999999999999999999999999
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCC
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 188 (356)
.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99997666679999999999999999999999 999999999999999999999999999987654322111111112
Q ss_pred CCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHH
Q 047701 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267 (356)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
++..|+|||.+.+. .++.++||||||+++|++++ |..|+..... ......+........+..
T Consensus 158 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~ 220 (252)
T cd05084 158 IPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSN----------------QQTREAIEQGVRLPCPEL 220 (252)
T ss_pred CceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCH----------------HHHHHHHHcCCCCCCccc
Confidence 34579999999877 68999999999999999998 6665522111 111111111112223344
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 268 KAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.+.++.+++.+||+.+|++||++.+|.+.|.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 5678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.54 Aligned_cols=249 Identities=26% Similarity=0.327 Sum_probs=212.6
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
-|++++.||.|+.|.|-.|++ .+|+..|||++.+. ........+.+|+-+|+.+.||||+++|+++.++..+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 477899999999999999987 57999999999864 233445678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|++||-|.+++. ..+++.+..+.+++.||+.|+.|+|. .+|+||||||+|+|+|..+++||+|||+|..-..+.
T Consensus 93 yv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 93 YVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred ecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 999999999994 55678999999999999999999999 999999999999999999999999999997644333
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....+|++.|.+||++.|....+.++||||.|||||.||+|..||..+... .+...+. .+.
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir----------------~LLlKV~-~G~ 228 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR----------------VLLLKVQ-RGV 228 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH----------------HHHHHHH-cCc
Confidence 2344679999999999999977899999999999999999999998633221 1111122 233
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.+.+..++.++.+|+.+|+..||++|.|+++|+++.
T Consensus 229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 456677889999999999999999999999999943
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=321.96 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=205.0
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
++....|++.++||+|+||.||+|.+. ++..||||++...........+.+|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 455678899999999999999998652 35679999986544334556788999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 94 HMTALVYEYMENGSLDGYLFGKK---------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
...++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCE
Confidence 99999999999999999985422 246788999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHH
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~ 243 (356)
+|+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+..... .
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~-- 228 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------E-- 228 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------H--
Confidence 99999998765543332222223457789999999876 68999999999999999999 5555432111 0
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.....+........+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 -------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111111122223345677999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=335.84 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=229.9
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcC---C--CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFP---N--GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
.-++....+.+.+.||.|-||.||+|.+. . .-.||||+.+.+.+....+.|+.|..+|++++||||++++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 44566667778889999999999999652 2 335899999988888889999999999999999999999999998
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
. ..+||||++.-|-|..||+.+...++..+...++.||+.||+|||+ ..+|||||..+|||+...-.+||+||||+
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 5 5699999999999999998888999999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhc
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
+.+.+....... ..+-++-|||||-+.-. .++.++|||.|||.+||+++ |.+|| ....+.+
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPf----------------qgvkNsD 600 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPF----------------QGVKNSD 600 (974)
T ss_pred hhccccchhhcc-ccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCcc----------------ccccccc
Confidence 998876655432 33456789999999877 79999999999999999886 55554 4555666
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+...+.++.+.+.+++|++.+..|+.+||..+|.+||.+.++...|..+..
T Consensus 601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 666777888889999999999999999999999999999999998877654
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=316.17 Aligned_cols=252 Identities=27% Similarity=0.416 Sum_probs=203.2
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
..+++.+.||+|+||.||++.++++..+|+|.+.... .....+..|+.++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4567789999999999999998778889999886432 33467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++|+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence 9999999996655678999999999999999999999 99999999999999999999999999998865433221 1
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....++..|+|||++.+. .++.++||||||+++|+|++ |+.|+...... ........ ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~i~~---------~~~~ 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVEMISR---------GFRL 220 (256)
T ss_pred cCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHC---------CCCC
Confidence 1233456789999999876 68999999999999999999 77776332211 00111111 1111
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..+...+.++.+++.+||..+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112234567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.39 Aligned_cols=242 Identities=25% Similarity=0.315 Sum_probs=197.0
Q ss_pred cccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.||+|+||.||+|.. .+|+.||||++.... .......+..|+.++++++||||+++++++..+...++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999976 468999999997542 2234456788999999999999999999999999999999999999
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecC
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 186 (356)
+|.+++. ....+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 154 (323)
T cd05571 81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence 9999884 44678999999999999999999999 9999999999999999999999999999875332211 1233
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhH
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
..||+.|+|||++.+. .++.++|||||||++|||++|..|+....... .... +... ....+.
T Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~---------~~~~-~~~~p~ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFEL---------ILME-EIRFPR 216 (323)
T ss_pred eecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHH---------HHcC-CCCCCC
Confidence 5699999999999877 68999999999999999999999874322110 0010 1100 112233
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 267 EKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
..+.++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4567899999999999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=329.74 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=207.5
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
|++...+|++.+.||+|+||.||+|... +++.||+|++...........+..|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3445668999999999999999999532 35789999987654444456788899999999 8999999999886
Q ss_pred c-CCeeeEEEEecCCCCHhHHhccCC------------------------------------------------------
Q 047701 92 D-QHMTALVYEYMENGSLDGYLFGKK------------------------------------------------------ 116 (356)
Q Consensus 92 ~-~~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------------------ 116 (356)
. ....+++|||+++++|.+++....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 456789999999999999884321
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCC
Q 047701 117 ------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190 (356)
Q Consensus 117 ------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt 190 (356)
..+++..+..++.||+.||+|||+ .+++||||||+||++++++.++|+|||++..+.............++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 268999999999999999999999 99999999999999999999999999999876443322222334567
Q ss_pred CCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHH
Q 047701 191 PGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269 (356)
Q Consensus 191 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (356)
..|+|||++.+. .++.++|||||||++|||++ |..|+...... ...... +........+...+
T Consensus 239 ~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~ 302 (337)
T cd05054 239 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRR---------LKEGTRMRAPEYAT 302 (337)
T ss_pred ccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHH---------HhccCCCCCCccCC
Confidence 789999999877 79999999999999999998 87776321111 000111 11111112233455
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 270 KQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 270 ~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.++.+++.+||+.+|++||++.+|+++|..+..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 779999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=319.66 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=201.9
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
+|...+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|+.++.+++|+||+.+++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 466788999999999999976 4799999999875421 2233467889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+|+|..++... ...+++..+..++.|++.||+|||+ .+++||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999887543 3468999999999999999999999 9999999999999999999999999999987543322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....||..|+|||++.+. .++.++|||||||++|+|++|+.|+........ .... ...+. ..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-------~~~~-----~~~~~-~~ 220 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-------REEV-----DRRVK-ED 220 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-------HHHH-----HHHhh-cc
Confidence 2345689999999999877 789999999999999999999999864432110 0000 00010 11
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
....+...+.++.+|+.+||+.||.+||+ ++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 12233345678999999999999999997 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=331.39 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=202.9
Q ss_pred cccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 28 YSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 28 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
-.+.||+|+.|.||+|++ .++.||||.++.- -..++.-|++|.||||+.+.|+|.....+|||||||..|-
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 346799999999999999 6688999977531 1247888999999999999999999999999999999999
Q ss_pred HhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCC
Q 047701 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187 (356)
Q Consensus 108 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 187 (356)
|..+| +.+..++......|..+||.||.|||. +.|||||||.-||||..+..+||+|||-++......+. -.+
T Consensus 199 L~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk---MSF 271 (904)
T KOG4721|consen 199 LYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK---MSF 271 (904)
T ss_pred HHHHH-hccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh---hhh
Confidence 99999 566789999999999999999999999 99999999999999999999999999999876655433 347
Q ss_pred CCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHH
Q 047701 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267 (356)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.||..|||||+|... +.++|.|||||||+|||||||..|...-+...+- ...=.+......+..
T Consensus 272 aGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------------wGVGsNsL~LpvPst 335 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------------WGVGSNSLHLPVPST 335 (904)
T ss_pred hhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeE---------------EeccCCcccccCccc
Confidence 799999999999988 8999999999999999999999886322221111 111112223455667
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 268 KAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
++.-+.-|+++||+..|..||+|.+|+..|+-.
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 888899999999999999999999999998744
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=316.86 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=208.7
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
++....|.+.++||+|+||.||+|...++..||+|.+.... .....+..|+.++++++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 34556788899999999999999988778889999986532 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999998643 4578999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... ......++..|+|||++.+. .++.++||||||+++|+|++ |..|+...... ...... .
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~---------~ 218 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSAL---------Q 218 (261)
T ss_pred cee-ccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHH---------H
Confidence 222 12234467789999999876 68899999999999999998 77776322111 011111 1
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.....+....++.++.+++.+||..+|++||+++++.++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 219 RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1111122234567799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=302.65 Aligned_cols=236 Identities=27% Similarity=0.297 Sum_probs=202.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.+++.+.||.|+||.|.+++.+ +|..+|+|++++. ..-...++...|.++|+.+.||.++++++.+.+...+|||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 3556788999999999999875 5899999999864 233455778899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|..||-|..++ .+.+++++..+..++.||+.||+|||+ .++++|||||+|||+|.+|.+||+|||+|+......
T Consensus 125 yv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT-- 198 (355)
T KOG0616|consen 125 YVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT-- 198 (355)
T ss_pred ccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCcE--
Confidence 99999999999 456789999999999999999999999 999999999999999999999999999999876541
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
-..+||+.|+|||+++.+ +++.++|-|||||++|||+.|.+||....+. ..++..-.. .
T Consensus 199 ---~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~----------~ 257 (355)
T KOG0616|consen 199 ---WTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEG----------K 257 (355)
T ss_pred ---EEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhC----------c
Confidence 235799999999999998 7999999999999999999999998765541 112222111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCC
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADR 287 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~R 287 (356)
-..+.-.+.++.+|+...++.|-.+|
T Consensus 258 v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 23455667889999999999999999
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=319.34 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=207.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
..+|.+.+.||+|+||.||+|... +++.||||.+...........+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 456888899999999999999753 35789999998665555667899999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKK-------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
++||||+++++|.+++...+ ..+++..+..++.|++.|+.|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999995432 357899999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHH
Q 047701 164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~ 242 (356)
++|+|||++................+++.|+|||++.+. .++.++||||||+++|+|++ |..|+......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 999999998765433222222233467889999999877 68999999999999999998 88776432221
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.....+........+...+..+.+++.+||..||++||++.+|++.|.
T Consensus 232 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 --------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 011111122222223456678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=326.77 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=209.1
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|.+.+.||+|.||.||+|+- .+.+.||+|.+.+. ..+.....+.+|+++++.++||||+.++++|+.....++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 466778999999999999965 47899999999754 3344556789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.| +|..++ ...+.++++.+..++.+++.||.|||+ .+|+|||+||.|||++..|.+|+||||+|+.+..+ ..
T Consensus 83 a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~ 155 (808)
T KOG0597|consen 83 AVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TS 155 (808)
T ss_pred hhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--ce
Confidence 977 999999 566789999999999999999999999 99999999999999999999999999999987753 33
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
..+..+||+.|||||...+. .|+..+|+||+|||+||+..|++||+... .. .+.+.+.... .
T Consensus 156 vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~s----------i~------~Lv~~I~~d~-v 217 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARS----------IT------QLVKSILKDP-V 217 (808)
T ss_pred eeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHH----------HH------HHHHHHhcCC-C
Confidence 45678899999999999977 89999999999999999999999983221 11 1122222211 1
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+...+..+..++...+.+||..|.+..+++.
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 234467788999999999999999999998876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=320.00 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=204.3
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-------------hhHHHHHHHHHHHHhcCCCCCeeeEeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-------------KIAEEQFMAEVGTIGRTYHINLVRLHGF 89 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~niv~~~~~ 89 (356)
++|++.+.||+|.||.|-+|+. .+++.||||++.+... -...++..+|+.+|++++|||||+++.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 4788899999999999999986 4699999999975311 1112578899999999999999999999
Q ss_pred EEcC--CeeeEEEEecCCCCHhHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEE
Q 047701 90 CHDQ--HMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 166 (356)
Q Consensus 90 ~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 166 (356)
..+. +.+|||+|||..|.+... ..... +++.+++++++++..||+|||. +||+||||||+|+||+++|++||
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred ecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEe
Confidence 9874 578999999998876532 12344 9999999999999999999999 99999999999999999999999
Q ss_pred eccCCccccCCC---CCceeecCCCCCCCCCCcccccC---CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh
Q 047701 167 ADFGLAKLCDRN---RSHVTISGYKGTPGYSAPEFLSG---NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240 (356)
Q Consensus 167 ~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~ 240 (356)
+|||.+..+... .........+||+.|+|||...+ ....+.+.||||+||+||.|+.|+.||..+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--------- 322 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--------- 322 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---------
Confidence 999999876332 12222344779999999999876 234678999999999999999999998433
Q ss_pred HHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
...+.+.. ++......+..+.+..++.+||+++|.+||..|.+..+|.....-.
T Consensus 323 -~~~~l~~K-----Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 323 -FELELFDK-----IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred -hHHHHHHH-----HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 22233222 2222222233446678899999999999999999999999876543
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=317.31 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=203.5
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..+++.+.||+|+||+||+|.+. +++ .+++|.+..........++..|+..+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45667889999999999999863 444 4778877644333444677888889999999999999999864 45688
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
++||+.+|+|.+++......+++..+..++.||+.||.|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999997767789999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
..........++..|+|||++.+. .++.++||||||+++||+++ |..|+....... ....+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----------------~~~~~~ 225 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----------------VPDLLE 225 (279)
T ss_pred CcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHH
Confidence 332223345577899999999876 68999999999999999998 877763322110 011111
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.......+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111111222345568899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=321.92 Aligned_cols=265 Identities=22% Similarity=0.291 Sum_probs=202.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.+.++||+|+||.||+|... +++.||+|++...........+.+|+.++++++||||+++++++......++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 4777899999999999999764 689999999875433334456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++ +|.+++......+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~ 159 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--T 159 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--c
Confidence 75 9999886666678999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhh-hchhh
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEK-SELGA 254 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~ 254 (356)
.....|++.|+|||++.+...++.++||||||+++|+|++|+.|+........-. .+...|..... .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 2334578999999998775568999999999999999999998875433211100 00000111000 00111
Q ss_pred hHhhcCC----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILACGI----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....... .......+.++.+++.+|+..||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1110000 0001123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=324.77 Aligned_cols=269 Identities=27% Similarity=0.371 Sum_probs=213.0
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC--------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP--------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLH 87 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 87 (356)
..+++...+|++.+.||+|+||.||+|... +...||+|.+...........+.+|+.+++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 346677778999999999999999999642 12368999987655555667899999999999 799999999
Q ss_pred eeEEcCCeeeEEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Q 047701 88 GFCHDQHMTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 152 (356)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 152 (356)
+++......++++||+.+|+|.+++... ...+++.++..++.|++.||+|||+ ++++|||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlk 161 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccc
Confidence 9999999999999999999999998542 2358889999999999999999999 999999999
Q ss_pred ccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccC
Q 047701 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVG 231 (356)
Q Consensus 153 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~ 231 (356)
|+||+++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+...
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999866543322222223355689999999876 68999999999999999998 66554221
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.. .+....+........+..++.++.+++.+||+.+|.+||++.++++.|.++....+
T Consensus 241 ~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 241 PV----------------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CH----------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11 01111111112222334456789999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=315.16 Aligned_cols=257 Identities=31% Similarity=0.423 Sum_probs=207.3
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
++...++++.+.||+|++|.||+|.+.+++.||+|.+.... .....+.+|+.++++++||||+++++++...+..+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 34556788899999999999999988777889999987542 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999996543 578999999999999999999999 99999999999999999999999999999876533
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... .......+..|+|||++.+. .++.++||||||+++|+|++ |+.|+..... ...... +.
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~---------~~ 218 (261)
T cd05068 157 IYE-AREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQ---------VD 218 (261)
T ss_pred ccc-ccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHH---------HH
Confidence 211 11222334689999999876 68999999999999999999 7766532211 111111 11
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
.......+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 219 QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=319.37 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=209.8
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
+++....|++.+.||+|+||.||++.+. ....+|+|.+...........+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445567888899999999999999753 24689999987655445556788999999999 7999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhcc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccce
Q 047701 92 DQHMTALVYEYMENGSLDGYLFG---------------KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~---------------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 156 (356)
.+...+++|||+.+++|..++.. ....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence 99999999999999999999853 23568999999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCcc
Q 047701 157 LLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASES 235 (356)
Q Consensus 157 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~ 235 (356)
+++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|++++ |..|+.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 9999999999999999876544332222333456789999998776 68999999999999999997 7666522111
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.+....+........+..++..+.+++.+||..||++|||+.++++.|+++.
T Consensus 241 --------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --------------EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0011111122222233345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=318.20 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=205.0
Q ss_pred HhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..+++.++||+|+||.||+|.+ .++..||+|.+...........+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567789999999999999974 24678999999765444455678899999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 99 VYEYMENGSLDGYLFGK----------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~----------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
||||+.+++|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999998422 2347899999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhH
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPK 241 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~ 241 (356)
.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------- 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------- 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999876543332222334467789999999876 68999999999999999998 7666532111
Q ss_pred HHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
..+...+........+..++.++.+++.+||+.||++||++.+|.+.|.+
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111122222222334456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=324.00 Aligned_cols=246 Identities=22% Similarity=0.231 Sum_probs=200.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45778899999999999999874 68999999987531 1233456889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+.+++|.+++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999999853 4578999999999999999999999 9999999999999999999999999999986643321
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
...||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... ..+......
T Consensus 174 -----~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~---------- 230 (329)
T PTZ00263 174 -----TLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYEKILAG---------- 230 (329)
T ss_pred -----eecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcC----------
Confidence 24589999999999877 6899999999999999999999997533211 111111111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~~ 296 (356)
....+...+.++.+++.+||+.||.+||+ +.+++..
T Consensus 231 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122234567899999999999999997 6777753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.65 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=205.0
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.+.+.+.||+|+||.||+|+- .+|+.+|+|+++++. .......++.|-.+|...++|.||+++-.|.+.+++|||||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 455678999999999999975 469999999998752 34566788999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC----
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR---- 177 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~---- 177 (356)
|++||++..+| ...+.|++..+..++.+++.|+..+|. .|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 222 ylPGGD~mTLL-~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 222 YLPGGDMMTLL-MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred ecCCccHHHHH-HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999 566789999999999999999999999 9999999999999999999999999999863211
Q ss_pred ------------------C-CCc----e------------------eecCCCCCCCCCCcccccCCCCCCCCCceehhhH
Q 047701 178 ------------------N-RSH----V------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216 (356)
Q Consensus 178 ------------------~-~~~----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~ 216 (356)
. ... . .....+|||-|||||++.+. .|+..+|.|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHH
Confidence 0 000 0 01235799999999999998 6999999999999
Q ss_pred HHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC---HHHH
Q 047701 217 VSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP---MSAV 293 (356)
Q Consensus 217 il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v 293 (356)
|+||||.|-+||....+.. .|.....-. .....+....++.++.+||.+|+. ||+.|.- ++||
T Consensus 377 ImyEmLvGyPPF~s~tp~~-------T~rkI~nwr------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQE-------TYRKIVNWR------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHhCCCCCCCCCHHH-------HHHHHHHHh------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 9999999999997765532 222221111 011122233345889999999999 9999965 6777
Q ss_pred HH
Q 047701 294 VK 295 (356)
Q Consensus 294 ~~ 295 (356)
-+
T Consensus 443 K~ 444 (550)
T KOG0605|consen 443 KK 444 (550)
T ss_pred hc
Confidence 66
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.67 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=205.6
Q ss_pred HhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
..+.+.+.||+|+||.||+|.+. ++..||||++...........+..|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45778899999999999999753 257899999986544445567889999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 98 LVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
+++||+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 999999999999998421 2358889999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhH
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPK 241 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~ 241 (356)
.+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|||++ |..|+.....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999998866543332222334567899999998766 68999999999999999998 5555432111
Q ss_pred HHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
......+........+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 233 --------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 --------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11112222222233344567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=304.53 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=204.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhH-HHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIA-EEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 100 (356)
.|...++|++|.||.||+|+++ +++.||+|.++.+..+.. --..++|+.+|.+.+|||||.+-.+... -+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4555788999999999999874 699999999985532221 2356899999999999999999887764 35789999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|||+. +|..++....++++..++.-+..|++.|++|||. +.|+|||||++|+|++..|.+||+|||+|+.++....
T Consensus 157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 99988 9999998888899999999999999999999999 9999999999999999999999999999998886633
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc---------chhHHHHHHHhhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD---------WFPKYVWEEYEKSE 251 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 251 (356)
..+..+-|.+|.|||.+.|...|+.+.|+||+|||+.||+++++.+- +..+... ......|..+..-.
T Consensus 233 --~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~-G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 233 --PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP-GKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred --cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC-CCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 23556679999999999998899999999999999999999876543 2222110 00011122222211
Q ss_pred hhhhHh------hcCCCchhH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAMIL------ACGIEEKDK-EKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~~~------~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+. +........ ..+..-++|+..++..||.+|.|+.+.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111000 000000011 14577899999999999999999999887
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=318.09 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=205.9
Q ss_pred hccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+.+.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+......+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 567889999999999999752 23579999987665545557789999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccce
Q 047701 100 YEYMENGSLDGYLFGK-----------------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 156 (356)
+||+.+++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 9999999999988532 1357899999999999999999999 9999999999999
Q ss_pred EEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCcc
Q 047701 157 LLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASES 235 (356)
Q Consensus 157 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~ 235 (356)
++++++.++|+|||+++...............++..|+|||++.+. .++.++||||||+++|+|++ |..|+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999865433322222334467789999998776 68999999999999999998 7777632211
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
...++. +........+...+.++.+++.+||+.+|.+||++.++++.|+++..
T Consensus 236 -----~~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -----ERLFNL---------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHH---------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111 11111122233456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=312.60 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=203.1
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
..|.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4577889999999999999988777789999987542 23467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+++|.+++......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........ .
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence 9999999997655679999999999999999999999 99999999999999999999999999998866443221 2
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....++..|+|||++.+. .++.++||||||+++|+|++ |..|+...... .... .+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~~~~---------~~~~~~~~ 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------ETVE---------KVSQGLRL 220 (256)
T ss_pred cCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHH---------HHhcCCCC
Confidence 2233466789999999876 68999999999999999998 77765322110 0011 11111111
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
......+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 122234578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=317.39 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=207.5
Q ss_pred HHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
+...+.+.+.||+|+||.||++.. .++..+|+|.+.... ......+..|+.++.+++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 456788899999999999999964 235668999886542 3445678999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 96 TALVYEYMENGSLDGYLFGKK------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999999985332 358999999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHH
Q 047701 164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~ 242 (356)
++|+|||++................++..|+|||++.+. .++.++||||||+++|+|++ |..|+...... .
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~ 230 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------E 230 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence 999999999865433322222234467789999999876 68999999999999999998 77765322211 0
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.... +........+...+.++.+++.+||+.||.+||++.+|++.|+++..
T Consensus 231 ~~~~---------i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 231 VIEC---------ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHH---------HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111 11111112223355679999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=324.14 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=206.4
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
....|+..+.||+|+||.||++.+. ++..+|+|++...........+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3456788899999999999999864 688999999986655555678999999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 83 EHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE---KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhh---cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999999843 4568999999999999999999998 5 69999999999999999999999999987654322
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH-H---------------
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY-V--------------- 243 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~-~--------------- 243 (356)
.....||..|+|||++.+. .++.++||||||+++|||++|+.|+.............. .
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 1234689999999999877 689999999999999999999998743322110000000 0
Q ss_pred --------------HHHHhhhchhhhHhhcCCCch-hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 244 --------------WEEYEKSELGAMILACGIEEK-DKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 244 --------------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
............+........ ....+.++.+++.+||+.||++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000111111111111 12356789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=310.03 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=201.1
Q ss_pred ccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 31 RLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
.||+|+||.||+|.+. ++..||+|++.........+.+.+|+.++++++||||+++++++.. ...++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999753 3567999999766555556779999999999999999999998864 46799999999999
Q ss_pred HhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee-ecC
Q 047701 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-ISG 186 (356)
Q Consensus 108 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 186 (356)
|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999997666789999999999999999999999 9999999999999999999999999999986544332211 122
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
..++..|+|||++.+. .++.++||||||+++|++++ |..|+..... ......+..+.....+
T Consensus 158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------------PEVMSFIEQGKRLDCP 220 (257)
T ss_pred CCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----------------HHHHHHHHCCCCCCCC
Confidence 2346789999998876 68999999999999999996 8777632211 1111222222223344
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
..++.++.+++.+||..+|++||++.+|.+.|...
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 55678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=311.93 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=202.4
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.+++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 467889999999999999988777889999986532 234568889999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...+.... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-cc
Confidence 999999997666689999999999999999999999 99999999999999999999999999998765433221 11
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....++..|+|||.+.+. .++.++||||||+++|++++ |..|+...... .... .+.......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~---------~~~~~~~~~ 221 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVE---------SVSAGYRLY 221 (256)
T ss_pred CCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHH---------HHHcCCcCC
Confidence 222345689999999876 68999999999999999998 66665322111 0011 111111122
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.+...+.++.+++.+||..+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2334677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=330.92 Aligned_cols=266 Identities=24% Similarity=0.330 Sum_probs=211.0
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeee
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGF 89 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~ 89 (356)
..+++....+.+.++||+|+||.||+|.+. .++.||||++...........+..|+.++.++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 457777888888999999999999999752 356899999986544444567889999999997 9999999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccCC-----------------------------------------------------
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGKK----------------------------------------------------- 116 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------- 116 (356)
+......++||||+.+|+|.+++....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999985321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Q 047701 117 --------------------------------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 152 (356)
Q Consensus 117 --------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 152 (356)
..+++..++.++.|++.||+|||+ .+++|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCC
Confidence 236778899999999999999999 999999999
Q ss_pred ccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccC
Q 047701 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVG 231 (356)
Q Consensus 153 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~ 231 (356)
|+|||+++++.++|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+...
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999865433222122234577889999999876 68999999999999999998 77665322
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
... .. ....+........+..++.++.+++.+||..+|.+||++.+|++.|+++.
T Consensus 346 ~~~------~~---------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 PMN------EQ---------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred Cch------HH---------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 110 00 01111111112223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=314.75 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=208.3
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
....+++.++||+|+||+||+|.+ .+++ .||+|++...........+..|+.++..++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 345677889999999999999975 3444 48999987665555667888999999999999999999999764 56
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+++++|+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++...
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 89999999999999997666789999999999999999999999 999999999999999999999999999998775
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
............++..|+|||.+.+. .++.++||||||+++|||++ |..|+...... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~ 223 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----------------EIPDL 223 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------------HHHHH
Confidence 44333222333456789999999876 68999999999999999998 77765322110 11111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+........+..++.++.+++.+||+.||++||++.++++.|..+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11222222334456789999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.32 Aligned_cols=245 Identities=23% Similarity=0.226 Sum_probs=200.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4677899999999999999874 68999999986432 12344568889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+++|.+++.. .+.+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 82 YVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 9999999999853 4578999999999999999999999 999999999999999999999999999988654322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ......... .
T Consensus 156 ---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~----------~ 214 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAG----------K 214 (291)
T ss_pred ---ccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhC----------C
Confidence 224589999999999877 6899999999999999999999987543221 111111111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~~ 296 (356)
...+...+..+.+++.+||+.||.+||+ ++++++.
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1223334667899999999999999995 7887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=321.09 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=209.7
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC--------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeee
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP--------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGF 89 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 89 (356)
+++....|.+.+.||+|+||.||+|... +...+|+|.+...........+..|+.++.++ +||||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4555678999999999999999999652 23579999998654445556788899999999 79999999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCcc
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 154 (356)
+......++||||+.+++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHH
Confidence 999999999999999999999996432 358999999999999999999999 99999999999
Q ss_pred ceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCC
Q 047701 155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGAS 233 (356)
Q Consensus 155 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~ 233 (356)
||+++.++.++|+|||++................++..|+|||++.+. .++.++||||||+++|+|++ |..|+.....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999998765432222222223345789999999876 68999999999999999998 6665522111
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..+...+......+.+...+.++.+++.+||+.+|.+||++.+|++.|..+..
T Consensus 249 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 ----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ----------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 01111111222223344556789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=323.62 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=203.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.++||+|+||.||+|.+. +++.||||++..... ......+..|+.++.+++||||+++++++.+....|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 4678899999999999999875 589999999975421 1234568889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999994 44578999999999999999999999 9999999999999999999999999999976543
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
......||+.|+|||++.+. .++.++|||||||++|||++|..|+...... ..+....... ........
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~--~~~~~~~~ 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-------ETWENLKYWK--ETLQRPVY 222 (333)
T ss_pred -ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHH-------HHHHHHHhcc--ccccCCCC
Confidence 12345689999999999887 7999999999999999999999987543221 1111111100 00000001
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......+.++.+++.+||..+|.+||++.++++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11112456789999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=320.72 Aligned_cols=241 Identities=22% Similarity=0.274 Sum_probs=193.8
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||+|+||.||+|... +++.||+|++.... .......+..|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 58899999987531 233446678899999999999999999999999999999999999999
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCC
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 188 (356)
.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 154 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC 154 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence 999854 4578999999999999999999999 9999999999999999999999999999875432221 123456
Q ss_pred CCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHH
Q 047701 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268 (356)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... ..+.. ... .....+...
T Consensus 155 gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~---------~~~-~~~~~~~~~ 216 (312)
T cd05585 155 GTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRK---------ILQ-EPLRFPDGF 216 (312)
T ss_pred CCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHH---------HHc-CCCCCCCcC
Confidence 89999999999877 7899999999999999999999987532211 00111 011 011223345
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 269 AKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+.++.+++.+||..||.+||++..+.+.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 6789999999999999999865444333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=319.62 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=210.9
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc--------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeee
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF--------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGF 89 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 89 (356)
+++....|.+.+.||+|+||.||+|.. .++..||+|.+...........+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 456677888999999999999999963 124579999987654445567889999999999 89999999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCcc
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 154 (356)
+......++||||+.+++|.+++... ...+++.++..++.||+.||.|||+ ++++||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccc
Confidence 99999999999999999999998643 1357889999999999999999999 99999999999
Q ss_pred ceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCC
Q 047701 155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGAS 233 (356)
Q Consensus 155 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~ 233 (356)
||+++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|++++ |..|+... +
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~-~ 244 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI-P 244 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccC-C
Confidence 999999999999999999876544333222334467789999999876 68999999999999999998 55544211 1
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.. ++...+........+..++..+.+++.+||+.+|.+||++.+|++.|.++..
T Consensus 245 ------~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 ------VE---------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------HH---------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 00 1111111111222334566789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=312.64 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=206.2
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
....+.+.++||+|+||.||+|.+. +++.||+|.+..+. .....+.+|++++++++||||+++++++......+++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 3445778899999999999999764 58899999987542 33467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999998644 3568999999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. ......++..|+|||++.+. .++.++||||||+++|||++ |..|+...... ..+.. +..
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~---------~~~ 220 (263)
T cd05052 159 YT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYEL---------LEK 220 (263)
T ss_pred ee-ccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH---------HHC
Confidence 21 11223356789999999877 68999999999999999998 77665322111 11111 111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
......+...+.++.+++.+||..||++||++.++++.|+.+
T Consensus 221 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 221 GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112233344567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=314.39 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=210.6
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCC-----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CC
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QH 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 94 (356)
+...+|.+.+.||+|+||.||+|.+.. +..|++|++...........+.+|+.++++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 445678889999999999999998754 788999998866555666788999999999999999999998766 56
Q ss_pred eeeEEEEecCCCCHhHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEe
Q 047701 95 MTALVYEYMENGSLDGYLFGKK-------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 167 (356)
..+++++|+.+++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence 7889999999999999985432 468999999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHH
Q 047701 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 168 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
|||+++.+.............++..|+|||++.+. .++.++||||||+++|++++ |+.|+.......
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------- 227 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----------- 227 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----------
Confidence 99999866443332222334467789999999876 68999999999999999998 887764322110
Q ss_pred HhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+...+...........++.++.+++.+||..||++||++.++++.|..+..
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 228 -----MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -----HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111111112223356789999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=336.97 Aligned_cols=250 Identities=18% Similarity=0.220 Sum_probs=202.4
Q ss_pred hhccccccCcCCceEEEEEEcC-C-CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-N-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+..|+.+++.++||||+++++++..++..||||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4788899999999999999653 4 6789999775432 23445678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 103 MENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 103 ~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+++|+|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998743 24568999999999999999999999 999999999999999999999999999998765443
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.........||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... .+...+...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----------------~~~~~~~~~ 286 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQR----------------EIMQQVLYG 286 (478)
T ss_pred ccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC
Confidence 32223446699999999999876 7899999999999999999999987432110 011111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....+..++.++.+++.+||..||++||++.+++.
T Consensus 287 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112223345678999999999999999999998875
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=315.66 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=206.5
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
++...+|++.++||+|+||.||+|... .+..||+|.+...........+.+|+.++++++||||+++++++.++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 455678899999999999999999642 24589999987654444556788899999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 94 HMTALVYEYMENGSLDGYLFGK---------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
...++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999532 1345778899999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHH
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~ 243 (356)
+|+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |..|+.....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---------- 227 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------- 227 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----------
Confidence 99999998865433322222223456789999999876 68999999999999999998 5555422111
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.+....+........+...+..+.+++.+||+.||++||++.++++.|.+..
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 228 ------EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111112122223344678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.01 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=198.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.+++.++||+|+||.||+|.+. +++.||||++...........+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566789999999999999764 689999999976555555678899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++++|... ....+..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 224 (353)
T PLN00034 155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-- 224 (353)
T ss_pred CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--
Confidence 99998653 245677888999999999999999 99999999999999999999999999999866433211
Q ss_pred ecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 184 ISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....||..|+|||++... ...+.++|||||||++|||++|+.||........ .... ......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------~~~~-----~~~~~~ 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--------ASLM-----CAICMS 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--------HHHH-----HHHhcc
Confidence 1235689999999987532 1345689999999999999999999863322111 0000 000111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........++.++.+++.+||+.||++||++.++++.
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334566789999999999999999999999973
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=313.45 Aligned_cols=273 Identities=22% Similarity=0.351 Sum_probs=208.4
Q ss_pred HHhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--Ce
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HM 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 95 (356)
+.+|...++||+|+||.||++.+ .++..||+|.+...........+.+|+.++++++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45677889999999999999973 357899999987654455567899999999999999999999998875 56
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 889999999999999996655678999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCce-eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
....... ......|+..|+|||++.+. .++.++||||||+++|+|++++.+............... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 237 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT-HGQMTVTRLVR 237 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc-cccccHHHHHH
Confidence 5433221 12234577789999998876 689999999999999999998765322111000000000 00000000011
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.+......+....++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111112222334667899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=307.09 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=201.1
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHh
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLD 109 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 109 (356)
++||+|+||.||+|...++..+|+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999887889999999887655555667899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCC
Q 047701 110 GYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189 (356)
Q Consensus 110 ~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 189 (356)
+++......+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.++|+|||++.......... .....+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCC
Confidence 9997666678999999999999999999999 999999999999999999999999999987543322111 112234
Q ss_pred CCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHH
Q 047701 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268 (356)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
+..|+|||++.+. .++.++||||||+++|++++ |..|+...... ...... ........+..+
T Consensus 157 ~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~---------~~~~~~~~~~~~ 219 (250)
T cd05085 157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQV---------EKGYRMSCPQKC 219 (250)
T ss_pred cccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHH---------HcCCCCCCCCCC
Confidence 6679999999876 68999999999999999998 77776322111 001111 111111223345
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 269 AKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
+..+.+++.+||..+|++||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=319.11 Aligned_cols=242 Identities=26% Similarity=0.310 Sum_probs=196.0
Q ss_pred cccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.||+|+||.||++.. .+|+.||+|++.... .......+..|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999976 468999999997542 2234456778999999999999999999999999999999999999
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecC
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 186 (356)
+|..++. ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 9998884 44578999999999999999999999 9999999999999999999999999999875332221 1233
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhH
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.|+....... ........ ....+.
T Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~~~~~----------~~~~p~ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILME----------EIRFPR 216 (323)
T ss_pred ccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcC----------CCCCCC
Confidence 5689999999999877 68999999999999999999999875332210 01111000 011233
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 267 EKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
..+.++.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 4567889999999999999998 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.60 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=207.4
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
++....+.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.++..++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 345667888999999999999999763 24789999987654445566788999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 94 HMTALVYEYMENGSLDGYLFGK---------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
...++||||+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCE
Confidence 9999999999999999998532 2347889999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHH
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~ 243 (356)
||+|||+++...............++..|+|||.+.+. .++.++||||||+++||+++ |..|+......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------- 228 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------- 228 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHH---------
Confidence 99999998866543322222234467899999998776 68999999999999999998 77665321111
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.....+........+..++.++.+++.+||+.+|++|||+.+++..|+
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 -------EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111122222233345778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.42 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=208.1
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CC---cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NG---VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
...++..+.||+|+||.||+|..+ ++ ..+|+|.+...........+..|+.++++++|||++++++++.+....++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 446777899999999999999864 23 37999998766544556778999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999999999997666789999999999999999999999 99999999999999999999999999998866543
Q ss_pred CCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... ......+..|+|||++.+. .++.++||||||+++||+++ |..|+...... +....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----------------~~~~~i 223 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----------------EVMKAI 223 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----------------HHHHHH
Confidence 32211 1122235579999999876 68999999999999999997 88876432210 111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
......+....++.++.+++.+||..+|++||++.+|++.|.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112222334567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=318.53 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=200.2
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|.+.++||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 46788899999999999999875 68999999987543333345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+. ++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 95 58888886666789999999999999999999999 9999999999999999999999999999875432221
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh---h------chh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK---S------ELG 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~ 253 (356)
......||+.|+|||++.+...++.++|||||||++|+|++|..|+........ .+... ...... . ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLERI-FLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHH-HHHhCCCChhhccchhhcc
Confidence 123356899999999987765688999999999999999999998854322100 00000 000000 0 000
Q ss_pred hhHhhc---CCCchh------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILAC---GIEEKD------KEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~---~~~~~~------~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...... ...... ...+..+.+++.+|++.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000000 012356889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.98 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=207.1
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
++...+|++.++||+|+||.||+|..++++.||+|.+.... .....+.+|+.++++++|+||+++++++.. ...+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEE
Confidence 45678899999999999999999998888999999987543 334578899999999999999999998754 568999
Q ss_pred EEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999988543 4578999999999999999999999 99999999999999999999999999998766533
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... ......++..|+|||++.+. .++.++||||||+++|++++ |..|+...... ..... +.
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~---------~~ 217 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQN---------LE 217 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHH---------HH
Confidence 221 11234467789999999876 68999999999999999998 88776422211 01111 11
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
.......+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111122233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=311.17 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=205.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CC---cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NG---VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.+++.+.||+|+||.||+|.+. ++ ..||||.+...........+..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4778899999999999999764 23 4699999876655556678999999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++....+.+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999997666779999999999999999999999 9999999999999999999999999999876654332
Q ss_pred ceeecCC---CCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 181 HVTISGY---KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 181 ~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
....... ..+..|+|||++.+. .++.++||||||+++||+++ |..|+...... ......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i--------- 224 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAI--------- 224 (269)
T ss_pred ccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHH---------
Confidence 2111111 124579999999876 68999999999999999886 87776322211 001111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
........+..++..+.+++.+||..+|++||++.+|+..|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111122334567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.61 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=207.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...+.+.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 345677899999999999999642 35668999886542 23446788999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC
Q 047701 97 ALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 161 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 161 (356)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 99999999999999995432 348999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchh
Q 047701 162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFP 240 (356)
Q Consensus 162 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~ 240 (356)
+.++|+|||++................++..|+|||++.+. .++.++||||||+++|+|++ |..|+......
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------ 232 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------ 232 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999765443322222334567889999999876 68999999999999999998 88776433221
Q ss_pred HHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..++. .............+..+.+++.+||+.+|.+||++.+|++.|..+...
T Consensus 233 -~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -EVIEC---------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHH---------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111 111122222334567899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.68 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=203.4
Q ss_pred HHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...+.+.+.||+|+||.||+|.+. .+..||+|.............+..|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456778899999999999999764 35789999887655555567789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEEe
Q 047701 97 ALVYEYMENGSLDGYLFGKK------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVA 167 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 167 (356)
++||||+.+++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999985432 258999999999999999999999 9999999999999997654 58999
Q ss_pred ccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHH
Q 047701 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 168 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
|||+++...............++..|+|||++.+. .++.++|||||||++|+|++ |..|+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------------ 228 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------------ 228 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence 99999876433222111122345679999999876 69999999999999999997 77665322111
Q ss_pred HhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
+....+........+..++.++.+++.+||+.+|++||++.+|++.|.
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111112222222334455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=322.25 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=205.5
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+....|++.++||+|+||.||++.+. ++..+|+|.+...........+.+|++++++++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 45568889999999999999999875 68899999987665555567899999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999999853 4568999999999999999999997 1479999999999999999999999999987553321
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh-------------------
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP------------------- 240 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~------------------- 240 (356)
.....|+..|+|||++.+. .++.++|||||||++|+|++|+.|+............
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ----cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 1234689999999999876 6899999999999999999999887543221110000
Q ss_pred -HHHHHHHhh--------hchhhhHhhcCCCchh-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 241 -KYVWEEYEK--------SELGAMILACGIEEKD-KEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 241 -~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......+.. ......+......... ...+.++.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000000 0000011111111111 123567899999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.97 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=217.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.......+.++||+|-||.|.++....+.+||||.++.........+|.+|+++|.+|+||||+.++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 33445667899999999999999886779999999998877777899999999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+++|+|..|+..+..+ +.-....+|+.||+.||+||.+ .++|||||.+.|||+++++++||+|||+++-...+.
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999766433 4666777899999999999999 999999999999999999999999999999777666
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc--CCCccccCCCccccchhHHHHHHHhhhch----h
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG--RRRNAIVGASESLDWFPKYVWEEYEKSEL----G 253 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 253 (356)
........+-+.+|||+|.+.-. .+|.++|||+||+++||+++ ..+|+ ..+.++.. .
T Consensus 692 yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py----------------~~lt~e~vven~~ 754 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPY----------------SQLTDEQVVENAG 754 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCch----------------hhhhHHHHHHhhh
Confidence 66554556678899999998866 79999999999999999874 44443 22222222 2
Q ss_pred hhHhhcC---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 254 AMILACG---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 254 ~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.+..... ....++-++..+.+++.+||..+-.+||+++++...|...
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2222221 2344666888999999999999999999999999988754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=316.28 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=200.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4778899999999999999875 58899999987542 233456788899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
++++++..+. .....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 156 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA- 156 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence 9987776544 445679999999999999999999999 99999999999999999999999999999876433221
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhh-chh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKS-ELG 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~ 253 (356)
......||..|+|||++.+. .++.++|||||||++|+|++|+.|+.......... .+...+..+... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 12335689999999999877 68999999999999999999998875432211000 000000000000 000
Q ss_pred hhHhhcC--C----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACG--I----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~--~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....... . .......+.++.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0 0001124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=310.34 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=207.5
Q ss_pred HHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+...........+..|+.++.+++||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 346778899999999999999763 2347999998765555556788999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+++++|.+++......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999997666778999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... .....++..|+|||++.+. .++.++|+||||+++|++++ |..|+...... .... .+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~---------~~ 222 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIK---------AI 222 (267)
T ss_pred cceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHH---------HH
Confidence 32221 1222345689999999876 68999999999999999886 88776322111 0011 11
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
............+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11111122334567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.52 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=209.4
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
+.+....+.+.+.||+|+||.||++.. ..+..||||.+...........+..|+.+++++ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 456667888999999999999999964 135689999987654445556789999999999 7999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
..+..+++|||+.+++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999996433 348999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
++................++..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~------- 252 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SK------- 252 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HH-------
Confidence 99866544322222234467889999999877 68999999999999999998 77765322111 00
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.............+...+.++.+++.+||..+|++||++.++++.|.++
T Consensus 253 --~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 --FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0111111111122233456799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=311.32 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=208.4
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
...|.+.++||.|+||.||+|.+.++..+|+|++..... .....+..|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 456888999999999999999987789999999876532 3456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999653 4568999999999999999999999 99999999999999999999999999999766432211
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |..|+..... .+....+....
T Consensus 161 --~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----------------~~~~~~~~~~~ 221 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----------------HEVYDQITAGY 221 (261)
T ss_pred --ccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----------------HHHHHHHHhCC
Confidence 1234467789999998876 68999999999999999998 6766632211 01111111222
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
....+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 2233345567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.56 Aligned_cols=243 Identities=26% Similarity=0.315 Sum_probs=197.0
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.||+|+||.||++... +++.||||++.+.. .......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68999999997542 2234467888999999999999999999999999999999999999
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecC
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 186 (356)
+|..++. ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 154 (328)
T cd05593 81 ELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT 154 (328)
T ss_pred CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence 9998884 44679999999999999999999999 9999999999999999999999999999875432211 1233
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhH
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
..||+.|+|||++.+. .++.++|||||||++|+|++|..|+....... ....+.. .....+.
T Consensus 155 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----------------~~~~~~~-~~~~~p~ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------LFELILM-EDIKFPR 216 (328)
T ss_pred ccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHH----------------HHHHhcc-CCccCCC
Confidence 5699999999999877 68999999999999999999999874322110 0000100 0112233
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 047701 267 EKAKQLCMVALWCVQDSPADRP-----PMSAVVKM 296 (356)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~ 296 (356)
..+.++.+++.+||..||.+|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 4567799999999999999997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=316.63 Aligned_cols=242 Identities=24% Similarity=0.246 Sum_probs=195.1
Q ss_pred cccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 30 TRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+.||+|+||.||++.. .+++.||||++.... .......+..|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 358899999987531 122335677899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+++|.+++. ..+.+.+..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (323)
T cd05584 82 LSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV- 156 (323)
T ss_pred CCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc-
Confidence 99999999884 44568889999999999999999999 99999999999999999999999999998754322211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....||+.|+|||++.+. .++.++||||||+++|||++|..|+...... ....... .. ..
T Consensus 157 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~~~---------~~-~~ 217 (323)
T cd05584 157 -THTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDKIL---------KG-KL 217 (323)
T ss_pred -ccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHHHH---------cC-CC
Confidence 2235689999999999876 6899999999999999999999987533221 0011111 11 11
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
..+...+.++.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22334567789999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=323.97 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=205.2
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
|+....+|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 345567899999999999999999963 347889999997654444556788999999999 6899999999886
Q ss_pred c-CCeeeEEEEecCCCCHhHHhccCC------------------------------------------------------
Q 047701 92 D-QHMTALVYEYMENGSLDGYLFGKK------------------------------------------------------ 116 (356)
Q Consensus 92 ~-~~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------------------ 116 (356)
. +...+++|||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 456789999999999999985321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 117 ------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 117 ------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 236888999999999999999999 99999999999999999999999999998865433222222
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....++..|+|||++.+. .++.++||||||+++|+|++ |..|+...... ..... .+.......
T Consensus 239 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~---------~~~~~~~~~ 302 (343)
T cd05103 239 GDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR---------RLKEGTRMR 302 (343)
T ss_pred CCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHH---------HHhccCCCC
Confidence 233466789999998876 68999999999999999997 76665321110 00011 111111111
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+...+.++.+++..||+.||++||++.+|++.|+.+.+
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 222244678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.94 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=215.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe-eeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM-TALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 101 (356)
.|...+++|+|+||.++.++.+ +++.+++|.+.-. .....+...+.|+.+++++.|||||.+.+.|.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 5778899999999999999764 5889999998744 334455578899999999999999999999999887 999999
Q ss_pred ecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+||+|...+.... ..++++.+..|+.|++.|+.|||+ +.|+|||||+.||++..++.++|+|||+|+.......
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999996654 679999999999999999999998 9999999999999999999999999999998876652
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. ...++||+.||.||.+.+. +|..++|||||||++|||++-+++|...+.. .+...+....
T Consensus 162 ~--a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----------------~Li~ki~~~~ 222 (426)
T KOG0589|consen 162 L--ASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----------------ELILKINRGL 222 (426)
T ss_pred h--hheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchH----------------HHHHHHhhcc
Confidence 2 2447799999999999988 8999999999999999999998877444332 1222233333
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+.+..++.++..++..|++.+|..||++.+++..
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 566778889999999999999999999999999985
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=307.93 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=199.2
Q ss_pred cccCcCCceEEEEEEc---CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQF---PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||.||+|.+ .++..+|+|++.... .......+..|+.+++.+.||||+++++++.. ...++||||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 3699999999999964 357899999987543 23345678899999999999999999998864 466899999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee-e
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-I 184 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~ 184 (356)
++|.+++. ....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........... .
T Consensus 80 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999995 34578999999999999999999999 9999999999999999999999999999987654433211 1
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....++..|+|||.+... .++.++|+||||+++|||++ |..|+..... ......+.......
T Consensus 156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------------~~~~~~i~~~~~~~ 218 (257)
T cd05116 156 THGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----------------NEVTQMIESGERME 218 (257)
T ss_pred CCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHCCCCCC
Confidence 223356789999998765 68899999999999999998 8777642211 11122222222233
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.+..++.++.+++.+||+.||++||++++|++.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3445678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.37 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=207.8
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC--------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP--------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFC 90 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 90 (356)
++...++.+.++||+|+||.||+|... ....+|+|.+...........+..|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 445567888999999999999999641 24579999988655555567788999999999 699999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
.+....+++|||+.+|+|.+++... ...+++.++..++.|++.||.|||+ .+++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecccccee
Confidence 9999999999999999999999542 2358999999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCc
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASE 234 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~ 234 (356)
|+++.++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|+|++ |..|+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999866543222111222345679999999876 68999999999999999998 6655421111
Q ss_pred cccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 235 SLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..... .+........+..++.++.+++.+||..+|++||++.++++.|.++..
T Consensus 243 ------~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 ------EELFK---------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ------HHHHH---------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111 111111122334456688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.51 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=228.8
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCC-CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
-.|+++...+....+||-|-||.||.|.|+. .-.||||.++.+. ...++|+.|..+|+.+.|||+|+++|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4588888888889999999999999999964 7789999998754 456789999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 96 TALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
.|||+|||..|+|.+||+..+ ..++...++.++.||+.||+||.. +++|||||.++|+|+.++..+|++||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999997654 457888899999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
+...... ...+.+-.+-|.|||-+..+ .++.++|||+|||+|||+.|-....+. ..+...+..
T Consensus 415 MtgDTYT-AHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYP---------------GidlSqVY~ 477 (1157)
T KOG4278|consen 415 MTGDTYT-AHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYP---------------GIDLSQVYG 477 (1157)
T ss_pred hcCCcee-cccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCC---------------CccHHHHHH
Confidence 8754433 23455667889999999877 699999999999999999986543322 233445556
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
++..+.+.+.+.+|++.+++||+.||+.+|.+||++.|+.+.++.++.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 666777778889999999999999999999999999999999887654
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=307.86 Aligned_cols=249 Identities=33% Similarity=0.471 Sum_probs=206.4
Q ss_pred cccCcCCceEEEEEEcCC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|.+.. +..|++|.+...........+..|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998743 8899999998765444567899999999999999999999999999999999999999
Q ss_pred CCHhHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 106 GSLDGYLFGK--------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 106 ~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
++|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999665 4789999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcC-CCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGR-RRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
...........++..|+|||.+.+. .++.++||||||+++|+|+++ ..|+..... ...+. .+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~---------~~ 220 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLE---------YL 220 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHH---------HH
Confidence 4432233445678899999999877 689999999999999999984 666543311 11111 11
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
........+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112223334455788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=310.46 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=212.8
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..++|++.+.||+|.||.|-+|.. ..|+.||||.+.++. .+.+.-++.+|+++|+.|+||||+.++.+|...+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 577999999999999999999965 679999999998653 44556788999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||..+|.|.+|+ ...+.+++.....+++||..|+.|+|. ++++|||||.+|||+|.++++||+||||+-++...
T Consensus 131 vMEYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999999 566789999999999999999999999 99999999999999999999999999999887755
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. .+.++|++-|.+||++.|...-+...|-|||||+||-|+-|..||...+-. .+..-+..
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------------~lvrQIs~ 267 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------------RLVRQISR 267 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------------HHHHHhhc
Confidence 43 355789999999999999866678999999999999999999887433221 11111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
+.. ..+.-+....-||.+||..||++|.|+.+|.....
T Consensus 268 GaY--rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 268 GAY--REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ccc--cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 111 11223456788999999999999999999998664
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=309.84 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=197.5
Q ss_pred ccccccCcCCceEEEEEEcCC-Cc--EEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------Cee
Q 047701 27 NYSTRLGFGGFGQVYKGQFPN-GV--KIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------HMT 96 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 96 (356)
.+.++||+|+||.||+|.+.. +. .+|+|.++... .......+..|+.++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467899999999999998743 33 69999887542 334456788999999999999999999987432 246
Q ss_pred eEEEEecCCCCHhHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 97 ALVYEYMENGSLDGYLFG-----KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
+++|||+.+|+|.+++.. ....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988732 23458999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
++.+.............+++.|++||++.+. .++.++||||||+++|+|++ |..|+..... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~----- 225 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYD----- 225 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH-----
Confidence 9876544322222223467789999999876 68999999999999999999 5665532111 11111
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.+...........++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 ----YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111122334566799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.17 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=202.3
Q ss_pred HHHhhccccccCcCCceEEEEEEcCC---------------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPN---------------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 86 (356)
....|++.++||+|+||.||++.... ...||+|.+...........+.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45678899999999999999986532 235899999766555556779999999999999999999
Q ss_pred eeeEEcCCeeeEEEEecCCCCHhHHhccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKK-----------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
++++......++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999984321 247889999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC--CccccCCC
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR--RNAIVGAS 233 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~--~~~~~~~~ 233 (356)
|+++.++.+||+|||++................++..|+|||++.+. .++.++||||||+++|+|+++. .|+.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999865443322222334467789999998876 6899999999999999999843 34322111
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.. ....... .................+..+.+++.+||..||++||++++|++.|.
T Consensus 239 ~~-------~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQ-------VIENTGE--FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HH-------HHHHHHH--hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 00 0000000 00000000011122234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.96 Aligned_cols=249 Identities=23% Similarity=0.263 Sum_probs=202.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCC--CcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPN--GVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
+.-..|.+.+.||+|+||.||+|.+.. +..||+|++.... .......+..|+.+++.++||||+++++++.+....
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 344568888999999999999997533 4689999986431 223445688899999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+.+|+|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 107 ~lv~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999995 34578999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
... ....||+.|+|||++.+. .++.++|||||||++|||++|..|+...... ..+......
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~------ 243 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEG------ 243 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcC------
Confidence 321 234689999999999876 6899999999999999999999998543221 111111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVKM 296 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~ 296 (356)
....+...+..+.+++.+|++.||.+|+ +++++++.
T Consensus 244 ----~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 ----IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1112333456788999999999999995 88888774
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=304.71 Aligned_cols=266 Identities=20% Similarity=0.242 Sum_probs=210.1
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-----CCeee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-----QHMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~ 97 (356)
+|...+.||+|+||.|..+.. .+|+.||||.+.+. .......+..+|+.+|+.++|+||+.+++++.. -+..|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 344468899999999999976 47999999998743 233455678899999999999999999999865 45789
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+|+|+| +.+|...+ +.++.++...+..+..|++.||+|+|+ .+++||||||+|++++.+-.+||+|||+|+....
T Consensus 103 iV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 103 LVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccc
Confidence 999999 55999988 455669999999999999999999999 9999999999999999999999999999998865
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc--------cchhHHHHHHHhh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL--------DWFPKYVWEEYEK 249 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~--------~~~~~~~~~~~~~ 249 (356)
.......+..+-|..|.|||++.....|+.+.||||.||||.||++|++-|-..+.-.+ .............
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 43334446778899999999998777899999999999999999999876643322111 0111122233333
Q ss_pred hchhhhHhhcCC------CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SELGAMILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....++.+... ....++..+.+.+|+.+||..||.+|+|+++.+.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 334444443221 1223456688999999999999999999999997
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.11 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=204.5
Q ss_pred HHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...+++.+.||+|+||.||+|..+ ++..||+|++...........+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456788899999999999999753 46789999988665545567789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 97 ALVYEYMENGSLDGYLFGKK---------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999985321 247888999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCc
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASE 234 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~ 234 (356)
|++++++.++|+|||++................++..|+|||.+.+. .++.++||||||+++|+|++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998765433222222223456789999998876 68999999999999999997 65565321110
Q ss_pred cccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 235 SLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
+....+........+...+.++.+++.+||+.+|++||++.++++.|++
T Consensus 240 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ----------------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111111122233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=308.73 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=201.4
Q ss_pred hccccccCcCCceEEEEEEcC----CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe-----
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM----- 95 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 95 (356)
+.+.+.||+|+||.||+|... .+..||||.+.... .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 457889999999999999753 24789999987542 23445678999999999999999999998866544
Q ss_pred -eeEEEEecCCCCHhHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEecc
Q 047701 96 -TALVYEYMENGSLDGYLFGK-----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169 (356)
Q Consensus 96 -~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 169 (356)
.++++||+.+++|..++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999988432 2468999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHh
Q 047701 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
|+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------------- 221 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------------- 221 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCH---------------
Confidence 999876544332222223356789999998766 68999999999999999999 6666532111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.+....+........+..++.++.+++.+||+.||++||++.+|++.|.++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 222 -HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011111111222223445677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=310.98 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=202.5
Q ss_pred HHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...+.+.++||+|+||.||++.. .++..+|+|.+... .......+.+|++++++++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 34567789999999999999953 23668999988754 334556899999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 97 ALVYEYMENGSLDGYLFGKK--------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
+++|||+.+++|.+++.... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 99999999999999985432 358999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhH
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPK 241 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~ 241 (356)
.++|+|||++................+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+......
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------- 231 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------
Confidence 9999999998765433222212223457789999999877 68999999999999999998 77665322111
Q ss_pred HHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..............+..++..+.+++.+||+.||++||++.+|++.|+
T Consensus 232 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 ---------EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 001111111112223345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.79 Aligned_cols=256 Identities=25% Similarity=0.329 Sum_probs=206.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC----
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH---- 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 94 (356)
....+|.+.+.||+|+||+||+|.. .+++.||||++... ........+.+|+..+..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999975 46999999998754 23445567889999999999999999988775432
Q ss_pred ----eeeEEEEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEe
Q 047701 95 ----MTALVYEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167 (356)
Q Consensus 95 ----~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 167 (356)
..++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 367999999999999998543 3578999999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHH
Q 047701 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247 (356)
Q Consensus 168 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (356)
|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.|+......
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------------- 251 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENME------------- 251 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence 99999876543332223346799999999999877 6899999999999999999999987432110
Q ss_pred hhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..............+...+.++.+++.+||+.||.+||++.++++.
T Consensus 252 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 ---EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0111111122223345567889999999999999999999999863
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=322.12 Aligned_cols=254 Identities=20% Similarity=0.226 Sum_probs=197.0
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.++||+|+||+||+|.. .+++.||||++.... .......+..|+.++++++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 366788999999999999976 468999999997532 22344678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999853 4568999999999999999999999 99999999999999999999999999997643211000
Q ss_pred ---------------------------------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhH
Q 047701 182 ---------------------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216 (356)
Q Consensus 182 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~ 216 (356)
.......||+.|+|||++.+. .++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhh
Confidence 001234699999999999876 6899999999999
Q ss_pred HHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHh--hcCCCCCCCCCHHHHH
Q 047701 217 VSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALW--CVQDSPADRPPMSAVV 294 (356)
Q Consensus 217 il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~Rps~~~v~ 294 (356)
++|||++|..||........ ....... ............+.++.+++.+ |+..+|..||++.+++
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999854332110 0000000 0000111112345678888887 5566777799999998
Q ss_pred HH
Q 047701 295 KM 296 (356)
Q Consensus 295 ~~ 296 (356)
..
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 84
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=308.28 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=204.2
Q ss_pred HHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
....|++.++||+|+||.||+|.+.++..||+|.+.... .....+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 345789999999999999999988666779999987532 234578899999999999999999998754 55789999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999653 3468999999999999999999999 9999999999999999999999999999986654332
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. ......++..|+|||+..+. .++.++||||||+++|+|++ |..|+...... .... .....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~---------~~~~~ 219 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLD---------QVERG 219 (262)
T ss_pred c-cccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHH---------HHhcC
Confidence 2 12234467789999998766 68999999999999999999 66555322111 0011 11111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.........+..+.+++.+|++.||++||++.++++.|+...
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 112223456778999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=322.42 Aligned_cols=259 Identities=21% Similarity=0.245 Sum_probs=196.9
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.++||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++..+...++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 34688889999999999999976 4689999996532 346789999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
++. ++|..++.. ...+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 164 ~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 995 588888843 4578999999999999999999999 99999999999999999999999999999754322211
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh----HHHHHHHh---------
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP----KYVWEEYE--------- 248 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~----~~~~~~~~--------- 248 (356)
......||+.|+|||++.+. .++.++|||||||++|||++|..|+............ ........
T Consensus 239 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 239 -KYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred -ccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12345799999999999876 7899999999999999999999876543221100000 00000000
Q ss_pred -hhchh----hhHhh-----cCC--CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 -KSELG----AMILA-----CGI--EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 -~~~~~----~~~~~-----~~~--~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ..... ... .......+.++.+++.+||+.||.+|||+.++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000 000 0112235678999999999999999999999996
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=311.53 Aligned_cols=269 Identities=25% Similarity=0.341 Sum_probs=204.5
Q ss_pred hccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeE
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTAL 98 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 98 (356)
+.+.+.||+|+||+||++.. .++..||+|++...........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47789999999999988642 357889999997654444566788999999999999999999988653 46789
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999843 359999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
..... .....++..|+|||++.+. .++.++||||||+++|+|++|..|+........... .................
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLE 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchhhhhhhhh
Confidence 32211 1223356679999998876 689999999999999999999988643322111000 00000000111111112
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.......+..++.++.+++.+||+.+|++||++++|+..|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222223445678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=318.54 Aligned_cols=252 Identities=22% Similarity=0.242 Sum_probs=199.3
Q ss_pred hccccccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeee
Q 047701 26 SNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (356)
|++.++||+|+||.||+++. .+++.||+|++.+.. .......+..|+.++.++ +||||+.+++++......+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 67789999999999999965 358899999986431 123345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++.+..
T Consensus 82 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999853 4568999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
..... .....||..|+|||++.+...++.++||||||+++|||++|..|+......... ...... +.
T Consensus 158 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~---------~~ 224 (332)
T cd05614 158 EEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRR---------IL 224 (332)
T ss_pred cCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHH---------Hh
Confidence 32221 223569999999999987645789999999999999999999998543221110 000000 00
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
. .....+...+..+.+++.+||+.||++|| +++++++
T Consensus 225 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 K-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred c-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 11122334567789999999999999999 6677775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=309.62 Aligned_cols=259 Identities=26% Similarity=0.381 Sum_probs=209.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
...+++.+.||+|+||.||+|.++ +++ .+|+|.............+.+|+.++.+++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356778899999999999999763 333 5899998776555566788999999999999999999999987 7789
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+|+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999997766779999999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
...........++..|+|||.+... .++.++|+||||+++||+++ |..|+...... ++...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~ 224 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV----------------EIPDLL 224 (279)
T ss_pred cccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHHH
Confidence 4333322233346789999998766 68999999999999999998 88776432211 111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........+..++.++.+++.+||..||++||++.++++.|..+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1221222233455678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=307.21 Aligned_cols=255 Identities=29% Similarity=0.400 Sum_probs=204.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
+....|++.++||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 44557888999999999999999887888899999875432 34568999999999999999999998854 5678999
Q ss_pred EecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+.+++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999998653 3568999999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... .....++..|+|||++.+. .++.++|+||||+++|+|++ |..|+...... +....+..
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----------------~~~~~~~~ 218 (260)
T cd05070 157 YTA-RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----------------EVLEQVER 218 (260)
T ss_pred ccc-ccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----------------HHHHHHHc
Confidence 221 1233456789999998766 68999999999999999999 66665322110 01111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
....+.+...+..+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11222334456789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=307.18 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=198.1
Q ss_pred cccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE-cCCeeeEEEEecC
Q 047701 30 TRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH-DQHMTALVYEYME 104 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 104 (356)
+.||+|+||.||+|.+. ++..||+|.+...........+..|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999752 246799999865444455678889999999999999999999775 4556789999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce--
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-- 182 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-- 182 (356)
+++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997666677888999999999999999999 999999999999999999999999999987654322111
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+....... .....+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---------------DITVYLLQGRRL 221 (262)
T ss_pred ccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---------------HHHHHHhcCCCC
Confidence 11234467789999998876 68999999999999999999765543222110 011111111112
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
..+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 222334567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=323.64 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=196.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||+|+.. +++.||||++.+.. .......+.+|++++.+++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 4678899999999999999764 68999999986431 12234567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC-
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS- 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~- 180 (356)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999954 4568999999999999999999999 9999999999999999999999999999753321000
Q ss_pred ----------------------------------------ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHH
Q 047701 181 ----------------------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220 (356)
Q Consensus 181 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~e 220 (356)
........||+.|+|||++.+. .++.++|||||||++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeee
Confidence 0001234699999999999877 68999999999999999
Q ss_pred HhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC---CHHHHHHH
Q 047701 221 IVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP---PMSAVVKM 296 (356)
Q Consensus 221 ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp---s~~~v~~~ 296 (356)
|++|..||........ ........ ...........+.++.+++.+|+ .+|.+|+ ++.++++.
T Consensus 237 ll~G~~Pf~~~~~~~~-------~~~i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET-------QLKVINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH-------HHHHhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999854432110 00000000 00000111234567788888876 4999999 88888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=304.42 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=199.4
Q ss_pred cccCcCCceEEEEEEcC-C---CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-N---GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||.||+|.+. . +..+|+|.+...........+..|+.+++++.||||+++++++.. ...++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 47999999999999652 2 378999999866544456778999999999999999999998764 467999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee-e
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-I 184 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~ 184 (356)
++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999544 478999999999999999999999 9999999999999999999999999999987654332211 1
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....++..|+|||.+.+. .++.++||||||+++|++++ |..|+...... .....+.......
T Consensus 156 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~ 218 (257)
T cd05060 156 TAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----------------EVIAMLESGERLP 218 (257)
T ss_pred cCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHHcCCcCC
Confidence 222345689999999876 68999999999999999998 78776332110 1111111111222
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.+..++..+.+++.+||..+|.+||++.+|++.|+++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 33445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=323.26 Aligned_cols=253 Identities=26% Similarity=0.310 Sum_probs=203.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||+||+|... +++.||||++.... .......+..|+.++..++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 4778899999999999999875 69999999997532 22344678889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC--
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR-- 179 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~-- 179 (356)
|+.+++|.+++... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999544 679999999999999999999999 999999999999999999999999999998665433
Q ss_pred -------------------------CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCc
Q 047701 180 -------------------------SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234 (356)
Q Consensus 180 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~ 234 (356)
.........||+.|+|||++.+. .++.++|||||||++|+|++|+.|+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 00112235689999999999887 7999999999999999999999998544321
Q ss_pred cccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 047701 235 SLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP-MSAVVKM 296 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~~ 296 (356)
..+...... . ...........+.++.+++.+|+. ||.+||+ +.++++.
T Consensus 237 -------~~~~~i~~~-----~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -------ETYNKIINW-----K-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -------HHHHHHhcc-----C-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 011111100 0 000111112256789999999997 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=303.61 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=209.8
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
..+.-..+++.++||+|.-|+||++++. ++..+|+|++.+... .....+...|-+||+.++||.++.+|+.+....+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 3444456777899999999999999875 479999999986532 2333566779999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 96 TALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
.||+||||.||+|..+++++ ++.+++..+..++..++.||+|||- .|||+|||||+||||.++|.+.|+||.|+..
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999766 4679999999999999999999999 9999999999999999999999999998765
Q ss_pred cCC---------------------------------CCC---------------------ceeecCCCCCCCCCCccccc
Q 047701 175 CDR---------------------------------NRS---------------------HVTISGYKGTPGYSAPEFLS 200 (356)
Q Consensus 175 ~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~ 200 (356)
+.. ... ......++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 421 000 00112467999999999999
Q ss_pred CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhc
Q 047701 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCV 280 (356)
Q Consensus 201 ~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 280 (356)
|. ..+.+.|.|+|||++|||+-|..||........ +..++.....-...+..+..+.+||++.|
T Consensus 309 G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 309 GE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred cC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 98 799999999999999999999999865544211 12222222222233366788999999999
Q ss_pred CCCCCCCCC----HHHHHH
Q 047701 281 QDSPADRPP----MSAVVK 295 (356)
Q Consensus 281 ~~~p~~Rps----~~~v~~ 295 (356)
.+||.+|.- +.||-+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999988 778876
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=315.59 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=193.8
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHH---hcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTI---GRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
|++.+.||+|+||.||+|.+. +++.||||++++.. .......+.+|.+++ +.++||||+++++++..+...|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 467789999999999999764 68999999997532 122334566666655 567899999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++++|..++. ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999999998884 3579999999999999999999999 999999999999999999999999999987533221
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. ......|++.|+|||.+.+. .++.++||||||+++|+|++|..|+...... ...... ...
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~~~~~i---------~~~ 216 (324)
T cd05589 156 D--RTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------EVFDSI---------VND 216 (324)
T ss_pred C--cccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHH---------HhC
Confidence 1 12345689999999999877 6899999999999999999999987433211 001111 110
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
....+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 -EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1122334567789999999999999999 4666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=303.02 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=200.6
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHh
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLD 109 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 109 (356)
++||+|+||.||++.+.+++.||+|.+...........+..|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999876699999999876544445678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCC
Q 047701 110 GYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189 (356)
Q Consensus 110 ~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 189 (356)
+++......+++..+..++.+++.+|.|||+ ++++||||||+||+++.++.++|+|||++................+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997666678999999999999999999999 9999999999999999999999999999876543222111112234
Q ss_pred CCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHH
Q 047701 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268 (356)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
+..|+|||.+.+. .++.++|+||||+++|+|++ |..|+...... .....+........+...
T Consensus 158 ~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~ 220 (251)
T cd05041 158 PIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----------------QTRERIESGYRMPAPQLC 220 (251)
T ss_pred eeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHH----------------HHHHHHhcCCCCCCCccC
Confidence 5679999998876 68999999999999999998 55554222110 011111111111223345
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 269 AKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
+.++.+++.+||..+|.+||++.+|++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=310.38 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=203.6
Q ss_pred HhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 96 (356)
..+.+.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4677789999999999999964 358899999987542 3445678899999999999999999998754 3467
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 89999999999999996666679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceee-cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTI-SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
........ ....++..|+|||++.+. .++.++||||||+++|||++|..+........................+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 43322111 112234569999999876 6899999999999999999987654221111000000000000000001111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
+...........++.++.+++.+||..+|++|||+.+|++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 222222223344567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.08 Aligned_cols=253 Identities=23% Similarity=0.249 Sum_probs=202.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||+||+|... +++.||+|++.... .......+..|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4678899999999999999764 68999999997542 22344568889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999997666789999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeecCCCCCCCCCCcccccC-----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 182 VTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
......||+.|+|||++.. ...++.++||||||+++|+|++|..|+....... .+...... ..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~--~~-- 226 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNF--QR-- 226 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcC--CC--
Confidence 2233568999999999863 2357889999999999999999999975432210 01111000 00
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+.++.+++.+|+. +|.+||++.+++.
T Consensus 227 --~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 --FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00011122356778999999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.82 Aligned_cols=242 Identities=25% Similarity=0.321 Sum_probs=191.9
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|.+. +++.||||++.... .......+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 58899999997542 122334556677777654 899999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|..++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~ 154 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KAS 154 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--ccc
Confidence 999998853 4579999999999999999999999 9999999999999999999999999999976543221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... ..... +.. .....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~---------i~~-~~~~~~ 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDS---------ILN-DRPHFP 216 (316)
T ss_pred cccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHH---------HHc-CCCCCC
Confidence 45689999999999877 6899999999999999999999987533211 00111 110 112233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMS-AVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~ 295 (356)
...+.++.+++.+||+.||.+||++. ++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 44567789999999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.15 Aligned_cols=263 Identities=26% Similarity=0.340 Sum_probs=205.1
Q ss_pred HHhhccccccCcCCceEEEEEEcCC-----------------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPN-----------------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 85 (356)
...|++.++||+|+||.||+|.+.. +..||+|.+...........+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3467889999999999999997532 24689999987655566778999999999999999999
Q ss_pred EeeeEEcCCeeeEEEEecCCCCHhHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKK----------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
+++++..+...+++|||+.+++|..++.... ..+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999985432 268999999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc--CCCccccCCC
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG--RRRNAIVGAS 233 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~--g~~~~~~~~~ 233 (356)
|+++.++.++|+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999998865544333333344567889999998876 68999999999999999998 4444422111
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
...+...... ............+..++.++.+++.+||+.||.+||++.+|++.|.
T Consensus 240 -------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 -------QQVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -------HHHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111110 0000000011122344578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.56 Aligned_cols=266 Identities=19% Similarity=0.238 Sum_probs=197.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Ceee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 97 (356)
+|++.++||+|+||.||+|... +++.||||.+.... .......+.+|+.++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4678899999999999999764 68999999987432 223345688999999999999999999988643 2479
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68988884 44569999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCc-eeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHH
Q 047701 178 NRSH-VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEY 247 (356)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~ 247 (356)
.... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.|+......... ..+...+...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 2221 122345689999999998652 36889999999999999999999887433221000 0000001111
Q ss_pred hhhchhhhHhh---cC---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 248 EKSELGAMILA---CG---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 248 ~~~~~~~~~~~---~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........... .. .....+..+..+.+++.+||+.||++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11111111110 00 00111223567889999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.98 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=193.4
Q ss_pred cccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.||+|+||.||+|.+. ++..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999753 356799999876544445567889999999999999999999999999999999999999
Q ss_pred CHhHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 107 SLDGYLFGK----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 107 sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999998543 2356778888999999999999999 999999999999999999999999999987654333222
Q ss_pred eecCCCCCCCCCCcccccCC------CCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 183 TISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~------~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
......|+..|+|||++.+. ..++.++|+||||+++|||++ |..|+....... .............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-------VLTYTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHhhcccCCC
Confidence 22334578899999998643 135789999999999999996 887773322110 0000000000000
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.........+..+.+++.+|| .+|++||++++|++.|+
T Consensus 231 ----~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 ----PKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ----CCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 011112234566888999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.09 Aligned_cols=263 Identities=23% Similarity=0.333 Sum_probs=202.2
Q ss_pred HHhhccccccCcCCceEEEEEEcC-----------------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-----------------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 85 (356)
...|++.++||+|+||.||++.+. +...||+|++..........++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456888999999999999998532 244699999976555556678999999999999999999
Q ss_pred EeeeEEcCCeeeEEEEecCCCCHhHHhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKK----------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
+++++......++||||+.+++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999985432 247888999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc--CCCccccCCC
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG--RRRNAIVGAS 233 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~--g~~~~~~~~~ 233 (356)
|+++.++.++|+|||+++.+.............++..|++||+..+. .++.++||||||+++|||++ |..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999866443322222223456789999988776 68999999999999999998 5455432211
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
... . .......... ........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ~~~--~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQV--I-ENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH--H-HHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 100 0 0000000000 000011122345578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=324.20 Aligned_cols=257 Identities=22% Similarity=0.242 Sum_probs=202.2
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
+....|.+.++||+|+||.||+|... +++.||+|++.+.. .......+..|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34457788899999999999999764 68999999997431 1233345778999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998843 358889999999999999999999 9999999999999999999999999999986543
Q ss_pred CCCceeecCCCCCCCCCCcccccCC---CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
.... ......||+.|+|||++.+. ..++.++|||||||++|||++|..|+...... ..+.......
T Consensus 195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~--- 263 (370)
T cd05596 195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMDHK--- 263 (370)
T ss_pred CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------HHHHHHHcCC---
Confidence 3211 12345699999999998653 24788999999999999999999998543321 0111111100
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVKM 296 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~ 296 (356)
...........+.++.+++.+|+..+|.+ ||+++++++.
T Consensus 264 ---~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 ---NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00011112235678999999999999988 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=313.00 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=200.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCc--EEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGV--KIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
..+.+.+.||+|+||.||+|.+. ++. .+|+|.+...........+.+|+.++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 45677899999999999999864 444 46788776544445567788999999999 899999999999999999999
Q ss_pred EEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 100 YEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999985332 358899999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHH
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~ 243 (356)
+|+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++ |..|+...... ..
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~ 232 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------EL 232 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChH-------HH
Confidence 999999986322111 11112246679999998776 68999999999999999998 88776322111 00
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.. .+........+...+.++.+++.+||+.+|++||++.+++..|..+..
T Consensus 233 ~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 233 YE---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HH---------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111111112223345678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=314.77 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=195.7
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|.+. +++.||||++++.. .......+..|..++.++ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999764 68999999997542 223345678899999888 799999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|..++. ..+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (329)
T cd05588 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS 154 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence 99998884 34679999999999999999999999 9999999999999999999999999999874322111 122
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcc--ccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES--LDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...||+.|+|||++.+. .++.++|+||||+++|+|++|+.|+....... ........++... .. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~-~~~ 223 (329)
T cd05588 155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL---------EK-QIR 223 (329)
T ss_pred cccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH---------cC-CCC
Confidence 35689999999999877 68999999999999999999999985322111 1001111111111 11 112
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPP------MSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps------~~~v~~ 295 (356)
.+...+.++.+++.+||+.||.+||+ +.++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 23345677899999999999999998 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=312.22 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=219.5
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.-|.+.+.||+|.|+.|-+|++ -+|+.||||++.+. .......++.+|++-|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3578899999999999999975 38999999999865 344566789999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE-cCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-DANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~DfGla~~~~~~~~ 180 (356)
+-++|+|.+|+.++...+.+....+++.||+.|+.|+|. ..+|||||||+||.+ .+-|-+||.|||++-.+..+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999999999999999999999999999999999 999999999999887 5678999999999876665443
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.+..+|+..|-|||++.|.....++.||||||||||-|++|++||... .+.+...++.++
T Consensus 175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA----------------NDSETLTmImDC- 234 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA----------------NDSETLTMIMDC- 234 (864)
T ss_pred ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc----------------cchhhhhhhhcc-
Confidence 344679999999999999866678899999999999999999987322 223333344443
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--Hhhhccc
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK--MLEGVVE 302 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~~ 302 (356)
....+...+.++.+||..||..||.+|.+.++|+. +|.....
T Consensus 235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 34567888999999999999999999999999987 4444443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=304.93 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=206.4
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
++...++.+.++||+|+||.||+|.+..+..+|+|.+... ......+.+|+.++++++|+||+++++++.+ ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 4566788999999999999999998777788999988753 2345678899999999999999999999988 678999
Q ss_pred EEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999653 4568999999999999999999999 99999999999999999999999999998766443
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... ......++..|+|||++.+. .++.++|+||||+++|++++ |..|+...... ..... +.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~---------~~ 217 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRA---------LE 217 (260)
T ss_pred Ccc-cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHH---------Hh
Confidence 222 12234466789999999876 68999999999999999998 77665322110 00111 11
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
...........+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111122233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=290.05 Aligned_cols=263 Identities=22% Similarity=0.249 Sum_probs=208.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----- 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 94 (356)
+++.+|++.+.||.|||+-||.++. .+++.+|+|.+.... ..+.+..++|++..++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4677999999999999999999974 579999999997654 466778899999999999999999999886543
Q ss_pred eeeEEEEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEcCCCceEEecc
Q 047701 95 MTALVYEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVADF 169 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Df 169 (356)
..||+++|...|+|.+.++.. +..+++.+++.|+.++++||++||+ .. +.||||||.|||+.+++.++|.||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEec
Confidence 489999999999999998643 4579999999999999999999998 55 999999999999999999999999
Q ss_pred CCccccCCCCCce-------eecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh
Q 047701 170 GLAKLCDRNRSHV-------TISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240 (356)
Q Consensus 170 Gla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~ 240 (356)
|.++...-.-... .......|..|.|||.+.-+ ...++++|||||||+||.|+.|..||..-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~--------- 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI--------- 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------
Confidence 9987643211110 01224578999999998532 35889999999999999999999887321
Q ss_pred HHHHHHHhhhchhhhHhh-cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 241 KYVWEEYEKSELGAMILA-CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
++ ..+.+.-.+.+ ....+.....+..+.+++++|++.||.+||++.+++..++++.
T Consensus 245 ---~~--~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 ---YQ--QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---hh--cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 11111111111 1111222237888999999999999999999999999988764
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=311.63 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=202.0
Q ss_pred hhccccccCcCCceEEEEEEcCC-C--cEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPN-G--VKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.|.+.+.||+|+||.||+|...+ + ..+++|.++..........+..|+.++.++ +||||+++++++......++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 46788999999999999997643 3 357888887544445566789999999999 7999999999999999999999
Q ss_pred EecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceE
Q 047701 101 EYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 165 (356)
||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999985432 358899999999999999999999 9999999999999999999999
Q ss_pred EeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHH
Q 047701 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVW 244 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~ 244 (356)
|+|||++....... .......+..|+|||++.+. .++.++||||||+++|||++ |..|+...... ..+
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~~~ 228 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------ELY 228 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence 99999986432111 11112235579999999876 68999999999999999997 87776322211 111
Q ss_pred HHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 245 EEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.. +........+..++..+.+++.+||+.+|.+||+++++++.|..+...
T Consensus 229 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 229 EK---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HH---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 111111222334567799999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=304.78 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=202.9
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
+....|.+.++||+|+||.||+|.+..+..+|+|.+.... .....+.+|++++++++|||++++++++.. ...+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 3445688899999999999999988776789999876532 334568889999999999999999998865 5678999
Q ss_pred EecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+.+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999654 3458999999999999999999999 999999999999999999999999999997664432
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. ......++..|+|||+..+. .++.++||||||+++|+|++ |..|+...... ...... ..
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~---------~~ 218 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQV---------ER 218 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHH---------Hc
Confidence 21 11233467789999998876 68999999999999999999 77665322111 111111 11
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
......+...+..+.+++.+||..||.+||++++|++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122234556789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=304.92 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=196.0
Q ss_pred cccCcCCceEEEEEEcC-CCc--EEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGV--KIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|.+. ++. .+++|.++..........+..|+.++.++ +||||+++++++......+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999874 343 57889887554445567888999999999 799999999999999999999999999
Q ss_pred CCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 106 GSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 106 ~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999985421 357899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
++....... .......+..|+|||++.+. .++.++||||||+++|||++ |..|+...... .....
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~--- 223 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYEK--- 223 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------HHHHH---
Confidence 985322111 11112345679999998776 68999999999999999997 87776322110 01111
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
+......+.....+.++.+++.+||..||.+||++.+++..|.++.
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111111223345567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=302.46 Aligned_cols=264 Identities=25% Similarity=0.317 Sum_probs=201.7
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCC-eeeEeeeEEcCC------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHIN-LVRLHGFCHDQH------ 94 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------ 94 (356)
..|...++||+|.||+||+|+. .+|+.||+|.+.-... +.......+|+.++++|+|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3455677899999999999976 4789999999975533 234456789999999999999 999999998877
Q ss_pred eeeEEEEecCCCCHhHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 95 MTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
..++|+||++. +|..++.... ..++...+..+..||+.||+|||+ ++|+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 78999999965 9999997655 468889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH-----
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE----- 246 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~----- 246 (356)
|+.+.-... ..+..++|..|.|||++.|...|+...||||+|||+.||+++++-|- +..+.... ...++.
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp-G~se~~ql--~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP-GDSEIDQL--FRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC-CCcHHHHH--HHHHHHcCCCC
Confidence 996653322 24556789999999999998889999999999999999999765543 33321100 001111
Q ss_pred ------HhhhchhhhHhhc-----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 247 ------YEKSELGAMILAC-----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 247 ------~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.....-....... ......+.......+++.+|++.+|.+|.|++.++.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000000000000 0000111122478999999999999999999999975
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=315.32 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=194.8
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||.||+|+.. +++.||||++.... .......+..|.+++..+ +||||+++++++.++...|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 58899999987542 223445677888888866 799999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~ 154 (321)
T cd05591 81 GDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TT 154 (321)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--cc
Confidence 99998884 44578999999999999999999999 99999999999999999999999999998754332221 23
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ........ . ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~~~~~i~~---------~-~~~~p 216 (321)
T cd05591 155 TFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNED-------DLFESILH---------D-DVLYP 216 (321)
T ss_pred ccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHH-------HHHHHHHc---------C-CCCCC
Confidence 45689999999999876 6899999999999999999999988543221 01111111 0 01122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRP-------PMSAVVKM 296 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rp-------s~~~v~~~ 296 (356)
...+.++.+++.+||..||.+|| ++.++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 23457789999999999999999 77777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=307.94 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=193.7
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||+|+||.||++..+ +|+.||+|.+..... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999764 699999999864321 12234556799999999999999999999999999999999999999
Q ss_pred hHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCC
Q 047701 109 DGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187 (356)
Q Consensus 109 ~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 187 (356)
.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 9888543 3468999999999999999999999 9999999999999999999999999999886654322 1234
Q ss_pred CCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHH
Q 047701 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267 (356)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.|+..|+|||++.+. .++.++|||||||++|+|++|..|+........ ..... ..............
T Consensus 155 ~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------~~~~~-----~~~~~~~~~~~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------KEELK-----RRTLEDEVKFEHQN 221 (277)
T ss_pred CCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------HHHHH-----HHhhcccccccccc
Confidence 689999999999877 599999999999999999999998743221100 00000 00111111111234
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 268 KAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+.++.+++.+||+.||.+||++.++++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 5678999999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=315.93 Aligned_cols=237 Identities=26% Similarity=0.296 Sum_probs=191.1
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||+||+|..+ +++.||||++.+.. .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 58999999987542 223445677888888876 799999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~-~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (320)
T cd05590 81 GDLMFHIQ-KSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS 154 (320)
T ss_pred chHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence 99999884 34579999999999999999999999 9999999999999999999999999999875432221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ...... ... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i---------~~~-~~~~~ 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAI---------LND-EVVYP 216 (320)
T ss_pred ccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHH---------hcC-CCCCC
Confidence 35689999999999876 6899999999999999999999987533221 011111 111 11122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
...+.++.+++.+||+.||.+||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 3356778999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=331.83 Aligned_cols=266 Identities=22% Similarity=0.274 Sum_probs=211.9
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCCC-cEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeee-EEc-
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNG-VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGF-CHD- 92 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~- 92 (356)
+..++..++.++.+.|.+|||+.||.|.+..+ .+||+|++-.. .+.....+.+|+++|++|. |+|||.+++. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 33455667888889999999999999987554 99999998766 5677788999999999996 9999999993 321
Q ss_pred -----CCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEE
Q 047701 93 -----QHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 166 (356)
Q Consensus 93 -----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 166 (356)
.-+++|+||||.||.|-++++.+ ...|++.++++|+.|+++|+++||. .+.++||||||-+||||+.+|.+||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEe
Confidence 23678999999999999999754 3459999999999999999999998 2245999999999999999999999
Q ss_pred eccCCccccCCCCC-ceee------cCCCCCCCCCCccccc--CCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc
Q 047701 167 ADFGLAKLCDRNRS-HVTI------SGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD 237 (356)
Q Consensus 167 ~DfGla~~~~~~~~-~~~~------~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~ 237 (356)
||||.+........ .... -..-.|+.|+|||.+. ++..+++|+|||+|||+||-|+-...||.....-.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-- 265 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-- 265 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence 99999875433221 1100 0123689999999864 33379999999999999999999988885442211
Q ss_pred chhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 238 WFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
++......+..+.++..+.+||..||+.||.+||++-+|+..+.++...
T Consensus 266 -----------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 -----------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -----------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111222233467889999999999999999999999999988877654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.26 Aligned_cols=249 Identities=25% Similarity=0.315 Sum_probs=194.9
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|... +++.||+|++.+.. .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 68899999997542 223345677888888776 899999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++. ....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99998884 44679999999999999999999999 9999999999999999999999999999875332211 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc--cchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL--DWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...||..|+|||++.+. .++.++||||||+++|+|++|..|+........ .....+.+..... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------~~~~ 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------KQIR 223 (329)
T ss_pred cccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----------CCCC
Confidence 35689999999999877 689999999999999999999999853211111 0111111111111 1112
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPM------SAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~ 295 (356)
.+...+.++.+++.+||+.||.+||++ .++++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 334456778999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.49 Aligned_cols=272 Identities=24% Similarity=0.371 Sum_probs=209.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 96 (356)
..+.+.+.||+|+||.||+|.+. +++.||||++...........+..|+.+++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999752 3789999999865443356789999999999999999999999987 5678
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+++|||+++++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997666679999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
....... .....++..|++||.+.+. .++.++||||||+++|||++|..|+.............. ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA-QGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccc-cccccHHHHHHH
Confidence 4332221 1123355679999999776 689999999999999999999987643322211100000 000001111111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
+........+..++.++.+++.+||+.+|++||++.+|+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112122222344567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=307.48 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=201.7
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
+|+..++||+|+||.||++.. .+++.||+|.+..... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 467788999999999999976 4689999999875321 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888543 3568999999999999999999999 9999999999999999999999999999886543322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....|+..|+|||++.+. .++.++||||||+++|++++|..|+....... ..+. +...+.. .
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-------~~~~-----~~~~~~~-~ 220 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-------KREE-----VERRVKE-D 220 (285)
T ss_pred ---cccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhh-------HHHH-----HHHHhhh-c
Confidence 1234689999999999876 68999999999999999999999885332211 0011 1111111 1
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~ 296 (356)
....+...+..+.+++.+||..||.+|| +++++++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1223344667789999999999999999 78888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=303.79 Aligned_cols=250 Identities=29% Similarity=0.411 Sum_probs=204.4
Q ss_pred HHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
....+.+.+.||+|+||.||+|.. .++.||+|.+..... ...++..|+.++++++|+||+++++++.+....++|||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 345778899999999999999987 578999999976533 45678999999999999999999999999899999999
Q ss_pred ecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999996543 379999999999999999999999 9999999999999999999999999999986633221
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
...++..|+|||++.+. .++.++||||||+++|++++ |..|+...... .... .+...
T Consensus 158 -----~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~---------~~~~~ 215 (256)
T cd05039 158 -----SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVP---------HVEKG 215 (256)
T ss_pred -----cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHH---------HHhcC
Confidence 23356689999999866 68899999999999999997 77765322111 1111 11111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
.....+...+.++.+++.+||..+|++||++.++++.|..
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.87 Aligned_cols=238 Identities=28% Similarity=0.335 Sum_probs=188.1
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHH-HHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVG-TIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||.||+|... +++.||+|++.+.. .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999874 68999999987532 1222344555554 57788999999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|...+. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05603 81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS 154 (321)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence 99988884 44678899999999999999999999 9999999999999999999999999999875332221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++|||||||++|||++|..|+...... ...... ... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i---------~~~-~~~~~ 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------QMYDNI---------LHK-PLQLP 216 (321)
T ss_pred cccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------HHHHHH---------hcC-CCCCC
Confidence 45689999999999876 6899999999999999999999987543211 001111 110 11223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMS 291 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~ 291 (356)
...+.++.+++.+|++.||.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 34566789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=304.98 Aligned_cols=257 Identities=29% Similarity=0.445 Sum_probs=207.1
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
++....|.+.++||+|+||.||+|.+.++..||||.+.... .....+..|+.++++++|+||+++++++......++|
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 34556788899999999999999988778889999987543 3346788999999999999999999999998899999
Q ss_pred EEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999996543 578999999999999999999999 99999999999999999999999999998876542
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... ......++..|+|||.+.+. .++.++|+||||+++|++++ |+.|+..... ....... .
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~---------~ 218 (261)
T cd05034 157 EYT-AREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQV---------E 218 (261)
T ss_pred hhh-hhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHH---------H
Confidence 211 11223356789999999876 68999999999999999998 7776532211 1111111 1
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
.......+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111112233346789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=302.98 Aligned_cols=256 Identities=20% Similarity=0.354 Sum_probs=206.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.++||+|+||.||+|... +++.||||.+... ........+..|+.+++.++||||+++++++.+....++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 5678899999999999999864 6899999987642 233445678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988742 34568999999999999999999999 99999999999999999999999999998876543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|+.|+......... ....+..
T Consensus 160 ~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--------------~~~~~~~ 222 (267)
T cd08228 160 TTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--------------LCQKIEQ 222 (267)
T ss_pred hHH--HhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--------------HHHHHhc
Confidence 221 1234588899999999876 6889999999999999999999987543321110 0011111
Q ss_pred cCCCc-hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 259 CGIEE-KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 259 ~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
..... .....+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11111 2234567799999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.44 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=207.2
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
+...++.+.++||+|+||.||+|.+.+ ...||||...........+.+..|+.++++++||||+++++++.+. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-Cc
Confidence 445678889999999999999997532 3469999987655445567899999999999999999999998764 56
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+.+++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 89999999999999997666679999999999999999999999 999999999999999999999999999988665
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... .....++..|+|||.+.+. .++.++||||||+++|++++ |..|+....... ....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~--------- 220 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-------VIGR--------- 220 (270)
T ss_pred ccccee-cCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHH---------
Confidence 442211 1223355689999998766 68999999999999999886 887764332110 0011
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+........+..++.++.+++.+|+..+|.+||++.++++.|.++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 221 IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111112234456789999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=312.84 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=203.3
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.+|.+.++||+|+||.||+|... +++.||+|.+...........+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 35778899999999999999764 68899999987554434445678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+ +|..++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 975 8888886666778999999999999999999999 99999999999999999999999999998765432221
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch--------hHHHHHHHhhhchhh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF--------PKYVWEEYEKSELGA 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 254 (356)
.....+|..|+|||++.+...++.++||||||+++|+|++|+.|+........... ....|..........
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 12345789999999987655689999999999999999999988754332111000 000111111100000
Q ss_pred hHh-hcCC----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MIL-ACGI----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~-~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... .... .......+.++.+++.+|++.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 0000 0111234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.51 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=198.6
Q ss_pred cccCcCCceEEEEEEcCC-------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 30 TRLGFGGFGQVYKGQFPN-------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+.||+|+||.||+|...+ ++.+|||.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999997632 2579999887654445567788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-----ceEEeccCC
Q 047701 103 MENGSLDGYLFGK------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-----SPKVADFGL 171 (356)
Q Consensus 103 ~~~~sL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~DfGl 171 (356)
+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998542 2457899999999999999999999 9999999999999998877 899999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
+................++..|+|||++.+. .++.++||||||+++|+|++ |..|+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----------------~ 220 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----------------Q 220 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCH----------------H
Confidence 8765443322222223457789999999877 68999999999999999998 8777532211 0
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
+....+............+..+.+++.+||..+|.+||++++|++.|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111111222233456778999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=321.84 Aligned_cols=243 Identities=26% Similarity=0.298 Sum_probs=205.0
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 98 (356)
-..+++.++||+|+||.|+++..+ +++.+|||++++. ......+..+.|.+++...+ ||.++.++.+|...+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 346778899999999999999875 6899999999876 34566678899999999884 9999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+.||++.. ..+.+.+++..+..++..++.||.|||+ ++|||||||.+|||+|.+|.+||+|||+++..-..
T Consensus 447 vmey~~Ggdm~~--~~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMH--HIHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEE--EEecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999432 2456789999999999999999999999 99999999999999999999999999999865533
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. .+..++||+.|||||++.+. .|+...|.|||||+|||||.|..||..++.+ ++...+..
T Consensus 522 g~--~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----------------e~FdsI~~ 582 (694)
T KOG0694|consen 522 GD--RTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----------------EVFDSIVN 582 (694)
T ss_pred CC--ccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHhc
Confidence 32 34568899999999999988 7999999999999999999999998544332 11111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
. -...+..++.+..+++.+++..||.+|--+
T Consensus 583 d-~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 D-EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C-CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 123567788999999999999999999766
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=300.83 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=205.2
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|.+.+.||+|+||.||+|... +++.|++|.+... ........+..|+.++++++|||++++++++.+....++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 567789999999999999864 6899999998643 33455677899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
.+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 999999999654 5679999999999999999999999 99999999999999999999999999998866543222
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....|++.|+|||++.+. .++.++|+||||+++|+|++|..|+...... ............
T Consensus 158 -~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~ 219 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQG----------------ALILKIIRGVFP 219 (256)
T ss_pred -hhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCCCC
Confidence 1234588899999999877 6899999999999999999999987433210 000111111222
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+.++.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 2333566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=316.84 Aligned_cols=239 Identities=25% Similarity=0.266 Sum_probs=193.2
Q ss_pred cccCcCCceEEEEEEc----CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 30 TRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
+.||+|+||.||++.. .+|+.||+|++.... .......+..|+.++++++||||+++++++.++...|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 358999999997542 22234567789999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~ 155 (318)
T cd05582 82 GGDLFTRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--A 155 (318)
T ss_pred CCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--e
Confidence 999999984 34578999999999999999999999 99999999999999999999999999998765443221 2
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ...... ... ....
T Consensus 156 ~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~-------~~~~~i---------~~~-~~~~ 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-------ETMTMI---------LKA-KLGM 217 (318)
T ss_pred ecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHH-------HHHHHH---------HcC-CCCC
Confidence 335689999999999876 6899999999999999999999887432211 000110 010 1122
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPMSA 292 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~ 292 (356)
+...+..+.+++.+||+.||.+||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3345677899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=310.07 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=192.5
Q ss_pred hhccccccCcCCceEEEEEEc-C-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcC---CCCCeeeEeeeEE-----cC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-P-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRT---YHINLVRLHGFCH-----DQ 93 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~ 93 (356)
+|++.+.||+|+||.||+|.. . +++.||||.+..... ......+.+|+.+++++ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999976 3 478899999864422 22233456677776665 6999999999985 24
Q ss_pred CeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 94 HMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
...++||||+. ++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999996 5899988543 3568999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH-------H
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW-------E 245 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~-------~ 245 (356)
+...... ......||+.|+|||++.+. .++.++||||||+++|||++|.+|+........ +..... .
T Consensus 158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--~~~i~~~~~~~~~~ 231 (290)
T cd07862 158 RIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLPGEE 231 (290)
T ss_pred EeccCCc---ccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChh
Confidence 8655432 12345689999999999876 689999999999999999999988754432110 000000 0
Q ss_pred HHhhh-chhh-hHhhc---CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 246 EYEKS-ELGA-MILAC---GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 246 ~~~~~-~~~~-~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+... .... ..... ......+..+..+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0000 00000 000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.31 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=199.6
Q ss_pred HHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE-cCCeeeEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH-DQHMTALVY 100 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~ 100 (356)
.-..+.+.+.||+|+||.||++.. .+..||+|.+... .....+..|+.++++++|+|++++++++. .++..+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 345678889999999999999987 5788999998654 23456889999999999999999999764 456789999
Q ss_pred EecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999986543 358999999999999999999999 999999999999999999999999999987544322
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
. ...++..|+|||++.+. .++.++||||||+++|+|++ |+.|+...... . ....+..
T Consensus 157 ~-----~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~----------~~~~~~~ 214 (256)
T cd05082 157 D-----TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------D----------VVPRVEK 214 (256)
T ss_pred C-----CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------H----------HHHHHhc
Confidence 1 22346689999999876 68999999999999999997 77665321110 0 0011111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.........++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111222334567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=305.41 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=194.9
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||+|+||+||++... +++.||+|.+..... ......+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999764 689999999875321 12335677899999999999999999999999999999999999999
Q ss_pred hHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 109 DGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 109 ~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
..++.. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 988743 34579999999999999999999999 99999999999999999999999999999765543222 23
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|+.|+......... .. ........ ....+
T Consensus 156 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-------~~-----~~~~~~~~-~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------KE-----LKQRILND-SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-------HH-----HHHhhccc-CCCCc
Confidence 45689999999999877 7899999999999999999999987543221100 00 00000000 11223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
...+.++.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 34667899999999999999999 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.04 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=195.5
Q ss_pred cccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.||+|+||.||++.. .+++.||+|++.... .......+..|++++..++||||+++++++..+...++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 468999999997542 2233456778999999999999999999999999999999999999
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecC
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 186 (356)
+|..++. ....+++..+..++.||+.||.|||+ ..+++||||||+|||++.++.+||+|||+++........ ...
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~ 155 (325)
T cd05594 81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKT 155 (325)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--ccc
Confidence 9998884 44578999999999999999999995 169999999999999999999999999998754322211 223
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhH
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
..||+.|+|||++.+. .++.++||||||+++|+|++|..|+....... ... .+... ....+.
T Consensus 156 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~---------~i~~~-~~~~p~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFE---------LILME-EIRFPR 217 (325)
T ss_pred ccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHH-------HHH---------HHhcC-CCCCCC
Confidence 5699999999999877 68999999999999999999999874332110 000 01100 111223
Q ss_pred HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 047701 267 EKAKQLCMVALWCVQDSPADRP-----PMSAVVKM 296 (356)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~ 296 (356)
..+.++.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3567789999999999999996 88998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.46 Aligned_cols=242 Identities=23% Similarity=0.282 Sum_probs=192.4
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhc-CCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGR-TYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|.+. +++.||||++..... .........|..++.. ++||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 588999999975421 2233456677888876 4899999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|..++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... ..
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 154 (316)
T cd05619 81 GDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TC 154 (316)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--ee
Confidence 99999985 34578999999999999999999999 99999999999999999999999999998754322211 23
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||..|+|||++.+. .++.++|||||||++|+|++|..|+...... ...... ... ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i---------~~~-~~~~~ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSI---------RMD-NPCYP 216 (316)
T ss_pred eecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHH---------HhC-CCCCC
Confidence 35689999999999877 6899999999999999999999987432211 011111 100 11122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMS-AVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~ 295 (356)
...+.++.+++.+||+.||.+||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 33566789999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=311.22 Aligned_cols=249 Identities=25% Similarity=0.291 Sum_probs=196.1
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|... +++.||+|++.+.. .......+..|..++.++ +||||+.+++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 68899999998642 223345678899999888 699999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++. ..+.+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 99998884 34579999999999999999999999 9999999999999999999999999999875332211 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|..|+...............+..... . ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~-~~~~p 223 (327)
T cd05617 155 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------K-PIRIP 223 (327)
T ss_pred cccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------C-CCCCC
Confidence 35689999999999877 7899999999999999999999998543222111111111111111 1 11223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPM------SAVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~ 295 (356)
...+..+.+++.+||..||.+|+++ .++.+
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 3455678999999999999999984 46655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.34 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=204.0
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
...++..+.||+|+||.||+|.+. +++ .||+|.+...........+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 345567789999999999999763 444 57899887654444455788999999999999999999998764 467
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+++||+.+|+|.+++......+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999997766779999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
...........++..|+|||++.+. .++.++||||||+++||+++ |+.|+...... . ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-------~---------~~~~~ 224 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-------E---------IPDLL 224 (303)
T ss_pred cccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------H---------HHHHH
Confidence 3332222334467789999999876 68999999999999999997 77765322110 0 01111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........+..++..+.+++..||..+|++||++.++++.|..+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111112223345678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.56 Aligned_cols=241 Identities=25% Similarity=0.302 Sum_probs=192.4
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||.||+|.+. +++.||+|++..... ......+..|..++..+ +||||+++++++.+++..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 689999999975421 23345567788888754 899999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++....... ...
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 999998843 4678999999999999999999999 9999999999999999999999999999874322221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ..++... . .....+
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~---------~-~~~~~~ 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIR---------V-DTPHYP 216 (316)
T ss_pred ccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHH---------h-CCCCCC
Confidence 45689999999999877 6899999999999999999999988533221 1111111 0 011222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMS-AVV 294 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~ 294 (356)
...+.++.+++.+||+.||.+||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33566789999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=315.80 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=194.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||+||+|... +++.||||++.+.. .......+..|+.++.+++||||+++++.+.+....|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 3567889999999999999764 68999999997532 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++|+|.+++.. .+.+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999954 4679999999999999999999999 99999999999999999999999999998754321100
Q ss_pred ---------------------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCcc
Q 047701 182 ---------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNA 228 (356)
Q Consensus 182 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~ 228 (356)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCC
Confidence 001235699999999999877 6899999999999999999999998
Q ss_pred ccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcC--CCCCCCCCHHHHHHH
Q 047701 229 IVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQ--DSPADRPPMSAVVKM 296 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~Rps~~~v~~~ 296 (356)
...... ..+........ .. ........+.++.+++.+++. .++..||++++|++.
T Consensus 237 ~~~~~~-------~~~~~i~~~~~-~~-----~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQ-------ETYKKVMNWKE-TL-----IFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHH-------HHHHHHHcCcC-cc-----cCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 543221 11111110000 00 000111234567777777443 344456899999884
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=323.66 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=219.8
Q ss_pred HHHhhccccccCcCCceEEEEEEcC--CC--cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP--NG--VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
.+..+.+.++||+|.||.|++|.|. .| -.||||.+..........+|++|+.+|.+|+|||++++||+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 3456777899999999999999884 24 36899999877665678899999999999999999999999998 5678
Q ss_pred EEEEecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
||+|++..|+|.+.|++ ....+-...+..++.|||.||.||.+ +++|||||.++|+|+.....+||+||||.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999999999977 45678888999999999999999999 999999999999999988899999999999888
Q ss_pred CCCCceeecC-CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISG-YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.++..+.... ..-...|+|||.+... .++.++|||+|||++|||++++. .+|.......+.+.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGE---------------ePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGE---------------EPWVGCRGIQILKN 327 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCC---------------CCCCCCCHHHHHHh
Confidence 7766655443 3356689999999987 79999999999999999999653 23455555666667
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
++.+.+...+..|+++++++++.||..+|++||+|..|..
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 7777778888999999999999999999999999999974
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.97 Aligned_cols=242 Identities=26% Similarity=0.312 Sum_probs=194.9
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||+||+|.+. +++.||||++.+.. .......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 58899999997542 223445677888888887 799999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++........ ..
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~ 154 (318)
T cd05570 81 GDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TS 154 (318)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--cc
Confidence 99998884 34579999999999999999999999 99999999999999999999999999998753222211 12
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||..|+|||++.+. .++.++|||||||++|+|++|+.|+...... ....... .. ....+
T Consensus 155 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~---------~~-~~~~~ 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSIL---------ED-EVRYP 216 (318)
T ss_pred ceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHH---------cC-CCCCC
Confidence 34689999999999877 6899999999999999999999987433211 1111111 10 11123
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPM-----SAVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~ 295 (356)
...+.++.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3456789999999999999999999 77775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.57 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=203.9
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
|.+.++||+|+||.||++... +++.+|+|.+...........+..|+.++++++||||+++++.+.++...+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 567899999999999999764 6899999998754444556778899999999999999999999999999999999999
Q ss_pred CCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 105 NGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 105 ~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+++|.+++.. ....++...+..++.|++.||.|||+ ++++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-- 156 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-- 156 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--
Confidence 9999998854 34568999999999999999999999 99999999999999999999999999998766543221
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.....|+..|+|||++.+. .++.++|+||||+++|+|++|..|+...... . ....+.......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~----------~~~~~~~~~~~~ 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWK------N----------LILKVCQGSYKP 219 (255)
T ss_pred cccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHH------H----------HHHHHhcCCCCC
Confidence 1235688999999999877 6899999999999999999999987432210 0 001111111222
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.+...+..+.+++.+||+.||++||++.+|+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 334456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.20 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=190.8
Q ss_pred cccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
++||+|+||.||+|... ....+|+|.+...........+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 46999999999999653 245788888765544455567889999999999999999999999999999999999999
Q ss_pred CHhHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 107 SLDGYLFGKK----RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 107 sL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+|.+++.... ...++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999996542 235678889999999999999999 999999999999999999999999999987543332222
Q ss_pred eecCCCCCCCCCCcccccC------CCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 183 TISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~------~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
......++..|+|||++.. ...++.++||||||+++|||++ |..|+...... ............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~~~-- 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQDI-- 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhccCc--
Confidence 2233446778999998743 1256889999999999999999 55554221110 000000000000
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
....+......+..+.+++..|| .||++||++++|++.|.
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 --KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00011223345677888999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=310.13 Aligned_cols=238 Identities=28% Similarity=0.326 Sum_probs=188.6
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHH-HHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVG-TIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||+||+|... +++.||||++.... .......+..|.. +++.++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999874 68999999987532 1122334555554 45778999999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|..++. ....+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (323)
T cd05575 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS 154 (323)
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence 99999884 45678999999999999999999999 9999999999999999999999999999875432221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ...... ... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i---------~~~-~~~~~ 216 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNI---------LNK-PLRLK 216 (323)
T ss_pred cccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHH---------HcC-CCCCC
Confidence 45689999999999877 6899999999999999999999987432211 001111 010 11122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMS 291 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~ 291 (356)
...+..+.+++.+||+.||.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 34467799999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=299.51 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=208.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||+|... +++.||+|.++.. ........+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 5788899999999999999875 7999999988632 223345678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998853 34568999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|+.|+........ ..... ...
T Consensus 160 ~~~--~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~---------~~~ 222 (267)
T cd08224 160 TTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKK---------IEK 222 (267)
T ss_pred Ccc--cceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----HHHhh---------hhc
Confidence 221 1234588899999999876 689999999999999999999988743322100 00011 111
Q ss_pred cCCCchhH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 259 CGIEEKDK-EKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 259 ~~~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
......+. ..+..+.+++.+||..+|++||++.+|++.|..+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11122222 55678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=284.26 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=207.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..+++++.||+|-||.||.|+. +++--||+|++.++. ......++.+|+++-+.|+||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 3566789999999999999976 468889999997652 2344568899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||..+|.|...|+.. ..++++...+.+..|+|.||.|+|. ++++||||||+|+|++..+.+|++|||.+.....+
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~- 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN- 177 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence 999999999999643 5679999999999999999999999 99999999999999999999999999998754422
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....+||.-|++||...+. .++...|+|++|++.||++.|.+||.... ..+..+.+...
T Consensus 178 ---kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~----------------~~etYkrI~k~ 237 (281)
T KOG0580|consen 178 ---KRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQS----------------HSETYKRIRKV 237 (281)
T ss_pred ---CceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhh----------------hHHHHHHHHHc
Confidence 12336799999999999988 79999999999999999999999984332 11111111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+...+..+.++|.+|+..+|.+|.+..++++.
T Consensus 238 -~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 -DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122346677889999999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=320.03 Aligned_cols=252 Identities=22% Similarity=0.244 Sum_probs=197.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|+.++..++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 4677899999999999999864 68999999997531 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999854 4579999999999999999999999 99999999999999999999999999998754321110
Q ss_pred e------------------------------------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC
Q 047701 182 V------------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225 (356)
Q Consensus 182 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~ 225 (356)
. ......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCC
Confidence 0 00124699999999999876 6899999999999999999999
Q ss_pred CccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 047701 226 RNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP---MSAVVK 295 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v~~ 295 (356)
.|+....... ......... ...........+.++.+++.+|+. +|.+|++ +.++++
T Consensus 237 ~Pf~~~~~~~-------~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE-------TYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH-------HHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9985432210 000000000 000001111345678899999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=320.82 Aligned_cols=253 Identities=21% Similarity=0.221 Sum_probs=196.2
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.++||+|+||.||++.. .+++.||||++.+.. .......+..|++++.+++||||+++++++.++...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 466789999999999999976 468999999986531 22334568889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++|+|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.+......
T Consensus 82 ~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999985 44678999999999999999999999 99999999999999999999999999999643211000
Q ss_pred e---------------------------------------------eecCCCCCCCCCCcccccCCCCCCCCCceehhhH
Q 047701 182 V---------------------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216 (356)
Q Consensus 182 ~---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~ 216 (356)
. ......||+.|+|||++.+. .++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecch
Confidence 0 00124699999999999877 6899999999999
Q ss_pred HHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCC---CCHHHH
Q 047701 217 VSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADR---PPMSAV 293 (356)
Q Consensus 217 il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~~v 293 (356)
++|||++|..||...... ..+....... .. .........+.++.+++.+|+. +|.+| +++.++
T Consensus 237 il~elltG~~Pf~~~~~~-------~~~~~i~~~~-----~~-~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-------ETYRKIINWR-----ET-LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-------HHHHHHHccC-----Cc-cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999998533221 0011110000 00 0001112345678899999997 67765 599988
Q ss_pred HHH
Q 047701 294 VKM 296 (356)
Q Consensus 294 ~~~ 296 (356)
+..
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.58 Aligned_cols=241 Identities=25% Similarity=0.304 Sum_probs=193.5
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCC-CeeeEeeeEEcCCeeeEEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHI-NLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 101 (356)
|++.+.||+|+||.||+|... +++.||||++.+.. .......+..|.+++..+.|+ +|+.+++++.+.+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 677899999999999999764 57899999997542 223456778899999999764 68889999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++|+|..++. ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 82 YVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred CCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 999999999884 34568999999999999999999999 9999999999999999999999999999875332221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.|+...... ....... . ..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~---------~-~~ 217 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIM---------E-HN 217 (324)
T ss_pred -ceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHH---------c-CC
Confidence 12235689999999999877 6899999999999999999999987533211 0011111 1 11
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
...+...+.++.+++.+||..||.+|++.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 12233456778999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.25 Aligned_cols=241 Identities=26% Similarity=0.295 Sum_probs=189.2
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHH-HHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVG-TIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||+||+|.+. +++.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 57889999987532 1122234444444 46778999999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++.. ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~ 154 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS 154 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence 999998853 4568889999999999999999999 9999999999999999999999999999875432221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... ..+..... . .....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~---------~-~~~~~ 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILN---------K-PLQLK 216 (325)
T ss_pred cccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHh---------C-CcCCC
Confidence 45699999999999877 7899999999999999999999987532211 00111110 0 11122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSAVV 294 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~ 294 (356)
...+..+.+++.+|++.||.+||++.+.+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 34567789999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=300.35 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=200.0
Q ss_pred cccCcCCceEEEEEEcCC--C--cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFPN--G--VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|++|.||+|.+.+ + ..||||.+...........+..|+.++++++||||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999997632 3 36999999876544566789999999999999999999999988 888999999999
Q ss_pred CCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 106 GSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 106 ~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999996654 578999999999999999999999 99999999999999999999999999999877543322211
Q ss_pred -cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 185 -SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 185 -~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
....++..|+|||++.+. .++.++||||||+++|+|++ |..|+....... ....... .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~--------~~~~~ 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------ILKKIDK--------EGERL 220 (257)
T ss_pred ccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHh--------cCCcC
Confidence 234577899999998876 68999999999999999998 888763221110 0011000 11111
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=309.38 Aligned_cols=252 Identities=25% Similarity=0.307 Sum_probs=211.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch--hHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK--IAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 98 (356)
...|.+.+.||+|.||.||++..+ +|+.+|+|++.+.... .....+.+|+.+|+++. |||||.+++++.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 447888999999999999999865 5999999999865432 34478999999999998 9999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC----CCceEEeccCCccc
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFGLAKL 174 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~DfGla~~ 174 (356)
|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .|++||||||+|+|+.. ++.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999655 39999999999999999999999 99999999999999943 35799999999998
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
... .......+||+.|+|||++.+. .++..+||||+|+++|.|++|.+||......... ......+.
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~-- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF-- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC--
Confidence 776 2234567899999999999876 7999999999999999999999998655443211 11111111
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+.....+..+.+++..++..||..|+++.++++.
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11234455678889999999999999999999999984
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=319.61 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=205.0
Q ss_pred ccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHh
Q 047701 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLD 109 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 109 (356)
+||+|.||+||-|++. +...+|||-+..... ....-++.|+.+-++|+|.|||+++|.+.++++.-|.||-.+||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 4999999999999874 577899999976433 34456889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-CCCceEEeccCCccccCCCCCceeecC
Q 047701 110 GYLFGKKRAL--EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISG 186 (356)
Q Consensus 110 ~~l~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 186 (356)
++++..-+++ .+.++-.+..||++||.|||+ +.|||||||-+||||+ -.|.+||+|||-+++...-.. .+..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence 9998887888 889999999999999999999 9999999999999996 578999999999987664322 2344
Q ss_pred CCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 187 YKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
+.||..|||||++..+ ..|+.++|||||||++.||.||++||..-....-.+ ++-+ .-...++.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVG------myKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVG------MYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhc------ceecCCCCc
Confidence 6799999999999744 469999999999999999999999985433321111 0000 111245677
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+.++..+|.+|+.+||.+||++.+++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 888999999999999999999999999986
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=301.23 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=201.0
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.+++.+.||+|+||.||+|.+.++..+|+|.+.... .....+..|++++++++|||++++++++......++||||+.
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 567789999999999999988678899999987542 234568899999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++......+++..+..++.|++.+++|||+ .+++|+||||+||+++.++.++|+|||++......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-cc
Confidence 999999997666678999999999999999999999 99999999999999999999999999998765433221 11
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....++.+|+|||++.+. .++.++||||||+++|||++ |..|+...... ...... .......
T Consensus 159 ~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~---------~~~~~~~ 221 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETI---------NAGFRLY 221 (256)
T ss_pred CCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHH---------hCCCCCC
Confidence 223356789999999876 68899999999999999998 77665322110 001111 1111111
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1222457799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=309.95 Aligned_cols=256 Identities=21% Similarity=0.225 Sum_probs=197.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||.||++... +++.||+|++.+. ........+..|..++..++|+||+.+++++.++...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 4678899999999999999864 6899999998742 122334567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+|+|.+++......+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999996656789999999999999999999999 99999999999999999999999999998765433221
Q ss_pred eeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 182 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
......||+.|+|||++.+ ...++.++|||||||++|+|++|+.|+....... .+....... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-------~~~~i~~~~-----~ 225 (331)
T cd05597 159 -QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHK-----E 225 (331)
T ss_pred -cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC-----C
Confidence 1122458999999999863 2357889999999999999999999874332110 001100000 0
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCC--CCCCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSP--ADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p--~~Rps~~~v~~~ 296 (356)
...........+..+.+++.+|+..++ ..||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001111222356778889988775533 347899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=315.89 Aligned_cols=254 Identities=22% Similarity=0.242 Sum_probs=199.6
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
....|++.++||+|+||.||++.+. +++.||+|++.+.. .......+.+|+.+++.++||||+++++++.++...|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3457888899999999999999874 58899999986421 22334567889999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999999843 358899999999999999999999 99999999999999999999999999999876433
Q ss_pred CCceeecCCCCCCCCCCcccccCCC---CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||....... .+.. .
T Consensus 196 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-------~~~~--------i 259 (370)
T cd05621 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-------TYSK--------I 259 (370)
T ss_pred Cce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------HHHH--------H
Confidence 221 123456999999999987541 37889999999999999999999985432210 0111 1
Q ss_pred HhhcC--CCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 047701 256 ILACG--IEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVKM 296 (356)
Q Consensus 256 ~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~ 296 (356)
..... ........+..+.+++.+|+..++.+ |+++.++++.
T Consensus 260 ~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11100 11112234677889999999755543 8899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=309.82 Aligned_cols=256 Identities=21% Similarity=0.228 Sum_probs=198.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||+++.. +++.||+|++.+. ........+..|..++..++|+||+.+++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4678899999999999999864 6889999998752 122334557889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+|+|.+++......+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999997656789999999999999999999999 99999999999999999999999999999766543322
Q ss_pred eeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 182 VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
......||+.|+|||++.+. ..++.++||||||+++|+|++|+.|+...... ..+....... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~-----~ 225 (331)
T cd05624 159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHE-----E 225 (331)
T ss_pred -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCC-----C
Confidence 12235699999999998752 25788999999999999999999998533221 0011110000 0
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~ 296 (356)
....+......+.++.+++.+|+..++.+ |++++++++.
T Consensus 226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00011222335678999999999865544 4678887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=300.39 Aligned_cols=257 Identities=21% Similarity=0.370 Sum_probs=207.3
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||.||+|.. .+++.+|||.+... ........+..|+.+++.++||||+++++++..+...+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 467789999999999999985 47899999987643 223344678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998853 24568999999999999999999999 99999999999999999999999999998766543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... .....|+..|+|||++.+. .++.++|+||||+++|+|++|..|+......... ....+..
T Consensus 160 ~~~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~ 222 (267)
T cd08229 160 TTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------------LCKKIEQ 222 (267)
T ss_pred Ccc--cccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHH--------------Hhhhhhc
Confidence 322 1234688999999999876 6889999999999999999999887433221100 0001111
Q ss_pred cCCC-chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 259 CGIE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 259 ~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.... ......+.++.+++.+||..||++|||+.+|++.+.++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111 112346678999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=318.51 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=194.8
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|...++||+|+||.||+|.. .+++.||||++.+.. .......+..|+.++++++||||+++++++.++...|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 366788999999999999976 468899999987532 22344678889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC-
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS- 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~- 180 (356)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999999854 4568999999999999999999999 9999999999999999999999999999753321000
Q ss_pred --------------------------------------------ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhH
Q 047701 181 --------------------------------------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216 (356)
Q Consensus 181 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~ 216 (356)
........||+.|+|||++.+. .++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechH
Confidence 0001224699999999999877 6899999999999
Q ss_pred HHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC---HHHH
Q 047701 217 VSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP---MSAV 293 (356)
Q Consensus 217 il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v 293 (356)
++|||++|..||........ ...... . ............+.++.+++.+++ .+|.+|++ +.++
T Consensus 237 il~elltG~~Pf~~~~~~~~-------~~~i~~-----~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET-------QMKVIN-----W-QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH-------HHHHHc-----c-CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999854322100 000000 0 000011112234567788888765 59999997 7777
Q ss_pred HH
Q 047701 294 VK 295 (356)
Q Consensus 294 ~~ 295 (356)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=311.74 Aligned_cols=241 Identities=25% Similarity=0.324 Sum_probs=193.2
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 101 (356)
|++.+.||+|+||.||+|... +++.||||++.+.. .......+..|..++..+ +|++|+.+++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 567889999999999999764 58899999997542 223334567788888777 58999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++|+|..++. ....+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 82 YVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 999999999884 34568999999999999999999999 9999999999999999999999999999875432221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
......||+.|+|||++.+. .++.++|||||||++|||++|..|+...... ..... +... .
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~---------i~~~-~ 217 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQS---------IMEH-N 217 (323)
T ss_pred -ccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHH---------HHhC-C
Confidence 12345689999999999877 7899999999999999999999987533221 00111 1111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
...+...+.++.+++.+|++.||.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 12233456788999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=313.66 Aligned_cols=242 Identities=28% Similarity=0.382 Sum_probs=201.2
Q ss_pred ccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 29 STRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
.+.||.|+||.||-|++ .+++.||||.++-. ....-..+++.|++.|+++.|||++.+-||+......|||||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 56799999999999976 47899999998743 223444789999999999999999999999999999999999995
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
||-.+++..+.+++-+..+..|+.+.++||+|||+ .+.||||||+.|||+.+.|.|||+|||.|...... .
T Consensus 110 GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------n 180 (948)
T KOG0577|consen 110 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------N 180 (948)
T ss_pred ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch------h
Confidence 59999998889999999999999999999999999 99999999999999999999999999998765533 4
Q ss_pred CCCCCCCCCCccccc--CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 186 GYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.++|||.|||||+|. ..+.|+-++||||||++..||.-.++|.+.... -..+..+..+....-
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---------------MSALYHIAQNesPtL 245 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------MSALYHIAQNESPTL 245 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---------------HHHHHHHHhcCCCCC
Confidence 578999999999985 334699999999999999999999888642211 011111122222222
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....+..+..++..|++.-|.+|||.+++++
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 34567788999999999999999999988775
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=302.83 Aligned_cols=258 Identities=23% Similarity=0.284 Sum_probs=196.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----eee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-----MTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 97 (356)
..|.-.+++|+|+||.||+|... +++.||||.+..+... -.+|+.+|+++.|||||++.-+|.... +..
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 34555788999999999999764 5799999998765432 236999999999999999988886432 345
Q ss_pred EEEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCcc
Q 047701 98 LVYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAK 173 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~ 173 (356)
|||||++. +|..+++. .+..++...+.-+..||++||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999976 99998853 36788999999999999999999999 999999999999999865 899999999999
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH-------HHHH
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY-------VWEE 246 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~-------~~~~ 246 (356)
....++.... ...|..|+|||.+.|...|+.+.||||.||++.||+-|++-|-......+ +... ..+.
T Consensus 175 ~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 175 VLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTRED 249 (364)
T ss_pred eeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8877665533 33577899999999998999999999999999999999876543222111 0000 0011
Q ss_pred Hh-------hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 247 YE-------KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 247 ~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. +.+..++.............++++.+++.+++..+|.+|.++.+++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 11111111111111233456688999999999999999999998886
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=299.20 Aligned_cols=240 Identities=22% Similarity=0.309 Sum_probs=187.8
Q ss_pred cccCcCCceEEEEEEcCC-------------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 30 TRLGFGGFGQVYKGQFPN-------------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
+.||+|+||.||+|.+.+ ...|++|++.... ......+..|+.++++++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999997532 2358899876542 23445788899999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc-------eEEecc
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-------PKVADF 169 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~Df 169 (356)
++||||+++++|..++......+++..++.++.||++||+|||+ ++++||||||+|||++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999987666779999999999999999999999 99999999999999976654 899999
Q ss_pred CCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHh
Q 047701 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
|++...... ....++..|+|||++.....++.++||||||+++|+|++ |..|+....... .....
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~ 222 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KERFY 222 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HHHHH
Confidence 998654322 224578899999998754468999999999999999984 655542211100 00000
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
... .......+.++.+++.+||+.||.+||++.+|++.|
T Consensus 223 ~~~----------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQ----------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcC----------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 001112245789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=318.69 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=198.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.+.||+|+||.||+|.+. +++.||||.... ..+.+|++++++++|+||+++++++..+...++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346788899999999999999875 588999996432 235689999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
++. ++|..++......+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++........
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 995 68988886666689999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCc-cccchhHHHHHHHhhhch--------
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE-SLDWFPKYVWEEYEKSEL-------- 252 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-------- 252 (356)
.......||..|+|||++.+. .++.++|||||||++|||++|..+++..... ..................
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222345699999999999887 6899999999999999999988766443221 111111111111111000
Q ss_pred -----hhhHhh----cCCCc-------hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 253 -----GAMILA----CGIEE-------KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 253 -----~~~~~~----~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...... ..... ........+.+|+.+||..||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 00000 001223468899999999999999999999974
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=310.92 Aligned_cols=242 Identities=24% Similarity=0.266 Sum_probs=188.0
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC---CCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT---YHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
||+|+||+||+|... +++.||||++.+.. .......+..|..++..+ .||||+.+++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999764 68999999986431 112233455566666654 699999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|..++. ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.++|+|||++......... ..
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--~~ 154 (330)
T cd05586 81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TN 154 (330)
T ss_pred ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--cc
Confidence 99998884 45679999999999999999999999 99999999999999999999999999998754322211 23
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||..|+|||++.+...++.++|||||||++|+|++|..|+...... ..+...... ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~---------~~~~~~ 218 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFG---------KVRFPK 218 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcC---------CCCCCC
Confidence 3568999999999976545899999999999999999999987543221 011111110 011111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRP----PMSAVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rp----s~~~v~~ 295 (356)
...+.++.+++.+||..||.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12456788999999999999998 4566655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=309.38 Aligned_cols=239 Identities=25% Similarity=0.305 Sum_probs=189.0
Q ss_pred cccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHH-HHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVG-TIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|.. .+|+.||+|++.+.. .......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999976 468999999987532 1223344555554 46778999999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|..++. ....+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 99998884 45679999999999999999999999 9999999999999999999999999999875432221 123
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... ..+...... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~~~~~----------~~~~~ 216 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------EMYDNILHK----------PLVLR 216 (325)
T ss_pred cccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHH-------HHHHHHHcC----------CccCC
Confidence 45689999999999877 6899999999999999999999987543221 011111110 01112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSA 292 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~ 292 (356)
+..+..+.+++.+|++.+|.+||++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 235567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=316.63 Aligned_cols=263 Identities=21% Similarity=0.236 Sum_probs=202.8
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
+....+....|++.+.||+|+||.||+|... +++.||+|++.+.. .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344555678888999999999999999875 68999999986421 22333557789999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
+...++||||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999999843 358899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCC---CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
......... ......||+.|+|||++.+.. .++.++|||||||++|||++|..|+...... ..+.....
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~ 261 (371)
T cd05622 190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMN 261 (371)
T ss_pred eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHc
Confidence 876533221 123456999999999987541 3788999999999999999999998543221 01111110
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHh
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVKML 297 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~L 297 (356)
.. .. .........+..+.+++..|+..++.+ ||++.++++..
T Consensus 262 ~~-----~~-~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HK-----NS-LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CC-----Cc-ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00 00 001112345677899999999844433 77888888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=291.53 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=204.4
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..|.+.+.||+|.|+.||++.+ ++|+.+|+|++..+ .+....+++.+|+++-+.|+||||+++.+......+.|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3677889999999999999965 57999999998743 233466789999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc---CCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~~~~ 178 (356)
++.|+.|-.-+-.+ ...++..+....+||+++|.|+|. ++|||||+||.|+++. ...-+||+|||+|..+..+
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999987655333 557888899999999999999999 9999999999999994 3446899999999988732
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
....+..||++|||||++... +++..+|||+.|||||-|+.|.+||...... ..++....+.. -.
T Consensus 167 ---~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~y---d~- 231 (355)
T KOG0033|consen 167 ---EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAY---DY- 231 (355)
T ss_pred ---cccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhcccc---CC-
Confidence 234678899999999999987 8999999999999999999999998432221 11222221111 01
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......+.+++..+|+.+|+..||++|.|+.|.++
T Consensus 232 --~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 --PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 12244566788999999999999999999988876
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.82 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=190.8
Q ss_pred cccCcCCceEEEEEEcCC--------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 30 TRLGFGGFGQVYKGQFPN--------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
+.||+|+||.||+|.... ...||+|.+.... ......+..|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 479999999999997532 2348888876432 2344678889999999999999999999999899999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc--------eEEeccCCcc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--------PKVADFGLAK 173 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~DfGla~ 173 (356)
|+++|+|..++......+++..+..++.||+.||+|||+ ++++||||||+||+++.++. ++++|||++.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999997666679999999999999999999999 99999999999999977664 6999999886
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
..... ....++..|+|||++.+...++.++||||||+++|+|++|..++....... ...
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---------------~~~ 215 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---------------KKL 215 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---------------HHH
Confidence 54322 224578899999999875468999999999999999999964432211110 000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..... ....+...+.++.+++.+||+.||++|||++++++.|.
T Consensus 216 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00010 11222234467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.30 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=202.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.+.++||+|+||.||+|... +++.||+|.+...........+.+|+.++++++||||+++++++......++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 5777899999999999999764 688999999875443344456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
. ++|..++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 160 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 160 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--
Confidence 6 59999887666779999999999999999999999 99999999999999999999999999998764432211
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhh-chhh
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKS-ELGA 254 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~ 254 (356)
.....+++.|+|||++.+...++.++||||||+++|+|++|.+|+.......... .....|...... ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 1234578899999998776568899999999999999999998875433211000 000011111000 0000
Q ss_pred hHhhcCC----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILACGI----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....... .......+..+.+++.+|++.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0011234567899999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=298.04 Aligned_cols=250 Identities=31% Similarity=0.485 Sum_probs=202.1
Q ss_pred ccccccCcCCceEEEEEEcCC-----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 27 NYSTRLGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
++.+.||+|+||.||++.+.. +..||+|++...........+..|+..+..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 467899999999999998743 388999999766544466789999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+++|.+++...... +++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999654444 9999999999999999999999 9999999999999999999999999999987665432
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
... ....++..|+|||.+.+. .++.++||||||+++++|++ |..|+..... ..... .+...
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~---------~~~~~ 220 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLE---------YLKKG 220 (258)
T ss_pred ccc-ccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH---------HHhcC
Confidence 221 123477899999999665 68999999999999999998 5555422111 01111 11111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.........+.++.+++.+|+..||.+|||+.++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 22233344677899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.97 Aligned_cols=260 Identities=19% Similarity=0.251 Sum_probs=189.4
Q ss_pred ccccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEEEEec
Q 047701 29 STRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTALVYEYM 103 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~ 103 (356)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 568999999999999753 56889999987542 23456789999999999999999998854 45678999999
Q ss_pred CCCCHhHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE----cCCCceEEeccCC
Q 047701 104 ENGSLDGYLFGK--------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL 171 (356)
Q Consensus 104 ~~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGl 171 (356)
.+ +|..++... ...+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 54 888776421 2358999999999999999999999 999999999999999 4567899999999
Q ss_pred ccccCCCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch-----------
Q 047701 172 AKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF----------- 239 (356)
Q Consensus 172 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~----------- 239 (356)
++........ .......||+.|+|||++.+...++.++||||+||++|+|++|++|+...........
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 9876543221 1223466899999999998765689999999999999999999998864432211100
Q ss_pred ------hHHHHHHHhhhch----hhhHhhcCC---------CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 ------PKYVWEEYEKSEL----GAMILACGI---------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 ------~~~~~~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....|........ ......... .........++.+++.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0001111110000 000000000 0000011245789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=299.36 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=198.5
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
+.+.+.||+|+||.||+|.+ .+++.||+|++..+........+..|+.++.+++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 56778999999999999975 46899999999765444555678999999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|..+. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~ 150 (279)
T cd06619 83 GGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----A 150 (279)
T ss_pred CCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----c
Confidence 99997543 46888999999999999999999 999999999999999999999999999987654322 2
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....||..|+|||++.+. .++.++|+||||+++|+|++|..|+..................... .......
T Consensus 151 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 221 (279)
T cd06619 151 KTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD--------EDPPVLP 221 (279)
T ss_pred cCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc--------cCCCCCC
Confidence 235689999999999877 6899999999999999999999887542221111000000000000 0001111
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+.++.+++.+||+.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 12345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.62 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=201.6
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc----hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG----KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
.|...+.||+|++|.||+|.. .+++.||+|.+..... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 467789999999999999976 4689999999864321 12235688899999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+||+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++......
T Consensus 83 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999884 34568999999999999999999999 999999999999999999999999999987654322
Q ss_pred Ccee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.... .....|+..|+|||++.+. .++.++||||||+++|++++|+.|+...... .. .......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~-----~~~~~~~ 222 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----------AA-----IFKIATQ 222 (263)
T ss_pred cccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchH----------HH-----HHHHhcc
Confidence 1111 1234578899999999887 6899999999999999999999886432110 00 0001111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+...+..+.+++.+||..+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11223344566789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=302.18 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=203.1
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|...+.||+|+||.||+|.+. +++.||+|.+...........+..|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45667788999999999999764 58899999987654445556789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++. ...+++..+..++.|++.|+.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 84 LGGGSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred cCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 99999999884 3568999999999999999999999 9999999999999999999999999999876553321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
......|+..|+|||++.+. .++.++||||||+++|+|++|..|+........ ..........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------------~~~~~~~~~~ 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRV----------------LFLIPKNSPP 219 (277)
T ss_pred hhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhH----------------HhhhhcCCCC
Confidence 11234578899999999877 689999999999999999999988643221100 0001111112
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+.++.+++.+||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2233456779999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=309.61 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=193.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (356)
++++.+.||+|+||.||+|... +++.||||++.+.. .......+..|..++..+. |++|+.+++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3678899999999999999764 68999999997542 2233456778888888885 577888999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++|+|..++. ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999884 44579999999999999999999999 9999999999999999999999999999875432221
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
......||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ....... ..
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~---------~~- 216 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-------ELFQSIM---------EH- 216 (323)
T ss_pred --cccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHH---------hC-
Confidence 12335689999999999876 6899999999999999999999987533211 0011111 10
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
....+...+.++.+++.+||+.+|.+|++.
T Consensus 217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 112233456778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=300.09 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=201.1
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 45788899999999999999986 4688999999875422 334567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 87 YCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999999884 34578999999999999999999999 9999999999999999999999999999986643221
Q ss_pred eeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 182 VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
......|+..|+|||.+.+ ...++.++||||||+++|+|++|+.|+......... ........ ..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~-----~~ 228 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLMSKSNF-----QP 228 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-------eeeecCCC-----CC
Confidence 1123458889999998752 225788999999999999999999887432211000 00000000 00
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.........+..+.+++.+||..+|++||+++++++.|
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00111123456899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=306.61 Aligned_cols=256 Identities=19% Similarity=0.208 Sum_probs=198.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.++||+|+||.||++.++ +++.+|+|++.+.. .......+..|+.++..++|+||+++++++.+....++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 4677899999999999999864 58889999986421 22233457889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+|+|.+++......+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999997656789999999999999999999999 99999999999999999999999999998755432221
Q ss_pred eeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 182 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
......||+.|+|||++.+ ...++.++|||||||++|||++|+.|+...... .......... .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~-----~ 225 (332)
T cd05623 159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHK-----E 225 (332)
T ss_pred -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCC-----c
Confidence 1233569999999999862 235788999999999999999999998533211 0011110000 0
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~ 296 (356)
....+.....++.++.+++.+|+..++.+ |+++.++++.
T Consensus 226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00112222345678899999988654444 6889988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=312.17 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=196.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+....|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34457888999999999999999864 5789999975432 234689999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||++. ++|.+++......+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99995 58888887777789999999999999999999999 999999999999999999999999999987543221
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH----HHHHHh-----hh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY----VWEEYE-----KS 250 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~----~~~~~~-----~~ 250 (356)
. .....||..|+|||++.+. .++.++|||||||++|||+++..++.............. ...... ..
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred c---cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 1 1235689999999999877 689999999999999999987766544332211100000 000000 00
Q ss_pred c---------hhhhHhhcCCC---------chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 251 E---------LGAMILACGIE---------EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 251 ~---------~~~~~~~~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
. ...++...... ......+.++.++|.+||+.||.+|||+.++++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 00000000000 0001234456779999999999999999999863
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.18 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=207.5
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+....|++.++||+|+||+||++... +++.||+|++...........+.+|+++++.++||||+++++++.....+++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 44567888999999999999999764 68999999987654445567889999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++++|..++.. .+.+++..+..++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999998844 4578999999999999999999996 1589999999999999999999999999986543222
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc-hhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW-FPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 258 (356)
. ....|+..|+|||++.+. .++.++|+|||||++|++++|+.|+.......... .+...... .......
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 228 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----LQQIVQE 228 (284)
T ss_pred c----CccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-----HHHHhhc
Confidence 1 234689999999998776 78999999999999999999999986443321100 00000000 0111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
..........+.++.+++.+||..||++||++.++++..
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 001111122567799999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=315.14 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=198.4
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----eeeE
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-----MTAL 98 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 98 (356)
+.+.+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+.+++.++||||+++++++.... ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 45678999999999999986 468999999986532 2234467889999999999999999999998776 7899
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+. ++|..++. ....+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 82 VTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred Eeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 999996 58888773 44679999999999999999999999 99999999999999999999999999999865433
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc-h-------hHHHHHHHhhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW-F-------PKYVWEEYEKS 250 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~-~-------~~~~~~~~~~~ 250 (356)
... ......+|..|+|||++.+...++.++|||||||++|||++|+.||........-. . ....+.....
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~- 234 (372)
T cd07853 157 ESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE- 234 (372)
T ss_pred ccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-
Confidence 221 12334678999999999876568999999999999999999998875433211000 0 0000000000
Q ss_pred chhhhHhhcCC-C-------chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 251 ELGAMILACGI-E-------EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 251 ~~~~~~~~~~~-~-------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.....+..... . ......+.++.+++.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00001100000 0 0112235678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=300.85 Aligned_cols=240 Identities=22% Similarity=0.318 Sum_probs=187.4
Q ss_pred ccCcCCceEEEEEEcCC-------------------------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeee
Q 047701 31 RLGFGGFGQVYKGQFPN-------------------------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 85 (356)
+||+|+||.||+|.+.. ...|++|++..... .....+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999996411 23588998865422 33456888999999999999999
Q ss_pred EeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---
Q 047701 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF--- 162 (356)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~--- 162 (356)
+++++.+....++||||+++++|..++....+.+++..+..++.|++.||+|||+ ++++||||||+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999997666789999999999999999999999 9999999999999997543
Q ss_pred ----ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHh-cCCCccccCCCcccc
Q 047701 163 ----SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV-GRRRNAIVGASESLD 237 (356)
Q Consensus 163 ----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell-~g~~~~~~~~~~~~~ 237 (356)
.++++|||++...... ....++..|+|||.+.+...++.++||||||+++||++ +|..|+........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4799999987643322 12346788999999876546899999999999999985 67766543222110
Q ss_pred chhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 238 WFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
........ ..+.....++.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ---------------~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---------------ERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---------------HHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00000000 011122356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.78 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=198.2
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
..|++.+.||+|+||.||++.. +++.||+|.+... .....+..|+.++++++|||++++++++..+. .+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence 4578889999999999999976 7788999998654 23457889999999999999999999987654 69999999
Q ss_pred CCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
.+++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999996543 468999999999999999999999 999999999999999999999999999987543221
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....+..|+|||.+.+. .++.++|+||||+++|+|++ |..|+....... ..........
T Consensus 155 --~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~ 215 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----------------VKECVEKGYR 215 (254)
T ss_pred --CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----------------HHHHHhCCCC
Confidence 123345689999998766 68999999999999999997 777653222110 0111111111
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
......++..+.+++.+||+.+|++||++++|++.|++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 22233456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.84 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=202.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.++||+|+||.||++.+. ++..+|+|.+..........++.+|++++++++||||+++++++.++...++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 3677899999999999999764 688999999876544455567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++++|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 82 DGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 99999999954 3678999999999999999999997 1489999999999999999999999999987553322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh---------------
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE--------------- 248 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~--------------- 248 (356)
.....|+..|+|||++.+. .++.++|+||||+++|+|++|+.|+...........-........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 1235688999999998776 689999999999999999999988743322110000000000000
Q ss_pred -----hhchhhhHhhcCCCch-hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 249 -----KSELGAMILACGIEEK-DKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 249 -----~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
................ ....+.++.+++.+||..||++||++.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000011 11245679999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=316.11 Aligned_cols=266 Identities=20% Similarity=0.218 Sum_probs=202.9
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc---CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF---PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
..+...+|.+.++||+|+||.||++.. ..++.||+|.+... ....+|++++++++||||+++++++.....
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 334456789999999999999999964 24678999988653 134579999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++||++. ++|..++ .....+++..+..++.||+.||.|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 161 ~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999999995 5888888 455779999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh-----
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS----- 250 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~----- 250 (356)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.|+......................
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 554433333346799999999999877 68999999999999999999999986544332110000001100000
Q ss_pred -----chhhhH---hhcCCCch-------hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 251 -----ELGAMI---LACGIEEK-------DKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 251 -----~~~~~~---~~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.+.... ........ ....+.++.+++.+||..||++||++.+++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00000000 01234578899999999999999999999974
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=297.76 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=205.3
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|+..++||+|+||.||+|.+. ++..||+|++..+........+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667788999999999999864 58899999987654445567889999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 84 LGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 99999999884 3468999999999999999999999 99999999999999999999999999999766543211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..|+....+.. ...........
T Consensus 158 -~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----------------~~~~~~~~~~~ 219 (277)
T cd06640 158 -RNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMR----------------VLFLIPKNNPP 219 (277)
T ss_pred -cccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----------------HhhhhhcCCCC
Confidence 1234578899999999876 68999999999999999999998874332210 00111111223
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3445677889999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=322.74 Aligned_cols=257 Identities=20% Similarity=0.258 Sum_probs=190.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--------C
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--------H 94 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~ 94 (356)
..|.+.++||+|+||.||+|.. .+++.||||.+.... ....+|+.++++++||||+++++++... .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3578889999999999999976 468999999886432 1234699999999999999998876432 2
Q ss_pred eeeEEEEecCCCCHhHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccC
Q 047701 95 MTALVYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFG 170 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfG 170 (356)
.+++||||+.+ +|.+++. .....+++..+..++.||+.||+|||+ .+++||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 7777663 245679999999999999999999999 9999999999999998654 79999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh-
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK- 249 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~- 249 (356)
+++........ ....||+.|+|||++.+...++.++|||||||++|||++|.+|+........ +... ......
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i-~~~~~~p 290 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRI-IQVLGTP 290 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCC
Confidence 99866543222 2356899999999987765789999999999999999999988754332110 0000 000000
Q ss_pred --h-------chhhhHhhcC-----CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 --S-------ELGAMILACG-----IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 --~-------~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. .......... ....+...+.++.+|+.+||..||.+|||+.++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 0000000000 00011224568999999999999999999999986
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=295.34 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=188.5
Q ss_pred cccCcCCceEEEEEEcCC---CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQFPN---GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.||+|+||.||+|...+ ...+++|.+...........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999996533 33566777665544455678999999999999999999999999999999999999999
Q ss_pred CHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 107 SLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 107 sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+|.+++... ........+..++.||+.||+|||+ .+++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999643 2346777888999999999999999 9999999999999999999999999999764322211111
Q ss_pred ecCCCCCCCCCCcccccCC------CCCCCCCceehhhHHHHHHhcCCC-ccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 184 ISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVSFEIVGRRR-NAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~------~~~~~~~Dv~slG~il~ell~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.....|+..|+|||++... ..++.++||||||+++|||+++.. |+. .... ................
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~-~~~~------~~~~~~~~~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS-HLSD------REVLNHVIKDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC-CCCH------HHHHHHHHhhcccccC
Confidence 2335578899999997532 135789999999999999997544 432 1111 0111111111111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
. +.........+.+++.+|| .+|.+||++++|++.|.
T Consensus 231 ~----~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 K----PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred C----CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 1122234567888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=298.26 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=203.1
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+|.+.+.||.|+||.||+|.+. +++.||+|.+...........+.+|+++++.++|+||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4677899999999999999864 689999999876544445567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++....... .
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 154 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--K 154 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--c
Confidence 999999998543 88999999999999999999999 9999999999999999999999999999987664321 1
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.....|+..|+|||++.+. .++.++||||||+++|+|++|..|+....... ....+.......
T Consensus 155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----------------~~~~~~~~~~~~ 217 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMR----------------VLFLIPKNNPPS 217 (274)
T ss_pred cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHH----------------HHHHhhhcCCCC
Confidence 2334688899999999877 58999999999999999999998874332110 000011111111
Q ss_pred hhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKE-KAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... .+..+.+++.+||..+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122 5677999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.78 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=203.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.++||+|+||.||+|.+. +++.||||++..+. ......++.+|++++++++||||+++++++.+++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 5778899999999999999864 58999999997542 23445678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 102 YMENGSLDGYLFGK----------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 102 ~~~~~sL~~~l~~~----------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
|++|++|.+++... ....++..++.++.||++||+|||+ ++++||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999988531 2346678889999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCC----------------ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcc
Q 047701 172 AKLCDRNRS----------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235 (356)
Q Consensus 172 a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~ 235 (356)
++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.|+.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 987621110 0011124699999999999877 68999999999999999999999874322110
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhhhcccC
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP-PMSAVVKMLEGVVEV 303 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~~~ 303 (356)
. ... ... ............+..+.+++.+|+..||++|| +++++.+.|+.....
T Consensus 239 i------~~~----~~i----~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I------SYR----DVI----LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h------hhh----hhc----cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000 000 00000011124566789999999999999996 567777777766543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=296.77 Aligned_cols=254 Identities=32% Similarity=0.495 Sum_probs=198.9
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHH-HHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|++.+.||+|+||+||++... +++.||+|++......... ....+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999875 5779999999865432222 23456999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+++|.+++. ....+++..+..++.|+++||.+||+ .+++|+||||+||+++.++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN 154 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred cccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence 9999999995 55678999999999999999999999 9999999999999999999999999999876521 2223
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.....++..|+|||++.....++.++||||||+++|+|++|..|+....... ..................
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~--- 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-------QLEIIEKILKRPLPSSSQ--- 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-------HHHHHHHHHHTHHHHHTT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchh-------hhhhhhhccccccccccc---
Confidence 3456689999999999833378999999999999999999998875431100 000111100001111100
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.......++.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011278999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=296.46 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=200.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
-|++.++||+|+||.||+|.+. ++..+++|.+.... ......+..|+.+++.++||||+++++++..++..++|+||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 3677889999999999999864 57889999986543 244567888999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++++|..++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 9999999886666789999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred ecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 184 ISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....|+..|+|||++.. ...++.++|||||||++|+|++|++|+....... . ....... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~-~~~~~~~-------~~ 225 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------V-LLKIAKS-------EP 225 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------H-HHHHhhc-------CC
Confidence 233568899999999842 2257789999999999999999998863221100 0 0000000 00
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.....+..++.++.+++.+||+.||.+||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233456789999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=293.60 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=204.6
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.+.||.|+||.||.++. .+++.+++|.+... .......++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 367889999999999999975 46899999988643 2345556788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+++++|.+++... ...+++..+..++.|++.+|+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999654 4578999999999999999999999 9999999999999999999999999999886644332
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
......|+..|+|||+..+. .++.++||||||+++|+|++|..|+...... .... .......
T Consensus 157 -~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~----------~~~~~~~ 218 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVV----------KIVQGNY 218 (256)
T ss_pred -cccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHH----------HHHcCCC
Confidence 12335689999999999876 5889999999999999999999887432211 0000 1111112
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......+.++.+++.+||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 22234556789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=298.96 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=199.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
+|...+.||+|+||.||++... +++.||||.+..... ......+..|+.++++++|+|++.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4566788999999999999764 689999999865421 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999988543 3468999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....|+..|+|||++.+. .++.++||||||+++|+|++|..|+........ +... ...... .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-------~~~~-----~~~~~~-~ 220 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-------REEV-----ERLVKE-V 220 (285)
T ss_pred ---ccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccch-------HHHH-----Hhhhhh-h
Confidence 1234689999999999877 689999999999999999999999854322110 0000 000000 0
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
........+.++.+++.+||+.||.+||+ +.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01122334567899999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=296.18 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=200.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch--------hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK--------IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... .....+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999764 5889999988643211 122567889999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++|||+++++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999954 3678999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCc----eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 176 DRNRSH----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 176 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
...... .......|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~---- 221 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----------QAI---- 221 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHH----------HHH----
Confidence 532111 111234588899999999876 6889999999999999999999887422110 000
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. +........+...+..+.+++.+||+.||.+||++.+|++
T Consensus 222 -~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 -FK-IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HH-HhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 0011122334456678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=298.23 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=198.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
+|+..+.||+|+||+||+|.+ .+++.||+|.+..... ......+.+|++++++++|+||+.+++++..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 356678899999999999976 4689999999865421 1233457789999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999888543 3469999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....|+..|+|||++.+. .++.++|+||||+++|+|++|..|+........ ... +...+...
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-------~~~-----~~~~~~~~- 220 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-------REE-----VDRRVLET- 220 (285)
T ss_pred ---ccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH-----HHHhhhcc-
Confidence 1234689999999999876 689999999999999999999998753322100 000 00111100
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
........+.++.+++.+||+.||++||+ +.+++.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122345567899999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=297.70 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=203.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4778899999999999999875 689999999876544455578899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 104 ENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 104 ~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
++++|..++... ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 999999988543 3478999999999999999999996 15999999999999999999999999999876543221
Q ss_pred eeecCCCCCCCCCCcccccCCC-----CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 182 VTISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
....|+..|+|||.+.+.. .++.++|+||||+++|+|++|..|+...... ..+... ...
T Consensus 159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~------~~~ 222 (286)
T cd06622 159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-------NIFAQL------SAI 222 (286)
T ss_pred ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------hHHHHH------HHH
Confidence 2235788999999986431 3588999999999999999999987432111 001110 011
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+..++.++.+++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111122344457788999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.04 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=188.0
Q ss_pred cccCcCCceEEEEEEcCC-C----------cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 30 TRLGFGGFGQVYKGQFPN-G----------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
+.||+|+||.||+|.+.+ + ..+++|++..... ....+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 479999999999998753 3 2578887765422 15778899999999999999999999988 77899
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-------ceEEeccCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-------SPKVADFGL 171 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~DfGl 171 (356)
||||+.+++|.+++......+++..+..++.||+.||+|||+ ++++||||||+||+++.++ .++|+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999997665589999999999999999999999 9999999999999998877 799999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcC-CCccccCCCccccchhHHHHHHHhh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGR-RRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g-~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
+...... ....++..|+|||++.+. ..++.++||||||+++|+|++| ..|+........ ...+.
T Consensus 155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~- 220 (259)
T cd05037 155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQ- 220 (259)
T ss_pred ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHh-
Confidence 8765431 223467789999998765 3688999999999999999995 444422211100 00000
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.... .+......+.+++.+||..+|.+||++.+|++.|+
T Consensus 221 --------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --------DQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------cCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00011267899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=306.85 Aligned_cols=205 Identities=27% Similarity=0.370 Sum_probs=172.4
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-C-----CCeeeEeee
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-H-----INLVRLHGF 89 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~ 89 (356)
...+....+|...+.||+|.||.|-+|.+ ++++.||||++++.. .-..+...|+.+|..|+ | -|+|+++++
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 33444555888899999999999999964 679999999998753 44456777999999986 3 389999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC--CceEE
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--FSPKV 166 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl 166 (356)
|...+..|||+|+++. +|.+++..+ -..++...+..++.||+.||.+||+ .+|||+||||+||||.+. ..+||
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeE
Confidence 9999999999999955 999999654 4679999999999999999999999 999999999999999643 37999
Q ss_pred eccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCc
Q 047701 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234 (356)
Q Consensus 167 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~ 234 (356)
+|||.|+....... ....+..|+|||++.|. +|+.+.||||||||+.||++|. |.+.+..+
T Consensus 333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne 393 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGE-PLFPGDNE 393 (586)
T ss_pred EecccccccCCcce-----eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCc-cccCCCCH
Confidence 99999987664433 23457789999999998 8999999999999999999995 44444443
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.12 Aligned_cols=260 Identities=20% Similarity=0.288 Sum_probs=188.7
Q ss_pred ccccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEEEEec
Q 047701 29 STRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTALVYEYM 103 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~ 103 (356)
+.+||+|+||.||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 468999999999999854 46789999987542 23457789999999999999999998854 56778999999
Q ss_pred CCCCHhHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE----cCCCceEEeccCC
Q 047701 104 ENGSLDGYLFGK--------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGL 171 (356)
Q Consensus 104 ~~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGl 171 (356)
.+ +|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 65 777776321 2358899999999999999999999 999999999999999 4667899999999
Q ss_pred ccccCCCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh----------
Q 047701 172 AKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP---------- 240 (356)
Q Consensus 172 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~---------- 240 (356)
++........ .......||..|+|||++.+...++.++||||||+++|||++|.+|+...........+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9876543322 12234568999999999987546899999999999999999999988643322110000
Q ss_pred -------HHHHHHHhhhc-hhhhHh---hcC---------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 241 -------KYVWEEYEKSE-LGAMIL---ACG---------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 241 -------~~~~~~~~~~~-~~~~~~---~~~---------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...|....... ...... ... ...........+.+++.+|+..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00011110000 000000 000 00001112345888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.97 Aligned_cols=265 Identities=21% Similarity=0.256 Sum_probs=200.7
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.+.||+|+||.||+|.+. +|+.||+|.+.... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677889999999999999874 68999999986432 122234677899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+ +|.+++......+++..+..++.||++||.|||+ .+++||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 965 8888886666779999999999999999999999 99999999999999999999999999998865432211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch---------hHHHHHHHhhhchh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF---------PKYVWEEYEKSELG 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 253 (356)
.....++..|+|||++.+...++.++||||||+++|+|++|+.|+..+........ ....|.........
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12345788999999987765678999999999999999999988754433211000 00001110000000
Q ss_pred hhHh----hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMIL----ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... ........+..+.++.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00001112235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.70 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=194.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||.||+|... +++.||||++.... .......+..|+.++.+++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 3667889999999999999764 68999999997431 22344678889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++|+|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999984 44578999999999999999999999 99999999999999999999999999998754321100
Q ss_pred ---------------------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCcc
Q 047701 182 ---------------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNA 228 (356)
Q Consensus 182 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~ 228 (356)
.......||+.|+|||++.+. .++.++|||||||++|||++|..|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCC
Confidence 001134699999999999877 7899999999999999999999998
Q ss_pred ccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 047701 229 IVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP---MSAVVK 295 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v~~ 295 (356)
....... .+....... ...........+.++.+++.+++ .||.+|++ +.++++
T Consensus 237 ~~~~~~~-------~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQE-------TYRKVMNWK------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHH-------HHHHHHcCC------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 5433211 111111000 00000011124567888888876 49999986 556655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=306.71 Aligned_cols=261 Identities=22% Similarity=0.237 Sum_probs=194.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------e
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------M 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 95 (356)
..|.+.+.||+|+||.||++.. .+++.||||++.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 4788889999999999999976 468999999997542 2334567889999999999999999999986543 4
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.|+||||+++ +|...+. ..++...+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 101 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 6899999966 6666652 348899999999999999999999 99999999999999999999999999999754
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~ 247 (356)
.... ......||..|+|||++.+. .++.++||||||+++|+|++|..||........- ..........
T Consensus 174 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 174 CTNF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccCc---cCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 3322 12335689999999999877 6899999999999999999999988543221000 0000000000
Q ss_pred hhhchhhhHhhcC------------------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILACG------------------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
............ ........+.++.+++.+||..||++|||+.++++.
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 -QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred -HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 000111234678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=295.68 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=200.7
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccC-----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
|...+.||+|+||.||+|...+++.+|||.+.... .......+.+|++++++++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56788999999999999988788999999886432 1223356888999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 82 EFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999954 3568899999999999999999999 9999999999999999999999999999876532111
Q ss_pred ----ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 181 ----HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 181 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
........|+..|+|||++.+. .++.++||||||+++|+|++|..|+....... ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------~~~~~----~~ 222 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYI----GA 222 (265)
T ss_pred cccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHH----------HHHHh----hh
Confidence 1112234589999999999876 68999999999999999999999874321100 00000 00
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+...+.++.+++.+||+.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001112233446678999999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=298.89 Aligned_cols=272 Identities=28% Similarity=0.403 Sum_probs=212.1
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhc--CCCCCeeeEeeeEEcCC----eeeE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--TYHINLVRLHGFCHDQH----MTAL 98 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~l 98 (356)
-.++.+.||+|.||.||+|.+ +++.||||+++. ..++.|..|-++++. +.|+||+++++.-..+. .++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 566788999999999999999 669999999975 566788888888886 47999999999887665 8899
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc------CCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC------QQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
|++|.+.|+|.++| ....++|....+|+..+++||+|||+.. +.+|+|||||.+||||..++++.|+|||||
T Consensus 286 Vt~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999 4457999999999999999999999854 357999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCC-----CCCceehhhHHHHHHhcCCCccccCCCcccc-chhHHHHHH
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT-----HKCDVYSFGMVSFEIVGRRRNAIVGASESLD-WFPKYVWEE 246 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~Dv~slG~il~ell~g~~~~~~~~~~~~~-~~~~~~~~~ 246 (356)
..+..........+.+||.+|||||++.|...+. .+.||||+|.+||||++.-.....+..+... -+....-..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 9988665555556688999999999998765554 4699999999999999876655432222111 011011111
Q ss_pred HhhhchhhhHhhcCCCchhHH------HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 247 YEKSELGAMILACGIEEKDKE------KAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~------~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
-.-+++...+......+..++ ...-+.+.+..||..||+.|.|+.=|.+++..+...
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 112233333333222223222 235689999999999999999999999988877653
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=292.82 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=204.2
Q ss_pred HhhccccccCcCCceEEEEEEcCC-CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|++.++||+|+||.||+|.+.. ++.+++|.+.... ....+.+|++++++++||||+++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 467788999999999999998754 8899999987542 267899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence 99999999997667789999999999999999999999 99999999999999999999999999998876543321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....|+..|+|||++.+. .++.++||||||+++|+|++|..|+........ ...... ......
T Consensus 156 -~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~~~~~-------~~~~~~ 219 (256)
T cd06612 156 -RNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IFMIPN-------KPPPTL 219 (256)
T ss_pred -cccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hhhhcc-------CCCCCC
Confidence 1234478899999999877 789999999999999999999988743221100 000000 000011
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+...+..+.+++.+||+.||++||++.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 123345677999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=295.65 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=197.3
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcC------C
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQ------H 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~ 94 (356)
...|++.+.||+|+||.||+|.+. +++.||+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 346777889999999999999764 58899999987542 3345788899999998 699999999998753 4
Q ss_pred eeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 95 MTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..+++|||+.+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998653 3568999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
....... ......|+..|+|||++.+. ..++.++||||||+++|+|++|..|+...... .......
T Consensus 160 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~~~~- 229 (272)
T cd06637 160 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIP- 229 (272)
T ss_pred ecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHHHHh-
Confidence 6543221 12335689999999998632 25788999999999999999999887422111 0000000
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...........++.++.+++.+||..+|.+||++.++++
T Consensus 230 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 -------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -------cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 001111122234567899999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=329.54 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=203.0
Q ss_pred eeCHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
.+.+.+..-..|.+.++||+|+||+||+|.+. +++.||+|++... ........+..|+.++.+|+||||+++++++.+
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 45555666678999999999999999999864 5889999998743 233455678999999999999999999998854
Q ss_pred --CCeeeEEEEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccC----CCeeeeccCccceEEcC---
Q 047701 93 --QHMTALVYEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQ----QRIIHYDIKPENVLLDA--- 160 (356)
Q Consensus 93 --~~~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~Dlkp~Nill~~--- 160 (356)
...+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||+... .+|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45689999999999999998542 3579999999999999999999998221 34999999999999954
Q ss_pred --------------CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCC
Q 047701 161 --------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRR 225 (356)
Q Consensus 161 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~ 225 (356)
.+.+||+|||++........ .....||+.|+|||++.+. ..++.++|||||||+||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 23589999999986543321 1335689999999998643 25789999999999999999999
Q ss_pred CccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 226 RNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.||...... .. .... +... ........+.++.+||..||..+|.+||++.+++.
T Consensus 241 ~PF~~~~~~-----~q-li~~---------lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANNF-----SQ-LISE---------LKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCcH-----HH-HHHH---------HhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 997433221 00 0111 1110 01111234677999999999999999999999985
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.83 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=201.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
+..|++.++||+|+||.||+|... +++.+++|.+.... ......+..|+.++++++||||+++++++......++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356888999999999999999864 58999999987643 3445678889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|..++......+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999999998886666779999999999999999999999 9999999999999999999999999999875432211
Q ss_pred eeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 182 VTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
......++..|+|||++.+ ...++.++||||||+++|+|++|..|+...... ..........
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~------ 231 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSE------ 231 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCC------
Confidence 1123457889999999853 224688999999999999999999886432210 0000000000
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......+...+.++.+++.+||..||++||++.++++
T Consensus 232 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 -PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001122345567899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=294.32 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=199.6
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.++||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 34778889999999999999976 4689999999875432 334567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++. ..+.+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 999999999884 44579999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeecCCCCCCCCCCccccc--CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 182 VTISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
......|+..|+|||++. ....++.++|+|||||++|+|++|..|+........ .+. ....... .
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~-~~~~~~~----~- 228 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFL-MTKSNFQ----P- 228 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHh-hhccCCC----C-
Confidence 123456899999999974 222578899999999999999999988743322110 000 0000000 0
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........++..+.+++.+||..+|++||++++|++
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000011124456889999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=281.04 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=206.3
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-------chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-------GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHM 95 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 95 (356)
.|.-.+.||.|..++|.++.. ++|.++|+|++.... .....+.-.+|+.+|+++ .||||+++.+++..+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 555678899999999999965 479999999985321 123335567899999998 69999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++|+|.|+.|-|.++| ...-.++++...+|.+|+.+|++|||. ++||||||||+|||++++.+++|+|||+++..
T Consensus 98 ~FlVFdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999 455689999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeecCCCCCCCCCCccccc-----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
..++. ....+||++|+|||.+. +...|+...|+|++|||||.|+.|.+|| |. -+..
T Consensus 174 ~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF---------------wH-RkQm 234 (411)
T KOG0599|consen 174 EPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF---------------WH-RKQM 234 (411)
T ss_pred CCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch---------------hH-HHHH
Confidence 76543 35578999999999875 3346899999999999999999999886 11 1122
Q ss_pred chhhhHhhcC---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 ELGAMILACG---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 ~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
-+..++..+. ..+.-.+.+.++.+||.+|++.||.+|.|++|++.
T Consensus 235 lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2333333332 23445677889999999999999999999999987
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=299.85 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=191.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-hHHHHHHHHHHHHhcC---CCCCeeeEeeeEEc-----CC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-IAEEQFMAEVGTIGRT---YHINLVRLHGFCHD-----QH 94 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~ 94 (356)
+|++.+.||+|+||+||+|... +++.||+|.+...... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3677889999999999999764 6899999998753221 2223455677666655 79999999998864 34
Q ss_pred eeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 95 MTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..+++|||+.+ +|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 888888543 3458999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh---hh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE---KS 250 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~---~~ 250 (356)
....... .....||..|+|||++.+. .++.++|||||||++|+|++|.+++........ +.. ...... ..
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPED 229 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChh
Confidence 6653322 1234688999999999876 689999999999999999999888743322110 000 000000 00
Q ss_pred chhh-------hHhh---cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 ELGA-------MILA---CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 ~~~~-------~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... .... .......+..+..+.+++.+|++.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000 0000112234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=294.59 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=197.2
Q ss_pred hccccccCcCCceEEEEEEcC----CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------ 94 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 94 (356)
|.+.+.||+|+||.||+|.+. +++.||||++..+. .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999752 47899999987643 3344567889999999999999999999886532
Q ss_pred eeeEEEEecCCCCHhHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEecc
Q 047701 95 MTALVYEYMENGSLDGYLFGK-----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 169 (356)
..+++++|+.+|+|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 247889999999999887421 2357999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHh
Q 047701 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
|+++...............++..|++||.+.+. .++.++||||||+++|+|++ |..|+...... ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------~~~~~~- 228 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------EIYNYL- 228 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-------HHHHHH-
Confidence 999876543322222233456789999998876 68899999999999999999 66665322110 001111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
............+..+.+++.+||..+|++||++.++++.|+++
T Consensus 229 --------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 --------IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111112234557899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=297.39 Aligned_cols=249 Identities=20% Similarity=0.287 Sum_probs=201.3
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.+|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4778889999999999999975 4689999999876433 3346688999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 99 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred cCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 99999999984 3458999999999999999999999 99999999999999999999999999998754432211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....|++.|+|||.+.+. .++.++||||||+++|+|++|..|+........ ...... ......
T Consensus 173 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~--------~~~~~~ 236 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIAT--------NGTPEL 236 (296)
T ss_pred -cCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhc--------CCCCCC
Confidence 1234588999999999876 688999999999999999999998854322110 000000 000011
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+...+..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 123345677899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=295.98 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=201.2
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---HINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 100 (356)
.|++.+.||+|+||.||+|.+ .+++.||+|.+...........+.+|+.+++++. |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 356778999999999999986 4689999999876544455567888999999986 999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++.. ..+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999843 378999999999999999999999 9999999999999999999999999999987654432
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. .....|+..|+|||.+.+...++.++|+||||+++|+|++|..|+........ ...... ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~~~~~---------~~ 218 (277)
T cd06917 157 K--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MMLIPK---------SK 218 (277)
T ss_pred c--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hhcccc---------CC
Confidence 2 22346889999999987654678999999999999999999998743221100 000000 00
Q ss_pred CCchhH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDK-EKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~-~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...... ..+.++.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011111 14567999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=297.71 Aligned_cols=264 Identities=21% Similarity=0.266 Sum_probs=198.2
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|.+.+.||+|++|.||+|... +++.||||.+..... ......+..|+.++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 567789999999999999864 689999999864322 223456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 104 ENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 104 ~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
. ++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 5888887543 3678999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhhchh
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKSELG 253 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 253 (356)
......+++.|+|||++.+...++.++||||||+++|+|++|+.|+.......... .....|.........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 11234578899999998776567899999999999999999998875432210000 000001000000000
Q ss_pred h-hHhh---cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 A-MILA---CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~-~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. .... ..........+.++.+++.+||..||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000 0000111234677889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.51 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=200.5
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CCeeeEEEEe
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QHMTALVYEY 102 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 102 (356)
|.+.+.||+|++|.||++... +++.||+|.+.... .......+..|+.++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 678899999999999999764 57899999986532 23445678889999999999999999988764 4467899999
Q ss_pred cCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9999999998653 4568999999999999999999999 99999999999999999999999999998866443221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....|++.|+|||++.+. .++.++||||||++++++++|+.|+...... .... ....+..
T Consensus 159 --~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~----------~~~~~~~ 219 (257)
T cd08223 159 --ASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY----------RIIEGKL 219 (257)
T ss_pred --cccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH----------HHHhcCC
Confidence 2234588999999999877 6889999999999999999999876422110 0000 0111112
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...+...+.++.+++.+||..||.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 23344566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.32 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=202.7
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|...++||+|+||.||+|.+ .+++.||||.............+.+|+.++.+++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3566788999999999999976 468999999987554444556788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|..++. ...+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 99999999884 3468999999999999999999999 99999999999999999999999999998765433211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+...... .....+......
T Consensus 158 -~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~ 219 (277)
T cd06641 158 -RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPM----------------KVLFLIPKNNPP 219 (277)
T ss_pred -hccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchH----------------HHHHHHhcCCCC
Confidence 1234578899999999876 6889999999999999999999886422110 000111111122
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+.++.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2334456779999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=295.72 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=202.7
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|.+.++||+|+||.||+|.+. ++..+|+|++... .......+..|+.++++++||||+++++.+..+...++||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46888899999999999999864 6899999998754 234456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 99999999997666789999999999999999999999 9999999999999999999999999999875543221
Q ss_pred eecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 183 TISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
......|++.|+|||++.. ...++.++|+||||+++|+|++|..|+....... .........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~------- 224 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-------VLLKILKSE------- 224 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-------HHHHHhcCC-------
Confidence 1123458899999999752 2247789999999999999999998874321110 000000000
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+...+.++.+++.+||+.+|.+||++.+|++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00111223456778999999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=302.09 Aligned_cols=265 Identities=18% Similarity=0.201 Sum_probs=195.1
Q ss_pred cccccCcC--CceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 28 YSTRLGFG--GFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 28 ~~~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+.++||+| +|++||++.. .+|+.||||.+.... .......+..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999976 479999999997543 2334456778999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
++++|.+++..+ ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999654 3468999999999999999999999 999999999999999999999999998654332211110
Q ss_pred -----eecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccc------hh------HHHH
Q 047701 183 -----TISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW------FP------KYVW 244 (356)
Q Consensus 183 -----~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~------~~------~~~~ 244 (356)
......++..|+|||++.+. ..++.++|||||||++|||++|..|+.......... .+ ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 11223467789999999763 258899999999999999999999875322110000 00 0000
Q ss_pred HHHh--------hhchhhh---------HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 245 EEYE--------KSELGAM---------ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 245 ~~~~--------~~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+... ....... .............+.++.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0000000 0000000112234568999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.62 Aligned_cols=250 Identities=20% Similarity=0.336 Sum_probs=203.5
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.++||+|+||.||++.. .+++.||+|.+... ........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 467889999999999999976 46899999998643 2334456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999988654 3468999999999999999999999 99999999999999999999999999998765443221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....|++.|+|||+..+. ..+.++|+||||++++++++|..|+...... .. .........
T Consensus 158 --~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~----------~~~~~~~~~ 218 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NL----------VLKIIRGSY 218 (256)
T ss_pred --hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHH------HH----------HHHHhcCCC
Confidence 1224578899999999876 6889999999999999999999886432211 00 011111122
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...+...+.++.+++.+||+.+|.+||++.+|++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 23344567789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.20 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=203.6
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|++.++||+|+||.||+|... +++.+++|++..... .....+.+|+.++++++||||+++++++.++...+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35778899999999999999864 578899999976533 3457788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 99999999986665789999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 183 TISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
......++..|+|||.+.+. ..++.++|+||||+++|+|++|..|+....... .......... ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~~~~~~~~-----~~~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALFLISKSNF-----PPP 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccC-----CCc
Confidence 12235688899999998654 257889999999999999999998874322110 0000000000 000
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+.++.+++.+||..+|.+||++.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11123445678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=293.37 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=205.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.+.+.||+|+||.||+|.+. +++.||+|.+..........++.+|+.++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 3567789999999999999875 689999999987655556678899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+++|.+++......+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 9999999996655789999999999999999999997 369999999999999999999999999998755432211
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
...++..|+|||.+.+. .++.++||||||+++|+|++|..|+......... ..... +.........
T Consensus 158 --~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~------~~~~~~~~~~ 223 (265)
T cd06605 158 --TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-----IFELL------QYIVNEPPPR 223 (265)
T ss_pred --cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----HHHHH------HHHhcCCCCC
Confidence 15588899999999877 7899999999999999999999887543221111 01110 0011111112
Q ss_pred hhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKE-KAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+.. .+.++.+++.+||..||.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 2222 6778999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.74 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=203.4
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTALVYE 101 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 101 (356)
|++.+.||.|+||.||+|.. .+++.||+|++... ........+..|+.++++++||||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 66788999999999999975 46889999998753 334455678899999999999999999998754 456789999
Q ss_pred ecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH-----hccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 102 YMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLH-----EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 102 ~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
|+++++|.+++... ...+++..++.++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999998543 567999999999999999999999 6 899999999999999999999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
........ .....|+..|+|||++.+. .++.++|+||||+++|+|++|..|+..... ....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~ 219 (265)
T cd08217 159 ILGHDSSF--AKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQ----------------LQLA 219 (265)
T ss_pred cccCCccc--ccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCH----------------HHHH
Confidence 76544321 1234689999999999876 688999999999999999999988743321 0111
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+........+...+..+.+++.+|+..+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1222222334445667889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=305.77 Aligned_cols=262 Identities=21% Similarity=0.225 Sum_probs=195.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------Ce
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------HM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 95 (356)
.+|...+.||+|+||+||+|.. .+++.||||.+..... ......+.+|+.++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 4677889999999999999976 4688999999875422 23345677899999999999999999988543 34
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++++++ +++|..++. ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 68999998 779988873 4569999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc-c-------hhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD-W-------FPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~-~-------~~~~~~~~~ 247 (356)
.... ....||..|+|||++.+...++.++||||||+++|+|++|..|+........- . .........
T Consensus 169 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 169 DDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred CCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4322 33568999999999987546899999999999999999999887432211000 0 000000000
Q ss_pred hhhchhhhHhhcC-CC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILACG-IE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~~-~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
............. .. .......+.+.+++.+|+..||.+|||+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 00 0011223457899999999999999999999963
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=298.28 Aligned_cols=264 Identities=23% Similarity=0.332 Sum_probs=197.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.+.||+|++|.||+|... +++.||||.+...........+.+|+.++++++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 5677889999999999999865 689999999875433333345678999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+ +|.+++......+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++........
T Consensus 86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 159 (291)
T cd07844 86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-- 159 (291)
T ss_pred CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc--
Confidence 75 9999886666688999999999999999999999 99999999999999999999999999998754322111
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh----------HHHHHHHhhh-ch
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP----------KYVWEEYEKS-EL 252 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~----------~~~~~~~~~~-~~ 252 (356)
.....++..|+|||++.+...++.++||||||+++|+|++|..|+........ ... ...|...... ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12234688999999987654688999999999999999999988743321100 000 0000000000 00
Q ss_pred hhhHhh----cCCCchhHHH--HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILA----CGIEEKDKEK--AKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~----~~~~~~~~~~--~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...... .......... ..++.+++.+|++.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000000011 267889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=294.69 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=200.2
Q ss_pred HHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...+...+.||+|+||.||+|+.+ +.+.|++|.+...........+..|++++++++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 345667889999999999999753 34679999887654433556789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 97 ALVYEYMENGSLDGYLFGKK--------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999985433 168999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHH
Q 047701 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEY 247 (356)
Q Consensus 169 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~ 247 (356)
||++........ .......++..|+|||.+.+. ..+.++||||||+++|++++ |..|+..... .......
T Consensus 161 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~ 231 (275)
T cd05046 161 LSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRL 231 (275)
T ss_pred cccccccCcccc-cccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHH
Confidence 999875432221 112234467789999998876 68899999999999999998 5555421111 0011111
Q ss_pred hhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..... .......++..+.+++.+||..+|.+||++.++++.|.
T Consensus 232 ~~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11000 01112235567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.68 Aligned_cols=250 Identities=23% Similarity=0.292 Sum_probs=195.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 97 (356)
.|...+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 4677899999999999999764 68999999886431 12334568889999999999999999999875 35778
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+++||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999999853 3468999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRS-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
... ........++..|+|||++.+. .++.++||||||+++|+|++|+.|+..... ... .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----------~~~-----~~~~~ 222 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEA----------MAA-----IFKIA 222 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccch----------HHH-----HHHHh
Confidence 211 1112234588899999999876 689999999999999999999988742211 000 01111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+......+..++ .||..+|++||++++|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11112223344556677777 688889999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.80 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=204.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+..++.++|+|++++++.+...+..++|||++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 4678899999999999999864 688999999976544446678899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 104 ENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 104 ~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999643 2568999999999999999999999 99999999999999999999999999998876544322
Q ss_pred e--eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 182 V--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 182 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. ......|+..|+|||++.....++.++|+||||+++|+|++|..|+....... ........ .....
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~~---- 227 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN-DPPSL---- 227 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC-CCCCc----
Confidence 1 12334588999999998765468999999999999999999999874332210 00010000 00000
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||..||++||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000011245678999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=296.13 Aligned_cols=265 Identities=21% Similarity=0.312 Sum_probs=200.1
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|++.+.||+|+||.||+|.+. +++.||+|++..... ......+..|+.++++++|||++++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4677889999999999999875 589999999865422 22335678899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|..++. ....+++..+..++.|++.+|+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 82 CDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred cCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 99988887763 44579999999999999999999999 99999999999999999999999999999876543321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH--------HHHhhhchh-
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW--------EEYEKSELG- 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~- 253 (356)
.....++..|+|||++.+...++.++||||||+++|+|++|..|+................ ..+......
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1234578899999998775468899999999999999999998875332211100000000 000000000
Q ss_pred hhHhhc--C---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILAC--G---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~--~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...... . ........+..+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 0 00111234677999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=299.96 Aligned_cols=265 Identities=24% Similarity=0.326 Sum_probs=200.1
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.++||+|+||.||+|.+. +++.||+|++..... ......+.+|+++++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4677899999999999999875 589999999865432 22345688899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|..+.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07846 82 VDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 156 (286)
T ss_pred CCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence 99988888763 34558999999999999999999999 99999999999999999999999999998865443321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHHhhhchhh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEYEKSELGA 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 254 (356)
.....++..|+|||++.+...++.++||||||+++|+|++|.+++......... .+.......+.......
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 223457889999999876546788999999999999999998776433211000 00000000000000000
Q ss_pred -hHhhc-----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 -MILAC-----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 -~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ......+..+..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 000112245678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.71 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=203.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3678899999999999999864 689999999875432 34456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+ +++|.+++......+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR- 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-
Confidence 9 999999987666789999999999999999999999 99999999999999999999999999998876543321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch---------hHHHHHHHhhhc-h
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF---------PKYVWEEYEKSE-L 252 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~---------~~~~~~~~~~~~-~ 252 (356)
......|+..|+|||.+.+...++.++||||||+++++|++|.+++...... .... ....|....... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence 1233568999999999876646789999999999999999996655322211 0000 000011000000 0
Q ss_pred hhhHhhcC----CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 253 GAMILACG----IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 253 ~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........ ......+.+..+.+++.+|+..+|.+||++++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 001112345789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.74 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=200.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc---------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG---------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
.|...+.||+|+||.||+|... +++.||+|.+..... ....+.+..|+.++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999754 689999998753211 112346788999999999999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999544 578999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCC-CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
..............|+..|+|||.+.... .++.++|+||||+++|++++|..|+...... ...+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~- 229 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGN-KRS- 229 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhc-ccc-
Confidence 54332222223456889999999987652 4789999999999999999999887422110 00000000 000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...........++..+.+++.+||..+|++||++.+|++.
T Consensus 230 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 ---APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000111223456789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=288.90 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=200.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|++.+.||+|+||.||++... +++.+|||.+.... .......+..|+.++++++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 3677899999999999999764 68899999987542 334456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCccccCCCCC
Q 047701 103 MENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 103 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~~~~~~~~ 180 (356)
+++++|.+++... ...+++..+..++.|++.+|+|||+ ++++|+||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999654 3458999999999999999999999 999999999999999754 4689999999987654332
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. ....|+..|+|||.+.+. .++.++||||||+++|+|++|..|+...... ... .......
T Consensus 158 ~---~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~----------~~~~~~~ 217 (256)
T cd08220 158 A---YTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLP------ALV----------LKIMSGT 217 (256)
T ss_pred c---cccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchH------HHH----------HHHHhcC
Confidence 2 224578899999999876 6899999999999999999998886432211 000 0011111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+...+.++.+++.+||..+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12223345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.42 Aligned_cols=262 Identities=19% Similarity=0.194 Sum_probs=195.4
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------C
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------H 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 94 (356)
..+|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 347888899999999999999764 68899999987542 233446678899999999999999999987543 3
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..|+||||+++ +|...+. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999965 7777763 348899999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHH
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEE 246 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~ 246 (356)
...... .....||..|+|||++.+. .++.++|||||||++|+|++|+.||.......... .....+..
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 176 AGTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cCCCCc---ccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 543221 2335689999999999877 78999999999999999999999885432211000 00000000
Q ss_pred HhhhchhhhHhhcC------------------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 247 YEKSELGAMILACG------------------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 247 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
... .......... ..........++.+++.+|++.||.+|||+.++++.
T Consensus 252 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhH-HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0000000000 000111123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=289.04 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=196.4
Q ss_pred ccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 29 STRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
...||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++++++|+||+++++++..++..++|+||+.+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 457999999999999854 688899998875432 345678899999999999999999999999999999999999999
Q ss_pred HhHHhccCCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCccccCCCCCceee
Q 047701 108 LDGYLFGKKRAL--EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 108 L~~~l~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
|.+++......+ +...+..++.|++.||+|||+ .+++||||||+||+++. ++.++|+|||++......... .
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~ 166 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--T 166 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--c
Confidence 999997654555 888999999999999999999 99999999999999976 679999999998765432221 1
Q ss_pred cCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....|+..|+|||++.+. ..++.++||||||+++|+|++|..|+......... .+. .........
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~---------~~~~~~~~~ 232 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFK---------VGMFKIHPE 232 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhh---------hhhhccCCC
Confidence 224578999999998654 24788999999999999999999887432211000 000 000011122
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.+...+.++.+++.+||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 334556789999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.55 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=201.1
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+|...+.||+|+||.||+|... +++.|++|.+.... .......+..|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3567789999999999999875 78999999986432 123456788999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999999854 3568999999999999999999999 999999999999999999999999999987654433
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
......|+..|++||.+.....++.++|+||||+++|+|++|..|+...... ...+... ...
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~---------~~~ 218 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIG---------RSK 218 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHH---------hcc
Confidence 1233558889999999876533889999999999999999999887433210 0111100 001
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....+......+.+++.+||..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112223345677899999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.37 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=199.4
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc----hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG----KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
|++.+.||+|+||.||+|... +++.||||.+..... ......+..|+.++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 667889999999999999864 689999999975432 123345678999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+ +++|.+++......+++..+..++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 889999996554579999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHH--------hh-hc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY--------EK-SE 251 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~ 251 (356)
. .....++..|+|||.+.+...++.++||||||+++|+|++|.+++....... .+... .... .. ..
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 158 K--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKI-FEALGTPTEENWPGVTS 232 (298)
T ss_pred c--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHH-HHHcCCCchhhhhhccc
Confidence 1 1233567889999998765468899999999999999999966543222110 00000 0000 00 00
Q ss_pred hhhhHhhc-----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 252 LGAMILAC-----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 252 ~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........ .........+..+.+++.+||..||.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 0011123346789999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=289.86 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.5
Q ss_pred hccccccCcCCceEEEEEEcCC--CcEEEEEEeccc---------CchhHHHHHHHHHHHHhc-CCCCCeeeEeeeEEcC
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPN--GVKIAVKVLNKN---------LGKIAEEQFMAEVGTIGR-TYHINLVRLHGFCHDQ 93 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 93 (356)
|.+.+.||+|+||.||+|.+.. ++.+|+|.+... .......++..|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5678899999999999998754 788999987532 122344567788888875 7999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 94 HMTALVYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
...+++|||+.+++|.+++.. ....+++..++.++.|++.+|.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999988743 45679999999999999999999995 1679999999999999999999999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
++....... ......|+..|++||.+.+. .++.++|+||||+++|+|++|..|+....... ........
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------~~~~~~~~ 228 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------LATKIVEA 228 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHH-------HHHHHhhc
Confidence 998765443 22345688999999999876 68999999999999999999998864332110 00111110
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
. ..+......+..+.+++.+||+.||++||++.+|..++.
T Consensus 229 ~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V--------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c--------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 011111134567999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=305.57 Aligned_cols=261 Identities=21% Similarity=0.236 Sum_probs=195.3
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------C
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------H 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 94 (356)
..+|...+.||+|+||.||++... +++.||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 347788899999999999999764 68999999987543 233446778899999999999999999988643 3
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 46899999965 6766663 358899999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc---------chhHHHHH
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD---------WFPKYVWE 245 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~---------~~~~~~~~ 245 (356)
...... .....||..|+|||++.+. .++.++||||||+++|+|++|+.||......... ..+. .+.
T Consensus 169 ~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 243 (355)
T cd07874 169 AGTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE-FMK 243 (355)
T ss_pred CCCccc---cCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH-HHH
Confidence 543321 2335689999999999877 6899999999999999999999987533211000 0000 000
Q ss_pred HHhhhchhhhHhhcC------------------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 246 EYEKSELGAMILACG------------------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 246 ~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
... ......+.... ........+.++.+++.+|+..||++|||+.++++.
T Consensus 244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00000000000 000111234578999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=294.62 Aligned_cols=249 Identities=20% Similarity=0.287 Sum_probs=201.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.+|.+.+.||.|+||.||+|.. .+++.|++|.+..... .....+..|+.+++.++|||++++++++......++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3577788999999999999975 4689999999875432 3346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+++|..++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 98 LAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred cCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 99999999884 3468999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....|+..|+|||.+.+. .++.++||||||+++|++++|..|+........ . ...... .....
T Consensus 172 -~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~--~~~~~~-------~~~~~ 235 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----L--YLIATN-------GTPEL 235 (296)
T ss_pred -CCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----H--HHHHhc-------CCccc
Confidence 1234588899999999876 689999999999999999999988744322100 0 000000 00011
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+...+..+.+++.+||..||.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 123345667899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=288.19 Aligned_cols=250 Identities=22% Similarity=0.254 Sum_probs=196.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--Ceee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 97 (356)
.|.+.+.||+|+||.||+|... +++.||||.+.... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4667899999999999999864 58999999875321 123346788899999999999999999998763 4678
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
++|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 999999999999998533 568999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... .......|+..|+|||++.+. .++.++||||||+++|+|++|+.|+...... .. .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~-----~~~~~ 222 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------AA-----IFKIA 222 (265)
T ss_pred ccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchH----------HH-----HHHHh
Confidence 2111 112234588899999999876 6899999999999999999999887422110 00 01111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+......+.+++.+|+. +|++||++++|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111223345566778899999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=293.83 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=201.9
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+..|+.+++.++||||+++++++..+...++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36788889999999999999986 4799999999875433 334668889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999999843 458999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....|++.|+|||.+.+. .++.++|+||||+++|++++|..|+.......... ... ......
T Consensus 172 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~--------~~~~~~ 234 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIA--------TNGTPE 234 (297)
T ss_pred --cCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eec--------cCCCCC
Confidence 1234578899999999876 68899999999999999999999885432211100 000 000001
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+..+.+++.+||..+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123345567889999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=287.88 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=201.7
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-----hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-----KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
|+..+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++|+||+++++++.+++..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 56678999999999999975 5689999999874321 12346788999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~ 178 (356)
+||+.+++|.+++. ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 82 VEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999985 34578999999999999999999999 9999999999999998765 5999999998776543
Q ss_pred CCce--eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSHV--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... ......|+..|+|||.+.+. .++.++||||||+++++|++|..|+......... .. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~---------~~~~~ 224 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---AL---------IFKIA 224 (268)
T ss_pred cccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HH---------HHHHh
Confidence 2111 11234588899999998776 6899999999999999999999887433221100 00 00111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+...+.++.+++.+||..+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111223344566788999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=293.02 Aligned_cols=248 Identities=27% Similarity=0.358 Sum_probs=197.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|...++||+|+||+||+|... +++.||+|.+.... .......+.+|+.+++.++||||+++++++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999864 68999999986432 2234457889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+. |+|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 58878776556679999999999999999999999 99999999999999999999999999998754422
Q ss_pred ceeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 181 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
....|+..|+|||++.+ ...++.++||||||+++|+|++|..|+....... .... .. ..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~--------~~ 229 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IA--------QN 229 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-Hh--------cC
Confidence 22457889999998852 2358889999999999999999998864322110 0000 00 00
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.........++..+.+++.+||..+|++||++.+|+..
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111123356789999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=290.43 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=207.7
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.-+.+.++||+|+||.||+|.++ .|+.+|||.+.-. .+..++..|+.++.+...|+||++||.+..+..+++||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 35667889999999999999764 6999999998764 4567789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
|..|++.+.++.+.+++++..+..+++..+.||+|||. ..-+|||||+.|||++-+|..||+|||.+..+.+.-.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-- 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-- 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence 99999999999999999999999999999999999999 8889999999999999999999999999876554322
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH--hhcC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI--LACG 260 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 260 (356)
....+.||+.|||||+++.- .|..++||||||++..||..|++|...-.+ ....-++ .+..
T Consensus 185 KRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------------MRAIFMIPT~PPP 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHP----------------MRAIFMIPTKPPP 247 (502)
T ss_pred hhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccc----------------cceeEeccCCCCC
Confidence 22346799999999999876 799999999999999999999988532111 0000000 1111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+...+.++.++++.|+-.+|++|-++..+++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 22345677889999999999999999999887776
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=292.99 Aligned_cols=244 Identities=25% Similarity=0.280 Sum_probs=199.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 4678899999999999999864 68999999986532 22344678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++... ..++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999998543 679999999999999999999999 99999999999999999999999999998876543
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....|++.|+|||.+.+. ..+.++||||||+++|+|++|..|+..... ......... ..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~----------~~ 214 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILE----------GK 214 (290)
T ss_pred --CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhc----------CC
Confidence 1234588999999999876 688999999999999999999988743321 001111110 11
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
...+...+..+.+++.+||..||.+|+ +++++++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 122334467889999999999999999 6667664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=289.87 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=193.7
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHH-HhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGT-IGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|++.+.||+|+||.||+|.+. +|+.||+|.+...........+..|+.. ++.++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 3567889999999999999874 6999999999765443444556667665 5566899999999999999999999999
Q ss_pred cCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 103 MENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 103 ~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
++ ++|.+++.. ....+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 588887743 34578999999999999999999998 6 9999999999999999999999999998865432
Q ss_pred CCceeecCCCCCCCCCCcccccCC---CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.. .....|+..|+|||.+.+. ..++.++|+||||+++|+|++|+.|+...... ++.. ...
T Consensus 158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~-----~~~ 220 (283)
T cd06617 158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------FQQL-----KQV 220 (283)
T ss_pred cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------HHHH-----HHH
Confidence 21 1224578899999988652 24688999999999999999999887421111 0000 011
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............++.++.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100001111235678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=291.25 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=197.8
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc------C
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD------Q 93 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~ 93 (356)
....|.+.+.||+|+||.||+|.+ .+++.+|+|++.... ....++..|+.++.++ +|+||+++++++.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 345788889999999999999986 468999999986532 3445688899999998 79999999999853 4
Q ss_pred CeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 94 HMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
...+++|||+.+++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 5789999999999999998643 3568899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
........ ......|+..|+|||.+.. ...++.++||||||+++|+|++|..|+....+...
T Consensus 169 ~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------------ 234 (282)
T cd06636 169 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------------ 234 (282)
T ss_pred hhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------------
Confidence 76543221 1123458899999998752 22578899999999999999999988743221100
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
................++.++.+++.+||..||.+||++.++++
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 ---LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00001111111122345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.42 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=200.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.++||+|+||.||+|.+. +++.||||.+.... .......+.+|++++++++|+||+++++++..++..+++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999875 58899999987532 233456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
++++.+..+. .....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~- 156 (288)
T cd07833 82 VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS- 156 (288)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence 9987776655 445668999999999999999999999 99999999999999999999999999998876554321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH--------HHHHhh-hchh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV--------WEEYEK-SELG 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~ 253 (356)
......++..|+|||++.+...++.++||||||+++|+|++|..|+........-+..... ...+.. ....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 1233567889999999987656889999999999999999999877432211000000000 000000 0000
Q ss_pred h--hHhhcC---CC-chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 A--MILACG---IE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~--~~~~~~---~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ...... .. ..+..++.++.+++.+||..+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000000 00 011123678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=292.44 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=196.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.+.+.||+|+||.||+|... +++.||+|++...........+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 5677889999999999999764 688999999875543333446778999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
. ++|.+++......+.+..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 159 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-- 159 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--
Confidence 5 57777775555678899999999999999999999 99999999999999999999999999998754332211
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHH-----------hhh-c
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY-----------EKS-E 251 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~ 251 (356)
.....++..|+|||++.+...++.++||||||+++|+|++|..|+.......... ...+... ... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL--EKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH--HHHHHHcCCCChhhhhhhhhccc
Confidence 1234578899999998765467889999999999999999998875332211000 0000000 000 0
Q ss_pred hhhhHhhcCCCch------hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAMILACGIEEK------DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............. ....+..+.+++.+|+..||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 0012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=309.33 Aligned_cols=206 Identities=29% Similarity=0.431 Sum_probs=179.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------e
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------M 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 95 (356)
+..|...+.||+|+||.||+|+++ +|+.||||+++........+...+|++++++|+|||||+++++=.... .
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 356677889999999999999964 699999999988766677889999999999999999999999876544 5
Q ss_pred eeEEEEecCCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--CCC--ceEEecc
Q 047701 96 TALVYEYMENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANF--SPKVADF 169 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Df 169 (356)
..+|||||.||||...++.. ...+++..++.++.+++.||.|||+ +||+||||||.||++- .+| ..||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 67999999999999999643 4679999999999999999999999 9999999999999993 333 5799999
Q ss_pred CCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCc
Q 047701 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234 (356)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~ 234 (356)
|.|+...++. ..+.+.||..|++||.+..+..|+...|.|||||++|+..||..||......
T Consensus 169 G~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 169 GAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9999888766 3356789999999999985447999999999999999999999998764443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.03 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=200.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 101 (356)
++...++||.|++|.||+|.+. +++.+|+|.+..........++.+|++++++++||||+++++++.+. ..+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 4567789999999999999874 68999999998654445567789999999999999999999988653 46899999
Q ss_pred ecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ....++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988642 34668999999999999999999999 99999999999999999999999999998755432
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. ....++..|+|||.+.+. .++.++||||||+++|+|++|..|+........... .. ........... +..
T Consensus 159 ~~----~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~-~~~ 230 (287)
T cd06621 159 LA----GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-EL-LSYIVNMPNPE-LKD 230 (287)
T ss_pred cc----ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HH-HHHHhcCCchh-hcc
Confidence 21 123478899999999876 689999999999999999999998865433111100 00 01101100000 000
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+..+.+++.+||+.+|.+||++.+|++
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 --EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 01111234577999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=293.06 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=196.6
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE-----cCC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH-----DQH 94 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~ 94 (356)
...+|++.+.||+|+||.||+|... +++.+|+|+..... .....+..|+.++..+ +||||+++++++. .+.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 4557888899999999999999764 58899999876432 2335677899999999 6999999999884 345
Q ss_pred eeeEEEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 95 MTALVYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCc
Confidence 78999999999999998742 34578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHH
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (356)
+......... .....|+..|+|||++... ..++.++||||||+++|+|++|+.|+........ ....
T Consensus 171 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~~~ 241 (286)
T cd06638 171 SAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFKI 241 (286)
T ss_pred eeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hhhc
Confidence 8765432211 2234689999999997532 2478899999999999999999988743321100 0000
Q ss_pred hhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.... . .....+...+.++.+++.+||+.||++||++.+|++.
T Consensus 242 ~~~~-----~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PRNP-----P--PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccC-----C--CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 0 0001112235679999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=293.38 Aligned_cols=265 Identities=20% Similarity=0.231 Sum_probs=199.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 100 (356)
.|.+.+.||+|+||.||+|.+. +++.+|+|.++..... .....+.+|+.++.+++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5777899999999999999875 5889999998754322 2234567899999999999999999998877 8899999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++ +|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99975 9999886666679999999999999999999999 9999999999999999999999999999987655422
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhhch
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKSEL 252 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 252 (356)
. .....++..|+|||.+.+...++.++|+||||+++|+|++|..|+.......... .....|..+.....
T Consensus 162 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 162 P--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 1234578899999998876457899999999999999999998875332211000 00000111100000
Q ss_pred hh---h--HhhcCCCchhHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GA---M--ILACGIEEKDKE--KAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~---~--~~~~~~~~~~~~--~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. . ..........+. .+..+.+++.+||+.+|++||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0 000000001111 3667899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=294.05 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=200.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||++... +++.|++|.+..... ......+..|+.+++.++||||+++++.+..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4667899999999999999864 588999999875421 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|++|++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++........
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999954 4578999999999999999999999 99999999999999999999999999998642111000
Q ss_pred -------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 182 -------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 182 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
.......|+..|+|||.+.+. .++.++|+||||+++|++++|..|+...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~~~~~~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH
Confidence 011124578899999998876 6899999999999999999999887432211 0111111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
.... .........+.++.+++.+||+.||++||+..++.+.|+.
T Consensus 230 ~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDI-------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hccc-------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 0111112456779999999999999999998777777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.91 Aligned_cols=262 Identities=24% Similarity=0.288 Sum_probs=195.9
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcC--CeeeEEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQ--HMTALVYE 101 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 101 (356)
|++.++||+|+||.||+|... +++.||+|.+.............+|+..+.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 467789999999999999764 689999999876533333344567888999885 99999999999987 88999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+ +|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++. +.++|+|||++.........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 9965 8888886656789999999999999999999999 99999999999999999 99999999999866543222
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc-cch-------hHHHHHHHhhhchh
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL-DWF-------PKYVWEEYEKSELG 253 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~ 253 (356)
....++..|+|||++.+...++.++|||||||++|||++|..|+........ ... ..............
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2245788999999876544678999999999999999999888743322100 000 00000000000000
Q ss_pred hhHhhc----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILAC----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...... .........+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 000112345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=291.24 Aligned_cols=264 Identities=23% Similarity=0.314 Sum_probs=200.8
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
|++.++||+|++|.||+|.+. +++.||||.+...........+..|+.++++++||||+++++++.+.+..++||||+.
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 667899999999999999875 6899999998765444445667889999999999999999999999999999999997
Q ss_pred CCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 105 NGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 105 ~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+ +|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 5 8888885443 568999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhhchhh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKSELGA 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 254 (356)
.....++..|++||++.+...++.++||||||+++|+|++|..|+.......... .....|+.+.......
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1234578899999998776567899999999999999999998875433211000 0000111111000000
Q ss_pred hHhh----cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILA----CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... .......+..+..+.+++.+|++.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0001112344677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=310.08 Aligned_cols=263 Identities=16% Similarity=0.216 Sum_probs=187.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC------CCCeeeEeeeEEcC
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY------HINLVRLHGFCHDQ 93 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~ 93 (356)
+...+|.+.++||+|+||+||+|.+. +++.||||++.... ........|+.++++++ |.+++.+++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 33457888899999999999999764 68899999996431 22233455666665554 45689999988764
Q ss_pred -CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC----------
Q 047701 94 -HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---------- 162 (356)
Q Consensus 94 -~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---------- 162 (356)
...++||+++ +++|.+++.. .+.+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4688999998 6788888854 3579999999999999999999997 14999999999999998665
Q ss_pred ------ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc
Q 047701 163 ------SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236 (356)
Q Consensus 163 ------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~ 236 (356)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 4999999987543221 2345689999999999887 799999999999999999999999854332110
Q ss_pred cc--------hhHHHHHHHhhhchhhhHhhcC-----------------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 047701 237 DW--------FPKYVWEEYEKSELGAMILACG-----------------IEEKDKEKAKQLCMVALWCVQDSPADRPPMS 291 (356)
Q Consensus 237 ~~--------~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 291 (356)
.. ++..............+..... ...........+.+||.+||+.||.+|||+.
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 00 0000000000000000000000 0000011235678999999999999999999
Q ss_pred HHHH
Q 047701 292 AVVK 295 (356)
Q Consensus 292 ~v~~ 295 (356)
++++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=317.70 Aligned_cols=265 Identities=29% Similarity=0.383 Sum_probs=222.2
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcC----C----CcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEee
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFP----N----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHG 88 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 88 (356)
.+++......+.+.||+|.||.|++|... . ...||||.++..........+..|+.+++.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45666666677789999999999999642 1 4679999998776667778999999999999 6999999999
Q ss_pred eEEcCCeeeEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCc
Q 047701 89 FCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153 (356)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 153 (356)
+|...+..++|+||+..|+|..+++... ..++...++.++.|||.||+||++ .+++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence 9999999999999999999999997655 349999999999999999999999 9999999999
Q ss_pred cceEEcCCCceEEeccCCccccCCCCCceeecCCC--CCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccC
Q 047701 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVG 231 (356)
Q Consensus 154 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~ 231 (356)
+|||+.++..+||+|||+++........... ... -...|||||.+... .++.++||||||++||||++.+.+.+.+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDR-VFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccC-cccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999976655444322 122 24469999999985 7999999999999999999966544333
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
... ..++.+.+..+.+.+.+..+..++.++|+.||+.+|++||++.++++.++...
T Consensus 525 ~~~--------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IPP--------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCc--------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 110 22334456677777888889999999999999999999999999999998853
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=291.53 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=200.1
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|...+.||+|+||.||+|.+. ++..||+|.+.... .......+..|++++++++|||++++++++.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34667888999999999999864 68999999986432 2234457888999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+.+ +|.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99965 8888776666779999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 181 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
....|+..|+|||++.+ ...++.++||||||+++|+|++|..|+...... .... .....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~--------~~~~~ 239 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALY--------HIAQN 239 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHH--------HHHhc
Confidence 23457889999999742 225788999999999999999999886432110 0000 01111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
..........+..+.+++.+||+.+|.+||++.+|++.+...
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 111122234556799999999999999999999999865543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=294.51 Aligned_cols=252 Identities=22% Similarity=0.248 Sum_probs=200.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch--hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK--IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||+||+|... +++.||+|.+...... .....+..|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 4677889999999999999764 5899999999764322 245678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+.+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998643 3578999999999999999999999 9999999999999999999999999999875432211
Q ss_pred ce---------------------------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCC
Q 047701 181 HV---------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS 233 (356)
Q Consensus 181 ~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~ 233 (356)
.. ......||..|+|||++.+. .++.++||||||+++|+|++|..|+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 01124688999999999877 689999999999999999999998743322
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHH
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP----MSAVVK 295 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps----~~~v~~ 295 (356)
. ..+.. ..............+.++.+++.+||..||++||+ +.+++.
T Consensus 238 ~-------~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D-------ETFSN--------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-------HHHHH--------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 00111 11111111111225678999999999999999999 666666
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.95 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=202.1
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
|...+.||+|++|.||++.+. +++.+++|++..... .....+.+|++.+++++|+|++++++++......++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 566789999999999999875 689999999976533 355788999999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++......+++..+..++.|++.+|.|||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 999999996665789999999999999999999999 9999999999999999999999999999887654432 2
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....|+..|++||.+.+. ..+.++|+||||+++++|++|+.|+........ ...... ......
T Consensus 155 ~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~---------~~~~~~ 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIAT---------NGPPGL 217 (253)
T ss_pred cceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHh---------cCCCCc
Confidence 234588899999999877 589999999999999999999988643221100 000000 111111
Q ss_pred --hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 265 --DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 265 --~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+..+.+++.+||..||++||++.++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112577999999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.99 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=197.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.+.....||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 3444577999999999999764 68999999986532 244566889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++++|.+++. ...+++..+..++.||+.||.|||+ ++++||||||+||+++.++.++|+|||++.........
T Consensus 102 ~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-- 174 (292)
T cd06658 102 EGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-- 174 (292)
T ss_pred CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--
Confidence 9999999883 3468999999999999999999999 99999999999999999999999999998755432221
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.....|+..|+|||.+.+. .++.++||||||+++||+++|..|+....... ....... .... ...
T Consensus 175 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~-----~~~~--~~~ 239 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRD-----NLPP--RVK 239 (292)
T ss_pred CceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh-----cCCC--ccc
Confidence 1224588999999999776 68999999999999999999998875332210 0000000 0000 001
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.....+..+.+++.+||..||.+||++.++++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.38 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=198.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCC------
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQH------ 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------ 94 (356)
..+|++.+.||+|+||.||+|... +++.+++|++.... .....+..|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 457888999999999999999874 58899999987643 2346788999999999 7999999999997644
Q ss_pred eeeEEEEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 95 MTALVYEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988542 4679999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHH
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (356)
+......... .....|+..|+|||++... ..++.++||||||+++|++++|..|+...... .. ....
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~-~~~~ 230 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RA-LFKI 230 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HH-HHHh
Confidence 8765433221 2234588999999987532 24678999999999999999999987422110 00 0000
Q ss_pred hhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... . .........+.++.+++.+||..||++|||+.++++
T Consensus 231 ~~~~-----~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNP-----P--PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccC-----C--CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 0 001112235678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=290.71 Aligned_cols=264 Identities=19% Similarity=0.213 Sum_probs=189.2
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCC----CcEEEEEEecccCchhH----------HHHHHHHHHHHhcCCCCCeee
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIA----------EEQFMAEVGTIGRTYHINLVR 85 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~ 85 (356)
++....|.+.++||+|+||.||+|.+.+ +..+|+|+......... ......+...+..+.|+|++.
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3455688999999999999999997643 45677776543211110 011233445566778999999
Q ss_pred EeeeEEcCC----eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC
Q 047701 86 LHGFCHDQH----MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 161 (356)
Q Consensus 86 ~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 161 (356)
+++++.... ..+++++++.. ++.+.+. .....++..+..++.|++.||+|||+ .+++||||||+|||++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 999876543 34678888744 7776663 33446788899999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCCc-----eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc
Q 047701 162 FSPKVADFGLAKLCDRNRSH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236 (356)
Q Consensus 162 ~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~ 236 (356)
+.++|+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999876432211 111234699999999999877 689999999999999999999999854422111
Q ss_pred cchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 237 DWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
. . ..... .....+.... ....+++.++.+++..||..+|++||++.++++.|+
T Consensus 242 ~-~-~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 L-I-HAAKC-----DFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred H-H-HHhHH-----HHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0 00000 0001111100 112234678999999999999999999999998763
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.52 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=201.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|...+.||+|+||.||+|... +++.|++|.+..... ......+..|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999764 689999999876533 24567889999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999999854 4568999999999999999999999 999999999999999999999999999988765433221
Q ss_pred e--ecCCCCCCCCCCcccccCCC--CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 183 T--ISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 183 ~--~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
. .....++..|+|||++.+.. ..+.++||||||+++|++++|+.|+...... . ...+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~----~~~~~~~~--------~~ 223 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-F----QIMFHVGA--------GH 223 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-H----HHHHHHhc--------CC
Confidence 1 12345788999999987652 2789999999999999999999987432211 0 00000000 00
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+..+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001111223677889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=286.19 Aligned_cols=247 Identities=23% Similarity=0.240 Sum_probs=202.3
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
|++.++||+|+||.||+|... +++.||+|++.+.. .......+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 677899999999999999875 58999999997542 223456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+++|..++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 9999999999544 689999999999999999999999 9999999999999999999999999999876654321
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....|+..|+|||++.+. .++.++|+||||+++|+|++|..|+........ ..... .... ...
T Consensus 156 -~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~---------~~~~-~~~ 219 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRA---------KQET-ADV 219 (258)
T ss_pred -ccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHH---------Hhcc-ccc
Confidence 2335588899999999877 589999999999999999999998764443211 00000 1110 122
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCH--HHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPM--SAVV 294 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~--~~v~ 294 (356)
..+...+..+.+++.+||..||.+||++ ++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 3344456889999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.84 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=202.5
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.+.||+|+||.||+|.+. ++..|++|++..... ....+..|++.+++++|+|++++++++......++++|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 345667789999999999999875 688999999976433 45678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999997655589999999999999999999999 99999999999999999999999999998755433211
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....++..|++||++.+. .++.++|+||||+++|+|++|..|+........ ....... ....
T Consensus 173 --~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~~~~~~~-------~~~~ 235 (286)
T cd06614 173 --RNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------LFLITTK-------GIPP 235 (286)
T ss_pred --hccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhc-------CCCC
Confidence 1224478899999998876 689999999999999999999988642211100 0000000 0001
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......++..+.+++.+||+.+|.+||++.+|+.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122235678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.01 Aligned_cols=267 Identities=20% Similarity=0.257 Sum_probs=197.7
Q ss_pred hhccccccCcCCceEEEEEEcC---CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--Ceee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 97 (356)
+|++.++||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999864 47999999997632 122335678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHhHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC----CCceEEecc
Q 047701 98 LVYEYMENGSLDGYLFGK----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADF 169 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df 169 (356)
+||||+++ +|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666322 2378999999999999999999999 99999999999999998 899999999
Q ss_pred CCccccCCCCC-ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhH-------
Q 047701 170 GLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK------- 241 (356)
Q Consensus 170 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~------- 241 (356)
|++........ ........++..|+|||++.+...++.++||||||+++++|++|..|+...........+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987654332 1122335678899999998775468899999999999999999998886544332110000
Q ss_pred ----------HHHHHHhhh-chhhhHhhcCC---C--chhH------HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 242 ----------YVWEEYEKS-ELGAMILACGI---E--EKDK------EKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 242 ----------~~~~~~~~~-~~~~~~~~~~~---~--~~~~------~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..|...... ........... . .... ..+.++.+++.+|++.||++|||+.+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00000000000 0 0000 23457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=298.70 Aligned_cols=267 Identities=21% Similarity=0.266 Sum_probs=197.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----eee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-----MTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 97 (356)
..|.+.++||+|+||.||+|.+ .+|+.||||.+...........+..|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 3677889999999999999975 4689999999875433344567888999999999999999999876543 478
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+++||+.+ +|..++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 85 IVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 99999965 8887773 4579999999999999999999999 9999999999999999999999999999886543
Q ss_pred CCCce-eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc-ch-------hHHHHHHHh
Q 047701 178 NRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD-WF-------PKYVWEEYE 248 (356)
Q Consensus 178 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~-~~-------~~~~~~~~~ 248 (356)
..... ......|+..|+|||.+.+...++.++||||||+++|+|++|+.|+......... .. ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 32211 1233568999999998765546899999999999999999999887432211000 00 000000000
Q ss_pred hhchhhhHhhcC---C---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 249 KSELGAMILACG---I---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 249 ~~~~~~~~~~~~---~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
............ . ....+..+.++.+++.+||+.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 0 00112345779999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.34 Aligned_cols=252 Identities=27% Similarity=0.327 Sum_probs=210.7
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|..+..||.|.||.||-|.+ .+|+..|+|-+.-- ........+.+|+.++..++|||+|+++|+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 555667899999999999976 46999999987622 2233445688899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc-
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH- 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~- 181 (356)
|++|+|.+++ .+++..++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|....++...
T Consensus 1316 C~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1316 CEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred hccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999998 566667777777889999999999999 99999999999999999999999999999987765322
Q ss_pred -eeecCCCCCCCCCCcccccCCC--CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc-hhhhHh
Q 047701 182 -VTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE-LGAMIL 257 (356)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 257 (356)
.......||+.|||||++.+.. +...++|||||||++.||+||++|| ..++... +.-.+.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW----------------~~~dne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPW----------------AELDNEWAIMYHVA 1455 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCch----------------hhccchhHHHhHHh
Confidence 2234567999999999998642 4678999999999999999999986 4444332 334455
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.+-.+..+...+.+-.+++.+|+..||..|.++.++++.
T Consensus 1456 ~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 666677788899999999999999999999988877763
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.61 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=206.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.+.||+|++|.||+|... +++.|+||.+...........+..|+..+.+++|+|++++++++......++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 3567899999999999999875 599999999876544345678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++++|.+++... ..+++..++.++.|++++|.|||+. .+++|+||+|+||+++.++.++|+|||++..........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 999999999543 6799999999999999999999962 799999999999999999999999999988765433221
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+........ .. ....+.......
T Consensus 158 -~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~----------~~~~~~~~~~~~ 222 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FE----------LMQAICDGPPPS 222 (264)
T ss_pred -cceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HH----------HHHHHhcCCCCC
Confidence 234578899999999877 789999999999999999999988754432100 00 001111111222
Q ss_pred hhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 264 KDKE-KAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 264 ~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.... .+..+.+++.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 3333 67789999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.48 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=204.7
Q ss_pred HHhhccccccCcCCceEEEEEEcCC-CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..-|++...||-|+||.||+|..++ +-.-|-|++... .....++++-|+++|....||+||++++.+...+.++|+.|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 3467888999999999999998765 444556776543 44666889999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||.||-++.++..-+..+++.++.-++.|++.||.|||+ ++|||||||+.|||+.-+|.++|+|||.+..... +.
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 999999999998888999999999999999999999999 9999999999999999999999999998753221 11
Q ss_pred eeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 182 VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.....+.||+.|||||+.+.. .+|..++||||||++|.||..+.+|-..-.+ ..+ +..+..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRV--------llKiaK 249 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRV--------LLKIAK 249 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHH--------HHHHhh
Confidence 223457899999999997632 3789999999999999999999887421111 111 111111
Q ss_pred hc-CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 AC-GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.. .....+..++..+.+++.+||..||..||++.++++.
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11 1122355677889999999999999999999999873
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.79 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=195.7
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.+...++||+|+||.||++.+. +++.||+|.+...........+..|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445688999999999999764 689999999876544455667889999999996 99999999999998899999999
Q ss_pred cCCCCHhHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 103 MENGSLDGYLF----GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 103 ~~~~sL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
+.. +|.++.. .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 6665432 224679999999999999999999997 149999999999999999999999999998765433
Q ss_pred CCceeecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
... ....|+..|+|||++.+. ..++.++||||||+++|+|++|+.|+..... ..+....... ..
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~--~~ 227 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---------VFDQLTQVVK--GD 227 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---------HHHHHhhhcC--CC
Confidence 222 223578899999998765 3688999999999999999999988642210 0111110000 00
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...........++.++.+++.+||+.+|++||++.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111123466789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=285.25 Aligned_cols=244 Identities=22% Similarity=0.258 Sum_probs=188.7
Q ss_pred ccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHH---HHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVG---TIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.||+|+||.||++... +++.+|+|.+.+... ......+..|.. .+...+||||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 689999999865421 122223344443 3334579999999999999899999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|..++. ..+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc----
Confidence 999999885 34569999999999999999999999 9999999999999999999999999999875543221
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....|+..|+|||.+.+...++.++||||||+++|+|++|..|+.......... ... .. .......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------~~~-----~~-~~~~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------IDR-----MT-LTVNVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------HHH-----Hh-hcCCcCC
Confidence 234589999999998754468899999999999999999999885433221110 000 00 0011223
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRP-----PMSAVVKM 296 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~ 296 (356)
+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 445677899999999999999999 58888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=289.92 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=199.8
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeEEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTALVYE 101 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 101 (356)
|++.++||+|+||.||+|... +++.+|+|.+.... .......+.+|+.++++++|||++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999875 58999999998653 223345688899999999999999999999988 88999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++ +|.+++......+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 8998886655689999999999999999999999 99999999999999999999999999999876554321
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc-ch-------hHHHHHHHhhhchh
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD-WF-------PKYVWEEYEKSELG 253 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~ 253 (356)
......++..|+|||.+.+...++.++||||||+++|+|++|..|+......... .. ....|.........
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1233456888999998876556899999999999999999999887543321100 00 00000000000000
Q ss_pred hhHhh-----cCCCchhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILA-----CGIEEKDKE-KAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~-----~~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ......... ++.++.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 000011111 2678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=282.21 Aligned_cols=243 Identities=24% Similarity=0.333 Sum_probs=196.2
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||.|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999874 48999999997543 224456789999999999999999999999999999999999999999
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCC
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 188 (356)
.+++.. ...++...+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~~~ 153 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFC 153 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccccc
Confidence 999954 3568999999999999999999999 9999999999999999999999999999987654421 12245
Q ss_pred CCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHH
Q 047701 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268 (356)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
|+..|++||.+.+. .++.++|+||||+++|+|++|..|+.....+.. .... ...........+...
T Consensus 154 ~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~--------~~~~~~~~~~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----EIYN--------DILKGNGKLEFPNYI 219 (262)
T ss_pred CCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----HHHH--------HHhccCCCCCCCccc
Confidence 78899999998766 689999999999999999999998754432110 0000 111101112223334
Q ss_pred HHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 269 AKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
+.++.+++.+||..+|++||+ +.++++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 678999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=291.00 Aligned_cols=279 Identities=20% Similarity=0.260 Sum_probs=238.9
Q ss_pred HhhhcCCCcceeCHHHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC
Q 047701 5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT 78 (356)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 78 (356)
.++.+.+...|.....+...++++...+-+|.||.||+|.| .+.+.|.+|.++...++.....++.|.-.+..+
T Consensus 265 ~~~~p~e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~ 344 (563)
T KOG1024|consen 265 YEHEPEEFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA 344 (563)
T ss_pred ccCChHHHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC
Confidence 34445556667788899999999999999999999999954 346678899998887778888899999999999
Q ss_pred CCCCeeeEeeeEEc-CCeeeEEEEecCCCCHhHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeec
Q 047701 79 YHINLVRLHGFCHD-QHMTALVYEYMENGSLDGYLFG-------KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150 (356)
Q Consensus 79 ~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 150 (356)
.|||+..+.+++.+ ....+.++.++.-|+|..|+.. ..+.++-.+...++.|++.|++|||+ .++||.|
T Consensus 345 sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkD 421 (563)
T KOG1024|consen 345 SHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKD 421 (563)
T ss_pred cCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccch
Confidence 99999999999865 4567888999999999999962 23568889999999999999999999 9999999
Q ss_pred cCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCcccc
Q 047701 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIV 230 (356)
Q Consensus 151 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~ 230 (356)
|.++|++|++..++||+|=.+++..-..+.+.-..+.-.+..||+||.++.. .|+.++||||||++||||+|-..
T Consensus 422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~---- 496 (563)
T KOG1024|consen 422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGK---- 496 (563)
T ss_pred hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCC----
Confidence 9999999999999999999999876555554443444457789999999988 79999999999999999998442
Q ss_pred CCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 231 GASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.++.+.++.++..++.++.+...+-+|+.+++.+|..||...|++||++++++..|.+...
T Consensus 497 -----------~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 497 -----------LPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred -----------CCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2245666778888999999999999999999999999999999999999999999987643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.51 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=199.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3667889999999999999875 58899999986532 223446788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCCCCC
Q 047701 103 MENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 103 ~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~~~ 180 (356)
+.+++|.+++.... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999985433 358999999999999999999999 9999999999999998875 469999999876654322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. .....|++.|+|||+..+. .++.++|+||||+++|++++|..|+...... ..... .....
T Consensus 158 ~--~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~----------~~~~~ 218 (257)
T cd08225 158 L--AYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK----------ICQGY 218 (257)
T ss_pred c--ccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH----------Hhccc
Confidence 1 1224588999999998876 6899999999999999999999886432110 11110 01111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........+.++.+++.+||..+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 222233455679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.84 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=199.4
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
+...+.||+|+||.||+|.. .++..||||.+..... ....|++.+++++||||+++++++.+....++||||++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 34456899999999999986 4789999999864321 11245888999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+|+|.+++. .++|..+.+++.|+++||+|||..+..+++||||||+||+++.++..++. ||........
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------ 835 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------ 835 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------
Confidence 999999994 48999999999999999999996444899999999999999998888775 6655432211
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC--CC
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG--IE 262 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 262 (356)
....||+.|+|||++.+. .++.++|||||||++|||++|+.|+...... ......+....+........++... ..
T Consensus 836 ~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCC
Confidence 123578999999999877 7999999999999999999999997433222 1222333322222222222222211 11
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........++.+++.+||+.||++||+|.+|++.|+++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2234556778999999999999999999999999998755
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.15 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=196.7
Q ss_pred cccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 28 YSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 28 ~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
...+||+|+||.||+|... +++.||+|.+..... .....+.+|+.++..++||||+++++++..+...++|+||++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3457999999999999764 689999999865432 33456889999999999999999999999999999999999999
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecC
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 186 (356)
+|..++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ...
T Consensus 104 ~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~ 176 (297)
T cd06659 104 ALTDIVS--QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS 176 (297)
T ss_pred CHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence 9999873 3568999999999999999999999 99999999999999999999999999998755432211 123
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhH
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (356)
..|+..|+|||++.+. .++.++||||||+++|+|++|..|+....... .......... .......
T Consensus 177 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~-------~~~~~~~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPP-------PKLKNAH 241 (297)
T ss_pred eecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCC-------CCccccC
Confidence 4588999999999876 68999999999999999999999875332210 0001110000 0011122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 267 ~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+..+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 345678899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.21 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=192.0
Q ss_pred ccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc---------------
Q 047701 29 STRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--------------- 92 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------------- 92 (356)
.+.||+||||.||+++++ +|+.||||.+.-.........+.+|+.++.+|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 467999999999999886 8999999999876556667889999999999999999999875310
Q ss_pred --------------------------------------------------------------------------------
Q 047701 93 -------------------------------------------------------------------------------- 92 (356)
Q Consensus 93 -------------------------------------------------------------------------------- 92 (356)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 047701 93 ----------------Q--------HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148 (356)
Q Consensus 93 ----------------~--------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 148 (356)
. ..+||-||||+..+|.+++..+...-.....++++++|++||+|+|+ +|+||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---Cceee
Confidence 0 12467899999877777774332222578899999999999999999 99999
Q ss_pred eccCccceEEcCCCceEEeccCCccccC----------------CCCCceeecCCCCCCCCCCcccccCCC--CCCCCCc
Q 047701 149 YDIKPENVLLDANFSPKVADFGLAKLCD----------------RNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCD 210 (356)
Q Consensus 149 ~Dlkp~Nill~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~D 210 (356)
|||||.||+++++..|||+|||+|+... ........++.+||.-|+|||++.+.. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999999721 011111345678999999999998775 5999999
Q ss_pred eehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch---hHHHHHHHHHHHHhhcCCCCCCC
Q 047701 211 VYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK---DKEKAKQLCMVALWCVQDSPADR 287 (356)
Q Consensus 211 v~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~p~~R 287 (356)
+||||+||+||+-- | -..+.+..+..-++.+..+.. ..+..+.-..+|.++++.||++|
T Consensus 801 mYSLGIVlFEM~yP---F---------------~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLYP---F---------------GTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hHHHHHHHHHHhcc---C---------------CchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 99999999999842 1 112222222223333333333 44556677899999999999999
Q ss_pred CCHHHHHH
Q 047701 288 PPMSAVVK 295 (356)
Q Consensus 288 ps~~~v~~ 295 (356)
||+.++++
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999986
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.69 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=197.4
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|+..+.||.|+||.||+|... +++.||||.+.... .......+..|++++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 567789999999999999764 68999999987542 2233357889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
. ++|..++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 6 5898888543 4578999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhhchhh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKSELGA 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 254 (356)
.....++..|+|||++.+...++.++||||||+++|+|++|+.|+..+....... .....|..........
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 1233468899999998776457889999999999999999998875432211000 0000000000000000
Q ss_pred hHhh----cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILA----CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... .......+..+.++.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 0000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=293.56 Aligned_cols=257 Identities=20% Similarity=0.212 Sum_probs=203.9
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecc-cCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
+....|+..++||+||-+.||++...+.+.+|+|.+.. ........-|..|+..|.+| .|.+||+++++-...+++||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34567888899999999999999987778888887653 33456667899999999999 58999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||-+ .+|..+|.+....+..-.+..+..||+.++.++|. .||||.||||.|+|+-+ |.+||+|||.|..+...
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 999874 49999997776666645889999999999999999 99999999999999954 59999999999988877
Q ss_pred CCceeecCCCCCCCCCCcccccCC----------CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
.+.......+||.-||+||++... -..++++||||||||||+|+-|++||..- ...|..
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------~n~~aK-- 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------INQIAK-- 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------HHHHHH--
Confidence 766666778999999999998532 12678999999999999999999986211 011222
Q ss_pred hhchhhhHhhcCCCchh-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 249 KSELGAMILACGIEEKD-KEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+..+.+.....+.+ .....++.++++.||..||.+||+..++++.
T Consensus 582 ---l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22222221111111 1112339999999999999999999999973
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=279.63 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=204.8
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeEEEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTALVYE 101 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 101 (356)
|...+.||+|++|.||+|... +++.|++|++..... ......+.+|+..+++++||||+++++++... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 566789999999999999875 689999999875432 24456788999999999999999999999988 88999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++.... .+++..+..++.|++.+|+|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999995443 89999999999999999999999 99999999999999999999999999998877655432
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.......++..|+|||.+.+. ..+.++||||||+++++|++|..|+...... ....+. .......
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---------~~~~~~~ 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYK---------IGSSGEP 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHh---------ccccCCC
Confidence 112335588899999999877 5899999999999999999999887543310 000111 0111112
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+..+.+++.+|+..||++||++.++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2334445788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=281.48 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=204.4
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|.+.+.||.|+||.||++.+. ++..|++|++.... .......+..|++++++++|||++++++.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 667789999999999999874 68999999987543 2355567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 104 ENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 104 ~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 999999999654 4789999999999999999999999 9999999999999999999999999999987654431
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
......|++.|+|||...+. .++.++|+||+|+++++|++|..|+...... .+........
T Consensus 159 --~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~~ 219 (258)
T cd08215 159 --LAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLL----------------ELALKILKGQ 219 (258)
T ss_pred --eecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHH----------------HHHHHHhcCC
Confidence 12234688899999998877 6899999999999999999999886433211 0111111111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+...+.++.+++.+||..+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222333556789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=285.30 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=195.4
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcC-----Cee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQ-----HMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~ 96 (356)
..|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.++.++ +|||++++++++... ...
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 4677788999999999999976 468899999986532 2345677899999998 799999999998753 357
Q ss_pred eEEEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 97 ALVYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 999999999999998853 34678999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCC----CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNY----PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
........ .....|+..|+|||++.... .++.++||||||+++|+|++|+.|+....... . ......
T Consensus 177 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~-~~~~~~ 247 (291)
T cd06639 177 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------T-LFKIPR 247 (291)
T ss_pred hccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------H-HHHHhc
Confidence 65432211 12345888999999976432 36889999999999999999998874322110 0 000100
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.... ...........+.+++.+||+.+|++||++.++++.
T Consensus 248 ~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 248 NPPP-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCC-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 001122344679999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=294.80 Aligned_cols=268 Identities=22% Similarity=0.251 Sum_probs=198.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcC--Ceee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQ--HMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~ 97 (356)
...|.+.+.||+|+||.||+|.+. +++.+|||.+.... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 346778899999999999999864 68899999886431 223345677899999999 999999999998653 4679
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+ +|..++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999974 999888543 78999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc---eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHH
Q 047701 178 NRSH---VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEE 246 (356)
Q Consensus 178 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~ 246 (356)
.... .......|+..|+|||++.+...++.++||||||+++|+|++|+.|+......... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 3321 12234568999999999876556889999999999999999999887432211100 000000011
Q ss_pred HhhhchhhhHh---hc---CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 247 YEKSELGAMIL---AC---GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 247 ~~~~~~~~~~~---~~---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+.......+.. .. ......+..+.++.+++.+||+.||++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 10000000110 00 0011122246789999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.65 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=198.0
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 99 (356)
..|+..+.||+|+||.||+|.+. +|+.||+|.+...... .....+.+|+.++++++|+||+++++++.+. +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 35778899999999999999864 6899999998744221 2223466799999999999999999998765 568999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+.+ +|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999965 8988886656789999999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc-hh-------HHHHHHHhhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW-FP-------KYVWEEYEKSE 251 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~ 251 (356)
.. .....++..|+|||.+.+...++.++||||||+++|+|++|..|+........-. .. ...|.......
T Consensus 163 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 KP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred CC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 1223457889999998765568999999999999999999998875332211000 00 00000000000
Q ss_pred h-hhhHhhcC----CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 252 L-GAMILACG----IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 252 ~-~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
. ........ ........+..+.+++.+|++.||++||++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00000000 000111236678899999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=310.37 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=222.2
Q ss_pred HhhccccccCcCCceEEEEEEc-CC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
......++||+|+||+||+|.| +. .-+||||++...........++.|+-+|.+++|||+++++|+|.... +.|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3344467899999999999976 33 34799999887766666788999999999999999999999998765 789
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|++|++.|+|.++++.+...+..+..+.|..|||+||.|||+ +.++||||.++||||.....+|+.|||+++.....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999999999999999999999999999999999 99999999999999999999999999999988766
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC-CccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR-RNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.........+-.+.|||-|.+... .++.++|||||||++||++|-. .| +......++..++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~P----------------y~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKP----------------YDGIPAEEIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCc----------------cCCCCHHHhhHHHh
Confidence 555554555556789999999877 7999999999999999999843 33 33444556667777
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+.+...++.++.++..++.+||..|+..||+|+++...+.+...
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 777788889999999999999999999999999999988776543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=310.05 Aligned_cols=267 Identities=19% Similarity=0.265 Sum_probs=187.2
Q ss_pred HHhhccccccCcCCceEEEEEEcC--CCcEEEEEEe--------------ccc--CchhHHHHHHHHHHHHhcCCCCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP--NGVKIAVKVL--------------NKN--LGKIAEEQFMAEVGTIGRTYHINLV 84 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~--------------~~~--~~~~~~~~~~~e~~~l~~l~h~niv 84 (356)
...|++.++||+|+||+||++... .+...++|.+ .+. ........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 357888999999999999998653 2222222211 110 1123345678999999999999999
Q ss_pred eEeeeEEcCCeeeEEEEecCCCCHhHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC
Q 047701 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGK----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 160 (356)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 160 (356)
++++++.+....|+|++++.+ +|..++... ........+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 999999999999999999954 777766432 2234567788999999999999999 99999999999999999
Q ss_pred CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCC-ccccch
Q 047701 161 NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS-ESLDWF 239 (356)
Q Consensus 161 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~-~~~~~~ 239 (356)
++.+||+|||+++.+...... ......||..|+|||++.+. .++.++|||||||++|||++|+.++..... .....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999876543322 12335699999999999887 699999999999999999998764432221 111000
Q ss_pred hHHHH------HHHhh--hchhhhHhhcCC-------Cch--hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 PKYVW------EEYEK--SELGAMILACGI-------EEK--DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 ~~~~~------~~~~~--~~~~~~~~~~~~-------~~~--~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ..+.. ..+...+..... ... ....+..+.+++.+|++.||.+||++.|++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 00000 000111100000 000 0112356788899999999999999999987
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.82 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=204.2
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.++||+|+||.||++.. .+++.+|+|.+.... .......+..|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 367788999999999999975 468899999987532 334456778899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 103 MENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 103 ~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+++++|..++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988542 3578999999999999999999999 999999999999999999999999999998765441
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....|+..|++||.+.+. .++.++|+||||+++|+|++|..|+...... .........
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~ 216 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------DLRYKVQRG 216 (256)
T ss_pred ----cccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcC
Confidence 1224578899999999876 6889999999999999999999887432211 011111222
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.........+.++.+++.+|+..+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2333445677889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.44 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=198.7
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEec---ccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe--eeE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLN---KNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM--TAL 98 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~l 98 (356)
..+|..+||+|+|-+||+|.+. +|-+||.-.++ .........+|..|+.+|+.|+||||+++++.+.+... .-+
T Consensus 41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 4456789999999999999763 58888865443 22344555889999999999999999999999987554 778
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~ 177 (356)
|+|++..|+|..|+. +-+.++...+.+|++||+.||.|||+.. .+|+|||||-+||+|+. .|.|||+|+|||.....
T Consensus 121 iTEL~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 121 ITELFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeecccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999999994 4567899999999999999999999843 58999999999999975 58999999999998775
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... .+.|||.|||||.+.. .|.+..||||||+.++||+|+..|.. +......+.+.+.
T Consensus 199 s~ak----svIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYs---------------EC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 199 SHAK----SVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYS---------------ECTNPAQIYKKVT 257 (632)
T ss_pred cccc----eeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChh---------------hhCCHHHHHHHHH
Confidence 5433 3679999999999984 59999999999999999999998752 2222333333344
Q ss_pred hcCCCchhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACGIEEKDKE-KAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+..+..... -.+++.++|.+|+.. ..+|||+.|+++
T Consensus 258 SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 258 SGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 3332222111 136799999999999 999999999997
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=285.65 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=201.3
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|.+.+.||+|+||.||++.. .+++.||+|.+..... .....+..|+.++++++||||+++++++...+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 35788889999999999999975 4688999999864322 344678889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999999999843 357899999999999999999999 99999999999999999999999999988765433221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....|++.|++||.+.+. .++.++|+||||+++|++++|..|+.......... .... .....
T Consensus 172 --~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~--------~~~~~ 234 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPE 234 (293)
T ss_pred --cccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--------CCCCC
Confidence 1234588899999998776 68999999999999999999999885432211100 0000 00001
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......+..+.+++.+||..+|++||++.+++..
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=284.46 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=197.4
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
+...+.||+|++|.||++.. .+++.+++|++.... ......+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 33457899999999999975 468999999886432 2334568899999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... .
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~ 172 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--R 172 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--c
Confidence 9999999854 568999999999999999999999 99999999999999999999999999988755432211 1
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....|+..|+|||.+.+. .++.++||||||+++|+|++|..|+...... .......... ......
T Consensus 173 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~~~~~~~-------~~~~~~ 237 (285)
T cd06648 173 KSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMKRIRDNL-------PPKLKN 237 (285)
T ss_pred ccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHhcC-------CCCCcc
Confidence 234588999999999876 6899999999999999999999887432211 0001111100 001111
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+..+.+++.+||..+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2225578999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=285.94 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=197.4
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|.+.+.||+|+||.||+|... +++.|+||.+.............+|+..+.+++ |||++++++++.++...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 467889999999999999875 588999999876544334445567999999998 999999999999999999999999
Q ss_pred CCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++|.+++.... ..+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 779988885543 578999999999999999999999 99999999999999999999999999998765443221
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHHh-hhchh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEYE-KSELG 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~ 253 (356)
....++..|+|||++.+...++.++|+||||+++++|++|..|+......... ......|.... .....
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 23457889999999866556899999999999999999998776433211000 00000000000 00000
Q ss_pred hhHhhcC----CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACG----IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....... ........+..+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 00111122467999999999999999999999985
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=288.48 Aligned_cols=267 Identities=23% Similarity=0.283 Sum_probs=195.1
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC--------
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-------- 94 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 94 (356)
.|+..++||+|+||.||+|... +++.||||.+..... ......+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 5788899999999999999764 689999998864322 222345678999999999999999999987654
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+.+ +|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 34999999965 8888886666679999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHH
Q 047701 175 CDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVW 244 (356)
Q Consensus 175 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~ 244 (356)
....... .......++..|+|||.+.+...++.++||||||+++|+|++|..|+.......... .+...+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6543221 112334578899999998766457889999999999999999998775433211000 000000
Q ss_pred HHHhhhchhhh-HhhcCCCch------hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 245 EEYEKSELGAM-ILACGIEEK------DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 245 ~~~~~~~~~~~-~~~~~~~~~------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........... ......... .......+.+++.+||..||.+||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 000000000 0012345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=286.19 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=197.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
..+|...+.||+|+||.||+|... +++.+|+|.+... .......++..|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344666788999999999999864 5889999998642 2223445788899999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+. |+|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99996 58888776666778999999999999999999999 99999999999999999999999999998754422
Q ss_pred CceeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
....|+..|+|||.+.+ ...++.++||||||+++|+|++|..|+....... ... ....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~--------~~~~ 228 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY--------HIAQ 228 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHH--------HHhh
Confidence 22457889999999752 2257889999999999999999998863221100 000 0000
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
...........+..+.+++.+||..+|.+||++.++++...
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11111122345677999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.47 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=197.5
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|+..+.||.|++|.||+|.+. +|+.||+|++..+.. ......+..|+.++++++|||++++++++.++...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456788999999999999764 699999999875432 223356788999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 58999885443 468999999999999999999999 99999999999999999999999999998765432211
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHhhh-chh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYEKS-ELG 253 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~ 253 (356)
.....++..|+|||++.+...++.++|+||||+++|+|++|..|+.......... .....|...... ...
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 1223468899999998765457889999999999999999998875433211000 000000000000 000
Q ss_pred hhHhh---cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILA---CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ..........+..+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0001112234467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=288.64 Aligned_cols=266 Identities=22% Similarity=0.253 Sum_probs=198.7
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----- 94 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 94 (356)
.-..|.+.+.||+|+||.||+|..+ +++.||+|++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3456788899999999999999875 58999999987542 2233356778999999999999999999987654
Q ss_pred -----eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEecc
Q 047701 95 -----MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169 (356)
Q Consensus 95 -----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 169 (356)
..++|+||+++ +|..++......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999976 7777776556679999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
|++......... ......++..|+|||.+.+...++.++||||||+++|+|++|++|+........ +. ........
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~-~~~~~~~~ 236 (302)
T cd07864 161 GLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LE-LISRLCGS 236 (302)
T ss_pred cccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHHHhCC
Confidence 999876543321 112234677899999887654678999999999999999999988753322100 00 00000000
Q ss_pred hc------hhhh-----Hhh-----cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SE------LGAM-----ILA-----CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~------~~~~-----~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. +... .+. ..........+..+.+++.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 000 0000111124577999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=287.04 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=197.0
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (356)
-..|.+.++||+|+||.||+|.+. +++.||||.+...........+..|+.++.+. .||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 345778899999999999999875 48999999997654334445667788777776 4999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+. ++|.+++......+++..+..++.|++.||+|||+ ..+++||||+|+||++++++.++|+|||++........
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9985 48888876656689999999999999999999996 14899999999999999999999999999876543322
Q ss_pred ceeecCCCCCCCCCCcccccCC---CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 181 HVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
. ....++..|+|||.+.+. ..++.++||||||+++|+|++|+.|+...... .+... ....
T Consensus 171 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~~~~~-----~~~~ 233 (296)
T cd06618 171 K---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------FEVLT-----KILQ 233 (296)
T ss_pred c---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------HHHHH-----HHhc
Confidence 2 223478899999998754 24788999999999999999999887432111 00000 0000
Q ss_pred hc-CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 AC-GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.. ........++.++.+++.+||+.||.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0011111346679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=287.99 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=194.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCe-----e
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHM-----T 96 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~ 96 (356)
+|+..+.||+|+||.||+|.+. +++.||||.+..... ......+.+|+.+++.+. ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4677889999999999999864 689999999865432 123356788999999994 6999999999987655 7
Q ss_pred eEEEEecCCCCHhHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCC
Q 047701 97 ALVYEYMENGSLDGYLFGK----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGL 171 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGl 171 (356)
|+||||+++ +|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+||+++. ++.++|+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999976 888887533 2468999999999999999999999 99999999999999998 88999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh-
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS- 250 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~- 250 (356)
+......... .....+++.|+|||++.+...++.++||||||+++|+|++|..|+.......... . ........
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~--~-~~~~~~~~~ 232 (295)
T cd07837 158 GRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL--H-IFKLLGTPT 232 (295)
T ss_pred ceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--H-HHHHhCCCC
Confidence 8765432211 1223468889999998765467999999999999999999998875432211000 0 00000000
Q ss_pred -c-------hhhhHh-hc----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 -E-------LGAMIL-AC----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 -~-------~~~~~~-~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ...... .. ......+..+.++.+++.+||..||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000000 00 000111235677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=291.29 Aligned_cols=268 Identities=19% Similarity=0.259 Sum_probs=199.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 97 (356)
..|.+.+.||+|+||.||+|... +++.||+|++..... ......+..|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 46777889999999999999764 699999999875422 2334567789999999999999999998753 35679
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+. ++|..++. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 85 lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999995 58998884 34569999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHH
Q 047701 178 NRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEY 247 (356)
Q Consensus 178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~ 247 (356)
.... .......|+..|+|||.+.+...++.++||||||+++|+|++|+.|+......... ..+...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 3221 11233568899999999876546899999999999999999999987443221100 0000001111
Q ss_pred hhhchhhhHhhcC-C-----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILACG-I-----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~~-~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
............. . ....+..+.++.+++.+||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111111100 0 01123356789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.39 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=197.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc----CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--Ceee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN----LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 97 (356)
.|.+.+.||+|+||.||+|.+. +++.||+|.+... ........+.+|+.++++++|+||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 4678899999999999999864 6899999987532 1223446788999999999999999999998764 4678
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+++||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....
T Consensus 83 ~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 999999999999998543 458999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCC-ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRS-HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
... ........|+..|+|||++.+. .++.++|+||||+++|+|++|+.|+..... .. ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~-----~~~~~~ 222 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEA----------MA-----AIFKIA 222 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCH----------HH-----HHHHHH
Confidence 211 1112234588999999999876 689999999999999999999988742211 00 011111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+...+.++.+++.+||. +|..||+..+++.
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111233455677889999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=282.36 Aligned_cols=244 Identities=27% Similarity=0.342 Sum_probs=192.6
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||+|+||+||+|... +++.||+|.+.... .......+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 68999999987532 122344567899999999999999999999999999999999999999
Q ss_pred hHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCC
Q 047701 109 DGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187 (356)
Q Consensus 109 ~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 187 (356)
.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence 99986543 468999999999999999999999 9999999999999999999999999999876543221 1234
Q ss_pred CCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHH
Q 047701 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267 (356)
Q Consensus 188 ~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (356)
.++..|+|||++.+. .++.++||||||+++|+|++|+.|+........ ....... ... .....+..
T Consensus 155 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~-----~~~-~~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------KEELKRR-----TLE-MAVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------HHHHHhc-----ccc-ccccCCcc
Confidence 578899999999877 589999999999999999999998744332110 0000000 000 01122234
Q ss_pred HHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 268 KAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 268 ~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
.+..+.+++.+||+.||.+|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 467899999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.71 Aligned_cols=243 Identities=22% Similarity=0.270 Sum_probs=188.4
Q ss_pred ccCcCCceEEEEEEcC-CCcEEEEEEecccCch--hHHHHHHHH---HHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK--IAEEQFMAE---VGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.||+|+||.||+|... +++.||+|.+.+.... .....+..| ...++...||||+.+++++......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 5889999998754211 111223333 334455689999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
|++|..++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC----
Confidence 999999884 44679999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....|+..|+|||++.+...++.++||||+|+++|+|++|..|+.......... ..... .......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-------------~~~~~-~~~~~~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-------------IDRMT-LTMAVEL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-------------HHHHh-hccCCCC
Confidence 224589999999999765468899999999999999999999875432211100 00000 0011122
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
+...+.++.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 333467899999999999999999 8889885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=280.82 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=195.8
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||+|+||.||++.+. +++.+++|++..... ......+..|++++++++||||+++++.+..+...|+++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999875 499999999875422 23456788899999999999999999999999999999999999999
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC------ce
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS------HV 182 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~------~~ 182 (356)
.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999543 478999999999999999999999 9999999999999999999999999999876543321 11
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
......++..|++||...+. ..+.++||||||+++|++++|..|+...... ........ . ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~---------~-~~ 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILN---------G-KI 218 (265)
T ss_pred cccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhc---------C-Cc
Confidence 22334578899999999876 5889999999999999999999887433211 00111100 0 01
Q ss_pred chhHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 263 EKDKE--KAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 263 ~~~~~--~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..+.. .+..+.+++.+||+.+|.+||++..+.+.|.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11112 3678999999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=268.31 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=203.5
Q ss_pred ccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 27 NYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.+...||+|..|+|++++.. +|...|||.+.++.......+++.+++++.+-+ +|+||+.+|+|..+..+++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34567999999999999864 699999999998777777788999999988875 9999999999999999999999995
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
. .++.++..-.+++++.-+-++...++.||.||-+ +++++|||+||+|||+|+.|++||||||.+.++.+...+.
T Consensus 175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht-- 249 (391)
T KOG0983|consen 175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT-- 249 (391)
T ss_pred H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc--
Confidence 4 7778886667889999999999999999999998 4799999999999999999999999999998877655443
Q ss_pred cCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC-C
Q 047701 185 SGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG-I 261 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 261 (356)
...|-+.|||||.+.- ...|..++||||||++++||.||+.|+.....+... . ...+.+.. .
T Consensus 250 -rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~------l--------tkvln~ePP~ 314 (391)
T KOG0983|consen 250 -RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV------L--------TKVLNEEPPL 314 (391)
T ss_pred -cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH------H--------HHHHhcCCCC
Confidence 2447889999999863 346889999999999999999999987554333111 1 11111110 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......++.+.+++..||..|+.+||.+.++++.
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11122367889999999999999999999999873
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=284.68 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=201.5
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|...+.||+|++|.||+|... +++.+++|.+...... .....+..|+.++++++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 355678999999999999874 6899999998754322 34567888999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+ +|..++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 8888886666789999999999999999999999 999999999999999999999999999987765443 11
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch--------hHHHHHHHhh---hch
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF--------PKYVWEEYEK---SEL 252 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~ 252 (356)
.....++..|+|||.+.+...++.++|+||||+++|+|++|+.++........-.. ....|..... ...
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 22345788999999987664689999999999999999999877643322110000 0000000000 000
Q ss_pred hhhHh--hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMIL--ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ...........+.++.+++.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 00011123346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=284.49 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=194.6
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+...++||+|+||+||+|... +++.|++|.+.... .......+..|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455678999999999999864 68999999986432 223345688899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+. ++|.+++......+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 58888886666789999999999999999999999 9999999999999999999999999999864321
Q ss_pred eecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 183 TISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....|+..|+|||++.. ...++.++||||||+++|+|++|..|+........ .... .....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~---------~~~~~ 237 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHI---------AQNDS 237 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH---------HhcCC
Confidence 123468889999999852 23578899999999999999999988643322100 0000 00000
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........+..+.+++.+||+.+|.+||++.+++..
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122344568999999999999999999999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=287.40 Aligned_cols=249 Identities=25% Similarity=0.304 Sum_probs=205.7
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
...++...++||+||||.||-+.. .+|+-+|.|.+.+.. ......-.+.|-.+|.+++.+.||.+--.+.....++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 344556678899999999999965 479999999876442 12233446789999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
|+..|+||+|.-+|.+.+ ..+++..+..++.+|+.||++||+ .+||+|||||+|||+|+.|+++|+|.|||..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999998886554 579999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... .+.+||.+|||||+++.. .|+...|-|||||++|||+.|..||.. -.+..+..++.+.+.
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~------------~KeKvk~eEvdrr~~ 403 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQ------------RKEKVKREEVDRRTL 403 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhh------------hhhhhhHHHHHHHHh
Confidence 6543 345899999999999988 599999999999999999999988722 123333444444444
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
.. ..+.+...++++.++....|..||.+|--.
T Consensus 404 ~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 ED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cc-hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 33 234556778899999999999999999543
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.01 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=202.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.+.||+|++|.||++... +++.|++|.+..... ......+.+|++++.+++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667899999999999999764 588999999876532 24556789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++... ..+++..+..++.|++.+|.|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998544 679999999999999999999999 99999999999999999999999999999876544332
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
.....++..|+|||...+. ..+.++||||||+++|+|++|..|+...... ...+... .....
T Consensus 156 -~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~----------~~~~~ 217 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIV----------QDDHP 217 (254)
T ss_pred -ccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh----------ccCCC
Confidence 1234578899999998877 5889999999999999999999886422210 0001100 01112
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+...+..+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 233345678999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.30 Aligned_cols=262 Identities=21% Similarity=0.217 Sum_probs=195.8
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------C
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------H 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 94 (356)
...|...+.||+|+||.||+|.. .+++.||||.+.+.. .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 45688889999999999999976 468999999986532 223445677899999999999999999988643 3
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..|+||||+.+ +|...+... ++...+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 56999999965 888877432 8999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHH
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEE 246 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~ 246 (356)
...... .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.|+......... ..+......
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 168 AGTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCCCCC---CCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 543322 1234578899999999877 7899999999999999999999887543211000 000000000
Q ss_pred HhhhchhhhHhhcC-------------------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 247 YEKSELGAMILACG-------------------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 247 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.. ........... ........+..+.+++.+||+.||++||++.+++..
T Consensus 244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQ-PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hh-hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000000 000012345678999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=292.41 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=210.1
Q ss_pred HHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCch-hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK-IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
+.....|.+.+.||+|.|+.|.+|++ .++..||||.+.+.... .....+.+|+++|+.|+|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 33444677789999999999999976 46999999999876433 33356889999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+|.+.+++.++ +++.+..+..++.|+..|++|||+ ++++|||||++|+|++.+.++||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999999655 455559999999999999999999 9999999999999999999999999999988774
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.. .....+|++.|.|||++++....+..+|+||+|+++|-|++|..||........+. ..+ .
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-----------rvl----~ 269 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-----------RVL----R 269 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-----------hhe----e
Confidence 33 23457899999999999998778899999999999999999999986554433221 000 0
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+....+.-.+.++.+++.+++-++|.+|++++++.+
T Consensus 270 --gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 --GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --eeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 011123334567889999999999999999999987
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.31 Aligned_cols=262 Identities=23% Similarity=0.277 Sum_probs=195.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|++.+.||+|++|+||+|.+. +++.||+|.+..... ......+..|+.++++++||||+++++++.++...++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4677889999999999999874 689999999865322 23345688899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCccccCCCCC
Q 047701 103 MENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 103 ~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~~~~ 180 (356)
+++ +|..++.... ..+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++........
T Consensus 83 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 83 LDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 964 7877774433 346888999999999999999999 99999999999999985 55799999999976543211
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh--c-------
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS--E------- 251 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~------- 251 (356)
......+++.|+|||++.+...++.++||||||+++|+|++|..|+........ ... ........ .
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTPNEETWPGVTS 233 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChhhcccccc
Confidence 112345788999999987654678999999999999999999988754322110 000 00000000 0
Q ss_pred hhhh--HhhcCC----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAM--ILACGI----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~--~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... ...... ....+..+.++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 0011234567899999999999999999999996
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=291.30 Aligned_cols=265 Identities=20% Similarity=0.251 Sum_probs=197.9
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Ceee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 97 (356)
.|...+.||+|+||+||+|.. .+++.||||.+.... .......+..|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 577788999999999999976 468999999987532 223345677899999999999999999988654 3479
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 86 IVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 9999995 68988884 44679999999999999999999999 9999999999999999999999999999986644
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHHhh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEYEK 249 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~~~ 249 (356)
... ......++..|+|||.+.+...++.++||||||+++|+|++|..|+......... ......+.....
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Ccc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 321 1223457889999999875435899999999999999999999887432210000 000000000011
Q ss_pred hchhhhHhhcC------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 250 SELGAMILACG------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 250 ~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+.... ........+.++.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 11111111000 011123456789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.50 Aligned_cols=245 Identities=24% Similarity=0.263 Sum_probs=189.7
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHH-hcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTI-GRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+.||+|+||.||+|... +++.||||++.+... ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999764 589999999875321 12223344454444 455899999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
++|.+++. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999984 34578999999999999999999999 9999999999999999999999999999875433 12
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...|+..|+|||.+.+. .++.++||||||+++|+|++|..|+...... ..+........ .......
T Consensus 152 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------~~~~~~~ 217 (260)
T cd05611 152 KFVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRI------NWPEEVK 217 (260)
T ss_pred cCCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhccc------CCCCccc
Confidence 34578899999999877 5899999999999999999999987433221 11111111110 0011122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
..++.++.+++.+||..||++||++..+.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 245678999999999999999998876665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=283.15 Aligned_cols=258 Identities=16% Similarity=0.144 Sum_probs=194.9
Q ss_pred cccccCcCCceEEEEEEcCCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 28 YSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 28 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+++.+|.|+++.||++.. +++.||||++... ........+..|+.++++++||||+++++++.+.+..+++|||+.++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 455566666666666655 7899999998764 34456678999999999999999999999999999999999999999
Q ss_pred CHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc----
Q 047701 107 SLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH---- 181 (356)
Q Consensus 107 sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~---- 181 (356)
+|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999653 4568999999999999999999999 99999999999999999999999999988755322211
Q ss_pred -eeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh---------
Q 047701 182 -VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS--------- 250 (356)
Q Consensus 182 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 250 (356)
.......++..|+|||++.+. ..++.++|+||||+++|+|++|..|+........ ..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM------LLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCccccccCc
Confidence 111234577889999998764 2578899999999999999999998754322110 00000000
Q ss_pred ------chh--------hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 ------ELG--------AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 ------~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... .................++.+++.+||..||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 000000011223345678999999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.81 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=196.3
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
++...+||+|+||.||++.. .+++.||||.+.... ......+.+|+.+++.++|+|++++++++..++..++||||++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 33457899999999999976 468999999886432 2345678899999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++. ...+++..+..++.|++.+|+|||+ .+++||||+|+||+++.++.++|+|||++......... .
T Consensus 101 ~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~ 173 (292)
T cd06657 101 GGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R 173 (292)
T ss_pred CCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--c
Confidence 999999873 3468999999999999999999999 99999999999999999999999999998765432211 1
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....|+..|++||.+.+. .++.++|+||||+++|+|++|..|+....... ........ . . .....
T Consensus 174 ~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-------~~~~~~~~-~-----~-~~~~~ 238 (292)
T cd06657 174 KSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-L-----P-PKLKN 238 (292)
T ss_pred cccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhh-C-----C-cccCC
Confidence 234588999999998766 68899999999999999999998874322110 00000000 0 0 00111
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+..+.+++.+||..+|.+||++.+++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2234567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=284.66 Aligned_cols=262 Identities=20% Similarity=0.258 Sum_probs=192.6
Q ss_pred cccCcC--CceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFG--GFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
..||+| +||+||++.+ .+++.||||++.... .....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999986 479999999987542 333446788899999999999999999999999999999999999
Q ss_pred CCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee-
Q 047701 106 GSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT- 183 (356)
Q Consensus 106 ~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~- 183 (356)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998643 3468999999999999999999999 9999999999999999999999999976543322111100
Q ss_pred ----ecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCcccc---------------chhHHH
Q 047701 184 ----ISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD---------------WFPKYV 243 (356)
Q Consensus 184 ----~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~---------------~~~~~~ 243 (356)
.....++..|+|||++.+. ..++.++||||||+++|+|++|..|+......... ..+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE- 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh-
Confidence 0112356679999998764 24789999999999999999999887433211000 00000
Q ss_pred HHHHhhh------chh----------hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 244 WEEYEKS------ELG----------AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 244 ~~~~~~~------~~~----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....... .+. ..............++..+.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000 000 000000111223456778999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.88 Aligned_cols=261 Identities=19% Similarity=0.202 Sum_probs=195.1
Q ss_pred ccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchh-------------HHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 27 NYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKI-------------AEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
.+.+.||+|+||+||+|.+. +++.||||.+....... ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 35678999999999999864 68999999986432211 01247789999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
....++||||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccce
Confidence 999999999996 58998884 44568999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCC------------ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh
Q 047701 173 KLCDRNRS------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP 240 (356)
Q Consensus 173 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~ 240 (356)
........ ........++..|+|||.+.+...++.++||||||+++|+|++|..|+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--- 243 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL--- 243 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 86652110 111123446888999999987645789999999999999999999887544321100
Q ss_pred HHHHHHHhhhc---hhhh--------H---hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 241 KYVWEEYEKSE---LGAM--------I---LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 241 ~~~~~~~~~~~---~~~~--------~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........... .... . ............+.++.+++.+||+.+|++||++++++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 00000000000 0000 0 000000111234567899999999999999999999997
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=280.44 Aligned_cols=267 Identities=26% Similarity=0.346 Sum_probs=199.9
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhc--CCCCCeeeEeeeEEcCC----ee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--TYHINLVRLHGFCHDQH----MT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~ 96 (356)
.-++.+.+.||+|.||.||+|.| .|+.||||++.. .++..+.+|.++++. |+|+||+.+++....++ .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 34677788999999999999999 889999999975 445678888888885 59999999999876543 57
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
+||++|.+.|||.|||.. ..++....++++..+|.||+|||.+. +..|.|||||..||||..+|.+.|+|+||
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 899999999999999943 78999999999999999999999742 45699999999999999999999999999
Q ss_pred ccccCCCCCc--eeecCCCCCCCCCCcccccCCCC-----CCCCCceehhhHHHHHHhcC----C------CccccCCCc
Q 047701 172 AKLCDRNRSH--VTISGYKGTPGYSAPEFLSGNYP-----ITHKCDVYSFGMVSFEIVGR----R------RNAIVGASE 234 (356)
Q Consensus 172 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~Dv~slG~il~ell~g----~------~~~~~~~~~ 234 (356)
|......... ......+||.+|||||++...-. .-..+||||||.++||+... . .|+. +-.+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy-d~Vp 441 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY-DVVP 441 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc-cCCC
Confidence 9877654322 22244679999999999864311 12469999999999998742 2 1221 1111
Q ss_pred cccchhHHHHHHHhhhchhhhHhhcC-CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 235 SLDWFPKYVWEEYEKSELGAMILACG-IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... .++.+..---.+.+.+.. ...........+.++|+.||..||..|-|+--|.+.|.++.+
T Consensus 442 ~DP-----s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDP-----SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCC-----CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 110 012222111111111110 111123456779999999999999999999999999988754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.31 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=195.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc----CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN----LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+|.+.++||+|+||.||++.+. .+..+++|++... .......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999764 3555666665432 1223344677899999999999999999999999999999
Q ss_pred EEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 100 YEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+||+.+++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998853 34679999999999999999999999 99999999999999975 579999999987664
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..|+..... ... ....
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------~~~------~~~~ 217 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------LSV------VLRI 217 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHH------HHHH
Confidence 33221 1234578899999998766 688899999999999999999987632211 000 0011
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+..++.++.+++.+||..+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112223334566778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=279.93 Aligned_cols=257 Identities=23% Similarity=0.257 Sum_probs=201.3
Q ss_pred hccccccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeee
Q 047701 26 SNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (356)
|++.+.||+|+||.||++.. .+++.||||++.+.. .......+..|+.++.++ +||||+++++++..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56788999999999999964 357889999986431 123345678899999999 6999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+++|.+++.. ...+++..+..++.|++++|.|||+ .+++||||+|+||+++.++.++|+|||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999853 3568999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCceeecCCCCCCCCCCcccccCCC-CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... .....|+..|+|||.+.+.. ..+.++||||||+++|+|++|..|+........ ...... .+
T Consensus 158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~-----~~ 224 (288)
T cd05583 158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-------QSEISR-----RI 224 (288)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-------HHHHHH-----HH
Confidence 32221 12345888999999987652 368899999999999999999988753322110 001100 01
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.. .....+...+..+.+++.+||+.||++|||+.++.+.|...
T Consensus 225 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 LK-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred Hc-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11 11223344567789999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=285.38 Aligned_cols=268 Identities=24% Similarity=0.269 Sum_probs=195.4
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-------- 93 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 93 (356)
..|.+.++||+|+||.||+|.+. +++.+|||.+..... ......+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 46778899999999999999864 689999999864422 12234567899999999999999999987543
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...++|+||+.+ +|...+......+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346899999965 7887776666789999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCce---------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch-----
Q 047701 174 LCDRNRSHV---------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF----- 239 (356)
Q Consensus 174 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~----- 239 (356)
......... ..+...|+..|+|||.+.+...++.++||||||+++|+|++|.+|+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 654322111 112345788899999987654688999999999999999999988743322110000
Q ss_pred ---hHHHHHHHhhhchhh--hHhhcCC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 ---PKYVWEEYEKSELGA--MILACGI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 ---~~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+..+....... ....... ..........+.+++.+|++.||.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000000000 0000000 0011123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.96 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=200.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (356)
.|.+.+.||+|+||.||+|... +++.||+|++.... .......+..|+.++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 4677899999999999999864 69999999987532 2233467888999999998 999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|++.+++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999954 3479999999999999999999999 9999999999999999999999999999886643321
Q ss_pred c------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH
Q 047701 181 H------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 181 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~ 242 (356)
. .......|+..|+|||++.+. ..+.++|+||||++++++++|+.|+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~ 229 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------L 229 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHH-------H
Confidence 1 112234578899999998876 6899999999999999999999887433210 0
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHH
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM----SAVVK 295 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~----~~v~~ 295 (356)
..... . ......+...+..+.+++.+||+.+|.+||++ .++++
T Consensus 230 ~~~~~--------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 TFQKI--------L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH--------H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 0 01122333446789999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.07 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=193.0
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcC---CCCCeeeEeeeEEcCCe-----
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRT---YHINLVRLHGFCHDQHM----- 95 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 95 (356)
|++.+.||+|+||.||+|.+. +++.||+|++..... ......+..|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999875 489999999974322 22234566677776655 69999999999988776
Q ss_pred eeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 96 TALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
.+++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8988885433 468999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh-----
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK----- 249 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~----- 249 (356)
....... ....++..|+|||++.+. .++.++|+||||+++|+|++|.+|+....... ..... ......
T Consensus 157 ~~~~~~~---~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~ 229 (287)
T cd07838 157 YSFEMAL---TSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKI-FDVIGLPSEEE 229 (287)
T ss_pred ccCCccc---ccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHH-HHHcCCCChHh
Confidence 6543221 223478899999999877 68999999999999999999987764322210 00000 000000
Q ss_pred ---hch--hhhHhh---cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 ---SEL--GAMILA---CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ---~~~--~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... ...... ..........+..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000 0011122345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.70 Aligned_cols=241 Identities=22% Similarity=0.246 Sum_probs=186.5
Q ss_pred hhcccccc--CcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRL--GFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~l--g~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.+.+.+.+ |+|+||.||++.. .++..+|+|.+....... .|......+ +||||+++++++...+..++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 44555555 9999999999976 468899999986532111 122222222 6999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~~ 179 (356)
||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 164 (267)
T PHA03390 89 DYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164 (267)
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence 999999999999544 489999999999999999999999 9999999999999999888 99999999987654322
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
...|+..|+|||++.+. .++.++||||||+++|+|++|..|+......... ...+... . .
T Consensus 165 ------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~-----~--~ 224 (267)
T PHA03390 165 ------CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD------LESLLKR-----Q--Q 224 (267)
T ss_pred ------cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh------HHHHHHh-----h--c
Confidence 23578999999999876 6899999999999999999999988633221110 1111110 0 0
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPP-MSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~ 295 (356)
.........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111223356778999999999999999996 688875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=278.33 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=195.9
Q ss_pred hccccccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeee
Q 047701 26 SNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (356)
|++.+.||+|+||.||+|.. .+|+.||+|++.... .......+..|+.++.++ +|+||+.+++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56788999999999999975 368899999987532 123345678899999999 6999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999854 4568999999999999999999999 9999999999999999999999999999886543
Q ss_pred CCCceeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... ......|+..|+|||.+.+. ..++.++||||||+++|+|++|..|+........ . ... ...+
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~-----~~~-----~~~~ 224 (290)
T cd05613 158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--Q-----AEI-----SRRI 224 (290)
T ss_pred cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--H-----HHH-----HHHh
Confidence 3221 11234588999999998753 2467899999999999999999988753222110 0 000 0001
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
.. .....+...+..+.+++.+||..||++|| ++.+++.
T Consensus 225 ~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 LK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 10 01122334567789999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=287.84 Aligned_cols=271 Identities=20% Similarity=0.251 Sum_probs=204.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----eee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-----MTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 97 (356)
+|.+.+.||+|+||.||+|... +++.||||.+..... ......+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4678899999999999999875 589999999876432 344567889999999999999999999998765 789
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
++|||+.+ +|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~~-~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999974 8988884 34489999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHHh
Q 047701 178 NRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEYE 248 (356)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~~ 248 (356)
.... .......++..|+|||++.+...++.++|+||||+++|+|++|..|+.......... .....+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 4311 112334578899999999876568999999999999999999998874433211000 0000000011
Q ss_pred hhchhhhHhhcC------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hhhc
Q 047701 249 KSELGAMILACG------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM--LEGV 300 (356)
Q Consensus 249 ~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~~ 300 (356)
.......+.... ........+.++.+++.+||+.+|.+||++.+++.. +.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 111111111000 001122346779999999999999999999999983 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=281.99 Aligned_cols=263 Identities=22% Similarity=0.259 Sum_probs=196.3
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 99 (356)
...|.+.+.||.|+||.||+|... +++.||||.+.... .......+..|+.++++++||||+++++++.. ....+++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 446778899999999999999754 79999999886432 22344678889999999999999999999865 5678899
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
+||+ +++|..++. ...++...+..++.|+++||.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 89 ~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 89 TELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred eehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 9999 568988884 3467888999999999999999999 999999999999999999999999999987543221
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHHhhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEYEKSE 251 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 251 (356)
....++..|+|||++.+...++.++||||||+++|+|++|..|+......... ..+...........
T Consensus 163 -----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 163 -----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred -----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 23457889999999876446899999999999999999999887433221000 00000000000111
Q ss_pred hhhhHhhcCC-C-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 252 LGAMILACGI-E-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 252 ~~~~~~~~~~-~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......... . ......+.++.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111000 0 1112345789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=284.48 Aligned_cols=266 Identities=21% Similarity=0.230 Sum_probs=194.2
Q ss_pred hhccccccCcCCceEEEEEEcC-C--CcEEEEEEecccCc-hhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcC----Ce
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-N--GVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQ----HM 95 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 95 (356)
.|++.+.||+|+||.||++... + +..||+|.+..... ......+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677889999999999999864 4 78999999875322 22345678899999999 599999999875432 45
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++++|+. ++|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 688899985 58998884 45678999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHH
Q 047701 176 DRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWE 245 (356)
Q Consensus 176 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~ 245 (356)
...... .......||..|+|||++.+...++.++|+||||+++|++++|..|+......... ..+...+.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 533221 11233568999999999876546899999999999999999999887543211000 00000011
Q ss_pred HHhhhchhhhHhhc---C---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 246 EYEKSELGAMILAC---G---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 246 ~~~~~~~~~~~~~~---~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.............. . .....+..+..+.+++.+|++.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111100010000 0 00011123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=270.87 Aligned_cols=247 Identities=26% Similarity=0.306 Sum_probs=204.7
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.+.|.++||+|.||.|.+++-+ +++.+|||++++.. .+....+-+.|-++|+..+||.+..+--.|..+..+|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 4667899999999999999754 79999999998762 34555677889999999999999999989999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|..||.|.-.| .+.+.+++.....+...|+.||.|||+ ++||+||||.+|.|+|++|.+||+||||++.-... .
T Consensus 249 yanGGeLf~HL-srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g 322 (516)
T KOG0690|consen 249 YANGGELFFHL-SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--G 322 (516)
T ss_pred EccCceEeeeh-hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc--c
Confidence 99999998888 566789999999999999999999999 99999999999999999999999999999854322 2
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....++||+.|+|||++... .|+.+.|.|.+||++|||++|+.||...+.. ++...+... -
T Consensus 323 ~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----------------kLFeLIl~e-d 384 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----------------KLFELILME-D 384 (516)
T ss_pred ceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchh----------------HHHHHHHhh-h
Confidence 234568899999999999988 7999999999999999999999998543322 222222211 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
...+...+++...|+...+..||.+|. ++.||.+
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 224556778899999999999999994 3455544
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=276.54 Aligned_cols=264 Identities=24% Similarity=0.278 Sum_probs=199.8
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|++.+.||+|+||.||+|... +++.||+|++.... .......+..|+.++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999875 59999999997653 2233456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+ ++|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--
Confidence 7 59999996655679999999999999999999999 99999999999999999999999999998766543221
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHHhhhchhhh
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 255 (356)
.....++..|+|||.+.+...++.++||||||+++||+++|..|+........- ......|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 122345778999999876656899999999999999999998777443321000 000001111111000000
Q ss_pred Hhhc----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILAC----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... ......+..+..+.+++.+||..||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 000111223667999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.07 Aligned_cols=262 Identities=20% Similarity=0.234 Sum_probs=196.3
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------ 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 94 (356)
..+|...+.||+|+||.||+|.. .+++.||||.+.... .......+..|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 34677888999999999999975 469999999986532 2233456889999999999999999999987543
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 458999999 779998884 3568999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHH
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEE 246 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~ 246 (356)
..... ....++..|+|||.+.+...++.++|+||||+++|++++|..|+......... ..+......
T Consensus 168 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 54321 23457889999999876445889999999999999999999887533221000 000000011
Q ss_pred HhhhchhhhHhhcC------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 247 YEKSELGAMILACG------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 247 ~~~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.............. ........+.++.+++.+|++.||++||++.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111111111000 00111234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=285.17 Aligned_cols=266 Identities=20% Similarity=0.239 Sum_probs=195.4
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------e
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------M 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 95 (356)
..|...+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 35667789999999999999864 689999999875422 233456789999999999999999999987543 4
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++|+||+.. +|..++ +..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 5899999964 777765 3468999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~ 247 (356)
.... ....++..|+|||.+.+...++.++||||||+++|||++|+.|+........-. .........
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 3221 234578899999998764468899999999999999999999885432110000 000000000
Q ss_pred hhhchhhhHhhcC---C---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--Hhhhcc
Q 047701 248 EKSELGAMILACG---I---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK--MLEGVV 301 (356)
Q Consensus 248 ~~~~~~~~~~~~~---~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~ 301 (356)
............. . ....+..+.++.+++.+||+.||.+||++.+++. .++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000011111000 0 0011234567899999999999999999999996 355543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=284.43 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=196.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM------ 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 95 (356)
..|...+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++++.|||++++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 35777899999999999999874 58899999986532 22334567789999999999999999998876554
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 95 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6699998843 569999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc-c-------chhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL-D-------WFPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~-~-------~~~~~~~~~~ 247 (356)
... .....++..|+|||.+.+...++.++||||||+++|++++|+.|+........ . ..+...+..+
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 432 12345788999999987644678999999999999999999988753322100 0 0000001111
Q ss_pred hhhchhhhHhhcCC------CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 248 EKSELGAMILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 248 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.......++..... .......+.++.+++.+||..||.+|||+.+|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 11111111111000 0111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.25 Aligned_cols=237 Identities=30% Similarity=0.354 Sum_probs=192.4
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
||+|+||.||++... +++.+|+|++..... ......+..|+.++++++||||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999864 589999999876432 23456788999999999999999999999999999999999999999
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCC
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 188 (356)
.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 999953 3468999999999999999999999 9999999999999999999999999999877654321 123355
Q ss_pred CCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHH
Q 047701 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268 (356)
Q Consensus 189 gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (356)
++..|++||.+.+. ..+.++|+||||+++|++++|..|+...... .. ... +.. .....+...
T Consensus 155 ~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~-~~~---------~~~-~~~~~~~~~ 216 (250)
T cd05123 155 GTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EI-YEK---------ILK-DPLRFPEFL 216 (250)
T ss_pred CCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH-HHH---------Hhc-CCCCCCCCC
Confidence 78899999999876 5889999999999999999999887433210 00 000 000 111223334
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHH
Q 047701 269 AKQLCMVALWCVQDSPADRPPMSA 292 (356)
Q Consensus 269 ~~~l~~l~~~cl~~~p~~Rps~~~ 292 (356)
+..+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 677899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=285.54 Aligned_cols=264 Identities=21% Similarity=0.223 Sum_probs=193.4
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC---------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--------- 93 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 93 (356)
.+|.+.+.||.|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4677889999999999999976 4689999999865432 3446688899999999999999999876553
Q ss_pred -----CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-CCCceEEe
Q 047701 94 -----HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVA 167 (356)
Q Consensus 94 -----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~ 167 (356)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+ .+++||||||+||+++ +++.++|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 58988874 3468999999999999999999999 9999999999999997 45678999
Q ss_pred ccCCccccCCCCCce-eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch-------
Q 047701 168 DFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF------- 239 (356)
Q Consensus 168 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~------- 239 (356)
|||++.......... ......|+..|+|||.+.+...++.++|||||||++|+|++|+.|+...........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987654322111 112235788999999876544688999999999999999999998854322110000
Q ss_pred -hHHHHHHHhhhchhhhHh-hcCCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 -PKYVWEEYEKSELGAMIL-ACGIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.......... ....... ..... ......+.++.+++.+||..||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000 0000000 00000 011234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=281.29 Aligned_cols=262 Identities=19% Similarity=0.240 Sum_probs=194.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------Ce
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------HM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 95 (356)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 4677788999999999999975 578999999987542 223345678899999999999999999988643 34
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++++++ +++|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 97 ~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 97 VYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred EEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 67888887 779988874 3468999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc-c-------chhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL-D-------WFPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~-~-------~~~~~~~~~~ 247 (356)
... .....|+..|+|||.+.+...++.++||||||+++|+|++|+.|+........ . ..+.......
T Consensus 171 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 171 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 322 12345788999999987644688999999999999999999988743222100 0 0000001111
Q ss_pred hhhchhhhHhhc-CCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILAC-GIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~-~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......+.... ... ......+.++.+++.+|++.||.+||++.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 111000111000 000 0011235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=302.73 Aligned_cols=259 Identities=24% Similarity=0.254 Sum_probs=209.4
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
...+....|.+.++||+|+||.|..++.+ +++.||+|++++- ........|..|-++|..-+.+=|+.++-.|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34455667888999999999999999874 6999999999762 22345577899999999988999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
++|+|||||.||+|-.++.+.. .+++..+..++..|+-||.-||+ .|+|||||||+|||||..|++||+|||.+-.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999996666 89999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
+...... .....+|||-|.+||+++. .+.|+..+|.||+||++|||+.|..||+.+.. -+.+.
T Consensus 225 m~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----------veTY~-- 291 (1317)
T KOG0612|consen 225 MDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----------VETYG-- 291 (1317)
T ss_pred cCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----------HHHHH--
Confidence 7654433 3456789999999999862 24689999999999999999999999854322 11111
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP---MSAVVK 295 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps---~~~v~~ 295 (356)
++......-..+ ....++.++.+||.+.+. +|..|-. ++++..
T Consensus 292 KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 292 KIMNHKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHhchhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 111111111122 224578889999988775 6777877 888876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=270.85 Aligned_cols=279 Identities=26% Similarity=0.296 Sum_probs=216.2
Q ss_pred HHHhhhcCCCcceeCHHHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--Cc----hhHHHHHHHHHHHH
Q 047701 3 RFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LG----KIAEEQFMAEVGTI 75 (356)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~----~~~~~~~~~e~~~l 75 (356)
+.|-++.++..-.|-+.-+.+.+|-+...||+|||+.||+|.+ ...+.||||+-..+ .. ..-.....+|.++-
T Consensus 442 RELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIH 521 (775)
T KOG1151|consen 442 RELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIH 521 (775)
T ss_pred HHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhh
Confidence 3455666677777877778889999999999999999999964 56889999985422 21 12224677899999
Q ss_pred hcCCCCCeeeEeeeEE-cCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCcc
Q 047701 76 GRTYHINLVRLHGFCH-DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154 (356)
Q Consensus 76 ~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 154 (356)
+.|+||.||++|+++. +....|-|+|||+|.+|+-+| +..+.++++.+..|..||+.||.||.+.. .+|||.||||.
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPg 599 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPG 599 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCc
Confidence 9999999999999996 556778999999999999988 56678999999999999999999999743 68999999999
Q ss_pred ceEEc---CCCceEEeccCCccccCCCCCce-----eecCCCCCCCCCCccccc-C--CCCCCCCCceehhhHHHHHHhc
Q 047701 155 NVLLD---ANFSPKVADFGLAKLCDRNRSHV-----TISGYKGTPGYSAPEFLS-G--NYPITHKCDVYSFGMVSFEIVG 223 (356)
Q Consensus 155 Nill~---~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~--~~~~~~~~Dv~slG~il~ell~ 223 (356)
|||+. ..|.+||.||||++++.+..... .+....||.+|++||++. + -...+.+.||||.|||+|..+-
T Consensus 600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 99994 35789999999999987654331 223466999999999875 2 2358899999999999999999
Q ss_pred CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC-CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 224 RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG-IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 224 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
|+.||+-+..+.. .+....+. .+.. ..+.-+..+.+..++|.+||+..-++|.+..++..
T Consensus 680 GrKPFGhnqsQQd---------ILqeNTIl---kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 680 GRKPFGHNQSQQD---------ILQENTIL---KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred cCCCCCCchhHHH---------HHhhhchh---cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 9999976655321 11111111 1110 11223345678999999999999999987766653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=264.21 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=195.0
Q ss_pred ccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 29 STRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
...||.|+||+|++-.+ +.|+..|||.+..........+++.|.++..+- ++||||++||.+-..+.+++.||+|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 35699999999999876 469999999998776666777888888877665 799999999999998999999999955
Q ss_pred CHhHHhc----cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 107 SLDGYLF----GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 107 sL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
||+.+-. .+...++++-+-+|+...+.||.||-. ..+++|||+||+|||++..|.+||||||.+..+.++-..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk- 224 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK- 224 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh-
Confidence 8877652 235679999999999999999999997 378999999999999999999999999998765543322
Q ss_pred eecCCCCCCCCCCcccccCCC-CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh-hcC
Q 047701 183 TISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL-ACG 260 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 260 (356)
+.-.|-..|||||.+.... .|..+|||||||++|+|+.||+.|. ..|...-+. +...+. ...
T Consensus 225 --T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPy-------------r~w~svfeq-l~~Vv~gdpp 288 (361)
T KOG1006|consen 225 --TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPY-------------RKWDSVFEQ-LCQVVIGDPP 288 (361)
T ss_pred --hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCc-------------chHHHHHHH-HHHHHcCCCC
Confidence 2345777899999997553 4899999999999999999999764 222221111 111111 111
Q ss_pred C---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 I---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+ .....+.+..+..++.-|+.+|-.+||.++++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 11234467889999999999999999999999873
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=263.60 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=204.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--------
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-------- 92 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 92 (356)
..+|.-..+||+|.||.||+|+.+ +|+.||+|.+--+ ....--...++|+++|..|.|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 345666788999999999999764 5888998865422 122233467889999999999999999998854
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
....|+|+++|+. +|..+|.....+++..++.++..+++.||.|+|+ ..|+|||+||.|+||+.+|.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2357999999987 9999997777899999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCC--ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc--------cchhHH
Q 047701 173 KLCDRNRS--HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL--------DWFPKY 242 (356)
Q Consensus 173 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~--------~~~~~~ 242 (356)
+.+..... ....+..+-|..|++||.+.|...++.+.|||.-|||+.||+++.+-+-.+..+.. ......
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87654332 23345556799999999999988999999999999999999999865543333221 111222
Q ss_pred HHHHHhhhchhhhHhhcCCC----chhHHH------HHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 243 VWEEYEKSELGAMILACGIE----EKDKEK------AKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~----~~~~~~------~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+|....+-.+.+.+...... ....+. ..+..+|+..++..||.+|+++++++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 33333333332222111000 011111 2478899999999999999999998874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=263.43 Aligned_cols=269 Identities=20% Similarity=0.245 Sum_probs=198.0
Q ss_pred HhhccccccCcCCceEEEEEEc-C--C--CcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CCee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-P--N--GVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QHMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~--~--~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 96 (356)
..|+....||+|.||.||+|.- + + ...+|||.++.... ........+|+.+++.++||||+.+..++.. ...+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4678889999999999999943 2 2 34799999875422 1222456789999999999999999999977 7788
Q ss_pred eEEEEecCCCCHhHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC----CceEEec
Q 047701 97 ALVYEYMENGSLDGYLFGK----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN----FSPKVAD 168 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~D 168 (356)
+|++||.+. +|...+.-+ .+.++...+..|+-||+.|+.|||+ +=++||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 887777432 3578999999999999999999999 889999999999999766 8999999
Q ss_pred cCCccccCCCCCce-eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc-------h-
Q 047701 169 FGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW-------F- 239 (356)
Q Consensus 169 fGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~-------~- 239 (356)
||+++.+.+.-... ....++-|..|.|||.+.|...||.+.|||+.|||+.||++-.+-|.......... +
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999987654332 33456678999999999998899999999999999999999776554322211110 0
Q ss_pred ---------hHHHHHHHhhhchh-hhH---hhcCCCch--------hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 240 ---------PKYVWEEYEKSELG-AMI---LACGIEEK--------DKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 240 ---------~~~~~~~~~~~~~~-~~~---~~~~~~~~--------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..-.|..+....-. ..+ ........ ....++...+|+.+++..||.+|.|+++.++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 00011111111000 000 00000000 00112347899999999999999999998874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=239.93 Aligned_cols=264 Identities=21% Similarity=0.255 Sum_probs=204.0
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
|.-.++||+|.+|+||+|++. +++-||+|.+..+. .+......++|+-+++.+.|+|||+++++......+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 444688999999999999864 58899999987542 3344467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+. +|..++..-++.++.+.+..++.|++.||.++|+ +++.||||||+|.||+.+|.+|++|||+++.++-....
T Consensus 84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-- 157 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-- 157 (292)
T ss_pred hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--
Confidence 65 9999998888999999999999999999999999 99999999999999999999999999999987644322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH--Hhhhch---hhhHhh
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE--YEKSEL---GAMILA 258 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~ 258 (356)
....+-|..|.+|.++.|..-|+...|+||-|||+.|+.....|.+.+..-... +....+.. ..+... ....+-
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCCCC
Confidence 223446889999999998878999999999999999999887777665543211 11111111 001111 111110
Q ss_pred cCCCc---------hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 259 CGIEE---------KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 259 ~~~~~---------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...+. .-+.....-.+++...+.-+|..|.++++.++.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00111 112233445788888999999999999988763
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=277.67 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=198.5
Q ss_pred ccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 29 STRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
.++||+|-||+||-|.+ ++|+.||||++.+-. .+....++..|+.+|.++.||.||.+.--|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999976 579999999997542 3455578999999999999999999999999999999999999887
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC---CceEEeccCCccccCCCCCcee
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~~~~~~~~~~~ 183 (356)
-|+-.|....+++++..-..+..||+.||.|||. ++|+|.||||+|||+... -.+||||||+|++.......
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-- 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-- 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--
Confidence 7777777778899999999999999999999999 999999999999999644 37999999999988765433
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
..++||+.|+|||+++.+ .|...-|+||.|||+|.-++|-.||..+..-.. ...+ ..++ ..+.
T Consensus 724 -rsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQN---AaFM---yPp~ 786 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQN---AAFM---YPPN 786 (888)
T ss_pred -hhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhH---------Hhhc---cccc---cCCC
Confidence 457899999999999988 799999999999999999999988744332110 0000 0111 1122
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.-.+.+.+..+||...++..-.+|-|.+.-+.
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 23445667788888888888888877765543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.24 Aligned_cols=219 Identities=21% Similarity=0.165 Sum_probs=174.8
Q ss_pred CCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhc
Q 047701 35 GGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF 113 (356)
Q Consensus 35 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 113 (356)
|.||.||++.+. +++.||+|.+.... .+..|...+....||||+++++++.+....++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999764 68999999997542 12334445555679999999999999999999999999999999985
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCC
Q 047701 114 GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193 (356)
Q Consensus 114 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 193 (356)
.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||++....... ....++..|
T Consensus 78 ~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 78 KF-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred Hh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 43 468999999999999999999999 999999999999999999999999999876554322 223457789
Q ss_pred CCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHH
Q 047701 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLC 273 (356)
Q Consensus 194 ~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (356)
+|||.+.+. .++.++|+||+|+++|+|++|..++....... ........+...+..+.
T Consensus 149 ~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 149 CAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEAR 206 (237)
T ss_pred cCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHH
Confidence 999998766 68899999999999999999986642111100 00000112234567789
Q ss_pred HHHHhhcCCCCCCCCCH
Q 047701 274 MVALWCVQDSPADRPPM 290 (356)
Q Consensus 274 ~l~~~cl~~~p~~Rps~ 290 (356)
+++.+|++.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=258.62 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=202.8
Q ss_pred ccccCcCCceEEEEEE-cCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 29 STRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
.+.||+|+++.|--+. ..++.++|||++.+. ....+.++.+|++++.+. .|+||++++.+|.+....|||||.|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 4689999999999986 478999999999875 557888999999999998 5999999999999999999999999999
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEEeccCCccccCC--CCC-
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDR--NRS- 180 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~~~~--~~~- 180 (356)
+|-..+. ....+++..+.++..+|+.||.|||. +||.||||||+|||-.+.. -+|||||.|..-... ..+
T Consensus 162 plLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 162 PLLSHIQ-KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred hHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999995 44678999999999999999999999 9999999999999996654 479999987653221 111
Q ss_pred --ceeecCCCCCCCCCCccccc----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 181 --HVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 181 --~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
.......+|+..|||||+.. ....|..+.|.||||+|+|-||+|-+||.......-.|-...+...- ...+.+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C-Q~~LFe 316 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC-QNKLFE 316 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH-HHHHHH
Confidence 11223467889999999864 22368899999999999999999999997665544333211111100 111111
Q ss_pred hHhhcCC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILACGI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+..+.. ...-..++.+..+++...+..|+..|-++..++.
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2222211 1223456788999999999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=279.52 Aligned_cols=238 Identities=24% Similarity=0.290 Sum_probs=192.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|.+...+|.|+|+.|-++.. .+++..++|++.+.. .+-.+|+.++.+. +||||+++.+++.++...|+|||+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 567778899999999999975 578999999998652 2233466565555 799999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE-cCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL-DANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
++|+-|.+.+.... ..+ ..+..|+.+|+.|+.|||+ +|+|||||||+|||+ +..++++|+|||.++......
T Consensus 398 l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-- 470 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-- 470 (612)
T ss_pred ccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchhh--
Confidence 99988777774332 223 7888999999999999999 999999999999999 688999999999998766551
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
...+-|..|.|||+.... +++.++|+||||++||+||+|..|+.....+ .++...+. .
T Consensus 471 ---~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------------~ei~~~i~---~ 528 (612)
T KOG0603|consen 471 ---DTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------------IEIHTRIQ---M 528 (612)
T ss_pred ---cccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCch---------------HHHHHhhc---C
Confidence 122357789999999966 8999999999999999999999987655443 11111111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......+.++.+|+.+||+.||.+||++.++...
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22336678889999999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=293.37 Aligned_cols=145 Identities=30% Similarity=0.347 Sum_probs=129.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.++||+|+||+||+|.+. +++.||||++.... .......+..|+.++..++||||+++++++......|||||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 5677899999999999999875 68999999997532 23344678889999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
|+.+++|.+++.. .+.+++..++.++.||+.||.|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999843 4568999999999999999999999 999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=253.26 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=192.4
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc----CCeeeEEEEec
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD----QHMTALVYEYM 103 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~ 103 (356)
++||-|-.|.|-.+..+ +++++|+|++... .+..+|++.--.. .|||||.+++++.+ ...+.+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 78999999999999764 7999999998542 3456777765555 59999999999864 34667899999
Q ss_pred CCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCccccCCCC
Q 047701 104 ENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 104 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~~~~~~~ 179 (356)
+||.|...++.++ +.+++.++..|..||+.|+.|||+ .+|.||||||+|+|... +-.+||+|||+|+......
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 9999999997654 579999999999999999999999 99999999999999953 4579999999998766433
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. ....+-|+.|.|||++... .|....|+||+||++|-|++|-+||+...-.... + .+...+..+
T Consensus 219 ~---L~TPc~TPyYvaPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~hg~ais--p----------gMk~rI~~g 282 (400)
T KOG0604|consen 219 D---LMTPCFTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--P----------GMKRRIRTG 282 (400)
T ss_pred c---ccCCcccccccCHHHhCch-hcCCCCCccchhHHHHHhhcCCCcccccCCccCC--h----------hHHhHhhcc
Confidence 2 2335679999999999776 7999999999999999999999999754332111 0 111111211
Q ss_pred C---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 G---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
. ..+.-...++...++|+.+|+.+|.+|.++.++...
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 122334567889999999999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=266.55 Aligned_cols=243 Identities=26% Similarity=0.317 Sum_probs=200.2
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 97 (356)
....++|..+||+|+||.|-+|.-+ +.+.+|||+++++. +..+.+.-+.|-++|... .-|.+++++.++..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3446889999999999999999654 57889999998763 344555567788888877 4678999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.||+|--.++ +-+.+.+..+..++..|+-||-+||+ +||++||||.+||+++.+|.+||+|||+++.---
T Consensus 427 FVMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eEEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999998884 44678888999999999999999999 9999999999999999999999999999975332
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
. ..++..++||+-|+|||++... +|+..+|.|||||+||||+.|++|+...+.. ++.+.+.
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~aI~ 563 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQAIM 563 (683)
T ss_pred C--CcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHH
Confidence 2 2234557899999999999887 8999999999999999999999998654432 1111111
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCC
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRP 288 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp 288 (356)
.. .-..+...+.+..++.+..+...|.+|.
T Consensus 564 eh-nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EH-NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Hc-cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11 1245677888999999999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=252.17 Aligned_cols=237 Identities=30% Similarity=0.383 Sum_probs=191.4
Q ss_pred CceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhcc
Q 047701 36 GFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFG 114 (356)
Q Consensus 36 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 114 (356)
+||.||+|.+. +++.+|+|++...........+.+|++.+++++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 58999999997654333267899999999999999999999999999999999999999999999854
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCC
Q 047701 115 KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194 (356)
Q Consensus 115 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 194 (356)
.. .+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 33 38999999999999999999999 999999999999999999999999999998765442 223355788999
Q ss_pred CcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHH--HHHHH
Q 047701 195 APEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE--KAKQL 272 (356)
Q Consensus 195 aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l 272 (356)
+||.+.+. .++.++||||||++++++++|..|+...... . ................. .+.++
T Consensus 154 ~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 154 APEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQL------L---------ELFKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred CHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------H---------HHHHHHhccCCCCccccccCCHHH
Confidence 99999866 6888999999999999999999887442111 0 01111111111111111 56789
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHH
Q 047701 273 CMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 273 ~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=258.27 Aligned_cols=271 Identities=18% Similarity=0.236 Sum_probs=203.6
Q ss_pred cceeCHHHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC--CC----Ceee
Q 047701 13 PVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HI----NLVR 85 (356)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~ 85 (356)
...+...|....+|.+...+|+|.||.|-.+-+ ..+..||||+++.- ..-.+..+.|++++.++. -| -++.
T Consensus 78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 345677788888999999999999999999954 35789999999752 234456778999999993 23 2788
Q ss_pred EeeeEEcCCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC----
Q 047701 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---- 160 (356)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---- 160 (356)
+.+||...+..|||+|.+ |.|+.+++..+ -.+++...+..++.|++++++|||+ .+++|-||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 999999999999999999 77999999654 3578999999999999999999999 99999999999999931
Q ss_pred ----------------CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcC
Q 047701 161 ----------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGR 224 (356)
Q Consensus 161 ----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g 224 (356)
+..++|+|||.|+.-.... ...+.|.-|.|||++.+- +++.++||||+||||.|+.+|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeecc
Confidence 2358999999998655444 234578899999999998 799999999999999999999
Q ss_pred CCccccCCCccc-----cchhHHHHHHHhhhchh-------------------hhHhhcCCC-----chhHHHHHHHHHH
Q 047701 225 RRNAIVGASESL-----DWFPKYVWEEYEKSELG-------------------AMILACGIE-----EKDKEKAKQLCMV 275 (356)
Q Consensus 225 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~-----~~~~~~~~~l~~l 275 (356)
...|.....-+. +.+...+.......... ..+.....+ ........++++|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 876644432210 00000011111111000 011110100 0112345679999
Q ss_pred HHhhcCCCCCCCCCHHHHHH
Q 047701 276 ALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 276 ~~~cl~~~p~~Rps~~~v~~ 295 (356)
+.+|+..||.+|+|+.|++.
T Consensus 386 l~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHccCccccccHHHHhc
Confidence 99999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=272.42 Aligned_cols=243 Identities=25% Similarity=0.312 Sum_probs=202.4
Q ss_pred ccccCcCCceEEEEEEcCC-CcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 29 STRLGFGGFGQVYKGQFPN-GVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
...||-||||.|=+++.+. ...+|+|.+++. ......+++..|-++|...+.|.||++|..|.+..++|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 3458999999999998744 334899988754 3456667899999999999999999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|.|...++ ..+.++..+...++..+++|++|||+ ++||+|||||+|.+++.+|-+||.|||+|+....+....+
T Consensus 505 GElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT-- 578 (732)
T KOG0614|consen 505 GELWTILR-DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT-- 578 (732)
T ss_pred chhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCceee--
Confidence 99999994 45678999999999999999999999 9999999999999999999999999999999887766554
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc-CCCch
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC-GIEEK 264 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 264 (356)
++||+.|.|||++..+ ....++|.||||+++|||++|.+||...++- .....+..+ .....
T Consensus 579 -FcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpm----------------ktYn~ILkGid~i~~ 640 (732)
T KOG0614|consen 579 -FCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPM----------------KTYNLILKGIDKIEF 640 (732)
T ss_pred -ecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchH----------------HHHHHHHhhhhhhhc
Confidence 6799999999999987 6899999999999999999999998544331 111111111 11234
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
+...+....+|+++....+|.+|-- ..+|.+
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 4566778899999999999999976 566665
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=273.90 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=201.5
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc-----CCe
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD-----QHM 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~ 95 (356)
..++.|.+.||.|.+|.||+++. ++++..|+|+..... ...+.+..|..+++.+ +|||++.+++++.. ++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34678899999999999999976 468889999887643 2334577788899887 79999999999864 568
Q ss_pred eeEEEEecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 96 TALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
++||||||.|||..+++.+ .+.++.|..+..|++.++.|+.+||. ..++|||||-.|||++.++.+||+|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 8999999999999999853 36789999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
...... ......||+.|||||++... ..|+.++|+||||++..||--|.+|+...-+- .
T Consensus 173 ldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------------r 235 (953)
T KOG0587|consen 173 LDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------------R 235 (953)
T ss_pred eecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------------h
Confidence 554322 22346799999999998643 34788999999999999999999886322110 0
Q ss_pred chhhhHhh-cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 ELGAMILA-CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+.....+ ......+...+.++.++|..|+..|...||++.++++
T Consensus 236 aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01111111 1112235667889999999999999999999998876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=275.91 Aligned_cols=261 Identities=18% Similarity=0.177 Sum_probs=164.3
Q ss_pred HhhccccccCcCCceEEEEEEcC-C----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeee------EEc
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-N----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF------CHD 92 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~~ 92 (356)
..|.+.++||+|+||.||+|.+. + +..||||.+..... .+....+ .+....+.++..++.. ...
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 46777899999999999999864 4 78999998764311 1111111 1111122222222111 245
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRA-------------------LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 153 (356)
....++|+||+.+++|.+++...... .....+..++.|++.||+|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 56789999999999999988543211 1234466899999999999999 9999999999
Q ss_pred cceEEcC-CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCC---------------------CCCCCCce
Q 047701 154 ENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY---------------------PITHKCDV 211 (356)
Q Consensus 154 ~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Dv 211 (356)
+|||++. ++.+||+|||+++........ ......|++.|+|||.+.... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 579999999999865433222 123456899999999654221 23456799
Q ss_pred ehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc------hhHHHHHHHHHHHHhhcCCCCC
Q 047701 212 YSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE------KDKEKAKQLCMVALWCVQDSPA 285 (356)
Q Consensus 212 ~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~ 285 (356)
|||||++|||+++..+.... ...+........................+ ..........+|+.+|++.||.
T Consensus 363 wSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999865432111 00000000000000000000000000000 0001123456899999999999
Q ss_pred CCCCHHHHHHH
Q 047701 286 DRPPMSAVVKM 296 (356)
Q Consensus 286 ~Rps~~~v~~~ 296 (356)
+|||+.++++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999973
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=242.28 Aligned_cols=278 Identities=18% Similarity=0.203 Sum_probs=229.8
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
....|+.+++||+|+||.++.|++ -+++.||||..+.. ....++..|.+.++.| ..++|..++-+..++.+..||
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 455788899999999999999974 58999999998764 3346788999999998 589999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-----CceEEeccCCccc
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-----FSPKVADFGLAKL 174 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~DfGla~~ 174 (356)
+|++ |.||++++.-.++.++.++++.+|.|++.-++|+|+ +.+|+|||||+|+||... ..+.++|||+|+.
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999 889999998888999999999999999999999999 999999999999999643 4689999999999
Q ss_pred cCCCCCceee-----cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 175 CDRNRSHVTI-----SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 175 ~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
+.+..+...+ ....||.+||+-..+.|. +.+.+.|+-|||-++.++|.|..||-.-..... ...+
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn----K~kY----- 248 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN----KEKY----- 248 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcch----HHHH-----
Confidence 8876655432 446699999999999998 799999999999999999999988743222211 1111
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCCCCCccccccc
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPFRYLDLN 316 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~p~~~~~~~ 316 (356)
+++.+......+.+.+.+.+.++...+...-..+..+-|+++.+...+..++..........|.|..
T Consensus 249 eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ 315 (449)
T KOG1165|consen 249 EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMG 315 (449)
T ss_pred HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 2233333344456677788999999999999999999999999999999988877766554444443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=230.72 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=171.1
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
+......-...||+|++|.|=+-++ .+|...|+|.+..........+.+.|+.+..+- .+|.+|.+||........++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3333334457799999999988876 579999999998776667778889999988876 79999999999999999999
Q ss_pred EEEecCCCCHhHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 99 VYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 99 v~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.||.|+. ||+.+-. .+++.+++..+-+|+..+.+||.|||+ +..++|||+||+||||+.+|++|+||||.+..+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999965 8887763 467889999999999999999999999 378999999999999999999999999999877
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCC---CCCCCCCceehhhHHHHHHhcCCCccc
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGN---YPITHKCDVYSFGMVSFEIVGRRRNAI 229 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Dv~slG~il~ell~g~~~~~ 229 (356)
.++-... -..|-..|||||.+..+ ..|+.++||||||+++.||.+++.|..
T Consensus 200 ~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 200 VDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 6554322 23367789999998643 268999999999999999999998764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=264.61 Aligned_cols=204 Identities=25% Similarity=0.354 Sum_probs=173.2
Q ss_pred ccccCcCCceEEEEEE-cCCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 29 STRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
.+.||-|+||.|.+++ ..+...+|+|.+.+. ...........|-+||...+.+=||+||-.|.++..+|+||||+.|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 4569999999999995 446889999998754 2345556788899999999999999999999999999999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC--------
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR-------- 177 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~-------- 177 (356)
|++-.+|. +-+-+.+..+..++..+..|+++.|. .|+|||||||+|||||.+|.+||.||||+.=+.-
T Consensus 714 GDmMSLLI-rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 714 GDMMSLLI-RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccHHHHHH-HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999884 44678888889999999999999999 9999999999999999999999999999874310
Q ss_pred CCCce--------------------------------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC
Q 047701 178 NRSHV--------------------------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225 (356)
Q Consensus 178 ~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~ 225 (356)
...+. .....+||+-|+|||++... .++..+|.||.|||||||+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhCC
Confidence 00000 01236799999999999987 7999999999999999999999
Q ss_pred CccccCCCcccc
Q 047701 226 RNAIVGASESLD 237 (356)
Q Consensus 226 ~~~~~~~~~~~~ 237 (356)
.||..+.+.+..
T Consensus 869 ~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 869 PPFLADTPGETQ 880 (1034)
T ss_pred CCccCCCCCcce
Confidence 999877776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=272.78 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=183.9
Q ss_pred ccccCcCCce-EEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 29 STRLGFGGFG-QVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 29 ~~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
.+++|.|+-| .||+|.+ +|+.||||++-. .......+|+..++.- .|||||++|+.-.+....||..|+|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 4668888886 5799998 889999998864 3344567899999987 699999999999999999999999955
Q ss_pred CHhHHhccCCC---CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---C--CceEEeccCCccccCCC
Q 047701 107 SLDGYLFGKKR---ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---N--FSPKVADFGLAKLCDRN 178 (356)
Q Consensus 107 sL~~~l~~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~DfGla~~~~~~ 178 (356)
+|.+++..... .......+.++.|+++||++||+ .+||||||||+||||+. + .+++|+|||+++.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 99999966311 12225567899999999999999 99999999999999965 2 47899999999988654
Q ss_pred CCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... ....+..||.+|+|||++... .-+.++|||||||++|+.++|+...+.+....+.. ...+... .
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~~~~~---L 732 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILTGNYT---L 732 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhcCccc---e
Confidence 433 334567799999999999877 56789999999999999999854332222211100 0000000 0
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ......++ ++.+||.+|++++|..||++.+|+.
T Consensus 733 ~--~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 V--HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e--eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 00111112 7889999999999999999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=261.99 Aligned_cols=261 Identities=18% Similarity=0.176 Sum_probs=177.2
Q ss_pred HHhhccccccCcCCceEEEEEEc-----------------CCCcEEEEEEecccCchhHHH--------------HHHHH
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-----------------PNGVKIAVKVLNKNLGKIAEE--------------QFMAE 71 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~~e 71 (356)
...|.+.++||+|+||+||+|.+ ..++.||||.+..... .... ....|
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHHH
Confidence 44677889999999999999953 2356899999864322 1112 23346
Q ss_pred HHHHhcCCCCCe-----eeEeeeEEc--------CCeeeEEEEecCCCCHhHHhccCC----------------------
Q 047701 72 VGTIGRTYHINL-----VRLHGFCHD--------QHMTALVYEYMENGSLDGYLFGKK---------------------- 116 (356)
Q Consensus 72 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~---------------------- 116 (356)
+..+.+++|.++ +.++++|.. ....+|||||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777765543 667777653 346799999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCC
Q 047701 117 -RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195 (356)
Q Consensus 117 -~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 195 (356)
..+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++.......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 134677889999999999999999 999999999999999999999999999997654322211 112235789999
Q ss_pred cccccCCC---------------------CCCCCCceehhhHHHHHHhcCCCccccCCCccccch-----hHHHHHHHhh
Q 047701 196 PEFLSGNY---------------------PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF-----PKYVWEEYEK 249 (356)
Q Consensus 196 PE~~~~~~---------------------~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~-----~~~~~~~~~~ 249 (356)
||.+.... ....+.||||+||++++|++|..+...+........ ....|..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875321 112347999999999999998753222111000000 0001111111
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSP---ADRPPMSAVVKM 296 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~Rps~~~v~~~ 296 (356)
.. .........+....+++.+++..+| .+|+|+++++++
T Consensus 459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 0111223346778999999998766 689999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=230.35 Aligned_cols=212 Identities=36% Similarity=0.589 Sum_probs=184.3
Q ss_pred cCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhH
Q 047701 32 LGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDG 110 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~ 110 (356)
||+|++|.||++... +++.+++|++...........+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999875 3899999999865433245678999999999999999999999999999999999999899999
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCccccCCCCCceeecCCCC
Q 047701 111 YLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKG 189 (356)
Q Consensus 111 ~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~g 189 (356)
++......++...+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 996544578999999999999999999999 99999999999999998 89999999999986654431 1223457
Q ss_pred CCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHH
Q 047701 190 TPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269 (356)
Q Consensus 190 t~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (356)
...|++||........+.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 88999999987643578999999999999988
Q ss_pred HHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 270 KQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 270 ~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+.+++..|+..||++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 458899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=239.71 Aligned_cols=253 Identities=24% Similarity=0.279 Sum_probs=199.2
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCC
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQH 94 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 94 (356)
+.+.-..+++.++||+|+|+.|-.++++ +.+-+|+|++++..- .++.+=...|-.+..+. +||.+|-++.+|....
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3333345677899999999999999874 688999999986532 23333455677777776 7999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
.+++|.||.+||+|--.+ .+++.++++.+..+...|+-||.|||+ +||++||||.+|||+|..|.+||.|+|+++.
T Consensus 325 rlffvieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred eEEEEEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999999997666 456789999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCc-cccchhHHHHHHHhhhchh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE-SLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 253 (356)
--.. ...+..++||+.|.|||+++|. .|....|.|+|||+++||+.|+.||..-..+ .....-.+.++..-+..
T Consensus 401 ~l~~--gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-- 475 (593)
T KOG0695|consen 401 GLGP--GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-- 475 (593)
T ss_pred CCCC--CcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--
Confidence 4322 2233558899999999999998 7999999999999999999999998653322 22222222222222111
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP 288 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp 288 (356)
...+...+-....+++..+++||.+|.
T Consensus 476 --------iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 --------IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --------ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 123445556677889999999999994
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=230.23 Aligned_cols=277 Identities=18% Similarity=0.223 Sum_probs=222.8
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 98 (356)
+....|.+.++||+|+||.+|.|.. .+|+.||||+.+.. ....++..|..+++.|+ ...|+.+..++.+..+..+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3456889999999999999999964 67999999998765 33456888999999996 4678888889999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc---CCCceEEeccCCcccc
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLC 175 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~ 175 (356)
|||++ |.||+++++-..+.++..+++.++-|++..++|+|. ++++||||||+|+|+. ....+.|+|||+|+.+
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999 889999998888999999999999999999999999 9999999999999995 3457899999999988
Q ss_pred CCCCCcee-----ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 176 DRNRSHVT-----ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 176 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
.+..+... .....||.+|.+-.++.+. ..+.+.|+-|+|++|.++..|..||-.-.... ...+-+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t---------k~QKyE 234 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT---------KKQKYE 234 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhh---------HHHHHH
Confidence 65444322 2446799999999999887 78999999999999999999998873322211 111122
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCCCCCccccc
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPFRYLD 314 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~p~~~~~ 314 (356)
++.+...+..+...+.+.|.++...+..|-....++-|++..+.+.+.-+...+.....+.+.|
T Consensus 235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence 2333333344455667788999999999999999999999999998877766655444444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=221.14 Aligned_cols=257 Identities=17% Similarity=0.264 Sum_probs=197.6
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcC--CeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQ--HMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l 98 (356)
...|++.+++|+|.++.||.|.. .++++++||+++. ..+..+.+|+.+|..|. ||||+.++++..+. ....|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 44677889999999999999964 5789999999975 45567999999999996 99999999999875 46689
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~~~~~ 177 (356)
|+||.++.+...+. +.++...+..+..+++.||.|+|+ +||.|||+||.|++||.. -.++|+|+|||.++..
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999887766555 578889999999999999999999 999999999999999854 4799999999998775
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh---------
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE--------- 248 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~--------- 248 (356)
...... .+-+..|--||.+..-..+...-|+|||||++..|+..+.||+-+.+...... ..+ ..+.
T Consensus 186 ~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV-kIa-kVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 186 GKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-KIA-KVLGTDELYAYLN 260 (338)
T ss_pred Cceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH-HHH-HHhChHHHHHHHH
Confidence 543321 23455678899987666789999999999999999999999987766532211 110 0000
Q ss_pred ------hhchhhhHhhcC--------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 ------KSELGAMILACG--------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ------~~~~~~~~~~~~--------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+.+....+.... ..+.....++++.+++...+..|-++|+|+.|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111110 01111123478999999999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=236.22 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=194.0
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-----eeeE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-----MTAL 98 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 98 (356)
++-.+-||-|+||.||.+.++ +|+.||+|.+..-. .-.....+.+|+..++.+.|.|++..+++..... +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344678999999999999875 69999999886432 1234467889999999999999999998876543 4678
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
++|+|.. +|...+ -..+.++...+.-++.||+.||+|||+ .+|.||||||.|.|++.+-.+||||||+++.....
T Consensus 135 ~TELmQS-DLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELMQS-DLHKII-VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHh-hhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8999954 888877 566789999999999999999999999 99999999999999999999999999999976544
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcc-ccchhHH----HHHHHh---hh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES-LDWFPKY----VWEEYE---KS 250 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~-~~~~~~~----~~~~~~---~~ 250 (356)
+... .+..+-|-.|.|||+++|...|+.+.||||.|||+.||+..+..|-...+-. ....... ..+.++ ++
T Consensus 210 ~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 3332 2333457789999999998889999999999999999997765443322211 1100000 001111 01
Q ss_pred chhhhHhhcCCCc---------hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 251 ELGAMILACGIEE---------KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 251 ~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
.-..++......+ .+.....+...+...++..||.+|.+-.+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111110 0112234567788889999999999988887754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=246.87 Aligned_cols=194 Identities=26% Similarity=0.367 Sum_probs=166.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHH---------HHHHHHHHHhcCC---CCCeeeEeeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEE---------QFMAEVGTIGRTY---HINLVRLHGFCH 91 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~---------~~~~e~~~l~~l~---h~niv~~~~~~~ 91 (356)
.|...+.+|.|+||.|+.|.++ +...|+||.+.++. .-.+ .+-.|+++|..|+ |+||++++++|+
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR--IL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER--ILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhh--hhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4666788999999999999775 58899999997642 1111 2345999999997 999999999999
Q ss_pred cCCeeeEEEEecC-CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 92 DQHMTALVYEYME-NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 92 ~~~~~~lv~e~~~-~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
+++++||+||... |-+|.+++ .....+++..+..|+.|++.|+++||+ .+|||||||-+||.++.+|-+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 9999999999864 45888888 456789999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCcc
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNA 228 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~ 228 (356)
.+.+..++.. ..++||..|.|||++.|....+..-|||++|++||.++-...|+
T Consensus 716 saa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 716 SAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred chhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9876654432 34679999999999999877788999999999999998777664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=222.11 Aligned_cols=252 Identities=17% Similarity=0.256 Sum_probs=195.1
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeE-EcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFC-HDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~-~~~~~~~lv 99 (356)
...|++.+.||+|.||.+-++++. +++.+++|.+++.. ....+|.+|+..--.| .|.||+..|++. ...+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 446888899999999999999874 58899999998754 4456899999877677 589999988764 455678899
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--CCCceEEeccCCccccCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~~~~~ 177 (356)
+||++.|+|..-+. ...+.+....+++.|+++|+.|+|+ +++||||||.+||||- +..++||||||+.+..+.
T Consensus 101 qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999998773 3568888999999999999999999 9999999999999992 334899999999875442
Q ss_pred CCCceeecCCCCCCCCCCccccc----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.. .....+..|.+||... +.......+|+|.||++++.+++|..||-... .+.-+.+.|..|..+...
T Consensus 176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhcccCc
Confidence 21 2223456789999754 22346778999999999999999999986332 233345667777766654
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+ .+......++.+..+.++-+..+|++|--..++.+
T Consensus 248 ~------~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 A------LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred c------CchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 3 23344556677888999999999999955444444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=243.87 Aligned_cols=271 Identities=21% Similarity=0.272 Sum_probs=203.8
Q ss_pred eeCHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC------CCCeeeEe
Q 047701 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY------HINLVRLH 87 (356)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~ 87 (356)
+....++...+|......|+|-|++|.+|.+. .|..||||++.++. .....=+.|+++|++|+ .-|+++++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 45667888889999999999999999999864 48899999998752 33344567999999996 23899999
Q ss_pred eeEEcCCeeeEEEEecCCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-Cce
Q 047701 88 GFCHDQHMTALVYEYMENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSP 164 (356)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~ 164 (356)
..|...+.+|||+|-+ ..+|.++|.+- .-.|....+..++.|+.-||..|-. .+|+|.||||+|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCccee
Confidence 9999999999999998 55999999654 3468889999999999999999998 999999999999999865 468
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCc-cccchhH--
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE-SLDWFPK-- 241 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~-~~~~~~~-- 241 (356)
||||||.|.....++... ..-+..|.|||++.|. .|....|+||.||+||||.||+..|-..... .+.++..
T Consensus 577 KLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 577 KLCDFGSASFASENEITP----YLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeccCccccccccccccH----HHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 999999998776654332 2234579999999998 7999999999999999999998654221111 0000000
Q ss_pred --HHHHHHh------------------------------------h-hchhhhHhhc-CCCchhHHHHHHHHHHHHhhcC
Q 047701 242 --YVWEEYE------------------------------------K-SELGAMILAC-GIEEKDKEKAKQLCMVALWCVQ 281 (356)
Q Consensus 242 --~~~~~~~------------------------------------~-~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~ 281 (356)
.+...+. + ..+...+... ..+........++.+|+..|+.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 0000000 0 0111111111 1223334556789999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 047701 282 DSPADRPPMSAVVKM 296 (356)
Q Consensus 282 ~~p~~Rps~~~v~~~ 296 (356)
+||++|.|..+.++.
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999988763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-33 Score=251.77 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=199.5
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+..++|+|.+|.||++++. +++..|||+++.... .+..-+.+|+-+++..+||||+.+++.+......++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 346778899999999999999875 689999999986533 455667789999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||.||+|.+.- .-.+++++.++..+++..+++++|||+ ++-+|||||-.||++++.|.+|++|||.+..+... .
T Consensus 93 ycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i 166 (829)
T KOG0576|consen 93 YCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I 166 (829)
T ss_pred ecCCCccccee-eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence 99999999865 456789999999999999999999999 99999999999999999999999999988655432 2
Q ss_pred eeecCCCCCCCCCCccccc--CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 182 VTISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....+.||+.|||||+.. ....|...+|||++|+...|+---++|.+.--+ -..+.-+..+.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------------mr~l~LmTkS~ 231 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------------MRALFLMTKSG 231 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------------HHHHHHhhccC
Confidence 2235678999999999853 334689999999999999998776665421111 11111111111
Q ss_pred CC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. ........+.+.++++.|+..+|.+||+++.++.
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 1112335667899999999999999999976654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=220.68 Aligned_cols=200 Identities=35% Similarity=0.501 Sum_probs=170.6
Q ss_pred hccccccCcCCceEEEEEEcCC-CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
|.+.+.||+|++|.||++.... ++.+|+|.+...........+.+|++.+.+++|+|++++++++......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998754 899999999865433256788899999999999999999999999899999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+++|.+++......+++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 999999985443338999999999999999999999 89999999999999999999999999998877654311 11
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAI 229 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~ 229 (356)
....++..|++||.+.+...++.++|+|+||+++++|++|+.||.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 234577889999998433367889999999999999999998873
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=230.93 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=195.6
Q ss_pred HhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
.-|...++||.|.|++||++.+. .++.||+|.+.... ....+..|++.|..+ -+.||+.+.+++..++...+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 35666789999999999999653 47899999997653 335688999999999 58999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~~~~~ 177 (356)
|+||++.....++. ..++...+..++..++.||.++|. +|||||||||+|+|.+. .+.-.|+|||||.....
T Consensus 113 vlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999998988888 356788999999999999999999 99999999999999974 56789999999983210
Q ss_pred C-------------CCc--------------------e---------eecCCCCCCCCCCcccccCCCCCCCCCceehhh
Q 047701 178 N-------------RSH--------------------V---------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215 (356)
Q Consensus 178 ~-------------~~~--------------------~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG 215 (356)
. ... . ......||+||.|||++.+....+.+.||||-|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 000 0 001245999999999998877899999999999
Q ss_pred HHHHHHhcCCCccccCCCcccc--chh---------HH--------HHHHHhhhchh-----------hhHhhc-----C
Q 047701 216 MVSFEIVGRRRNAIVGASESLD--WFP---------KY--------VWEEYEKSELG-----------AMILAC-----G 260 (356)
Q Consensus 216 ~il~ell~g~~~~~~~~~~~~~--~~~---------~~--------~~~~~~~~~~~-----------~~~~~~-----~ 260 (356)
+|++.+++++.||+....+... ... +. .|+......+. +..... .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999998754443211 000 00 00100000000 000000 0
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........+..+.+++.+|++.||.+|.++++.++.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001111233478999999999999999999999873
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=230.85 Aligned_cols=261 Identities=19% Similarity=0.218 Sum_probs=198.3
Q ss_pred hhccccccCcCCceEEEEEEcCC--CcEEEEEEecccCchhHHHHHHHHHHHHhcCC----CCCeeeEeeeE-EcCCeee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPN--GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY----HINLVRLHGFC-HDQHMTA 97 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~ 97 (356)
.|.+.++||+|+||.||.|.... ...+|+|+.......... .+..|..++..+. .+++..+++.+ ....+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 78899999999999999998644 358999998764332222 5777888888886 26899999999 5778899
Q ss_pred EEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-----CceEEeccCC
Q 047701 98 LVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-----FSPKVADFGL 171 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~DfGl 171 (356)
+||+.+ |.+|.++..... +.++..++++++.|++.+|++||+ .|++||||||+|+++... ..+.|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999998 779999885554 889999999999999999999999 999999999999999754 3699999999
Q ss_pred cc--ccCCCCCc----e-e-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH
Q 047701 172 AK--LCDRNRSH----V-T-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 172 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~ 243 (356)
++ .+...... . . ....+||.+|++++++.+. ..+.+.|+||+++++.+++.|..||........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------- 245 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------- 245 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccch-------
Confidence 99 33222211 1 1 2346799999999999988 799999999999999999999888732221111
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.. ++................+.++..+...+-..+..++|.+..+...|......
T Consensus 246 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 KS-----KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HH-----HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 11111111111101223446677777778889999999999999998877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=225.17 Aligned_cols=132 Identities=29% Similarity=0.376 Sum_probs=111.8
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-----C---CCeeeEeeeEEc
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-----H---INLVRLHGFCHD 92 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~ 92 (356)
...+|-..++||=|.|++||++-+ .+.+.||+|+.+.. ..-.+..+.|+.+|++++ | .+||++++.|..
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 347888999999999999999965 56889999999754 234466788999999873 2 369999999975
Q ss_pred ----CCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE
Q 047701 93 ----QHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 158 (356)
Q Consensus 93 ----~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 158 (356)
+..+|||+|++ |.+|-.+|... -+.++...+..|++||+.||.|||++ .||||-||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 56889999999 66888888654 36799999999999999999999984 699999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=220.70 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=186.9
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------ee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------MT 96 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~ 96 (356)
+|--..-+|.|.- .|-.+.+ -.++.||+|.+.... ......+..+|...+..++|+||+.++.++.-.. ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3444556888887 5665643 368899999876431 1233356778999999999999999999997543 56
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|+|||+|.. +|...+. -.++.+++..++.|++.|++|||+ .+|+||||||+||++..+..+||.|||+++...
T Consensus 97 y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccC
Confidence 899999965 9988884 457889999999999999999999 999999999999999999999999999997544
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch---------hHHHHHHH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF---------PKYVWEEY 247 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~---------~~~~~~~~ 247 (356)
.. ...+..+.|..|.|||++.+. .+.+.+||||+||++.||++|.--+- +......|. .......+
T Consensus 170 ~~---~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~-g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 170 TD---FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFP-GKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cc---cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEec-CchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 32 344667788999999999988 59999999999999999999875442 111100000 00000000
Q ss_pred h-------h-------hchhhhHhhcC---CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 E-------K-------SELGAMILACG---IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~-------~-------~~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
. . ....+.+.+.. ..+..+.-...+.+++.+||-.||++|.|.+++++.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0 00000000000 011112234568899999999999999999999984
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=257.63 Aligned_cols=196 Identities=16% Similarity=0.183 Sum_probs=138.4
Q ss_pred cCCC-CCeeeEeeeE-------EcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 047701 77 RTYH-INLVRLHGFC-------HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148 (356)
Q Consensus 77 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 148 (356)
.++| +||+.++++| .+....++++|++ +++|.+++......+++..+..++.||++||.|||+ ++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 3445 5777777776 2234567789988 559999997666779999999999999999999999 99999
Q ss_pred eccCccceEEcC-------------------CCceEEeccCCccccCCCCC--------------ceeecCCCCCCCCCC
Q 047701 149 YDIKPENVLLDA-------------------NFSPKVADFGLAKLCDRNRS--------------HVTISGYKGTPGYSA 195 (356)
Q Consensus 149 ~Dlkp~Nill~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~a 195 (356)
|||||+||||+. ++.+|++|||+++....... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 34556666666654221000 000112458899999
Q ss_pred cccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHH
Q 047701 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMV 275 (356)
Q Consensus 196 PE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 275 (356)
||++.+. .++.++|||||||+||||++|.+|+.... ........ ............+...+
T Consensus 184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~---------~~~~~~~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRH---------RVLPPQILLNWPKEASF 244 (793)
T ss_pred hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHH---------hhcChhhhhcCHHHHHH
Confidence 9999877 68999999999999999999876532100 00000000 00111111223456788
Q ss_pred HHhhcCCCCCCCCCHHHHHH
Q 047701 276 ALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 276 ~~~cl~~~p~~Rps~~~v~~ 295 (356)
+.+||+.+|.+||++.+|++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 89999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=200.86 Aligned_cols=168 Identities=20% Similarity=0.197 Sum_probs=126.2
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|+|.+++..++..+++..++.++.|++.||.|||+ .+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 68999997667789999999999999999999999 66 999999999999999 99987654322
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
..||+.|+|||++.+. .++.++||||||+++|||++|+.|+........ . ......... .. .. ......
T Consensus 64 -~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~-~~~~~~~~~-~~-~~-~~~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSA-----I-LEILLNGMP-AD-DP-RDRSNL 132 (176)
T ss_pred -CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----H-HHHHHHHhc-cC-Cc-cccccH
Confidence 2588999999999887 689999999999999999999998743222110 0 000000000 00 00 000112
Q ss_pred HHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 266 KEKAK--QLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 266 ~~~~~--~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
..... ++.+++.+||..||.+||++.++++.+....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 23333 6999999999999999999999999876553
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=212.75 Aligned_cols=165 Identities=22% Similarity=0.186 Sum_probs=129.8
Q ss_pred HHHhhccccccCcCCceEEEEEEcC--CCcEEEEEEecccC----chhHHHHHHHHHHHHhcCCCCCeee-EeeeEEcCC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP--NGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINLVR-LHGFCHDQH 94 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~ 94 (356)
....|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|++++++++|+|++. ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4457889999999999999999764 57788999875331 2234566899999999999999985 4432 3
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeecc-CccceEEcCCCceEEeccCCcc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI-KPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~DfGla~ 173 (356)
..|+||||++|++|.. +... . ...++.|++++|.|||+ +|++|||| ||+|||++.++.+||+|||+++
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~~-~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARPH-G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHH-hCcc-c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 5799999999999963 2111 1 14678999999999999 99999999 9999999999999999999999
Q ss_pred ccCCCCCcee------ecCCCCCCCCCCcccccC
Q 047701 174 LCDRNRSHVT------ISGYKGTPGYSAPEFLSG 201 (356)
Q Consensus 174 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 201 (356)
.+........ .+...++..|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 8765432222 145668889999999863
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-28 Score=199.68 Aligned_cols=252 Identities=20% Similarity=0.362 Sum_probs=192.6
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecc-cCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
..++..+|....-|..|+|+| .|..+++|++.- ..+.....+|..|+-.++-+.||||+.+++.|.....+.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345677899999999999999 445677787753 233344467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 104 ENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 104 ~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.|+|..++..... -++..++.+++.+++.|++|||+-. .-+..--|....++||++.+.+|.- +-.+ ...
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~k------fsf 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTK------FSF 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccce------eee
Confidence 99999999966543 4778899999999999999999831 2233446889999999998776641 1011 000
Q ss_pred eecCCCCCCCCCCcccccCCCC--CCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh-hhHhhc
Q 047701 183 TISGYKGTPGYSAPEFLSGNYP--ITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG-AMILAC 259 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 259 (356)
...+..-.+.||+||.++.... --.++|+|||++++|||.|..-||. .+.+.+.. +....+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa----------------dlspmecgmkialeg 405 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA----------------DLSPMECGMKIALEG 405 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc----------------cCCchhhhhhhhhcc
Confidence 1122335788999999987632 2357999999999999999987763 23333322 223344
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.+...+++.+..+..|+.-|+..||.+||.++.|+-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 556678888999999999999999999999999999998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=220.47 Aligned_cols=255 Identities=19% Similarity=0.180 Sum_probs=191.6
Q ss_pred cccccCcCCceEEEEEEc-CCCcEEEEEEec----ccCchhHH-HHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 28 YSTRLGFGGFGQVYKGQF-PNGVKIAVKVLN----KNLGKIAE-EQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 28 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~----~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...++|.|++|.|+.... ...+.++.|... ........ ..+..|+-+-..|.|||++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 467799999997777643 233334444322 11111111 226668878888999999888888877666666699
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||++ +|..++ .....++...+..++.|++.|+.|+|+ .|+.|||||++|+++..+|.+||+|||.+..+......
T Consensus 402 ~~~~-Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHH-hcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988 344678999999999999999999999 99999999999999999999999999999877655444
Q ss_pred --eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 182 --VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 182 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
....+.+|+..|+|||++.+........||||.|+++..|.+|+.||.........+ .........-...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIFE 548 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccccccc
Confidence 445678899999999999988556678999999999999999999987665543322 0000001111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.+...++.++++.||.+|.++++|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 122334566788999999999999999999999997
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=191.80 Aligned_cols=262 Identities=29% Similarity=0.341 Sum_probs=198.0
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCchh--HHHHHHHHHHHHhcCCCC-CeeeEeeeEEcCCeeeEEEEe
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI--AEEQFMAEVGTIGRTYHI-NLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 102 (356)
|.+.+.||.|+||.||++... ..+++|.+....... ....+.+|..++..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999875 789999998654433 467899999999999888 799999999887778999999
Q ss_pred cCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCCCC
Q 047701 103 MENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNR 179 (356)
Q Consensus 103 ~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~~ 179 (356)
+.++++.+++.... ..+.......+..|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997774443 379999999999999999999999 9999999999999999988 79999999998655443
Q ss_pred Cce----eecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 180 SHV----TISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 180 ~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
... ......||..|++||.+.+. ...+...|+||+|++++++++|..|+...... ......+.........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 321 23456799999999999873 36889999999999999999999884333221 0001111111111100
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.. ...............+.+++..|+..+|..|.+..+....
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000002223568899999999999999999887764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=182.40 Aligned_cols=141 Identities=17% Similarity=0.192 Sum_probs=110.1
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchh-H------------------------HHHHHHHHHHHhcCCCCCe
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI-A------------------------EEQFMAEVGTIGRTYHINL 83 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~e~~~l~~l~h~ni 83 (356)
...||+|+||.||+|...+|+.||||+++...... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999998789999999997542110 0 1122459999999987776
Q ss_pred eeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeeeccCccceEEcCCC
Q 047701 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL-HEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
.....+... ..+|||||++|+++..... ....++...+..++.|++.+|.|+ |+ .+++||||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence 443333222 2389999999877765532 345789999999999999999999 68 8999999999999998 47
Q ss_pred ceEEeccCCccccC
Q 047701 163 SPKVADFGLAKLCD 176 (356)
Q Consensus 163 ~~kl~DfGla~~~~ 176 (356)
.++|+|||++....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=180.42 Aligned_cols=175 Identities=12% Similarity=0.093 Sum_probs=134.0
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchh--HHHH------HHHHHHHHhcCCCCCeeeEeeeE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI--AEEQ------FMAEVGTIGRTYHINLVRLHGFC 90 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~e~~~l~~l~h~niv~~~~~~ 90 (356)
.+..+.+|+..+.||.|+||.||++.. ++..+|||++....... .... +.+|++.+.++.|++|..+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 345677889999999999999999866 67789999997543211 1122 57899999999999999998886
Q ss_pred EcC--------CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 91 HDQ--------HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 91 ~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
... ...+|+|||++|.+|.++. .++. ....+++.+|..+|+ .|++|||+||+||+++.+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 643 3578999999999998864 1232 345699999999999 9999999999999999888
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHh
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell 222 (356)
++|+|||............ .+.... .+..++|+||||+++.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d--------------~~vler-~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD--------------RIDLER-HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHH--------------HHHHHh-HhcccccccceeEeehHHH
Confidence 9999999876543211110 022223 4667999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=170.67 Aligned_cols=143 Identities=19% Similarity=0.222 Sum_probs=111.8
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCch-------------------------hHHHHHHHHHHHHhcCCCCCe
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGK-------------------------IAEEQFMAEVGTIGRTYHINL 83 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~ni 83 (356)
.+.||+|+||.||+|.+.+|+.||||++...... .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998778999999998754211 001223578999999999887
Q ss_pred eeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
.....+.... .+|||||++|+++..... ....++...+..++.|++.++.++|+ ..|++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence 5544443332 489999998875544321 23567889999999999999999997 27999999999999998 789
Q ss_pred eEEeccCCccccCC
Q 047701 164 PKVADFGLAKLCDR 177 (356)
Q Consensus 164 ~kl~DfGla~~~~~ 177 (356)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=178.02 Aligned_cols=232 Identities=20% Similarity=0.221 Sum_probs=150.6
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEecc--cCchhHHHHHHHHHHHHhcCCC----------CCeeeEeeeEE-
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNK--NLGKIAEEQFMAEVGTIGRTYH----------INLVRLHGFCH- 91 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~- 91 (356)
....+.||.|+++.||.+++. +++++|||+... .......+++.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344678999999999999875 599999998753 2333455677777655555432 12222222221
Q ss_pred -----------cCC-----eeeEEEEecCCCCHhHHhc---cCC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeee
Q 047701 92 -----------DQH-----MTALVYEYMENGSLDGYLF---GKK---RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149 (356)
Q Consensus 92 -----------~~~-----~~~lv~e~~~~~sL~~~l~---~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 149 (356)
+.+ ..+++|+-+.+ +|.+++. ... ..+....++.+..|+++.+++||+ .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 111 23678888854 9988863 122 235566777888999999999999 999999
Q ss_pred ccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccC-------CCCCCCCCceehhhHHHHHHh
Q 047701 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-------NYPITHKCDVYSFGMVSFEIV 222 (356)
Q Consensus 150 Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~ell 222 (356)
||+|+|++++.+|.++|+||+.....+... .. ...+..|.+||.... ...++.+.|.|+||+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999998776544221 11 334578999997643 125788999999999999999
Q ss_pred cCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCC
Q 047701 223 GRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADR 287 (356)
Q Consensus 223 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R 287 (356)
+++.|+....+...... ...... +.++.+..||..+++.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999865544322210 011223 788899999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=165.50 Aligned_cols=186 Identities=17% Similarity=0.045 Sum_probs=139.7
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCc---hhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG---KIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
...|++|+||+||.+.- .+.+++.+.+..... ......+.+|+++|++|. |++++.++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 56899999999998766 677888777765432 122235788999999995 5889999886 34589999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeecc-CccceEEcCCCceEEeccCCccccCCCCCc--
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDI-KPENVLLDANFSPKVADFGLAKLCDRNRSH-- 181 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~DfGla~~~~~~~~~-- 181 (356)
|.+|...+.. ....++.|++.+|.++|+ .|++|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9898654311 124578899999999999 99999999 799999999999999999999865543311
Q ss_pred --ee-------ecCCCCCCCCCCcccccCCCCCC-CCCceehhhHHHHHHhcCCCcccc
Q 047701 182 --VT-------ISGYKGTPGYSAPEFLSGNYPIT-HKCDVYSFGMVSFEIVGRRRNAIV 230 (356)
Q Consensus 182 --~~-------~~~~~gt~~y~aPE~~~~~~~~~-~~~Dv~slG~il~ell~g~~~~~~ 230 (356)
.. ......++.|++|+...-....+ .+.+.++.|.-+|.++|++.+...
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 11234788899998765332233 467888999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=178.37 Aligned_cols=198 Identities=23% Similarity=0.303 Sum_probs=144.5
Q ss_pred CCCCeeeEeeeEEc---------------------------CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHH
Q 047701 79 YHINLVRLHGFCHD---------------------------QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT 131 (356)
Q Consensus 79 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi 131 (356)
.|||||++++.|.+ +..+|+||..++. +|..++.. ...+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHH
Confidence 49999999998753 3456899999865 99999953 456777888899999
Q ss_pred HHHHHHHHhccCCCeeeeccCccceEE--cCCC--ceEEeccCCccccCCCCCcee----ecCCCCCCCCCCcccccCCC
Q 047701 132 AKGLVYLHEECQQRIIHYDIKPENVLL--DANF--SPKVADFGLAKLCDRNRSHVT----ISGYKGTPGYSAPEFLSGNY 203 (356)
Q Consensus 132 ~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~--~~kl~DfGla~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~ 203 (356)
++|+.|||. +|+.|||+|.+|||+ ++++ .+.|+|||.+-...+...... ....-|....||||+.....
T Consensus 351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 999999999999999 4444 578999998754443222211 12344788899999976431
Q ss_pred C-----CCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHh
Q 047701 204 P-----ITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALW 278 (356)
Q Consensus 204 ~-----~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 278 (356)
. .-.++|.|+.|.+.||+++...||+....-... . ..+.+. ..+..+..+++.+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---~---r~Yqe~---------qLPalp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---T---RTYQES---------QLPALPSRVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---h---hhhhhh---------hCCCCcccCChHHHHHHHH
Confidence 1 235899999999999999999988652111111 0 112222 2344556677889999999
Q ss_pred hcCCCCCCCCCHHHHHHHh
Q 047701 279 CVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 279 cl~~~p~~Rps~~~v~~~L 297 (356)
.++.||++|++..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999976554443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=199.45 Aligned_cols=202 Identities=21% Similarity=0.214 Sum_probs=164.8
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEc
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---HINLVRLHGFCHD 92 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 92 (356)
.+..++....+.+.+.||+|+||.||+|...+|+.||+|+.+....-+ |.-=.+++.+|. -+-|..+..+...
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 356677788899999999999999999988779999999987643221 111122333333 2455566666666
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-------CCCceE
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-------ANFSPK 165 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-------~~~~~k 165 (356)
.+..+||+||.+.|+|.++++ ..+.+++.-+..+..|++..+++||. .+||||||||+|+||. +...++
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 777789999999999999996 67789999999999999999999999 9999999999999993 234689
Q ss_pred EeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCC
Q 047701 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRR 226 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~ 226 (356)
|+|||.+-.+.--.........++|-++--+|...|. .++..+|.|.|+.+++.||.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999877655444555678899999999999998 89999999999999999999874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=183.84 Aligned_cols=218 Identities=24% Similarity=0.335 Sum_probs=163.9
Q ss_pred HhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCcc
Q 047701 75 IGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154 (356)
Q Consensus 75 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 154 (356)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....+.++|+.||+|||+. ....|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4678899999999999999999999999999999999988888999999999999999999999982 33499999999
Q ss_pred ceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCC--CC----CCCCCceehhhHHHHHHhcCCCcc
Q 047701 155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN--YP----ITHKCDVYSFGMVSFEIVGRRRNA 228 (356)
Q Consensus 155 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~----~~~~~Dv~slG~il~ell~g~~~~ 228 (356)
|++++....+||.|||+.................-..-|.|||.+.+. .. .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776431111111112234569999998763 11 477899999999999999999888
Q ss_pred ccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 229 IVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD--KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
......... ...... ... .- ....++... .....++..++..||..+|.+||+++.|...++.+..
T Consensus 159 ~~~~~~~~~--~eii~~-~~~-~~----~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDP--DEIILR-VKK-GG----SNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCCh--HHHHHH-HHh-cC----CCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 654443221 111111 111 00 000111111 1334579999999999999999999999998887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=197.70 Aligned_cols=249 Identities=22% Similarity=0.222 Sum_probs=179.6
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHH---HHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEE---QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.+.+.+.||++.|=.|.+|++.+|. |+||++-+........ +.+.|++ ...+++||++++.-+.......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4667789999999999999997777 9999986543333333 3344444 455689999999888888888899999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|... +|.|.+ .-...+...+..-|+.|++.||..+|. .||+|||||.+||||..=+-+.|+||..-+...-.+..
T Consensus 102 yvkh-nLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9976 999888 344567888888899999999999999 99999999999999999889999999876654322111
Q ss_pred ----e-eecCCCCCCCCCCcccccCC----------CCCCCCCceehhhHHHHHHhcC-CCccccCCCccccchhHHHHH
Q 047701 182 ----V-TISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVSFEIVGR-RRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 182 ----~-~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~ell~g-~~~~~~~~~~~~~~~~~~~~~ 245 (356)
. .....+.-.+|.|||.+... ...+.+-||||+||++.||++- +++|...+ .-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----------L~ 245 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----------LL 245 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----------HH
Confidence 1 11112233479999987542 1267889999999999999885 44442111 11
Q ss_pred HHhhh--chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 246 EYEKS--ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 246 ~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.++.+ ...+.+... +++ ..+.+|+..|++.||.+|.++++.++.-.
T Consensus 246 aYr~~~~~~~e~~Le~-Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEK-IED------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred hHhccCccCHHHHHHh-CcC------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111 111111111 111 24889999999999999999999998643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-21 Score=159.11 Aligned_cols=134 Identities=18% Similarity=0.237 Sum_probs=103.9
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-----CCCCeeeEeeeEEcCC---eee-EE
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-----YHINLVRLHGFCHDQH---MTA-LV 99 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv 99 (356)
.+.||+|+||.||. ++.....+||++..... .....+.+|+.+++.+ .||||+++++++.++. ..+ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 56899999999996 44333347998875422 3456789999999999 5799999999998863 333 78
Q ss_pred EEe--cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHH-HHHHhccCCCeeeeccCccceEEcC----CCceEEeccCCc
Q 047701 100 YEY--MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGL-VYLHEECQQRIIHYDIKPENVLLDA----NFSPKVADFGLA 172 (356)
Q Consensus 100 ~e~--~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~DfGla 172 (356)
+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 447899999943 245555 35677888777 99999 99999999999999964 347999995443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=186.30 Aligned_cols=226 Identities=26% Similarity=0.256 Sum_probs=182.0
Q ss_pred ccCcCCceEEEEEEc----CCCcEEEEEEecccCch-hHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 31 RLGFGGFGQVYKGQF----PNGVKIAVKVLNKNLGK-IAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.+|+|.||.|++++- ..|..+|+|+.++.... ..+.....|..++...+ ||.++++.-.+......++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998843 24788999998754321 11124556788888886 9999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
||.|...+ .....+++.....+...++-++.++|. .+++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l-~~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRL-SKEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhcc-ccCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99998877 445667888888899999999999999 99999999999999999999999999999876544332
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
+||..|||||++.+ ....+|.||||++++||++|-.|+.. ..+..++.. ....
T Consensus 154 ---cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~-------------------~~~~~Il~~--~~~~ 206 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG-------------------DTMKRILKA--ELEM 206 (612)
T ss_pred ---ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch-------------------HHHHHHhhh--ccCC
Confidence 68999999999983 57899999999999999999888733 111111111 2345
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
+...+..+.+++..+...+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66777888899999999999999655
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=163.43 Aligned_cols=142 Identities=18% Similarity=0.179 Sum_probs=111.1
Q ss_pred hccccccCcCCceEEEEEE--cCCCcEEEEEEecccCch-----------------------hHHHHHHHHHHHHhcCCC
Q 047701 26 SNYSTRLGFGGFGQVYKGQ--FPNGVKIAVKVLNKNLGK-----------------------IAEEQFMAEVGTIGRTYH 80 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h 80 (356)
|.+.+.||+|+||.||+|. ..+|+.||||++...... .....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6678899999999999998 468999999998753210 011235679999999975
Q ss_pred C--CeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eeeeccCccceE
Q 047701 81 I--NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR-IIHYDIKPENVL 157 (356)
Q Consensus 81 ~--niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~Dlkp~Nil 157 (356)
. .++.++++ ...++||||+.|.+|..... ....+....+..++.|++.++.+||+ .+ ++||||||+||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIl 181 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNIL 181 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEE
Confidence 3 34455543 23489999999988876542 23456677788999999999999999 99 999999999999
Q ss_pred EcCCCceEEeccCCccccC
Q 047701 158 LDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 158 l~~~~~~kl~DfGla~~~~ 176 (356)
++ ++.++|+|||++....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 7899999999986433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=157.80 Aligned_cols=135 Identities=23% Similarity=0.291 Sum_probs=113.4
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+.||+|++|.||+|.+ +|..++||+...... ......+.+|+.++..+.|++++....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 777899998653321 11224577899999999999988777777777788999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
++|++|.+++.... . .+..++.+++.+|.++|+ .+++|||++|+||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999984332 2 888999999999999999 9999999999999999 78899999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=156.08 Aligned_cols=139 Identities=19% Similarity=0.237 Sum_probs=110.3
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCch---------------------hHHHHHHHHHHHHhcCCCC--
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGK---------------------IAEEQFMAEVGTIGRTYHI-- 81 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~l~h~-- 81 (356)
+|.+.+.||+|+||.||++...+|+.||||++..+... ........|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 57788999999999999999888999999987643210 1112356788888888777
Q ss_pred CeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC
Q 047701 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 161 (356)
Q Consensus 82 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 161 (356)
.++..++. ...++||||++|++|..... ......++.+++.++.++|+ .+++||||||+||+++++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence 44444442 34589999999999876542 13456789999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCC
Q 047701 162 FSPKVADFGLAKLCDR 177 (356)
Q Consensus 162 ~~~kl~DfGla~~~~~ 177 (356)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=155.20 Aligned_cols=131 Identities=22% Similarity=0.294 Sum_probs=106.2
Q ss_pred ccCcCCceEEEEEEcCCCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.||+|+||.||+|.+ ++..+++|+...... .....++.+|++++..+.|+++.....++.+....++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 678899998653211 112356778999999998887655555555666778999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
+|++|.+++..... .++.+++.+|.+||+ .+++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743211 789999999999999 9999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-21 Score=174.04 Aligned_cols=174 Identities=21% Similarity=0.314 Sum_probs=135.2
Q ss_pred CeeeEEEEecCCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 94 HMTALVYEYMENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
.+.|+.|++|...+|.+++..+ ....++...+.++.|++.++.| ++.+|+|+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3578999999999999999533 4568889999999999999999 5899999999999999988999999999
Q ss_pred ccccCCCC----CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHH
Q 047701 172 AKLCDRNR----SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 172 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
........ .....+..+||..||+||.+.+. .|+.++||||||+||+|++. -+. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T-------------------~ 462 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFST-------------------Q 462 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhcc-------------------H
Confidence 88766554 22234557799999999999988 79999999999999999996 221 1
Q ss_pred HhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 047701 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAV 293 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v 293 (356)
........-++++.+++.....-++-..|+.+++.+.|.+||++.++
T Consensus 463 ~er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 463 FERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 11222223334444443333334556789999999999999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=172.90 Aligned_cols=134 Identities=20% Similarity=0.251 Sum_probs=109.3
Q ss_pred ccccccCcCCceEEEEEEcCCCcEEEEEEe-cccCc------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 27 NYSTRLGFGGFGQVYKGQFPNGVKIAVKVL-NKNLG------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~-~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
...+.||+|+||+||+|.+..+ .+++|+. .+... ......+.+|++++.+++|++++....++.+....++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 3467899999999999987443 3444442 22111 12235688999999999999998887777777778999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
|||++|++|.+++. ....++.|++.+|.|||+ .+++||||||+||++ +++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999884 457899999999999999 999999999999999 577999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=173.44 Aligned_cols=207 Identities=22% Similarity=0.276 Sum_probs=142.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.++..+.|..|++|.||.++++ +.+.+|+|+-+++. +.+- ++.....|.+|
T Consensus 84 df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccceeEeeccCCCCceeeeeccccccchhhcccccch-------hhhc--cccccCCccee-------------------
Confidence 4455688999999999999885 47788885433221 1111 33333344433
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce-
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV- 182 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~- 182 (356)
|+-.+.+ +..+.+... ++.+++|||+ -+|+|||+||+|.+|..-|.+|+.|||+++..-......
T Consensus 136 --gDc~tll-k~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLL-KNIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhc-ccCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 3333334 222333322 2789999999 999999999999999999999999999987532111110
Q ss_pred ------------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 183 ------------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 183 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
....++||+.|.|||++..+ .|+...|.|++|+|+||++-|..||+.+.++.. +...-..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeel-------fg~visd 273 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-------FGQVISD 273 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-------Hhhhhhh
Confidence 11346899999999999887 799999999999999999999999877655422 0110000
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP 288 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp 288 (356)
.....+.....+.++.+++.+.++.+|..|-
T Consensus 274 -------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 -------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0011223444567899999999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=140.93 Aligned_cols=140 Identities=19% Similarity=0.224 Sum_probs=98.6
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchh-HHHH----------------------HHHHHHHHhcCCCC--Ce
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI-AEEQ----------------------FMAEVGTIGRTYHI--NL 83 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~e~~~l~~l~h~--ni 83 (356)
.+.||+|+||+||+|...+++.||||++....... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 56899999999999998789999999987532111 1111 13456666665433 24
Q ss_pred eeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
.+++++ ...++||||++++.+......... . ...+..++.+++.++.++|. ..+++|+||||+||+++ ++.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCc
Confidence 444443 235899999998543211101100 1 16678899999999999996 27899999999999999 889
Q ss_pred eEEeccCCccccCC
Q 047701 164 PKVADFGLAKLCDR 177 (356)
Q Consensus 164 ~kl~DfGla~~~~~ 177 (356)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=141.71 Aligned_cols=136 Identities=20% Similarity=0.232 Sum_probs=105.4
Q ss_pred ccccC-cCCceEEEEEEcCCCcEEEEEEecccC------------chhHHHHHHHHHHHHhcCCCCCe--eeEeeeEEcC
Q 047701 29 STRLG-FGGFGQVYKGQFPNGVKIAVKVLNKNL------------GKIAEEQFMAEVGTIGRTYHINL--VRLHGFCHDQ 93 (356)
Q Consensus 29 ~~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 93 (356)
...|| .||.|+||.+.. .+..++||.+.... .......+.+|++++.+|.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 899999999988 46789999875311 11233567889999999988774 6677764432
Q ss_pred -Ce---eeEEEEecCC-CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 94 -HM---TALVYEYMEN-GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 94 -~~---~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
.. .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+ .|++||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2599999997 699988843 345544 35789999999999 9999999999999999888999999
Q ss_pred cCCccc
Q 047701 169 FGLAKL 174 (356)
Q Consensus 169 fGla~~ 174 (356)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=132.61 Aligned_cols=134 Identities=20% Similarity=0.164 Sum_probs=113.1
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCC--CCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH--INLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..+++ .++++++++....+..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4679999999999999844 7899999865432 4578889999999976 58999999888888899999999887
Q ss_pred CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 107 SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 107 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5667788999999999999984334799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-19 Score=172.34 Aligned_cols=258 Identities=22% Similarity=0.230 Sum_probs=198.0
Q ss_pred HHhhccccccCcCCceEEEEEEcC--CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP--NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 98 (356)
...|.+.+.||+|+|+.|-..... ....+|+|.+.... ......+...|..+-..+. |+|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 557788888999999999988663 34556666655432 2233344555777777776 9999999999999999999
Q ss_pred EEEecCCCCHhHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCeeeeccCccceEEcCCC-ceEEeccCCcccc
Q 047701 99 VYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLH-EECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLC 175 (356)
Q Consensus 99 v~e~~~~~sL~~~l-~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~ 175 (356)
+++|..|+++.+.+ .......+....-.++.|+..++.|+| . .++.|+||||+|.+++..+ .++++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999998888 444436777888899999999999999 7 9999999999999999999 9999999999988
Q ss_pred CC-CCCceeecCCCC-CCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 176 DR-NRSHVTISGYKG-TPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 176 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.. ...........| ++.|+|||...+........|+||.|+++..+++|..|+.........+... .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~---~~~~~---- 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW---KSNKG---- 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee---ccccc----
Confidence 77 444444455667 9999999999885467889999999999999999999987655543221110 00000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...............+++.+++..+|..|.+.+++..
T Consensus 249 -----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0001122334456778888999999999999888775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=146.37 Aligned_cols=140 Identities=18% Similarity=0.215 Sum_probs=98.5
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHH---------------------------------------HHHHH
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAE---------------------------------------EQFMA 70 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------~~~~~ 70 (356)
+.||+|++|+||+|++++|+.||||+...+..+... -++..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 459999999999999999999999998654321111 02334
Q ss_pred HHHHHhcCC-----CCCeeeEeeeE-EcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHH-HHHHHHhccC
Q 047701 71 EVGTIGRTY-----HINLVRLHGFC-HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK-GLVYLHEECQ 143 (356)
Q Consensus 71 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~-~l~~LH~~~~ 143 (356)
|.+.+.++. ++++ .+-.++ ...+..+|||||++|++|.++......... ...++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---
Confidence 555454442 3333 222222 223456899999999999887643222222 3456666665 4678888
Q ss_pred CCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
.|++|+|++|.||+++.++.++++|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=138.84 Aligned_cols=256 Identities=22% Similarity=0.210 Sum_probs=191.3
Q ss_pred HHHHHHHhhccccccCc--CCceEEEEEEc---CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcC-CCCCeeeEeeeE
Q 047701 18 SLQLNNFTSNYSTRLGF--GGFGQVYKGQF---PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRT-YHINLVRLHGFC 90 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 90 (356)
..+....+......+|. |.+|.||.+.. .++..+|+|.-+... .......=.+|+...+.+ .|+|.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34555667777889999 99999999966 358889999743221 112223334566666666 599999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHH----HHHHHHhccCCCeeeeccCccceEEcCC-CceE
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDAN-FSPK 165 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~k 165 (356)
...+..++-+|+|. .+|..+.......+....++..+.++.+ ||.++|+ .+++|-|+||.||++..+ ...+
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceee
Confidence 99999999999995 6888888777777888999999999999 9999999 999999999999999888 8899
Q ss_pred EeccCCccccCCCCCcee---ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH
Q 047701 166 VADFGLAKLCDRNRSHVT---ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~ 242 (356)
++|||+...+........ .....|...|++||..++. ++..+|+|++|.++.+..++......+.-..+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W------ 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSW------ 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCc------
Confidence 999999988776542211 1223578889999999876 78999999999999998887655544422221
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......-+ ..+.......++...+..+++.+|-.|++...+..
T Consensus 336 --~~~r~~~i--------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 --SQLRQGYI--------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cccccccC--------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111 11222233445566888999999999998877765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.6e-15 Score=138.08 Aligned_cols=137 Identities=18% Similarity=0.217 Sum_probs=90.3
Q ss_pred cccCcCCceEEEEEEcCC-CcEEEEEEecccCchh---------------------------------HHH------HHH
Q 047701 30 TRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKI---------------------------------AEE------QFM 69 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~~------~~~ 69 (356)
+-||+|++|+||+|++++ |+.||||+...+..+. -.. ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999876 9999999997543111 011 133
Q ss_pred HHHHHHhcCC----CCCeeeEeeeEEc-CCeeeEEEEecCCCCHhHHhccCCC-----CCCHHHHHHHHHHHHHHHHHHH
Q 047701 70 AEVGTIGRTY----HINLVRLHGFCHD-QHMTALVYEYMENGSLDGYLFGKKR-----ALEWEKLHEIAIGTAKGLVYLH 139 (356)
Q Consensus 70 ~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-----~l~~~~~~~i~~qi~~~l~~LH 139 (356)
+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+++.++-.-... .+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 3444444432 3333333233322 3456899999999999875321111 23333333444443 3
Q ss_pred hccCCCeeeeccCccceEEcCCC----ceEEeccCCccccC
Q 047701 140 EECQQRIIHYDIKPENVLLDANF----SPKVADFGLAKLCD 176 (356)
Q Consensus 140 ~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla~~~~ 176 (356)
. .|++|+|+||.||+++.++ .++++|||++....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 8999999999999999887 99999999988765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.8e-14 Score=115.48 Aligned_cols=126 Identities=21% Similarity=0.120 Sum_probs=94.1
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
+.|+.|.++.||++.. .+..|++|+...... ....+..|+.+++.+.+.++ ++++.+.. ...++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 5689999999999987 477899999765421 12345778888888865444 45555443 335799999999887
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-----eeeeccCccceEEcCCCceEEeccCCcc
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR-----IIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...- .....++.+++++|+.||. .+ ++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6420 1123457889999999998 55 59999999999998 5689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.8e-13 Score=108.90 Aligned_cols=139 Identities=15% Similarity=0.115 Sum_probs=100.0
Q ss_pred ccccCcCCceEEEEEEcCC-------CcEEEEEEecccCc---------------------hhHHHHHH----HHHHHHh
Q 047701 29 STRLGFGGFGQVYKGQFPN-------GVKIAVKVLNKNLG---------------------KIAEEQFM----AEVGTIG 76 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~~----~e~~~l~ 76 (356)
...||.|--+.||.|...+ +..+|||+.+.... ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 47999998752110 01122223 7999999
Q ss_pred cCC--CCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHH-HhccCCCeeeeccCc
Q 047701 77 RTY--HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL-HEECQQRIIHYDIKP 153 (356)
Q Consensus 77 ~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dlkp 153 (356)
++. .-+++.++++ ...+|||||+.+..+..... ....++......+..+++.+|..| |. .+++||||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 985 3467777765 34589999997643322111 122355567778889999999999 88 8999999999
Q ss_pred cceEEcCCCceEEeccCCccccC
Q 047701 154 ENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 154 ~Nill~~~~~~kl~DfGla~~~~ 176 (356)
.||++++ +.++|+|||.+....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-14 Score=124.39 Aligned_cols=206 Identities=22% Similarity=0.314 Sum_probs=139.4
Q ss_pred HHHHHHHHhcCCCCCeeeEeeeEEcCC-----eeeEEEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHH
Q 047701 68 FMAEVGTIGRTYHINLVRLHGFCHDQH-----MTALVYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLH 139 (356)
Q Consensus 68 ~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH 139 (356)
...-+..+-++-|-|+|+++.++.+.. ...+++|||..|+|..+|+. ....+......+|+.||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 333455566667999999999997644 46899999999999999963 3567899999999999999999999
Q ss_pred hccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc---eeecCCCCCCCCCCcccccCCCCCCCCCceehhhH
Q 047701 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH---VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGM 216 (356)
Q Consensus 140 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~ 216 (356)
+ +...++|+++..+.|++..+|-+|+. .+........... .......|-++|.+||.=... ..+.++|||+||.
T Consensus 194 s-~~PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgm 270 (458)
T KOG1266|consen 194 S-CDPPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGM 270 (458)
T ss_pred c-cCCccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhH
Confidence 8 44789999999999999988777763 3322211111100 011224467899999986544 5788999999999
Q ss_pred HHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 217 VSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 217 il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..++|.-+.....-+.+... .+..+...+. ......-..++..|++..|..||+|.+++.
T Consensus 271 cAlemailEiq~tnseS~~~-----------~ee~ia~~i~--------~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVE-----------VEENIANVII--------GLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHHHHheeccCCCcceee-----------hhhhhhhhee--------eccCccccCcCcccccCCCCCCcchhhhhc
Confidence 99998765432111111000 0000000000 000112346778899999999999988765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.9e-13 Score=123.93 Aligned_cols=166 Identities=15% Similarity=0.166 Sum_probs=129.6
Q ss_pred cCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHH
Q 047701 45 FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKL 124 (356)
Q Consensus 45 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~ 124 (356)
..++.+|.|.+.+.... .......+-+..++.++||||+++++.+......|||+|.+. .|..++... +...+
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHH
Confidence 34688899998876644 444567788889999999999999999999999999999985 788888433 36677
Q ss_pred HHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCC
Q 047701 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204 (356)
Q Consensus 125 ~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 204 (356)
..-+.||+.||.|||+ +.+++|++|..+.|+|+..|..||++|-++.......... ....---.|..|+.+...
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s-- 180 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPS-- 180 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCcc--
Confidence 7789999999999986 3799999999999999999999999998775443322111 111112246777776544
Q ss_pred CCCCCceehhhHHHHHHhcC
Q 047701 205 ITHKCDVYSFGMVSFEIVGR 224 (356)
Q Consensus 205 ~~~~~Dv~slG~il~ell~g 224 (356)
.-..|.|-||++++|++.|
T Consensus 181 -~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 -EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccchhhhhHHHHHHHHhCc
Confidence 2457999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.9e-13 Score=104.57 Aligned_cols=131 Identities=21% Similarity=0.249 Sum_probs=98.2
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEec-ccCc------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLN-KNLG------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~-~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..+++|+-+.||.+.+ -|..+++|.-. +... .....+..+|++++.++.--.|....=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4588999999999988 44456777533 3221 22334567799999988654444444445555566799999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
++|..|.+.+... ...++..+-.-+.-||. .||+|+||.++||++..++ +.++||||+.
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 9999999888544 25677777788888999 9999999999999997764 9999999986
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.5e-13 Score=103.92 Aligned_cols=142 Identities=20% Similarity=0.306 Sum_probs=106.5
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEec-ccC------chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLN-KNL------GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~-~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|-||+-+.|+++.+ .|+...||.-. +.. ..-...+..+|++.+.++.--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 46788999999999998 77777787543 221 23444677889999998764444443345555556679999
Q ss_pred ecCC-CCHhHHhccCCCCCCH-HHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEEeccCCccc
Q 047701 102 YMEN-GSLDGYLFGKKRALEW-EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKL 174 (356)
Q Consensus 102 ~~~~-~sL~~~l~~~~~~l~~-~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~ 174 (356)
|.+| .++.+++......-+. .....++.+|-+.+.-||. .+++|+||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 5888888765444333 3447899999999999999 9999999999999996554 458999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.4e-14 Score=129.94 Aligned_cols=245 Identities=20% Similarity=0.210 Sum_probs=175.5
Q ss_pred hhccccccCcCCceEEEEEEc--CCCcEEEEEEecccCchhHHH-HHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF--PNGVKIAVKVLNKNLGKIAEE-QFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (356)
++.+...||.|.|+.|+.... .++..+++|.+.+.......+ .-+.|+.+...+ .|.+++..+..+......|+=.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 455567899999999999853 358889999887664333322 234455555555 5888998888888777778999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~~~~~~~ 179 (356)
|||+++++...+ .-...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||....+.-..
T Consensus 346 e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 346 EFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred hhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec
Confidence 999999887766 344567888999999999999999999 999999999999999775 788999999876422111
Q ss_pred CceeecCCCCCCCCC-CcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYS-APEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
....+.-++. ..|++.....+..+.|++|||..+.+.+++..-...+ .-...+..
T Consensus 422 -----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------------------~~~~~i~~ 477 (524)
T KOG0601|consen 422 -----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------------------VQSLTIRS 477 (524)
T ss_pred -----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-------------------ccceeeec
Confidence 1122333455 3666665557899999999999999998876421000 00001111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
.......+...++..+.+.++..++..||.+.++.....
T Consensus 478 -~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 478 -GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 112233334467888888899999999999988876544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.5e-12 Score=110.91 Aligned_cols=142 Identities=19% Similarity=0.190 Sum_probs=110.3
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCC--CCeeeEeeeEEcCC---eeeEEEEecC
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH--INLVRLHGFCHDQH---MTALVYEYME 104 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~ 104 (356)
+.|+.|..+.||++...+|+.+++|.............+..|+.++..+.+ .++++++.+...+. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998766688999997654322234568889999999865 34677777776642 5689999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC------------------------------------------ 142 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------ 142 (356)
|.++...+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888765521 45777888888899999999998521
Q ss_pred -----------CCCeeeeccCccceEEcC--CCceEEeccCCcc
Q 047701 143 -----------QQRIIHYDIKPENVLLDA--NFSPKVADFGLAK 173 (356)
Q Consensus 143 -----------~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~ 173 (356)
...++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999988 5678999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=101.25 Aligned_cols=140 Identities=14% Similarity=0.006 Sum_probs=100.4
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchh----------HHHHHHHHHHHHhcCCCCC--eeeEeeeEEc-----
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI----------AEEQFMAEVGTIGRTYHIN--LVRLHGFCHD----- 92 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~----- 92 (356)
+.+-.-.-..|+++.+ +|+.|.||......... ....+.+|.+.+.++...+ ++.+++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344333345777777 67889999764322111 1114778999888885333 3445555543
Q ss_pred CCeeeEEEEecCCC-CHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-------CCc
Q 047701 93 QHMTALVYEYMENG-SLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-------NFS 163 (356)
Q Consensus 93 ~~~~~lv~e~~~~~-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~ 163 (356)
....+||||++++. +|.+++... ....+......++.+++..+.-||. .|++|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999875 899988432 3455677788999999999999999 99999999999999975 468
Q ss_pred eEEeccCCcc
Q 047701 164 PKVADFGLAK 173 (356)
Q Consensus 164 ~kl~DfGla~ 173 (356)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.8e-11 Score=96.40 Aligned_cols=127 Identities=24% Similarity=0.309 Sum_probs=84.0
Q ss_pred EEEEEEcCCCcEEEEEEecccC-------------------------chhHHHHHHHHHHHHhcCCCC--CeeeEeeeEE
Q 047701 39 QVYKGQFPNGVKIAVKVLNKNL-------------------------GKIAEEQFMAEVGTIGRTYHI--NLVRLHGFCH 91 (356)
Q Consensus 39 ~Vy~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 91 (356)
.||.|...+|..+|||+..... .........+|++.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899988889999999874210 011223466799999999755 567777553
Q ss_pred cCCeeeEEEEecC--CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHH-HHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 92 DQHMTALVYEYME--NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVY-LHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 92 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
..+|||||++ |..+..+.... ++......++.+++..+.. +|. .|++|+||.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 65555443211 1134456677778775555 567 999999999999999887 999999
Q ss_pred cCCccccC
Q 047701 169 FGLAKLCD 176 (356)
Q Consensus 169 fGla~~~~ 176 (356)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.5e-11 Score=119.69 Aligned_cols=244 Identities=18% Similarity=0.199 Sum_probs=166.6
Q ss_pred ccccCcCCceEEEEEEcC-CCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 29 STRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
.+-+-+|.++.++.+.-. .|...++|+.... ..+...+....+-.++....+|-++..+.-+......+|+++|+.+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 346788899988887542 3555565554322 1112222333333344334556666666555667788999999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC--------
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR-------- 177 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~-------- 177 (356)
++|...+...+ ..+.+-.......+.++++|||. ..+.|+|++|.|.++..++..++.|||.......
T Consensus 889 ~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 889 GDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred CCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 99999885443 45666666677788899999998 7799999999999999999999999984332110
Q ss_pred -------------CCCc--------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc
Q 047701 178 -------------NRSH--------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236 (356)
Q Consensus 178 -------------~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~ 236 (356)
.... .......||+.|.+||...+. .....+|.|+.|++++|.++|.+|+....++.
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~- 1042 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-RHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ- 1042 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccccc-cCCCcchhhhhhhhhhhhhcCCCCCCCcchhh-
Confidence 0000 011235689999999999988 68889999999999999999999875544432
Q ss_pred cchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 047701 237 DWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMS 291 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 291 (356)
.++......+ .....+...+.+..+++...+..+|.+|-.+.
T Consensus 1043 ------~f~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ------IFENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ------hhhccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1111111111 12233444567788899999999999997766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.5e-10 Score=100.61 Aligned_cols=165 Identities=15% Similarity=0.219 Sum_probs=125.1
Q ss_pred ceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCeeeEEEEecCC-CCHhH
Q 047701 37 FGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMTALVYEYMEN-GSLDG 110 (356)
Q Consensus 37 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-~sL~~ 110 (356)
-.+.|++.. .+|..|++|++.-+. .........-++..+++.|.|||++..++.. ...+++|++|.++ ++|-+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDR-DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccc-ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 357899964 579999999994221 1112223445778899999999999998873 4467899999875 57766
Q ss_pred HhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 111 YLFGK--------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 111 ~l~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+.... +....+..+|.++.|+..||.++|+ .|+.-+-|.+.+|+++.+.+++|..+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 55321 2347889999999999999999999 999999999999999999899999998876554
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~ 225 (356)
.... +.+. --.+-|.=.||.+++.|.+|.
T Consensus 445 ~d~~----------------~~le----~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDPT----------------EPLE----SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCCC----------------cchh----HHhhhhHHHHHHHHHHHhhcc
Confidence 3321 1121 123678889999999999985
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-10 Score=96.03 Aligned_cols=136 Identities=24% Similarity=0.228 Sum_probs=101.7
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccC---------------------chhHHHHHHHHHHHHhcCCCC--C
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL---------------------GKIAEEQFMAEVGTIGRTYHI--N 82 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h~--n 82 (356)
..+++.||-|--+.||.|..+.|.++|||.=.-.. ...+.....+|+++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678899999999999999999999999632110 012234567899999999644 6
Q ss_pred eeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
|+..+++- ...+||||++|-.|...- ++.+..-.++..|++-+.-+-. .|+||+|+.+-||+++++|
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCccccc----cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCC
Confidence 77777654 447999999986554322 2445555666666666666666 8999999999999999999
Q ss_pred ceEEeccCCccc
Q 047701 163 SPKVADFGLAKL 174 (356)
Q Consensus 163 ~~kl~DfGla~~ 174 (356)
.++++||.-+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3e-10 Score=106.56 Aligned_cols=145 Identities=18% Similarity=0.258 Sum_probs=96.5
Q ss_pred ccc-cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHH---------------------------------------
Q 047701 27 NYS-TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEE--------------------------------------- 66 (356)
Q Consensus 27 ~~~-~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~--------------------------------------- 66 (356)
+|. +-|+.++-|+||+|++++|+.||||+...+..+....
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 344 4589999999999999999999999986543211111
Q ss_pred HHHHHHHHHhcCC-----CCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 047701 67 QFMAEVGTIGRTY-----HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141 (356)
Q Consensus 67 ~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 141 (356)
++.+|...+.++. .+++.-..=+....+...|+|||++|-.+.+.........+.+.+.....++. +..+-.
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~- 283 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR- 283 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh-
Confidence 2334444444432 33332222233334556899999999999888533345556444444443332 222223
Q ss_pred cCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 142 ~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
.|++|.|..|.||+++.+|.+.+.|||+.....
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 799999999999999999999999999987654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.9e-09 Score=93.84 Aligned_cols=264 Identities=13% Similarity=0.091 Sum_probs=160.6
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhc-CCCCCeeeEeeeE------Ec-CCee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHGFC------HD-QHMT 96 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~------~~-~~~~ 96 (356)
-+.+++-||+|+-+.+|-.-- -...+-|+...... ....+. +..|.. -.||-+-.-+.|= .+ +...
T Consensus 12 ~i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Ppp-a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 12 PIPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPP-AAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred ccCCCccccCCccceeeecch--hhchhheeecCCCc-hHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 345678899999999996532 11234476654322 222222 222333 2455433212211 12 2235
Q ss_pred eEEEEecCCC-CHhHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 97 ALVYEYMENG-SLDGYLFG-----KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 97 ~lv~e~~~~~-sL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
.++|..+.+. .+.++.+. +.....|...+++++.++.+.+-||. .|.+-+|++++|+|+++++.+.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccc
Confidence 6788888763 34444422 23458999999999999999999999 999999999999999999999999865
Q ss_pred CccccCCCCCceeecCCCCCCCCCCccccc-----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHH
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~ 245 (356)
.-....+.. .....+|...|.+||.-. +. .-+...|.|.||+++++++.|.+..+.+.......-+... .
T Consensus 163 sfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~-~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E-~ 237 (637)
T COG4248 163 SFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGF-ERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE-T 237 (637)
T ss_pred ceeeccCCc---eEecccCccccCCHHHhcccccccc-CCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch-h
Confidence 544332222 123356888999999754 22 4577899999999999999885544444333221110000 0
Q ss_pred HHhhhchhhhHh------hcCCCchhHHHHHHHHHHHHhhcCC--CCCCCCCHHHHHHHhhhccc
Q 047701 246 EYEKSELGAMIL------ACGIEEKDKEKAKQLCMVALWCVQD--SPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 246 ~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~--~p~~Rps~~~v~~~L~~~~~ 302 (356)
....+.+....+ .........-.++.+..|..+|+.. ++.-||+++..+..|..+..
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 111111111111 1111112223457788888899853 46789999998888876543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-09 Score=91.73 Aligned_cols=124 Identities=19% Similarity=0.205 Sum_probs=92.0
Q ss_pred CCcEEEEEEecccCc------hhHHHHHHHHHHHHhcCCCC--CeeeEeeeEEcCC----eeeEEEEecCCC-CHhHHhc
Q 047701 47 NGVKIAVKVLNKNLG------KIAEEQFMAEVGTIGRTYHI--NLVRLHGFCHDQH----MTALVYEYMENG-SLDGYLF 113 (356)
Q Consensus 47 ~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~ 113 (356)
.++.+-+|....... ........+|...+.+|... .++.++++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 356666775432211 12345677888888877433 3566666665532 347999999874 7999885
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEEeccCCccc
Q 047701 114 GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKL 174 (356)
Q Consensus 114 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~ 174 (356)
.... .+......++.+++..+.-||. .|++|+|+++.|||++.++ .+.++||+.++.
T Consensus 111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQ-LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcc-cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 4222 6777888999999999999999 9999999999999998876 899999987764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-10 Score=108.92 Aligned_cols=153 Identities=22% Similarity=0.319 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec-------CCCCCCCCCCccccc
Q 047701 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS-------GYKGTPGYSAPEFLS 200 (356)
Q Consensus 128 ~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~-------~~~gt~~y~aPE~~~ 200 (356)
+.+++.|+.|+|. ..++||++|.|++|.++..+.+||+.|+.+............. -..-..-|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445599999998 4799999999999999999999999999876544322111100 012345699999998
Q ss_pred CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhc
Q 047701 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCV 280 (356)
Q Consensus 201 ~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 280 (356)
+. ..+.++|+||+|+++|-+..|+.+.......... .......+...........+.++.+=+.+++
T Consensus 183 ~~-~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GT-TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cc-cccccccceeeeeEEEEEecCCcchhhccCCcch------------hhhhhcccccccccccccCcHHHHHHHHHHh
Confidence 86 6899999999999999999766654333221111 0011111111122233567788999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 047701 281 QDSPADRPPMSAVVK 295 (356)
Q Consensus 281 ~~~p~~Rps~~~v~~ 295 (356)
..++..||++..+..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998776654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-08 Score=83.35 Aligned_cols=138 Identities=15% Similarity=0.067 Sum_probs=102.5
Q ss_pred cCcCCceEEEEEEcCCCcEEEEEEecccC----c-hhHHHHHHHHHHHHhcCCCC--CeeeEeeeEEc----CCeeeEEE
Q 047701 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNL----G-KIAEEQFMAEVGTIGRTYHI--NLVRLHGFCHD----QHMTALVY 100 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----~-~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~----~~~~~lv~ 100 (356)
-|+||-+.|++..+ +|+.+-+|.-.... . +.....|.+|+..+.+|..- .++++...... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 57799999999987 55578888764221 1 34557899999999998532 34555422211 12357999
Q ss_pred EecCC-CCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc--eEEeccCCcc
Q 047701 101 EYMEN-GSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLAK 173 (356)
Q Consensus 101 e~~~~-~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla~ 173 (356)
|-+.| -+|.+++... -.+.+......+..+++..+.-||+ .|+.|+|+.+.||+++.++. +.++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 5899888443 2466888888999999999999999 99999999999999986666 9999995443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.2e-09 Score=96.33 Aligned_cols=140 Identities=19% Similarity=0.224 Sum_probs=93.2
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHH------------------------------------HHHHHHH
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEE------------------------------------QFMAEVG 73 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~------------------------------------~~~~e~~ 73 (356)
+-||.-+.|+||+|++++|+.||||+-+....+.... +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4589999999999999999999999986543222111 2233333
Q ss_pred HHhcC----CCCC------eeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccC
Q 047701 74 TIGRT----YHIN------LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143 (356)
Q Consensus 74 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 143 (356)
-..+. .|-+ |++++-.+ .....|+||||+|..+.+.-.-....++...+...+.+... +....
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~-----~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL-----EQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH-----HHHHh
Confidence 33322 2334 33343222 33568999999998887765434556676665555554432 22222
Q ss_pred CCeeeeccCccceEEc----CCCceEEeccCCccccC
Q 047701 144 QRIIHYDIKPENVLLD----ANFSPKVADFGLAKLCD 176 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill~----~~~~~kl~DfGla~~~~ 176 (356)
.|++|.|-.|.||++. .++.+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 6899999999999998 36789999999987554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-07 Score=80.09 Aligned_cols=137 Identities=16% Similarity=0.233 Sum_probs=85.0
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC--eeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN--LVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +++++++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 24467889876543 2344688999998885333 5778888888888889999998863
Q ss_pred -HhHHhc--------------c-----CC---CCCCHHHHH-HHHH----------HHHH-HHHHHHh-ccCCCeeeecc
Q 047701 108 -LDGYLF--------------G-----KK---RALEWEKLH-EIAI----------GTAK-GLVYLHE-ECQQRIIHYDI 151 (356)
Q Consensus 108 -L~~~l~--------------~-----~~---~~l~~~~~~-~i~~----------qi~~-~l~~LH~-~~~~~ivH~Dl 151 (356)
+...+. . +. ......... .+.. .+.. ...+|.. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 211110 0 00 011111100 0100 0111 1122221 11246799999
Q ss_pred CccceEEcCCCceEEeccCCcc
Q 047701 152 KPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 152 kp~Nill~~~~~~kl~DfGla~ 173 (356)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-07 Score=77.38 Aligned_cols=138 Identities=15% Similarity=0.118 Sum_probs=86.8
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHH---------HHHHHHHhcCC---CCCeeeEee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQF---------MAEVGTIGRTY---HINLVRLHG 88 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~~ 88 (356)
+.+..+...+++-.....-|.+... +|+.+++|....... .....| .+.+..+.++. -.....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3445566666666666666666666 678899998764321 111111 22333333332 122223232
Q ss_pred eEEc-----CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 89 FCHD-----QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 89 ~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
+... ....+|+|||++|..|.+... ++. .++..+.+++.-||. .|++|+|..|+|++++++ .
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-c
Confidence 2222 234568999999988766541 222 355667788999999 999999999999999865 5
Q ss_pred eEEeccCCcc
Q 047701 164 PKVADFGLAK 173 (356)
Q Consensus 164 ~kl~DfGla~ 173 (356)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999997754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.8e-07 Score=78.40 Aligned_cols=138 Identities=20% Similarity=0.270 Sum_probs=93.6
Q ss_pred ccCcCCceEEEEEEcCCCcEEEEEEecccCchh------------------HHH-----HHHHHHHHHhcCC--CCCeee
Q 047701 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKI------------------AEE-----QFMAEVGTIGRTY--HINLVR 85 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~-----~~~~e~~~l~~l~--h~niv~ 85 (356)
-|++|--+.||+|...++..+|||+........ ... =...|++-|.++. +=.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 467888899999988789999999986432111 001 1235777887773 345566
Q ss_pred EeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceE
Q 047701 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165 (356)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 165 (356)
.+++... .|||||+....+..-. -..-.+.......+..++++.+.-|-. ..++||+||..-|||+. ++.+.
T Consensus 135 Pi~~~~n----VLvMEfIg~~g~pAP~-LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 135 PIAFRNN----VLVMEFIGDDGLPAPR-LKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred ceeecCC----eEEEEeccCCCCCCCC-cccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEE
Confidence 6665533 7999999653111000 011223333577778888888877765 27999999999999999 77999
Q ss_pred EeccCCccccC
Q 047701 166 VADFGLAKLCD 176 (356)
Q Consensus 166 l~DfGla~~~~ 176 (356)
++|||-|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999886544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.5e-07 Score=77.80 Aligned_cols=75 Identities=9% Similarity=0.043 Sum_probs=53.5
Q ss_pred cCcCCc-eEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecCCCCHh
Q 047701 32 LGFGGF-GQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMENGSLD 109 (356)
Q Consensus 32 lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 109 (356)
|..|.. ..||+.... +..+.||...... ...+.+|+++++.+. +--+++++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444544 789999764 4788889876532 335667888888773 344667788777766779999999998776
Q ss_pred HH
Q 047701 110 GY 111 (356)
Q Consensus 110 ~~ 111 (356)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 44
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.6e-07 Score=76.18 Aligned_cols=140 Identities=21% Similarity=0.178 Sum_probs=82.8
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC--CeeeEeeeEEc---CCeeeEEEEecC
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI--NLVRLHGFCHD---QHMTALVYEYME 104 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~ 104 (356)
+.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .++.++..... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 468899999999998866 68999997653 3556677888888887432 35666664433 345689999999
Q ss_pred CCCHhH----------------Hhc---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 047701 105 NGSLDG----------------YLF---GK---KRALEWEK---------LHEI------------AIGTAK-GLVYLHE 140 (356)
Q Consensus 105 ~~sL~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~qi~~-~l~~LH~ 140 (356)
|..+.. .+. .. ...+.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 110 01 01111100 0000 111222 3333332
Q ss_pred c----cCCCeeeeccCccceEEc-CCCceEEeccCCcc
Q 047701 141 E----CQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK 173 (356)
Q Consensus 141 ~----~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~ 173 (356)
. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 236799999999999999 56666899998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.6e-06 Score=70.45 Aligned_cols=129 Identities=22% Similarity=0.310 Sum_probs=91.6
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccC---------------chhHHHHHHHHHHHHhcCC------CCCeeeEe
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL---------------GKIAEEQFMAEVGTIGRTY------HINLVRLH 87 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~~~ 87 (356)
...||+|+.-.||. +++....+||+..... ......+..+|+....++. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999995 5566778999987654 1122345666666665555 77899999
Q ss_pred eeEEcCCeeeEEEEecCC------CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC
Q 047701 88 GFCHDQHMTALVYEYMEN------GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 161 (356)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 161 (356)
|+...+....+|+|.+.+ .+|.+++. .+.++. .... .+-+-..||-+ .+|+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~---~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQ---ALDEFKRYLLD---HHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHH---HHHHHHHHHHH---cCCeecCCCcccEEEEec
Confidence 999999888999998653 26777773 234554 3333 33344567777 899999999999999432
Q ss_pred --C--ceEEec
Q 047701 162 --F--SPKVAD 168 (356)
Q Consensus 162 --~--~~kl~D 168 (356)
+ .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.2e-07 Score=70.42 Aligned_cols=127 Identities=20% Similarity=0.291 Sum_probs=88.5
Q ss_pred ccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEecCC
Q 047701 27 NYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 105 (356)
+..+.|++|.+|.||++.+ .|..+|+|+-..+ ..+..+..|++++..+.-.++ .+++.+..+ ++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 3456799999999999999 5568999987654 344568889999998876655 445555544 456999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccC-c-cceEEcCCCceEEeccCCcc
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK-P-ENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk-p-~Nill~~~~~~kl~DfGla~ 173 (356)
.+|.+..... +.+++ ..++++---|-. .||-|+.|. | .||++.+ +.+.|+||..|+
T Consensus 97 ~~L~~~~~~~----~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At 154 (201)
T COG2112 97 RPLGKLEIGG----DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSAT 154 (201)
T ss_pred cchhhhhhcc----cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence 8988766321 22333 334444333334 788888886 4 4555544 489999998876
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.4e-06 Score=86.53 Aligned_cols=80 Identities=14% Similarity=0.213 Sum_probs=58.0
Q ss_pred ccccCcCCceEEEEEEcCCC---cEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCe--eeEeeeEEcC---CeeeEE
Q 047701 29 STRLGFGGFGQVYKGQFPNG---VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINL--VRLHGFCHDQ---HMTALV 99 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 99 (356)
.+.++.|.+..+|+....++ ..+++|+............+.+|+++++.+. |.++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999976543 4678887654322223456889999999985 6654 7888888764 457899
Q ss_pred EEecCCCCH
Q 047701 100 YEYMENGSL 108 (356)
Q Consensus 100 ~e~~~~~sL 108 (356)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.9e-08 Score=90.26 Aligned_cols=182 Identities=17% Similarity=0.109 Sum_probs=130.5
Q ss_pred cccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC-eeeEeeeEEcCCeeeEEEEecCCC
Q 047701 28 YSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN-LVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 28 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+...+++|+++.+++.+....+....+.+... ....-++++|.+.+||| .+..++-+......+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 44567899999999987644444556766543 23445788999999999 666666666677888999999876
Q ss_pred -CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 107 -SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 107 -sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
+-..........+..-+...+.+.-.+++++||+ ..-+|+| ||+..+ +..+..||+....+.... ...
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 3222221222334555566677777889999998 4458888 776655 588999999877665443 223
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCc
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRN 227 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~ 227 (356)
...+|+.++|||+.... .+...-|+|++|+-..++--|.+|
T Consensus 389 t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCC
Confidence 45689999999999877 688999999999876666655544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=2e-06 Score=70.81 Aligned_cols=102 Identities=22% Similarity=0.182 Sum_probs=80.7
Q ss_pred HHHHHHhcCCC-CCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 047701 70 AEVGTIGRTYH-INLVRLHGFCHDQHMTALVYEYMENGSLDGYLF--GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146 (356)
Q Consensus 70 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 146 (356)
.|.-++..+++ +++++++|.|-. +++.||...+++...-. .+--..+|..+.+|+.++++.+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47777888865 699999999944 68999998665532100 111357999999999999999999998655568
Q ss_pred eeeccCccceEEcCCCceEEeccCCcccc
Q 047701 147 IHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 147 vH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.-.|++++|+-++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.9e-06 Score=72.08 Aligned_cols=73 Identities=14% Similarity=0.084 Sum_probs=46.1
Q ss_pred cccCcCCce-EEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC---CeeeEeeeEEcC---CeeeEEEEe
Q 047701 30 TRLGFGGFG-QVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI---NLVRLHGFCHDQ---HMTALVYEY 102 (356)
Q Consensus 30 ~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~ 102 (356)
+.|+.|+.. .||+.. ..+++|..... .....+.+|.+++..+... .+..+++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777776 589762 35777865432 2345688899998877422 344555444332 235889999
Q ss_pred cCCCCHh
Q 047701 103 MENGSLD 109 (356)
Q Consensus 103 ~~~~sL~ 109 (356)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.3e-05 Score=69.62 Aligned_cols=79 Identities=8% Similarity=0.003 Sum_probs=57.2
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCC---CCeeeEeeeEEcC---CeeeEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH---INLVRLHGFCHDQ---HMTALV 99 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---~~~~lv 99 (356)
..-.+-||.|..+.||+....++ .+.+|..+.. .....+..|...++.|.. -.++++++++... +..+||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 33346799999999999987555 4677775431 123467889999988842 3688888887643 567999
Q ss_pred EEecCCCCH
Q 047701 100 YEYMENGSL 108 (356)
Q Consensus 100 ~e~~~~~sL 108 (356)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.9e-06 Score=66.49 Aligned_cols=127 Identities=24% Similarity=0.369 Sum_probs=90.0
Q ss_pred HHhhccccccCcCCc-eEEEEEEcCCCcEEEEEEecc---c--------Cch---------hHHHHHHHHHHHHhcCC--
Q 047701 23 NFTSNYSTRLGFGGF-GQVYKGQFPNGVKIAVKVLNK---N--------LGK---------IAEEQFMAEVGTIGRTY-- 79 (356)
Q Consensus 23 ~~~~~~~~~lg~G~f-g~Vy~~~~~~~~~vavK~~~~---~--------~~~---------~~~~~~~~e~~~l~~l~-- 79 (356)
...+++.+.||.|.- |.||+++. +|+.+|+|+... . ... .-..-|..|.+...+|.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 368888999999999 99999998 778999999321 0 000 11235778888888874
Q ss_pred -CCCe--eeEeeeEEcC------------------CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 047701 80 -HINL--VRLHGFCHDQ------------------HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL 138 (356)
Q Consensus 80 -h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~L 138 (356)
+.++ |+++||..=. ....||.||..... .++ ..-+.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHH
Confidence 4456 8999988321 12246777765422 222 33456677778889
Q ss_pred HhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 139 H~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 99 99999999999975 3589999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.1e-05 Score=77.69 Aligned_cols=198 Identities=16% Similarity=0.154 Sum_probs=134.4
Q ss_pred HHHHHHHHhcCCCCCeeeEeeeEEcCCeee----EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccC
Q 047701 68 FMAEVGTIGRTYHINLVRLHGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143 (356)
Q Consensus 68 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~ 143 (356)
...|+..+.+..|+|++.++.+........ +..+++...++...+ ..-..++..+.+.+..++.+||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~--- 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHS--- 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHH---
Confidence 344677777889999999999987654332 446778777887777 455778999999999999999999999
Q ss_pred CCeeeeccCcc---ceEEcCCCceEEe--ccCCccccCCCCCceeecCCCCCCCCCCcccccCCC-CCCCCCceehhhHH
Q 047701 144 QRIIHYDIKPE---NVLLDANFSPKVA--DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMV 217 (356)
Q Consensus 144 ~~ivH~Dlkp~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~i 217 (356)
....|.-+..+ +..++..+...+. ||+.+....+..... ...-+..+.++|...... ..+...|+|.+|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 66666555555 4444566666666 888877665543221 122344577788776541 23344799999999
Q ss_pred HHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 047701 218 SFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297 (356)
Q Consensus 218 l~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L 297 (356)
+..+..|......... ...+ .+........+....|+..++++|++..+++...
T Consensus 382 ~~~~~~~~~i~~~~~~------------------~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------------PVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc------------------hhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999887643211100 0000 0111111577788899999999999999999754
Q ss_pred h
Q 047701 298 E 298 (356)
Q Consensus 298 ~ 298 (356)
-
T Consensus 436 f 436 (1351)
T KOG1035|consen 436 F 436 (1351)
T ss_pred h
Confidence 3
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.8e-05 Score=65.22 Aligned_cols=73 Identities=15% Similarity=0.108 Sum_probs=47.3
Q ss_pred cccCcCCceEEEEEEcCC--CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC-eeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQFPN--GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN-LVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.|..|-...+|++...+ ++.|++|+...... ......+|+.+++.+...+ .+++++.+.. .++|||++|.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCC
Confidence 457778888999998754 67899997654321 1122346788888774333 3445444322 4899999987
Q ss_pred CH
Q 047701 107 SL 108 (356)
Q Consensus 107 sL 108 (356)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 66
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.4e-06 Score=72.15 Aligned_cols=135 Identities=14% Similarity=0.089 Sum_probs=92.3
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccC---------------------chhHHHHHHHHHHHHhcCCC-C-C
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL---------------------GKIAEEQFMAEVGTIGRTYH-I-N 82 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h-~-n 82 (356)
+.+++.||-|--+.||.+.+.+|.+.++|.=.... ..-++-...+|+..|+.|.. - -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 45678999999999999999889999999532110 01112245568888888842 2 3
Q ss_pred eeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
|+..+++. ..++|||++.|-+|...-.- ....+ +...+..-+.-|-. .|+||+|.+-=||++.+++
T Consensus 174 VPkpiD~~----RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDHN----RHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCccccc----ceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHH---cCceecccchheeEEecCC
Confidence 55555554 44899999998877654311 12222 33333333444555 9999999999999999999
Q ss_pred ceEEeccCCccc
Q 047701 163 SPKVADFGLAKL 174 (356)
Q Consensus 163 ~~kl~DfGla~~ 174 (356)
.++++||.-...
T Consensus 240 ~i~vIDFPQmvS 251 (465)
T KOG2268|consen 240 KIVVIDFPQMVS 251 (465)
T ss_pred CEEEeechHhhc
Confidence 999999975443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00018 Score=64.85 Aligned_cols=139 Identities=17% Similarity=0.189 Sum_probs=74.3
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC--CeeeEee------eEEcCCeeeEEEE
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI--NLVRLHG------FCHDQHMTALVYE 101 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e 101 (356)
+.|+.|....+|+....+| .+++|+.. ... ...+..|+.++..|... .+++++. +....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 3466777789999987555 68889875 211 22233344444444211 1333332 1122456789999
Q ss_pred ecCCCCHh-----------HHh---ccCC----------CCCCH-HHHHH------------HHHH-HHHHHHHHHh---
Q 047701 102 YMENGSLD-----------GYL---FGKK----------RALEW-EKLHE------------IAIG-TAKGLVYLHE--- 140 (356)
Q Consensus 102 ~~~~~sL~-----------~~l---~~~~----------~~l~~-~~~~~------------i~~q-i~~~l~~LH~--- 140 (356)
|++|..+. ..+ .... ..+.+ ..... ...+ +...+..+..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 111 0000 01111 11111 1111 1112222221
Q ss_pred -ccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 141 -ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 141 -~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..+.+++|+|+.|.||+++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 134689999999999999876556899998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.5e-05 Score=68.58 Aligned_cols=139 Identities=18% Similarity=0.156 Sum_probs=82.0
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC--eeeEeee------EEcCCeeeEEEE
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN--LVRLHGF------CHDQHMTALVYE 101 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 101 (356)
+.|..|....+|+....+ ..+++|+... .....+..|++++..+.+.+ +++++.. ...++..++|++
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457778778999987644 4688898764 22345666777777774322 4444332 122345689999
Q ss_pred ecCCCCHhH----Hh----------cc--CC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----ccC
Q 047701 102 YMENGSLDG----YL----------FG--KK--------RALEWEKLH----------EIAIGTAKGLVYLHE----ECQ 143 (356)
Q Consensus 102 ~~~~~sL~~----~l----------~~--~~--------~~l~~~~~~----------~i~~qi~~~l~~LH~----~~~ 143 (356)
+++|..+.. .. .. .. ....|.... .....+..++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 00 00 001111110 011112334444442 123
Q ss_pred CCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 144 QRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999988777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0002 Score=65.76 Aligned_cols=75 Identities=12% Similarity=0.123 Sum_probs=53.8
Q ss_pred cccCcCCceEEEEEEcCCC-cEEEEEEecccC------chhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEcCCeeeEE
Q 047701 30 TRLGFGGFGQVYKGQFPNG-VKIAVKVLNKNL------GKIAEEQFMAEVGTIGRTY---HINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 99 (356)
+.||-|.+..||++...+| +.|+||.-.... -....++...|.+.|..+. -.++++++.+.. ...++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 5689999999999998776 589999854211 1234456777888888762 346778877744 456899
Q ss_pred EEecCCC
Q 047701 100 YEYMENG 106 (356)
Q Consensus 100 ~e~~~~~ 106 (356)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=63.73 Aligned_cols=136 Identities=12% Similarity=0.096 Sum_probs=77.6
Q ss_pred ccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEecCCCCHh
Q 047701 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYMENGSLD 109 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~ 109 (356)
.+..|-...+|+... +++.+++|+........ .....+|.++++.+...++ ++++.... -++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 356678889999974 56788898765432111 0134668888888753323 44444432 26999999987654
Q ss_pred HH-------h----------ccC---CCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----cCCCeeeeccCcc
Q 047701 110 GY-------L----------FGK---KRALEWE-KLHEIAIGT---------AKGLVYLHEE-----CQQRIIHYDIKPE 154 (356)
Q Consensus 110 ~~-------l----------~~~---~~~l~~~-~~~~i~~qi---------~~~l~~LH~~-----~~~~ivH~Dlkp~ 154 (356)
.. + ... ..+++.. .+..+..++ ...+..+-.. .+..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 000 1122222 111221111 1112222211 1236899999999
Q ss_pred ceEEcCCCceEEeccCCcc
Q 047701 155 NVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 155 Nill~~~~~~kl~DfGla~ 173 (356)
||++++++ +.|+||..+.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99998876 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00021 Score=63.78 Aligned_cols=73 Identities=19% Similarity=0.246 Sum_probs=46.8
Q ss_pred ccCcCCceEEEEEEcCC-------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC-eeeEeeeEEcCCeeeEEEEe
Q 047701 31 RLGFGGFGQVYKGQFPN-------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN-LVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~ 102 (356)
.+..|-...+|++...+ ++.+++|+...... ......+|.+++..+...+ .+++++.+.. .+|++|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 45566667899987654 57899999765321 2234567777777774322 3455555542 368999
Q ss_pred cCCCCHh
Q 047701 103 MENGSLD 109 (356)
Q Consensus 103 ~~~~sL~ 109 (356)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0013 Score=58.94 Aligned_cols=140 Identities=19% Similarity=0.192 Sum_probs=79.1
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC--eeeEeeeE------EcCCeeeEEEE
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN--LVRLHGFC------HDQHMTALVYE 101 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~------~~~~~~~lv~e 101 (356)
+.++.|....+|++...++ .+++|+...... ...+..|.+++..|...+ +++++... ...+..+++++
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 3467777789999876444 577887654321 233455666666663222 33443321 22355689999
Q ss_pred ecCCCCHhH-----------Hh---ccCCCC-----------CCHHHHH------------HHHHHHHHHHHHHHh----
Q 047701 102 YMENGSLDG-----------YL---FGKKRA-----------LEWEKLH------------EIAIGTAKGLVYLHE---- 140 (356)
Q Consensus 102 ~~~~~sL~~-----------~l---~~~~~~-----------l~~~~~~------------~i~~qi~~~l~~LH~---- 140 (356)
|++|..+.. .+ ...... ..|.... .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998854321 01 000000 1111100 011122334555532
Q ss_pred ccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 141 ~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234789999999999999988777899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00056 Score=60.94 Aligned_cols=141 Identities=17% Similarity=0.169 Sum_probs=96.1
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCc-------------------------hhHHHHHHHHHHHHhcCCCCCee
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG-------------------------KIAEEQFMAEVGTIGRTYHINLV 84 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~e~~~l~~l~h~niv 84 (356)
.-|..|--+.||-|...+|..+|||+.+.+.. +...-=...|++-|.+|+...|+
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 34778888999999988999999998753210 01111123588888888765554
Q ss_pred eEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
..--+... ...|||+|+.......-. -..-.++...+..+-+|++.-|.-|... .++||.||.--|+|+.+ |.+
T Consensus 230 ~PePIlLk--~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCceeee--cceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC-CEE
Confidence 33333333 236999999542221111 1234577778888888998888888763 68999999999999854 589
Q ss_pred EEeccCCccccC
Q 047701 165 KVADFGLAKLCD 176 (356)
Q Consensus 165 kl~DfGla~~~~ 176 (356)
+++|-+-+....
T Consensus 304 yiIDVSQSVE~D 315 (520)
T KOG2270|consen 304 YIIDVSQSVEHD 315 (520)
T ss_pred EEEEccccccCC
Confidence 999988765433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0013 Score=57.79 Aligned_cols=30 Identities=27% Similarity=0.515 Sum_probs=24.9
Q ss_pred CCeeeeccCccceEEcCCCc-eEEeccCCcc
Q 047701 144 QRIIHYDIKPENVLLDANFS-PKVADFGLAK 173 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~-~kl~DfGla~ 173 (356)
..++|+|+.|.||++++++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 35899999999999987555 5699998874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0022 Score=56.43 Aligned_cols=76 Identities=17% Similarity=0.222 Sum_probs=48.1
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEcCCeeeEEEEe
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---HINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
++-.+.++-|....+|+... +++.+.||+-.. .....|..|.+-|+.|. .-.+++++++....+..+|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~-~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT-DGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEET-TS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEEC-CCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 33456689899999999984 778899998763 22345677777777773 44688999999887788999999
Q ss_pred cCCC
Q 047701 103 MENG 106 (356)
Q Consensus 103 ~~~~ 106 (356)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.003 Score=57.45 Aligned_cols=137 Identities=18% Similarity=0.267 Sum_probs=79.4
Q ss_pred ccCcCCceEEEEEEcCC-----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEecC
Q 047701 31 RLGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 104 (356)
.|..|-.-.+|++.+.+ ++.|++|+...... .. -.-..|..+++.+...++ +++++.+..+ .|.+|++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 45557888999987532 36789998765421 11 123568888887753333 4556665432 5899998
Q ss_pred CCCHhHH-------h----------ccCC----C-CCCHHHHHHHHHHH-----------------HHHHHHHHh-----
Q 047701 105 NGSLDGY-------L----------FGKK----R-ALEWEKLHEIAIGT-----------------AKGLVYLHE----- 140 (356)
Q Consensus 105 ~~sL~~~-------l----------~~~~----~-~l~~~~~~~i~~qi-----------------~~~l~~LH~----- 140 (356)
+.+|... + .... . ..-+.++.++..++ ...+..|..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 0 0000 0 11233333333221 111222221
Q ss_pred ccCCCeeeeccCccceEEcC-CCceEEeccCCcc
Q 047701 141 ECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK 173 (356)
Q Consensus 141 ~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~ 173 (356)
..+..++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11247999999999999976 4689999997764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0064 Score=54.03 Aligned_cols=139 Identities=18% Similarity=0.202 Sum_probs=79.5
Q ss_pred CCceEEEEEEcCCCcEEEEEEecc-cCchhHHHHHHHHHHHHhcCCC--CCeeeEeeeEEcCC--eeeEEEEecCCCCHh
Q 047701 35 GGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYH--INLVRLHGFCHDQH--MTALVYEYMENGSLD 109 (356)
Q Consensus 35 G~fg~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~~sL~ 109 (356)
|.--.+|.... +++++++. .+. ........+..+|+.+++.+.- --+...+++|.++. ..+.||+|++|..+.
T Consensus 36 G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~ 113 (321)
T COG3173 36 GWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW 113 (321)
T ss_pred CcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence 33334555544 37778888 442 2223445567788888888742 23455667776655 679999999884222
Q ss_pred HHhccC-----------------------------C--CCCCHHHHHHHHHH--------------HHHHHHHHHhcc--
Q 047701 110 GYLFGK-----------------------------K--RALEWEKLHEIAIG--------------TAKGLVYLHEEC-- 142 (356)
Q Consensus 110 ~~l~~~-----------------------------~--~~l~~~~~~~i~~q--------------i~~~l~~LH~~~-- 142 (356)
+.+... + ......++..+..+ ...-..+|+...
T Consensus 114 ~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~ 193 (321)
T COG3173 114 SALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPP 193 (321)
T ss_pred CcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCC
Confidence 111000 0 00000111111111 122334444321
Q ss_pred ---CCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 143 ---QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 143 ---~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
...++|+|+.+.|++++.++-+-|+||+++..-
T Consensus 194 ~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 194 WAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 246999999999999998888999999998643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0071 Score=54.58 Aligned_cols=73 Identities=18% Similarity=0.124 Sum_probs=48.3
Q ss_pred ccCcCCceEEEEEEcCCC-cEEEEEEecc------cCchhHHHHHHHHHHHHhcCC--CC-CeeeEeeeEEcCCeeeEEE
Q 047701 31 RLGFGGFGQVYKGQFPNG-VKIAVKVLNK------NLGKIAEEQFMAEVGTIGRTY--HI-NLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~~-~~vavK~~~~------~~~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 100 (356)
.||-|....||++..++| +.|+||.-.. ...+....+...|...|+... .| .+++++.+- .+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence 579999999999998654 6899997531 112334455667777777653 34 455665444 44557999
Q ss_pred EecCC
Q 047701 101 EYMEN 105 (356)
Q Consensus 101 e~~~~ 105 (356)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.04 E-value=5.1e-05 Score=78.21 Aligned_cols=158 Identities=11% Similarity=0.010 Sum_probs=109.1
Q ss_pred HHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEEEEecCCCCHhHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcc
Q 047701 68 FMAEVGTIGRTYHINLVRLHGFCHD--QHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYLHEEC 142 (356)
Q Consensus 68 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~ 142 (356)
...|...++...|+++...+.=... ...-+.+++|+.+|.+.+.+-+.. ..+...-+...-.+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666678887665554433 335578899999999999885432 23343334333334355555655532
Q ss_pred C--CCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHH
Q 047701 143 Q--QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220 (356)
Q Consensus 143 ~--~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~e 220 (356)
+ .-.+|++||+-|.+|..+..++++++|+.+...... .......+++.|++|+....- .++.++|+|..|+.+|+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHHHHHHH
Confidence 2 237899999999999999999999999998322211 112335577888999988765 68888999999999999
Q ss_pred HhcCCCcc
Q 047701 221 IVGRRRNA 228 (356)
Q Consensus 221 ll~g~~~~ 228 (356)
...|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.017 Score=53.07 Aligned_cols=74 Identities=15% Similarity=0.142 Sum_probs=51.0
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCc------hhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEcCCeeeEE
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG------KIAEEQFMAEVGTIGRTY---HINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 99 (356)
.+.||-|....||+.... +..++||.-..... .....+...|...|+.+. ..++++++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 456899999999999874 45699998652111 123344555677776653 2478889888875 45789
Q ss_pred EEecCC
Q 047701 100 YEYMEN 105 (356)
Q Consensus 100 ~e~~~~ 105 (356)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.021 Score=51.18 Aligned_cols=29 Identities=28% Similarity=0.334 Sum_probs=25.3
Q ss_pred CCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 144 QRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 68999999999999987 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.026 Score=47.32 Aligned_cols=79 Identities=18% Similarity=0.202 Sum_probs=57.8
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEcCCeeeEEEEe
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---HINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+.-.+.+.-|.--..|+..+ ....+-||+-.. .....|..|+.-|+.|. .-+|.+++.+..+....|+||||
T Consensus 18 i~er~~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 18 IKEREEVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred hhcccccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 33445677777777777766 556788886433 33456777877777663 45688999999999999999999
Q ss_pred cCCCCHh
Q 047701 103 MENGSLD 109 (356)
Q Consensus 103 ~~~~sL~ 109 (356)
++-+.++
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9987665
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.012 Score=53.21 Aligned_cols=137 Identities=15% Similarity=0.200 Sum_probs=76.0
Q ss_pred ccCcCCceEEEEEEcCC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEecCC
Q 047701 31 RLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 105 (356)
.|..|-.-.+|++...+ +..|++|+...... ..-.-.+|..+++.+..-++ +++++++.. . +|.+|+++
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 34557777889886532 24788998765422 11223467778777754444 455655532 2 58999887
Q ss_pred CCHhH-------Hh----------ccCC----C-CCCHHHHHHHHHHH----------------------HHHHHHHHhc
Q 047701 106 GSLDG-------YL----------FGKK----R-ALEWEKLHEIAIGT----------------------AKGLVYLHEE 141 (356)
Q Consensus 106 ~sL~~-------~l----------~~~~----~-~l~~~~~~~i~~qi----------------------~~~l~~LH~~ 141 (356)
.+|.. .+ +... . .--+..+..+..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 11 0101 1 11233333332222 1112222110
Q ss_pred -----cCCCeeeeccCccceEEcC-CCceEEeccCCcc
Q 047701 142 -----CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK 173 (356)
Q Consensus 142 -----~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~ 173 (356)
.+.-++|.|+.+.||++++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1124899999999999974 5689999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.022 Score=50.95 Aligned_cols=31 Identities=16% Similarity=0.225 Sum_probs=27.8
Q ss_pred CCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 143 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
+.+++|+|+.+.||++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4589999999999999999899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.059 Score=48.63 Aligned_cols=70 Identities=13% Similarity=0.102 Sum_probs=42.4
Q ss_pred CceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC--eeeEe---e--eEEcCCeeeEEEEecCCCC
Q 047701 36 GFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN--LVRLH---G--FCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 36 ~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~~s 107 (356)
.-..||+....++..+++|+..... .....+..|.+.+..|.... ++... | +...++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4457999987778889999875322 23455666777776663211 22211 1 1222456778999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0065 Score=51.11 Aligned_cols=30 Identities=30% Similarity=0.482 Sum_probs=21.3
Q ss_pred CCeeeeccCccceEE-cCCCceEEeccCCcc
Q 047701 144 QRIIHYDIKPENVLL-DANFSPKVADFGLAK 173 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill-~~~~~~kl~DfGla~ 173 (356)
.-++|+|+.|.||++ +.++.++++||-.+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 469999999999999 888899999997764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.015 Score=54.29 Aligned_cols=50 Identities=22% Similarity=0.222 Sum_probs=39.1
Q ss_pred HHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-eeeEEEEecCCCCHhHHhccC
Q 047701 65 EEQFMAEVGTIGRTYHINLVRLHGFCHDQH-MTALVYEYMENGSLDGYLFGK 115 (356)
Q Consensus 65 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~ 115 (356)
..+++--+..++.+.|+|....+++..... ...+|+|++ +.||.+.+..+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 346777788999999999999998886543 456789999 55999988543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.012 Score=53.45 Aligned_cols=60 Identities=22% Similarity=0.239 Sum_probs=38.8
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 159 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 159 (356)
..|+=+|..|-++..++....+ .+.-..+++.-.+.|+--+--- .+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~--pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQ--PEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcccC--hHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 3567788888899988843332 3334444444444444333321 6899999999999994
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.011 Score=52.93 Aligned_cols=106 Identities=15% Similarity=0.176 Sum_probs=73.4
Q ss_pred cCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
++.+.|++|++- |++|. ......+.+++.++.+.+..+.-+.. +-.+=|||+.-.||||+ .|++-|+||-+
T Consensus 297 e~~y~yl~~kdh-gt~is-----~ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS-----IIKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecC-Cceee-----eeecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence 345667888875 55653 23456788999999999888888876 35789999999999999 89999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG 215 (356)
++.-..+... . -.++--|-.+.|. -+..-+||-+-
T Consensus 368 sRl~~~q~~i-s------y~rldhp~lF~G~--dd~QFeIYrlM 402 (488)
T COG5072 368 SRLSYSQGII-S------YNRLDHPDLFNGV--DDYQFEIYRLM 402 (488)
T ss_pred eecccCCcee-e------ccccCchhhhcCc--cceeeeHHHHH
Confidence 9854332211 1 1123345566654 25566676543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.074 Score=55.43 Aligned_cols=156 Identities=17% Similarity=0.150 Sum_probs=83.5
Q ss_pred eeCHHHH---HHHhhccc---cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-------CCC
Q 047701 15 RFTSLQL---NNFTSNYS---TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-------YHI 81 (356)
Q Consensus 15 ~~~~~~~---~~~~~~~~---~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ 81 (356)
.++..++ ....|.+. +.|+ |..-.+|+....+|..+++|+...... ......|.+.+..| .-|
T Consensus 10 ~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP 85 (1013)
T PRK06148 10 EFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVP 85 (1013)
T ss_pred CCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcC
Confidence 4544444 33345543 3464 345788999877788899999875422 22233344455433 233
Q ss_pred CeeeEee-----eEE--cCC-eeeEEEEecCCCCHhHHh---------------------c--cC---CCCCCHH-----
Q 047701 82 NLVRLHG-----FCH--DQH-MTALVYEYMENGSLDGYL---------------------F--GK---KRALEWE----- 122 (356)
Q Consensus 82 niv~~~~-----~~~--~~~-~~~lv~e~~~~~sL~~~l---------------------~--~~---~~~l~~~----- 122 (356)
.+++..+ ... ++. ..+-+++|++|..+.+.. . .. ...+.|.
T Consensus 86 ~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~ 165 (1013)
T PRK06148 86 RLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAG 165 (1013)
T ss_pred eeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccch
Confidence 3333211 111 111 456789999997775410 0 00 0112221
Q ss_pred ------------HHHHHHHHHHHHHHH----HHhccCCCeeeeccCccceEEcCCC--ceE-EeccCCccc
Q 047701 123 ------------KLHEIAIGTAKGLVY----LHEECQQRIIHYDIKPENVLLDANF--SPK-VADFGLAKL 174 (356)
Q Consensus 123 ------------~~~~i~~qi~~~l~~----LH~~~~~~ivH~Dlkp~Nill~~~~--~~k-l~DfGla~~ 174 (356)
....++.++++...- .....+.++||+|+++.||+++.++ .+. |+|||-+..
T Consensus 166 ~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 166 RARDRLHFIDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 111222233332221 1122346899999999999998775 454 999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.024 Score=51.98 Aligned_cols=75 Identities=15% Similarity=0.148 Sum_probs=50.1
Q ss_pred ccccCcCCceEEEEEEcCC-CcEEEEEEecc-----cCchhHHHHHHHHHHHHhcCC--CC-CeeeEeeeEEcCCeeeEE
Q 047701 29 STRLGFGGFGQVYKGQFPN-GVKIAVKVLNK-----NLGKIAEEQFMAEVGTIGRTY--HI-NLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~lv 99 (356)
.+.||-|.-.-||++.+++ ++.|+||.-.. ..-+....+...|.+.|+... .| ++++++.+- .+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence 3568999999999998753 56799996431 112344566677878887653 34 566676554 3455688
Q ss_pred EEecCC
Q 047701 100 YEYMEN 105 (356)
Q Consensus 100 ~e~~~~ 105 (356)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.0019 Score=48.84 Aligned_cols=45 Identities=29% Similarity=0.400 Sum_probs=35.5
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT 78 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 78 (356)
+-||+|+.|+||+|++++|++||||+...+ ....+..++.+++.+
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~----i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPG----IEEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchH----HHHHHHHHHHHHHHH
Confidence 459999999999999989999999998764 444566666666543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.034 Score=46.40 Aligned_cols=122 Identities=19% Similarity=0.236 Sum_probs=76.5
Q ss_pred HHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC
Q 047701 66 EQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145 (356)
Q Consensus 66 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 145 (356)
.-|..+.+++.+++ .|+++..= ++..+.++.|+|..... .. .-.+... +.+|.-.|++ ..+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~---~N~i~ag-i~~L~~fH~~-~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NF---SNFITAG-IKDLMDFHSE-NQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------ch---hHHHHHh-HHHHHHhhcc-CCC
Confidence 45677888888873 67777622 33456689999854221 11 1112221 4667888853 378
Q ss_pred eeeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcC
Q 047701 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGR 224 (356)
Q Consensus 146 ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g 224 (356)
.+|||..|+||+-|..|.+||.|=+..- .+.. -|.--|+ . ..|.++.+-+|=.-++++...
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~~V------------~~vN~~Y---~-~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVCLL--ENQV------------NMVNIEY---E-SLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhhhh--hhee------------eEEeeec---c-ccChHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999976432 1111 1222111 1 357778877776666666643
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.15 Score=45.79 Aligned_cols=137 Identities=22% Similarity=0.287 Sum_probs=80.2
Q ss_pred cCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCee---e---E----eeeEEcCCeeeEEEE
Q 047701 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV---R---L----HGFCHDQHMTALVYE 101 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv---~---~----~~~~~~~~~~~lv~e 101 (356)
|.+ .-..+|+....+|+. ++|+.... ....++..|...+..|.-.+|. + + +.....+...+-+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 456789998866665 88988764 2344566677777766322211 1 1 111111136778999
Q ss_pred ecCCCCHhH-H-----------h-------cc----CC---CCCCHHH-------------HHHHHHHHHHHHHHHHhc-
Q 047701 102 YMENGSLDG-Y-----------L-------FG----KK---RALEWEK-------------LHEIAIGTAKGLVYLHEE- 141 (356)
Q Consensus 102 ~~~~~sL~~-~-----------l-------~~----~~---~~l~~~~-------------~~~i~~qi~~~l~~LH~~- 141 (356)
|++|..+.. . + .. +. ....|.. -.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999987762 0 0 00 11 1123320 011334444555555542
Q ss_pred ---cCCC---eeeeccCccceEEcCCCc-eEEeccCCcc
Q 047701 142 ---CQQR---IIHYDIKPENVLLDANFS-PKVADFGLAK 173 (356)
Q Consensus 142 ---~~~~---ivH~Dlkp~Nill~~~~~-~kl~DfGla~ 173 (356)
.+.. +||+|+.|.||+++.+.. +.++|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2334 999999999999998874 8999998763
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 356 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-112
Identities = 120/307 (39%), Positives = 169/307 (55%), Gaps = 23/307 (7%)
Query: 7 EIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIA 64
E+ + RF+ +L + N+S + LG GGFG+VYKG+ +G +AVK L + +
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 65 EEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---LEW 121
E QF EV I H NL+RL GFC LVY YM NGS+ L + + L+W
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
K IA+G+A+GL YLH+ C +IIH D+K N+LLD F V DFGLAKL D +H
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES------ 235
VT + +GT G+ APE+LS + K DV+ +G++ E++ +R + +
Sbjct: 191 VT-TAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 236 LDWFPKYVWEEYEKSELGAMI---LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSA 292
LDW V ++ +L A++ L E+ +QL VAL C Q SP +RP MS
Sbjct: 249 LDW----VKGLLKEKKLEALVDVDLQ---GNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 293 VVKMLEG 299
VV+MLEG
Sbjct: 302 VVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 1e-96
Identities = 106/304 (34%), Positives = 160/304 (52%), Gaps = 30/304 (9%)
Query: 15 RFTSLQLNNFTSNYSTR--LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEV 72
R + L T+N+ + +G G FG+VYKG +G K+A+K E+F E+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 73 GTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---LEWEKLHEIAI 129
T+ H +LV L GFC +++ L+Y+YMENG+L +L+G + WE+ EI I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC-DRNRSHVTISGYK 188
G A+GL YLH IIH D+K N+LLD NF PK+ DFG++K + +++H++ + K
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVK 202
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV-GRRRNAIVGASES-----LDWFPKY 242
GT GY PE+ +T K DVYSFG+V FE++ R AIV + +W
Sbjct: 203 GTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEW---- 255
Query: 243 VWEEYEKSELGAMI---LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299
E + +L ++ LA I E ++ A+ C+ S DRP M V+ LE
Sbjct: 256 AVESHNNGQLEQIVDPNLADKI---RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 300 VVEV 303
+ +
Sbjct: 313 ALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 8e-96
Identities = 99/303 (32%), Positives = 143/303 (47%), Gaps = 27/303 (8%)
Query: 15 RFTSLQLNNFTSNYSTR--------LGFGGFGQVYKGQFPNGVKIAVKVLNKNL---GKI 63
F+ +L N T+N+ R +G GGFG VYKG N +AVK L + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 64 AEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKR--ALEW 121
++QF E+ + + H NLV L GF D LVY YM NGSL L L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-RS 180
+IA G A G+ +LHE IH DIK N+LLD F+ K++DFGLA+ ++ ++
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES--LDW 238
+T S GT Y APE L G IT K D+YSFG+V EI+ LD
Sbjct: 190 VMT-SRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 239 FPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
E ++ + + + + D + + VA C+ + RP + V ++L+
Sbjct: 247 ----KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 299 GVV 301
+
Sbjct: 303 EMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 6e-73
Identities = 73/292 (25%), Positives = 112/292 (38%), Gaps = 26/292 (8%)
Query: 28 YSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
G FG V+K Q +AVK+ Q EV ++ H N+++
Sbjct: 28 LLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFI 84
Query: 88 GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE-- 141
G L+ + E GSL +L K + W +L IA A+GL YLHE+
Sbjct: 85 GAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIP 142
Query: 142 -----CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
+ I H DIK +NVLL N + +ADFGLA + +S G GT Y AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 197 EFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252
E L G + D+Y+ G+V +E+ R A E + F + + + ++
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262
Query: 253 GAMILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+++ + LC C R V + +
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-59
Identities = 73/326 (22%), Positives = 113/326 (34%), Gaps = 45/326 (13%)
Query: 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAE--VGTI 75
SL L+N +G G +G VYKG + +AVKV + + F+ E + +
Sbjct: 9 SLDLDNLK--LLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRV 61
Query: 76 GRTYHINLVRLHGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIG 130
H N+ R LV EY NGSL YL +W +A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHS 119
Query: 131 TAKGLVYLHEE------CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR----- 179
+GL YLH E + I H D+ NVL+ + + ++DFGL+ NR
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 180 -SHVTISGYKGTPGYSAPEFLSGNY------PITHKCDVYSFGMVSFEIVGRRRNAIVGA 232
GT Y APE L G + D+Y+ G++ +EI R + G
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 233 SESLDWFPKYVWEEYEKSELGAMILACGIE----------EKDKEKAKQLCMVALWCVQD 282
S + E M + E +++ + L C
Sbjct: 240 SVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 283 SPADRPPMSAVVKMLEGVVEVLPPPK 308
R + + ++ + K
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 74/285 (25%), Positives = 131/285 (45%), Gaps = 32/285 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G FG V++ ++ +G +AVK+L + + +F+ EV + R H N+V G
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
++V EY+ GSL L + L+ + +A AKG+ YLH I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H ++K N+L+D ++ KV DFGL++L + + ++ GTP + APE L P
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE-PSNE 218
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG----IEE 263
K DVYSFG++ +E+ ++ P W +++ A + I
Sbjct: 219 KSDVYSFGVILWELATLQQ-------------P---WGNLNPAQVVAAVGFKCKRLEIPR 262
Query: 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV-EVLPPP 307
+ + C + P RP + ++ +L ++ +PPP
Sbjct: 263 NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-57
Identities = 76/279 (27%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
R+G G FG VYKG++ V AVK+LN + F EVG + +T H+N++ G+
Sbjct: 31 RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ A+V ++ E SL +L + E +KL +IA TA+G+ YLH + IIH
Sbjct: 89 STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITH 207
D+K N+ L + + K+ DFGLA R G+ + APE + + P +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 208 KCDVYSFGMVSFEIVGRR--------RNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259
+ DVY+FG+V +E++ + R+ I+ V +L + C
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM----------VGRGSLSPDLSKVRSNC 254
Query: 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
K++ + C++ +RP ++ +E
Sbjct: 255 P---------KRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-57
Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 54/298 (18%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V K ++ +A+K + + + F+ E+ + R H N+V+L+G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRA--LEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ LV EY E GSL L G + + ++G+ YLH + +IH
Sbjct: 71 LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 149 YDIKPENVLLDANFS-PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
D+KP N+LL A + K+ DFG A ++ KG+ + APE G+ +
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGS-NYSE 182
Query: 208 KCDVYSFGMVSFEIVGRRR------------NAIVGASESLDWFPKYVWEEYEKSELGAM 255
KCDV+S+G++ +E++ RR+ V K + + E +
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIKNLPKPIES-----L 236
Query: 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP-PPKPFRY 312
+ C W P+ RP M +VK++ ++ P +P +Y
Sbjct: 237 MTRC------------------W--SKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-56
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 52/290 (17%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVL------NKNLGKIAEEQFMAEVGTIGRTYHINL 83
++G GGFG V+KG+ + +A+K L + ++F EV + H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
V+L+G H+ +V E++ G L L K ++W + + A G+ Y+
Sbjct: 86 VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 144 QRIIHYDIKPENVLLD-----ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
I+H D++ N+ L A KVADFGL++ S ++SG G + APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPET 197
Query: 199 LSG-NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257
+ T K D YSF M+ + I+ P +++ G +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG-------------P------FDEYSYGKIKF 238
Query: 258 ACGIEEKDK---------EKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
I E+ + + + + W P RP S +VK L
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRNV-IELCW--SGDPKKRPHFSYIVKELS 285
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 75/315 (23%), Positives = 113/315 (35%), Gaps = 40/315 (12%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G FGQ K G + +K L + + F+ EV + H N+++ G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ + EY++ G+L G + W + A A G+ YLH IIH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK------------GTPGYSAPE 197
D+ N L+ N + VADFGLA+L ++ G P + APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257
++G K DV+SFG+V EI+GR +Y + +
Sbjct: 193 MINGR-SYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFGLN 235
Query: 258 ACGIEEKDKEKA--KQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL----PPPKPFR 311
G ++ + + C P RP + LE + L P
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
Query: 312 YLDLNKMTGLRSLES 326
LD R ES
Sbjct: 296 QLDRGFWETYRRGES 310
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-53
Identities = 68/283 (24%), Positives = 109/283 (38%), Gaps = 42/283 (14%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNK---NLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G GGFG+VY+ + G ++AVK E E H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G C + LV E+ G L+ L GK+ + + L A+ A+G+ YLH+E II
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 148 HYDIKPENVLLDANFSP--------KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
H D+K N+L+ K+ DFGLA R T G + APE +
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVI 186
Query: 200 SGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259
+ + DV+S+G++ +E++ P + + + +
Sbjct: 187 RAS-MFSKGSDVWSYGVLLWELLTGEV-------------P---FRGIDGLAVAYGVAMN 229
Query: 260 G----IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
I E +L M W P RP + ++ L
Sbjct: 230 KLALPIPSTCPEPFAKL-MEDCW--NPDPHSRPSFTNILDQLT 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-53
Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 28/290 (9%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
++G G +G+V+ G++ G K+AVKV + A E+ H N++
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 91 HDQHMT----ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR- 145
+ L+ +Y ENGSL YL K L+ + + ++A + GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS--GYKGTPGYSAPEFL 199
I H D+K +N+L+ N + +AD GLA + + V I GT Y PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 200 SG-----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254
++ D+YSFG++ +E+ RR + E + V + ++
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 255 MILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
++ + E +Q+ + C +PA R V K L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 41/284 (14%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+G G FGQVY G++ V A+++++ + + F EV +T H N+V G
Sbjct: 40 LIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
C A++ + +L + K L+ K +IA KG+ YLH + I+H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 150 DIKPENVLLDANFSPKVADFGLAKL---CDRNRSHVTISGYKGTPGYSAPEFLSGNYPI- 205
D+K +NV D N + DFGL + R + G + APE + P
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 206 -------THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258
+ DV++ G + +E+ R +P ++ A+I
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHARE-------------WP------FKTQPAEAIIWQ 254
Query: 259 CGIEEK----DKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
G K K++ + L+C +RP + ++ MLE
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-52
Identities = 61/301 (20%), Positives = 114/301 (37%), Gaps = 45/301 (14%)
Query: 8 IGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEE 66
+ + + F L T+L G+++KG++ G I VKVL +
Sbjct: 1 MNKHSGIDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR 52
Query: 67 QFMAEVGTIGRTYHINLVRLHGFCHDQHMT--ALVYEYMENGSLDGYLF-GKKRALEWEK 123
F E + H N++ + G C L+ +M GSL L G ++ +
Sbjct: 53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQ 112
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183
+ A+ A+G+ +LH + I + + +V++D + + +++ + S +
Sbjct: 113 AVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQS 165
Query: 184 ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK 241
G P + APE L D++SF ++ +E+V R P
Sbjct: 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV-------------P- 210
Query: 242 YVWEEYEKSELGAMILACG----IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
+ + E+G + G I +L C+ + PA RP +V +L
Sbjct: 211 --FADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265
Query: 298 E 298
E
Sbjct: 266 E 266
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 70/290 (24%), Positives = 124/290 (42%), Gaps = 28/290 (9%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG+V++G++ G ++AVK+ + + AE+ H N++
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 91 HDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR- 145
+ + T LV +Y E+GSL YL + + E + ++A+ TA GL +LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 146 ----IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS--GYKGTPGYSAPEFL 199
I H D+K +N+L+ N + +AD GLA D + I+ GT Y APE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 200 SG-----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254
++ + D+Y+ G+V +EI RR + + + V + E+
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 255 MILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
++ + + E + + + C + A R + K L
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 63/295 (21%), Positives = 113/295 (38%), Gaps = 38/295 (12%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G +G+V++G + G +AVK+ + E+ H N++
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 91 HDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE----- 141
++ L+ Y E GSL YL + L+ I + A GL +LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS--GYKGTPGYSAPEFL 199
+ I H D+K +N+L+ N +AD GLA + ++ + + + GT Y APE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 200 SG-----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254
+ + D+++FG+V +E+ RR G E K + + ++
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDY----KPPFYDVVPNDPSF 243
Query: 255 MILACGIEEKD------KEKAKQLCMVALW-----CVQDSPADRPPMSAVVKMLE 298
+ + + +L C +P+ R + K L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 24/275 (8%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G FG+V+ G+ + +AVK + L + +F+ E + + H N+VRL G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
C + +V E ++ G +L + L + L ++ A G+ YL + IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPE-FLSGNYPITH 207
D+ N L+ K++DFG+++ + G + P ++APE G Y +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYGRY--SS 294
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267
+ DV+SFG++ +E SL P + + + G +
Sbjct: 295 ESDVWSFGILLWETF------------SLGASP---YPNLSNQQTREFVEKGGRLPCPEL 339
Query: 268 KAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
+ + C P RP S + + L+ + +
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 31 RLGFGGFGQVYKGQFPNG-----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG VYKG + + +A+K L + A ++ + E + + ++ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
L G C + L+ + M G L Y+ K + + L + AKG+ YL + +R
Sbjct: 82 LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPE-FLSGNY 203
++H D+ NVL+ K+ DFGLAKL G K P + A E L Y
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-VPIKWMALESILHRIY 196
Query: 204 PITHKCDVYSFGMVSFEIV 222
TH+ DV+S+G+ +E++
Sbjct: 197 --THQSDVWSYGVTVWELM 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-38
Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 24/269 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + ++A+K L G ++ E F+ E + + H LV+L+
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 91 HDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ + +V EYM GSL +L + L +L ++A A G+ Y+ +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D++ N+L+ N KVADFGLA+L + N + G K ++APE T K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKS 362
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269
DV+SFG++ E+ + P + E+ + E
Sbjct: 363 DVWSFGILLTELT------------TKGRVP---YPGMVNREVLDQVERGYRMPCPPECP 407
Query: 270 KQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ L + C + P +RP + LE
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 26/226 (11%)
Query: 31 RLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V ++ G ++AVK L G E+ + YH N+V+
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 86 LHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
G C + L+ E++ +GSL YL K + ++ + A+ KG+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS--- 144
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE 197
++ +H D+ NVL+++ K+ DFGL K + ++ + Y + APE
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-----YTVKDDRDSPVFWYAPE 199
Query: 198 FLSGNYPI-THKCDVYSFGMVSFEIV--GRRRNAIVGASESLDWFP 240
DV+SFG+ E++ ++ + +
Sbjct: 200 --CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G FG V G++ +AVK++ + G ++E++F E T+ + H LV+ +G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
++ +V EY+ NG L YL + LE +L E+ +G+ +L + IH D
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRD 129
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNY 203
+ N L+D + KV+DFG+ + + Y + G +SAPE F Y
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDD-------QYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 204 PITHKCDVYSFGMVSFEIV--GRR 225
+ K DV++FG++ +E+ G+
Sbjct: 183 --SSKSDVWAFGILMWEVFSLGKM 204
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 70/271 (25%), Positives = 129/271 (47%), Gaps = 26/271 (9%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G +G+VY+G + + +AVK L + + E+F+ E + H NLV+L G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 90 CHDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + ++ E+M G+L YL ++ + L +A + + YL + + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
++ N L+ N KVADFGL++L + ++ +G K ++APE L+ N + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYN-KFSIK 399
Query: 209 CDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE-YEKSELGAMILACGIEEKDKE 267
DV++FG++ +EI + + +P + YE E E+ +
Sbjct: 400 SDVWAFGVLLWEIA----------TYGMSPYPGIDLSQVYELLEKD------YRMERPEG 443
Query: 268 KAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+++ + C Q +P+DRP + + + E
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 2e-37
Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 24/269 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + ++A+K L G ++ E F+ E + + H LV+L+
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 91 HDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ + +V EYM GSL +L + L +L ++A A G+ Y+ +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D++ N+L+ N KVADFGLA+L + N + G K ++APE T K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGR-FTIKS 445
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269
DV+SFG++ E+ + P + E+ + E
Sbjct: 446 DVWSFGILLTELT------------TKGRVP---YPGMVNREVLDQVERGYRMPCPPECP 490
Query: 270 KQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ L + C + P +RP + LE
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 31 RLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG V+KG + + + +KV+ G+ + + + IG H ++VR
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
L G C + LV +Y+ GSL ++ + AL + L + AKG+ YL E
Sbjct: 80 LLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HG 135
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
++H ++ NVLL + +VADFG+A L + + S K + A E S ++
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE--SIHFGK 193
Query: 206 -THKCDVYSFGMVSFEIV 222
TH+ DV+S+G+ +E++
Sbjct: 194 YTHQSDVWSYGVTVWELM 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 31 RLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG VYKG + + +A+K L + A ++ + E + + ++ R
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
L G C + L+ + M G L Y+ K + + L + AKG+ YL + +R
Sbjct: 82 LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RR 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
++H D+ NVL+ K+ DFGLAKL G K + A E S + I
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRI 195
Query: 206 -THKCDVYSFGMVSFEIV 222
TH+ DV+S+G+ +E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ + K+AVK + G ++ E F+AE + H LV+LH
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 91 HDQHMTALVYEYMENGSLDGYLF-GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ + ++ E+M GSL +L + KL + + A+G+ ++ + + IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D++ N+L+ A+ K+ADFGLA++ + N + G K ++APE ++ T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINFG-SFTIKS 366
Query: 210 DVYSFGMVSFEIV 222
DV+SFG++ EIV
Sbjct: 367 DVWSFGILLMEIV 379
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 30 TRLGFGGFGQVYKGQFPNG---VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG V +G + + +A+KVL + K E+ M E + + + +VRL
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 87 HGFC-HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
G C + M LV E G L +L GK+ + + E+ + G+ YL E +
Sbjct: 76 IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 130
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-F 198
+H D+ NVLL K++DFGL+K + S+ Y + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-----YTARSAGKWPLKWYAPECI 185
Query: 199 LSGNYPITHKCDVYSFGMVSFEIV--GRR 225
+ + + DV+S+G+ +E + G++
Sbjct: 186 NFRKF--SSRSDVWSYGVTMWEALSYGQK 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-37
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V+ G + N K+A+K + + G ++EE F+ E + + H LV+L+G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
+Q LV E+ME+G L YL ++ E L + + +G+ YL E +IH D
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRD 129
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNY 203
+ N L+ N KV+DFG+ + ++ Y + G +++PE F Y
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ-------YTSSTGTKFPVKWASPEVFSFSRY 182
Query: 204 PITHKCDVYSFGMVSFEIV--GRR 225
+ K DV+SFG++ +E+ G+
Sbjct: 183 --SSKSDVWSFGVLMWEVFSEGKI 204
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 72/299 (24%), Positives = 115/299 (38%), Gaps = 39/299 (13%)
Query: 31 RLGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
LG G FG+V + G +AVK L + G + E+ + YH ++++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 86 LHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
G C D + LV EY+ GSL YL + ++ +L A +G+ YLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLHA--- 152
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS-----APEF 198
Q IH D+ NVLLD + K+ DFGLAK + G S APE
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPE- 207
Query: 199 LSGNYPI-THKCDVYSFGMVSFEIV--GRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255
+ DV+SFG+ +E++ + L + +EL
Sbjct: 208 -CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL--- 263
Query: 256 ILACGIEEKDKEKAKQLCMVALW-----CVQDSPADRPPMSAVVKMLEGVVEVLPPPKP 309
+E ++ C ++ C + + RP ++ +L+ V E P
Sbjct: 264 -----LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G FG V G++ +A+K++ + G ++E++F+ E + H LV+L+G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
Q ++ EYM NG L YL + + ++L E+ + + YL ++ +H D
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNY 203
+ N L++ KV+DFGL++ + Y + G +S PE + +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE-------YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 204 PITHKCDVYSFGMVSFEIV--GRR 225
+ K D+++FG++ +EI G+
Sbjct: 199 --SSKSDIWAFGVLMWEIYSLGKM 220
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 24 FTSNYST--RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH 80
+ S++ LG G FGQV K + + A+K + + ++EV + H
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNH 61
Query: 81 INLVRLHG-FCHDQHMTA------------LVYEYMENGSLDGYLFGKKRALEWEKLHEI 127
+VR + + ++ + EY ENG+L + + + ++ +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
+ L Y+H Q IIH D+KP N+ +D + + K+ DFGLAK R+ + +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 188 K------------GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
GT Y A E L G K D+YS G++ FE
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 39/289 (13%)
Query: 31 RLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
+LG G FG V ++ G +AVK L + + + F E+ + H N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75
Query: 86 LHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
G C+ L+ EY+ GSL YL K ++ KL + KG+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 132
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE 197
+R IH D+ N+L++ K+ DFGL K+ +++ +K + APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-----FKVKEPGESPIFWYAPE 187
Query: 198 FLSGNYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256
S + DV+SFG+V +E+ + +E + + L +
Sbjct: 188 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL- 244
Query: 257 LACGIEEKDKEKAKQLC-------MVALWCVQDSPADRPPMSAVVKMLE 298
++ + C M W ++ RP + ++
Sbjct: 245 ----LKNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 27/234 (11%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF--PNG---VKIAVKV 55
+ +F EI + +G G FG+VYKG +G V +A+K
Sbjct: 34 VLKFTTEIHPS------CVTRQK-------VIGAGEFGEVYKGMLKTSSGKKEVPVAIKT 80
Query: 56 LNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK 115
L + F+ E G +G+ H N++RL G ++ EYMENG+LD +L K
Sbjct: 81 LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140
Query: 116 KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
+L + G A G+ YL +H D+ N+L+++N KV+DFGL+++
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 176 -DRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIV--GRR 225
D + T SG K ++APE + T DV+SFG+V +E++ G R
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF--TSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 69/200 (34%), Positives = 108/200 (54%), Gaps = 23/200 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
RLG G FG+V+ G + K+AVK L + G ++ + F+AE + + H LVRL+
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91 HDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ + ++ EYMENGSL +L L KL ++A A+G+ ++ E + IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS-GN 202
D++ N+L+ S K+ADFGLA+L + N Y G ++APE ++ G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE-------YTAREGAKFPIKWTAPEAINYGT 186
Query: 203 YPITHKCDVYSFGMVSFEIV 222
+ T K DV+SFG++ EIV
Sbjct: 187 F--TIKSDVWSFGILLTEIV 204
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 31 RLGFGGFGQVYKGQF--PNGVKI--AVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+VY+G + G KI AVK K+ +E+FM+E + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G ++ T ++ E G L YL K +L+ L ++ K + YL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INC 134
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLSG 201
+H DI N+L+ + K+ DFGL++ + YK + + +PE S
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDE------DYYKASVTRLPIKWMSPE--SI 186
Query: 202 NYPI-THKCDVYSFGMVSFEIV 222
N+ T DV+ F + +EI+
Sbjct: 187 NFRRFTTASDVWMFAVCMWEIL 208
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 31 RLGFGGFGQVYKGQF--PNG--VKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLV 84
+LG G FG V +G++ P+G V +AVK L ++ A + F+ EV + H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
RL+G M +V E GSL L + L A+ A+G+ YL +
Sbjct: 85 RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 140
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE- 197
R IH D+ N+LL K+ DFGL + +N H Y + APE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-----YVMQEHRKVPFAWCAPES 195
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIV--GRR 225
+ + +H D + FG+ +E+ G+
Sbjct: 196 LKTRTF--SHASDTWMFGVTLWEMFTYGQE 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 31 RLGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G FG V++G + + + +A+K E+F+ E T+ + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G + + ++ E G L +L +K +L+ L A + L YL +R
Sbjct: 82 IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 137
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPE-FLS 200
+H DI NVL+ +N K+ DFGL++ + + + YK + G + APE
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPESINF 191
Query: 201 GNYPITHKCDVYSFGMVSFEIV 222
+ T DV+ FG+ +EI+
Sbjct: 192 RRF--TSASDVWMFGVCMWEIL 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 31 RLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
+LG G FG V ++ G +AVK L + + + F E+ + H N+V+
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 106
Query: 86 LHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
G C+ L+ EY+ GSL YL K ++ KL + KG+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT--- 163
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGN 202
+R IH D+ N+L++ K+ DFGL K+ +++ + + +P + APE S
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE--SLT 221
Query: 203 YPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
+ DV+SFG+V +E+ + +E + + L + +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-----L 276
Query: 262 EEKDKEKAKQLC-------MVALWCVQDSPADRPPMSAVVKMLE 298
+ + C M W ++ RP + ++
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 31 RLGFGGFGQVYKGQFP-----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR 85
+LG G FG V ++ G +AVK L ++ G + F E+ + + +V+
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 86 LHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
G + + LV EY+ +G L +L + L+ +L + KG+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGN 202
+R +H D+ N+L+++ K+ADFGLAKL ++ + + +P + APE S +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLS 203
Query: 203 YPI-THKCDVYSFGMVSFEIV--GRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259
I + + DV+SFG+V +E+ + P + E L+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS-----------CSPSAEFLRMMGCERDVPALSR 252
Query: 260 GIE--EKDKEKAK-QLC-----MVALWCVQDSPADRPPMSAVVKMLE 298
+E E+ + C + C SP DRP SA+ L+
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 31 RLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G G+V G+ V +A+K L + F++E +G+ H N++RL
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G + +V EYMENGSLD +L +L + G G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGY 172
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FL 199
+H D+ NVL+D+N KV+DFGL+++ + + T G ++APE
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD-----PDAAYTTTGGKIPIRWTAPEAIA 227
Query: 200 SGNYPITHKCDVYSFGMVSFEIV--GRR 225
+ + DV+SFG+V +E++ G R
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGER 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 30 TRLGFGGFGQVYKGQFPNG---VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG V +G + + +A+KVL + K E+ M E + + + +VRL
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + + LV E G L +L GK+ + + E+ + G+ YL E +
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 457
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP-GYSAPEFLSGNYPI 205
+H ++ NVLL K++DFGL+K + S+ T P + APE N+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE--CINFRK 515
Query: 206 -THKCDVYSFGMVSFEIV--GRR 225
+ + DV+S+G+ +E + G++
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-LGKI-AEEQFMAEVGTIGRTYHINLVRLHG 88
LG GGF + ++ A K++ K+ L K E+ E+ H ++V HG
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQR 145
F D +V E SL +K E E L +I G YLH + R
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 135
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGN-Y 203
+IH D+K N+ L+ + K+ DFGLA + + + GTP Y APE LS +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 192
Query: 204 PITHKCDVYSFGMVSFE-IVGR 224
+ + DV+S G + + +VG+
Sbjct: 193 --SFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-LGKI-AEEQFMAEVGTIGRTYHINLVRLHG 88
LG GGF + ++ A K++ K+ L K E+ E+ H ++V HG
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQR 145
F D +V E SL +K E E L +I G YLH + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLH---RNR 161
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGN-Y 203
+IH D+K N+ L+ + K+ DFGLA + + + GTP Y APE LS +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 218
Query: 204 PITHKCDVYSFGMVSFE-IVGR 224
+ + DV+S G + + +VG+
Sbjct: 219 --SFEVDVWSIGCIMYTLLVGK 238
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 29/201 (14%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V G + G K+AVK + + + F+AE + + H NLV+L G
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 91 -HDQHMTALVYEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
++ +V EYM GSL YL + R L + L + ++ + + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 312
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLSGN 202
D+ NVL+ + KV+DFGL K ++APE L
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL--R 359
Query: 203 YPI-THKCDVYSFGMVSFEIV 222
+ K DV+SFG++ +EI
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 26/233 (11%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNG----VKIAVKVL 56
+ F +E+ ++ ++ +G G FG+V G+ + +A+K L
Sbjct: 35 VHEFAKELDAT------NISIDK-------VVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 57 NKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK 116
+ F+ E +G+ H N++RL G +V EYMENGSLD +L
Sbjct: 82 KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 117 RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LC 175
+L + G A G+ YL + +H D+ N+L+++N KV+DFGL + L
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVSFEIV--GRR 225
D + T G K +++PE + Y T DV+S+G+V +E++ G R
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPE--AIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 50/235 (21%), Positives = 91/235 (38%), Gaps = 30/235 (12%)
Query: 9 GREKPVRFTSLQLNNFTSNYST--RLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAE 65
+ + F S+ + YS ++G GG +V++ A+K +N
Sbjct: 13 LGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL 70
Query: 66 EQFMAEVGTIGRTYHINL--VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE- 122
+ + E+ + + + +RL+ + +V E N L+ +L KK WE
Sbjct: 71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER 129
Query: 123 --KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
+ + + +H Q I+H D+KP N L+ + K+ DFG+A + +
Sbjct: 130 KSYWKNML----EAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181
Query: 181 HVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVSFE-IVGR 224
V GT Y PE + I+ K DV+S G + + G+
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 37/296 (12%)
Query: 32 LGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG VY G + + AVK LN+ QF+ E + H N++ L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 88 GFCHDQHMTAL-VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + L V YM++G L ++ + + L + AKG+ +L ++
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKF 213
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLSG 201
+H D+ N +LD F+ KVADFGLA+ + T + A E S
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMALE--SL 268
Query: 202 NYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260
T K DV+SFG++ +E++ + P + + ++ +L
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELM------------TRGAPP---YPDVNTFDITVYLLQGR 313
Query: 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPFRYLDLN 316
+ + L V L C RP S +V + + Y+ +N
Sbjct: 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS---AIFSTFIGEHYVHVN 366
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 17/199 (8%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIA----EEQFMAEVGTIGRTYHINLVRL 86
LG G FG VY + + +A+KVL K ++ E Q EV H N++RL
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+G+ HD L+ EY G++ L + E I A L Y H +R+
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCH---SKRV 130
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
IH DIKPEN+LL + K+ADFG + +R GT Y PE + G
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR-MHD 185
Query: 207 HKCDVYSFGMVSFE-IVGR 224
K D++S G++ +E +VG+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIA----EEQFMAEVGTIGRTYHINLVRL 86
LG G FG VY + N +A+KVL K+ ++ E Q E+ H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQ 143
+ + HD+ L+ E+ G L L R E + E+A L Y H +
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA----DALHYCH---E 132
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN- 202
+++IH DIKPEN+L+ K+ADFG + R GT Y PE + G
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKT 188
Query: 203 YPITHKCDVYSFGMVSFE-IVGR 224
+ K D++ G++ +E +VG
Sbjct: 189 H--DEKVDLWCAGVLCYEFLVGM 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 19/200 (9%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIA--EEQFMAEVGTIGRTYHINLVRLHGF 89
LG G G + + +AVK + A E Q + E H N++R
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRES-----DEHPNVIRYFCT 86
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
D+ + E +L Y+ K A + + T GL +LH I+H
Sbjct: 87 EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHR 142
Query: 150 DIKPENVLL-----DANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNY 203
D+KP N+L+ ++DFGL K R + SG GT G+ APE LS +
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202
Query: 204 --PITHKCDVYSFGMVSFEI 221
T+ D++S G V + +
Sbjct: 203 KENPTYTVDIFSAGCVFYYV 222
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 28 YSTRLGFGGFGQVYKG-QFPNGVKIAVKVLN-KNLGKIAEEQFMAEVGTIGRTYHINLVR 85
+ +G G F VYKG V++A L + L K ++F E + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 86 LHGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ LV E M +G+L YL + + ++ + L KGL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 142 CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
IIH D+K +N+ + S K+ D GLA L + + GTP + APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 203
Query: 201 GNYPITHKCDVYSFGMVSFEIV 222
Y DVY+FGM E+
Sbjct: 204 EKY--DESVDVYAFGMCMLEMA 223
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 31 RLGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G FG VY G++ + ++ A+K L++ E F+ E + H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 87 HGFCHDQHMTAL-VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
G + YM +G L ++ +R + L + A+G+ YL E Q+
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QK 144
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLS 200
+H D+ N +LD +F+ KVADFGLA+ + S + ++A E S
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYY---SVQQHRHARLPVKWTALE--S 199
Query: 201 GNYPI-THKCDVYSFGMVSFEIV 222
T K DV+SFG++ +E++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELL 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 31 RLGFGGFGQVYKGQFPNG---VKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG V KG + +AVK+L +++ +AE + + + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + LV E E G L+ YL + R ++ + + E+ + G+ YL E
Sbjct: 84 IGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 138
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS 200
+H D+ NVLL K++DFGL+K + ++ YK + APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-----YKAQTHGKWPVKWYAPE--C 191
Query: 201 GNYPI-THKCDVYSFGMVSFEIV--GRR 225
NY + K DV+SFG++ +E G++
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 31 RLGFGGFGQVYKGQFPNG-VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G +G+VY+G + + +AVK L + + E+F+ E + H NLV+L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 90 CHDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + ++ E+M G+L YL ++ + L +A + + YL + + IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLS-G 201
D+ N L+ N KVADFGL++L +T Y G ++APE L+
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL-------MTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 202 NYPITHKCDVYSFGMVSFEIV 222
+ + K DV++FG++ +EI
Sbjct: 188 KF--SIKSDVWAFGVLLWEIA 206
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 25/207 (12%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINL--VRLHG 88
+G GG +V++ A+K +N + + E+ + + + +RL+
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQR 145
+ +V E N L+ +L KK WE + + + +H Q
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH---QHG 128
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG---- 201
I+H D+KP N L+ + K+ DFG+A + + V GT Y PE +
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 202 ------NYPITHKCDVYSFGMVSFEIV 222
I+ K DV+S G + + +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-LGKI-AEEQFMAEVGTIGRTYHINLVRLHG 88
LG G F VY+ + G+++A+K+++K + K ++ EV + H +++ L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAL-EWE---KLHEIAIGTAKGLVYLHEECQQ 144
+ D + LV E NG ++ YL + + E E +H+I G++YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLH---SH 131
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS-HVTISGYKGTPGYSAPEFLSGNY 203
I+H D+ N+LL N + K+ADFGLA H T+ GTP Y +PE + +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSA 188
Query: 204 PITH--KCDVYSFGMVSFE-IVGR 224
H + DV+S G + + ++GR
Sbjct: 189 ---HGLESDVWSLGCMFYTLLIGR 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 32 LGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG VY G + + AVK LN+ QF+ E + H N++ L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 88 GFCHDQHMTAL-VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + L V YM++G L ++ + + L + AKG+ YL ++
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKF 149
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRN---RSHVTISG---YKGTPGYSAPE-FL 199
+H D+ N +LD F+ KVADFGLA+ H K A E
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQ 205
Query: 200 SGNYPITHKCDVYSFGMVSFEIV 222
+ + T K DV+SFG++ +E++
Sbjct: 206 TQKF--TTKSDVWSFGVLLWELM 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 39/234 (16%)
Query: 5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF--------PNGVKIAVKVL 56
+I E L N LG G F +++KG + ++ +KVL
Sbjct: 2 FHKIRNE------DLIFNE-------SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL 48
Query: 57 NKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK 116
+K +E F + + H +LV +G C LV E+++ GSLD YL K
Sbjct: 49 DKAHRNYSES-FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK 107
Query: 117 RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--------KVAD 168
+ E+A A + +L E +IH ++ +N+LL K++D
Sbjct: 108 NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
Query: 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
G++ + + PE + + D +SFG +EI
Sbjct: 165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 31 RLGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G FG V++G + + + +A+K E+F+ E T+ + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G + + ++ E G L +L +K +L+ L A + L YL +R
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG-----YSAPEFLS- 200
+H DI NVL+ +N K+ DFGL++ + + + YK + G + APE ++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPESINF 566
Query: 201 GNYPITHKCDVYSFGMVSFEIV 222
+ T DV+ FG+ +EI+
Sbjct: 567 RRF--TSASDVWMFGVCMWEIL 586
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V G + G K+AVK + + + F+AE + + H NLV+L G
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 91 -HDQHMTALVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
++ +V EYM GSL YL + L + L + ++ + + YL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 140
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPEFLSGN 202
D+ NVL+ + KV+DFGL K ++APE L
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEAL--R 187
Query: 203 YPI-THKCDVYSFGMVSFEIV 222
+ K DV+SFG++ +EI
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 7e-33
Identities = 65/208 (31%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH-- 87
RLG GGFG V + G ++A+K + L E++ E+ + + H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 88 ----GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT-----AKGLVYL 138
+ L EY E G L YL + L E I T + L YL
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYL 137
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
HE RIIH D+KPEN++L K+ D G AK D+ + GT Y A
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLA 191
Query: 196 PEFLSG-NYPITHKCDVYSFGMVSFEIV 222
PE L Y T D +SFG ++FE +
Sbjct: 192 PELLEQKKY--TVTVDYWSFGTLAFECI 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG GGFG V++ + + A+K + ++A E+ M EV + + H +VR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 90 CHD---------QHMTALVY---EYMENGSLDGYLFGKKRA--LEWEKLHEIAIGTAKGL 135
+ +Y + +L ++ G+ E I + A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI----------S 185
+LH + ++H D+KP N+ + KV DFGL D++ T+ +
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
G GT Y +PE + GN +HK D++S G++ FE+
Sbjct: 189 GQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL 223
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 44/207 (21%), Positives = 80/207 (38%), Gaps = 25/207 (12%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINL--VRLHG 88
+G GG +V++ A+K +N + + E+ + + + +RL+
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQR 145
+ +V E N L+ +L KK WE + + + +H Q
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTIH---QHG 175
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG---- 201
I+H D+KP N L+ + K+ DFG+A + + V G Y PE +
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 202 ------NYPITHKCDVYSFGMVSFEIV 222
I+ K DV+S G + + +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMT 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 16/215 (7%)
Query: 12 KPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQ 67
P F + + + + Y LG G +G+V + V+ A+K++ K ++ + +
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 68 FMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI 127
+ EV + H N+++L+ F D+ LV E + G L + + + E I
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-VDAAVI 141
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTI 184
G+ YLH + I+H D+KPEN+LL + + K+ DFGL+ + + +
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198
Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSF 219
GT Y APE L Y KCDV+S G++ F
Sbjct: 199 L---GTAYYIAPEVLRKKY--DEKCDVWSIGVILF 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 12 KPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEE 66
P F F+ Y + LG G FG+V + G + AVKV++K K +E
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 67 QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHE 126
+ EV + + H N+++L+ F D+ LV E G L + +KR E
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE-VDAAR 130
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVT 183
I G+ Y+H + +I+H D+KPEN+LL + + ++ DFGL+ + ++
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSF 219
GT Y APE L G Y KCDV+S G++ +
Sbjct: 188 KI---GTAYYIAPEVLHGTY--DEKCDVWSTGVILY 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 63/295 (21%), Positives = 116/295 (39%), Gaps = 53/295 (17%)
Query: 23 NFTSNYST--RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY 79
F ++ +G GGFGQV+K + +G +K + N E+ EV + +
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAKLD 62
Query: 80 HINLVRLHGFCHDQHMTA----------------LVYEYMENGSLDGYLFGKK-RALEWE 122
H+N+V +G + E+ + G+L+ ++ ++ L+
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 123 KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182
E+ KG+ Y+H +++I+ D+KP N+ L K+ DFGL +
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242
KGT Y +PE +S + D+Y+ G++ E++ A
Sbjct: 180 RS---KGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTA-------------- 221
Query: 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKML 297
+E S+ + I + +K K L + P DRP S +++ L
Sbjct: 222 ----FETSKFFTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 48/211 (22%), Positives = 76/211 (36%), Gaps = 28/211 (13%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G V++G+ G A+KV N + M E + + H N+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 90 --CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT-----AKGLVYLHEEC 142
L+ E+ GSL L A L E G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 143 QQRIIHYDIKPENVLL----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEF 198
I+H +IKP N++ D K+ DFG A+ + + V++ GT Y P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM 186
Query: 199 LSGNYPI-------THKCDVYSFGMVSFEIV 222
D++S G+ +
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 79/308 (25%), Positives = 119/308 (38%), Gaps = 53/308 (17%)
Query: 31 RLGFGGFGQVYKGQFPNG------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG+VY+GQ +++AVK L + + E F+ E I + H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL------FGKKRALEWEKLHEIAIGTAKGLVYL 138
R G ++ E M G L +L + +L L +A A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 139 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGY--KGTPGY 193
E IH DI N LL K+ DFG+A+ R Y KG
Sbjct: 157 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-------SYYRKGGCAM 206
Query: 194 S-----APE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
PE F+ G + T K D +SFG++ +EI SL + P +
Sbjct: 207 LPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSK 249
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV---EVL 304
E+ + + G + K + + C Q P DRP + +++ +E +V+
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309
Query: 305 PPPKPFRY 312
P Y
Sbjct: 310 NTALPIEY 317
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 38/219 (17%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIA--EEQFMAEVGTIGRTYHINLVRLHGF 89
LG+G G V G +AVK + + IA E + + E H N++R +
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----DDHPNVIRYYCS 77
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLH------EIAIGTAKGLVYLHEECQ 143
+ E +L + K + E KL + A G+ +LH
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 144 QRIIHYDIKPENVLLD-------------ANFSPKVADFGLAKLCDRNRS--HVTISGYK 188
+IIH D+KP+N+L+ N ++DFGL K D +S ++
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 189 GTPGYSAPEFLSGNY------PITHKCDVYSFGMVSFEI 221
GT G+ APE L + +T D++S G V + I
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 18/197 (9%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTY-HINLVRLH 87
RLG G +G+V+K + +G AVK G + +AEVG+ + H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 88 G-FCHDQHMTALVYEYME--NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
+ + Y E SL + +L ++ T L +LH Q
Sbjct: 124 QAWEEGGIL----YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---Q 176
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
++H D+KP N+ L K+ DFGL + +G P Y APE L G+Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSY- 232
Query: 205 ITHKCDVYSFGMVSFEI 221
DV+S G+ E+
Sbjct: 233 -GTAADVFSLGLTILEV 248
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 57/228 (25%), Positives = 93/228 (40%), Gaps = 29/228 (12%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLN 57
M + + F + + LG G FG V+ + +G++ +K +N
Sbjct: 1 MHHHHHHSSGRENLYFQG----TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN 56
Query: 58 KNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK-- 115
K+ ++ EQ AE+ + H N++++ D H +V E E G L +
Sbjct: 57 KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LERIV 112
Query: 116 KRALEWEKLHEIAIGT-----AKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 167
+ L E + L Y H Q ++H D+KPEN+L + K+
Sbjct: 113 SAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKII 169
Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
DFGLA+L + + GT Y APE + T KCD++S G
Sbjct: 170 DFGLAELFKSDEHSTNAA---GTALYMAPEVFKRDV--TFKCDIWSAG 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 48/210 (22%), Positives = 76/210 (36%), Gaps = 28/210 (13%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF- 89
LG G V++G+ G A+KV N + M E + + H N+V+L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 90 -CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT-----AKGLVYLHEECQ 143
L+ E+ GSL L A L E G+ +L E
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE--- 130
Query: 144 QRIIHYDIKPENVLL----DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
I+H +IKP N++ D K+ DFG A+ + + V++ GT Y P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMY 187
Query: 200 SGNYPI-------THKCDVYSFGMVSFEIV 222
D++S G+ +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 71/312 (22%), Positives = 121/312 (38%), Gaps = 50/312 (16%)
Query: 31 RLGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG VY+G VK +A+K +N+ +F+ E + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL---------FGKKRALEWEKLHEIAIGTAKGL 135
RL G T ++ E M G L YL K+ ++A A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY--KGTPGY 193
YL+ + +H D+ N ++ +F+ K+ DFG+ + Y KG G
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-------DYYRKGGKGL 201
Query: 194 -----SAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
+PE G + T DV+SFG+V +EI +L P ++
Sbjct: 202 LPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIA------------TLAEQP---YQGL 244
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPP 307
++ ++ G+ +K L + C Q +P RP ++ ++ +E
Sbjct: 245 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304
Query: 308 KPFRYLDLNKMT 319
F Y + NK+
Sbjct: 305 VSFYYSEENKLP 316
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 33/283 (11%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G G V+K P+G+ +A K+++ + Q + E+ + +V +G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ ++ E+M+ GSLD L R E + L +++I KGL YL E+ +I+H
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILGKVSIAVIKGLTYLREK--HKIMHR 156
Query: 150 DIKPENVLLDANFSPKVADFGLA-KLCDRNR-SHVTISGYKGTPGYSAPEFLSGNYPITH 207
D+KP N+L+++ K+ DFG++ +L D S V GT Y +PE L G +
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT-HYSV 209
Query: 208 KCDVYSFGMVSFEI-VGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
+ D++S G+ E+ VGR +P + E + E D
Sbjct: 210 QSDIWSMGLSLVEMAVGR--------------YPIPPPDAKELELMFG-----CQVEGDA 250
Query: 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKP 309
+ + D P A+ ++L+ +V PP P
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 44/198 (22%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+G G FG+ + +G + +K +N + E+ EV + H N+V+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ +V +Y E G L + +K + +++ + + L ++H+ ++I+H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILH 148
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
DIK +N+ L + + ++ DFG+A++ + GTP Y +PE P +K
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACIGTPYYLSPEICENK-PYNNK 205
Query: 209 CDVYSFGMVSFEIVGRRR 226
D+++ G V +E+ +
Sbjct: 206 SDIWALGCVLYELCTLKH 223
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 52/237 (21%), Positives = 80/237 (33%), Gaps = 46/237 (19%)
Query: 23 NFTSNYSTR------LGFGGFGQVYKGQ-FPNGVKIAVKVLNK-NLGKIAEEQFMAEVGT 74
S Y+T +G G FG V+K +G A+K K G + E+ + EV
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 75 IGRTY-HINLVRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT- 131
H ++VR + D HM + EY GSL + + E +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHML-IQNEYCNGGSLADAI--SENYRIMSYFKEAELKDL 120
Query: 132 ----AKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-------------------KVAD 168
+GL Y+H ++H DIKP N+ + P K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
G + G + A E L NY K D+++ + G
Sbjct: 178 LGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 79/308 (25%), Positives = 121/308 (39%), Gaps = 53/308 (17%)
Query: 31 RLGFGGFGQVYKGQFPNG------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG+VY+GQ +++AVK L + + E F+ E I + H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL------FGKKRALEWEKLHEIAIGTAKGLVYL 138
R G ++ E M G L +L + +L L +A A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 139 HEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNRSHVTISGY--KGTPGY 193
E IH DI N LL K+ DFG+A+ + +GY KG
Sbjct: 198 EE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-------IYRAGYYRKGGCAM 247
Query: 194 S-----APE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
PE F+ G + T K D +SFG++ +EI SL + P +
Sbjct: 248 LPVKWMPPEAFMEGIF--TSKTDTWSFGVLLWEIF------------SLGYMP---YPSK 290
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV---EVL 304
E+ + + G + K + + C Q P DRP + +++ +E +V+
Sbjct: 291 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
Query: 305 PPPKPFRY 312
P Y
Sbjct: 351 NTALPIEY 358
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 40/213 (18%), Positives = 73/213 (34%), Gaps = 30/213 (14%)
Query: 32 LGFGGFGQVYKGQF------PNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G F QVY+ N K +KV N + + E + + +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER--LKPSMQHMFM 130
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHE-----IAIGTAKGLVYLH 139
+ + Q+ + LV E G+L + + + + + A+ + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 140 EECQQRIIHYDIKPENVLL-----------DANFSPKVADFGLAKLCDRNRSHVTISGYK 188
+ IIH DIKP+N +L D + + D G + +
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEI 221
T G+ E LS P ++ D + + +
Sbjct: 247 ETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCM 278
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 71/314 (22%), Positives = 123/314 (39%), Gaps = 64/314 (20%)
Query: 31 RLGFGGFGQVYKGQFPNG---VKIAVKVLNKNLGKIAEEQFMAEV---GTIGRTYHINLV 84
+G G FGQV K + + A+K + + K F E+ +G H N++
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNII 89
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRALEWEKLHEIAI 129
L G C + L EY +G+L +L L ++L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
A+G+ YL + ++ IH D+ N+L+ N+ K+ADFGL++ + Y
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VYVK 197
Query: 190 TPG------YSAPEFLSGNYPI-THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242
+ A E L NY + T DV+S+G++ +EIV SL P
Sbjct: 198 KTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV------------SLGGTP-- 241
Query: 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
+ +EL + EK ++ + C ++ P +RP + ++ L ++E
Sbjct: 242 -YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300
Query: 303 VLPPPKPFRYLDLN 316
Y++
Sbjct: 301 ERKT-----YVNTT 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRT 78
F Y+ LG G FG+V K + + AVKV+NK + + EV + +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL 138
H N+++L D +V E G L + +KR E I G+ Y+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYM 137
Query: 139 HEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
H + I+H D+KPEN+LL + + K+ DFGL+ +N GT Y A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIA 191
Query: 196 PEFLSGNYPITHKCDVYSFGMVSF 219
PE L G Y KCDV+S G++ +
Sbjct: 192 PEVLRGTY--DEKCDVWSAGVILY 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 46/204 (22%), Positives = 79/204 (38%), Gaps = 25/204 (12%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG GGF V + +G A+K + + + E+ E H N++RL +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 90 CHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHE-----IAIGTAKGLVYLHE 140
C + L+ + + G+L + ++ + L E + +G +GL +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN-RSHVTISG------YKGTPGY 193
+ H D+KP N+LL P + D G + + T Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 194 SAPEFLSG--NYPITHKCDVYSFG 215
APE S + I + DV+S G
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLG 233
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 65/314 (20%), Positives = 122/314 (38%), Gaps = 52/314 (16%)
Query: 31 RLGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVR 85
LG G FG V + Q VK+AVK+L ++ ++ E+F+ E + H ++ +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 86 LHGFCHDQHMTA------LVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKG 134
L G ++ +M++G L +L L + L + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY-KGTPG- 192
+ YL + IH D+ N +L + + VADFGL+ R + Y +G
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS------RKIYSGDYYRQGCASK 200
Query: 193 ----YSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
+ A E Y T DV++FG+ +EI+ + P +
Sbjct: 201 LPVKWLALESLADNLY--TVHSDVWAFGVTMWEIM------------TRGQTP---YAGI 243
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPP 307
E +E+ ++ ++ E +++ + C P RP + + LE ++ L
Sbjct: 244 ENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303
Query: 308 KPFR---YLDLNKM 318
+ Y+++ +
Sbjct: 304 STSQDPLYINIERA 317
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-30
Identities = 62/200 (31%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRT 78
F Y+ LG G FG+V K + + AVKV+NK + + EV + +
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL 138
H N+++L D +V E G L + +KR E I G+ Y+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYM 137
Query: 139 HEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
H + I+H D+KPEN+LL + + K+ DFGL+ +N GT Y A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIA 191
Query: 196 PEFLSGNYPITHKCDVYSFG 215
PE L G Y KCDV+S G
Sbjct: 192 PEVLRGTY--DEKCDVWSAG 209
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 76/304 (25%), Positives = 127/304 (41%), Gaps = 57/304 (18%)
Query: 31 RLGFGGFGQVYKGQFPNG------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG+V+ + N + +AVK L K+ A + F E + H ++V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRALEWEKLHEIAI 129
+ +G C D +V+EYM++G L+ +L K L ++ IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY-- 187
A G+VYL Q +H D+ N L+ AN K+ DFG++ R+ V + Y
Sbjct: 141 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMS----RD---VYSTDYYR 190
Query: 188 KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK 241
G + PE + + T + DV+SFG++ +EI + P
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIF------------TYGKQP- 235
Query: 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301
W + +E+ I + E+ + K++ V L C Q P R + + K+L +
Sbjct: 236 --WFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293
Query: 302 EVLP 305
+ P
Sbjct: 294 KATP 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 32/218 (14%)
Query: 32 LGFGGFGQVYKGQFPNGVKIAVKVLNK------------NLGKIA----EEQFMAEVGTI 75
L G F ++ + + A+K K N KI+ + F E+ I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEKLHE-----IA 128
+ + G + ++YEYMEN S+ + F + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK 188
Y+H ++ I H D+KP N+L+D N K++DFG ++ + + +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----R 211
Query: 189 GTPGYSAPEFLSGNYPI-THKCDVYSFGMVSFE-IVGR 224
GT + PEF S K D++S G+ +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 52/220 (23%), Positives = 83/220 (37%), Gaps = 39/220 (17%)
Query: 31 RLGFGGFGQVYKGQFPNG------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG FG+VYKG +A+K L E+F E R H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRALEWEKLHEIAI 129
L G ++++ Y +G L +L K ALE +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
A G+ YL ++H D+ NVL+ + K++D GL + YK
Sbjct: 136 QIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA------DYYKL 186
Query: 190 TPG------YSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
+ APE + G + + D++S+G+V +E+
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKF--SIDSDIWSYGVVLWEVF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 70/297 (23%), Positives = 120/297 (40%), Gaps = 48/297 (16%)
Query: 31 RLGFGGFGQVYKGQFPNG----VKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVR 85
LG G FG V +G +K+AVK + + E E+F++E + H N++R
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 86 LHGFCHDQHMTA-----LVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGL 135
L G C + ++ +M+ G L YL + + + L + + A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY-KGTPG-- 192
YL + +H D+ N +L + + VADFGL+K Y +G
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG------DYYRQGRIAKM 211
Query: 193 ---YSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248
+ A E Y T K DV++FG+ +EI + P + +
Sbjct: 212 PVKWIAIESLADRVY--TSKSDVWAFGVTMWEIA------------TRGMTP---YPGVQ 254
Query: 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305
E+ +L ++ ++ +L + C + P DRP S + LE ++E LP
Sbjct: 255 NHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 61/269 (22%), Positives = 106/269 (39%), Gaps = 32/269 (11%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G +G+ K + +G + K L+ ++ + ++ ++EV + H N+VR +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 89 FCHDQHMTAL--VYEYMENGSLDGYLFGKKRALEWEKLHE-----IAIGTAKGLVYLHE- 140
D+ T L V EY E G L + K E + L E + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 141 -ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
+ ++H D+KP NV LD + K+ DFGLA++ + + S + GTP Y +PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFVGTPYYMSPEQM 188
Query: 200 SGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259
+ K D++S G + +E+ S+ EL I
Sbjct: 189 NRM-SYNEKSDIWSLGCLLYELCALMP-PFTAFSQ---------------KELAGKIREG 231
Query: 260 GIEEKDKEKAKQLCMVALWCVQDSPADRP 288
+ +L + + RP
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRP 260
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 16/199 (8%)
Query: 23 NFTSNYST--RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY 79
+ Y+ +G G +G+V ++ A K + K + ++F E+ +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLD 64
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH 139
H N++RL+ D LV E G L + K+ E I + Y H
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE-SDAARIMKDVLSAVAYCH 123
Query: 140 EECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
+ + H D+KPEN L + K+ DFGLA + T G TP Y +P
Sbjct: 124 ---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG---TPYYVSP 177
Query: 197 EFLSGNYPITHKCDVYSFG 215
+ L G Y +CD +S G
Sbjct: 178 QVLEGLY--GPECDEWSAG 194
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 80/321 (24%), Positives = 129/321 (40%), Gaps = 66/321 (20%)
Query: 31 RLGFGGFGQVYKG--------QFPNGVKIAVKVLNKNLGKIAEEQFMAEVG---TIGRTY 79
LG G FGQV + V +AVK+L + + ++E+ IG+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 99
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRALEWEKL 124
H N++ L G C ++ EY G+L YL + + ++ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
A+G+ YL Q+ IH D+ NVL+ N K+ADFGLA+ +
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARD-------INN 209
Query: 185 SGY--KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236
Y K T G + APE Y TH+ DV+SFG++ +EI +L
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TL 255
Query: 237 DWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
P + EL ++ +K +L M+ C P+ RP +V+
Sbjct: 256 GGSP---YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 297 LEGVVEVLPPPKPFRYLDLNK 317
L+ ++ + + YLDL++
Sbjct: 313 LDRILTLTTNEE---YLDLSQ 330
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 72/313 (23%), Positives = 119/313 (38%), Gaps = 61/313 (19%)
Query: 31 RLGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG+V+ + N + +AVK L + A + F E + H ++V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTMLQHQHIV 106
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL--------------FGKKRALEWEKLHEIAIG 130
R G C + +V+EYM +G L+ +L L +L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY--K 188
A G+VYL +H D+ N L+ K+ DFG++ R+ + + Y
Sbjct: 167 VAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMS----RD---IYSTDYYRV 216
Query: 189 GTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242
G + PE L + T + DV+SFG+V +EI + P
Sbjct: 217 GGRTMLPIRWMPPESILYRKF--TTESDVWSFGVVLWEIF------------TYGKQP-- 260
Query: 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
W + +E I E+ + ++ + C Q P R + V L+ + +
Sbjct: 261 -WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
Query: 303 VLPPPKPFRYLDL 315
P YLD+
Sbjct: 320 APPV-----YLDV 327
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 12/200 (6%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLVRLH 87
+G GG G VY+ + +A+K++++ L + E T GR ++V +H
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
F + + L L ++ L + I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-GTPGYSAPEFLSGNYPIT 206
H D+KPEN+L+ A+ + DFG+A +T G GT Y APE S + T
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSES-HAT 213
Query: 207 HKCDVYSFGMVSFEIV-GRR 225
++ D+Y+ V +E + G
Sbjct: 214 YRADIYALTCVLYECLTGSP 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 12 KPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNKN--------- 59
P + + +Y LG G +G+V + + A+KV+ K+
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 60 ---LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK 116
+ E+ E+ + H N+++L D+ LV E+ E G L + +
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 117 RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAK 173
+ E I G+ YLH + I+H DIKPEN+LL ++ + K+ DFGL+
Sbjct: 142 KFDE-CDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSF 219
++ GT Y APE L Y KCDV+S G++ +
Sbjct: 198 FFSKDYKLRDRL---GTAYYIAPEVLKKKY--NEKCDVWSCGVIMY 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-29
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 19/198 (9%)
Query: 32 LGFGGFGQVYKG-QFPNGVKIAVK-VLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G +G VY G N V+IA+K + ++ + E+ H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLGS 87
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEW-EKLHEIAIGTA---KGLVYLHEECQQR 145
+ + E + GSL L K L+ E+ I T +GL YLH+ +
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT--IGFYTKQILEGLKYLHD---NQ 142
Query: 146 IIHYDIKPENVLLDA-NFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
I+H DIK +NVL++ + K++DFG +K L N T GT Y APE +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGP 199
Query: 204 P-ITHKCDVYSFGMVSFE 220
D++S G E
Sbjct: 200 RGYGKAADIWSLGCTIIE 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 16/197 (8%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLN-KNLGKIAE-EQFMAEVGTIGRTYHINLVRLHG 88
+G G F +VY+ +GV +A+K + +L + E+ + + H N+++ +
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT-----AKGLVYLHEECQ 143
+ + +V E + G L + K + + E + L ++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
+R++H DIKP NV + A K+ D GL + + GTP Y +PE + N
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHEN- 211
Query: 204 PITHKCDVYSFGMVSFE 220
K D++S G + +E
Sbjct: 212 GYNFKSDIWSLGCLLYE 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 22 NNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIA--------EEQFMA 70
+ F NY + LG G V + P + AVK+++ G E +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 71 EVGTIGR-TYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAI 129
EV + + + H N+++L LV++ M+ G L YL K E ++ +I
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE-KETRKIMR 131
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
+ + LH+ I+H D+KPEN+LLD + + K+ DFG + D + G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---G 185
Query: 190 TPGYSAPEFLSGNYPITHK-----CDVYSFG 215
TP Y APE + + H D++S G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 31 RLGFGGFGQVYKGQ------FPNGVKIAVKVLNKNLGKIAEEQFMAEVG---TIGRTYHI 81
LG G FG+V + + +AVK+L + E M+E+ +G H+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN--HM 87
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYL-----------------FGKKRALEWEKL 124
N+V L G C T ++ EY G L +L + AL+ E L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
+ AKG+ +L + IH D+ N+LL K+ DFGLA R
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA------RDIKND 198
Query: 185 SGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
S Y + APE + Y T + DV+S+G+ +E+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELF 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 76/306 (24%), Positives = 121/306 (39%), Gaps = 63/306 (20%)
Query: 31 RLGFGGFGQVYKG--------QFPNGVKIAVKVLNKNLGKIAEEQFMAEVG---TIGRTY 79
LG G FGQV + V +AVK+L + + ++E+ IG+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-- 145
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSLDGYL---------------FGKKRALEWEKL 124
H N++ L G C ++ EY G+L YL + + ++ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184
A+G+ YL Q+ IH D+ NVL+ N K+ADFGLA+ +
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARD-------INN 255
Query: 185 SGY--KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236
Y K T G + APE Y TH+ DV+SFG++ +EI +L
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIF------------TL 301
Query: 237 DWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
P + EL ++ +K +L M+ C P+ RP +V+
Sbjct: 302 GGSP---YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 297 LEGVVE 302
L+ ++
Sbjct: 359 LDRILT 364
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 14/198 (7%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHG 88
+G G GQV+K +F G IAVK + ++ K ++ + ++ + ++ +V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ E M + + E L ++ + K L YL E+ +IH
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPE-RILGKMTVAIVKALYYLKEK--HGVIH 148
Query: 149 YDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI-- 205
D+KP N+LLD K+ DFG+ +L D + G Y APE + P
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDPPDPTKP 204
Query: 206 --THKCDVYSFGMVSFEI 221
+ DV+S G+ E+
Sbjct: 205 DYDIRADVWSLGISLVEL 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLVRLH 87
+LG GG VY + +K+A+K + + E ++F EV + H N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
+ LV EY+E +L Y+ L + G+ + H RI+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-GTPGYSAPEFLSGNYPIT 206
H DIKP+N+L+D+N + K+ DFG+AK + + +T + + GT Y +PE G
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE-ATD 190
Query: 207 HKCDVYSFGMVSFEIV-GRR 225
D+YS G+V +E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 3e-28
Identities = 27/250 (10%), Positives = 58/250 (23%), Gaps = 46/250 (18%)
Query: 10 REKPVRFTSLQLNNFTSNYST--RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGK--IA 64
+ SL L+ L G V+ A+KV
Sbjct: 47 QNAETTVDSL-LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105
Query: 65 EEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA--------------------------L 98
E+ R + + L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 99 VYEYM-----ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153
+ S +++ + LH + + L + ++H P
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTP 222
Query: 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVY 212
+N+ + + + D + Y+ EFL+ + TH + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAW 277
Query: 213 SFGMVSFEIV 222
G+ + +
Sbjct: 278 QLGLSIYRVW 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 65/245 (26%), Positives = 96/245 (39%), Gaps = 55/245 (22%)
Query: 7 EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKG------QFPNGVKIAVKVLNKNL 60
E R LQ LG G FG+V + + +K+AVK+L
Sbjct: 42 EFPRNN------LQFGK-------TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 61 GKIAEEQFMAEVG---TIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKR 117
+E M+E+ +G+ H N+V L G C ++ EY G L +L K R
Sbjct: 89 HADEKEALMSELKIMSHLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 118 ALEWEK-------------LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164
LE + L + A+G+ +L + IH D+ NVLL
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVA 203
Query: 165 KVADFGLAKLCDRNRSHVTISGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMV 217
K+ DFGLA R + S Y + APE Y T + DV+S+G++
Sbjct: 204 KIGDFGLA------RDIMNDSNYIVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGIL 255
Query: 218 SFEIV 222
+EI
Sbjct: 256 LWEIF 260
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHG 88
LG G +G V K + P+G +AVK + + +++ + ++ RT V +G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 89 FCHDQHMTALVYEYMENGSLDGYL---FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+ + E M + SLD + K + + + L +IA+ K L +LH +
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
+IH D+KP NVL++A K+ DFG++ + + G Y APE ++
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERINPELNQ 187
Query: 206 ---THKCDVYSFGMVSFEI 221
+ K D++S G+ E+
Sbjct: 188 KGYSVKSDIWSLGITMIEL 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 22 NNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR- 77
F Y + +G G V + G + AVK++ +++ EQ R
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 78 -------TYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIG 130
H +++ L LV++ M G L YL K E ++ I
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE-KETRSIMRS 208
Query: 131 TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
+ + +LH I+H D+KPEN+LLD N +++DFG + + + GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GT 262
Query: 191 PGYSAPEFLSGNYPITHK-----CDVYSFG 215
PGY APE L + TH D+++ G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHG 88
+G G +G V K P+G +AVK + + + ++Q + ++ + R+ +V+ +G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+ + E M Y + + E L +I + T K L +L E +
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LK 146
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
IIH DIKP N+LLD + + K+ DFG+ +L D G Y APE + +
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSAS 202
Query: 205 I---THKCDVYSFGMVSFEI 221
+ DV+S G+ +E+
Sbjct: 203 RQGYDVRSDVWSLGITLYEL 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
R+G G FG+V++ + G + AVK + E + E+ +V L+G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTA---KGLVYLHEECQQRI 146
+ + E +E GSL + + L E +GL YLH +RI
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI-KQMGCLP-EDR--ALYYLGQALEGLEYLHT---RRI 171
Query: 147 IHYDIKPENVLLDANFSP-KVADFGLAK---LCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
+H D+K +NVLL ++ S + DFG A +S +T GT + APE + G
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 203 YPITHKCDVYSFGMVSFE 220
P K D++S +
Sbjct: 232 -PCDAKVDIWSSCCMMLH 248
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLVRLH 87
LGFGG +V+ + + +AVKVL +L + +F E H +V ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 88 GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ +V EY++ +L + + + ++ E+ + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSHQ--- 134
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK-GTPGYSAPEFLSGN 202
IIH D+KP N+++ A + KV DFG+A+ + + VT + GT Y +PE G+
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 203 YPITHKCDVYSFGMVSFEIV-GRR 225
+ + DVYS G V +E++ G
Sbjct: 195 -SVDARSDVYSLGCVLYEVLTGEP 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+G G F +V + G ++A+K+++K L + ++ EV + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQRI 146
+ L+ EY G + YL R E E K +I + Y H Q+RI
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCH---QKRI 135
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+K EN+LLDA+ + K+ADFG + + + G P Y+APE G
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDG 192
Query: 207 HKCDVYSFGMVSFEIV 222
+ DV+S G++ + +V
Sbjct: 193 PEVDVWSLGVILYTLV 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRT 78
F+ NY + LG G F V + G++ A K++N L ++ E +
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 79 YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL 138
H N+VRLH ++ LV++ + G L + ++ E + + Y
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHCIQQILESIAYC 121
Query: 139 HEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
H I+H ++KPEN+LL + K+ADFGLA + + + + GTPGY +
Sbjct: 122 HS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLS 175
Query: 196 PEFLSGNYPITHKCDVYSFG 215
PE L + P + D+++ G
Sbjct: 176 PEVLKKD-PYSKPVDIWACG 194
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 69/322 (21%), Positives = 118/322 (36%), Gaps = 69/322 (21%)
Query: 31 RLGFGGFGQVYKGQFPNGVK------IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
+G G FG+V++ + P + +AVK+L + + F E + + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRALEW 121
+L G C L++EYM G L+ +L L
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
+ IA A G+ YL E ++ +H D+ N L+ N K+ADFGL+ RN
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS----RN--- 223
Query: 182 VTISGY--KGTPGY-----SAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS 233
+ + Y PE Y T + DV+++G+V +EI
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIF----------- 270
Query: 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAV 293
S P + E+ + I + +L + C PADRP ++
Sbjct: 271 -SYGLQP---YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 294 VKMLEGVVEVLPPPKPFRYLDL 315
++L+ + E + +
Sbjct: 327 HRILQRMCERAEG-----TVGV 343
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 47/225 (20%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNK 58
++F ++I ++ + ++ + Y LG G FG V++ + G K +N
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 59 NLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL------DGYL 112
+ E+ + + +H L+ LH D++ L+ E++ G L + Y
Sbjct: 87 PYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 145
Query: 113 FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFG 170
+ + + + + +GL ++H + I+H DIKPEN++ + + K+ DFG
Sbjct: 146 MSEAEVINY--MRQAC----EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
LA + + + T ++APE + P+ D+++ G
Sbjct: 197 LATKLNPDEIVKVTT---ATAEFAAPEIVDRE-PVGFYTDMWAIG 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 60/266 (22%), Positives = 91/266 (34%), Gaps = 54/266 (20%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLN 57
M + + F L Y + +G G +G V + A+K++N
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 58 K----NLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLF 113
K + E+ EV + + +H N+ RL+ D+ LV E G L L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 114 GKKRALEWEKLHEIAIGTAK---------------------------------------G 134
+ ++
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 135 LVYLHEECQQRIIHYDIKPENVLL--DANFSPKVADFGLAKLCDRNRSH--VTISGYKGT 190
L YLH Q I H DIKPEN L + +F K+ DFGL+K + + ++ GT
Sbjct: 181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 191 PGYSAPEFLSG-NYPITHKCDVYSFG 215
P + APE L+ N KCD +S G
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAG 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 12 KPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNK-NLGKIAEEQ 67
+ F F+ NY + LG G F V + G++ A K++N L ++
Sbjct: 15 RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK 74
Query: 68 FMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI 127
E + H N+VRLH ++ LV++ + G L + ++ E + H I
Sbjct: 75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNRSHVTI 184
+ + Y H I+H ++KPEN+LL A + K+ADFGLA + + +
Sbjct: 135 QQ-ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
+ GTPGY +PE L + P + D+++ G
Sbjct: 191 A---GTPGYLSPEVLKKD-PYSKPVDIWACG 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 46/203 (22%), Positives = 77/203 (37%), Gaps = 22/203 (10%)
Query: 31 RLGFGGFGQVYKG--QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH- 87
+ GG G +Y + NG + +K L + A+ MAE + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 88 -GFCHDQHMTALVY---EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
D+H + Y EY+ SL + L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS--- 200
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
+++ D+KPEN++L K+ D G + GTPG+ APE +
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY------GTPGFQAPEIVRTG- 252
Query: 204 PITHKCDVYSFGMVSFEIVGRRR 226
T D+Y+ G +
Sbjct: 253 -PTVATDIYTVGRTLAALTLDLP 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 13 PVRFTSLQLNNFTSNYS----TRLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQ 67
R + + S Y+ LG G FGQV+K + G+K+A K++ G +E+
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEE 132
Query: 68 FMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL------DGYLFGKKRALEW 121
E+ + + H NL++L+ ++ LV EY++ G L + Y + + +
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNR 179
+ +I +G+ ++H Q I+H D+KPEN+L + K+ DFGLA+
Sbjct: 193 --MKQIC----EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
GTP + APE ++ ++ ++ D++S G
Sbjct: 244 KLKVNF---GTPEFLAPEVVNYDF-VSFPTDMWSVG 275
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 67/250 (26%), Positives = 102/250 (40%), Gaps = 61/250 (24%)
Query: 7 EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN--------GVKIAVKVLNK 58
E+ R++ L L LG G FGQV + K+AVK+L
Sbjct: 65 ELPRDR------LVLGK-------PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111
Query: 59 NLGKIAEEQFMAEVG---TIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL--- 112
+ + ++E+ IG+ H N++ L G C ++ EY G+L YL
Sbjct: 112 DATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 169
Query: 113 ------------FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA 160
+ L + L A A+G+ YL ++ IH D+ NVL+
Sbjct: 170 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 226
Query: 161 NFSPKVADFGLAKLCDRNRSHVTISGY--KGTPG-----YSAPE-FLSGNYPITHKCDVY 212
+ K+ADFGLA+ + Y K T G + APE Y TH+ DV+
Sbjct: 227 DNVMKIADFGLARD-------IHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVW 277
Query: 213 SFGMVSFEIV 222
SFG++ +EI
Sbjct: 278 SFGVLLWEIF 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 23 NFTSNYSTR---LGFGGFGQVYKG-QFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGR 77
NF + Y LG G F V + G + A K L K G+ + + E+ +
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 78 TYHI-NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHE-IAIGTAK-- 133
++ LH + L+ EY G + F E + E I K
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQI 140
Query: 134 --GLVYLHEECQQRIIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYK 188
G+ YLH+ I+H D+KP+N+LL + + K+ DFG+++ I
Sbjct: 141 LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--- 194
Query: 189 GTPGYSAPEFLSGNYPITHKCDVYSFG 215
GTP Y APE L+ + PIT D+++ G
Sbjct: 195 GTPEYLAPEILNYD-PITTATDMWNIG 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 55/192 (28%), Positives = 81/192 (42%), Gaps = 11/192 (5%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G +G+V +AVK+++ E E+ H N+V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQRII 147
+ ++ L EY G L + E + H++ G YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H DIKPEN+LLD + K++DFGLA + N ++ GT Y APE L
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 208 KCDVYSFGMVSF 219
DV+S G+V
Sbjct: 188 PVDVWSCGIVLT 199
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 29/237 (12%), Positives = 65/237 (27%), Gaps = 54/237 (22%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-------LGKIAEE---------------- 66
LG + G V V + ++ EE
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 67 ----QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM----ENGSLDGYLFG---K 115
+F+ + ++R+ D + + + Y + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 116 KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
++L ++ + + L LH ++H ++P +++LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLS----------GNYPITHKCDVYSFGMVSFEIV 222
+ G+ PE + +T D ++ G+V + I
Sbjct: 257 GARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 60/224 (26%), Positives = 89/224 (39%), Gaps = 45/224 (20%)
Query: 31 RLGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVG---TIGRTYHI 81
LG G FGQV + +AVK+L + M+E+ IG H+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HL 91
Query: 82 NLVRLHGFCHDQHM-TALVYEYMENGSLDGYL---------------FGKKRALEWEKLH 125
N+V L G C ++ E+ + G+L YL K L E L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 126 EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185
+ AKG+ +L ++ IH D+ N+LL K+ DFGLA+ D +
Sbjct: 152 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPD--- 203
Query: 186 GYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
Y + APE Y T + DV+SFG++ +EI
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIF 244
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 17 TSLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAE-----EQF 68
+ + Y LG G F V K + G++ A K + K + + E+
Sbjct: 3 ETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 69 MAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI- 127
EV + + H N++ LH ++ L+ E + G LF + E L E
Sbjct: 63 EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE----LF--DFLAQKESLSEEE 116
Query: 128 AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNR 179
A K G+ YLH ++I H+D+KPEN++L P K+ DFGLA +
Sbjct: 117 ATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
I GTP + APE ++ P+ + D++S G
Sbjct: 174 EFKNIF---GTPEFVAPEIVNYE-PLGLEADMWSIG 205
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-26
Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 32/211 (15%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAE-----EQFMAEVGT 74
+Y LG G F V K Q G + A K + K + E+ EV
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 75 IGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHEI-AIGTA 132
+ H N++ LH ++ L+ E + G L D E E L E A
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-------FLAEKESLTEDEATQFL 114
Query: 133 K----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTI 184
K G+ YLH +RI H+D+KPEN++L P K+ DFG+A + I
Sbjct: 115 KQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
GTP + APE ++ P+ + D++S G
Sbjct: 172 F---GTPEFVAPEIVNYE-PLGLEADMWSIG 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAE-----EQFMAEVGT 74
Y LG G F V K + G++ A K + K + + E+ EV
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 75 IGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI-AIGTAK 133
+ + H N++ LH ++ L+ E + G LF + E L E A K
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGE----LF--DFLAQKESLSEEEATSFIK 122
Query: 134 ----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTIS 185
G+ YLH ++I H+D+KPEN++L P K+ DFGLA + I
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
GTP + APE ++ P+ + D++S G
Sbjct: 180 ---GTPEFVAPEIVNYE-PLGLEADMWSIG 205
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 23/213 (10%)
Query: 22 NNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKN-------LGKIAEEQFMAE 71
Y LG G G+V + K+A+++++K E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 72 VGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT 131
+ + + H ++++ F + +V E ME G L + G KR E
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQM 248
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYK 188
+ YLHE IIH D+KPENVLL + + K+ DFG +K+ T+
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--- 302
Query: 189 GTPGYSAPEFLSGNY--PITHKCDVYSFGMVSF 219
GTP Y APE L D +S G++ F
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
+G G V P K+A+K +N + + ++ + E+ + + +H N+V +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 89 FCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEK-LHEIAIG-----TAKGLVYLHEE 141
F + LV + + GS+ D + L E I +GL YLH+
Sbjct: 82 FVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCD-----RNRSHVTISGYKGTPGYSA 195
IH D+K N+LL + S ++ADFG+ A L RN+ T GTP + A
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV---GTPCWMA 194
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEI 221
PE + K D++SFG+ + E+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 47/228 (20%)
Query: 31 RLGFGGFGQVYKGQ------FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG+V K +AVK+L +N ++E + + H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYL-----------------------FGKKRALEW 121
+L+G C L+ EY + GSL G+L +RAL
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
L A ++G+ YL E +++H D+ N+L+ K++DFGL++ D
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEED 204
Query: 182 VTISGY-KGTPG-----YSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
Y K + G + A E Y T + DV+SFG++ +EIV
Sbjct: 205 S----YVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIV 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 41/198 (20%), Positives = 67/198 (33%), Gaps = 24/198 (12%)
Query: 33 GFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQF---MAEVGTIGRTYHINLVRLHG 88
GF V ++ P G + V+ +N L + E E+ H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRIN--LEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93
Query: 89 -FCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHEIAI---GTAKGLVYLHEECQ 143
F D + +V +M GS D + E IA G K L Y+H
Sbjct: 94 TFIADNEL-WVVTSFMAYGSAKDLICTHFMDGMN-ELA--IAYILQGVLKALDYIH---H 146
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFG-LAKLCD----RNRSHVTISGYKGTPGYSAPEF 198
+H +K ++L+ + ++ + + H + +PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 199 LSGN-YPITHKCDVYSFG 215
L N K D+YS G
Sbjct: 207 LQQNLQGYDAKSDIYSVG 224
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 55/192 (28%), Positives = 81/192 (42%), Gaps = 11/192 (5%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G +G+V +AVK+++ E E+ H N+V+ +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQRII 147
+ ++ L EY G L + E + H++ G YLH I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H DIKPEN+LLD + K++DFGLA + N ++ GT Y APE L
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 208 KCDVYSFGMVSF 219
DV+S G+V
Sbjct: 188 PVDVWSCGIVLT 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 23 NFTSNYSTR---LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR- 77
F Y + LG G +V + AVK++ K G + EV + +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQC 67
Query: 78 TYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKG 134
H N++ L F ++ LV+E M GS+ ++ ++ E E + ++ A
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV----ASA 123
Query: 135 LVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYK--- 188
L +LH + I H D+KPEN+L + K+ DF L N IS +
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 189 --GTPGYSAPEFLSGNYPITH----KCDVYSFG 215
G+ Y APE + +CD++S G
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
LG G FG+VYK + G A KV+ + E ++ E+ + H +V+L G
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAI---GTAKGLVYLHEECQQR 145
+ HD + ++ E+ G++D + R L E +I + + L +LH +R
Sbjct: 85 YYHDGKLW-IMIEFCPGGAVDAIMLELDRGLT-EP--QIQVVCRQMLEALNFLH---SKR 137
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPE------F 198
IIH D+K NVL+ ++ADFG+ AK + + + GTP + APE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETM 194
Query: 199 LSGNYPITHKCDVYSFG 215
Y +K D++S G
Sbjct: 195 KDTPY--DYKADIWSLG 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 13/219 (5%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYST--RLGFGGFGQVYKGQF-PNGVKIAVKVLNK 58
+ ++ +I ++ + ++ ++ +Y LG G FG V++ G A K +
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 59 NLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA 118
+E E+ T+ H LV LH D + ++YE+M G L + +
Sbjct: 193 PHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 119 LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCD 176
+ ++ E KGL ++HE +H D+KPEN++ S K+ DFGL D
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
+S + GT ++APE G P+ + D++S G
Sbjct: 309 PKQSVKVTT---GTAEFAAPEVAEGK-PVGYYTDMWSVG 343
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 28/210 (13%)
Query: 18 SLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGT 74
S+Q N + LG G F +V+ Q G A+K + K+ + E+
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAV 59
Query: 75 IGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHE-----IA 128
+ + H N+V L LV + + G L D R LE E +
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD-------RILERGVYTEKDASLVI 112
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTIS 185
+ YLHE I+H D+KPEN+L + N + DFGL+K+
Sbjct: 113 QQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC- 168
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
GTPGY APE L+ P + D +S G
Sbjct: 169 ---GTPGYVAPEVLAQK-PYSKAVDCWSIG 194
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
++G G FG+V+KG +A+K+++ + E E+ + + + + +G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAI---GTAKGLVYLHEECQQR 145
+ D + ++ EY+ GS L + L+ E +IA KGL YLH ++
Sbjct: 89 YLKDTKL-WIIMEYLGGGSALDLL--EPGPLD-ET--QIATILREILKGLDYLHS---EK 139
Query: 146 IIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNY 203
IH DIK NVLL + K+ADFG+ +L D T + GTP + APE + Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 204 PITHKCDVYSFGMVSFEI 221
K D++S G+ + E+
Sbjct: 197 --DSKADIWSLGITAIEL 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 56/223 (25%), Positives = 88/223 (39%), Gaps = 28/223 (12%)
Query: 5 LQEIGREKPVRFTSLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLG 61
+Q +G V+ FT Y + +G G + + ++ AVK+++K+
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 62 KIAEE-QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALE 120
EE + + G H N++ L D +V E M+ G L + +K E
Sbjct: 61 DPTEEIEILLRYGQ-----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 121 WE---KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSP-KVADFGLAK 173
E L I K + YLH Q ++H D+KP N+L N ++ DFG AK
Sbjct: 116 REASAVLFTI----TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFG 215
+ T + APE L Y CD++S G
Sbjct: 169 QLRAENG--LLMTPCYTANFVAPEVLERQGY--DAACDIWSLG 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 64/216 (29%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 17 TSLQLNNFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAE-----EQF 68
T + N Y T LG G F V K + G++ A K + K K + E
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 69 MAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI- 127
EV + H N++ LH ++ L+ E + G LF E E L E
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE----LF--DFLAEKESLTEEE 115
Query: 128 AIGTAK----GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNR 179
A K G+ YLH +I H+D+KPEN++L P K+ DFGLA D
Sbjct: 116 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
I GTP + APE ++ P+ + D++S G
Sbjct: 173 EFKNIF---GTPEFVAPEIVNYE-PLGLEADMWSIG 204
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 38/204 (18%), Positives = 78/204 (38%), Gaps = 26/204 (12%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY 79
Y LG G FG V++ + + K + + E+ +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR 59
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSL------DGYLFGKKRALEWEKLHEIAIGTAK 133
H N++ LH +++E++ + + ++ + + +H++ +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--VHQVC----E 113
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTP 191
L +LH I H+DI+PEN++ S K+ +FG A+ + + P
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAP 167
Query: 192 GYSAPEFLSGNYPITHKCDVYSFG 215
Y APE + ++ D++S G
Sbjct: 168 EYYAPEVHQHD-VVSTATDMWSLG 190
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 30/208 (14%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-----------TY 79
LG GGFG V+ G + +++A+KV+ +N ++ +++ T
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRN--RVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGS-LDGYLFGKKRALEWE---KLHEIAIGTAKGL 135
H ++RL + Q LV E L Y+ K E ++ +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAI 152
Query: 136 VYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYS 194
+ H + ++H DIK EN+L+D K+ DFG L GT YS
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYS 205
Query: 195 APEFLSGNYPITHKCDVYSFGMVSFEIV 222
PE++S + V+S G++ +++V
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMV 233
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 62/230 (26%), Positives = 90/230 (39%), Gaps = 51/230 (22%)
Query: 31 RLGFGGFGQVYKGQ------FPNGVKIAVKVLNKNLGKIAEEQFMAEVG---TIGRTYHI 81
LG G FG+V +++AVK+L + E M+E+ +G H
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HE 109
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYL----------------------FGKKRAL 119
N+V L G C L++EY G L YL L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 120 EWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179
+E L A AKG+ +L + +H D+ NVL+ K+ DFGLA R
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA------R 220
Query: 180 SHVTISGYKGTPG------YSAPE-FLSGNYPITHKCDVYSFGMVSFEIV 222
++ S Y + APE G Y T K DV+S+G++ +EI
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIF 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 29/231 (12%), Positives = 59/231 (25%), Gaps = 43/231 (18%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQ---------------------- 67
LG + G V V +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 68 -------FMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME--NGSLDGYLFGKKR- 117
F ++ + + VRL +Y M+ + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 118 --ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
+L ++ + + L LH ++H ++P +++LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYP----ITHKCDVYSFGMVSFEIV 222
+ G+ P +A L +T D ++ G+ + I
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 27/210 (12%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKG-QFPNGVKIAVKVLNK----NLGKIAEEQFMAEVGTI 75
F Y +G G F V + G + AVK+++ + ++ E E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEW--EK-----LHEIA 128
H ++V L M +V+E+M+ L + + A E + +I
Sbjct: 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSP-KVADFGLAKLCDRNRSHVTIS 185
+ L Y H+ IIH D+KP VLL N +P K+ FG+A + +
Sbjct: 141 ----EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAG 191
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
G GTP + APE + P DV+ G
Sbjct: 192 GRVGTPHFMAPEVVKRE-PYGKPVDVWGCG 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 73/341 (21%), Positives = 123/341 (36%), Gaps = 76/341 (22%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRL--H 87
L GGF VY+ Q +G + A+K L N + + EV + + + H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 88 GFCHDQHMTALVYEY---ME--NGSLDGYLFGKKRALEWEKLHE-----IAIGTAKGLVY 137
+ E+ E G L +L K+ L I T + + +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYK--------- 188
+H + IIH D+K EN+LL + K+ DFG A + + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 189 -GTPGYSAPEF--LSGNYPITHKCDVYSFGMVSFEIVGRR-------RNAIVGASESLDW 238
TP Y PE L N+PI K D+++ G + + + R+ + IV S+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPP 270
Query: 239 FPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ ++I +Q +P +R ++ VV L+
Sbjct: 271 HDTQ------YTVFHSLI--------------------RAMLQVNPEERLSIAEVVHQLQ 304
Query: 299 GVVEV--LPPPKPFRYLDLNKMTGLRSLESSDGSNSSNQSR 337
+ + P P L LE + G S+ SR
Sbjct: 305 EIAAARNVNPKSPITEL----------LEQNGGYGSATLSR 335
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 23 NFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY 79
+ + LG G VY+ + A+KVL K + ++ E+G + R
Sbjct: 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK---TVDKKIVRTEIGVLLRLS 106
Query: 80 HINLVRLHGFCHDQHMTALVYEYMENGSL-DGYLFGKKRALEWEKLHE-----IAIGTAK 133
H N+++L +LV E + G L D R +E E +
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFD-------RIVEKGYYSERDAADAVKQILE 159
Query: 134 GLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKGT 190
+ YLHE I+H D+KPEN+L + K+ADFGL+K+ + T+ GT
Sbjct: 160 AVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GT 213
Query: 191 PGYSAPEFLSGNYPITHKCDVYSFG 215
PGY APE L G + D++S G
Sbjct: 214 PGYCAPEILRGC-AYGPEVDMWSVG 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 17 TSLQLNNFTSNYSTR--LGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQFMAEV 72
++ FT Y LG G F V + G + A ++N L ++ E
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61
Query: 73 GTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTA 132
H N+VRLH ++ L+++ + G L + ++ E
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE-ADASHCIQQIL 120
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTISGYKG 189
+ +++ H+ ++H ++KPEN+LL + K+ADFGLA + + G+ G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAG 175
Query: 190 TPGYSAPEFLSGNYPITHKCDVYSFG 215
TPGY +PE L + P D+++ G
Sbjct: 176 TPGYLSPEVLRKD-PYGKPVDLWACG 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 52/192 (27%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG + +AVK + + G +E E+ H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQQRII 147
A++ EY G L + R E E ++ G + Y H +I
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQIC 138
Query: 148 HYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
H D+K EN LLD + +P K+ DFG +K + + GTP Y APE L
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYD 195
Query: 206 THKCDVYSFGMV 217
DV+S G+
Sbjct: 196 GKIADVWSCGVT 207
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-LGKIA--EEQFMAEVGTIGRTYHINLVRLH 87
LG G +G+V + + AVK+L K L +I E E+ + R H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 88 GFCHDQHMTA--LVYEYMENGSLDGYLFG---KKRALEWE---KLHEIAIGTAKGLVYLH 139
+++ +V EY G + + +KR + ++ G YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
Q I+H DIKP N+LL + K++ G+A+ + T +G+P + PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 200 SGNYPIT-HKCDVYSFGMVSFEIV 222
+G + K D++S G+ + I
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNIT 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMA----EVGTIGRTYHINLVRL 86
LG G FG+V G+ G K+AVK+LN+ KI + E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQ 143
+ +V EY+ G L Y+ R E E +I Y H +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---R 129
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
++H D+KPENVLLDA+ + K+ADFGL+ + T G+P Y+APE +SG
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186
Query: 204 PITHKCDVYSFGMVSFEIV 222
+ D++S G++ + ++
Sbjct: 187 YAGPEVDIWSCGVILYALL 205
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 45/206 (21%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI--------- 81
LG GGFG VY G + + +A+K + K+ +I++ + + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKD--RISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 82 NLVRLHGFCHDQHMTALVYEYMEN-GSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVY 137
++RL + L+ E E L ++ + E ++ + + +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL----EAVRH 164
Query: 138 LHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
H ++H DIK EN+L+D N K+ DFG L GT YS P
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPP 217
Query: 197 EFLSGNYPITHKCDVYSFGMVSFEIV 222
E++ + V+S G++ +++V
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMV 243
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 58/225 (25%), Positives = 86/225 (38%), Gaps = 39/225 (17%)
Query: 18 SLQLNNFTSNYST--RLGFGGFGQVYKG-QFPNGVKIAVKVLNKN-------LGKIAEEQ 67
S+ Y LG G G+V + K+A+K+++K
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 68 FMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEI 127
E+ + + H ++++ F + +V E ME G L + G KR E
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEAT----- 115
Query: 128 AIGTAKGLV--------YLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCD 176
K YLHE IIH D+KPENVLL + + K+ DFG +K+
Sbjct: 116 ----CKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 177 RNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSF 219
T+ GTP Y APE L D +S G++ F
Sbjct: 169 ETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMA---------EVGTIGRTYHI 81
LG G FG V+ ++ VK + K K+ E+ ++ E+ + R H
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGS-LDGYLFGKKRALEWE---KLHEIAIGTAKGLVY 137
N++++ +Q LV E +G L ++ R E ++ Y
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPE 197
L + IIH DIK EN+++ +F+ K+ DFG A +R + T + GT Y APE
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPE 199
Query: 198 FLSGNYPITHKCDVYSFGMVSFEIV 222
L GN + +++S G+ + +V
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLV 224
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 59/197 (29%), Positives = 85/197 (43%), Gaps = 29/197 (14%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEE--QFMAEVGTIGRTYHINLVRLH 87
+G G FG VY + N +A+K ++ + + E+ + EV + + H N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 88 G-FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAI---GTAKGLVYLHEECQ 143
G + + LV EY + D KK E EIA G +GL YLH
Sbjct: 121 GCYLREHTA-WLVMEYCLGSASDLLEVHKKPLQE----VEIAAVTHGALQGLAYLHS--- 172
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPE----F 198
+IH D+K N+LL K+ DFG + + N S V GTP + APE
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-SFV------GTPYWMAPEVILAM 225
Query: 199 LSGNYPITHKCDVYSFG 215
G Y K DV+S G
Sbjct: 226 DEGQY--DGKVDVWSLG 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 27/235 (11%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKN- 59
++F + + L +N+F + +G GGFG+VY + + K+ A+K L+K
Sbjct: 169 DKFTRFCQWKNVELNIHLTMNDF--SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
Query: 60 -LGKIAEEQFMAE---VGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL--- 112
K E + E + + +V + H + + + M G L +L
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH 286
Query: 113 --FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170
F + + EI +G L ++H + +++ D+KP N+LLD + +++D G
Sbjct: 287 GVFSEADMRFY--AAEIILG----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
LA + + H GT GY APE L D +S G + F+ + G
Sbjct: 338 LACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 31 RLGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
++G G G VY G ++A++ +N + +E + E+ + + N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ + +V EY+ GSL + + ++ ++ + + L +LH ++IH
Sbjct: 86 YLVGDELW-VVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 149 YDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
DIK +N+LL + S K+ DFG A++ T+ GTP + APE ++
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRK-AYGP 195
Query: 208 KCDVYSFGMVSFEIV 222
K D++S G+++ E++
Sbjct: 196 KVDIWSLGIMAIEMI 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 44/217 (20%), Positives = 81/217 (37%), Gaps = 37/217 (17%)
Query: 87 HGFCHDQHMTALVY---EYMENGSLDGYLFGKKRALEWEKLHEIAIGT--AKGLVYLHEE 141
G +Y + +L ++ + + E + I A+ + +LH
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-- 181
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS----------GYKGTP 191
+ ++H D+KP N+ + KV DFGL D++ T+ G GT
Sbjct: 182 -SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251
Y +PE + GN +HK D++S G++ FE+ + + E+
Sbjct: 241 LYMSPEQIHGN-NYSHKVDIFSLGLILFEL----------------LYSFS--TQMERVR 281
Query: 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP 288
+ + +K Q M+ + SP +RP
Sbjct: 282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 18/76 (23%), Positives = 32/76 (42%), Gaps = 1/76 (1%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+G GGFG V++ + + A+K + ++A E+ M EV + + H +VR
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 90 CHDQHMTALVYEYMEN 105
+ E E
Sbjct: 73 WLETPPEKWQEEMDEI 88
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 30 TRLGFGGFGQVYKGQ-FPNGVKIAVKV--LNKNLGKIAEE-QFMAEVGTIGRTYHINLVR 85
+LG G +G VYK G +A+K + +L +I +E M + ++V+
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ------CDSPHVVK 88
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAI---GTAKGLVYLHEEC 142
+G +V EY GS+ + + + L E EIA T KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-ED--EIATILQSTLKGLEYLH--- 142
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
R IH DIK N+LL+ K+ADFG+ +L D T+ GTP + APE +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI---GTPFWMAPEVIQE 199
Query: 202 NYPITHKCDVYSFG 215
D++S G
Sbjct: 200 I-GYNCVADIWSLG 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 48/195 (24%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG- 88
++G G G V + +G ++AVK+++ + E EV + H N+V ++
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
+ + + ++ E+++ G+L + + L E++ + + L YLH Q +IH
Sbjct: 111 YLVGEELW-VLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIH 164
Query: 149 YDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
DIK +++LL + K++DFG A++ ++ GTP + APE +S +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRS-LYAT 220
Query: 208 KCDVYSFGMVSFEIV 222
+ D++S G++ E+V
Sbjct: 221 EVDIWSLGIMVIEMV 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G FG+V Q + K+ A+K +NK + + E+ + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAL--EWEKLH--EIAIGTAKGLVYLHEECQQ 144
D+ +V + + G L Y + E KL E+ + L YL Q
Sbjct: 83 SFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMA----LDYLQN---Q 134
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
RIIH D+KP+N+LLD + + DF +A + R T++ GT Y APE S
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRKG 191
Query: 205 ITHKCDV--YSFGMVSFE-IVGRR 225
+ V +S G+ ++E + GRR
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 51/197 (25%), Positives = 79/197 (40%), Gaps = 18/197 (9%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAEVGTIGRTYHINLVRL 86
LG G F V + + A+K+L K I + E + R H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLH---EIAIGTAKGLVYLHEECQ 143
+ D Y +NG L Y+ E EI L YLH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA----LEYLHG--- 148
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
+ IIH D+KPEN+LL+ + ++ DFG AK+ + + GT Y +PE L+
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK- 207
Query: 204 PITHKCDVYSFGMVSFE 220
D+++ G + ++
Sbjct: 208 SACKSSDLWALGCIIYQ 224
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMA----EVGTIGRTYHINLVRL 86
LG G FG+V G+ G K+AVK+LN+ KI + E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQ 143
+ +V EY+ G L Y+ R E E +I G Y H +
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---R 134
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY 203
++H D+KPENVLLDA+ + K+ADFGL+ + T G+P Y+APE +SG
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 191
Query: 204 PITHKCDVYSFGMVSFEIV 222
+ D++S G++ + ++
Sbjct: 192 YAGPEVDIWSSGVILYALL 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-23
Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGK----IAEEQFMAEVGTIGRTYHINLVR 85
+G G +GQVYKG+ G A+KV++ + E + + H N+
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-----HRNIAT 85
Query: 86 LHG-FCHDQHMTA-----LVYEYMENGSL-DGYLFGKKRALEWEKLHEIAI---GTAKGL 135
+G F LV E+ GS+ D K L+ E+ IA +GL
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EE--WIAYICREILRGL 142
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL-AKLCDRNRSHVTISGYKGTPGYS 194
+LH+ ++IH DIK +NVLL N K+ DFG+ A+L T GTP +
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWM 196
Query: 195 APE------FLSGNYPITHKCDVYSFGMVSFEI 221
APE Y K D++S G+ + E+
Sbjct: 197 APEVIACDENPDATY--DFKSDLWSLGITAIEM 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-23
Identities = 51/211 (24%), Positives = 79/211 (37%), Gaps = 35/211 (16%)
Query: 22 NNFTSNY---STRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR 77
T +Y LG G G+V + G K A+K+L + E +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG--- 80
Query: 78 TYHINLVRLHGFCHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEK-----LHEIA 128
++V + + H ++ E ME G L + + E+ + +I
Sbjct: 81 --GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVTIS 185
+ +LH I H D+KPEN+L + + K+ DFG AK +N
Sbjct: 139 ----TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC- 190
Query: 186 GYKGTPGYSAPEFLSG-NYPITHKCDVYSFG 215
TP Y APE L Y CD++S G
Sbjct: 191 ---YTPYYVAPEVLGPEKY--DKSCDMWSLG 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 19 LQLNNFTSNYSTR-----LGFGGFGQVYKG-QFPNGVKIAVKVLNKNLGKIAEEQFMAEV 72
++ + F +Y LG G F K + AVK+++K E E+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEI 56
Query: 73 GTIGR-TYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIA 128
+ H N+V+LH HDQ T LV E + G L + KK E E + ++
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL- 115
Query: 129 IGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAK-LCDRNRSHVTI 184
+ ++H+ ++H D+KPEN+L + N K+ DFG A+ N+ T
Sbjct: 116 ---VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 185 SGYKGTPGYSAPEFLSGN-YPITHKCDVYSFG 215
T Y+APE L+ N Y CD++S G
Sbjct: 170 C---FTLHYAAPELLNQNGY--DESCDLWSLG 196
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMA----EVGTIGRTYHINLVRL 86
LG G FG+V + K+A+K +++ + + E+ + H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWE---KLHEIAIGTAKGLVYLHEECQ 143
+ +V EY G L Y+ KKR E E +I Y H +
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH---R 126
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKL-CDRNRSHVTISGYKGTPGYSAPEFLSGN 202
+I+H D+KPEN+LLD N + K+ADFGL+ + D N + G+P Y+APE ++G
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGK 182
Query: 203 YPITHKCDVYSFGMVSFEIV 222
+ DV+S G+V + ++
Sbjct: 183 LYAGPEVDVWSCGIVLYVML 202
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 68/235 (28%), Positives = 96/235 (40%), Gaps = 30/235 (12%)
Query: 1 MERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKN 59
RFLQ K + + N F LG GGFG+V Q K+ A K L K
Sbjct: 167 FNRFLQW----KWLERQPVTKNTF--RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 60 --LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSL-------DG 110
+ E + E + + +V L + LV M G L
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 111 YLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170
F + RA+ + EI G L LH +RI++ D+KPEN+LLD + +++D G
Sbjct: 281 AGFPEARAVFY--AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLG 331
Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
LA TI G GT GY APE + T D ++ G + +E I G+
Sbjct: 332 LAV---HVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQ 382
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 43/217 (19%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKN---------------LGKIAEEQFMAEVGTI 75
+G G +G V + A+KVL+K + A + G I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 76 GRTY----------HINLVRLHGFCHDQHMTAL--VYEYMENGSLDGYLFGKKRALEWE- 122
+ Y H N+V+L D + L V+E + G + K E +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139
Query: 123 --KLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
++ KG+ YLH Q+IIH DIKP N+L+ + K+ADFG++ + +
Sbjct: 140 RFYFQDLI----KGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 181 HVTISGYKGTPGYSAPEFLSGNYPITH--KCDVYSFG 215
++ + GTP + APE LS I DV++ G
Sbjct: 193 LLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMG 227
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 55/229 (24%), Positives = 84/229 (36%), Gaps = 38/229 (16%)
Query: 6 QEIGREKPVRFTSLQLNNFTSNYSTR---LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG 61
Q+ + ++ N +Y LG G G+V + K A+K+L
Sbjct: 41 QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK 100
Query: 62 KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA----LVYEYMENGSL-------DG 110
E + ++VR+ + + +V E ++ G L
Sbjct: 101 ARREVELHWRASQ-----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 155
Query: 111 YLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVA 167
F ++ A E + I + + YLH I H D+KPEN+L N K+
Sbjct: 156 QAFTEREASEI--MKSIG----EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206
Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS-GNYPITHKCDVYSFG 215
DFG AK + S T TP Y APE L Y CD++S G
Sbjct: 207 DFGFAKETTSHNSLTTPC---YTPYYVAPEVLGPEKY--DKSCDMWSLG 250
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 69/238 (28%), Positives = 105/238 (44%), Gaps = 35/238 (14%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKN- 59
RFLQ K + + + F LG GGFG+V+ Q K+ A K LNK
Sbjct: 169 LRFLQW----KWLEAQPMGEDWF--LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR 222
Query: 60 -LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL--VYEYMENGSL-------- 108
+ + M E + + + +V L + + T L V M G +
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAF-ETKTDLCLVMTIMNGGDIRYHIYNVD 280
Query: 109 -DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167
D F + RA+ + +I G L +LH+ + II+ D+KPENVLLD + + +++
Sbjct: 281 EDNPGFQEPRAIFY--TAQIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRIS 331
Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
D GLA ++ GY GTPG+ APE L G D ++ G+ +E I R
Sbjct: 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAAR 386
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G FG+V + N K+ A+K+LNK L + F E + + LH
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRAL--EWEK--LHEIAIGTAKGLVYLHEECQQ 144
D + LV +Y G L L + L E + L E+ I + +H Q
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVH---QL 194
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
+H DIKP+N+L+D N ++ADFG + + + GTP Y +PE L
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEG 253
Query: 205 ITHK----CDVYSFGMVSFE 220
+ CD +S G+ +E
Sbjct: 254 GKGRYGPECDWWSLGVCMYE 273
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 16/197 (8%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G FG+V + + K+ A+K+L+K + + F E + +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEK--LHEIAIGTAKGLVYLHEECQQRI 146
D +V EYM G L + +W + E+ + L +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIH---SMGF 189
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---GNY 203
IH D+KP+N+LLD + K+ADFG ++ + GTP Y +PE L G+
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDG 248
Query: 204 PITHKCDVYSFGMVSFE 220
+CD +S G+ +E
Sbjct: 249 YYGRECDWWSVGVFLYE 265
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G F +V + ++ A+K++NK L + F E + + +LH
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 89 FCHDQHMTALVYEYMENGSLDGYL--FGKKRALEWEK--LHEIAIGTAKGLVYLHEECQQ 144
D++ LV EY G L L FG++ E + L EI + + +H +
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH---RL 181
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL----- 199
+H DIKP+N+LLD ++ADFG + + ++ GTP Y +PE L
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGG 240
Query: 200 -SGNYPITHKCDVYSFGMVSFE 220
G +CD ++ G+ ++E
Sbjct: 241 GPGTGSYGPECDWWALGVFAYE 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 33/284 (11%), Positives = 72/284 (25%), Gaps = 54/284 (19%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQ--FMAEVGTIGRTYHINLVRLH 87
G Q ++ ++A+ ++ + ++ + R + R+
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
H + +V E++ GSL + A H + +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAGVA 151
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
P V V+ G L P
Sbjct: 152 LSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA--------NP 181
Query: 208 KCDVYSFGMVSFEIV-GRRRNAIVGASESLDWFPKYVWEEYEK-SELGAMILACGIEEKD 265
+ D+ G + ++ R G L + + + +++ I
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI--------- 232
Query: 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKP 309
Q+ VA VQ R S ++ +++ V +
Sbjct: 233 ---PFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 9e-18
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 47/209 (22%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAEVGTIGRTYHINLVRL 86
LG G FG+V+ + + + A+KVL K + E E + H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGLVYLH 139
G D ++ +Y+E G L L F A K + E+ + L YLH
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----KFYAAEVCLA----LEYLH 123
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--------LCDRNRSHVTISGYKGTP 191
+ II+ D+KPEN+LLD N K+ DFG AK LC GTP
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-------------GTP 167
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
Y APE +S P D +SFG++ +E
Sbjct: 168 DYIAPEVVSTK-PYNKSIDWWSFGILIYE 195
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 49/231 (21%)
Query: 10 REKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE--- 65
+ + + QL+ F + LG G FG+V + A+K+L+K K+ +
Sbjct: 29 KWETPSQNTAQLDQF--DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQ 84
Query: 66 -EQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYL-----FGKKRAL 119
E + E + LV+L D +V EY+ G + +L F + A
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA- 143
Query: 120 EWEKLH--EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK---- 173
+ + +I + YLH +I+ D+KPEN+L+D +V DFG AK
Sbjct: 144 ---RFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 174 ----LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
LC GTP APE + D ++ G++ +E
Sbjct: 194 RTWTLC-------------GTPEALAPEIILSK-GYNKAVDWWALGVLIYE 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 40/213 (18%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ------FMA--EVGTIGRTYHI 81
++G G +G V+K + G +A+K K E + +A E+ + + H
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIK-------KFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
NLV L + LV+EY ++ ++ L +R + + I T + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSH--VTISGYKGTPGYSAP 196
+ IH D+KPEN+L+ + K+ DFG A+L T Y +P
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-------WYRSP 171
Query: 197 EFLSG--NY--PITHKCDVYSFGMVSFEIVGRR 225
E L G Y P+ DV++ G V E++
Sbjct: 172 ELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQF--------MAEVGTIGRTYHIN 82
++G G +G VYK + G +A+K +I + + E+ + +H N
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALK-------RIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+V L H + LV+E+ME L L K L+ ++ +G+ + H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH--- 136
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFL 199
Q RI+H D+KP+N+L++++ + K+ADFGLA+ R+ +H + T Y AP+ L
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWYRAPDVL 191
Query: 200 SGNYPITHKCDVYSFGMVSFEIVGRR 225
G+ + D++S G + E++ +
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 36/207 (17%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--------TYHIN 82
+G G FGQV K +A+K++ +N + Q E+ + T ++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHR-QAAEEIRILEHLRKQDKDNTMNV- 161
Query: 83 LVRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYL 138
+ + F H+ + +E + S++ Y KK + + + A + L L
Sbjct: 162 -IHMLENFTFRNHI-CMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTI--SGYKGTPGYS 194
H + RIIH D+KPEN+LL KV DFG + C ++ T S + Y
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRF-----YR 266
Query: 195 APEFLSGNYPITHKCDVYSFGMVSFEI 221
APE + G D++S G + E+
Sbjct: 267 APEVILG-ARYGMPIDMWSLGCILAEL 292
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 39/237 (16%)
Query: 6 QEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVK-VLNKNLGKI 63
E R++ RF + G G FG V G+ G+ +A+K V+ +
Sbjct: 15 DERSRKEMDRFQVER----------MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64
Query: 64 AEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA-------LVYEYMENGSLDGYLFGKK 116
E Q M + + +H N+V+L + + +V EY+ + +
Sbjct: 65 RELQIMQD---LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRN 118
Query: 117 RALEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFG 170
I I + + LH + H DIKP NVL++ A+ + K+ DFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRR 225
AK + +V Y + Y APE + G +Y T D++S G + E++
Sbjct: 178 SAKKLSPSEPNV---AYICSRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 40/217 (18%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTI-----------GRTY 79
LG+G F V+ + N +A+K++ + K+ E E+ +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIV-RG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 80 HINLVRLHG-FCH----DQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGT 131
++++L F H H+ +V+E + + KK R + + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHV-VMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSP------KVADFGLAKLCDRNRSHVTIS 185
GL Y+H C IIH DIKPENVL++ SP K+AD G A C + +
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE---HYT 193
Query: 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
T Y +PE L G P D++S + FE++
Sbjct: 194 NSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELI 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 5e-17
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 28/216 (12%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF--------MAEVGTIGRTYHI 81
++G G +G V+K + +A+K ++ + + E+ + H
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALK-------RVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
N+VRLH H LV+E+ + L Y L+ E + KGL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEF 198
+ ++H D+KP+N+L++ N K+A+FGLA+ R S + T Y P+
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRPPDV 172
Query: 199 LSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234
L G + D++S G + E+ R G
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 32/209 (15%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQ------FMA--EVGTIGRTYHI 81
+G G +G V K + G +A+K K E +A E+ + + H
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIK-------KFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
NLV L C + LV+E++++ ++ L L+++ + + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK-LCDRNRSHVTISGYKGTPGYSAPEFLS 200
IIH DIKPEN+L+ + K+ DFG A+ L T Y APE L
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPELLV 197
Query: 201 G--NY--PITHKCDVYSFGMVSFEIVGRR 225
G Y + DV++ G + E+
Sbjct: 198 GDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-17
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQF--------MAEVGTIGRTYHIN 82
++G G +G VYK Q G A+K KI E+ + E+ + H N
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALK-------KIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+V+L+ H + LV+E+++ L L + LE + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFL 199
+R++H D+KP+N+L++ K+ADFGLA+ R +H + T Y AP+ L
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVL 172
Query: 200 SGNYPITHKCDVYSFGMVSFEIVGRR 225
G+ + D++S G + E+V
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 36/209 (17%)
Query: 32 LGFGGFGQVY---KGQFPNGVKI-AVKVLNKNLGKIAE-----EQFMAEVGTIGRTYHIN 82
LG G +G+V+ K + K+ A+KVL K I + E E +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA--TIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 83 -LVRLHGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTA 132
LV LH + Q T L + +Y+ G L +L F + +++ EI +
Sbjct: 120 FLVTLH-YAF-QTETKLHLILDYINGGELFTHLSQRERFTEHEV----QIYVGEIVLA-- 171
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
L +LH+ II+ DIK EN+LLD+N + DFGL+K + + + GT
Sbjct: 172 --LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIE 225
Query: 193 YSAPEFLSGN-YPITHKCDVYSFGMVSFE 220
Y AP+ + G D +S G++ +E
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVK-VLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+G G FG VY+ + +G +A+K VL K E Q M ++ H N+VRL F
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNIVRLRYF 115
Query: 90 CHDQHMTA------LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIG-----TAKGLVYL 138
+ LV +Y+ Y + + + L I + + L Y+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAKLCDRNRSHVT--ISGYKGTPGYSA 195
H I H DIKP+N+LLD + + K+ DFG AK R +V+ S Y Y A
Sbjct: 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRA 224
Query: 196 PEFLSG--NYPITHKCDVYSFGMVSFEIVGRR 225
PE + G +Y T DV+S G V E++ +
Sbjct: 225 PELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 46/236 (19%)
Query: 7 EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVK-VLNKNLGKIAE 65
+ G ++ + +T+ + +G G FG V++ + ++A+K VL K E
Sbjct: 33 KTGEQREIAYTNCK----------VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE 82
Query: 66 EQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA------LVYEYMENGSLDGYLFGKKRAL 119
Q M V H N+V L F + LV EY+ Y + A
Sbjct: 83 LQIMRIVK------HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAK 133
Query: 120 EWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-KVADFGLAK 173
+ + + I + L Y+H I H DIKP+N+LLD K+ DFG AK
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 174 LCDRNRSHVT--ISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRR 225
+ +V+ S Y Y APE + G NY T D++S G V E++ +
Sbjct: 191 ILIAGEPNVSYICSRY-----YRAPELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKI---AEEQF----MAEVGTIGRTYHIN 82
+LG G + VYKG+ +A+K +I EE + EV + H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALK-------EIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+V LH H + LV+EY++ L YL + + +GL Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSHVTISGYKGTPGYSAPEFL 199
+Q+++H D+KP+N+L++ K+ADFGLA+ + + + T Y P+ L
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPPDIL 172
Query: 200 SGNYPITHKCDVYSFGMVSFEIVGRR 225
G+ + + D++ G + +E+ R
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 30/204 (14%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--------TYHIN 82
+G G FGQV K +A+K++ KN Q EV + Y+I
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLN-QAQIEVRLLELMNKHDTEMKYYI- 118
Query: 83 LVRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYL 138
V L F H+ LV+E + S + Y + R + + A L++L
Sbjct: 119 -VHLKRHFMFRNHL-CLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 139 HEECQQRIIHYDIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
+ IIH D+KPEN+LL K+ DFG + C + Y + Y +P
Sbjct: 174 ATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQ---YIQSRFYRSP 227
Query: 197 EFLSGNYPITHKCDVYSFGMVSFE 220
E L G P D++S G + E
Sbjct: 228 EVLLG-MPYDLAIDMWSLGCILVE 250
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 34/205 (16%)
Query: 32 LGFGGFGQVY---KGQFPNGVKI-AVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG+V+ K + ++ A+KVL K L + E + H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 87 HGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGLVY 137
H + Q L + +++ G L L F ++ K + E+A+ L +
Sbjct: 92 H-YAF-QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV----KFYLAELALA----LDH 141
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSA 195
LH II+ D+KPEN+LLD K+ DFGL+K + +++ + GT Y A
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFC---GTVEYMA 194
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFE 220
PE ++ T D +SFG++ FE
Sbjct: 195 PEVVNRR-GHTQSADWWSFGVLMFE 218
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 32 LGFGGFGQVY---KGQFPNGVKI-AVKVLNKN--LGKIAE-EQFMAEVGTIGRTYHINLV 84
LG GG+G+V+ K N KI A+KVL K + + AE + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 85 RLHGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGL 135
L + Q L + EY+ G L L F + A + EI++ L
Sbjct: 85 DLI-YAF-QTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----CFYLAEISMA----L 134
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGY 193
+LH+ + II+ D+KPEN++L+ K+ DFGL K + D +H T GT Y
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-TFC---GTIEY 187
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFE 220
APE L + D +S G + ++
Sbjct: 188 MAPEILMRS-GHNRAVDWWSLGALMYD 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
LG G FG+V + + A+K+L K + K + E + + H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 89 -FCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGLVYLHE 140
F + V EY G L +L F + RA + + EI L YLH
Sbjct: 216 SFQTHDRL-CFVMEYANGGELFFHLSRERVFSEDRA----RFYGAEIVSA----LDYLHS 266
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
E + +++ D+K EN++LD + K+ DFGL K ++ + T+ + GTP Y APE L
Sbjct: 267 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLE 322
Query: 201 GNYPITHKCDVYSFGMVSFE-IVGR 224
N D + G+V +E + GR
Sbjct: 323 DN-DYGRAVDWWGLGVVMYEMMCGR 346
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 45/212 (21%), Positives = 69/212 (32%), Gaps = 57/212 (26%)
Query: 22 NNFTSNYSTR---LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR 77
N +Y LG G G+V + K A+K+L E +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ--- 69
Query: 78 TYHINLVRLHGFCHDQHMTA----LVYEYMENGSL-------DGYLFGKKRALEWEKLHE 126
++VR+ + + +V E ++ G L F ++ A E +
Sbjct: 70 --CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI--MKS 125
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRNRSHVT 183
I + + YLH I H D+KPEN+L N K+ DFG
Sbjct: 126 IG----EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFG 215
A E Y CD++S G
Sbjct: 167 -----------AKETTGEKY--DKSCDMWSLG 185
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 36/189 (19%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKI---AEEQF----MAEVGTIGRTYHIN 82
+LG G + VYKG GV +A+K ++ +EE + E+ + H N
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALK-------EVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT-----AKGLVY 137
+VRL+ H ++ LV+E+M+N L Y+ + L + +GL +
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSH--VTISGYKGTPG 192
H + +I+H D+KP+N+L++ K+ DFGLA+ S VT+
Sbjct: 124 CH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL-------W 173
Query: 193 YSAPEFLSG 201
Y AP+ L G
Sbjct: 174 YRAPDVLMG 182
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 34/233 (14%)
Query: 7 EIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKI 63
E+ +E+P L++ +F LG G FG+V+ +F + A+K L K+ L
Sbjct: 2 ELNKERPSLQIKLKIEDF--ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD 59
Query: 64 AEEQFMAE---VGTIGRTYHINLVRLHG-FCHDQHMTALVYEYMENGSLDGYL-----FG 114
E M E + H L + F +++ V EY+ G L ++ F
Sbjct: 60 DVECTMVEKRVLSLAWE--HPFLTHMFCTFQTKENLF-FVMEYLNGGDLMYHIQSCHKFD 116
Query: 115 KKRALEWEKLH--EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
RA + EI +G L +LH + I++ D+K +N+LLD + K+ADFG+
Sbjct: 117 LSRA----TFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165
Query: 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
K + T + + GTP Y APE L G H D +SFG++ +E ++G+
Sbjct: 166 KE-NMLGDAKTNT-FCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 61/205 (29%), Positives = 86/205 (41%), Gaps = 36/205 (17%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAEVGTIGRTYHINLVRL 86
LG G FG+V + + A+K+L K I + E + T H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 87 HGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGLVY 137
+ Q L V EY G L +L F ++RA + + EI L Y
Sbjct: 71 K-YAF-QTHDRLCFVMEYANGGELFFHLSRERVFTEERA----RFYGAEIVSA----LEY 120
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSA 195
LH + +++ DIK EN++LD + K+ DFGL K + D T GTP Y A
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFC---GTPEYLA 173
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFE 220
PE L N D + G+V +E
Sbjct: 174 PEVLEDN-DYGRAVDWWGLGVVMYE 197
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF--MA--EVGTIGRTYHINLVR 85
LG G F VYK + +A+K + A++ A E+ + H N++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
L + +LV+++ME L+ + L + + T +GL YLH Q
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 132
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLC---DRNRSH--VTISGYKGTPGYSAPEFLS 200
I+H D+KP N+LLD N K+ADFGLAK +R +H VT Y APE L
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-------WYRAPELLF 185
Query: 201 G--NYPITHKCDVYSFGMVSFEIVGRR 225
G Y D+++ G + E++ R
Sbjct: 186 GARMY--GVGVDMWAVGCILAELLLRV 210
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF----MAEVGT---IGRTYHIN 82
+G G +G VYK + +G +A+K + G + EV + H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 83 LVRLHGFCHDQHMTA-----LVYEYMENGSLDGYL-FGKKRALEWEKLHEIAIGTAKGLV 136
+VRL C LV+E+++ L YL L E + ++ +GL
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR--SHVTISGYKGTPGYS 194
+LH I+H D+KPEN+L+ + + K+ADFGLA++ + V + T Y
Sbjct: 135 FLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-----TLWYR 186
Query: 195 APEFLSG-NYPITHKCDVYSFGMVSFEIVGRR 225
APE L Y D++S G + E+ R+
Sbjct: 187 APEVLLQSTY--ATPVDMWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 36/210 (17%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAE---VGTIGRTYHINL 83
LG G FG+V + ++ AVK+L K + + E M E + G+ L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVEKRVLALPGK--PPFL 404
Query: 84 VRLHG-FCHDQHMTALVYEYMENGSLDGYL-----FGKKRALEWEKLHEIAIGTAKGLVY 137
+LH F + V EY+ G L ++ F + A+ + EIAIG L +
Sbjct: 405 TQLHSCFQTMDRLY-FVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIG----LFF 457
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSA 195
L + II+ D+K +NV+LD+ K+ADFG+ K + D + T GTP Y A
Sbjct: 458 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFC---GTPDYIA 510
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
PE ++ P D ++FG++ +E + G+
Sbjct: 511 PEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 47/224 (20%)
Query: 31 RLGFGGFGQVYKGQ---FPNGVKIAVKVLNKNLGKIAEEQF----MAEVGTIGRTYHINL 83
++G G +G VYK + + A+K +I E+ + H N+
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALK-------QIEGTGISMSACREIALLRELKHPNV 80
Query: 84 VRLHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK-------- 133
+ L L+++Y E+ L + + + +K ++ G K
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP----KVADFGLAKLC---DRNRSH----- 181
G+ YLH ++H D+KP N+L+ K+AD G A+L + +
Sbjct: 140 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
VT Y APE L G T D+++ G + E++
Sbjct: 197 VTF-------WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 9e-15
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 54/222 (24%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQF--------MAEVGTIGRTYHI 81
+LG G +G+VYK +A+K +I E + EV + H
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIK-------RIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK-------- 133
N++ L H H L++EY EN L Y+ +K ++++ K
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---------DKNPDVSMRVIKSFLYQLIN 143
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSP-----KVADFGLAKLC---DRNRSH--VT 183
G+ + H +R +H D+KP+N+LL + + K+ DFGLA+ R +H +T
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
+ Y PE L G+ + D++S + E++ +
Sbjct: 201 L-------WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 42/213 (19%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAE---VGTIGRTYHINL 83
LG G FG+V + + AVKVL K I + E M E + H L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKK--DVILQDDDVECTMTEKRILSLARN--HPFL 86
Query: 84 VRLHGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKG 134
+L C Q L V E++ G L ++ F + RA + + EI
Sbjct: 87 TQLF-CCF-QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA----RFYAAEIISA---- 136
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPG 192
L++LH+ + II+ D+K +NVLLD K+ADFG+ K +C+ + T GTP
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFC---GTPD 189
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFE-IVGR 224
Y APE L D ++ G++ +E + G
Sbjct: 190 YIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 41/208 (19%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKNLGKIAE----EQFMAE---VGTIGRTYHINL 83
LG G FG+V + ++ AVK+L K + + E M E + G+ L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKK--DVVIQDDDVECTMVEKRVLALPGK--PPFL 83
Query: 84 VRLHGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKG 134
+LH C Q M L V EY+ G L ++ F + A + EIAIG
Sbjct: 84 TQLH-SCF-QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAEIAIG---- 133
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPG 192
L +L + II+ D+K +NV+LD+ K+ADFG+ K + D + T GTP
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFC---GTPD 186
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFE 220
Y APE ++ P D ++FG++ +E
Sbjct: 187 YIAPEIIAYQ-PYGKSVDWWAFGVLLYE 213
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 39/236 (16%)
Query: 2 ERFLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKI-AVKVLNKN- 59
E RE +SL L +F + +G G + +V + +I A++V+ K
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL 89
Query: 60 -LGKIAEEQFMAE---VGTIGRTYHINLVRLHGFCHDQHMTAL--VYEYMENGSLDGYL- 112
+ E H LV LH C Q + L V EY+ G L ++
Sbjct: 90 VNDDEDIDWVQTEKHVFEQASN--HPFLVGLH-SCF-QTESRLFFVIEYVNGGDLMFHMQ 145
Query: 113 ----FGKKRALEWEKLH--EIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 166
++ A + + EI++ L YLHE + II+ D+K +NVLLD+ K+
Sbjct: 146 RQRKLPEEHA----RFYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKL 194
Query: 167 ADFGLAK--LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
D+G+ K L + + T GTP Y APE L G D ++ G++ FE
Sbjct: 195 TDYGMCKEGLRPGDTTS-TFC---GTPNYIAPEILRGE-DYGFSVDWWALGVLMFE 245
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 49/240 (20%), Positives = 84/240 (35%), Gaps = 32/240 (13%)
Query: 9 GREKPVRFTSLQLNN----FTSNYS--TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGK 62
G + L S Y+ + G +G V G G+ +A+K + +
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 63 IAEEQFMAEVGTIGRTY----------HINLVRLHGFCHDQHMTA-----LVYEYMENGS 107
+++ R H N++ L A LV E M
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-D 119
Query: 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167
L + ++ + + + GL LHE ++H D+ P N+LL N +
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176
Query: 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVSFEIVGRR 225
DF LA+ + + + Y Y APE + + T D++S G V E+ R+
Sbjct: 177 DFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGF--TKLVDMWSAGCVMAEMFNRK 231
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 37/206 (17%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAE---VGTIGRTYHINLVR 85
+G G + +V + +I A+KV+ K + E H LV
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN--HPFLVG 74
Query: 86 LHGFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGLV 136
LH C Q + L V EY+ G L ++ ++ A + + EI++ L
Sbjct: 75 LH-SCF-QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA----RFYSAEISLA----LN 124
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYS 194
YLHE + II+ D+K +NVLLD+ K+ D+G+ K L + + T GTP Y
Sbjct: 125 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-TFC---GTPNYI 177
Query: 195 APEFLSGNYPITHKCDVYSFGMVSFE 220
APE L G D ++ G++ FE
Sbjct: 178 APEILRGE-DYGFSVDWWALGVLMFE 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 67/204 (32%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 32 LGFGGFGQVYKGQFPNGVKI-AVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRLH 87
+G G FG+V + AVKVL K L K E+ M+E + + H LV LH
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 88 GFCHDQHMTAL--VYEYMENGSLDGYL-----FGKKRALEWEKLH--EIAIGTAKGLVYL 138
F Q L V +Y+ G L +L F + RA + + EIA L YL
Sbjct: 106 -FSF-QTADKLYFVLDYINGGELFYHLQRERCFLEPRA----RFYAAEIASA----LGYL 155
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK--LCDRNRSHVTISGYKGTPGYSAP 196
H I++ D+KPEN+LLD+ + DFGL K + + + T GTP Y AP
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS-TFC---GTPEYLAP 208
Query: 197 EFLSGNYPITHKCDVYSFGMVSFE 220
E L P D + G V +E
Sbjct: 209 EVLHKQ-PYDRTVDWWCLGAVLYE 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 62/228 (27%)
Query: 31 RLGFGGFGQVYKGQ--FPNGVKIAVKVLNKNLGKI----AEEQF----MAEVGT---IGR 77
+G G +G+V+K + G +A+K ++ EE + EV +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK-------RVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 78 TYHINLVRLHGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTA 132
H N+VRL C LV+E+++ L YL +K+ E + T
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---------DKVPEPGVPTE 120
Query: 133 ----------KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR--S 180
+GL +LH R++H D+KP+N+L+ ++ K+ADFGLA++ +
Sbjct: 121 TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 181 HVTISGYKGTPGYSAPEFLSG-NY--PITHKCDVYSFGMVSFEIVGRR 225
V + T Y APE L +Y P+ D++S G + E+ R+
Sbjct: 178 SVVV-----TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIA--EEQFMAEVGTIGRTY--------- 79
+G G +G V N V++A+K KI+ E Q + RT
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIK-------KISPFEHQTYCQ-----RTLREIKILLRF 82
Query: 80 -HINLVRLHGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK 133
H N++ ++ + +V + ME D Y K + L + + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICYFLYQILR 139
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPG 192
GL Y+H ++H D+KP N+LL+ K+ DFGLA++ D + H + Y T
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 193 YSAPEFL--SGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE + S Y T D++S G + E++ R
Sbjct: 197 YRAPEIMLNSKGY--TKSIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 36/193 (18%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ------FMA--EVGTIGRTYHI 81
++G G FG+V+K + G K+A+K K+ E A E+ + H
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK-------KVLMENEKEGFPITALREIKILQLLKHE 76
Query: 82 NLVRLHGFCHDQHMTA--------LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK 133
N+V L C + LV+++ E+ L G L ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG- 192
GL Y+H + +I+H D+K NVL+ + K+ADFGLA+ ++ + Y T
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP-NRY--TNRV 189
Query: 193 ----YSAPEFLSG 201
Y PE L G
Sbjct: 190 VTLWYRPPELLLG 202
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 47/218 (21%), Positives = 90/218 (41%), Gaps = 39/218 (17%)
Query: 25 TSNYS--TRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--TY 79
+Y +LG G + +V++ N K+ VK+L + +++ E+ I
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREI-KILENLRG 89
Query: 80 HINLVRLHGFCHDQH--MTALVYEYMENGSLDGYLFGKKRALEWEK----LHEIAIGTAK 133
N++ L D ALV+E++ N + L ++EI K
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEIL----K 141
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
L Y H I+H D+KP NV++D + ++ D+GLA+ + + + +
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRY 195
Query: 193 YSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRR 226
+ PE L +Y + D++S G + ++ R+
Sbjct: 196 FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKE 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---------- 79
+G G +G V G K+A+K L + + + A+ R Y
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAK-----RAYRELRLLKHMR 82
Query: 80 HINLVRL-HGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK 133
H N++ L F D+ + LV +M D K L +++ + K
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
GL Y+H IIH D+KP N+ ++ + K+ DFGLA+ D ++GY T Y
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWY 191
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
APE + T D++S G + E++ +
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 49/242 (20%), Positives = 85/242 (35%), Gaps = 65/242 (26%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVK-VLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G FG V + +G + A+K VL K E M + H+N+++L +
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLD------HVNIIKLVDY 68
Query: 90 CHDQHMTA--------------------------------------LVYEYMENGSLDGY 111
+ ++ EY+ +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTLH 125
Query: 112 LFGKKRALEWEKLHEIAIG-----TAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP-K 165
K + I + + ++H I H DIKP+N+L+++ + K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182
Query: 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVSFEIVG 223
+ DFG AK + V Y + Y APE + + Y T D++S G V E++
Sbjct: 183 LCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEY--TPSIDLWSIGCVFGELIL 237
Query: 224 RR 225
+
Sbjct: 238 GK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 53/234 (22%), Positives = 89/234 (38%), Gaps = 44/234 (18%)
Query: 15 RFTSLQLNN----FTSNYS--TRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ 67
F +N Y T +G G +G V +G K+A+K L + + +
Sbjct: 9 GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSE 64
Query: 68 FMAEVGTIGRTY----------HINLVRLHGFCHDQHMTA------LVYEYMENGSLDGY 111
A+ R Y H N++ L LV +M+ L
Sbjct: 65 IFAK-----RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKI 118
Query: 112 LFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
+ EK+ + KGL Y+H ++H D+KP N+ ++ + K+ DFGL
Sbjct: 119 M---GLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
A+ D ++GY T Y APE + D++S G + E++ +
Sbjct: 173 ARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 54/224 (24%)
Query: 32 LGFGGFGQVYKG--QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--------TYHI 81
LG G FG+V + ++A+K++ +N+GK E E+ + + +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII-RNVGKYRE-AARLEINVLKKIKEKDKENKFLC 84
Query: 82 NLVRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVY 137
V + F HM + +E + + + F K+ + + +A L +
Sbjct: 85 --VLMSDWFNFHGHM-CIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSP-------------------KVADFGLAKLCDRN 178
LHE ++ H D+KPEN+L + +VADFG A +
Sbjct: 139 LHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDH 193
Query: 179 RSHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
H TI + + Y PE + CDV+S G + FE
Sbjct: 194 EHHTTIVATRH-----YRPPEVILE-LGWAQPCDVWSIGCILFE 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 39/213 (18%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---------- 79
+G G G V +A+K L++ + R Y
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---------RAYRELVLMKCVN 82
Query: 80 HINLVRL-HGFCHDQHMTA-----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAK 133
H N++ L + F + + +V E M+ +L + + L+ E++ +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI---QMELDHERMSYLLYQMLC 138
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
G+ +LH IIH D+KP N+++ ++ + K+ DFGLA+ + ++ Y T Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 192
Query: 194 SAPEF-LSGNYPITHKCDVYSFGMVSFEIVGRR 225
APE L Y D++S G + E++
Sbjct: 193 RAPEVILGMGY--KENVDIWSVGCIMGEMIKGG 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 54/224 (24%)
Query: 32 LGFGGFGQVYKGQ--FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--------TYHI 81
LG G FG+V + G +AVK++ KN+ + E +E+ + T+
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCE-AARSEIQVLEHLNTTDPNSTFRC 79
Query: 82 NLVRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVY 137
V++ F H H+ +V+E + L Y F K+ + + ++A K + +
Sbjct: 80 --VQMLEWFEHHGHI-CIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 138 LHEECQQRIIHYDIKPENVLLDANFSP-------------------KVADFGLAKLCDRN 178
LH ++ H D+KPEN+L + KV DFG A +
Sbjct: 134 LHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDD 188
Query: 179 RSHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
H T+ + + Y APE + + CDV+S G + E
Sbjct: 189 EHHSTLVSTRH-----YRAPEVILA-LGWSQPCDVWSIGCILIE 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 15 RFTSLQLNN----FTSNYS--TRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQ 67
+F S+++ + Y +G G G V +A+K L + + Q
Sbjct: 47 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQ 102
Query: 68 FMAEVGTIGRTY----------HINLVRL-HGFCHDQHMTA-----LVYEYMENGSLDGY 111
A+ R Y H N++ L + F + + LV E M+ +L
Sbjct: 103 THAK-----RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQV 156
Query: 112 LFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171
+ + L+ E++ + G+ +LH IIH D+KP N+++ ++ + K+ DFGL
Sbjct: 157 I---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210
Query: 172 AKLCDRNRSHVTISGYKGTPGYSAPE-FLSGNYPITHKCDVYSFGMVSFEIVGRR 225
A+ + ++ Y T Y APE L Y D++S G + E+V +
Sbjct: 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMVRHK 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 46/223 (20%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIA-EEQFMAEVGTIGRTY--------- 79
LG GG G V+ ++A+K KI + +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK-------KIVLTDPQSVK-----HALREIKIIRRL 65
Query: 80 -HINLVRLHGFCHDQHMTA--------------LVYEYMENGSLDGYLFGKKRALEWEKL 124
H N+V++ +V EYME D ++ L E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQGPLLEEHA 122
Query: 125 HEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVT 183
+GL Y+H ++H D+KP N+ ++ + K+ DFGLA++ D + SH
Sbjct: 123 RLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 184 I-SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225
S T Y +P L T D+++ G + E++ +
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 58/248 (23%), Positives = 93/248 (37%), Gaps = 44/248 (17%)
Query: 1 MERFLQEIGREKPVRFTSLQLNN----FTSNYS--TRLGFGGFGQVYKGQ-FPNGVKIAV 53
M +E+P F +LN Y + +G G +G V G+++AV
Sbjct: 1 MAHHHHHHSQERPT-FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59
Query: 54 KVLNKNLGKIAEEQFMAEVGTIGRTY----------HINLVRLHGFCHDQHMTA------ 97
K L + + A+ RTY H N++ L
Sbjct: 60 K----KLSRPFQSIIHAK-----RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110
Query: 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 157
LV M D K + L + + + +GL Y+H IIH D+KP N+
Sbjct: 111 LVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLA 164
Query: 158 LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMV 217
++ + K+ DFGLA+ ++GY T Y APE + D++S G +
Sbjct: 165 VNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 218 SFEIVGRR 225
E++ R
Sbjct: 220 MAELLTGR 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 57/228 (25%), Positives = 83/228 (36%), Gaps = 58/228 (25%)
Query: 32 LGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVG---TIGRT----YHINL 83
+G G FG+V Q N AVKV+ +N+ K E I +I
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTR-SAKIEADILKKIQNDDINNNNI-- 98
Query: 84 VRLHG-FCHDQHMTALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYLH 139
V+ HG F + HM L++E + Y + E + I K L YL
Sbjct: 99 VKYHGKFMYYDHM-CLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 140 EECQQRIIHYDIKPENVLLDANFSP-------------------------KVADFGLAKL 174
+ + H D+KPEN+LLD + K+ DFG A
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-- 209
Query: 175 CDRNRSHVTI--SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFE 220
++ H +I + Y APE + D++SFG V E
Sbjct: 210 TFKSDYHGSIINTRQ-----YRAPEVILN-LGWDVSSDMWSFGCVLAE 251
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 116 KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175
K L E L + AKG+ +L ++ IH D+ N+LL K+ DFGLA+
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPI-THKCDVYSFGMVSFEIV 222
++ +V + + APE + + T + DV+SFG++ +EI
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 27/103 (26%), Positives = 43/103 (41%), Gaps = 8/103 (7%)
Query: 31 RLGFGGFGQVYKG------QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGT-IGRTYHINL 83
LG G FGQV + + +AVK+L + M+E+ I +H+N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 84 VRLHGFC-HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLH 125
V L G C ++ E+ + G+L YL K+ K
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 54/275 (19%), Positives = 88/275 (32%), Gaps = 88/275 (32%)
Query: 23 NFTSNYS--TRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKN-------------LGKIAEE 66
F Y +LG+G F V+ +A+KV+ L +
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN- 92
Query: 67 QFMAEVGTIGRTYHINLVRLHGFCHD----QHMTALVYEYMENG-SLDGYLFG-KKRALE 120
++ R + L L F H+ +V+E + G L ++ + L
Sbjct: 93 ---SDPNDPNREMVVQL--LDDFKISGVNGTHI-CMVFEVL--GHHLLKWIIKSNYQGLP 144
Query: 121 WEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---------------------- 158
+ +I +GL YLH +C+ IIH DIKPEN+LL
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 159 ---------------------------DANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
K+AD G A ++ + I T
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-IQ----TR 257
Query: 192 GYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRR 226
Y + E L G+ D++S ++FE+
Sbjct: 258 QYRSLEVLIGS-GYNTPADIWSTACMAFELATGDY 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 15/103 (14%)
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT--------I 184
+ + LH +IH D+KP N+L+++N KV DFGLA++ D + + + +
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 185 SGYKGTPGYSAPEFL--SGNYPITHKCDVYSFGMVSFEIVGRR 225
+ T Y APE + S Y + DV+S G + E+ RR
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 36/159 (22%), Positives = 59/159 (37%), Gaps = 32/159 (20%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---------- 79
+G G +G V + +A+K KI F + R
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIK-------KILRV-FEDLIDCK-RILREIAILNRLN 110
Query: 80 HINLVRLHGFCHDQHMTA-----LVYEYMENGSLDGY-LFGKKRALEWEKLHEIAIGTAK 133
H ++V++ + + +V E + D LF L + +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172
G+ Y+H I+H D+KP N L++ + S KV DFGLA
Sbjct: 168 GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 5e-09
Identities = 37/269 (13%), Positives = 73/269 (27%), Gaps = 67/269 (24%)
Query: 5 LQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVL-------- 56
+ E ++ PV F+ L ++G G FG+V++ + +A+K++
Sbjct: 2 MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLV 59
Query: 57 NKNLGKIAEE--------QFMAEVGTIGRTYHINLVRLHGFCHDQ--------------- 93
N + K EE + ++ + + L+ Q
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 94 ---------------HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYL 138
+V E+ G + + I L
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVA 177
Query: 139 HEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK------------LCDRNRSHVTISG 186
+ H D+ NVLL K+ K + D S + G
Sbjct: 178 EASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG 235
Query: 187 -YKGTPGYSAPEFLSGNYPITHKCDVYSF 214
+ +G+ ++ D+Y
Sbjct: 236 IVVFCDVSMDEDLFTGDG--DYQFDIYRL 262
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 58/230 (25%), Positives = 86/230 (37%), Gaps = 52/230 (22%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---------- 79
+LG G +G V+K G +AVK + + A+ RT+
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVK----KIFDAFQNSTDAQ-----RTFREIMILTELS 66
Query: 80 -HINLVRLHGFCHDQHMTA--LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLV 136
H N+V L + LV++YME D + + LE + K +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMET---DLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG---- 192
YLH ++H D+KP N+LL+A KVADFGL++ R
Sbjct: 124 YLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 193 ---------------YSAPEFL--SGNYPITHKCDVYSFGMVSFEIVGRR 225
Y APE L S Y T D++S G + EI+ +
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGK 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 42/207 (20%), Positives = 69/207 (33%), Gaps = 43/207 (20%)
Query: 31 RLGFGGFGQVYKGQ---------FPNGVKIAVKVLNKNLGKIAEEQFM------AEVGTI 75
G +Y+ P K ++K+ K+ E+ F +V
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 76 GRTYHINLV---RLHGF-CHDQHMTALVYEYMENG-SLDGYL-------FGKKRALEWEK 123
+ Y L+ GF H LV + G SL L ++ L+
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQ--- 163
Query: 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNRSH 181
+A L +LHE +H ++ EN+ +D +V A +G A + H
Sbjct: 164 ---VACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHK 208
V +P EF+S + HK
Sbjct: 218 VAYVEGSRSPHEGDLEFISMD---LHK 241
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 47/222 (21%), Positives = 78/222 (35%), Gaps = 52/222 (23%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---------- 79
+G G +G VY +A+K + ++ E+ + R
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCK-----RILREITILNRLK 83
Query: 80 HINLVRLHGFCHDQHMTA-----LVYEYMENGSLDGY-LFGKKRALEWEKLHEIAIGTAK 133
++RL+ + +V E ++ D LF L E + I
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 134 GLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG- 192
G ++HE IIH D+KP N LL+ + S KV DFGLA+ + + ++ +
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 193 -------------------YSAPEFLSGNYPITHKCDVYSFG 215
Y APE + T D++S G
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 44/189 (23%), Positives = 71/189 (37%), Gaps = 32/189 (16%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIA---VKVLNKNLGKIAEE----QFMAEVGTIGRTYHIN 82
++G GGFG +Y K A VKV + G + E Q +A+ I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 83 LVRLHGFCH----------DQHMTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAIGT 131
+ G + +V E + G L + G+ + + ++ I
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KISGQNGTFKKSTVLQLGIRM 160
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNRSHVTI----- 184
L Y+HE +H DIK N+LL +V AD+GL+ N +H
Sbjct: 161 LDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 185 SGYKGTPGY 193
G+ GT +
Sbjct: 218 KGHNGTIEF 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 38/201 (18%), Positives = 66/201 (32%), Gaps = 31/201 (15%)
Query: 31 RLGFGGFGQVYKGQFPNG------VKIAVKVLNKNLGKIAEE----QFMAEVGTIGRTYH 80
+G GGFG +Y + VKV + G + E Q A+ I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 81 INLVRLHGFCH----------DQHMTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAI 129
++ G + ++ + G L + + + ++++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 130 GTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV--ADFGLAKLCDRNRSHVTISGY 187
L Y+HE +H DIK N+LL+ +V D+GLA H +
Sbjct: 160 RILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 188 KGTPGYSAPEFLSGNYPITHK 208
EF S + H
Sbjct: 217 PKRCHDGTIEFTSID---AHN 234
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 29/180 (16%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI-----NLV 84
++G G FG++ G+ +A+K+ Q E R Y +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEY----RFYKQLGSGDGIP 68
Query: 85 RLHGFCHDQHMTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+++ F A+V E + G SL+ R + + IAI + Y+H +
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 144 QRIIHYDIKPENVLLDANFSPK-----VADFGLAKLCDRNRSHVTIS-----GYKGTPGY 193
+I+ D+KPEN L+ + + DF LAK + I GT Y
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 27/179 (15%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGK---IAEEQFMAEV-GTIGRTYHINLVR 85
R+G G FG +++G N ++A+K + E + + G G +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG------IPN 70
Query: 86 LHGFCHDQHMTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
++ F + LV + + G SL+ L R + + A + +HE +
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125
Query: 145 RIIHYDIKPENVLLDANFSPK-----VADFGLAKLCDRNRSHVTIS-----GYKGTPGY 193
+++ DIKP+N L+ S V DFG+ K + I GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 42/178 (23%), Positives = 70/178 (39%), Gaps = 27/178 (15%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI-----NLV 84
++G G FG++Y G ++A+K+ N K Q + E + Y I +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV---KTKHPQLLYES----KIYRILQGGTGIP 66
Query: 85 RLHGFCHDQHMTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ F + LV + + G SL+ R L + + +A + ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 144 QRIIHYDIKPENVLLDANFSPK---VADFGLAKLCDRNRSHVTIS-----GYKGTPGY 193
+H DIKP+N L+ + DFGLAK +H I GT Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 40/178 (22%), Positives = 66/178 (37%), Gaps = 27/178 (15%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI-----NLV 84
++G G FG +Y G G ++A+K+ Q E + Y + +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIES----KIYKMMQGGVGIP 68
Query: 85 RLHGFCHDQHMTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ + +V E + G SL+ R + + +A + Y+H
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 123
Query: 144 QRIIHYDIKPENVLLDANFSPK---VADFGLAKLCDRNRSHVTI-----SGYKGTPGY 193
+ IH D+KP+N L+ + DFGLAK R+H I GT Y
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 25/223 (11%), Positives = 57/223 (25%), Gaps = 39/223 (17%)
Query: 4 FLQEIGREKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYK--GQFPNGVKIAVKVLN---K 58
+ + +K LN + +++ FP I +L+
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAE--------YRKMFDRLSVFPPSAHIPTILLSLIWF 397
Query: 59 NLGKIAEEQFMAEV---GTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK 115
++ K + ++ + + + + + + + + +D Y
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNI-- 455
Query: 116 KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL--AK 173
+ + + L + Y H I H+ E+ F DF K
Sbjct: 456 PKTFDSDDLIPPYL---DQYFYSH------IGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLS-GNYP--ITHKCDVYS 213
+ H + + G Y I Y
Sbjct: 507 IR-----HDSTA--WNASGSILNTLQQLKFYKPYICDNDPKYE 542
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.36 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.77 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.67 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.12 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.77 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.73 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.58 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.28 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 91.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.87 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.98 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-63 Score=440.73 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=219.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
+...+++|.++||+|+||+||+|.+. +++.||||+++........+.|.+|+.++++++|||||+++|+|.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 44567888999999999999999862 468899999986655566678999999999999999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc
Q 047701 95 MTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 159 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 159 (356)
..+||||||++|+|.++|..+ ...+++..++.++.||+.||+|||+ ++++||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEEC
Confidence 999999999999999999543 2458999999999999999999999 9999999999999999
Q ss_pred CCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccc
Q 047701 160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDW 238 (356)
Q Consensus 160 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~ 238 (356)
+++.+||+|||+++...............||++|||||++.+. .++.++|||||||++|||+| |..|+....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~------ 252 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------ 252 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCC------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCC------
Confidence 9999999999999876554433334556799999999999887 79999999999999999998 777763221
Q ss_pred hhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 239 FPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
..++...+..+...+.+..++.++.+|+.+||+.||++||||.+|++.|+..
T Consensus 253 ----------~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 ----------NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1222333444445556667888999999999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-63 Score=437.19 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=217.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...+.+.++||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++|||||+++++|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 345678899999999999999763 4788999999764 345567899999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 97 ALVYEYMENGSLDGYLFGK------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
+||||||++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 9999999999999999643 2479999999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHH
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~ 243 (356)
||+|||+|+...............||++|||||++.+. .++.++|||||||++|||+| |+.|+....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~----------- 235 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLS----------- 235 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----------
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----------
Confidence 99999999876654444333445699999999999887 79999999999999999998 788864321
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..++...+..+.....+..++.++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 236 -----~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 236 -----NNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -----HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1122233333444455667788999999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=430.83 Aligned_cols=270 Identities=27% Similarity=0.411 Sum_probs=212.0
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
|++....+.+.++||+|+||+||+|++.. .||||+++.. ......+.|.+|+.++++++|||||++++++.+ +.++
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34555567788999999999999999743 5999998743 344556789999999999999999999999876 4579
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
||||||++|+|.+++......+++..++.|+.||+.||+|||+ ++|+||||||+||||++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999998777889999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCceeecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...........||+.|||||++.+. ..++.++|||||||++|||+||+.||...... ...........
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~---- 254 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGY---- 254 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTC----
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC----
Confidence 4443344557899999999999643 25899999999999999999999998432221 00111111100
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
........+.+++.++.+|+.+||+.||++|||+.+|++.|+.+...+|
T Consensus 255 -~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 255 -ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0001123345677889999999999999999999999999998866443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-62 Score=436.71 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=209.0
Q ss_pred HhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
..+.+.++||+|+||+||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++++|.+....+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34566789999999999999863 4789999999764 3455678999999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 98 LVYEYMENGSLDGYLFGK--------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~--------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
||||||++|+|.+++... ..++++..++.++.||+.||+|||+ ++|+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence 999999999999999643 2469999999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHH
Q 047701 164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~ 242 (356)
+||+|||+++...........+...||+.|||||++.+. .++.++|||||||++|||+| |+.||.....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------- 266 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------- 266 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---------
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999977655444444556799999999999987 79999999999999999998 7888743211
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.++...+..+...+.+..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 267 -------~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 -------TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 112222333334445566788999999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-60 Score=425.71 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=203.8
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.++||+|+||+||+|++ .+|+.||||++... ........+.+|++++++|+|||||++++++.+++.+||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 578889999999999999986 46999999999754 3445567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+||+|.+++..+ ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE- 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence 9999999999654 4567999999999999999999999 9999999999999999999999999999987643211
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....+||+.|||||++.+. .|+.++|||||||++|||++|+.||...... . +...+.....
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~----------~~~~i~~~~~ 242 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMK------N----------LVLKIISGSF 242 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H----------HHHHHHHTCC
T ss_pred -cccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------H----------HHHHHHcCCC
Confidence 12345799999999999987 7999999999999999999999998543221 0 1111112222
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+..++.++.+|+.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3344456788999999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-60 Score=427.78 Aligned_cols=268 Identities=25% Similarity=0.341 Sum_probs=223.6
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCC-CCeeeEee
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH-INLVRLHG 88 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~ 88 (356)
...|++....|++.++||+|+||+||+|.+. .++.||||++...........+.+|+.++.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 3456777778999999999999999999753 2468999999877666667789999999999965 89999999
Q ss_pred eEEc-CCeeeEEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Q 047701 89 FCHD-QHMTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 152 (356)
Q Consensus 89 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 152 (356)
+|.+ +..++||||||++|+|.++|... ...+++..++.++.|||.||+|||+ ++++|||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccC
Confidence 9976 45689999999999999999643 2458999999999999999999999 999999999
Q ss_pred ccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccC
Q 047701 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVG 231 (356)
Q Consensus 153 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~ 231 (356)
|+|||+++++.+||+|||+|+...............||+.|||||++.+. .++.++|||||||++|||+| |+.|+...
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665555555667799999999999887 79999999999999999998 78887432
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... . .+...+..+.....+..+++++.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 292 ~~~------~---------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 292 KID------E---------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCS------H---------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH------H---------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 221 1 1122233333444555677889999999999999999999999999988754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-59 Score=413.86 Aligned_cols=253 Identities=22% Similarity=0.227 Sum_probs=205.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.+.++||+|+||.||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++.+|||||||
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4566788999999999999864 699999999976422 246999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCCCCCc-
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRNRSH- 181 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~~~~- 181 (356)
+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+||||+.+| .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999954 4579999999999999999999999 9999999999999999887 6999999999987643322
Q ss_pred --eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 182 --VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 182 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
......+||+.|||||++.+. .++.++|||||||++|||++|+.||......... . ...... .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~-----~i~~~~-------~ 273 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--L-----KIASEP-------P 273 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--H-----HHHHSC-------C
T ss_pred ceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--H-----HHHcCC-------C
Confidence 122346799999999999987 7999999999999999999999998644332211 0 000000 0
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.....+..++.++.+++.+||+.||.+|||+.|+++.|.....
T Consensus 274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0112345567889999999999999999999999998876654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-59 Score=411.25 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=209.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||+||+|+. .+++.||||++.+.. .......+.+|++++++++|||||++++++.+.+.+|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 488899999999999999976 479999999997542 22345678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 113 y~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 113 YAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999953 4679999999999999999999999 99999999999999999999999999999987655444
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
......+||+.|||||++.+. .++.++|||||||++|+|++|..||...... ..........
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~---------- 250 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEG-------LIFAKIIKLE---------- 250 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTC----------
T ss_pred ccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCC----------
Confidence 444567899999999999987 7999999999999999999999998543221 1111111111
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVV 294 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~ 294 (356)
...+...+.++.+|+.+||..||++|||++|+.
T Consensus 251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 122334567899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=413.12 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=206.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.++||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++.+|||||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4777889999999999999864 699999999975422 23456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+||+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 99999999953 469999999999999999999999 99999999999999999999999999999877644322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....+||+.|||||++.+. .|+.++|||||||++|||++|..||...... .......... .....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~-------~~~~~ 291 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNL-------PPRLK 291 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSS-------CCCCS
T ss_pred ccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCC-------CCCCC
Confidence 2456899999999999877 7999999999999999999999998533221 0111111100 01122
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....++.++.+|+.+||..||++|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33456788999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-58 Score=400.77 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=199.0
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCeeeEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMTALV 99 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 99 (356)
+++.++||+|+||+||+|.+. +++.||||++... ........+.+|++++++++|||||++++++.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999864 6899999999754 344556789999999999999999999999865 3567999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEc-CCCceEEeccCCccccC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAKLCD 176 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~ 176 (356)
||||+||+|.+++. ....+++..+..++.||+.||+|||+ ++ |+||||||+||||+ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999995 44679999999999999999999998 77 99999999999997 47899999999998644
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||...... ...... +
T Consensus 184 ~~~----~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~---------i 242 (290)
T 3fpq_A 184 ASF----AKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRR---------V 242 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHH---------H
T ss_pred CCc----cCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHH---------H
Confidence 322 234679999999999875 4899999999999999999999998432221 111111 1
Q ss_pred hhcCC-CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGI-EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ...+...++++.+|+.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 1223334567999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=409.87 Aligned_cols=272 Identities=25% Similarity=0.316 Sum_probs=201.9
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC----eeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----MTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 100 (356)
++.+.++||+|+||+||+|++ +|+.||||+++... ........|+..+.+++|||||++++++.+.+ .+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 567889999999999999998 78999999997532 22223345666677889999999999998653 579999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
|||++|+|.+++.. ..+++..+.+++.|++.||+|||+.. ..+|+||||||+||||+.++++||+|||+++..
T Consensus 81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999954 46899999999999999999999721 239999999999999999999999999999877
Q ss_pred CCCCCce--eecCCCCCCCCCCcccccCCC-----CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 176 DRNRSHV--TISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
....... ......||+.|||||++.+.. .++.++|||||||++|||+||.+|+.........+.... .....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~-~~~~~ 237 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV-PSDPS 237 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS-CSSCC
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc-cccch
Confidence 6544332 123457999999999997642 367799999999999999999887654433222111000 00000
Q ss_pred hhchhhhHhh-cCCCc-----hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 249 KSELGAMILA-CGIEE-----KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 249 ~~~~~~~~~~-~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
...+...+.. ...+. .....+..+.+|+.+||+.||++||||.+|++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011111111 11111 123466789999999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=396.09 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=192.7
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|++.+.||+|+||+||+|... +|+.||||++.+.. .......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999864 69999999997542 2234467899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||| +|+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 999 6799999854 4679999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....||+.|||||++.+...++.++|||||||++|+|++|+.||...... ........ .
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~~~~~i~~---------~- 227 (275)
T 3hyh_A 168 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------VLFKNISN---------G- 227 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH---------T-
T ss_pred ---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHc---------C-
Confidence 234679999999999998744568999999999999999999998532211 11111111 1
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+...++++.+++.+||+.||++|||++++++
T Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223445678999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=415.08 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=206.1
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.++||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 4778899999999999999864 699999999975432 33456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+||+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 303 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 303 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence 99999999943 469999999999999999999999 99999999999999999999999999999877544322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....+||+.|||||++.+. .|+.++|||||||++|||++|..||...... .......... .....
T Consensus 304 ~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~~i~~~~-------~~~~~ 368 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNL-------PPRLK 368 (423)
T ss_dssp BCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-------CCCCS
T ss_pred ccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHcCC-------CCCCc
Confidence 2456799999999999887 7999999999999999999999998533221 0111111100 00112
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....++.++.+|+.+||..||++|||+.|+++
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23345678999999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=395.59 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=192.3
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC---------
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH--------- 94 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------- 94 (356)
.|++.+.||+|+||+||+|++. +|+.||||++.........+.+.+|+.++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3778899999999999999864 699999999986655566678999999999999999999999987544
Q ss_pred ---eeeEEEEecCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEecc
Q 047701 95 ---MTALVYEYMENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169 (356)
Q Consensus 95 ---~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 169 (356)
..|+|||||++|+|.+++.... ....+..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 3689999999999999996543 345677889999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCCce----------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch
Q 047701 170 GLAKLCDRNRSHV----------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF 239 (356)
Q Consensus 170 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~ 239 (356)
|+|+......... ..+..+||+.|||||++.+. .++.++|||||||++|||++ |+...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~-------- 230 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ-------- 230 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--------
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--------
Confidence 9998775432211 12346799999999999987 79999999999999999996 33110
Q ss_pred hHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 PKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ........+.....+......++.+.+++.+||+.||++|||+.++++
T Consensus 231 --~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 --M-----ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --H-----HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --c-----HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000111112222334445556677889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=400.98 Aligned_cols=248 Identities=24% Similarity=0.245 Sum_probs=197.4
Q ss_pred HhhccccccCcCCceEEEEEEc----CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..|++.+.||+|+||+||+|+. .+++.||||++++.. .......+.+|++++++++|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999975 247899999997542 22233468889999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999954 4579999999999999999999999 99999999999999999999999999999865543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... ....+||+.|||||++.+. .++.++|||||||++|||++|+.||....... .... +..
T Consensus 180 ~~~--~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~---------i~~ 240 (304)
T 3ubd_A 180 EKK--AYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-------TMTM---------ILK 240 (304)
T ss_dssp -CC--CCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH---------HHH
T ss_pred Ccc--ccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-------HHHH---------HHc
Confidence 322 2346799999999999887 79999999999999999999999985432210 1111 111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPM-----SAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~ 295 (356)
. ....+..+++++.+|+.+||+.||++|||+ +++++
T Consensus 241 ~-~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 A-KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C-CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 122344567889999999999999999995 56664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=389.04 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=201.7
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc------CCee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD------QHMT 96 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 96 (356)
.|.+.++||+|+||+||+|.+ .+|+.||||++.+.. .......+.+|+.+|++++|||||++++++.. ...+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 477889999999999999986 479999999997543 33445678899999999999999999998764 3578
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|||||||+ |+|.+++. ..+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 135 ~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 99999996 58999984 45689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCC--ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH--------
Q 047701 177 RNRS--HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE-------- 246 (356)
Q Consensus 177 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~-------- 246 (356)
.... .......+||+.|||||++.+...++.++||||+||++|||++|++||........ +.. ....
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~-I~~~~g~p~~~~ 286 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQL-IMMVLGTPSPAV 286 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHH-HHHHHCCCCGGG
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHhcCCCChHH
Confidence 4321 22234578999999999998875689999999999999999999999854322110 000 0000
Q ss_pred ---HhhhchhhhHhhcC-C-----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 247 ---YEKSELGAMILACG-I-----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 247 ---~~~~~~~~~~~~~~-~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.... . ....+..+.++.+|+.+||..||.+|||+.++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000011111000 0 0111234577899999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=380.38 Aligned_cols=262 Identities=20% Similarity=0.234 Sum_probs=199.9
Q ss_pred HhhccccccCcCCceEEEEEEc----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
..|++.++||+|+||+||+|+. .+++.||||.+.... ...++.+|+++++.+ +||||+++++++.+++.+||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4688999999999999999964 247899999987542 335678899999988 69999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla~~~~~ 177 (356)
|||||++|+|.+++ +.+++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999998 358999999999999999999999 999999999999999876 7999999999986543
Q ss_pred CCCc--------------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccC
Q 047701 178 NRSH--------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVG 231 (356)
Q Consensus 178 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~ 231 (356)
.... ...+..+||+.|+|||++.+...++.++||||+||++|||++|+.||..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2211 11234579999999999987756899999999999999999999999765
Q ss_pred CCccccchh---------HHHHHHHhh-----------hchhhhHh------------------hcCCCchhHHHHHHHH
Q 047701 232 ASESLDWFP---------KYVWEEYEK-----------SELGAMIL------------------ACGIEEKDKEKAKQLC 273 (356)
Q Consensus 232 ~~~~~~~~~---------~~~~~~~~~-----------~~~~~~~~------------------~~~~~~~~~~~~~~l~ 273 (356)
......... ...+..... ........ .....+.....+.++.
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 543211000 000000000 00000000 0000011122456789
Q ss_pred HHHHhhcCCCCCCCCCHHHHHH
Q 047701 274 MVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 274 ~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+|+.+||..||++|||++|+++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=391.22 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=200.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHH---HHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQF---MAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
.|++.++||+|+||.||+|+.. +|+.||||++.+.. .......+ ..++.+++.++|||||++++++.+.+.+||
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 4777899999999999999864 69999999997431 11112223 344677788899999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 270 VmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999954 4679999999999999999999999 99999999999999999999999999999877644
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. ...+||+.|||||++.+...|+.++|+|||||++|||++|..||......... .+...+..
T Consensus 346 ~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-------------~i~~~i~~ 408 (689)
T 3v5w_A 346 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDRMTLT 408 (689)
T ss_dssp CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-------------HHHHHHHH
T ss_pred CC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-------------HHHHhhcC
Confidence 32 34679999999999975447999999999999999999999998543322110 00111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
. ....+...+.++.+|+.+||..||.+|++ +++|.+
T Consensus 409 ~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 M-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C-CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 12234456788999999999999999998 677776
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=362.34 Aligned_cols=274 Identities=34% Similarity=0.564 Sum_probs=228.3
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
..|++.+.||+|+||.||+|.+.+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 3667788999999999999998889999999987653 245677899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 104 ENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 104 ~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999996543 359999999999999999999999 9999999999999999999999999999987554333
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
........||+.|+|||++.+. .++.++||||||+++|+|++|+.|+....+........+.........+...+....
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 3223445689999999999877 689999999999999999999999876655544434444333333444444444444
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 445567888999999999999999999999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=392.10 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=208.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+|++++|||||++++++.+...+|||||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5788999999999999999764 69999999997643 344567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC--CCceEEeccCCccccCCCCCc
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~~~~~ 181 (356)
+||+|.+++......+++..+..++.||+.||+|||+ ++|+||||||+|||++. .+.+||+|||+++.+......
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 9999999997677789999999999999999999999 99999999999999975 489999999999987654332
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
...+||+.|||||++.+. .++.++|||||||++|||++|..||...... ........... ...
T Consensus 314 ---~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~~~~~i~~~~~------~~~ 376 (573)
T 3uto_A 314 ---KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW------NMD 376 (573)
T ss_dssp ---EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC------CCC
T ss_pred ---eeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHHHHHhCCC------CCC
Confidence 335799999999999987 7999999999999999999999998533221 01111111100 011
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......++.++.+||.+||+.||.+||++.++++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233456778999999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=369.35 Aligned_cols=260 Identities=27% Similarity=0.380 Sum_probs=216.7
Q ss_pred HHhhccccccCcCCceEEEEEEc--------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcC
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF--------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQ 93 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 93 (356)
...|.+.+.||+|+||.||+|.+ .++..||||++...........+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 45677889999999999999975 235679999998766666677899999999999 899999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE
Q 047701 94 HMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL 158 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 158 (356)
+..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999996543 358999999999999999999999 999999999999999
Q ss_pred cCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCcccc
Q 047701 159 DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLD 237 (356)
Q Consensus 159 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~ 237 (356)
+.++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++ |..|+......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999877654433333445678899999999877 79999999999999999999 77776432211
Q ss_pred chhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 238 WFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+...+........+..++.++.+++.+||+.||.+||++.++++.|+++..
T Consensus 313 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 -------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112222222334445667789999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=362.88 Aligned_cols=263 Identities=26% Similarity=0.422 Sum_probs=217.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
+...+|.+.+.||+|+||.||+|.+. .+..||||++...........+.+|+.++++++||||+++++++.++...
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34567888899999999999999874 34569999998766666778899999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999997777789999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 177 RNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
..... .......+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+..... .....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~----------------~~~~~ 265 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTN----------------RDVIS 265 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------HHHHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----------------HHHHH
Confidence 54322 223334567889999999877 68999999999999999999 8877632211 11112
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.+........+..++.++.+++.+||..||.+||++.+|++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 2222223334455678899999999999999999999999999988764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=361.44 Aligned_cols=269 Identities=28% Similarity=0.470 Sum_probs=208.4
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
...++....|++.+.||+|+||+||+|++ +++.||||++.... .......+.+|+.++++++||||+++++++.+...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 44455667888899999999999999988 68899999987543 34455678999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEcCCCceEEeccCC
Q 047701 96 TALVYEYMENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999996543 249999999999999999999999 88 99999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
++....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+....... .
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-------~-------- 247 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-------V-------- 247 (309)
T ss_dssp ------------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-------H--------
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------H--------
Confidence 976443321 12345699999999999887 68999999999999999999999874322110 0
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCCC
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPP 307 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~ 307 (356)
.............+..++.++.+++.+||+.||.+|||+.++++.|+.+.....++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 00111112223344556778999999999999999999999999999987754443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=371.05 Aligned_cols=262 Identities=25% Similarity=0.425 Sum_probs=204.4
Q ss_pred HHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
....|.+.+.||+|+||.||+|++. ++..||||++...........+.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3446777889999999999999764 577899999987655566778999999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+++++|.+++......+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 9999999999999997777789999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 178 NRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.... .......++..|+|||++.+. .++.++||||||+++|||++ |+.|+..... ......
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----------------~~~~~~ 262 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------------QDVIKA 262 (373)
T ss_dssp --------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----------------HHHHHH
T ss_pred CCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence 3322 112233467889999999877 68999999999999999998 8887633211 111112
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
+........+..++.++.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 222222223345667899999999999999999999999999988653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=376.57 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=218.0
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
.+++....|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|++++++++||||+++++++.+.+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 44556667888999999999999999875 68999999998665555566789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 99999999999999997666789999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
............++..|+|||++.+. .++.++||||||+++|||++ |..|+..... ......
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~----------------~~~~~~ 327 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSN----------------QQTREF 327 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----------------HHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence 32211111122356789999999876 68999999999999999998 7776532211 111222
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+........+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 22333333445567789999999999999999999999999987753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=362.53 Aligned_cols=283 Identities=39% Similarity=0.629 Sum_probs=223.8
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
+...++....|.+.+.||+|+||.||+|.+.+++.||||++...........+.+|+.++++++||||+++++++.+...
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 34455555678888999999999999999878999999999765433333468999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 96 TALVYEYMENGSLDGYLFGKK---RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
.++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+....+++||||||+||+++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 999999999999999996543 35999999999999999999999921129999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCC--ccccchhHHHHHHHhhh
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS--ESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~--~~~~~~~~~~~~~~~~~ 250 (356)
.......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+..... ........+........
T Consensus 182 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 182 KLMDYKDTHV-TTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp EECCSSSSCE-ECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccCcccccc-cccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 8775443332 3445699999999999876 689999999999999999999999852211 11111222222222233
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
..................+.++.+++.+||+.||.+|||+.+|++.|+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 33333333334455677889999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=357.51 Aligned_cols=254 Identities=23% Similarity=0.276 Sum_probs=205.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.++...++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 6788899999999999999865 799999999975544344467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++++|.+++. ....+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++.+........
T Consensus 88 ~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 88 SGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999984 44579999999999999999999999 9999999999999999999999999999987654433333
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|..|+......... +..+... .....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~--------~~~~~ 229 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEK--------KTYLN 229 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTT--------CTTST
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhcc--------cccCC
Confidence 345679999999999987744588999999999999999999998544332111 1111111 11111
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.....+.++.+++.+||..||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 223456778899999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=357.90 Aligned_cols=274 Identities=26% Similarity=0.349 Sum_probs=212.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC----ee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----MT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 96 (356)
+....|.+.++||+|+||.||+|++ .++.||||++... .........|+.++++++||||+++++++.+.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 4456788899999999999999988 4799999999753 233445667999999999999999999998754 36
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCC----------CeeeeccCccceEEcCCCceEE
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ----------RIIHYDIKPENVLLDANFSPKV 166 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~----------~ivH~Dlkp~Nill~~~~~~kl 166 (356)
++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ . +++||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999999954 459999999999999999999998 7 9999999999999999999999
Q ss_pred eccCCccccCCCCCceeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH
Q 047701 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 167 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~ 242 (356)
+|||+++...............||+.|+|||++.+. ..++.++||||||+++|||++|+.|+..........+...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999877655444344456799999999999863 2456788999999999999999999865443322111111
Q ss_pred HHHHHhhhchhhhHhhcCCCc------hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 243 VWEEYEKSELGAMILACGIEE------KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.........+...+....... .....+.++.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000000111111111111111 123456779999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=366.67 Aligned_cols=269 Identities=26% Similarity=0.357 Sum_probs=222.9
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEc--------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQF--------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLH 87 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 87 (356)
..+++...+|.+.++||+|+||.||+|.+ ..+..||||++...........+.+|+++++++ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 33456677889999999999999999975 124679999998776666678899999999999 899999999
Q ss_pred eeEEcCCeeeEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Q 047701 88 GFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 152 (356)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 152 (356)
+++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+++|||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlk 218 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLA 218 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCC
Confidence 99999999999999999999999996543 459999999999999999999999 999999999
Q ss_pred ccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccC
Q 047701 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVG 231 (356)
Q Consensus 153 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~ 231 (356)
|+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|+|++ |..|+...
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999877654443334455678899999999877 78999999999999999999 87776322
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.. ..+...+........+..++.++.+++.+||+.||.+||++.+|++.|+++.....
T Consensus 298 ~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 298 PV----------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp CH----------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CH----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11 11122222222333344567789999999999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=365.83 Aligned_cols=273 Identities=24% Similarity=0.340 Sum_probs=222.6
Q ss_pred CCcceeCHHHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCe
Q 047701 11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINL 83 (356)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 83 (356)
..|.....+++....|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 44555677778888999999999999999999973 346899999998766556667899999999999 79999
Q ss_pred eeEeeeEEcCC-eeeEEEEecCCCCHhHHhccCCC---------------------------------------------
Q 047701 84 VRLHGFCHDQH-MTALVYEYMENGSLDGYLFGKKR--------------------------------------------- 117 (356)
Q Consensus 84 v~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------- 117 (356)
+++++++.+.. ..++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999998754 48999999999999999965432
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 118 --------------------ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 118 --------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
.+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 18999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
...........||+.|+|||++.+. .++.++||||||+++|+|++ |..|+....... . ....+
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~---------~~~~~ 309 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------E---------FCRRL 309 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------H---------HHHHH
T ss_pred cccchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------H---------HHHHH
Confidence 5444444556789999999999876 68999999999999999998 888874332211 1 11111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1222223334456789999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=352.70 Aligned_cols=263 Identities=26% Similarity=0.389 Sum_probs=214.1
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.++||+|+||+||+|.+. +++.||+|.+... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 456788999999999999999864 6999999998653 44566789999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999998777889999999999999999999999 99999999999999999999999999999876543322
Q ss_pred ee------------ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 182 VT------------ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 182 ~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
.. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence 11 1145699999999999887 7899999999999999999998876543332211100
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCC
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~ 304 (356)
........ ..+..++.++.+++.+||+.||++|||+.++++.|+.+....
T Consensus 235 -~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 235 -NVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -CHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000110 012334567899999999999999999999999999886543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=353.74 Aligned_cols=268 Identities=17% Similarity=0.162 Sum_probs=213.7
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..|.+.+.||+|+||.||+|.. .+++.||||++..... ...+..|+.+++++ +||||+++++++.+....++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678899999999999999985 5799999999875422 23578899999999 99999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc-----eEEeccCCccccC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-----PKVADFGLAKLCD 176 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~DfGla~~~~ 176 (356)
|+ +++|.+++......+++..++.++.|++.||+|||+ .+++||||||+|||++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 899999997667789999999999999999999999 99999999999999998877 9999999999765
Q ss_pred CCCCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 177 RNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 177 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
...... ......||+.|+|||++.+. .++.++||||||+++|||++|..||.......... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~ 236 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE----RYQKIGDTK 236 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH----HHHHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHH----HHHHHHhhh
Confidence 543321 12346799999999999987 68999999999999999999999986543322111 011111100
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCCCCC
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKP 309 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~~p 309 (356)
. ...........+ ++.+++.+||+.||.+||++++|++.|+.+.........
T Consensus 237 ~-----~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 237 R-----ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp H-----HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred c-----cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 0 000000111233 899999999999999999999999999988766544433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=348.24 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=215.7
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
+....|.+.+.||+|+||.||+|.+.++..||||++.... .....+.+|+.++.+++||||+++++++.+....++||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4566888999999999999999998888899999997643 23467899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999997766779999999999999999999999 9999999999999999999999999999987655432
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. ......+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .....+...
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------~~~~~~~~~ 221 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----------------EVVLKVSQG 221 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----------------HHHHHHHTT
T ss_pred h-cccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChH----------------HHHHHHHcC
Confidence 2 23445577789999999876 68999999999999999999 88776332211 111111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.....+...+.++.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1222233346679999999999999999999999999998864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=358.28 Aligned_cols=280 Identities=23% Similarity=0.352 Sum_probs=214.1
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD- 92 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~- 92 (356)
.++....|++.++||+|+||+||+|++ .+++.||||++... .......+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345567899999999999999999973 36899999999754 33455678999999999999999999999865
Q ss_pred -CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 93 -QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 93 -~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
....++||||+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 356899999999999999997777779999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 172 AKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 172 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
+......... .......|+..|+|||++.+. .++.++||||||+++|+|++|..|+......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9876544322 122334577789999999877 68999999999999999999987763221100000000000001111
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.....+........+..++.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 22222333334444556778899999999999999999999999999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=362.35 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=216.3
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
++....|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334567888899999999999999863 34889999998765556677899999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeec
Q 047701 94 HMTALVYEYMENGSLDGYLFGKK-----------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 150 (356)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++++|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 99999999999999999996532 579999999999999999999999 9999999
Q ss_pred cCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccc
Q 047701 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAI 229 (356)
Q Consensus 151 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~ 229 (356)
|||+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|+|++ |..|+.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999876543332233345688999999999877 68999999999999999999 887764
Q ss_pred cCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 230 VGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..... .....+........+..++.++.+++.+||+.||.+||++.+|++.|+++...
T Consensus 279 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAHE----------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCHH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCChH----------------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 32211 11111222222233445667899999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=354.98 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=220.9
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeE
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 90 (356)
..+++....|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 44455667888899999999999999975 245889999998766666667899999999999999999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCee
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGKK-----------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRII 147 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv 147 (356)
.+....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCc
Confidence 99999999999999999999996532 248999999999999999999999 9999
Q ss_pred eeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCC
Q 047701 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRR 226 (356)
Q Consensus 148 H~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~ 226 (356)
||||||+||+++.++.+||+|||++................+|+.|+|||++.+. .++.++||||||+++|+|++ |..
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999877655444444445678899999999876 68999999999999999999 887
Q ss_pred ccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 227 NAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
|+...... .+...+........+..++.++.+++.+||+.||.+||++.++++.|+++..
T Consensus 252 p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 252 PYPGIPPE----------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSTTCCGG----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHH----------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 76433221 1111222222233344567789999999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=340.90 Aligned_cols=280 Identities=35% Similarity=0.537 Sum_probs=227.0
Q ss_pred cceeCHHHHHHHhhccc--------cccCcCCceEEEEEEcCCCcEEEEEEecccC---chhHHHHHHHHHHHHhcCCCC
Q 047701 13 PVRFTSLQLNNFTSNYS--------TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRTYHI 81 (356)
Q Consensus 13 ~~~~~~~~~~~~~~~~~--------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ 81 (356)
...|+..++.+.+.+|. ++||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 34688889999988876 4599999999999998 68899999987532 234567899999999999999
Q ss_pred CeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc
Q 047701 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK--KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 159 (356)
Q Consensus 82 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 159 (356)
||+++++++.+....++||||+++++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998543 4569999999999999999999999 9999999999999999
Q ss_pred CCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch
Q 047701 160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF 239 (356)
Q Consensus 160 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~ 239 (356)
.++.+||+|||++................||+.|+|||++.+. ++.++||||||+++|+|++|..|+........ .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999877654444444456799999999998764 78999999999999999999998865433321 1
Q ss_pred hHHHHHHHhhh-chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 240 PKYVWEEYEKS-ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
........... .+...+ ...........+..+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYI-DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHS-CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhc-cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111111 111211 22234456678889999999999999999999999999998774
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=346.65 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=214.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
+....|++.+.||+|+||.||+|.+.+++.||||++.... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 3456788899999999999999998788899999998643 23457899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999999999997777789999999999999999999999 9999999999999999999999999999986643221
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.......||+.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .....+...
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----------------~~~~~~~~~ 223 (269)
T 4hcu_A 162 -TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----------------EVVEDISTG 223 (269)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHHHHTT
T ss_pred -ccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----------------HHHHHHhcC
Confidence 112334577789999999877 68999999999999999999 77776332111 111111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.....+...+.++.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 224 FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 2222334456779999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=357.22 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=207.4
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcE----EEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVK----IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
....|++.++||+|+||+||+|.+. +++. ||+|.+...........+.+|+.++++++||||+++++++.++. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 4567888999999999999999863 4443 58888765544455678999999999999999999999998865 6
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++|++|+.+|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 89999999999999998777889999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
............||+.|+|||++.+. .++.++||||||+++|||++ |..|+..... ..+...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------------~~~~~~ 231 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------------SEISSI 231 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----------------GGHHHH
T ss_pred CCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCH----------------HHHHHH
Confidence 55544444455678899999999877 78999999999999999999 8887643222 112222
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+........+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22333333445566789999999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=363.30 Aligned_cols=261 Identities=26% Similarity=0.350 Sum_probs=212.9
Q ss_pred HHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
....|.+.++||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3456788899999999999999842 4678999999866566667789999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEE
Q 047701 96 TALVYEYMENGSLDGYLFGKK------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKV 166 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl 166 (356)
.++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999996432 469999999999999999999999 9999999999999998554 5999
Q ss_pred eccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHH
Q 047701 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 167 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~ 245 (356)
+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++ |..|+.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~------------ 292 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------ 292 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 999999865332222222334578999999999877 69999999999999999998 7777633211
Q ss_pred HHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 246 EYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..+...+........+..++.++.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 293 ----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 293 ----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 11222222222333445567789999999999999999999999999987754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=349.09 Aligned_cols=264 Identities=23% Similarity=0.388 Sum_probs=215.0
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
+..+++....|.+.+.||+|+||.||+|.+.++..||||++..... ....+.+|+.++.+++||||+++++++.+...
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 4555666778888999999999999999988888999999986532 34678999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+.+++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999999999999999997766789999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
..... .......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.|+..... .....
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----------------~~~~~ 232 (283)
T 3gen_A 171 LDDEY-TSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SETAE 232 (283)
T ss_dssp CCHHH-HSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------------HHHHH
T ss_pred ccccc-ccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccCh----------------hHHHH
Confidence 53321 112334577889999999877 68999999999999999998 8877643221 11111
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+........+...+..+.+++.+||+.||.+|||+.++++.|.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 233 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 112222222333446779999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=371.60 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=216.2
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
..+++....+++.++||+|+||.||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 34566677888999999999999999998888999999998643 34578999999999999999999999987 5678
Q ss_pred eEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 97 ALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999996443 468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
...... ......+|..|+|||++.+. .++.++||||||+++|||++ |+.|+..... .++..
T Consensus 335 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----------------~~~~~ 396 (454)
T 1qcf_A 335 EDNEYT-AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----------------PEVIR 396 (454)
T ss_dssp CCHHHH-TTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHHH
T ss_pred CCCcee-ccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----------------HHHHH
Confidence 532211 12334567889999999876 68999999999999999999 8877632211 11112
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.+........+..++.++.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 397 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 397 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 2222223334456678899999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=355.95 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=214.7
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCH 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 91 (356)
+++....|.+.+.||+|+||.||+|.+ .++..||||++...........+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 455567888899999999999999975 246789999998654445557899999999999 8999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhccCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeee
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGKKR----------------------ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 149 (356)
..+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+ .+++||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 99999999999999999999965432 37999999999999999999999 999999
Q ss_pred ccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCcc
Q 047701 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNA 228 (356)
Q Consensus 150 Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~ 228 (356)
||||+||+++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|+|++ |..|+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999877655444444556688899999999876 68999999999999999998 88777
Q ss_pred ccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 229 IVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
....... . ....+........+..++.++.+++.+||..||.+|||+.+|++.|..+...
T Consensus 276 ~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDA------N---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSH------H---------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHH------H---------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 4332211 1 1111112222233444567899999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=350.24 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=206.9
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.++++++||||+++++++......++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3688899999999999999986 579999999997542 34455778899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++... +.+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 95 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 95 YASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp CCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 99999999999543 569999999999999999999999 9999999999999999999999999999987654332
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....||+.|+|||++.+....+.++||||||+++|+|++|..||...... .... .+... .
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~---------~i~~~-~ 230 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRE---------RVLRG-K 230 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH---------HHHHC-C
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHH---------HHHhC-C
Confidence 244679999999999988744458999999999999999999998533211 0011 11111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
...+...+.++.+++.+||..||.+|||+.++++.
T Consensus 231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12233456779999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=353.17 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=219.6
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC--------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP--------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLH 87 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 87 (356)
..+++....|.+.+.||+|+||.||+|.+. ++..||||++...........+.+|+.+++++ +||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 445566778999999999999999999752 46789999998766656677899999999999 899999999
Q ss_pred eeEEcCCeeeEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Q 047701 88 GFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIK 152 (356)
Q Consensus 88 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 152 (356)
+++.+.+..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .+++|||||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlk 184 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLA 184 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCc
Confidence 99999999999999999999999996543 248999999999999999999999 999999999
Q ss_pred ccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccC
Q 047701 153 PENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVG 231 (356)
Q Consensus 153 p~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~ 231 (356)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+...
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999999877655443333445678899999999876 68999999999999999999 87776322
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
... .+...+........+..++.++.+++.+||..||.+||++.++++.|+++...
T Consensus 264 ~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 264 PVE----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp CHH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHH----------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 110 11111222222333445667899999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=352.70 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=206.6
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcE----EEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVK----IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
....|++.++||+|+||.||+|.+. +++. ||+|.+...........+.+|+.++++++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 3567888999999999999999863 4544 57777765544556678999999999999999999999998865 7
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++|++|+.+|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 89999999999999998777889999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
............||+.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .+...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----------------~~~~~ 231 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------------EISSI 231 (327)
T ss_dssp -----------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GHHHH
T ss_pred CccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------HHHHH
Confidence 54444444445678899999999877 68999999999999999999 88877433221 12222
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+........+..++.++.+++.+||+.||.+||++.++++.|+++..
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22333333445567789999999999999999999999999998865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=349.69 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=219.8
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeE
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFC 90 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 90 (356)
.+++...+|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.+++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3455567889999999999999999974 357899999998765555667899999999999 999999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCc
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGKKR-----------------ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 153 (356)
.+.+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++++||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCcc
Confidence 999999999999999999999965432 48999999999999999999999 9999999999
Q ss_pred cceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCC
Q 047701 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGA 232 (356)
Q Consensus 154 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~ 232 (356)
+||+++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|+|++ |..|+....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999887665544444455678899999999876 68999999999999999998 877764332
Q ss_pred CccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 233 SESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... .... .+........+...+.++.+++.+||+.||.+|||+.++++.|+++..
T Consensus 253 ~~~------~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 253 VDS------KFYK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp SSH------HHHH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chh------HHHH---------HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 211 1111 111111222234456789999999999999999999999999998765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=344.14 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=202.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC--------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-------- 94 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 94 (356)
..|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 36788899999999999999875 799999999986555566788999999999999999999999986543
Q ss_pred -------------------------------------------------eeeEEEEecCCCCHhHHhccCC--CCCCHHH
Q 047701 95 -------------------------------------------------MTALVYEYMENGSLDGYLFGKK--RALEWEK 123 (356)
Q Consensus 95 -------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~--~~l~~~~ 123 (356)
..++||||+++++|.+++.... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999996543 3467778
Q ss_pred HHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc----------eeecCCCCCCCC
Q 047701 124 LHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH----------VTISGYKGTPGY 193 (356)
Q Consensus 124 ~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~y 193 (356)
++.++.||+.||+|||+ ++++||||||+||+++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 99999999999999999999999999999887654321 112345699999
Q ss_pred CCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHH
Q 047701 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLC 273 (356)
Q Consensus 194 ~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (356)
+|||++.+. .++.++||||||+++|+|++|..+.. ..............+......+.++.
T Consensus 243 ~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM------------------ERVRIITDVRNLKFPLLFTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH------------------HHHHHHHHHHTTCCCHHHHHHCHHHH
T ss_pred cChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh------------------HHHHHHHHhhccCCCcccccCChhHH
Confidence 999999887 78999999999999999999865421 00111111222233444566677889
Q ss_pred HHHHhhcCCCCCCCCCHHHHHH
Q 047701 274 MVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 274 ~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+++.+||+.||.+||++.++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=341.57 Aligned_cols=250 Identities=20% Similarity=0.284 Sum_probs=206.4
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|++.++||+|+||+||+|.+ .+++.||||++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45788899999999999999986 4799999999875432 335678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999543 68999999999999999999999 99999999999999999999999999999876544322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....||+.|+|||++.+. .++.++||||||+++|+|++|..|+....... ....... .....
T Consensus 173 --~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~--------~~~~~ 235 (297)
T 3fxz_A 173 --RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIAT--------NGTPE 235 (297)
T ss_dssp --BCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH--------HCSCC
T ss_pred --cCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh--------CCCCC
Confidence 2345799999999999887 78999999999999999999999874332210 0000000 00111
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2223455677999999999999999999999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=343.27 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=203.4
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
++...+|.+.+.||+|+||.||+|.+. .+..||+|++...........+.+|+.++++++||||+++++++.+ +.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-Cc
Confidence 345668889999999999999999763 2557999998866555667789999999999999999999999854 56
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+.+++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 799999999999999997777789999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
....... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+...... ....
T Consensus 167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----------------~~~~ 228 (281)
T 1mp8_A 167 EDSTYYK-ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------DVIG 228 (281)
T ss_dssp -------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----------------GHHH
T ss_pred Ccccccc-cccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----------------HHHH
Confidence 5433221 2234467889999999876 68999999999999999997 77776432221 1111
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+........+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 229 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 229 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112222233445567889999999999999999999999999988753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=346.53 Aligned_cols=282 Identities=21% Similarity=0.329 Sum_probs=219.0
Q ss_pred eeCHHHHHHHhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeee
Q 047701 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89 (356)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 89 (356)
...+..+....|++.++||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||++++++
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 3455555667788999999999999999983 36899999999865544556789999999999999999999999
Q ss_pred EEcC--CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEe
Q 047701 90 CHDQ--HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVA 167 (356)
Q Consensus 90 ~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 167 (356)
+.+. ...++||||+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEEC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEEC
Confidence 9876 66899999999999999997777789999999999999999999999 999999999999999999999999
Q ss_pred ccCCccccCCCCCce-eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH
Q 047701 168 DFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 168 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
|||++.......... ......||..|+|||++.+. .++.++||||||+++|+|++|..|+........... ......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~ 246 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI-GPTHGQ 246 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CSCCGG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc-CCcccc
Confidence 999998876554332 22345688889999999877 688999999999999999999887532110000000 000000
Q ss_pred HhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.........+........+..++.++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111222222333333445566788999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=355.16 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=208.4
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcE----EEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVK----IAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
...|++.+.||+|+||.||+|.+. +++. ||+|.+...........+.+|+.++++++||||+++++++.+ ...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 456788899999999999999863 4544 788887644333334567789999999999999999999874 5678
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+|+|.+++......+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999999997766789999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
...........||..|+|||++.+. .++.++||||||+++|+|++ |..|+...... .....+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~ 230 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----------------EVPDLL 230 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----------------HHHHHH
T ss_pred ccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHH----------------HHHHHH
Confidence 5544444556788899999999877 68999999999999999999 88887543221 111112
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........+..++.++.+++.+||..||.+||++.++++.|..+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2222222333455678899999999999999999999999988754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=354.02 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=217.9
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeE
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 90 (356)
..+++....|.+.+.||+|+||.||+|.+. +++.||||.+...........+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 445666778999999999999999999753 37889999998765556667899999999999999999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGKK---------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 161 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 161 (356)
.+....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence 99999999999999999999985421 467999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchh
Q 047701 162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFP 240 (356)
Q Consensus 162 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~ 240 (356)
+.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|+|++ |..|+.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~------- 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------- 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCH-------
Confidence 99999999999866544333222334578899999999876 68999999999999999999 6666532211
Q ss_pred HHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 241 KYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
......+........+..++..+.+++.+||+.||.+||++.++++.|++...
T Consensus 247 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 ---------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111222222233344567789999999999999999999999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=340.65 Aligned_cols=266 Identities=18% Similarity=0.185 Sum_probs=214.5
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (356)
...|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.+++++ +|+|++.+++++.+....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45788899999999999999985 579999999987542 223578899999999 7999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc-----eEEeccCCcccc
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-----PKVADFGLAKLC 175 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~DfGla~~~ 175 (356)
||+ +++|.+++......+++..++.++.||+.||+|||+ ++++||||||+||+++.++. +||+|||+++..
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999 899999997777789999999999999999999999 99999999999999987765 999999999877
Q ss_pred CCCCCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 176 DRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 176 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+.......... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----~~~~~~~~ 236 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----KYERIGEK 236 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----HHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH----HHHHHHhh
Confidence 6543321 22446799999999999877 68999999999999999999999986543322111 11111110
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
. ...........++.++.+++.+||+.||++||++.+|++.|+++.....
T Consensus 237 ~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 237 K-----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp H-----HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred c-----cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0 0011111222456789999999999999999999999999998876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=364.54 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=208.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-eeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH-MTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv 99 (356)
+....|.+.++||+|+||.||+|.+ .++.||||+++... ....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 3345677789999999999999998 57899999997642 4467899999999999999999999987765 78999
Q ss_pred EEecCCCCHhHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+++|+|.+++..... .+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999976543 47999999999999999999999 99999999999999999999999999999854432
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
. ....++..|+|||++.+. .++.++||||||+++|||++ |..|+...... +....+.
T Consensus 343 ~-----~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----------------~~~~~i~ 400 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPRVE 400 (450)
T ss_dssp ---------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----------------THHHHHH
T ss_pred c-----cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHH
Confidence 1 123578899999999877 79999999999999999998 88776432221 1112222
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+.....+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 401 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 223334455677889999999999999999999999999988753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=349.47 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=207.3
Q ss_pred HHHhhccccccCcCCceEEEEEEcCC-----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
....|.+.+.||+|+||.||+|.+.. +..||||++...........+.+|+.++++++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34456667899999999999997632 3469999998765556667899999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+++++|.+++......+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999997777889999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 177 RNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
..... .......+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+..... .....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------------~~~~~ 261 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEVMK 261 (333)
T ss_dssp ------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHH
T ss_pred cccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCH----------------HHHHH
Confidence 43222 112234467889999999877 68999999999999999998 8887632211 11111
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+........+..++.++.+++.+||+.||.+||++.++++.|+++..
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 122222223344567789999999999999999999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=343.78 Aligned_cols=273 Identities=26% Similarity=0.428 Sum_probs=203.2
Q ss_pred cceeCHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEE
Q 047701 13 PVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91 (356)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 91 (356)
+..+.+.|+...+|++.++||+|+||+||+|.+.. .||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (289)
T 3og7_A 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90 (289)
T ss_dssp -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc
Confidence 33466678888899999999999999999998743 59999997543 3455577899999999999999999999764
Q ss_pred cCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
....++||||+.+++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 91 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 91 -APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp -SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred -CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEcccee
Confidence 456799999999999999997777889999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
+................||+.|+|||++.. ...++.++||||||+++|+|++|+.|+...... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~ 240 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGR 240 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHH
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcc
Confidence 986654333333345679999999999862 226788999999999999999999987533221 111111111
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.... .........++.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 241 ~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 241 GSLS-----PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCC-----CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccC-----cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1110 01112233556789999999999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=349.49 Aligned_cols=274 Identities=24% Similarity=0.351 Sum_probs=217.5
Q ss_pred hccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeE
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTAL 98 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 98 (356)
|++.++||+|+||+||++.+ .+++.||||++...........+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999998864 258899999998766666677899999999999999999999999874 67899
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+++++|.+++... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999543 49999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
..... .....||..|+|||++.+. .++.++||||||+++|+|++|..|+......... .................+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHHHHHh
Confidence 43322 2345578889999999877 6889999999999999999999887432111000 0000001111222333344
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCC
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPP 306 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~ 306 (356)
.......+..++.++.+++.+||+.||.+|||+.++++.|+.+.+....
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 4444445566778899999999999999999999999999988765443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=342.76 Aligned_cols=264 Identities=21% Similarity=0.256 Sum_probs=204.9
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|.+.++||+|+||+||+|.+.+++.||||++.... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 34788889999999999999998889999999997543 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++ +|.+++......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9975 8888887777789999999999999999999999 99999999999999999999999999999876543222
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh---chh-----
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS---ELG----- 253 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----- 253 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|+.|+......... .. ........ ...
T Consensus 176 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 176 --YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PK-IFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HH-HHHHHCCCCTTTSGGGTTS
T ss_pred --ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHHCCCChHHhhhhhcc
Confidence 234568999999999987557899999999999999999999988544332210 00 00000000 000
Q ss_pred -hh-------HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 -AM-------ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 -~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. .............+.++.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0000000112234567899999999999999999999997
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=343.41 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=211.0
Q ss_pred HHhhccccccCcCCceEEEEEEcCC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE-cCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH-DQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~ 97 (356)
..+|.+.+.||+|+||.||+|.+.+ ...+|+|.+...........+.+|+.++++++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4467788999999999999997532 33689999987656566778999999999999999999999864 456789
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999997777889999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 178 NRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.... .......||+.|+|||.+.+. .++.++||||||+++|+|++|+.|+..+..... ....
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---------------~~~~ 244 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVY 244 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---------------HHHH
T ss_pred cchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---------------HHHH
Confidence 3321 122345678899999999877 689999999999999999996665443322211 1111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~ 304 (356)
.........+..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 245 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111222223345677999999999999999999999999999887643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=370.36 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=218.3
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
..+++....|.+.++||+|+||.||+|.+. ++..||||++.... .....+.+|+.++++++||||+++++++.+...
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 345666778888999999999999999875 48899999997643 345679999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 96 TALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
.++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeeccccee
Confidence 99999999999999999654 4569999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
..... ........++..|+|||++.+. .++.++||||||+++|||++ |..|+...... .+.
T Consensus 368 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----------------~~~ 429 (495)
T 1opk_A 368 MTGDT-YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVY 429 (495)
T ss_dssp CTTCC-EECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------GHH
T ss_pred ccCCc-eeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----------------HHH
Confidence 65432 2222345577889999999876 68999999999999999999 77666332211 111
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..+........+..++.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 430 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 2222222333445667889999999999999999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=366.85 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=210.3
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
.+++....|.+.++||+|+||.||+|.+..+..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 3556667888899999999999999998777889999997643 234679999999999999999999999977 6689
Q ss_pred EEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 999999999999999643 3569999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
..... ......++..|+|||++.+. .++.++||||||+++|||++ |..|+..... .+....
T Consensus 332 ~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------------~~~~~~ 393 (452)
T 1fmk_A 332 DNEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQ 393 (452)
T ss_dssp ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHH
T ss_pred CCcee-cccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence 43221 12334578899999999876 68999999999999999999 7777632211 111122
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~ 304 (356)
+........+..++..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 2222233344566788999999999999999999999999999886543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=342.60 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=213.8
Q ss_pred HhhccccccCcCCceEEEEEEcC-C---CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee-eE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-N---GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT-AL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~l 98 (356)
.+|...++||+|+||+||+|.+. + +..||+|.+...........+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35566789999999999999752 2 3379999998765556678899999999999999999999999876655 89
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+.+++|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999997777889999999999999999999999 99999999999999999999999999999866443
Q ss_pred CCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.|+...... ......+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---------------~~~~~~~ 241 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---------------FDLTHFL 241 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---------------GGHHHHH
T ss_pred cccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCH---------------HHHHHHh
Confidence 211 122335678899999999877 6899999999999999999977665433221 1112222
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
........+..++..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 242 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2222233344456789999999999999999999999999998876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=355.39 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=200.9
Q ss_pred hhccccccCcCCceEEEEEEcC--C--CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CCeeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP--N--GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QHMTALV 99 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 99 (356)
.|.+.+.||+|+||.||+|.+. + +..||||.+...........+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4567789999999999999753 2 346899998765555667889999999999999999999998754 5578999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++|+|.+++......+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999998777789999999999999999999999 999999999999999999999999999998765432
Q ss_pred Cce--eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 180 SHV--TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 180 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.|+..+..... ....+.
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---------------~~~~~~ 310 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------------ITVYLL 310 (373)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---------------HHHHHH
T ss_pred cccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---------------HHHHHH
Confidence 211 22345578899999999877 689999999999999999995544333222111 111111
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.......+..++.++.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 311 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 112222334456789999999999999999999999999998876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=350.42 Aligned_cols=268 Identities=22% Similarity=0.344 Sum_probs=199.6
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcCC-C---cEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeE
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN-G---VKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 90 (356)
+....+....|.+.+.||+|+||.||+|.+.. + ..||||++.... .......+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 33444556688999999999999999998753 3 279999997542 334567899999999999999999999999
Q ss_pred EcCCee------eEEEEecCCCCHhHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc
Q 047701 91 HDQHMT------ALVYEYMENGSLDGYLFGK-----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 159 (356)
Q Consensus 91 ~~~~~~------~lv~e~~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 159 (356)
...... ++||||+.+++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+||+++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEc
Confidence 887655 8999999999999998532 2269999999999999999999999 9999999999999999
Q ss_pred CCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccc
Q 047701 160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDW 238 (356)
Q Consensus 160 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~ 238 (356)
.++.+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|+|++ |..|+......
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---- 246 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---- 246 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChH----
Confidence 9999999999999876554433333445578899999999877 68999999999999999999 77776432221
Q ss_pred hhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 239 FPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.....+........+..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 247 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 247 ------------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------------HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11122222222334445667899999999999999999999999999988653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=336.79 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=207.1
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
..+|.+.+.||+|+||.||+|.+ .+++.||+|++... ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45788899999999999999986 46899999998643 2334557889999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999999954 3579999999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.. ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ......... ......
T Consensus 166 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~~~~--- 233 (294)
T 4eqm_A 166 LT-QTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVPNVT--- 233 (294)
T ss_dssp ----------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCCCHH---
T ss_pred cc-ccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCCCcc---
Confidence 22 12345699999999999887 6899999999999999999999988433221 000111110 000000
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhhhcccC
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRP-PMSAVVKMLEGVVEV 303 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~~~ 303 (356)
.......+..+.+++.+||+.||.+|| +++++.+.|..+...
T Consensus 234 --~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 234 --TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp --HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred --hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 011233567899999999999999998 899999999887653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=339.03 Aligned_cols=259 Identities=26% Similarity=0.362 Sum_probs=214.0
Q ss_pred Hhhcccc-ccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYST-RLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
.++.+.+ .||+|+||.||+|.+. ++..||||++...........+.+|+.++++++||||+++++++. .+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 4555555 8999999999999753 578899999987655667788999999999999999999999994 4568999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+.+++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 99999999999997777789999999999999999999999 999999999999999999999999999998775443
Q ss_pred Ccee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 180 SHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 180 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... .....||+.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .....+.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~i~ 227 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------EVMAFIE 227 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----------------HHHHHHH
T ss_pred ceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----------------HHHHHHh
Confidence 3222 2334578899999999876 68999999999999999998 88887433221 1111122
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.......+..++.++.+++.+||..||.+||++.++++.|+.+...
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 228 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2222334456678899999999999999999999999999988653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=347.39 Aligned_cols=271 Identities=24% Similarity=0.345 Sum_probs=220.0
Q ss_pred cceeCHHHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeee
Q 047701 13 PVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVR 85 (356)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 85 (356)
|.....+++....|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 334455666677899999999999999999973 357899999998766556667899999999999 7999999
Q ss_pred EeeeEEcCC-eeeEEEEecCCCCHhHHhccCCC---------------CCCHHHHHHHHHHHHHHHHHHHhccCCCeeee
Q 047701 86 LHGFCHDQH-MTALVYEYMENGSLDGYLFGKKR---------------ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149 (356)
Q Consensus 86 ~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 149 (356)
+++++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||.|||+ .+++||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence 999987754 58999999999999999965433 28999999999999999999999 999999
Q ss_pred ccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCcc
Q 047701 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNA 228 (356)
Q Consensus 150 Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~ 228 (356)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|+|++ |..|+
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999877655544444556688999999999877 68999999999999999998 88776
Q ss_pred ccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 229 IVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
....... .... .+........+...+.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 252 ~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 252 PGVKIDE------EFCR---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TTCCCSH------HHHH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchhH------HHHH---------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 4322211 1111 111111222333456789999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=350.04 Aligned_cols=274 Identities=14% Similarity=0.186 Sum_probs=209.6
Q ss_pred HHhhccccccCcCCceEEEEEEcCC------CcEEEEEEecccCchh----------HHHHHHHHHHHHhcCCCCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKI----------AEEQFMAEVGTIGRTYHINLVRL 86 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~ 86 (356)
...|.+.++||+|+||.||+|.+.. ++.||||++....... ....+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4478889999999999999998743 4789999987543211 11234456677888899999999
Q ss_pred eeeEEcC----CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--C
Q 047701 87 HGFCHDQ----HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--A 160 (356)
Q Consensus 87 ~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~ 160 (356)
++++... ...+|||||+ +++|.+++......+++..++.++.||+.||+|||+ ++++||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 9999764 4589999999 999999997777889999999999999999999999 9999999999999998 8
Q ss_pred CCceEEeccCCccccCCCCCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcc
Q 047701 161 NFSPKVADFGLAKLCDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235 (356)
Q Consensus 161 ~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~ 235 (356)
++.+||+|||+++.+....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8999999999998765332211 11335599999999999887 69999999999999999999999986433221
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCCCC
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPP 307 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~~~ 307 (356)
. ......... ...+...+..... ...++.++.+++..||..||.+||++.+|++.|..+.......
T Consensus 269 ~--~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 K--YVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp H--HHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred H--HHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1 001111111 1122222222110 1234678999999999999999999999999999887655443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=338.40 Aligned_cols=272 Identities=18% Similarity=0.199 Sum_probs=212.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC--eeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH--MTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 99 (356)
+.+|.+.+.||+|+||+||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457888999999999999999875 599999999986544445677889999999999999999999998765 77999
Q ss_pred EEecCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE----cCCCceEEeccCCcc
Q 047701 100 YEYMENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGLAK 173 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGla~ 173 (356)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+++||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999996543 349999999999999999999999 999999999999999 777889999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccC-------CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSG-------NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
........ ....||+.|+|||++.. ...++.++||||||+++|||++|..||......... .......
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence 77654332 23568999999999862 236899999999999999999999998643322111 1111111
Q ss_pred Hhhhc---hhhh-------H----hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 247 YEKSE---LGAM-------I----LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 247 ~~~~~---~~~~-------~----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..... .... . ............+..+.+++.+||+.||++|||++++++...+...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11000 0000 0 0000113346778889999999999999999999999998876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=344.92 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=205.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-----hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...|.+.+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 346888999999999999999864 6999999999754321 2356789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC----ceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla 172 (356)
++||||+.||+|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999994 45679999999999999999999999 9999999999999998776 7999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...... ...........
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~ 235 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITAVSY 235 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC
T ss_pred eEcCCCCc---cccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCC
Confidence 87665332 2345699999999999877 6899999999999999999999998543221 11111111100
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+.++.+++.+||..||.+|||+.++++
T Consensus 236 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 ------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001112334677999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=341.48 Aligned_cols=250 Identities=18% Similarity=0.233 Sum_probs=206.6
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|.+.+.||+|+||.||+|.+. +++.||+|.+... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 36788999999999999999864 6899999998753 24456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC--CCceEEeccCCccccCCCCC
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~~~~ 180 (356)
+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 99999999997666789999999999999999999999 99999999999999986 78999999999987764432
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ............ .
T Consensus 160 ~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~------~ 222 (321)
T 1tki_A 160 F---RLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYT------F 222 (321)
T ss_dssp E---EEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCC------C
T ss_pred c---ccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------HHHHHHHcCCCC------C
Confidence 2 335689999999999877 6899999999999999999999988543221 111111111100 0
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+.++.+++.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112245678999999999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=339.16 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=209.1
Q ss_pred eeCHHHHHHHh------------hccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC
Q 047701 15 RFTSLQLNNFT------------SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI 81 (356)
Q Consensus 15 ~~~~~~~~~~~------------~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ 81 (356)
.++..++...+ +...++||+|+||.||+|.+. +|+.||||++..... .....+.+|+.++++++||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCC
Confidence 45666665554 455678999999999999875 799999999975432 3456788999999999999
Q ss_pred CeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC
Q 047701 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN 161 (356)
Q Consensus 82 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 161 (356)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999984 3469999999999999999999999 999999999999999999
Q ss_pred CceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhH
Q 047701 162 FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK 241 (356)
Q Consensus 162 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~ 241 (356)
+.+||+|||++......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.|+......
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------- 247 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------- 247 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred CcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 99999999999876543222 2345799999999999877 6899999999999999999999988543221
Q ss_pred HHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........... .........+.++.+++.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRDSPP-------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSSC-------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCC-------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111100 0111223456779999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.57 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=202.5
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
..|++.+.||+|+||.||+|.+ .++.||||.+... .....+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 4677889999999999999988 5789999998653 445678999999999999999999999874 478999999
Q ss_pred CCCCHhHHhccCCC--CCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc-eEEeccCCccccCCCCC
Q 047701 104 ENGSLDGYLFGKKR--ALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS-PKVADFGLAKLCDRNRS 180 (356)
Q Consensus 104 ~~~sL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~DfGla~~~~~~~~ 180 (356)
++++|.+++..... .+++..++.++.|+++||+|||+...++++||||||+||+++.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 99999999965442 5889999999999999999999854468999999999999988876 7999999997554322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
....||+.|+|||++.+. .++.++||||||+++|+|++|+.|+........ ...+ ......
T Consensus 161 ----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~----------~~~~~~ 221 (307)
T 2eva_A 161 ----TNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMW----------AVHNGT 221 (307)
T ss_dssp --------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHH----------HHHTTC
T ss_pred ----ccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHH----------HHhcCC
Confidence 234589999999999877 789999999999999999999998753222110 0101 111112
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.......++..+.+++.+||+.||.+|||+.++++.|+.+....+
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 223344556789999999999999999999999999998876554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=336.62 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=212.7
Q ss_pred HHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
....|.+.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 3457888999999999999999988888999999986532 34678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999999997777789999999999999999999999 9999999999999999999999999999986643211
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.......|+..|+|||++.+. .++.++||||||+++|+|++ |..|+...... .... .+....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~---------~i~~~~ 222 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVE---------DISTGF 222 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH---------HHHTTC
T ss_pred cccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHH-------HHHH---------HHhcCC
Confidence 112334577889999999876 68999999999999999999 77776432111 0111 111111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
....+...+..+.+++.+||+.||.+||++.++++.|..+.+
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 222233456779999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=371.95 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=205.3
Q ss_pred ccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 31 RLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
+||+|+||.||+|.+. ++..||||+++..........+.+|+.++++++||||+++++++.. +..++||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999763 4678999999876555667889999999999999999999999987 45899999999999
Q ss_pred HhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce-eecC
Q 047701 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISG 186 (356)
Q Consensus 108 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 186 (356)
|.+++......+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......... ....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 999997777789999999999999999999999 999999999999999999999999999998765433221 1122
Q ss_pred CCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 187 ~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
..+|+.|+|||++.+. .++.++||||||+++|||++ |+.|+...... ++...+..+.....+
T Consensus 499 ~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----------------~~~~~i~~~~~~~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------EVMAFIEQGKRMECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----------------HHHHHHHTTCCCCCC
T ss_pred CCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------HHHHHHHcCCCCCCC
Confidence 3467899999999876 69999999999999999998 88886433221 122223333334445
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..++.++.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 5677889999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=343.11 Aligned_cols=249 Identities=25% Similarity=0.296 Sum_probs=205.0
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|++.+.||+|+||.||+|+.. +++.||||++.+.. .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46788899999999999999864 69999999997532 2234467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||++||+|..++. ..+.+++..+..++.||+.||+|||+ ++++||||||+|||++.+|.+||+|||+++.......
T Consensus 85 E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 85 EYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999985 34579999999999999999999999 9999999999999999999999999999986433222
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
......||+.|+|||++.+. .++.++||||||+++|||++|..|+...... ....... ..
T Consensus 161 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~---------~~- 220 (337)
T 1o6l_A 161 --TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELIL---------ME- 220 (337)
T ss_dssp --CBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH---------HC-
T ss_pred --cccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHH---------cC-
Confidence 12345699999999999877 7899999999999999999999998543211 1111111 11
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~ 296 (356)
....+...+.++.+++.+||+.||.+|| ++.+|++.
T Consensus 221 ~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1122334567899999999999999999 89999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.76 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=206.3
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-----hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457889999999999999999864 6999999999754321 2456789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC----ceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla 172 (356)
++||||+++++|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999994 45679999999999999999999999 9999999999999998877 7999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
+....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ...........
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~ 234 (326)
T 2y0a_A 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY 234 (326)
T ss_dssp EECCTTSC---CCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHTCC
T ss_pred eECCCCCc---cccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHHhcCC
Confidence 87654332 2335699999999999877 6899999999999999999999988533221 01111111000
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..........+..+.+++.+||..||.+|||+.++++.
T Consensus 235 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111123346778999999999999999999999973
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=335.07 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=205.6
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.++||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.++...++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 5778899999999999999874 68999999997543 334457788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++ +|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 976 6666666667789999999999999999999999 99999999999999999999999999999876533222
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh---chhhhH---
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS---ELGAMI--- 256 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 256 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|+.|+..+...... ........... ......
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhcccc
Confidence 234568999999999987755899999999999999999999887554332110 00001100000 000000
Q ss_pred ---------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 ---------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ---------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............+.++.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000111122345677899999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=344.35 Aligned_cols=275 Identities=25% Similarity=0.366 Sum_probs=205.8
Q ss_pred CCcceeCHHHHHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeee
Q 047701 11 EKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVR 85 (356)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 85 (356)
+....+....+....|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||++
T Consensus 21 el~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 21 ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp ---CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeee
Confidence 333344555556678888999999999999999753 35589999987542 3345577899999999999999999
Q ss_pred EeeeEEcCC-----eeeEEEEecCCCCHhHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 86 LHGFCHDQH-----MTALVYEYMENGSLDGYLFG-----KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 86 ~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
+++++.+.. ..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~N 177 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARN 177 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGG
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcce
Confidence 999998754 34999999999999999842 34679999999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCc
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASE 234 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~ 234 (356)
|+++.++.+||+|||++................+++.|+|||++.+. .++.++||||||+++|+|++ |..|+......
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 99999999999999999876544333333345578899999999877 68999999999999999999 66665332221
Q ss_pred cccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 235 SLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.....+........+..++.++.+++.+||..||.+||++.++++.|+++....+
T Consensus 257 ----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 257 ----------------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ----------------GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----------------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111122222233344566789999999999999999999999999998876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=342.14 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=220.4
Q ss_pred eeCHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
.+..+++....|++.+.||+|+||.||+|.+. ++..||||++.... .....+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45566777889999999999999999999875 48899999997643 4456789999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 94 HMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
...++||||+.+++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999999999654 4569999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhc
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
........ .......+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----------------~ 220 (288)
T 3kfa_A 159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------Q 220 (288)
T ss_dssp GTSCSSSS-EEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----------------G
T ss_pred eeccCCcc-ccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------H
Confidence 87664432 233445578899999999877 68999999999999999999 77766432221 1
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
....+........+..++.++.+++.+||..||.+|||+.++++.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 111222222233344566789999999999999999999999999988764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=347.44 Aligned_cols=276 Identities=25% Similarity=0.343 Sum_probs=217.4
Q ss_pred HHHhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE--cCC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH--DQH 94 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~ 94 (356)
....|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.++++++||||+++++++. +..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 356888899999999999999983 36889999999765 3345567899999999999999999999887 456
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+++++|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 7899999999999999997666679999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 175 CDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 175 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
......... .....||..|+|||++.+. .++.++||||||+++|+|++|..|+............. ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-ERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-ccccccHHHHH
Confidence 765443322 2335588889999999877 68999999999999999999998874322110000000 00000011222
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..+........+..++.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 23333334444556778899999999999999999999999999988654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=337.03 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=200.4
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhc--CCCCCeeeEeeeEEc----CCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--TYHINLVRLHGFCHD----QHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~ 96 (356)
...|.+.+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 45788899999999999999988 7899999998653 33455566666665 799999999998754 3467
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hccCCCeeeeccCccceEEcCCCceEEec
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH--------EECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
++||||+++|+|.+++. ...+++..++.++.|++.||+||| + .+++||||||+|||++.++.+||+|
T Consensus 82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 89999999999999993 457999999999999999999999 7 9999999999999999999999999
Q ss_pred cCCccccCCCCCcee--ecCCCCCCCCCCcccccCCC-----CCCCCCceehhhHHHHHHhcC----------CCccccC
Q 047701 169 FGLAKLCDRNRSHVT--ISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVSFEIVGR----------RRNAIVG 231 (356)
Q Consensus 169 fGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~ell~g----------~~~~~~~ 231 (356)
||+++.......... .....||+.|+|||++.+.. .++.++||||||+++|||++| ..|+...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999987655443322 23347999999999998652 234689999999999999999 5555332
Q ss_pred CCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 232 ASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
....... .. ........... ............+.++.+++.+||+.||.+|||+.+|++.|+++
T Consensus 237 ~~~~~~~-~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSF-ED-MRKVVCVDQQR---PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCH-HH-HHHHHTTSCCC---CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcch-hh-hhHHHhccCCC---CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221110 00 00000000000 00000112345778899999999999999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=338.45 Aligned_cols=249 Identities=25% Similarity=0.302 Sum_probs=199.4
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCee
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 96 (356)
++....|.+.++||+|+||+||+|.+. +++.||||++.... ..........|+..+.++ +||||+++++++.++...
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344567888999999999999999875 79999999986542 233444555666666555 899999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
++||||+ +++|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999 669999987777789999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... .....||+.|+|||++.+ .++.++||||||+++|||++|..++.. ...+........
T Consensus 209 ~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~----------~~~~~~~~~~~~---- 269 (311)
T 3p1a_A 209 TAGA---GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHG----------GEGWQQLRQGYL---- 269 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSS----------HHHHHHHTTTCC----
T ss_pred cCCC---CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCC----------ccHHHHHhccCC----
Confidence 4332 233568999999999986 489999999999999999999765421 111222222111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........+.++.+++.+||+.||++|||+.++++
T Consensus 270 ----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 ----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11223345678999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=336.58 Aligned_cols=259 Identities=24% Similarity=0.324 Sum_probs=209.4
Q ss_pred HHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
....|.+.+.||+|+||.||+|.+. ++..||||++...........+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 4567888999999999999999753 23469999998765556678899999999999999999999998764 568
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999997777789999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.|+....... ....+
T Consensus 166 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----------------~~~~~ 227 (281)
T 3cc6_A 166 EDYY-KASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----------------VIGVL 227 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----------------HHHHH
T ss_pred cccc-ccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHH----------------HHHHH
Confidence 3322 12334578899999999876 68999999999999999998 888875332211 11111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
........+..++..+.+++.+||..||.+||++.++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1112222333456779999999999999999999999999987753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=332.42 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=206.7
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHH------HHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAE------EQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
...+|++.+.||+|+||.||+|.+ .+++.||||++......... ..+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 356788899999999999999986 47999999998654221111 57889999999999999999999997765
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEcCCCc-----eEEe
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFS-----PKVA 167 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----~kl~ 167 (356)
++||||+++++|.+++......+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999999997777889999999999999999999999 88 999999999999987776 9999
Q ss_pred ccCCccccCCCCCceeecCCCCCCCCCCcccccC-CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH
Q 047701 168 DFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG-NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 168 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
|||+++..... .....||+.|+|||++.+ ...++.++||||||+++|+|++|+.|+.......... ..
T Consensus 172 Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-----~~- 240 (287)
T 4f0f_A 172 DFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-----IN- 240 (287)
T ss_dssp CCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-----HH-
T ss_pred CCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-----HH-
Confidence 99999754332 234569999999999843 2257889999999999999999999985433221110 00
Q ss_pred HhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
...........+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 241 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 -------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111222333445677899999999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=337.00 Aligned_cols=262 Identities=21% Similarity=0.252 Sum_probs=201.6
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+|.+.+.||+|+||+||+|...+++.||||++..... ......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 4778899999999999999887899999999975432 223367889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.+ +|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 76 9999997777889999999999999999999999 99999999999999999999999999999876533221
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh---chhhhH----
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS---ELGAMI---- 256 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 256 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|..|+........ . .......... ......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHHCCCChhhchhhhcccc
Confidence 23356899999999998765689999999999999999999988753322100 0 0000000000 000000
Q ss_pred -h-------hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 -L-------ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 -~-------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ...........+.++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000111234677899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=338.34 Aligned_cols=262 Identities=30% Similarity=0.433 Sum_probs=213.2
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
.+++...+|++.+.||+|+||.||+|.+.++..||||++.... .....+.+|+.++++++||||+++++++.+ +..+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 3455667889999999999999999998788899999997643 235678999999999999999999999875 4579
Q ss_pred EEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+||||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999995432 369999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.... .......++..|+|||++.+. .++.++||||||+++|+|++ |..|+...... .....
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----------------~~~~~ 222 (279)
T 1qpc_A 161 DNEY-TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----------------EVIQN 222 (279)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHH
T ss_pred Cccc-ccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----------------HHHHH
Confidence 4332 222345578899999999876 68999999999999999999 77776322110 11111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
+........+..++.++.+++.+||..||.+|||+.++++.|+.+...
T Consensus 223 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 111122223345567899999999999999999999999999988653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=343.07 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=206.2
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
...|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999864 68999999997543 3345567899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC---CceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~~~~~ 177 (356)
||+.+|+|.+++. ....+++..+..++.||+.||.|||+ ++++||||||+|||++.+ +.+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999884 44679999999999999999999999 999999999999999754 4599999999987664
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ..+.........
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-------~~~~~i~~~~~~---- 248 (362)
T 2bdw_A 184 SEA---WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD---- 248 (362)
T ss_dssp CCS---CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC----
T ss_pred Ccc---cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC----
Confidence 332 2345799999999999877 6899999999999999999999987533211 111111111100
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........++.++.+++.+||..||.+||++.++++.
T Consensus 249 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111223456789999999999999999999999873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=344.89 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=215.6
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcC-CC-----cEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeE
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NG-----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFC 90 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 90 (356)
.+++....|.+.+.||+|+||.||+|.+. ++ ..||+|++...........+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34555667888899999999999999863 23 479999998765556677899999999999 899999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceE
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGK-------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVL 157 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 157 (356)
.+....++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence 9999999999999999999998542 3468999999999999999999999 99999999999999
Q ss_pred EcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccc
Q 047701 158 LDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESL 236 (356)
Q Consensus 158 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~ 236 (356)
++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|+|++ |..|+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence 999999999999999876554444334445678899999999876 68999999999999999998 777764322211
Q ss_pred cchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 237 DWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... ..+........+...+.++.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 275 -----~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 -----KFY---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -----HHH---------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHH---------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111 1111111222233446779999999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=331.48 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=207.1
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC--CeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ--HMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 99 (356)
-..|.+.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 34688899999999999999998 58899999997543 345557799999999999999999999999887 788999
Q ss_pred EEecCCCCHhHHhccCCC-CCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 100 YEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|||+++++|.+++..... .+++..++.++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999965543 59999999999999999999999 88 9999999999999999999999998875432
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCC--CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
. ....||+.|+|||++.+.. .++.++||||||+++|+|++|+.|+...... . ....
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~--------~~~~ 222 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------E--------IGMK 222 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------H--------HHHH
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------H--------HHHH
Confidence 2 2345899999999998752 2233799999999999999999987432211 0 0111
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..........+..++.++.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 112222233445567789999999999999999999999999988753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.43 Aligned_cols=254 Identities=19% Similarity=0.264 Sum_probs=205.6
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
...|.+.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45788899999999999999975 479999999997543 3344567899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc---CCCceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~~~ 177 (356)
||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++ .++.+||+|||++.....
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999999998854 4579999999999999999999999 9999999999999997 567899999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ..+.........
T Consensus 166 ~~~~--~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~---- 231 (444)
T 3soa_A 166 EQQA--WFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQH-------RLYQQIKAGAYD---- 231 (444)
T ss_dssp TCCB--CCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHTCCC----
T ss_pred CCce--eecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHHhCCCC----
Confidence 3322 2346799999999999877 7899999999999999999999987433211 111111111100
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.........+.++.+++.+||+.||.+|||+.++++.
T Consensus 232 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 --FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111123456789999999999999999999999983
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=344.61 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=206.5
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
.-..|.+.+.||+|+||.||+|... +++.||||++.+.. .......+.+|+.++++++||||+++++++.+....|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457888999999999999999864 68999999987532 22344678899999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+.||+|..++. ....+++..+..++.||+.||.|||+ .|++||||||+|||++.+|.+||+|||+++.....
T Consensus 93 v~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999995 45679999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCceeecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.. .....||+.|+|||++.+. ..++.++|||||||++|+|++|..|+.......... .....
T Consensus 169 ~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~~~~~--------- 232 (384)
T 4fr4_A 169 TQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----IVHTF--------- 232 (384)
T ss_dssp CC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH----HHHHH---------
T ss_pred Cc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH----HHHHH---------
Confidence 32 2346799999999998742 258999999999999999999999986443322110 01111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPP-MSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~ 295 (356)
.. .....+..++.++.+++.+||+.||.+||+ +++|.+
T Consensus 233 ~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ET-TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HH-CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hh-cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 112233445678999999999999999999 677765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=369.53 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=214.5
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
.+++....|.+.++||+|+||.||+|.+..+..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 3556667888899999999999999998777889999998643 234679999999999999999999999977 6789
Q ss_pred EEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|||||+.+|+|.+++... ...+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999999643 3569999999999999999999999 999999999999999999999999999998665
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.... .......++..|+|||++.+. .++.++||||||+++|||++ |..|+..... .++...
T Consensus 415 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----------------~~~~~~ 476 (535)
T 2h8h_A 415 DNEY-TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQ 476 (535)
T ss_dssp CHHH-HTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----------------HHHHHH
T ss_pred CCce-ecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence 3211 112234577889999999876 68999999999999999999 7777632211 111122
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
+........+..++.++.+||.+||+.||++||++.+|++.|+.+...
T Consensus 477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 222223333455677899999999999999999999999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=346.72 Aligned_cols=256 Identities=25% Similarity=0.305 Sum_probs=202.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
-..|++.++||+|+||.||+|++. +++.||||++.+.. .......+..|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 346788899999999999999864 68899999997542 222334578899999887 89999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 9999999999999853 4679999999999999999999999 99999999999999999999999999999863322
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--chhHHHHHHHhhhchhhhH
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--WFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 256 (356)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ......+. .+
T Consensus 207 ~~--~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~---------~i 274 (396)
T 4dc2_A 207 GD--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VI 274 (396)
T ss_dssp TC--CBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH---------HH
T ss_pred CC--ccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH---------HH
Confidence 22 22446799999999999987 7999999999999999999999998543221110 00011111 11
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM------SAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~ 295 (356)
... ....+...+.++.+++.+||+.||.+||++ .+|++
T Consensus 275 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 275 LEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred hcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111 122334566789999999999999999996 56665
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=345.78 Aligned_cols=277 Identities=23% Similarity=0.351 Sum_probs=215.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-----CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC-
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-----PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH- 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 94 (356)
+....|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 3455788899999999999999983 368999999997643 355578999999999999999999999987644
Q ss_pred -eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 95 -MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 95 -~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..++||||+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 7899999999999999997777789999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 174 LCDRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 174 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
.......... .....++..|+|||++.+. .++.++||||||+++|+|++|..|+.......................+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8765443322 2234577789999999877 6899999999999999999998876421100000000000000001112
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
...+........+..++.++.+++.+||..||.+||++.+|++.|+.+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22233333333445567889999999999999999999999999988753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=333.44 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=194.7
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCc---hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG---KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 4678889999999999999998 588999999875422 223467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC---eeeeccCccceEEcC--------CCceEEecc
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR---IIHYDIKPENVLLDA--------NFSPKVADF 169 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~---ivH~Dlkp~Nill~~--------~~~~kl~Df 169 (356)
||+++++|.+++. ...+++..++.++.|++.||.|||+ ++ ++||||||+||+++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999984 4579999999999999999999999 77 999999999999985 678999999
Q ss_pred CCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 170 GLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
|++........ ....||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ..
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~------- 222 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AV------- 222 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HH-------
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-------
Confidence 99986554322 234689999999999877 6899999999999999999999887432211 00
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.............+..++.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 --AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011111112223345567899999999999999999999999999753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=328.77 Aligned_cols=254 Identities=23% Similarity=0.280 Sum_probs=208.1
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 47888999999999999999874 68999999997554445567889999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999984 44679999999999999999999999 999999999999999999999999999998765433222
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCC
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (356)
......||+.|+|||++.+....+.++||||||+++|+|++|..|+......... +..+.... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~--------~~~ 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKK--------TYL 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTC--------TTS
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcc--------ccc
Confidence 2344668999999999987644578999999999999999999998654332111 11111110 111
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......+..+.+++.+||..||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 122345667899999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=338.86 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=191.5
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|++.++||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 46788899999999999999874 68999999997654444456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 103 MENGSLDGYLFGK-----KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 103 ~~~~sL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
++ ++|.+++... ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 97 5999988533 2469999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh--hchhhh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK--SELGAM 255 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 255 (356)
.... .....||+.|+|||++.+...++.++||||||+++|+|++|+.|+........ .......... ......
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 161 PVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp CCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGG
T ss_pred Cccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhh
Confidence 3221 23456899999999998754689999999999999999999998854332110 0000000000 000000
Q ss_pred Hhh----------cC--------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILA----------CG--------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~----------~~--------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... .. ........+.++.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 00 00001124567999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=342.61 Aligned_cols=262 Identities=26% Similarity=0.367 Sum_probs=209.2
Q ss_pred HHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
+....|.+.+.||+|+||.||+|.+ .+++.||||++...........+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 4566888999999999999999984 2477899999976655566778999999999999999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceE
Q 047701 95 MTALVYEYMENGSLDGYLFGKK------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPK 165 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~k 165 (356)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999996543 459999999999999999999999 99999999999999984 44699
Q ss_pred EeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHH
Q 047701 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVW 244 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~ 244 (356)
|+|||++................||+.|+|||++.+. .++.++||||||+++|+|++ |..|+......
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------- 252 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---------- 252 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----------
Confidence 9999999865443333233345688999999999876 68999999999999999998 77776332111
Q ss_pred HHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 245 EEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.....+........+..++..+.+++.+||+.||.+||++.+|++.|..+..
T Consensus 253 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 253 ------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111222222233344566789999999999999999999999999987754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=339.46 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=203.9
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
...|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+....|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 567899999999999999999764 69999999986421 1124567899999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc---eEEeccCC
Q 047701 98 LVYEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGL 171 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGl 171 (356)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887532 3468999999999999999999999 99999999999999976554 99999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
+......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+..... ..+.......
T Consensus 180 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~ 248 (351)
T 3c0i_A 180 AIQLGESGLV--AGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGK 248 (351)
T ss_dssp CEECCTTSCB--CCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTC
T ss_pred eeEecCCCee--ecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCC
Confidence 9877653321 2345799999999999877 689999999999999999999998853210 1111111111
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. .........+.++.+++.+||..||.+||++.++++
T Consensus 249 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000111234678999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=337.96 Aligned_cols=275 Identities=25% Similarity=0.326 Sum_probs=202.0
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC--CCCCeeeEeeeEEcC--
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT--YHINLVRLHGFCHDQ-- 93 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~-- 93 (356)
..+.....|.+.++||+|+||.||+|++ +++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3444566899999999999999999988 5899999998643 233455566666554 899999999999887
Q ss_pred --CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCC--------CeeeeccCccceEEcCCCc
Q 047701 94 --HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ--------RIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 94 --~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~--------~ivH~Dlkp~Nill~~~~~ 163 (356)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ . +++||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCC
Confidence 688999999999999999953 369999999999999999999998 6 9999999999999999999
Q ss_pred eEEeccCCccccCCCCCcee--ecCCCCCCCCCCcccccCCCCCCCC------CceehhhHHHHHHhcCCCccccCCCcc
Q 047701 164 PKVADFGLAKLCDRNRSHVT--ISGYKGTPGYSAPEFLSGNYPITHK------CDVYSFGMVSFEIVGRRRNAIVGASES 235 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~------~Dv~slG~il~ell~g~~~~~~~~~~~ 235 (356)
+||+|||+++.......... .....||+.|+|||++.+. ..+.. +||||||+++|||++|..++.......
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999987654332211 2245799999999999876 34444 899999999999999954432211111
Q ss_pred ccchh----HHHHHHHhhhchhhhHhhcC-CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 236 LDWFP----KYVWEEYEKSELGAMILACG-IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 236 ~~~~~----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..+.. ...+................ .......++.++.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 10000 00000010000000000000 0111236788899999999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=335.69 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=196.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCch-------------------------hHHHHHHHHHHHHhc
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK-------------------------IAEEQFMAEVGTIGR 77 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~ 77 (356)
..|.+.+.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4688899999999999999976 46899999998754211 123468899999999
Q ss_pred CCCCCeeeEeeeEEc--CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccc
Q 047701 78 TYHINLVRLHGFCHD--QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPEN 155 (356)
Q Consensus 78 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 155 (356)
++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||+|||+ .+++||||||+|
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 999999999999987 56889999999999998865 34579999999999999999999999 999999999999
Q ss_pred eEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCC--CCCCCceehhhHHHHHHhcCCCccccCCC
Q 047701 156 VLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP--ITHKCDVYSFGMVSFEIVGRRRNAIVGAS 233 (356)
Q Consensus 156 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~Dv~slG~il~ell~g~~~~~~~~~ 233 (356)
|+++.++.+||+|||+++........ .....||+.|+|||++.+... .+.++||||||+++|+|++|..|+.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999876644322 234679999999999976522 47789999999999999999998743221
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ........ ...........+.++.+++.+||+.||.+||++.++++
T Consensus 246 ~-------~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M-------CLHSKIKS--------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H-------HHHHHHHH--------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H-------HHHHHHhc--------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 0 00111111 00111112345677999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=337.49 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=206.2
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CC-------cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NG-------VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
....|.+.+.||+|+||.||+|.+. ++ ..||+|++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3567888999999999999999764 23 579999997543 34557799999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc--------eE
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--------PK 165 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~k 165 (356)
...++||||+++++|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999997766679999999999999999999999 99999999999999988876 99
Q ss_pred EeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHH
Q 047701 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~ 245 (356)
|+|||++...... ....||+.|+|||++.+...++.++||||||+++|+|++|..++........ ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQ 229 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHH
Confidence 9999998654322 1234788999999998744789999999999999999997665543322110 000
Q ss_pred HHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 246 EYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.. .. ....+...+.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 230 ~~---------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 230 FY---------ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HH---------HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred Hh---------hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00 00 1111222345688999999999999999999999999988653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=337.85 Aligned_cols=268 Identities=22% Similarity=0.333 Sum_probs=200.7
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe----
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM---- 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 95 (356)
..+|.+.+.||+|+||.||+|.+ .+++.||||++.... .......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 34788899999999999999986 579999999997643 23445678899999999999999999999876543
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 4999999999999999954 3579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
...... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ...+..........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP 239 (311)
T ss_dssp ---------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCH
T ss_pred cccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCc
Confidence 543322 222345689999999999887 7899999999999999999999987433221 11111111110000
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH-HHhhhcccCCCCCC
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVV-KMLEGVVEVLPPPK 308 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~-~~L~~~~~~~~~~~ 308 (356)
......++.++.+++.+||+.||.+||+..+++ +.|.......++..
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~ 287 (311)
T 3ork_A 240 -------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA 287 (311)
T ss_dssp -------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSS
T ss_pred -------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCC
Confidence 011123567799999999999999999766555 45555554444433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=342.19 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=202.3
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 678899999999999999986 5799999999875321 1223568899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+ +|+|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 90 ~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 90 YA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp CC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred CC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 99 6789888844 3579999999999999999999999 99999999999999999999999999999876544322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|+|||++.+....+.++||||||+++|+|++|..|+......... ..+.. ..
T Consensus 165 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~-~~ 224 (336)
T 3h4j_B 165 ---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS-CV 224 (336)
T ss_dssp ---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS-SC
T ss_pred ---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc-CC
Confidence 33569999999999988743478999999999999999999998543322111 00000 11
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+.++.+++.+||..||.+|||+.++++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223345677899999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=343.23 Aligned_cols=252 Identities=19% Similarity=0.279 Sum_probs=206.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46888899999999999999764 68999999997643 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--CCCceEEeccCCccccCCCCC
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~~~~~~~~ 180 (356)
+.+++|.+++......+++..++.++.||+.||+|||+ .+++||||||+|||++ ..+.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999997666789999999999999999999999 9999999999999997 457899999999987765433
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ........... ..
T Consensus 207 ~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~i~~~~~------~~ 269 (387)
T 1kob_A 207 V---KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDW------EF 269 (387)
T ss_dssp E---EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCC------CC
T ss_pred e---eeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CC
Confidence 2 224689999999999877 6899999999999999999999988543211 00111111000 00
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........+.++.+++.+||..||.+|||+.++++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112223456789999999999999999999999974
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=334.14 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=207.5
Q ss_pred HHhhcccc-ccCcCCceEEEEEEc---CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYST-RLGFGGFGQVYKGQF---PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~-~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
..+|.+.+ .||+|+||.||+|.+ .+++.||||++.... .......+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 899999999999954 347899999997543 233457799999999999999999999999 556779
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999954 4569999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 178 NRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..|+..... ......
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~ 232 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAM 232 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHH
T ss_pred CCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----------------HHHHHH
Confidence 443322 2234467889999999876 68999999999999999999 8887643221 111122
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+........+..++.++.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 233 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22222333445567889999999999999999999999999998864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.77 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=205.9
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcE--EEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVK--IAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
...|.+.+.||+|+||.||+|.+. ++.. +|||.+...........+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 457888999999999999999764 5654 4999987654445566789999999999 89999999999999999999
Q ss_pred EEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 99 VYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999996543 479999999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHH
Q 047701 164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~ 242 (356)
+||+|||+++....... .....+++.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~ 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E 249 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------H
Confidence 99999999874332111 1224478899999999876 68999999999999999998 88887432211 1
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
....+........+..++.++.+++.+||..||.+||++.++++.|..+...
T Consensus 250 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 250 ---------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ---------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111122233345567899999999999999999999999999988664
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=335.26 Aligned_cols=245 Identities=26% Similarity=0.301 Sum_probs=203.8
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|++.+.||+|+||.||+|+.. +|+.||+|++.+.. .......+.+|..+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46788899999999999999864 69999999997542 1233467888999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++.+|.+||+|||+++......
T Consensus 86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~- 160 (318)
T 1fot_A 86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 160 (318)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCcc-
Confidence 99999999999954 4579999999999999999999999 999999999999999999999999999998755321
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
....||+.|+|||++.+. .++.++||||||+++|||++|..|+...... ..+..... .
T Consensus 161 ----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~--------~-- 218 (318)
T 1fot_A 161 ----YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILN--------A-- 218 (318)
T ss_dssp ----CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHH--------C--
T ss_pred ----ccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh--------C--
Confidence 235699999999999877 7899999999999999999999998543221 11111111 1
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
....+...+.++.+++.+||..||.+|| +++++++
T Consensus 219 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1122334567899999999999999999 8899886
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=340.67 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=197.8
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCC--CCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYH--INLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv 99 (356)
...|.+.+.||+|+||.||+|...+++.||||++.... .......+.+|+.++.+++| |||+++++++.+....++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45688899999999999999998889999999987542 33455778999999999976 9999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||+ .+++|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+|||++ ++.+||+|||+++......
T Consensus 88 ~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 57799999954 4679999999999999999999999 9999999999999997 5789999999998776544
Q ss_pred CceeecCCCCCCCCCCcccccC----------CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSG----------NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
.........||+.|+|||++.+ ...++.++||||||+++|+|++|+.|+.......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------------- 227 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------------- 227 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--------------
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--------------
Confidence 3333345679999999999864 1368899999999999999999999874321110
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......+........+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 00111111111222223334678999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=343.04 Aligned_cols=268 Identities=22% Similarity=0.297 Sum_probs=199.0
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+|.+.++||+|+||+||+|... +++.||||++...........+.+|+.++++++||||+++++++.+....++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 5778899999999999999875 689999999975433222234567999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++ +|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... .
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~ 156 (324)
T 3mtl_A 83 DK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 156 (324)
T ss_dssp SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence 75 9999997777789999999999999999999999 9999999999999999999999999999986543322 1
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh---hhchhhh-----
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE---KSELGAM----- 255 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 255 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|+.|+......... ........ .......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcchh
Confidence 233568999999999987557899999999999999999999888543221100 00000000 0000000
Q ss_pred ----Hhhc----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--Hhhhcc
Q 047701 256 ----ILAC----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK--MLEGVV 301 (356)
Q Consensus 256 ----~~~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~~ 301 (356)
.... .........+.++.+++.+||+.||.+|||+.++++ .+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0000 000112234567899999999999999999999998 444443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=336.30 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=180.7
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 77999999999999874 6899999999653 3456788999999996 9999999999999999999999999999
Q ss_pred HhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEEeccCCccccCCCCCceee
Q 047701 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 108 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~DfGla~~~~~~~~~~~~ 184 (356)
|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++ .+||+|||+++........ .
T Consensus 93 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~ 166 (325)
T 3kn6_A 93 LFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L 166 (325)
T ss_dssp HHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence 9999954 4679999999999999999999999 9999999999999997665 8999999999866543222 2
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....||+.|+|||++.+. .++.++||||||+++|+|++|..|+........................ ......
T Consensus 167 ~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA 239 (325)
T ss_dssp -----------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred cccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence 345689999999999877 7899999999999999999999998544332111111111111111110 001122
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...++.++.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2345788999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=337.57 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=203.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
..|.+.+.||+|+||.||+|++. +++.||||++.+.. .......+.+|..++.++ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 35788899999999999999874 68999999997542 334456788999999987 899999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999999853 3579999999999999999999999 999999999999999999999999999998643322
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--chhHHHHHHHhhhchhhhHh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--WFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 257 (356)
. ......||+.|+|||++.+. .++.++||||||+++|||++|..|+......... ......+. .+.
T Consensus 165 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~i~ 232 (345)
T 3a8x_A 165 D--TTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VIL 232 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH---------HHH
T ss_pred C--cccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH---------HHH
Confidence 2 22346799999999999887 7899999999999999999999998542221100 00011111 111
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM------SAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~ 295 (356)
.. ....+...+.++.+++.+||+.||.+||++ .++++
T Consensus 233 ~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 233 EK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred cC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 11 112334566789999999999999999996 56665
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.50 Aligned_cols=254 Identities=21% Similarity=0.243 Sum_probs=193.3
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|.+.+.||+|+||+||++... +++.||||++.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 457899999999999999999875 79999999997643 223568899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc--eEEeccCCccccCCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLAKLCDRNR 179 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla~~~~~~~ 179 (356)
|+.+|+|.+++.. .+.+++..+..++.|++.||+|||+ ++++||||||+||+++.++. +||+|||+++......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 9999999999843 4579999999999999999999999 99999999999999987665 9999999987443222
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. .....||+.|+|||++.+....+.++||||||+++|+|++|+.|+........ ..... . ......
T Consensus 173 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~-~--------~~~~~~ 238 (361)
T 3uc3_A 173 Q---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI-Q--------RILSVK 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH-H--------HHHTTC
T ss_pred C---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH-H--------HHhcCC
Confidence 1 23356999999999998773334459999999999999999999854332211 00100 0 011111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.........+.++.+++.+||..||.+|||+.++++.
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111122345778999999999999999999999983
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=344.86 Aligned_cols=251 Identities=24% Similarity=0.269 Sum_probs=200.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 96 (356)
+.-..|++.++||+|+||.||+|+.. +++.||||++.+.. .......+..|..++..+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44457888999999999999999864 68999999997542 223446688899999988 799999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|+||||++||+|..++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999954 4679999999999999999999999 999999999999999999999999999998543
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|..||...... ..+.....
T Consensus 176 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~------- 238 (353)
T 3txo_A 176 CNGV--TTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLFEAILN------- 238 (353)
T ss_dssp C-----------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH-------
T ss_pred cCCc--cccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHHHHHHc-------
Confidence 3221 22346799999999999877 6899999999999999999999998543221 11111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM------SAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~------~~v~~ 295 (356)
. ....+...+.++.+++.+||..||.+||++ .++++
T Consensus 239 --~-~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 --D-EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --C-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --C-CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 112233456779999999999999999998 77776
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=328.99 Aligned_cols=265 Identities=19% Similarity=0.192 Sum_probs=208.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeee-EEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF-CHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e 101 (356)
..|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.++++++|++++..+.. ..+....++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4688899999999999999986 5799999999875432 2358899999999988776555544 466778899999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~~~ 178 (356)
|+ +++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||++ +.++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 889999997667789999999999999999999999 999999999999999 47889999999999877654
Q ss_pred CCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 179 RSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 179 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+.....................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 236 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 236 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----
T ss_pred ccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC----
Confidence 3321 12345799999999999887 6899999999999999999999998654332221111111110000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.........++.++.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 237 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 237 -----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00011123345779999999999999999999999999998876544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=341.30 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=197.9
Q ss_pred ccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 29 STRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 56799999999999976 469999999997643 2455678999999999999999999999999999999999999999
Q ss_pred HhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE--cCCCceEEeccCCccccCCCCCceeec
Q 047701 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL--DANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 108 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
|.+++......+++..++.++.||+.||.|||+ .+++||||||+|||+ +.++.+||+|||+++........ .
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---K 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---C
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---c
Confidence 999987666789999999999999999999999 999999999999999 56789999999999876544322 2
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchh
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (356)
...||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ........... .......
T Consensus 247 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~------~~~~~~~ 312 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRW------DLEDEEF 312 (373)
T ss_dssp CCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC------CSCSGGG
T ss_pred cccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccC------CCChhhh
Confidence 34699999999999876 6899999999999999999999988543221 00111111000 0111223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 266 ~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+.++.+++.+||+.||.+||++.++++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 345678999999999999999999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=342.63 Aligned_cols=276 Identities=16% Similarity=0.172 Sum_probs=207.5
Q ss_pred HHHhhccccccCcC--CceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 22 NNFTSNYSTRLGFG--GFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 22 ~~~~~~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
...+|++.++||+| +||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999875 69999999997543 3345567888999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999654 3679999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCc-----eeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--h----hHH--
Q 047701 177 RNRSH-----VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--F----PKY-- 242 (356)
Q Consensus 177 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--~----~~~-- 242 (356)
..... .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.|+.......... . +..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 22111 111234689999999999873 368999999999999999999999985433221100 0 000
Q ss_pred ----HHHHHh--------hhchhhhH---------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--hhh
Q 047701 243 ----VWEEYE--------KSELGAMI---------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM--LEG 299 (356)
Q Consensus 243 ----~~~~~~--------~~~~~~~~---------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~--L~~ 299 (356)
...... ........ ............+.++.+|+.+||+.||.+|||+.++++. +..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 000000 00000000 0000011233456779999999999999999999999973 444
Q ss_pred c
Q 047701 300 V 300 (356)
Q Consensus 300 ~ 300 (356)
+
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=330.45 Aligned_cols=266 Identities=19% Similarity=0.212 Sum_probs=206.8
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeE-EcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC-HDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 100 (356)
..+|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+.+|+.++++++|++++..+..+ .+....++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35788999999999999999986 579999999876532 223578899999999887766655544 6778889999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~~ 177 (356)
||+ +++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 889999997667789999999999999999999999 999999999999999 7889999999999987765
Q ss_pred CCCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 178 NRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 178 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
..... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+......................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 237 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 237 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--
T ss_pred cccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc--
Confidence 43321 12345699999999999887 68999999999999999999999986543332221111111110000
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
........++.++.+++.+||+.||++||++.+|++.|+++.....
T Consensus 238 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 238 -------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0011112345789999999999999999999999999998876443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=339.91 Aligned_cols=245 Identities=22% Similarity=0.224 Sum_probs=204.2
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|++.+.||+|+||.||+|+.. +++.||||++.+.. .......+.+|+.++++++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46778899999999999999864 69999999996532 1233467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++|+|.+++... +.+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 999999999999543 569999999999999999999999 999999999999999999999999999998765432
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... .........
T Consensus 196 ----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~---------- 253 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSG---------- 253 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHC----------
T ss_pred ----ccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHH-------HHHHHHHcC----------
Confidence 234689999999999877 7899999999999999999999998543221 111111111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
....+...+.++.+++.+||+.||.+||+ +.+|++
T Consensus 254 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11223345678999999999999999998 888876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=344.26 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=197.5
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCC--CCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTY--HINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||+|...+++.||||++.... .......+.+|+.++++++ ||||+++++++......++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 488889999999999999998789999999997542 3455678899999999996 5999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+.+++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++........
T Consensus 137 -~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 -CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp -CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred -cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 457899999954 4578999999999999999999999 9999999999999995 579999999999877654433
Q ss_pred eeecCCCCCCCCCCcccccCC----------CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 182 VTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... . .
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~---------~ 276 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S---------K 276 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H---------H
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H---------H
Confidence 333456799999999998651 258889999999999999999999884322110 0 0
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+...+........+...+.++.+++.+||..||.+||++.++++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111111222235678999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=339.83 Aligned_cols=270 Identities=17% Similarity=0.199 Sum_probs=201.5
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchh----------HHHHHHHHHHHHhcCCCCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKI----------AEEQFMAEVGTIGRTYHINLVRL 86 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~ 86 (356)
+....|.+.+.||+|+||.||+|.+. ++..||||++....... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 33457888999999999999999874 57889999987543211 11346678899999999999999
Q ss_pred eeeEEc----CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 87 HGFCHD----QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 87 ~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
++++.. ....++||||+ +++|.+++... +.+++..++.++.||+.||+|||+ .+++||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 999988 77899999999 99999999544 389999999999999999999999 9999999999999998777
Q ss_pred --ceEEeccCCccccCCCCCc-----eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcc
Q 047701 163 --SPKVADFGLAKLCDRNRSH-----VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235 (356)
Q Consensus 163 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~ 235 (356)
.+||+|||+++.+...... .......||+.|+|||++.+. .++.++||||||+++|||++|..||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 9999999999876432211 111345799999999999887 78999999999999999999999985432221
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... ........ ......+.... ....++.++.+++.+||..||.+||++.+|++.|+.+..
T Consensus 268 ~~~--~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAV--QTAKTNLL-DELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH--HHHHHHHH-HTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH--HHHHHhhc-ccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 100 00000000 01111110000 001345689999999999999999999999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=339.13 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=202.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577788999999999999985 579999999997542 2334467899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+. |+|.+++......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 58888886667789999999999999999999999 99999999999999999999999999999865432
Q ss_pred ceeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 181 HVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
....||+.|+|||++.+ ...++.++||||||+++|||++|..|+...... .... .....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~---------~~~~~ 268 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALY---------HIAQN 268 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH---------HHHHS
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHH---------HHHhc
Confidence 23568999999999852 236899999999999999999999987433211 0000 11111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..........+..+.+++.+||+.||.+|||+.++++.
T Consensus 269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111223446778999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=350.45 Aligned_cols=256 Identities=20% Similarity=0.210 Sum_probs=205.3
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|++.++||+|+||+||+|++. +++.||||++.+.. .......+..|..++..++||||+++++++.+....||||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 45777899999999999999875 58999999997531 1122234788999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+.+|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 9999999999997767789999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ceeecCCCCCCCCCCccccc----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 181 HVTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
. ......||+.|+|||++. +...++.++|||||||++|||++|+.||....... .+..... ..
T Consensus 231 ~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~-----~~ 297 (437)
T 4aw2_A 231 V-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMN-----HK 297 (437)
T ss_dssp E-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHT-----HH
T ss_pred c-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------HHHhhhh-----cc
Confidence 2 234467999999999987 23368999999999999999999999985432211 0111100 00
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~ 295 (356)
.....+......+.++.+|+.+||..+|++ ||+++++++
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 011112222335678999999999888888 999999988
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=345.62 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=198.7
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Cee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 96 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 47888999999999999999864 68999999997543 334557889999999999999999999999776 568
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|+||||+. ++|.+++. ....+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 106 ~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 99999996 59999994 45679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCc--------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc
Q 047701 177 RNRSH--------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236 (356)
Q Consensus 177 ~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~ 236 (356)
..... ...+...||+.|+|||++.....++.++|||||||++|||++|..|+........
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 43221 1235577999999999976555799999999999999999986544432111110
Q ss_pred cchh------------------------------------HHHHHHHhhhchhhhHhhcCCC------chhHHHHHHHHH
Q 047701 237 DWFP------------------------------------KYVWEEYEKSELGAMILACGIE------EKDKEKAKQLCM 274 (356)
Q Consensus 237 ~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~ 274 (356)
..++ ...+...........+...... ...+..+.++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 0000 0000000011111111110000 011235678999
Q ss_pred HHHhhcCCCCCCCCCHHHHHH
Q 047701 275 VALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 275 l~~~cl~~~p~~Rps~~~v~~ 295 (356)
|+.+||..||.+|||+.++++
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=347.39 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=205.7
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999874 79999999997532 1123467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 96 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 96 EYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp ECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 9999999999994 45679999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....||+.|+|||++.+....+.++||||||+++|+|++|..|+...... .........
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-------~~~~~i~~~---------- 231 (476)
T 2y94_A 172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-------TLFKKICDG---------- 231 (476)
T ss_dssp ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------HHHHHHHTT----------
T ss_pred ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHhcC----------
Confidence 234569999999999988744578999999999999999999998543221 111111111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+...+.++.+++.+||..||.+|||+.++++
T Consensus 232 ~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11122334567999999999999999999999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=328.18 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=199.5
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.++||+|+||.||+|.. .++..||+|++...........+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46789999999999999999986 46899999999866544556789999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCcccc
Q 047701 102 YMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLC 175 (356)
Q Consensus 102 ~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~ 175 (356)
|+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988532 4679999999999999999999999 999999999999999 45678999999999866
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+....... ........
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~----- 240 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE-------VQQKATYK----- 240 (285)
T ss_dssp ------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC-----
T ss_pred CCccc---CcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH-------HHhhhccC-----
Confidence 54322 233568999999999865 47899999999999999999999874332110 00000000
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...........+.++.+++.+||+.||.+|||+.++++
T Consensus 241 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 --EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011111124567889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=330.25 Aligned_cols=261 Identities=21% Similarity=0.355 Sum_probs=200.9
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||.||+|.. .+++.||||++... ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3688889999999999999986 47999999999743 23455677899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999853 35679999999999999999999999 9999999999999999999999999999886654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... .....|++.|+|||++.+. .++.++||||||+++|+|++|..|+........ .... .+.
T Consensus 189 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~---------~~~ 251 (310)
T 2wqm_A 189 KTTA--AHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCK---------KIE 251 (310)
T ss_dssp ------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-----HHHH---------HHH
T ss_pred CCcc--ccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-----HHHH---------Hhh
Confidence 3221 2235689999999999877 689999999999999999999998754322110 0001 111
Q ss_pred hcCCC-chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCC
Q 047701 258 ACGIE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304 (356)
Q Consensus 258 ~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~ 304 (356)
..... ......+.++.+++.+||..||.+|||+.+|++.|+++.+..
T Consensus 252 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11111 112345678999999999999999999999999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=346.59 Aligned_cols=197 Identities=23% Similarity=0.322 Sum_probs=156.1
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Cee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 96 (356)
.+|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 46888999999999999999764 68999999997543 334557789999999999999999999999543 568
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|+||||+ +++|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 133 ~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 569999884 45679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCc-------------------------eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC
Q 047701 177 RNRSH-------------------------VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225 (356)
Q Consensus 177 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~ 225 (356)
..... ...+..+||+.|+|||++.....++.++|||||||++|||++|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 32211 12345678999999998765547999999999999999999953
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=341.59 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=204.0
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCe
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHM 95 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 95 (356)
.+.-..|.+.+.||+|+||.||+|+++ +++.||||++.+.. .......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345567888999999999999999874 68999999997542 123445678899999876 89999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||+ ++++||||||+|||++.+|.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999954 4579999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... .....||+.|+|||++.+. .++.++|+||||+++|||++|..|+...... ..+....
T Consensus 169 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~------- 231 (345)
T 1xjd_A 169 MLGDAK--TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIR------- 231 (345)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH-------
T ss_pred ccCCCc--ccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHH-------
Confidence 332221 2346799999999999887 6899999999999999999999998533221 1111111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMS-AVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~ 295 (356)
.. ....+...+.++.+++.+||..||.+||++. +|.+
T Consensus 232 --~~-~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 232 --MD-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --HC-CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --hC-CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 1122334567899999999999999999997 6654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=332.74 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=207.8
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE----cCCe
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH----DQHM 95 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~ 95 (356)
+...+|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3456889999999999999999986 57999999998654 3355677899999999999999999999997 3457
Q ss_pred eeEEEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 96 TALVYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
.++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999999864 45779999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCce-------eecCCCCCCCCCCcccccCCC--CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH
Q 047701 173 KLCDRNRSHV-------TISGYKGTPGYSAPEFLSGNY--PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 173 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~--~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~ 243 (356)
.......... ......||+.|+|||++.+.. .++.++||||||+++|+|++|..|+......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------- 252 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--------- 252 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---------
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---------
Confidence 7654211110 011235799999999987652 2688999999999999999999886321000
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCC
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~ 304 (356)
....................+.++.+++.+||+.||.+||++.++++.|+.+....
T Consensus 253 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 253 -----GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -----TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -----cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00111111111112223345678999999999999999999999999999886543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=332.84 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=199.8
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|.+.++||+|+||+||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 5778899999999999999874 599999999865432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+++++|..++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 158 (311)
T 4agu_A 84 CDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY- 158 (311)
T ss_dssp CSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence 99999998874 45679999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhH--------HHHHHHhhhchhh
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK--------YVWEEYEKSELGA 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 254 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|..|+............. .....+.......
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2335689999999999875578999999999999999999999875433221100000 0000000000000
Q ss_pred hHh---hcCC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MIL---ACGI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~---~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... .... .......+.++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000 0011235667999999999999999999999997
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=337.88 Aligned_cols=271 Identities=24% Similarity=0.312 Sum_probs=199.5
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHH--HhcCCCCCeeeEeeeEEc-----CCe
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGT--IGRTYHINLVRLHGFCHD-----QHM 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~~~ 95 (356)
-..|.+.+.||+|+||.||+|++ +++.||||++... ....+..|.++ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 45788889999999999999987 7899999999753 22334444444 455899999999986542 335
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCC---------CeeeeccCccceEEcCCCceEE
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ---------RIIHYDIKPENVLLDANFSPKV 166 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~---------~ivH~Dlkp~Nill~~~~~~kl 166 (356)
.++||||+++|+|.+++... ..++..++.++.||+.||.|||+ . +++||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 68999999999999999543 34899999999999999999999 7 9999999999999999999999
Q ss_pred eccCCccccCCCCC------ceeecCCCCCCCCCCcccccCC------CCCCCCCceehhhHHHHHHhcCCCccccCCCc
Q 047701 167 ADFGLAKLCDRNRS------HVTISGYKGTPGYSAPEFLSGN------YPITHKCDVYSFGMVSFEIVGRRRNAIVGASE 234 (356)
Q Consensus 167 ~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~ 234 (356)
+|||+++....... ........||+.|+|||++.+. ..++.++||||||+++|||++|..|+..+...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654321 1122345699999999999863 24667899999999999999998887655443
Q ss_pred cccch-hHHHHHH-HhhhchhhhHhhc-CCC------chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 235 SLDWF-PKYVWEE-YEKSELGAMILAC-GIE------EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 235 ~~~~~-~~~~~~~-~~~~~~~~~~~~~-~~~------~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..... ....... .........+... ... ......+.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 21100 0000000 0000000001100 011 11234677899999999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.05 Aligned_cols=253 Identities=27% Similarity=0.375 Sum_probs=200.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-CeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-HMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv 99 (356)
+....|++.+.||+|+||.||+|.+ +++.||||++... .....+.+|+.++++++||||+++++++.+. ...++|
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 3456788899999999999999988 5889999999754 3456789999999999999999999997654 478999
Q ss_pred EEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999996443 248999999999999999999999 99999999999999999999999999998755432
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
. ....+++.|+|||++.+. .++.++||||||+++|+|++ |..|+...... .....+.
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----------------~~~~~~~ 228 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----------------DVVPRVE 228 (278)
T ss_dssp ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----------------GHHHHHT
T ss_pred c-----cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHh
Confidence 2 123478899999999876 68999999999999999998 88776432211 1111111
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.......+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 122223344567789999999999999999999999999988743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=336.22 Aligned_cols=271 Identities=25% Similarity=0.333 Sum_probs=209.5
Q ss_pred eeCHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhc--CCCCCeeeEeeeEEc
Q 047701 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR--TYHINLVRLHGFCHD 92 (356)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~ 92 (356)
.+...+....+|.+.+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3444555667899999999999999999998 6899999999652 34567788888887 789999999999988
Q ss_pred CC----eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hccCCCeeeeccCccceEEcC
Q 047701 93 QH----MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH--------EECQQRIIHYDIKPENVLLDA 160 (356)
Q Consensus 93 ~~----~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~ 160 (356)
.. ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| + .+++||||||+||+++.
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKK 182 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECT
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECC
Confidence 76 78999999999999999954 46899999999999999999999 7 89999999999999999
Q ss_pred CCceEEeccCCccccCCCCCce--eecCCCCCCCCCCcccccCCCC-----CCCCCceehhhHHHHHHhcCC--------
Q 047701 161 NFSPKVADFGLAKLCDRNRSHV--TISGYKGTPGYSAPEFLSGNYP-----ITHKCDVYSFGMVSFEIVGRR-------- 225 (356)
Q Consensus 161 ~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-----~~~~~Dv~slG~il~ell~g~-------- 225 (356)
++.+||+|||++.......... ......||+.|+|||++.+... ++.++||||||+++|+|++|.
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999998766544332 1234569999999999976522 236899999999999999994
Q ss_pred --CccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc--hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 226 --RNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE--KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 226 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.|+......... . ............ .. .... ....++..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 263 ~~~p~~~~~~~~~~-~-~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPSDPS-V-EEMRKVVCEQKL----RP-NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCSSCC-H-HHHHHHHTTSCC----CC-CCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcCccc-H-HHHHHHHHHHHh----CC-CCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 444322111110 0 000111100000 00 0111 12366788999999999999999999999999999886
Q ss_pred c
Q 047701 302 E 302 (356)
Q Consensus 302 ~ 302 (356)
.
T Consensus 336 ~ 336 (342)
T 1b6c_B 336 Q 336 (342)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=337.12 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=188.5
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 35778899999999999999875 5889999999764 2345688899999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCccccCCCC
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~~~~~~~ 179 (356)
+++++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 99999999994 44679999999999999999999999 99999999999999975 8899999999998665432
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+....... ........... .
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~------~ 269 (349)
T 2w4o_A 206 L---MKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY------Y 269 (349)
T ss_dssp ----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC------C
T ss_pred c---cccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC------c
Confidence 2 2335689999999999877 68999999999999999999999885433211 01111111110 0
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||..||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122345678999999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=323.38 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=203.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|.+.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 457889999999999999999864 588999999876433 345678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999998854 4569999999999999999999999 999999999999999 78889999999999876544
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... ....||+.|+|||++.+. ++.++||||||+++|+|++|..|+...... ............
T Consensus 163 ~~~---~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~----- 225 (277)
T 3f3z_A 163 KMM---RTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------EVMLKIREGTFT----- 225 (277)
T ss_dssp SCB---CCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC-----
T ss_pred cch---hccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhCCCC-----
Confidence 322 335689999999998764 899999999999999999999987433211 111111111000
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||+.||.+||++.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011135678999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=338.20 Aligned_cols=251 Identities=24% Similarity=0.285 Sum_probs=203.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 96 (356)
+.-..|++.+.||+|+||.||+|+.. +++.||||++.+.. .......+..|..++..+ +||||+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 33457888899999999999999875 58899999997542 223446788899999988 899999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||+ ++++||||||+|||++.+|.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999999953 3569999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|..|+...... ..+....
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~-------- 234 (353)
T 2i0e_A 173 WDGV--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIM-------- 234 (353)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH--------
T ss_pred cCCc--ccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHH-------HHHHHHH--------
Confidence 2221 22346799999999999877 6899999999999999999999998543221 1111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
.. ....+...+.++.+++.+||..||.+||+ +.+|++
T Consensus 235 -~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 -EH-NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -HC-CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -hC-CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 11223456678999999999999999996 467765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=338.26 Aligned_cols=254 Identities=17% Similarity=0.172 Sum_probs=205.8
Q ss_pred HHHHHhhccccccCcCCceEEEEEE------cCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC---CCCeeeEeeeE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQ------FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---HINLVRLHGFC 90 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~ 90 (356)
++...+|.+.++||+|+||+||+|. ..+++.||||++... ....+..|+.++.+++ |+||+.+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3445678888899999999999993 346899999999764 2345677777777776 99999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC------
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFG----KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA------ 160 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~------ 160 (356)
...+..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999964 35679999999999999999999999 99999999999999988
Q ss_pred -----CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcc
Q 047701 161 -----NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASES 235 (356)
Q Consensus 161 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~ 235 (356)
++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++|+.|+.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 899999999999876544444445667899999999999987 69999999999999999999999875443321
Q ss_pred ccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHhhhccc
Q 047701 236 LDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADR-PPMSAVVKMLEGVVE 302 (356)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-ps~~~v~~~L~~~~~ 302 (356)
.. ..... ... .....+.+++..|++.+|.+| |++.++.+.|+....
T Consensus 293 ~~--------------~~~~~-----~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 CK--------------PEGLF-----RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp EE--------------ECSCC-----TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ee--------------echhc-----ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 10 00000 000 124567789999999999999 678888888887654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.55 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=202.1
Q ss_pred cccCcCCceEEEEEEc---CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQF---PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||.||+|.+ .+++.||||+++... .......+.+|+.++++++||||+++++++..+ ..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence 3699999999999954 246889999997643 234467899999999999999999999999754 57899999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc-eee
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH-VTI 184 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~ 184 (356)
|+|.+++. ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++........ ...
T Consensus 454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999994 45679999999999999999999999 99999999999999999999999999999877644322 222
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....||+.|+|||++.+. .++.++||||||+++|||++ |+.|+..... ..+...+.......
T Consensus 530 ~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------------~~~~~~i~~~~~~~ 592 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAMLEKGERMG 592 (635)
T ss_dssp -----CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHHTTCCCC
T ss_pred cCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHcCCCCC
Confidence 334578889999999877 69999999999999999998 8888633211 12222333333344
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
.+..++.++.+++.+||+.||++||++.+|++.|+.+.
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 45567788999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=331.91 Aligned_cols=266 Identities=20% Similarity=0.229 Sum_probs=197.9
Q ss_pred hhcc-ccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNY-STRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~-~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+ .+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 5666 478999999999999864 69999999997653 24456788999999985 79999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc---eEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++. +||+|||++......
T Consensus 92 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999954 3579999999999999999999999 99999999999999987765 999999998865432
Q ss_pred CCc-----eeecCCCCCCCCCCcccccCC----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 179 RSH-----VTISGYKGTPGYSAPEFLSGN----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 179 ~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
... .......||+.|+|||++.+. ..++.++||||||+++|+|++|..|+.........+......... .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~ 246 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC-Q 246 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH-H
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH-H
Confidence 211 112234589999999998741 247889999999999999999999986554332221110000000 0
Q ss_pred hchhhhHhhcCCCc---hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 250 SELGAMILACGIEE---KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 250 ~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..+...+....... .....+.++.+++.+||..||.+|||+.++++.
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00111111111111 112346789999999999999999999999983
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=343.30 Aligned_cols=272 Identities=18% Similarity=0.192 Sum_probs=212.2
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC--eeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH--MTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv 99 (356)
+.+|.+.++||+|+||+||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457888999999999999999875 599999999986544455677889999999999999999999998755 67999
Q ss_pred EEecCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE----cCCCceEEeccCCcc
Q 047701 100 YEYMENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKVADFGLAK 173 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~DfGla~ 173 (356)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+ .+++||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999996543 349999999999999999999999 999999999999999 777789999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCC-------CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGN-------YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
....... .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 7654332 2335699999999998641 25788999999999999999999998643322111 0111111
Q ss_pred Hhhhc---hhhhH-----------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 247 YEKSE---LGAMI-----------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 247 ~~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..... ..... ............+..+.+++.+||+.||++||++.++++.+..+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11000 00000 0000112346778889999999999999999999999998887755
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=335.11 Aligned_cols=252 Identities=21% Similarity=0.223 Sum_probs=196.3
Q ss_pred HHHHHhhccccccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
.+....|.+.+.||+|+||.||+|+. .+++.||||++.+.. .......+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34456788999999999999999976 468999999997642 12334567889999999999999999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
.+..|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999999953 4568999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
+....... ......||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ......
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i----- 233 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KTIDKI----- 233 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHH-----
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HHHHHH-----
Confidence 75433221 12345799999999999877 6899999999999999999999988543221 011111
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
... ....+...+.++.+++.+||..||.+|| ++.++++
T Consensus 234 ---~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 ---LKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---HHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---HhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111 1122334567899999999999999999 7778876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=345.40 Aligned_cols=256 Identities=20% Similarity=0.201 Sum_probs=204.0
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
...|++.+.||+|+||.||+|+.. +++.||||++.+.. .......+..|..++.+++||||+++++++.+.+..|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 346777889999999999999874 69999999997531 112234578899999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+.||+|.+++...+..+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999997666689999999999999999999999 999999999999999999999999999998765443
Q ss_pred CceeecCCCCCCCCCCcccccC------CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.. ......||+.|+|||++.+ ...++.++|||||||++|||++|+.||....... .+.....
T Consensus 217 ~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~---- 284 (412)
T 2vd5_A 217 TV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-------TYGKIVH---- 284 (412)
T ss_dssp CE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHT----
T ss_pred cc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------HHHHHHh----
Confidence 22 2234679999999999872 2368999999999999999999999985432211 0111110
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADR---PPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---ps~~~v~~ 295 (356)
.......+......+.++.+++.+||. +|.+| |++++|++
T Consensus 285 -~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 -YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000111122234467789999999999 99998 68999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.40 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=207.5
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|...+.||+|+||.||+|.. .+++.||||++...........+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 34577889999999999999976 46899999999765544566789999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp CCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 999999999994 3579999999999999999999999 99999999999999999999999999999876543221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... . ....+.....
T Consensus 176 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~---------~~~~~~~~~~ 236 (303)
T 3a7i_A 176 --RNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPM-------K---------VLFLIPKNNP 236 (303)
T ss_dssp --BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H---------HHHHHHHSCC
T ss_pred --cCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHH-------H---------HHHHhhcCCC
Confidence 2345689999999999877 6899999999999999999999887432211 0 0011111112
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......++..+.+++.+||+.||.+||++.++++.
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22333456779999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=330.49 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=205.9
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch-----hHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567889999999999999999864 6899999999754321 2356789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC----ceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla 172 (356)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999995 45678999999999999999999999 9999999999999998887 7999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
......... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ...........
T Consensus 167 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~ 235 (321)
T 2a2a_A 167 HEIEDGVEF---KNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANITSVSY 235 (321)
T ss_dssp EECCTTCCC---CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHTTCC
T ss_pred eecCccccc---cccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhccc
Confidence 876653322 335689999999999877 6899999999999999999999987533221 01111111000
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+..+.+++.+||..||.+|||+.++++
T Consensus 236 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 ------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0001112334577999999999999999999999997
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=344.53 Aligned_cols=263 Identities=19% Similarity=0.250 Sum_probs=210.2
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCC-CCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH-INLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 101 (356)
..|.+.++||+|+||.||+|.+ .+++.||||++..... ...+..|+.+++.+.| +++..+..++.+....+||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4688899999999999999986 5699999999875432 2347889999999976 567777777788889999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~~~ 178 (356)
|+ +++|.+++......+++..++.++.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 889999997667789999999999999999999999 999999999999999 58889999999999987654
Q ss_pred CCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 179 RSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 179 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ..+.........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~i~~~~~~ 234 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKKVA 234 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----HHHHHHHHHHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----HHHHHHhhcccc
Confidence 4321 12356799999999999987 6999999999999999999999998654332211 111111111111
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
.........++.++.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 235 -----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 235 -----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp -----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111122234567899999999999999999999999999887543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=335.61 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=201.8
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
...|.+.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.++++++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45788899999999999999975 4699999999975421 112345778999999999999999999999999
Q ss_pred eeeEEEEecCCC-CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 95 MTALVYEYMENG-SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 95 ~~~lv~e~~~~~-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..++||||+.+| +|.+++. ....+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999998766 9999984 44579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
........ ....||+.|+|||++.+....+.++||||||+++|+|++|..|+.....
T Consensus 179 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------- 235 (335)
T 3dls_A 179 YLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------- 235 (335)
T ss_dssp ECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------
T ss_pred ECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------
Confidence 77654332 2346899999999998874448899999999999999999998742110
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.... ....+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 236 -~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -TVEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -GTTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HHhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 011122245679999999999999999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=340.09 Aligned_cols=272 Identities=24% Similarity=0.242 Sum_probs=207.8
Q ss_pred CcceeCHHHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-----CCCeee
Q 047701 12 KPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-----HINLVR 85 (356)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 85 (356)
....+...++....|.+.++||+|+||+||+|.+ .+++.||||++... ......+..|+.+++++. ||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 3345566666677899999999999999999986 46899999999752 344556778999999886 999999
Q ss_pred EeeeEEcCCeeeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC----
Q 047701 86 LHGFCHDQHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---- 160 (356)
Q Consensus 86 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---- 160 (356)
+++++......++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 999999999999999999 889999996543 469999999999999999999999 99999999999999975
Q ss_pred ---------------------CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHH
Q 047701 161 ---------------------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSF 219 (356)
Q Consensus 161 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 219 (356)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLA 250 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC-CCCCccchHHHHHHHH
Confidence 7899999999998654332 235689999999999887 7999999999999999
Q ss_pred HHhcCCCccccCCCcccc--------chhHHHHHHHhhhchhhhHh---------------------hcCCCchhHHHHH
Q 047701 220 EIVGRRRNAIVGASESLD--------WFPKYVWEEYEKSELGAMIL---------------------ACGIEEKDKEKAK 270 (356)
Q Consensus 220 ell~g~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~ 270 (356)
+|++|+.||......... ..+...+............. .............
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 999999998543321100 00000000000000000000 0000111111236
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 271 QLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 271 ~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+.+++.+||+.||++|||+.++++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 7889999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.02 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=209.7
Q ss_pred CCcceeCHHHHHHHhhccc-cccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcC-CCCCeeeE
Q 047701 11 EKPVRFTSLQLNNFTSNYS-TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRT-YHINLVRL 86 (356)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~ 86 (356)
.....|...+.-+..|.+. +.||+|+||.||+|... +++.||||++.... .......+.+|+.++.++ +||||+++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 3445677777777778876 88999999999999864 69999999987542 223456789999999999 57999999
Q ss_pred eeeEEcCCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CC
Q 047701 87 HGFCHDQHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NF 162 (356)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~ 162 (356)
++++.+....++||||+.+++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++. ++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBC
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999999998543 4679999999999999999999999 99999999999999987 78
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~ 242 (356)
.+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... .
T Consensus 172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~ 240 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------E 240 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H
T ss_pred cEEEeeCccccccCCccc---cccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------H
Confidence 999999999987654332 2335689999999999877 7899999999999999999999987433221 0
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......... ..........++..+.+++.+||+.||.+|||+.++++.
T Consensus 241 ~~~~i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 241 TYLNISQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111111100 011122233456779999999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=331.67 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=205.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
..+|.+.+.||+|+||.||++.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 346788899999999999999874 58899999987542 334567789999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 999999999998843 4579999999999999999999999 999999999999999999999999999998765332
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ..+......
T Consensus 196 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~--------- 256 (335)
T 2owb_A 196 ER--KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKN--------- 256 (335)
T ss_dssp CC--BCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHT---------
T ss_pred cc--ccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHHHHHhcC---------
Confidence 22 2345689999999999877 6899999999999999999999987433211 111111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+...+.++.+++.+||+.||.+||++.++++
T Consensus 257 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 257 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122344567899999999999999999999997
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.01 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=185.0
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|.+.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 577889999999999999986 4799999999964321 1224678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 999999999997777789999999999999999999999 99999999999999999999999999999876533221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.....||+.|+|||++.+. .++.++||||||+++|+|++|..|+......... ... ... .
T Consensus 169 --~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~--------~~~--~ 228 (278)
T 3cok_A 169 --HYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKV--------VLA--D 228 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C--------CSS--C
T ss_pred --ceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHH--------hhc--c
Confidence 1235689999999999877 6899999999999999999999988543322110 000 000 0
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+.++.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1122334567899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=325.46 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=201.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
...|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457888999999999999999875 79999999997542 234556788999999999 999999999999999999999
Q ss_pred EEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC---------------
Q 047701 100 YEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN--------------- 161 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--------------- 161 (356)
|||+++++|.+++... ...+++..++.++.||+.||.|||+ ++++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999643 3679999999999999999999999 999999999999999844
Q ss_pred ----CceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc
Q 047701 162 ----FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD 237 (356)
Q Consensus 162 ----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~ 237 (356)
..+||+|||++....... ...||+.|+|||++.+...++.++||||||+++|+|++|.+++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 479999999998765432 2348999999999987656778999999999999999998764211
Q ss_pred chhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 238 WFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+.... .......+..++.++.+++.+||+.||.+|||+.++++
T Consensus 235 ----~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 ----DQWHEIR---------QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HHHHHHH---------TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hHHHHHH---------cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111 11222333445678999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.99 Aligned_cols=257 Identities=23% Similarity=0.236 Sum_probs=200.1
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
..+|.+.+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++++++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 56888999999999999999976 468899999986431 2345578999999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccC---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 047701 98 LVYEYMENGSLDGYLFGK---------------------------------------KRALEWEKLHEIAIGTAKGLVYL 138 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~~l~~L 138 (356)
+||||+++|+|.+++... ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421 12246788899999999999999
Q ss_pred HhccCCCeeeeccCccceEEcCCC--ceEEeccCCccccCCCCCc--eeecCCCCCCCCCCcccccCC-CCCCCCCceeh
Q 047701 139 HEECQQRIIHYDIKPENVLLDANF--SPKVADFGLAKLCDRNRSH--VTISGYKGTPGYSAPEFLSGN-YPITHKCDVYS 213 (356)
Q Consensus 139 H~~~~~~ivH~Dlkp~Nill~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~s 213 (356)
|+ .+++||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+. ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 99 9999999999999998766 8999999999876432221 123446699999999999752 36889999999
Q ss_pred hhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 047701 214 FGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAV 293 (356)
Q Consensus 214 lG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v 293 (356)
||+++|+|++|+.|+...... .. ......... ..........+.++.+++.+||+.||.+||++.++
T Consensus 262 lG~il~el~~g~~pf~~~~~~------~~-~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA------DT-ISQVLNKKL------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCC------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChH------HH-HHHHHhccc------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999987433221 00 111110000 00112223356789999999999999999999999
Q ss_pred HH
Q 047701 294 VK 295 (356)
Q Consensus 294 ~~ 295 (356)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 88
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=338.72 Aligned_cols=265 Identities=24% Similarity=0.289 Sum_probs=191.8
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCC--eee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQH--MTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~ 97 (356)
-..|.+.+.||+|+||.||+|.+ .+++.||||++.... .......+.+|+.++.++. ||||+++++++...+ ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 34788899999999999999976 469999999986542 3345567889999999997 999999999997544 689
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++.+..
T Consensus 88 lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 9999997 589998854 479999999999999999999999 9999999999999999999999999999987643
Q ss_pred CC-------------------CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc
Q 047701 178 NR-------------------SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW 238 (356)
Q Consensus 178 ~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~ 238 (356)
.. .....+...||+.|+|||++.+...++.++|||||||++|||++|++||........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-- 239 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ-- 239 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 11 111224467999999999998755789999999999999999999998854322110
Q ss_pred hhHHHHHHHh-----------hhchhhhHh---------hcCCCchh-------------HHHHHHHHHHHHhhcCCCCC
Q 047701 239 FPKYVWEEYE-----------KSELGAMIL---------ACGIEEKD-------------KEKAKQLCMVALWCVQDSPA 285 (356)
Q Consensus 239 ~~~~~~~~~~-----------~~~~~~~~~---------~~~~~~~~-------------~~~~~~l~~l~~~cl~~~p~ 285 (356)
+... ..... .......+. ........ ..++.++.+|+.+||..||.
T Consensus 240 ~~~i-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 240 LERI-IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHH-HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHH-HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 0000 00000 000000000 00000000 13356799999999999999
Q ss_pred CCCCHHHHHHH
Q 047701 286 DRPPMSAVVKM 296 (356)
Q Consensus 286 ~Rps~~~v~~~ 296 (356)
+|||+.++++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=344.80 Aligned_cols=254 Identities=21% Similarity=0.233 Sum_probs=203.1
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.++||+|+||.||+|++. +++.||+|++.+.. .......+.+|+.++..++||||+++++++.+....|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46777899999999999999875 68999999996521 1112235788999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||++||+|.+++.. ..+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 149 E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp CCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999999999853 468999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ceeecCCCCCCCCCCcccccCCC---CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNY---PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.......||+.|+|||++.+.. .++.++||||||+++|||++|..||...... ..+....... .
T Consensus 224 -~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~-----~ 290 (410)
T 3v8s_A 224 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHK-----N 290 (410)
T ss_dssp -EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHH-----H
T ss_pred -ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhcc-----c
Confidence 2234567999999999998652 1788999999999999999999998543221 0111111100 0
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPAD--RPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--Rps~~~v~~~ 296 (356)
. .........+.++.+|+.+||..+|.+ ||++++|++.
T Consensus 291 ~-~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 S-LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H-CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c-ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 011112235678999999999999988 9999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=328.41 Aligned_cols=261 Identities=19% Similarity=0.223 Sum_probs=200.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 47888999999999999999864 68999999997543 2234477899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 114 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp ECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999999954 3579999999999999999999999 9999999999999999999999999999986654322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. ......||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ........ .. ..
T Consensus 190 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~-~~------~~ 253 (309)
T 2h34_A 190 T-QLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQ-AI------PR 253 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHS-CC------CC
T ss_pred c-cccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhcc-CC------CC
Confidence 1 12345689999999999877 7899999999999999999999887432110 00011100 00 00
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhhhcccCC
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRP-PMSAVVKMLEGVVEVL 304 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~~~~ 304 (356)
.......++.++.+++.+||+.||.+|| +++++++.|+......
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1122344567799999999999999999 9999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=338.41 Aligned_cols=245 Identities=27% Similarity=0.302 Sum_probs=191.5
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHH-HhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGT-IGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
...|++.+.||+|+||.||+|+.. +++.||||++.+.. .......+..|..+ ++.++||||+++++++.+....|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888899999999999999875 58999999997542 22334556777776 567899999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||++||+|..++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.+|.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999853 4578999999999999999999999 99999999999999999999999999999864332
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. ......||+.|+|||++.+. .++.++|+||||+++|||++|..|+...... ..+.....
T Consensus 193 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~--------- 253 (373)
T 2r5t_A 193 NS--TTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILN--------- 253 (373)
T ss_dssp CC--CCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HHHHHHHH---------
T ss_pred CC--ccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHh---------
Confidence 22 22346799999999999887 7999999999999999999999998533211 11111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMS 291 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~ 291 (356)
. ....+...+.++.+++.+||+.||.+||++.
T Consensus 254 ~-~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 254 K-PLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp S-CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred c-ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1 1112234567799999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=339.83 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=207.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+....|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.++++++||||+++++++.+....++|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 34567888999999999999999874 69999999998766666678899999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 110 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp ECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999954 3569999999999999999999998 6 8999999999999999999999999998755322
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh---------H--------
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP---------K-------- 241 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~---------~-------- 241 (356)
. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+............ .
T Consensus 186 ~----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 M----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp C--------CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred c----ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 1 1235689999999999887 7899999999999999999999998543322110000 0
Q ss_pred ------HHHHHHhhh---chhhhHhhcCCC-chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 242 ------YVWEEYEKS---ELGAMILACGIE-EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 242 ------~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......... .....+...... .....++.++.+++.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000 001111111111 111224667999999999999999999999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=324.11 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=204.5
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--------
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-------- 92 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 92 (356)
-...|.+.+.||+|+||.||+|.+. +++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3567888999999999999999875 79999999997543 246789999999999999999998864
Q ss_pred --------CCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc
Q 047701 93 --------QHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS 163 (356)
Q Consensus 93 --------~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 163 (356)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence 44579999999999999999644 4679999999999999999999999 99999999999999999999
Q ss_pred eEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH
Q 047701 164 PKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV 243 (356)
Q Consensus 164 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~ 243 (356)
+||+|||++......... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+... ...
T Consensus 161 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~ 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET---------SKF 227 (284)
T ss_dssp EEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH
T ss_pred EEECcchhheeccccccc---cccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH
Confidence 999999999876654322 235689999999999877 6899999999999999999998765210 000
Q ss_pred HHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 244 WEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
+.. +.... .....+.++.+++.+||+.||.+||++.++++.|..+...
T Consensus 228 ~~~---------~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 FTD---------LRDGI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHH---------HHTTC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHH---------hhccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111 11111 1123456788999999999999999999999999887543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=338.96 Aligned_cols=266 Identities=17% Similarity=0.172 Sum_probs=205.2
Q ss_pred HHhhccccccCcCCceEEEEEEcCC---------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeee--------
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPN---------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVR-------- 85 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------- 85 (356)
...|.+.+.||+|+||.||+|.+.. ++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4578889999999999999998753 789999998754 35778999999999999887
Q ss_pred -------EeeeEEc-CCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccce
Q 047701 86 -------LHGFCHD-QHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENV 156 (356)
Q Consensus 86 -------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 156 (356)
+++++.. +...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++++||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 6677765 67889999999 89999999654 4679999999999999999999999 9999999999999
Q ss_pred EEcCCC--ceEEeccCCccccCCCCCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccc
Q 047701 157 LLDANF--SPKVADFGLAKLCDRNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAI 229 (356)
Q Consensus 157 ll~~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~ 229 (356)
+++.++ .+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999988 89999999998765432211 11335799999999999887 68999999999999999999999886
Q ss_pred cCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 230 VGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
......... ... ...... ........ .......+.++.+++.+||..||.+||++.+|++.|+.+.....
T Consensus 270 ~~~~~~~~~-~~~-~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTEDI-MKQ-KQKFVD-KPGPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHHHH-HHH-HHHHHH-SCCCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHHHH-HHH-HHhccC-Chhhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 543221110 000 000000 00000000 00011235779999999999999999999999999998876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=323.39 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=204.0
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..|.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 46788899999999999999764 68999999997543 34455778899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc---eEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGla~~~~~~ 178 (356)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++. +||+|||++......
T Consensus 86 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 86 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999888844 3579999999999999999999999 99999999999999976554 999999999876543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ............
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----- 225 (284)
T 3kk8_A 162 EAW---HGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYAQIKAGAYD----- 225 (284)
T ss_dssp CBC---CCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC-----
T ss_pred ccc---cCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchh-------HHHHHHHhcccc-----
Confidence 322 345689999999999877 6899999999999999999999987433221 111111111100
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||+.||.+|||+.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011112345677999999999999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=322.57 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=206.2
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
..+|.+.+.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 456788999999999999999875 58899999987542 334567789999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 999999999998843 4579999999999999999999999 999999999999999999999999999998765332
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ..+......
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~--------- 230 (294)
T 2rku_A 170 ER--KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETYLRIKKN--------- 230 (294)
T ss_dssp CC--BCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT---------
T ss_pred cc--cccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhhc---------
Confidence 22 2335689999999999876 6899999999999999999999987433211 111111110
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+...+..+.+++.+||+.||.+||++.++++.
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 231 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111223445678999999999999999999999973
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=360.11 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=210.7
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcC----CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH 94 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 94 (356)
.++...+|.+.+.||+|+||.||+|.+. .+..||||.+...........+.+|+.++++++||||+++++++.+ +
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C
Confidence 3444567888899999999999999763 2567999998766555666789999999999999999999999865 5
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 6899999999999999997777789999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
....... ......+|+.|+|||++.+. .++.++||||||+++|||++ |..|+...... ...
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----------------~~~ 602 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------DVI 602 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHH
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----------------HHH
Confidence 6543322 12234577899999999877 78999999999999999997 77776322110 111
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..+........+..++..+.+++.+||..||.+||++.+|++.|+.+.+
T Consensus 603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1122222233445567889999999999999999999999999987753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=328.78 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=203.6
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 99 (356)
..|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++.+ +...++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46788899999999999999874 68999999997543 34556778999999999999999999998853 5688999
Q ss_pred EEecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCC-----eeeeccCccceEEcCCCceEEeccCC
Q 047701 100 YEYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQR-----IIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999643 3459999999999999999999999 77 99999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
+......... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... .
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~--------- 223 (279)
T 2w5a_A 163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------E--------- 223 (279)
T ss_dssp HHHC---CHH--HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H---------
T ss_pred heeecccccc--ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------H---------
Confidence 9876543221 1234589999999999877 6899999999999999999999887433211 1
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
+...+........+..++.++.+++.+||+.||.+||++.+|++.+.
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11111122222333456678999999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=333.76 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=187.5
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
.++.+....|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 345566678999999999999999999864 6899999998755444455678899999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 96 TALVYEYMENGSLDGYLFG-------KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~-------~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEe
Confidence 9999999999999999853 34569999999999999999999999 9999999999999999999999999
Q ss_pred cCCccccCCCCCc---eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHH
Q 047701 169 FGLAKLCDRNRSH---VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 169 fGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~ 245 (356)
||++......... .......||+.|+|||++.+...++.++||||||+++|+|++|..|+........ ...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~ 238 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LML 238 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHH
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHH
Confidence 9998876543211 1123356899999999987533589999999999999999999998754332111 000
Q ss_pred HHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 246 EYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... .................+.++.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000 00000000001111234567899999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=347.67 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=194.3
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.++||+|+||.||+|.. .+++.||||++... ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4677889999999999999976 46999999999753 12234456788999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++|+|..++.. ...+++..+..++.||+.||+|||+. .+++||||||+|||++.++.+||+|||+++.......
T Consensus 228 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 228 EYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp CCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999999999843 45799999999999999999999951 6899999999999999999999999999986433222
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
......||+.|+|||++.+. .++.++||||||+++|||++|+.|+...... ...... ...
T Consensus 305 --~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i---------~~~- 364 (446)
T 4ejn_A 305 --TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELI---------LME- 364 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH---------HHC-
T ss_pred --ccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHH---------HhC-
Confidence 22446799999999999877 7999999999999999999999998433221 011111 111
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
....+...+.++.+++.+||+.||.+|| ++.++++
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1122334567899999999999999999 9999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=320.87 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=198.9
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 97 (356)
..|.+.+.||+|+||.||+|.+ .++..||+|.+... ........+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3567788999999999999976 46889999998754 234556788999999999999999999999865 45689
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEc-CCCceEEeccCCccc
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAKL 174 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~DfGla~~ 174 (356)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||||+||+++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999953 3679999999999999999999999 88 99999999999997 788999999999975
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
...... ....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...... ...........
T Consensus 182 ~~~~~~----~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~--- 246 (290)
T 1t4h_A 182 KRASFA----KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGV--- 246 (290)
T ss_dssp CCTTSB----EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTC---
T ss_pred cccccc----ccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHHHHHhccC---
Confidence 543322 23468999999999875 4899999999999999999999987432221 11111111110
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||+.||.+|||+.++++
T Consensus 247 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011122233467999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=341.98 Aligned_cols=259 Identities=22% Similarity=0.250 Sum_probs=193.9
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------Ce
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------HM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 95 (356)
.+|.+.++||+|+||+||+|.+ .+++.||||++.... ......++.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 3577788999999999999976 469999999997542 334456788999999999999999999999765 35
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.|+||||+++ +|...+. ..+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 142 ~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 6999999976 5666663 348999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH----------HHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY----------VWE 245 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~----------~~~ 245 (356)
..... .+...||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +... .+.
T Consensus 215 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~--~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 215 GTSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp --CCC---C----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHT
T ss_pred CCCcc---cCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHH
Confidence 54322 2346799999999999987 799999999999999999999998854321100 0000 000
Q ss_pred HHhhhchhhhHhhc------------------CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 246 EYEKSELGAMILAC------------------GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 246 ~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
... ......+... .........+.++.+|+.+||..||.+|||++++++.
T Consensus 289 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Hcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000000 0011122346789999999999999999999999983
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=322.38 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=199.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 46788899999999999999764 58899999986532 1123467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 89 e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 89 EYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 99999999999854 3569999999999999999999999 999999999999999999999999999986544322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
.....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ........ .
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~----------~ 222 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISR----------V 222 (279)
T ss_dssp -------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHH----------T
T ss_pred ---ccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHH-------HHHHHHHh----------C
Confidence 2335689999999999877 6899999999999999999999987432211 11111111 1
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+...+..+.+++.+||+.||.+||++.++++.
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 112233356678999999999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=325.94 Aligned_cols=254 Identities=22% Similarity=0.274 Sum_probs=189.6
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHH-HHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEE-QFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
+....|++.++||+|+||+||+|.+ .+++.||||++.......... .+..+...++.++||||+++++++.+....++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3456788899999999999999986 479999999997654333333 34455556788899999999999999999999
Q ss_pred EEEecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 99 VYEYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
||||+++ +|.+++.. ....+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999975 88877743 46789999999999999999999999 7 999999999999999999999999999987
Q ss_pred cCCCCCceeecCCCCCCCCCCccccc---CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
....... ....||+.|+|||++. ....++.++||||||+++|+|++|+.|+....... . .
T Consensus 160 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~--------~ 222 (290)
T 3fme_A 160 LVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------Q--------Q 222 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------H--------H
T ss_pred ccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------H--------H
Confidence 6543322 2246899999999973 23368899999999999999999999874322210 0 0
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.................+.++.+++.+||+.||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111111111222345678999999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=331.41 Aligned_cols=265 Identities=23% Similarity=0.258 Sum_probs=199.8
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchh----HHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKI----AEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
..+|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++++++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 457888999999999999999875 58999999987532211 1246789999999999999999999999999999
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+++ +|..++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999976 8999997777789999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh---chh-
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS---ELG- 253 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 253 (356)
.... .....||+.|+|||++.+...++.++||||||+++|+|++|.+|+........ + ...+...... ...
T Consensus 165 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~-~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 165 PNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSSS
T ss_pred Cccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHHcCCCChhhhhh
Confidence 3222 23456899999999997764689999999999999999999887643322100 0 0001110000 000
Q ss_pred -----hhHhhcCCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 254 -----AMILACGIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 254 -----~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......... ......+.++.+++.+||..||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000 0112345789999999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=333.31 Aligned_cols=266 Identities=23% Similarity=0.293 Sum_probs=200.3
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 36777889999999999999874 59999999986543 33445668899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|..++ .....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 105 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp CCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99998888876 345679999999999999999999999 99999999999999999999999999999866543221
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch--------hHHHHHHHhhhchh
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF--------PKYVWEEYEKSELG 253 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 253 (356)
.....||+.|+|||++.+...++.++||||||+++|+|++|+.|+........... .......+......
T Consensus 181 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 181 --YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred --cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23456899999999998765689999999999999999999988754432211000 00000001110000
Q ss_pred hhH------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMI------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... .........+.++.++.+++.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000111235678999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=328.11 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=201.1
Q ss_pred HHHhhccccccCcCCceEEEEEEcC--CCc--EEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP--NGV--KIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
....|++.+.||+|+||+||+|.+. +++ .||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 4567889999999999999999752 333 68999987542 2345578899999999999999999999998765
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+.+++|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 789999999999999997666789999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 176 DRNRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 176 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
........ .....+|..|+|||++.+. .++.++||||||+++|+|++ |..|+...... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~-------- 235 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILH-------- 235 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH--------
T ss_pred cccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------HHHH--------
Confidence 65443322 2334578889999999876 68999999999999999999 88876432211 0011
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
...........+..++.++.+++.+||..||.+||++.++++.|.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 236 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111222334566789999999999999999999999999987753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=329.41 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=196.4
Q ss_pred HHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc----hhHHHHHHHHHHHHhcC---CCCCeeeEeeeEE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG----KIAEEQFMAEVGTIGRT---YHINLVRLHGFCH 91 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~ 91 (356)
++...+|++.++||+|+||+||+|.+ .+++.||||++..... ......+.+|+.+++++ +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45567899999999999999999986 4689999999864321 11123456677776665 5999999999998
Q ss_pred cCC-----eeeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceE
Q 047701 92 DQH-----MTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPK 165 (356)
Q Consensus 92 ~~~-----~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 165 (356)
... ..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 755 5789999996 59999996554 349999999999999999999999 9999999999999999999999
Q ss_pred EeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHH
Q 047701 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~ 245 (356)
|+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+........ . .....
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~i~~ 233 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--L-GKIFD 233 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--H-HHHHH
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHH
Confidence 999999987654332 2345689999999999877 689999999999999999999998754322110 0 00000
Q ss_pred HHhhh---ch------hhhHhh-c---CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 246 EYEKS---EL------GAMILA-C---GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 246 ~~~~~---~~------~~~~~~-~---~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... .. ...... . ......+..+.++.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 00 000000 0 000111234577899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=321.33 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=204.5
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-----hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-----KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
...|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999875 699999999875421 12357789999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC----ceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla 172 (356)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999953 4579999999999999999999999 9999999999999998776 8999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ...........
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQ-------ETLTNISAVNY 228 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTTCC
T ss_pred eeccCCCc---ccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------HHHHHhHhccc
Confidence 87654332 2334689999999999877 6899999999999999999999887433211 11111111000
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--Hhhhc
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK--MLEGV 300 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~ 300 (356)
..........+..+.+++.+||..||.+||++.++++ .+..+
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 229 ------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp ------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 0011122334577999999999999999999999998 44444
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=348.33 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=206.4
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||.||+|... +|+.||||++.+.. .......+.+|+.++++++||||+++++++.+....|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 45777889999999999999864 69999999996531 1233456889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 101 EYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||++||+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+++......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999986543 459999999999999999999999 999999999999999999999999999998765443
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. .....||+.|+|||++.+. .++.++|||||||++|||++|..|+......... .... ..+...
T Consensus 341 ~---~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~---------~~i~~~ 404 (576)
T 2acx_A 341 T---IKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVE---------RLVKEV 404 (576)
T ss_dssp C---EECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHH---------HHHHHC
T ss_pred c---ccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHH---------HHhhcc
Confidence 2 2345799999999999887 6899999999999999999999998654332110 0111 111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
....+...+.++.+++.+||..||.+|| ++.+|++
T Consensus 405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1122344567899999999999999999 7788876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=332.39 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=190.7
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEE-----
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCH----- 91 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~----- 91 (356)
+++...+|++.++||+|+||.||+|.+ .+++.||||++... .......+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 345566888999999999999999986 46899999998654 3345567899999999995 999999999994
Q ss_pred ---cCCeeeEEEEecCCCCHhHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEcCCCce
Q 047701 92 ---DQHMTALVYEYMENGSLDGYLFG--KKRALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 92 ---~~~~~~lv~e~~~~~sL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~ 164 (356)
.....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+ .+ ++||||||+|||++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCE
Confidence 3445789999996 699988854 45679999999999999999999999 88 9999999999999999999
Q ss_pred EEeccCCccccCCCCCce----------eecCCCCCCCCCCccccc--CCCCCCCCCceehhhHHHHHHhcCCCccccCC
Q 047701 165 KVADFGLAKLCDRNRSHV----------TISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGA 232 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~ 232 (356)
||+|||+++......... ......||+.|+|||++. ....++.++||||||+++|+|++|..|+....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765432211 111345899999999983 22368899999999999999999999874322
Q ss_pred CccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 233 SESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
... ..............+..+.+++.+||+.||.+||++.++++.|..+...
T Consensus 258 ~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 258 KLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 110 0000011111222334588999999999999999999999999988654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=333.37 Aligned_cols=269 Identities=21% Similarity=0.262 Sum_probs=202.5
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--------C
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--------Q 93 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 93 (356)
.+|.+.++||+|+||.||+|.+ .+++.||||++..... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4788899999999999999987 5799999999865432 2334567899999999999999999999987 4
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
+..++||||+++ +|.+.+......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999975 8888887777789999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH--------
Q 047701 174 LCDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV-------- 243 (356)
Q Consensus 174 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~-------- 243 (356)
........ .......||+.|+|||++.+...++.++||||||+++|+|++|..|+...............
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 76533222 22344678999999999987656899999999999999999999887543321110000000
Q ss_pred HHHHhhhchhhhHh--hcCCCchhH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 244 WEEYEKSELGAMIL--ACGIEEKDK-----EKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 244 ~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
|............. ......... ..+..+.+|+.+||+.||.+|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000000 000000000 114568999999999999999999999973
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.30 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=202.3
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEc--CCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHD--QHMTAL 98 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l 98 (356)
...|.+.++||+|+||.||+|.+ .+++.||||++... ....+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 35688889999999999999975 57999999999753 3456889999999996 9999999999988 667899
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~ 177 (356)
||||+.+++|..++. .+++..+..++.|++.||+|||+ .+++||||||+|||++.++ .+||+|||+++....
T Consensus 111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999999883 48999999999999999999999 9999999999999999776 899999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... ....||..|+|||++.+...++.++||||||+++|+|++|+.|+..+........ ..............+.
T Consensus 184 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~--~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 184 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV--RIAKVLGTEDLYDYID 258 (330)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH--HHHHHHCHHHHHHHHH
T ss_pred CCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH--HHHHhcCCchhhhHHH
Confidence 4322 3356899999999998754789999999999999999999999865444321110 0001111111111111
Q ss_pred hcC-----------------------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACG-----------------------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~-----------------------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... ........+.++.+++.+||+.||.+|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 100 01112225678999999999999999999999997
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.88 Aligned_cols=265 Identities=20% Similarity=0.244 Sum_probs=193.7
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..-.+|.+.++||+|+||+||+|.+ .+++.||||++..... ......+.+|+.++++++||||+++++++.++...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3445788899999999999999975 4799999999975432 2334567899999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-----CCCceEEeccCCcc
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-----ANFSPKVADFGLAK 173 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~~kl~DfGla~ 173 (356)
||||+++ +|.+++.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++ ..+.+||+|||+++
T Consensus 111 v~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999975 99999854 4569999999999999999999999 9999999999999994 45569999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh---h
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK---S 250 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~---~ 250 (356)
........ .....||+.|+|||++.+...++.++||||||+++|+|++|..|+........ ... ....... .
T Consensus 186 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~ 260 (329)
T 3gbz_A 186 AFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFK-IFEVLGLPDDT 260 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTT
T ss_pred ccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHH-HHHHhCCCchh
Confidence 76533222 23356899999999998765689999999999999999999998754322110 000 0000000 0
Q ss_pred chhhhH--------hhcCCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 ELGAMI--------LACGIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 ~~~~~~--------~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...... ...... ......+.++.+++.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 000000 001114567899999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.88 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=200.3
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCch------------hHHHHHHHHHHHHhcCCCCCeeeEeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGK------------IAEEQFMAEVGTIGRTYHINLVRLHGF 89 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 89 (356)
...|.+.++||+|+||+||+|... +++.||||++...... .....+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 456888899999999999999864 6899999999754211 234678899999999999999999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC---ceEE
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF---SPKV 166 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl 166 (356)
+.+....++|||||.+|+|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 9999999999999999999998854 3579999999999999999999999 9999999999999998765 6999
Q ss_pred eccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH
Q 047701 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 167 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...... .....
T Consensus 191 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-------DIIKK 258 (504)
T ss_dssp CCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH
T ss_pred EECCCCEEcCCCCc---cccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence 99999987664432 234569999999999875 4899999999999999999999998543221 11111
Q ss_pred HhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....... .........+.++.+++.+||..||.+|||+.++++
T Consensus 259 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111100 000111234678999999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.29 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=187.9
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhc-CCCCCeeeEeeeEEc----CCeeeEEEEec
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHGFCHD----QHMTALVYEYM 103 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e~~ 103 (356)
+.||+|+||+||+|.+. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....||||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 67999999999999764 6899999998642 246678887744 589999999999875 56789999999
Q ss_pred CCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCccccCCCC
Q 047701 104 ENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 104 ~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~~~~~~~ 179 (356)
++|+|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999996553 469999999999999999999999 99999999999999987 7899999999998665332
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ..........
T Consensus 219 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~------ 285 (400)
T 1nxk_A 219 S---LTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE------ 285 (400)
T ss_dssp -----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCC------
T ss_pred c---cccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCccc------
Confidence 2 2345689999999999876 7999999999999999999999998654432211000 0011110000
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........++.++.+++.+||..||.+|||+.++++.
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011113456789999999999999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=344.56 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=199.6
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
...|.+.++||+|+||+||+|... ++..||||++.... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999874 68999999997542 2233567899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~~~~~ 177 (356)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++. ++.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999998843 3569999999999999999999999 99999999999999975 45599999999987764
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...... ............
T Consensus 192 ~~~---~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~---- 255 (494)
T 3lij_A 192 QKK---MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYT---- 255 (494)
T ss_dssp TBC---BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCC----
T ss_pred Ccc---ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC----
Confidence 432 234569999999999874 4899999999999999999999998543221 111111111100
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||+.||.+|||+.++++
T Consensus 256 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 --FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 011122345678999999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=330.03 Aligned_cols=251 Identities=19% Similarity=0.285 Sum_probs=199.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 100 (356)
...|.+.+.||+|+||.||+|... +++.||||++.+... ...+|++++.++ +||||+++++++.++...|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888999999999999999864 689999999976432 234678888887 7999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC----CceEEeccCCccccC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAKLCD 176 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~~~~ 176 (356)
||++||+|.+++. ..+.+++..+..++.||+.||.|||+ ++++||||||+|||+.+. +.+||+|||+++...
T Consensus 96 E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999985 44679999999999999999999999 999999999999998433 359999999998765
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||........ .............
T Consensus 172 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~i~~~~~~--- 241 (342)
T 2qr7_A 172 AENGL--LMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP----EEILARIGSGKFS--- 241 (342)
T ss_dssp CTTCC--BCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH----HHHHHHHHHCCCC---
T ss_pred CCCCc--eeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH----HHHHHHHccCCcc---
Confidence 44322 2345689999999999876 588999999999999999999999864322211 1111111111110
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........+.++.+++.+||..||.+||++.++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011122345678999999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.71 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=205.0
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|.+.+.||+|+||.||+|++. +|+.||||++.+.. .......+..|+.++++++||||+++++++.+....|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 35666788999999999999874 69999999997532 1133467889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFGK---KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
||++||+|..++... ...+++..+..++.||+.||.|||+ ++++||||||+|||++.+|.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998654 3479999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|..||......... ...... +.
T Consensus 342 ~~~~--~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~---~~~~~~---------i~ 406 (543)
T 3c4z_A 342 GQTK--TKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQR---------VL 406 (543)
T ss_dssp TCCC--BCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH---HHHHHH---------HH
T ss_pred CCcc--cccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhH---HHHHHH---------Hh
Confidence 4322 2345799999999999887 7999999999999999999999998654322110 001111 11
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPM-----SAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~ 295 (356)
.. ....+...+.++.+++.+||..||.+||++ ++|++
T Consensus 407 ~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 EQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11 112234556789999999999999999975 66664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=344.46 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=203.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..+|++.++||+|+||+||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 567999999999999999999864 79999999986431 2234567899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc---CCCceEEeccCCccccCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~~~ 177 (356)
||+.+++|.+.+.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999998854 3579999999999999999999999 9999999999999994 456799999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... .....||+.|+|||++.+. ++.++||||||+++|+|++|..|+...... ...........
T Consensus 177 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~----- 239 (486)
T 3mwu_A 177 NTK---MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKY----- 239 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC-----
T ss_pred CCc---cCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC-----
Confidence 322 2345699999999999864 899999999999999999999998543221 11111111110
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+.....+.++.+++.+||..||.+|||+.++++.
T Consensus 240 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 -AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112233456789999999999999999999999983
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=328.39 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=201.8
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCC
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQH 94 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 94 (356)
..|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 46777899999999999999875 699999999875431 12245678899999999 7999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 99999999999999999953 4579999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccCC-----CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSGN-----YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
...... .....||+.|+|||++.+. ..++.++||||||+++|+|++|..|+...... .....
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~~~--- 316 (365)
T 2y7j_A 250 LEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------LMLRM--- 316 (365)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH---
T ss_pred cCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------HHHHH---
Confidence 664432 2345699999999998632 25788999999999999999999987432211 00111
Q ss_pred hchhhhHhhcCCCc---hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SELGAMILACGIEE---KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+....... .....+..+.+++.+||+.||.+||++.++++
T Consensus 317 ------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 ------IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ------HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111110 11234567999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.75 Aligned_cols=255 Identities=22% Similarity=0.255 Sum_probs=192.5
Q ss_pred HHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
....|.+.+.||+|+||+||+|.+ .+++.||||++..... ......+.+|+.++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 355788899999999999999976 4689999999875321 1122347899999999999999999999865
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC---CceEEeccC
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFG 170 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfG 170 (356)
+..++||||+.+++|.+++. ....+++..+..++.|++.||+|||+ ++++||||||+|||++.+ +.+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 45789999999999999884 45679999999999999999999999 999999999999999654 459999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
+++....... .....||+.|+|||++.+ ...++.++||||||+++|+|++|..|+........ . .....
T Consensus 288 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~i~ 358 (419)
T 3i6u_A 288 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQIT 358 (419)
T ss_dssp TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHHHH
T ss_pred cceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHHHh
Confidence 9987654322 234569999999999863 23678899999999999999999999854322211 0 01111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..... .........+.++.+++.+||+.||.+||++.++++.
T Consensus 359 ~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 SGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11000 0111122346789999999999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.40 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=203.0
Q ss_pred HhhccccccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 95 (356)
..|.+.+.||+|+||.||+|+. .+++.||||++.... .......+.+|+.+++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788889999999999999976 368999999987432 112334567799999999 79999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999954 3579999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
...... ......||+.|+|||++.+. ..++.++||||||+++|+|++|..|+......... ... ..
T Consensus 210 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~-~~--------- 276 (355)
T 1vzo_A 210 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEI-SR--------- 276 (355)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHH-HH---------
T ss_pred ccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHH-HH---------
Confidence 433222 12335699999999999863 24788999999999999999999998654332211 000 00
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHh
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVKML 297 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~~L 297 (356)
.+.. .....+...+..+.+++.+||..||.+|| ++.++++..
T Consensus 277 ~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 RILK-SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHhc-cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0011 11223344567789999999999999999 899998743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=326.95 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=196.6
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------e
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------M 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 95 (356)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.++++++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4678889999999999999986 469999999996543 3344567899999999999999999999998753 4
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 59999999 7799999854 569999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~ 247 (356)
... .....||+.|+|||++.+...++.++|||||||++|||++|+.|+........- ..+...+...
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 532 234568999999999987547999999999999999999999988543221100 0000000000
Q ss_pred hhhchhhhHhhc------CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 248 EKSELGAMILAC------GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 248 ~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.......++... .........+.++.+|+.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 011111111100 011122344678999999999999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=345.93 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=206.4
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
-...|.+.++||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567889999999999999999875 79999999986542 23456779999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCcccc
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLC 175 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~ 175 (356)
||||+.+++|.+++. ....+++..+..++.||+.||.|||+ ++++||||||+|||+ +.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999885 44679999999999999999999999 999999999999999 56789999999999877
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... ....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...... ............
T Consensus 180 ~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~-- 245 (484)
T 3nyv_A 180 EASKKM---KDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYT-- 245 (484)
T ss_dssp CCCCSH---HHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC--
T ss_pred cccccc---ccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCC--
Confidence 654322 23568999999999976 4899999999999999999999998543221 111111111100
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+.....+.++.+++.+||+.||.+|||+.++++
T Consensus 246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 011222345678999999999999999999999997
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.50 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=200.6
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
....|.+.+.||+|+||.||+|.+. +|+.||||.+.... ....+.+|+.++++++||||+++++++......++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3456788899999999999999874 59999999997542 3356889999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999997667789999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... .. ....... ...
T Consensus 181 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~~~~~-------~~~ 243 (314)
T 3com_A 181 K--RNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPM------RA-IFMIPTN-------PPP 243 (314)
T ss_dssp C--BCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-HHHHHHS-------CCC
T ss_pred c--cCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChH------HH-HHHHhcC-------CCc
Confidence 1 2335689999999999877 6899999999999999999999887432211 00 0000000 000
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+..++..+.+++.+||..||.+||++.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11123345678999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=319.12 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=194.5
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD---------- 92 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 92 (356)
..|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4688889999999999999986 47999999999653 3455778999999999999999999998865
Q ss_pred ---CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEecc
Q 047701 93 ---QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADF 169 (356)
Q Consensus 93 ---~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 169 (356)
....++||||+++++|.+++......+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 456799999999999999997777788999999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCC------------ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc
Q 047701 170 GLAKLCDRNRS------------HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD 237 (356)
Q Consensus 170 Gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~ 237 (356)
|++........ ........||+.|+|||++.+...++.++||||||+++|+|+++-.+ ..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~---~~----- 232 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST---GM----- 232 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSS---HH-----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCC---ch-----
Confidence 99987653211 11123456899999999998765689999999999999999983211 00
Q ss_pred chhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 238 WFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............ ............+..+.+++.+||+.||.+|||+.++++
T Consensus 233 -~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 000001111100 000111223345567899999999999999999999997
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=329.74 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=203.6
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Ceee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 97 (356)
.+|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++.+++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 47888999999999999999764 68899999998655555567889999999999999999999999765 3679
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+.+ +|.+++.. ..+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 107 iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999975 99998843 469999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCce-eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch--------hHHHHHHHh
Q 047701 178 NRSHV-TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF--------PKYVWEEYE 248 (356)
Q Consensus 178 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~--------~~~~~~~~~ 248 (356)
..... ......||+.|+|||++.+...++.++||||||+++|+|++|+.|+........... ....+....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 32221 123457999999999976654689999999999999999999988854432211000 000000000
Q ss_pred hhchhhhHhhcCC------CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 KSELGAMILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............. .......+.++.+++.+||..||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 0111234577999999999999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=319.55 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=196.4
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
...|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 346888999999999999999875 69999999986532 123345788999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999543 568999999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. .....||+.|+|||++.+....+.++||||||+++|+|++|..|+..... ......... .
T Consensus 166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~---------~ 226 (276)
T 2h6d_A 166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRG---------G 226 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHH---------C
T ss_pred c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhc---------C
Confidence 2 12346899999999998764447899999999999999999988743211 111111111 1
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 227 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 -VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111223345678999999999999999999999983
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=319.14 Aligned_cols=252 Identities=23% Similarity=0.249 Sum_probs=200.6
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC---chhHHHHHHHHHHHHhcCCCCCeeeEeeeEE--cCCeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRTYHINLVRLHGFCH--DQHMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 97 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 36888999999999999999874 68999999997532 1234567899999999999999999999984 456789
Q ss_pred EEEEecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+||||+.++ |.+++.. ....+++..+..++.||+.||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999875 7676644 35679999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCC-CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
............||+.|+|||++.+.. ..+.++||||||+++|+|++|..|+...... ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~------ 227 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGK------ 227 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHH------
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhc------
Confidence 444333444567999999999997642 2477999999999999999999987533211 11111111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
. ....+..++..+.+++.+||+.||.+||++.++++.
T Consensus 228 ---~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 ---G-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---C-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---C-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 112233456778999999999999999999999973
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.37 Aligned_cols=247 Identities=24% Similarity=0.292 Sum_probs=203.4
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
-..|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 356888899999999999999864 68899999986432 112346788999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999998543 569999999999999999999999 999999999999999999999999999987654322
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....|++.|+|||++.+. .++.++||||||+++|+|++|..|+...... ........
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~---------- 226 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHRRIVN---------- 226 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHT----------
T ss_pred ----cccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHHHHhc----------
Confidence 1235689999999999877 6899999999999999999999987433211 00111111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....+...+.++.+++.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 227 VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 011223345677899999999999999999999997
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=321.13 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=201.4
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 457888999999999999999864 699999999975422 334568899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE---cCCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL---DANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~DfGla~~~~~~ 178 (356)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999998843 3568999999999999999999999 999999999999999 77889999999998754432
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
. .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+...... ...........
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~------ 224 (304)
T 2jam_A 163 I----MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETES-------KLFEKIKEGYY------ 224 (304)
T ss_dssp T----THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHCCC------
T ss_pred c----cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCC------
Confidence 1 1224589999999999877 7899999999999999999999987433211 11111111100
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+.++.+++.+||..||.+||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011122345678999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.46 Aligned_cols=253 Identities=10% Similarity=0.006 Sum_probs=182.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHH---HHHhcCCCCCeeeEe-------eeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEV---GTIGRTYHINLVRLH-------GFCH 91 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~ 91 (356)
+|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+ ..++. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 4777889999999999999864 79999999998653 234445677774 45555 799988755 4443
Q ss_pred cC-----------------CeeeEEEEecCCCCHhHHhccCCCCCCHHHH------HHHHHHHHHHHHHHHhccCCCeee
Q 047701 92 DQ-----------------HMTALVYEYMENGSLDGYLFGKKRALEWEKL------HEIAIGTAKGLVYLHEECQQRIIH 148 (356)
Q Consensus 92 ~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~~~~ivH 148 (356)
.. ...++||||++ ++|.+++...+..+.+..+ ..++.||+.||+|||+ ++++|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 32 33799999998 7999999765555666666 7888999999999999 99999
Q ss_pred eccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCc
Q 047701 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRN 227 (356)
Q Consensus 149 ~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~ 227 (356)
|||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+. ..++.++||||||+++|+|++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998664321 134577999999999761 2689999999999999999999999
Q ss_pred cccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 228 AIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+........... ....................++.++.+++.+||+.||++||++.++++
T Consensus 293 f~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 865533211100 000000000001111112345678999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.84 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=201.6
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC--------CCCeeeEeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--------HINLVRLHGFCH 91 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~ 91 (356)
+...+|.+.++||+|+||+||+|.. .+++.||||++... ......+.+|+.++++++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3356788999999999999999975 46899999999753 344567889999999885 788999999998
Q ss_pred ----cCCeeeEEEEecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCC---
Q 047701 92 ----DQHMTALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANF--- 162 (356)
Q Consensus 92 ----~~~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~--- 162 (356)
+....++||||+. ++|.+++.. ....+++..+..++.||+.||.|||+ + +++||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhh
Confidence 5668899999995 466555544 34679999999999999999999999 8 999999999999998765
Q ss_pred ----------------------------------------------ceEEeccCCccccCCCCCceeecCCCCCCCCCCc
Q 047701 163 ----------------------------------------------SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196 (356)
Q Consensus 163 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 196 (356)
.+||+|||++...... .....||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999876533 2335689999999
Q ss_pred ccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH---HHHh--------hhchh------------
Q 047701 197 EFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW---EEYE--------KSELG------------ 253 (356)
Q Consensus 197 E~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~---~~~~--------~~~~~------------ 253 (356)
|++.+. .++.++|||||||++|+|++|+.|+................ .... .....
T Consensus 263 E~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 263 EVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred hhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999887 68999999999999999999999986544332211000000 0000 00000
Q ss_pred ----------hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 ----------AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... ........+..+.+|+.+||+.||.+|||+.++++
T Consensus 342 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000 11234567788999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.38 Aligned_cols=240 Identities=16% Similarity=0.133 Sum_probs=187.2
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEeccc--CchhHHHHHHHHH---HHHhcCCCCCeeeEe-------eeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEV---GTIGRTYHINLVRLH-------GFCH 91 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~~ 91 (356)
.|.+.+.||+|+||+||+|.+ .+|+.||||++... ........+.+|+ +.+++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 466678999999999999986 46999999999743 2334557788999 555566899999998 6665
Q ss_pred cCC-----------------eeeEEEEecCCCCHhHHhccCC------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 047701 92 DQH-----------------MTALVYEYMENGSLDGYLFGKK------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148 (356)
Q Consensus 92 ~~~-----------------~~~lv~e~~~~~sL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH 148 (356)
+.+ ..|+||||+ +|+|.+++.... ..+++..++.++.||+.||+|||+ ++++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 543 278999999 679999996432 234468899999999999999999 99999
Q ss_pred eccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCC----------CCCCCCCceehhhHHH
Q 047701 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVS 218 (356)
Q Consensus 149 ~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slG~il 218 (356)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. ..++.++||||||+++
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999985332 2234567 999999998764 2589999999999999
Q ss_pred HHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 219 FEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 219 ~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
|||++|+.|+........ ...+.. ....++.++.+++.+||+.||.+||++.++++
T Consensus 304 ~elltg~~Pf~~~~~~~~----------------~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALGG----------------SEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------CC----------------SGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCcccccccc----------------hhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999998743322111 111111 11234567999999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=334.82 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=203.6
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
..+++....|.+.+.||+|+||.||+|.+.. .+|+|++.... .......+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 4455556678889999999999999998743 49999987432 22233457789999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+++++|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++ ++.+||+|||+++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999997766789999999999999999999999 9999999999999998 679999999998765
Q ss_pred CCCCCc---eeecCCCCCCCCCCcccccC--------CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH
Q 047701 176 DRNRSH---VTISGYKGTPGYSAPEFLSG--------NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW 244 (356)
Q Consensus 176 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~ 244 (356)
...... .......||+.|+|||++.+ ...++.++||||||+++|+|++|..|+...... ...
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~ 252 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-------AII 252 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-------HHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 422111 11233458999999999875 225788999999999999999999887433221 001
Q ss_pred HHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 245 EEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
...... .........++.++.+++.+||..||.+||++.++++.|+.+...
T Consensus 253 ~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 253 WQMGTG--------MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHTT--------CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHhccC--------CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111110 000111123456789999999999999999999999999988654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.46 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=199.9
Q ss_pred HHHhhcccc-----ccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 22 NNFTSNYST-----RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 22 ~~~~~~~~~-----~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
....|.+.+ .||+|+||.||+|.+ .+++.||||.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 334455544 899999999999986 468999999987643 2445678999999999999999999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCc
Q 047701 96 TALVYEYMENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLA 172 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla 172 (356)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 999999999999999996553 356799999999999999999999 99999999999999987 889999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
......... .....||+.|+|||++.+. ..++.++||||||+++|+|++|..|+........ ....
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~------ 237 (295)
T 2clq_A 171 KRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFK------ 237 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHH------
T ss_pred cccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHh------
Confidence 876543221 2345689999999998754 1378899999999999999999998743222100 0000
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+...+.++.+++.+||+.||++||++.++++
T Consensus 238 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 238 ---VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111122334456678999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=325.95 Aligned_cols=260 Identities=20% Similarity=0.200 Sum_probs=192.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------e
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------M 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 95 (356)
..|.+.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4678889999999999999976 468999999997542 3345567889999999999999999999997654 6
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+++ +|.+++. ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred eEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 7999999975 7888874 358999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--------chhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--------WFPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--------~~~~~~~~~~ 247 (356)
.... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+......... ......+...
T Consensus 178 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 178 GTSF---MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccc---ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 5332 12345689999999999887 7899999999999999999999988543221000 0000000000
Q ss_pred hhhchhhhHhh------------------cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 248 EKSELGAMILA------------------CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 248 ~~~~~~~~~~~------------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ......... ..........+.++.+|+.+||..||.+|||++++++
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 Q-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp C-HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h-hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 000000000 0011123345778999999999999999999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=353.04 Aligned_cols=248 Identities=24% Similarity=0.301 Sum_probs=203.8
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
..|++.++||+|+||.||+|.+. +++.||||++.+.. .......+..|..++..+ +||||+.+++++.+.+.+|||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 35777889999999999999864 68899999997532 223345678899999988 799999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||+++|+|..++... +.+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 421 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999999543 579999999999999999999999 999999999999999999999999999998644332
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. ......||+.|+|||++.+. .++.++||||||+++|||++|..||...... ..+.. +...
T Consensus 497 ~--~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-------~~~~~---------i~~~ 557 (674)
T 3pfq_A 497 V--TTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQS---------IMEH 557 (674)
T ss_dssp C--CBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHH---------HHSS
T ss_pred c--ccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHH-------HHHHH---------HHhC
Confidence 2 23446799999999999877 7999999999999999999999998543221 11111 1111
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPM-----SAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~-----~~v~~ 295 (356)
....+...+.++.+|+.+||+.||.+||++ .+|++
T Consensus 558 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122334567889999999999999999998 67765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=327.65 Aligned_cols=264 Identities=18% Similarity=0.211 Sum_probs=195.9
Q ss_pred HHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCc----------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEE
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG----------KIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 91 (356)
....|.+.+.||+|+||.||+|...+++.||||++..... ......+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3457888999999999999999988899999999864321 122367899999999999999999999985
Q ss_pred c-----CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEE
Q 047701 92 D-----QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKV 166 (356)
Q Consensus 92 ~-----~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 166 (356)
. ....++||||+. |+|.+++......+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 4 346799999997 58888887777789999999999999999999999 99999999999999999999999
Q ss_pred eccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHH
Q 047701 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246 (356)
Q Consensus 167 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~ 246 (356)
+|||++........ .....||+.|+|||++.+...++.++||||||+++|+|++|+.|+........ . ......
T Consensus 176 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~ 249 (362)
T 3pg1_A 176 CDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ--L-NKIVEV 249 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHH
T ss_pred EecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHH
Confidence 99999975443322 23356899999999998754789999999999999999999998854322110 0 000000
Q ss_pred Hh-----------hhchhhhHhhcC-------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 247 YE-----------KSELGAMILACG-------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 247 ~~-----------~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. ............ ........+..+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00 000000000000 00112233567999999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=334.78 Aligned_cols=265 Identities=18% Similarity=0.256 Sum_probs=182.3
Q ss_pred hhcc-ccccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeE
Q 047701 25 TSNY-STRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTAL 98 (356)
Q Consensus 25 ~~~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 98 (356)
.|.+ +++||+|+||+||+|.+. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 4555 568999999999999864 58899999997542 22457889999999999999999999954 678899
Q ss_pred EEEecCCCCHhHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE----cCCCceEE
Q 047701 99 VYEYMENGSLDGYLFGK--------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL----DANFSPKV 166 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl 166 (356)
||||+.+ +|.+++... ...+++..+..++.||+.||.|||+ .+++||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999965 887777421 2359999999999999999999999 999999999999999 67789999
Q ss_pred eccCCccccCCCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc---chhHH
Q 047701 167 ADFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD---WFPKY 242 (356)
Q Consensus 167 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~---~~~~~ 242 (356)
+|||+++........ .......||+.|+|||++.+...++.++|||||||++|+|++|..||......... .....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876543221 22344679999999999987646899999999999999999999998644332100 00000
Q ss_pred ---HHHHH-----------hhhc-hhhhHhhcC----CC-ch-------hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 243 ---VWEEY-----------EKSE-LGAMILACG----IE-EK-------DKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 243 ---~~~~~-----------~~~~-~~~~~~~~~----~~-~~-------~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..... .... ......... .. .. ....+.++.+|+.+||..||.+|||+.++++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000 000000000 00 00 0001456889999999999999999999998
Q ss_pred H
Q 047701 296 M 296 (356)
Q Consensus 296 ~ 296 (356)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.77 Aligned_cols=254 Identities=23% Similarity=0.272 Sum_probs=197.5
Q ss_pred HHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 22 NNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 22 ~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
....|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3567899999999999999999764 689999999875321 12234578999999999999999999999876
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc---eEEeccC
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFG 170 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfG 170 (356)
. .++||||+++++|.+++. ....+++..+..++.||+.||.|||+ ++++||||||+||+++.++. +||+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 799999999999999884 45679999999999999999999999 99999999999999986654 9999999
Q ss_pred CccccCCCCCceeecCCCCCCCCCCccccc--CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLS--GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
++........ .....||+.|+|||++. +...++.++||||||+++|+|++|..|+........ +. ....
T Consensus 163 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~ 233 (322)
T 2ycf_A 163 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQIT 233 (322)
T ss_dssp TCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHH
T ss_pred cceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHH
Confidence 9987653321 12345899999999974 233688999999999999999999999854333211 00 0111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... ..........+.++.+++.+||..||.+||++.++++
T Consensus 234 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 0011112334678999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=321.47 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=200.3
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCC--CCCeeeEeeeEEc
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTY--HINLVRLHGFCHD 92 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~ 92 (356)
+...++....|.+.+.||+|+||.||+|.+.+++.||||++... ........+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34444556678889999999999999999888999999999754 23455678899999999996 5999999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
....++|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||++++ +.+||+|||++
T Consensus 100 ~~~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 100 DQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp SSEEEEEECC-CSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred CCEEEEEEec-CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999994 57799999954 4578999999999999999999999 99999999999999965 79999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCC----------CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGN----------YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~ 242 (356)
................||+.|+|||++.+. ..++.++||||||+++|+|++|+.|+....... .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~- 247 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S- 247 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H-
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----H-
Confidence 876554433333345689999999998751 257889999999999999999999874322210 0
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..............+...+.++.+++.+||+.||.+||++.++++.
T Consensus 248 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 --------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp --------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0111111111112222335678999999999999999999999973
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=323.39 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=199.1
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
...|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 457888999999999999999875 58999999987542 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999999999987667789999999999999999999999 999999999999999999999999999875432111
Q ss_pred eeecCCCCCCCCCCccccc----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 182 VTISGYKGTPGYSAPEFLS----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.......||+.|+|||++. ....++.++||||||+++|+|++|..|+...... ..........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~------ 238 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSD------ 238 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC------
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccC------
Confidence 0112345899999999984 2336889999999999999999999887433211 0001111000
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......+..++.++.+++.+||+.||.+|||+.++++
T Consensus 239 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 -PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011123445677999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.32 Aligned_cols=262 Identities=19% Similarity=0.230 Sum_probs=184.4
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------Ce
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------HM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 95 (356)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.++++++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4678889999999999999975 469999999997542 334556788999999999999999999999754 56
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 6799998843 579999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc-h-------hHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW-F-------PKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~-~-------~~~~~~~~ 247 (356)
... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||........-. . ....+...
T Consensus 183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 432 2345689999999999875578999999999999999999999875432211000 0 00000000
Q ss_pred hhhchhhhHhhcCC------CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......++..... .......+..+.+|+.+||..||.+|||+.++++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00011111111000 01112335678999999999999999999999973
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=328.88 Aligned_cols=260 Identities=19% Similarity=0.205 Sum_probs=195.8
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-------
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD------- 92 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 92 (356)
....+|.+.+.||+|+||+||+|.+ .+|+.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3455788999999999999999976 57999999998754221 2369999999999999999999843
Q ss_pred -------------------------------CCeeeEEEEecCCCCHhHHhc---cCCCCCCHHHHHHHHHHHHHHHHHH
Q 047701 93 -------------------------------QHMTALVYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYL 138 (356)
Q Consensus 93 -------------------------------~~~~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~L 138 (356)
....++||||+++ +|.+.+. .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999975 8877774 3467899999999999999999999
Q ss_pred HhccCCCeeeeccCccceEEc-CCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHH
Q 047701 139 HEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMV 217 (356)
Q Consensus 139 H~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~i 217 (356)
|+ .+++||||||+||+++ .++.+||+|||+++........ ....||+.|+|||++.+...++.++||||||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99 9999999999999997 6889999999999876544322 235689999999999876568999999999999
Q ss_pred HHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh----------hcCC-----CchhHHHHHHHHHHHHhhcCC
Q 047701 218 SFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL----------ACGI-----EEKDKEKAKQLCMVALWCVQD 282 (356)
Q Consensus 218 l~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~~~~~~~~~l~~l~~~cl~~ 282 (356)
+|+|++|+.|+........ +... .............. .... ...+...+.++.+++.+||..
T Consensus 232 l~ell~g~~pf~~~~~~~~--~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ--LVRI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999988854322110 0000 00000000000000 0000 001223456799999999999
Q ss_pred CCCCCCCHHHHHH
Q 047701 283 SPADRPPMSAVVK 295 (356)
Q Consensus 283 ~p~~Rps~~~v~~ 295 (356)
||.+|||+.++++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=325.02 Aligned_cols=260 Identities=20% Similarity=0.265 Sum_probs=204.1
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCch----------------hHHHHHHHHHHHHhcCCCCCeeeE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGK----------------IAEEQFMAEVGTIGRTYHINLVRL 86 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~niv~~ 86 (356)
...|.+.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999998 9999999998743211 111678999999999999999999
Q ss_pred eeeEEcCCeeeEEEEecCCCCHhHH------hccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc
Q 047701 87 HGFCHDQHMTALVYEYMENGSLDGY------LFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD 159 (356)
Q Consensus 87 ~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 159 (356)
++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.||.|||+ ..+++||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5432 5789999999999999999999996 37999999999999999
Q ss_pred CCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCC-CCceehhhHHHHHHhcCCCccccCCCccccc
Q 047701 160 ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH-KCDVYSFGMVSFEIVGRRRNAIVGASESLDW 238 (356)
Q Consensus 160 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~Dv~slG~il~ell~g~~~~~~~~~~~~~~ 238 (356)
.++.+||+|||++...... ......||..|+|||++.+...++. ++||||||+++|+|++|..|+.......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--- 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence 9999999999999876543 2344678999999999987644555 9999999999999999999886443310
Q ss_pred hhHHHHHHHhhhchhhh---------HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 239 FPKYVWEEYEKSELGAM---------ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 239 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.............. .............+.++.+++.+||+.||.+||++.++++
T Consensus 260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01111111100000 0000000011345678999999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=316.20 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=202.5
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--------hhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcC
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--------KIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQ 93 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 93 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.+++++. ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 47788899999999999999874 689999999864321 123456889999999995 99999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 999999999999999999954 4579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCccccc-----CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLS-----GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
........ ....||+.|+|||++. ....++.++||||||+++|+|++|..|+...... .......
T Consensus 173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~ 242 (298)
T 1phk_A 173 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIM 242 (298)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH
T ss_pred hcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------HHHHHHh
Confidence 76543322 3356899999999985 2235789999999999999999999887432211 1111111
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... ..........+.++.+++.+||+.||.+||++.++++
T Consensus 243 ~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1100 0011122345678999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=325.39 Aligned_cols=263 Identities=19% Similarity=0.241 Sum_probs=201.0
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Ceee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 97 (356)
..|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 46788899999999999999864 68999999997655555667788999999999999999999988764 6789
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 9999997 599998854 469999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCce--------eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh-
Q 047701 178 NRSHV--------TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE- 248 (356)
Q Consensus 178 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~- 248 (356)
..... ......||+.|+|||++.+...++.++||||||+++|+|++|..|+......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCC
Confidence 32211 1223568999999999876547899999999999999999999987543211000 00000000
Q ss_pred -----------hhchhhhHhhcC------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 -----------KSELGAMILACG------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 -----------~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............ ........+.++.+++.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 00112345678999999999999999999999997
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=331.05 Aligned_cols=260 Identities=20% Similarity=0.219 Sum_probs=194.4
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------ee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------MT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~ 96 (356)
..+|.+.++||+|+||.||+|++..+..||+|.+...... ..+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4578889999999999999999877667999988654221 236999999999999999999996533 37
Q ss_pred eEEEEecCCCCHhHHh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-CCCceEEeccCCcc
Q 047701 97 ALVYEYMENGSLDGYL--FGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVADFGLAK 173 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~DfGla~ 173 (356)
++||||+.++.+.... ......+++..+..++.||+.||+|||+ .+++||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8999999874443332 1235789999999999999999999999 9999999999999998 78999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH----------
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV---------- 243 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~---------- 243 (356)
........ ....||+.|+|||++.+...++.++|||||||++|||++|+.||........ +....
T Consensus 191 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQ 265 (394)
T ss_dssp ECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred cccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 76544332 3356899999999998765689999999999999999999998854322110 00000
Q ss_pred HHHHhhhchhhhHhhcCCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 244 WEEYEKSELGAMILACGIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
+..... ............ ......+.++.+|+.+||..||.+|||+.++++.
T Consensus 266 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhCh-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000 000000000000 0111245689999999999999999999999973
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=328.37 Aligned_cols=197 Identities=23% Similarity=0.293 Sum_probs=168.7
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcC------CCCCeeeEeeeEEcCCe
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT------YHINLVRLHGFCHDQHM 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~ 95 (356)
..+|.+.++||+|+||+||+|.+. +++.||||++... ......+.+|+.+++.+ +|+||+.+++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346888899999999999999764 6899999999753 23445677777777766 57899999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc--eEEeccCCc
Q 047701 96 TALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS--PKVADFGLA 172 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla 172 (356)
.++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 58998886543 469999999999999999999999 99999999999999998887 999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccC
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVG 231 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~ 231 (356)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++|.+|+...
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCcc-----cccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7654322 235689999999999887 6899999999999999999999887543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=321.90 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=194.4
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc------CC
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD------QH 94 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~ 94 (356)
...|.+.+.||+|+||.||+|.+ .+++.||||++.... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 34678889999999999999986 478999999987543 3345788999999998 79999999999977 46
Q ss_pred eeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 95 MTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 789999999999999999654 3579999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
........ .....||+.|+|||++.+ ...++.++||||||+++|+|++|..|+...... .... .
T Consensus 178 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~--- 245 (326)
T 2x7f_A 178 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALF-L--- 245 (326)
T ss_dssp ---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-H---
T ss_pred ecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHH-H---
Confidence 66533211 233468999999999862 225889999999999999999999887432211 0000 0
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.............++..+.+++.+||..||.+||++.++++
T Consensus 246 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 -----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01111111112334567999999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=332.26 Aligned_cols=258 Identities=22% Similarity=0.254 Sum_probs=192.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC------Cee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ------HMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 96 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++..... ...+|++++++++||||+++++++... .+.
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 36788899999999999999874 699999999865422 234699999999999999999998542 246
Q ss_pred eEEEEecCCCCHhHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-CceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~DfGla 172 (356)
++||||+.+ +|.+++. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999976 6666553 345789999999999999999999999 999999999999999855 57899999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH-------H
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW-------E 245 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~-------~ 245 (356)
+........ ....||+.|+|||++.+...++.++|||||||++|||++|+.||....... .+..... +
T Consensus 205 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred hhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 876543322 335689999999999876578999999999999999999999875432210 0000000 0
Q ss_pred HHhh--hchhhhHhhcCCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 246 EYEK--SELGAMILACGIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 246 ~~~~--~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.+.. ............. ......+.++.+|+.+||..||.+||++.++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000 0000000000000 011234578999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=319.58 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=196.3
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee-----
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT----- 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----- 96 (356)
.+|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 46777889999999999999764 69999999997643 334457788999999999999999999999887655
Q ss_pred -eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 97 -ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 97 -~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
++||||+. ++|.+++ ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 122 ~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 5888877 3449999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH----------HH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV----------WE 245 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~----------~~ 245 (356)
... .....||+.|+|||++.+...++.++||||||+++|+|++|+.|+........ +.... +.
T Consensus 195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHT
T ss_pred ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHHHHH
Confidence 432 23456899999999998755789999999999999999999998854322110 00000 00
Q ss_pred HHhhhchhhhHhhc---CC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 246 EYEKSELGAMILAC---GI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 246 ~~~~~~~~~~~~~~---~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.............. .. .......+.++.+++.+||+.||.+|||+.++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000 00 01112346789999999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=319.53 Aligned_cols=264 Identities=21% Similarity=0.237 Sum_probs=192.9
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE-----------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH----------- 91 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------- 91 (356)
.+|.+.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46788899999999999999875 5899999998754 3355677899999999999999999999874
Q ss_pred ---cCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-CCCceEEe
Q 047701 92 ---DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVA 167 (356)
Q Consensus 92 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~ 167 (356)
+....++||||+. |+|.+++. .+.+++..+..++.|++.||+|||+ ++++||||||+||+++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 59999984 3579999999999999999999999 9999999999999997 56799999
Q ss_pred ccCCccccCCCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch-------
Q 047701 168 DFGLAKLCDRNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF------- 239 (356)
Q Consensus 168 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~------- 239 (356)
|||+++........ .......||..|+|||++.+...++.++||||||+++|+|++|+.|+...........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999876533221 1123345799999999987644789999999999999999999998854432110000
Q ss_pred -hHHHHHHHhhhchhhhHhhcC------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 -PKYVWEEYEKSELGAMILACG------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
....+..... .+...+.... ........+.++.+++.+||+.||.+||++.++++
T Consensus 244 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 244 VHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred Cchhhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000000 0000000000 00111235678999999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=312.78 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=203.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
....+|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568899999999999999999875 68999999986542 23445678999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC---CceEEeccCCcccc
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN---FSPKVADFGLAKLC 175 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~DfGla~~~ 175 (356)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+ .+++||||||+||+++.+ +.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999998853 3579999999999999999999999 999999999999999654 47999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... ....||+.|+|||++.+. ++.++||||||+++|+|++|..|+...... ............
T Consensus 175 ~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-- 240 (287)
T 2wei_A 175 QQNTKM---KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYA-- 240 (287)
T ss_dssp CCCSSC---SCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC--
T ss_pred cCCCcc---ccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCC--
Confidence 543321 223478899999998764 789999999999999999999987543211 111111111100
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........++.++.+++.+||..||.+|||+.++++
T Consensus 241 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 011122345678999999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=320.07 Aligned_cols=261 Identities=22% Similarity=0.297 Sum_probs=200.0
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-----------CCCeeeEee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-----------HINLVRLHG 88 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~ 88 (356)
+...+|.+.+.||+|+||+||+|.+ .+++.||||++... ......+.+|+.++++++ ||||+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3456899999999999999999986 47999999999753 244567888999998876 899999999
Q ss_pred eEEcCC----eeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEc---
Q 047701 89 FCHDQH----MTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLD--- 159 (356)
Q Consensus 89 ~~~~~~----~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~--- 159 (356)
++.... ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+ + +++||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccC
Confidence 998654 789999999 88999998654 4569999999999999999999999 8 999999999999994
Q ss_pred ---CCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccc
Q 047701 160 ---ANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESL 236 (356)
Q Consensus 160 ---~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~ 236 (356)
..+.+||+|||++....... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 34479999999998765432 234689999999999887 689999999999999999999999865432211
Q ss_pred cchhHHHHHHH-----------hhhch----------------------hhhHhhcCCCchhHHHHHHHHHHHHhhcCCC
Q 047701 237 DWFPKYVWEEY-----------EKSEL----------------------GAMILACGIEEKDKEKAKQLCMVALWCVQDS 283 (356)
Q Consensus 237 ~~~~~~~~~~~-----------~~~~~----------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~ 283 (356)
........... ..... ..... .....+...+.++.+|+.+||+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccC
Confidence 10000000000 00000 00000 011234677889999999999999
Q ss_pred CCCCCCHHHHHH
Q 047701 284 PADRPPMSAVVK 295 (356)
Q Consensus 284 p~~Rps~~~v~~ 295 (356)
|.+|||+.++++
T Consensus 322 P~~Rpt~~ell~ 333 (373)
T 1q8y_A 322 PRKRADAGGLVN 333 (373)
T ss_dssp TTTCBCHHHHHT
T ss_pred ccccCCHHHHhh
Confidence 999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=318.80 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=201.1
Q ss_pred HHHHhhccccccCcCCceEEEEEEc--CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC------CeeeEeeeEEc
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF--PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI------NLVRLHGFCHD 92 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~ 92 (356)
+...+|.+.+.||+|+||.||+|.+ .+++.||||++... ......+.+|+.+++.++|+ +++++++++.+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 3355889999999999999999975 36899999999753 24456788899998888655 59999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-----------
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA----------- 160 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----------- 160 (356)
....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 789999986554 468999999999999999999999 99999999999999987
Q ss_pred --------CCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCC
Q 047701 161 --------NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGA 232 (356)
Q Consensus 161 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~ 232 (356)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|..|+....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999998654332 235689999999999877 68999999999999999999999885433
Q ss_pred Cccccc--------hhHHHHHHHhhhch--------------hhhHhhc-----CCCchhHHHHHHHHHHHHhhcCCCCC
Q 047701 233 SESLDW--------FPKYVWEEYEKSEL--------------GAMILAC-----GIEEKDKEKAKQLCMVALWCVQDSPA 285 (356)
Q Consensus 233 ~~~~~~--------~~~~~~~~~~~~~~--------------~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~ 285 (356)
...... .+...+........ ....... .........+.++.+++.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 221100 00000000000000 0000000 00111234577899999999999999
Q ss_pred CCCCHHHHHH
Q 047701 286 DRPPMSAVVK 295 (356)
Q Consensus 286 ~Rps~~~v~~ 295 (356)
+|||+.++++
T Consensus 319 ~Rpt~~ell~ 328 (339)
T 1z57_A 319 KRITLREALK 328 (339)
T ss_dssp TSCCHHHHTT
T ss_pred cccCHHHHhc
Confidence 9999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=318.79 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=181.7
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHH-HHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVG-TIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
+....|.+.+.||+|+||.||+|.+. +++.||||++...........+..|+. +++.++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 34456778899999999999999874 699999999987655455556666666 6777899999999999999999999
Q ss_pred EEEecCCCCHhHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 99 VYEYMENGSLDGYLFG----KKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||+++
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999976 88887742 35679999999999999999999999 8 99999999999999999999999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCccccc---CCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLS---GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
........ ....||+.|+|||++. ....++.++||||||+++|+|++|..|+....... ....
T Consensus 175 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~-- 240 (327)
T 3aln_A 175 QLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------DQLT-- 240 (327)
T ss_dssp C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--
T ss_pred eccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------HHHH--
Confidence 76543221 2346899999999984 22258899999999999999999998874322110 0000
Q ss_pred chhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 251 ELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.................++.++.+++.+||..||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000000001111235677999999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=320.78 Aligned_cols=266 Identities=20% Similarity=0.214 Sum_probs=187.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe----
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM---- 95 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 95 (356)
..-..|.+.+.||+|+||.||+|.+. +++.||||++.... .......+++..+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 33457888999999999999999874 68999999986542 222356678888888999999999999965333
Q ss_pred ---eeEEEEecCCCCHhHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHH--hccCCCeeeeccCccceEEcC-CCceEE
Q 047701 96 ---TALVYEYMENGSLDGYLF---GKKRALEWEKLHEIAIGTAKGLVYLH--EECQQRIIHYDIKPENVLLDA-NFSPKV 166 (356)
Q Consensus 96 ---~~lv~e~~~~~sL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dlkp~Nill~~-~~~~kl 166 (356)
.++||||+.+ +|...+. .....+++..+..++.|++.||.||| + .+++||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999976 5554442 35667999999999999999999999 8 99999999999999986 899999
Q ss_pred eccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch-------
Q 047701 167 ADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF------- 239 (356)
Q Consensus 167 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~------- 239 (356)
+|||+++........ ....||+.|+|||++.+...++.++||||||+++|+|++|..|+...........
T Consensus 174 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999876644322 3356899999999997765689999999999999999999998854332211000
Q ss_pred -hHHHHHHHhhhchhhhHhhcC-------CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 240 -PKYVWEEYEKSELGAMILACG-------IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+...+................ ........+.++.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000000000 00111124678999999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=317.62 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=196.7
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe------
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM------ 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 95 (356)
.+|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46788899999999999999864 69999999997543 33445678899999999999999999999987654
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 58888773 359999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHH----------HH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYV----------WE 245 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~----------~~ 245 (356)
... .....||+.|+|||++.+...++.++||||||+++|+|++|..|+........ +.... +.
T Consensus 177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHHT
T ss_pred CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHH
Confidence 432 23356899999999998754789999999999999999999998854332110 00000 00
Q ss_pred HHhhhchhhhHhh------cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 246 EYEKSELGAMILA------CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 246 ~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............. ..........+.++.+++.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000 0011122345678999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=312.11 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=182.5
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHH-HHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEE-QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..|.+.+.||+|+||.||+|.+. +++.||||++.......... .+..+..+++.++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46777889999999999999874 68999999997654433333 34445557788899999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ-RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+ ++.+..+.......+++..+..++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 99 557776665556789999999999999999999998 6 999999999999999999999999999976654322
Q ss_pred ceeecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 181 HVTISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
. ....||+.|+|||++.+ ...++.++||||||+++|+|++|..|+...... ...........
T Consensus 181 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~----- 246 (318)
T 2dyl_A 181 K---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEE----- 246 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSC-----
T ss_pred c---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccC-----
Confidence 1 23468999999999852 235888999999999999999999887532221 00111111100
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........++.++.+++.+||+.||.+||++.++++
T Consensus 247 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 --PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0001111234577999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.21 Aligned_cols=198 Identities=25% Similarity=0.309 Sum_probs=167.8
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CC-----CeeeEeeeEEcCCee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HI-----NLVRLHGFCHDQHMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 96 (356)
..|.+.+.||+|+||+||+|.+. +++.||||++... ......+..|+.+++.++ |+ +|+.+++++......
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 46778899999999999999764 6899999999753 234556777888888774 44 499999999999999
Q ss_pred eEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--CCCceEEeccCCcc
Q 047701 97 ALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAK 173 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~ 173 (356)
++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999999964 9999986554 5699999999999999999999941 17999999999999994 57789999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccC
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVG 231 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~ 231 (356)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.|+...
T Consensus 210 ~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 210 QLGQRI-----YQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ETTCCC-----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccccc-----ccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 765332 235689999999999887 6999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=314.70 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=196.8
Q ss_pred HhhccccccCcCCceEEEEEEc--CCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcC---CCCCeeeEeeeEE-----c
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF--PNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRT---YHINLVRLHGFCH-----D 92 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~ 92 (356)
..|.+.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4688899999999999999986 3688999999864322 11123455677766665 8999999999987 5
Q ss_pred CCeeeEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
....++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 567899999997 59999986543 459999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh--
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK-- 249 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (356)
+....... ......||..|+|||++.+. .++.++||||||+++|+|++|+.|+........ . .........
T Consensus 167 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~-~~i~~~~~~~~ 239 (326)
T 1blx_A 167 ARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--L-GKILDVIGLPG 239 (326)
T ss_dssp CCCCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCC
T ss_pred cccccCCC---CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHHHcCCCC
Confidence 97654322 22345689999999999877 689999999999999999999998754322110 0 000000000
Q ss_pred -hchh------hhH----hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 -SELG------AMI----LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 -~~~~------~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.... ... ............+..+.+++.+||..||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000 000011122345677899999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=315.79 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=191.6
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCch-----hHHHHHHHHHHHHhcC----CCCCeeeEe
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRT----YHINLVRLH 87 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~niv~~~ 87 (356)
..+.....|.+.+.||+|+||.||+|.+ .+++.||||++...... .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455566899999999999999999986 46899999999754221 1223456788888888 899999999
Q ss_pred eeEEcCCeeeEEEEe-cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-CCCceE
Q 047701 88 GFCHDQHMTALVYEY-MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPK 165 (356)
Q Consensus 88 ~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~k 165 (356)
+++...+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+ .+++||||||+||+++ .++.+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 999999999999999 788999999954 4569999999999999999999999 9999999999999998 889999
Q ss_pred EeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHH
Q 047701 166 VADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWE 245 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~ 245 (356)
|+|||++....... .....||..|+|||++.+....+.++||||||+++|+|++|+.|+....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------- 243 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------- 243 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence 99999998765432 2345689999999998766344568999999999999999998873210
Q ss_pred HHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 246 EYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.. ... ....+...+.++.+++.+||+.||.+||++.++++.
T Consensus 244 ~~--------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 EI--------LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HH--------HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HH--------hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000 111223456678999999999999999999999973
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=326.83 Aligned_cols=251 Identities=23% Similarity=0.251 Sum_probs=187.4
Q ss_pred HHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEE
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 101 (356)
..+|+..+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....|+|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 446777889999999996655445889999999965422 2356799999998 79999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-----CCceEEeccCCccccC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-----NFSPKVADFGLAKLCD 176 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~DfGla~~~~ 176 (356)
|+. |+|.+++...........++.++.||+.||.|||+ .+++||||||+|||++. ...+||+|||+++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 996 59999997766666666788999999999999999 99999999999999943 2357899999998765
Q ss_pred CCCCc-eeecCCCCCCCCCCcccccC--CCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhch
Q 047701 177 RNRSH-VTISGYKGTPGYSAPEFLSG--NYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 177 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
..... .......||+.|+|||++.+ ...++.++|||||||++|||++ |..|+....... . .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~-~~~~~~~- 245 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------A-NILLGAC- 245 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------H-HHHTTCC-
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------H-HHHhccC-
Confidence 43221 22344679999999999974 2357889999999999999999 776663221110 0 0000000
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...........+..+.+++.+||+.||.+|||+.+|++
T Consensus 246 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 -----SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00011112345567889999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=318.06 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=198.9
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCch-----hHHHHHHHHHHHHhcCC--CCCeeeEeeeE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRTY--HINLVRLHGFC 90 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~~~~~~ 90 (356)
.+.....|.+.+.||+|+||.||+|.+ .+++.||||++...... .....+..|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 334456788999999999999999975 46899999998754211 12245677999999986 59999999999
Q ss_pred EcCCeeeEEEEecCC-CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc-CCCceEEec
Q 047701 91 HDQHMTALVYEYMEN-GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD-ANFSPKVAD 168 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~D 168 (356)
...+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++ .++.+||+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 999999999999976 899999854 4579999999999999999999999 9999999999999998 788999999
Q ss_pred cCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 169 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
||++....... .....||+.|+|||++.+....+.++||||||+++|+|++|+.|+.... ...
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~ 256 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EII 256 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHH
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------------hhh
Confidence 99998765432 2335689999999999876445788999999999999999998873210 000
Q ss_pred hhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 KSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. ........+.++.+++.+||+.||.+||++.+|++
T Consensus 257 ~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 RG----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HC----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc----------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 01112234567899999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=325.63 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=184.6
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
+...+.||+|+||+||.+...+|+.||||++... ....+.+|+.++.++ +||||+++++++.+....++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 3446789999999998776558999999998653 234578899999876 89999999999999999999999996
Q ss_pred CCCHhHHhccCCCC------CCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCC-------------CceE
Q 047701 105 NGSLDGYLFGKKRA------LEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDAN-------------FSPK 165 (356)
Q Consensus 105 ~~sL~~~l~~~~~~------l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~~k 165 (356)
|+|.+++...... .++..++.++.||+.||+|||+ .+++||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 5999999654321 1334567899999999999999 999999999999999654 4899
Q ss_pred EeccCCccccCCCCCce--eecCCCCCCCCCCcccccC------CCCCCCCCceehhhHHHHHHhc-CCCccccCCCccc
Q 047701 166 VADFGLAKLCDRNRSHV--TISGYKGTPGYSAPEFLSG------NYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESL 236 (356)
Q Consensus 166 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~ 236 (356)
|+|||+++......... ......||+.|+|||++.+ ...++.++|||||||++|||++ |..|+.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999999876543221 1234579999999999975 2368999999999999999999 777764322110
Q ss_pred cchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 237 DWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........ .............+.++.+++.+||+.||.+||++.+|++
T Consensus 248 --------~~i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --------SNIIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --------HHHHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00000000 0000011124567788999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.50 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=198.3
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC-CC-cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC------eeeEeeeEEc
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP-NG-VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN------LVRLHGFCHD 92 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~ 92 (356)
.....|.+.+.||+|+||+||+|... ++ +.||||++... ......+.+|+.++++++|++ ++.+++++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 34568899999999999999999864 44 78999999753 344567888999999887655 9999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEE-------------
Q 047701 93 QHMTALVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLL------------- 158 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill------------- 158 (356)
....++||||+ +++|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999 55666666444 3679999999999999999999999 999999999999999
Q ss_pred ------cCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCC
Q 047701 159 ------DANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGA 232 (356)
Q Consensus 159 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~ 232 (356)
+.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|..|+....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999998654332 235689999999999877 68999999999999999999999985433
Q ss_pred Cccccc--------hhHHHHHHHhhhch--------------hhhHhhc-----CCCchhHHHHHHHHHHHHhhcCCCCC
Q 047701 233 SESLDW--------FPKYVWEEYEKSEL--------------GAMILAC-----GIEEKDKEKAKQLCMVALWCVQDSPA 285 (356)
Q Consensus 233 ~~~~~~--------~~~~~~~~~~~~~~--------------~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~ 285 (356)
...... .+...+........ ....... .........+.++.+++.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 211000 00000000000000 0000000 00011234466899999999999999
Q ss_pred CCCCHHHHHH
Q 047701 286 DRPPMSAVVK 295 (356)
Q Consensus 286 ~Rps~~~v~~ 295 (356)
+|||+.++++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.19 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=172.2
Q ss_pred HHhhccc-cccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCee
Q 047701 23 NFTSNYS-TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMT 96 (356)
Q Consensus 23 ~~~~~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 96 (356)
...|.+. +.||+|+||.||+|.+. +++.||||++.... .. .......++.+.||||+++++++.. +...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4466764 46999999999999875 69999999996531 11 1222334556789999999999976 4568
Q ss_pred eEEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla 172 (356)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999996553 479999999999999999999999 99999999999999975 456999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
+...... .....||+.|+|||++.+. .++.++||||||+++|+|++|..|+........... .......
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~--- 247 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRL--- 247 (336)
T ss_dssp EEC--------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhc---
Confidence 8655332 1234689999999999776 689999999999999999999999854332211000 0000000
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............++.++.+++.+||..||.+|||+.++++
T Consensus 248 ---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 ---GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011112345678999999999999999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=337.59 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=195.7
Q ss_pred HHHHhhccccccCcCCceEEEEEEcC--CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe---
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFP--NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM--- 95 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 95 (356)
+...+|.+.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++.+++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34467888999999999999999864 5899999998765455566788999999999999999999999987655
Q ss_pred --eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 96 --TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 96 --~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987743 79999999999999999999999 999999999999999875 89999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
..... ....||+.|+|||++.+. .+.++||||||+++|+|++|.+|+.........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------------- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------------- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------
T ss_pred hcccC------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccccc----------------
Confidence 76543 335689999999999865 488999999999999999998775321111000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHhhhc
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP-MSAVVKMLEGV 300 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-~~~v~~~L~~~ 300 (356)
........+..+.+++.+||+.||.+||+ ++++.+.|..+
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 01112234567899999999999999995 55666666544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.95 Aligned_cols=262 Identities=26% Similarity=0.312 Sum_probs=198.6
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc------CCee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD------QHMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 96 (356)
..|.+.++||+|+||.||+|.+ .+|+.||||++...........+.+|+.++++++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5799999999999999999986 46899999999876666667889999999999999999999999765 6778
Q ss_pred eEEEEecCCCCHhHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCc---eEEeccCC
Q 047701 97 ALVYEYMENGSLDGYLFGKK--RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFS---PKVADFGL 171 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~DfGl 171 (356)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999996543 369999999999999999999999 99999999999999987664 89999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCcccc--chhHHHHHH-Hh
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLD--WFPKYVWEE-YE 248 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~--~~~~~~~~~-~~ 248 (356)
+......... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+......... ......... ..
T Consensus 171 a~~~~~~~~~---~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELC---TEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCC---CCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc---ccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9876544322 345799999999999877 7899999999999999999999998543211000 000000000 00
Q ss_pred hhchhhhH-hh---cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 047701 249 KSELGAMI-LA---CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSA 292 (356)
Q Consensus 249 ~~~~~~~~-~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~ 292 (356)
........ .. ..........+..+.+++.+||..||.+|||+.+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000000 00 0011223456788999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.47 Aligned_cols=239 Identities=12% Similarity=0.000 Sum_probs=190.3
Q ss_pred eeCHHH-HHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCCCCeeeEeeeE
Q 047701 15 RFTSLQ-LNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYHINLVRLHGFC 90 (356)
Q Consensus 15 ~~~~~~-~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 90 (356)
.+.+.+ +...+|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++.+++||||+++++++
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 344444 55678999999999999999999874 589999999976532 34457889999999999999999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
.+.+..|+||||++|++|.+++.. ......+..++.|++.||.|||+ +|++||||||+|||++.++.+||+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc
Confidence 999999999999999999999943 24666789999999999999999 999999999999999999999997543
Q ss_pred CccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhh
Q 047701 171 LAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKS 250 (356)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (356)
|++ .++.++||||||+++|+|++|+.||...........
T Consensus 175 ----------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------- 213 (286)
T 3uqc_A 175 ----------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------- 213 (286)
T ss_dssp ----------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------
T ss_pred ----------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------
Confidence 332 368899999999999999999999865443211000
Q ss_pred chhhhHhhcC--CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 251 ELGAMILACG--IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 251 ~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
......... .......++.++.+++.+||+.||.+| |+.++++.|..+..
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 214 -AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp -CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred -HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000000 001123456779999999999999999 99999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=312.71 Aligned_cols=239 Identities=15% Similarity=0.098 Sum_probs=177.9
Q ss_pred hccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCCC-CCeee----------------
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTYH-INLVR---------------- 85 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h-~niv~---------------- 85 (356)
+...+.||+|+||+||+|.+ .+|+.||||++..... ....+.+.+|+.+++.+.| +|...
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 55668899999999999985 4699999999874322 2234678899999999976 32111
Q ss_pred -----EeeeEEc-----CCeeeEEEEecCCCCHhHHhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeee
Q 047701 86 -----LHGFCHD-----QHMTALVYEYMENGSLDGYLF------GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149 (356)
Q Consensus 86 -----~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 149 (356)
++.++.. ....+++|+++ +++|.+++. .....+++..++.++.||+.||+|||+ ++++||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence 1111111 22356778876 569999883 235568899999999999999999999 999999
Q ss_pred ccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCccccc---------CCCCCCCCCceehhhHHHHH
Q 047701 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS---------GNYPITHKCDVYSFGMVSFE 220 (356)
Q Consensus 150 Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~Dv~slG~il~e 220 (356)
||||+|||++.++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999998865432 334567 9999999983 22268889999999999999
Q ss_pred HhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 221 IVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 221 ll~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
|++|+.|+........ ...+... ...++.++.+++.+||+.||.+||++.++++
T Consensus 310 lltg~~Pf~~~~~~~~----------------~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALGG----------------SEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGSC----------------SGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhhh----------------HHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999854322111 1111111 1123467999999999999999999777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=304.54 Aligned_cols=243 Identities=14% Similarity=0.130 Sum_probs=185.4
Q ss_pred HHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-------chhHHHHHHHHHHHHhcCC---------CCCee
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-------GKIAEEQFMAEVGTIGRTY---------HINLV 84 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~---------h~niv 84 (356)
+....|.+.++||+|+||+||+|++ +|+.||||++.... .......+.+|+.++++++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456889999999999999999998 78999999997542 2233366788888888775 66666
Q ss_pred eEeeeE-----------------Ec-------------CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHH
Q 047701 85 RLHGFC-----------------HD-------------QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKG 134 (356)
Q Consensus 85 ~~~~~~-----------------~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~ 134 (356)
++.+++ .+ ....|+||||+.+|++.+.+.. ..+++..+..++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 666654 22 6789999999999976666632 578999999999999999
Q ss_pred HHHHH-hccCCCeeeeccCccceEEcCCC--------------------ceEEeccCCccccCCCCCceeecCCCCCCCC
Q 047701 135 LVYLH-EECQQRIIHYDIKPENVLLDANF--------------------SPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193 (356)
Q Consensus 135 l~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 193 (356)
|+||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 8 9999999999999998876 8999999999876532 23589999
Q ss_pred CCcccccCCCCCCCCCceehhhHH-HHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh--HhhcCCCchhHHHHH
Q 047701 194 SAPEFLSGNYPITHKCDVYSFGMV-SFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM--ILACGIEEKDKEKAK 270 (356)
Q Consensus 194 ~aPE~~~~~~~~~~~~Dv~slG~i-l~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 270 (356)
+|||++.+. . +.++||||||++ .+++++|..|+ ....|.......+... .............+.
T Consensus 244 ~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 244 MDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPY-----------SNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTH-----------HHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred cChhhhcCC-C-ccceehhhhhCCCCcccccccCCC-----------cchhhhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence 999999977 3 889999998777 67788887764 1111211111111110 011112334567889
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHH
Q 047701 271 QLCMVALWCVQDSPADRPPMSAVV 294 (356)
Q Consensus 271 ~l~~l~~~cl~~~p~~Rps~~~v~ 294 (356)
++.+|+.+||+.| |+.+++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 9999999999976 888888
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=289.26 Aligned_cols=225 Identities=21% Similarity=0.295 Sum_probs=176.1
Q ss_pred hhccc-cccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHH-hcCCCCCeeeEeeeEEc----CCeee
Q 047701 25 TSNYS-TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTI-GRTYHINLVRLHGFCHD----QHMTA 97 (356)
Q Consensus 25 ~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~ 97 (356)
.|.+. +.||+|+||.||+|.. .+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 34444 7799999999999976 46899999998642 3466788887 55689999999999987 67789
Q ss_pred EEEEecCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCcc
Q 047701 98 LVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAK 173 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~ 173 (356)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999996553 479999999999999999999999 99999999999999987 7899999999986
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.... . .++.++||||||+++|+|++|..|+......... ....
T Consensus 169 ~~~~------------------------~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~ 211 (299)
T 3m2w_A 169 ETTG------------------------E-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMK 211 (299)
T ss_dssp ECTT------------------------C-GGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSC
T ss_pred cccc------------------------c-cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHH
Confidence 4321 2 4788999999999999999999998543221100 0000
Q ss_pred hhHhhcCC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACGI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........ ......++.++.+++.+||+.||.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 0111235678999999999999999999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=279.34 Aligned_cols=187 Identities=16% Similarity=0.131 Sum_probs=132.6
Q ss_pred cccCcCCceEEEEEE-cCCCcEEEEEEecccC---------chhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeE
Q 047701 30 TRLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNL---------GKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 98 (356)
...+.|++|.+..++ ...|+.+++|++.+.. .+....++.+|+++|+++ .|+||+++++++.++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346777777776653 3368999999996531 233446799999999999 79999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||++|++|.+++. ..+.++.. +|+.||+.||+|||+ +|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999995 44566654 478999999999999 99999999999999999999999999999876543
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCc
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRN 227 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~ 227 (356)
... ....+||++|||||++.+. +..++|+||+|++++++.++..+
T Consensus 393 ~~~--~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW--PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC--SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred Ccc--ccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 322 2345699999999999875 57789999999999988776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=247.62 Aligned_cols=183 Identities=16% Similarity=0.159 Sum_probs=142.5
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCc-------hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG-------KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.+.||+|+||.||+|.. .++.+++|....... ....+++.+|++++++++||||+.+..++......+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 56899999999999966 678899998653211 1123568999999999999999966666667777899999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+++++|.+++.. +..++.|++++|.|||+ ++++||||||+|||++. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 9999999999954 67899999999999999 99999999999999998 9999999999987653222
Q ss_pred e-----eecCCCCCCCCCCcccccCC-CCCCCCCceehhhHHHHHHhcCCC
Q 047701 182 V-----TISGYKGTPGYSAPEFLSGN-YPITHKCDVYSFGMVSFEIVGRRR 226 (356)
Q Consensus 182 ~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~Dv~slG~il~ell~g~~ 226 (356)
. ......||+.|||||++... ..|+...|+||..+-..+-+.++.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 1 11345699999999999751 157888999998888887766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-27 Score=205.38 Aligned_cols=145 Identities=15% Similarity=0.072 Sum_probs=117.0
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCch-----------------hHHHHHHHHHHHHhcCCCCCeeeEee
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGK-----------------IAEEQFMAEVGTIGRTYHINLVRLHG 88 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~~~~ 88 (356)
|.+.+.||+|+||.||+|.+.+|+.||||++...... .....+.+|+.++++++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 3455899999999999998877999999999643211 23567889999999998 5 66666
Q ss_pred eEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+ .+++||||||+|||++ ++.+||+|
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred EEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 5544 45699999999999988 421 2345799999999999999 9999999999999999 99999999
Q ss_pred cCCccccCCCCCceeecCCCCCCCCCCcccccC
Q 047701 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201 (356)
Q Consensus 169 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 201 (356)
||+++. +..++|||++.+
T Consensus 236 FG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE---------------TTSTTHHHHHHH
T ss_pred CCCCeE---------------CCCCCHHHHHHH
Confidence 999862 335789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-23 Score=177.03 Aligned_cols=137 Identities=15% Similarity=0.127 Sum_probs=106.5
Q ss_pred hccccccCcCCceEEEEEEc-CCCcE--EEEEEecccCch-----------------------hHHHHHHHHHHHHhcCC
Q 047701 26 SNYSTRLGFGGFGQVYKGQF-PNGVK--IAVKVLNKNLGK-----------------------IAEEQFMAEVGTIGRTY 79 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~ 79 (356)
|.+.+.||+|+||.||+|.+ .+|+. ||||++...... .....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999987 67888 999997543111 11236788999999998
Q ss_pred CCCe--eeEeeeEEcCCeeeEEEEecCC-C----CHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCeeeecc
Q 047701 80 HINL--VRLHGFCHDQHMTALVYEYMEN-G----SLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH-EECQQRIIHYDI 151 (356)
Q Consensus 80 h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dl 151 (356)
|+++ +.++++ ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| + .+++||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 7754 444432 356899999942 3 67766532 234567889999999999999 8 99999999
Q ss_pred CccceEEcCCCceEEeccCCcccc
Q 047701 152 KPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 152 kp~Nill~~~~~~kl~DfGla~~~ 175 (356)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=4.6e-20 Score=166.16 Aligned_cols=139 Identities=12% Similarity=0.118 Sum_probs=101.0
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCc----------------h-----hHHHHHHHHHHHHhcCCCCCee
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG----------------K-----IAEEQFMAEVGTIGRTYHINLV 84 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------~-----~~~~~~~~e~~~l~~l~h~niv 84 (356)
|.+.+.||+|+||.||+|...+|+.||||+++.... . .......+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 677889999999999999988999999998753210 0 0011123577777777544442
Q ss_pred eEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC--
Q 047701 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-- 162 (356)
Q Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 162 (356)
...-+... ..+|||||++|++|..+... .....++.|++.+|.|||+ .|+|||||||.|||+++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCc
Confidence 22212222 23799999999888765421 2345788999999999999 9999999999999998766
Q ss_pred --------ceEEeccCCccccC
Q 047701 163 --------SPKVADFGLAKLCD 176 (356)
Q Consensus 163 --------~~kl~DfGla~~~~ 176 (356)
.+.|+||+-+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=119.48 Aligned_cols=141 Identities=11% Similarity=0.006 Sum_probs=109.7
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|.+...++.|+.+.||++.. .++.+++|+...... .....+.+|+++++.+. +..++++++++.+.+..|+|||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 466677788888899999986 468899999875311 12235788999999884 677889999999888999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC----------------------------------------- 142 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------- 142 (356)
+|.+|.+.+. +......++.+++++|..||+..
T Consensus 93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999987641 11233578899999999999810
Q ss_pred ---------------CCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 143 ---------------QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 143 ---------------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876566799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=3.6e-13 Score=116.26 Aligned_cols=128 Identities=13% Similarity=-0.004 Sum_probs=96.3
Q ss_pred CcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC--eeeEeeeEEcCCeeeEEEEecCCCCHhH
Q 047701 33 GFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN--LVRLHGFCHDQHMTALVYEYMENGSLDG 110 (356)
Q Consensus 33 g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 110 (356)
+.|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +++++++...++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence 455669999998777888999997653 1234678888888885434 566888888888889999999998884
Q ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------------------
Q 047701 111 YLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC------------------------------------------------ 142 (356)
Q Consensus 111 ~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------------ 142 (356)
.. . .+ ...++.+++..|..||+..
T Consensus 104 -~~-~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 -SS-H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp -TS-C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred -cC-c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 31 1 12 2367788888888888621
Q ss_pred -------CCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 143 -------QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 143 -------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
+..++|+|++|.||++++++.+.|+|||.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.36 E-value=4e-12 Score=115.13 Aligned_cols=141 Identities=14% Similarity=0.168 Sum_probs=105.8
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEec--ccCchhHHHHHHHHHHHHhcCC--CCCeeeEeeeEEcC---CeeeEEEEe
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLN--KNLGKIAEEQFMAEVGTIGRTY--HINLVRLHGFCHDQ---HMTALVYEY 102 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~ 102 (356)
+.|+.|.++.||++... +..+++|+.. ..........+.+|+.+++.+. +..+++++.++.+. +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 46899999999999874 4678888876 3322223456788999999886 45688899988776 457899999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC---------------------------------------- 142 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------- 142 (356)
++|..+.+.. -..++......++.+++..|..||+..
T Consensus 123 v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 123 VSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred cCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9998774322 234788889999999999999999721
Q ss_pred ---------------CCCeeeeccCccceEEcCCCc--eEEeccCCccc
Q 047701 143 ---------------QQRIIHYDIKPENVLLDANFS--PKVADFGLAKL 174 (356)
Q Consensus 143 ---------------~~~ivH~Dlkp~Nill~~~~~--~kl~DfGla~~ 174 (356)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.9e-11 Score=107.99 Aligned_cols=187 Identities=17% Similarity=0.161 Sum_probs=121.7
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCC--eeeEeeeEEcCC---eeeEEEEe
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HIN--LVRLHGFCHDQH---MTALVYEY 102 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~ 102 (356)
.+.++.|....||++. ..+++|+-... .....+.+|.++++.+. +.. ++.++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3458899999999863 46889986532 34567889999998873 322 445555544333 35899999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC---------------------------------------- 142 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------- 142 (356)
++|.+|..... ..++..+...++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988875432 35677888889999999999998610
Q ss_pred ---------------CCCeeeeccCccceEEcC--CCceEEeccCCccccCCCCCceeecC------------CCCCCCC
Q 047701 143 ---------------QQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNRSHVTISG------------YKGTPGY 193 (356)
Q Consensus 143 ---------------~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~y 193 (356)
...++|+|++|.||++++ ...+.|+||+.+.............. .....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999987 45678999998765321100000000 0000011
Q ss_pred CC-cccccCCCCCCCCCceehhhHHHHHHhcCCCcc
Q 047701 194 SA-PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNA 228 (356)
Q Consensus 194 ~a-PE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~ 228 (356)
.. |+.... .....+.|+++.++|.+.+|..++
T Consensus 255 ~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222111 112257899999999999998543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=4.8e-08 Score=86.17 Aligned_cols=134 Identities=16% Similarity=0.123 Sum_probs=95.0
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC---CeeeEeeeEE-cCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI---NLVRLHGFCH-DQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 105 (356)
+.++.|....||+. +..+++|+-.. ......+.+|.++++.+.+. .+++++.++. ..+..++||++++|
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888899998 46788888432 24456788999999998642 3667777774 44567899999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE-------------------------------------------- 141 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-------------------------------------------- 141 (356)
.+|..... ..++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 2245555566666666666666641
Q ss_pred -------------cCCCeeeeccCccceEEcC---CCc-eEEeccCCcc
Q 047701 142 -------------CQQRIIHYDIKPENVLLDA---NFS-PKVADFGLAK 173 (356)
Q Consensus 142 -------------~~~~ivH~Dlkp~Nill~~---~~~-~kl~DfGla~ 173 (356)
....++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1235799999999999987 455 4899998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=6e-08 Score=83.84 Aligned_cols=133 Identities=16% Similarity=0.071 Sum_probs=94.9
Q ss_pred cCcCCce-EEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecCCCCH
Q 047701 32 LGFGGFG-QVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMENGSL 108 (356)
Q Consensus 32 lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL 108 (356)
+..|.-| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--|.++++++.+.+..++|||+++|.++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 4444444 69998764 467899998754 34456788999888774 33477889999998999999999999888
Q ss_pred hHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------------
Q 047701 109 DGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC---------------------------------------------- 142 (356)
Q Consensus 109 ~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------------- 142 (356)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7655211 1223345566666666666420
Q ss_pred ---------CCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 143 ---------QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 143 ---------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...++|+|+.+.||++++++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0138999999999999987777899998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3.6e-08 Score=88.94 Aligned_cols=80 Identities=9% Similarity=-0.012 Sum_probs=54.7
Q ss_pred ccc-CcCCceEEEEEEcC-------CCcEEEEEEecccCc--hhHHHHHHHHHHHHhcCC-C--CCeeeEeeeEEcC---
Q 047701 30 TRL-GFGGFGQVYKGQFP-------NGVKIAVKVLNKNLG--KIAEEQFMAEVGTIGRTY-H--INLVRLHGFCHDQ--- 93 (356)
Q Consensus 30 ~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 93 (356)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+.+++.+. + -.++++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 556 88888999998763 267889998654320 001234677888888773 2 3577788887665
Q ss_pred CeeeEEEEecCCCCHh
Q 047701 94 HMTALVYEYMENGSLD 109 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~ 109 (356)
...++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=6.2e-07 Score=82.02 Aligned_cols=75 Identities=13% Similarity=0.049 Sum_probs=48.5
Q ss_pred cccCcCCceEEEEEEcC-CCcEEEEEEecccCc------hhHHHHHHHHHHHHhcCCC--C-CeeeEeeeEEcCCeeeEE
Q 047701 30 TRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG------KIAEEQFMAEVGTIGRTYH--I-NLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~lv 99 (356)
+.||.|..+.||++... +++.++||....... ......+..|.++++.+.. + .+++++.+. ....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 46899999999999764 468899998653211 0122356778888877632 3 345666543 3456899
Q ss_pred EEecCCC
Q 047701 100 YEYMENG 106 (356)
Q Consensus 100 ~e~~~~~ 106 (356)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.2e-06 Score=76.55 Aligned_cols=137 Identities=14% Similarity=0.154 Sum_probs=77.0
Q ss_pred ccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC--CCCeeeEee------eEEcCCeeeEEEEe
Q 047701 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HINLVRLHG------FCHDQHMTALVYEY 102 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~ 102 (356)
.|+.|..+.||++...++ .+++|+.... . ..+..|..+++.|. .-.+++++. +....+..+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 355577899999987554 5899998752 1 22333444444442 112333333 22345677899999
Q ss_pred cCCCCHh-----------HHh---cc--CC---C--------CCCHHHH-------------------------------
Q 047701 103 MENGSLD-----------GYL---FG--KK---R--------ALEWEKL------------------------------- 124 (356)
Q Consensus 103 ~~~~sL~-----------~~l---~~--~~---~--------~l~~~~~------------------------------- 124 (356)
++|.++. ..+ .. .. . ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 011 10 00 0 0122111
Q ss_pred HHHHHHHHHHHHHHHh----------ccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 125 HEIAIGTAKGLVYLHE----------ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 125 ~~i~~qi~~~l~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..+..++..++.+|+. ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223345666653 134789999999999999877889999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.34 E-value=4.5e-06 Score=73.42 Aligned_cols=135 Identities=16% Similarity=0.150 Sum_probs=90.3
Q ss_pred cccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC---CCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY---HINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.|+.|....+|+... ++..+++|+-... ....+..|++.|+.|. ...++++++++...+..++|||+++|.
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 4589999999999987 5678889987642 3456788988888873 356888999988888899999999987
Q ss_pred CHhH--------Hh---ccCCC---------------------CCCHHHHH---HHH----------------HHHHHHH
Q 047701 107 SLDG--------YL---FGKKR---------------------ALEWEKLH---EIA----------------IGTAKGL 135 (356)
Q Consensus 107 sL~~--------~l---~~~~~---------------------~l~~~~~~---~i~----------------~qi~~~l 135 (356)
.+.. .| ..... .-+|.... ++. .+++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 11 11110 12454332 111 1122222
Q ss_pred -HHHHh-ccCCCeeeeccCccceEEcCCCceEEeccC
Q 047701 136 -VYLHE-ECQQRIIHYDIKPENVLLDANFSPKVADFG 170 (356)
Q Consensus 136 -~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~DfG 170 (356)
..|.. .....++|+|+.+.|++++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1235799999999999998887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.6e-05 Score=73.21 Aligned_cols=31 Identities=23% Similarity=0.327 Sum_probs=27.4
Q ss_pred CCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 143 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
...++|+|++|.||+++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 37899999999999998776 99999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.3e-05 Score=65.35 Aligned_cols=101 Identities=12% Similarity=0.052 Sum_probs=69.4
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceeec
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS 185 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 185 (356)
-+|.++|...+.+++++++|.++.|.+.+|.-+-.. +.-..+=+-|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 389999988999999999999999999998776321 1112344567999999999988764 1110
Q ss_pred CCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCC
Q 047701 186 GYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR 225 (356)
Q Consensus 186 ~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~ 225 (356)
.....+.+||.... ..+.+.=|||||+++|.-+--+
T Consensus 98 --~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------CCSSS--SSCHHHHHHHHHHHHHHHHTTT
T ss_pred --ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcC
Confidence 11234678888752 4678889999999999888544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.96 E-value=2.7e-05 Score=67.73 Aligned_cols=76 Identities=16% Similarity=0.197 Sum_probs=53.6
Q ss_pred cccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-C--CCeeeEeeeEEcCCeeeEEEEecC
Q 047701 28 YSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-H--INLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 28 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
-.+.+|.|..+.||+++..+|+.|.+|+-..... .....+..|++.|+.|. . --+++++++. ..++||||+.
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 3466899999999999998999999998764321 22234678888888773 2 1345555543 2379999998
Q ss_pred CCCH
Q 047701 105 NGSL 108 (356)
Q Consensus 105 ~~sL 108 (356)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.88 E-value=5.2e-05 Score=67.36 Aligned_cols=139 Identities=18% Similarity=0.125 Sum_probs=72.1
Q ss_pred cccCcCCceE-EEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC--CCCeeeEeeeEEcCCeeeEEEEecCCC
Q 047701 30 TRLGFGGFGQ-VYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HINLVRLHGFCHDQHMTALVYEYMENG 106 (356)
Q Consensus 30 ~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~ 106 (356)
+.|+.|+... +|+....++..+++|....... ..+..|+.++..+. .-.+++++.+..+.+ +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 3465554443 7788764467788876543210 12344556655553 123566776644433 7899999776
Q ss_pred CHhHHhccC---------------------C----CCCCHHHHH-------HH-------------HHHHHHHHHHHHh-
Q 047701 107 SLDGYLFGK---------------------K----RALEWEKLH-------EI-------------AIGTAKGLVYLHE- 140 (356)
Q Consensus 107 sL~~~l~~~---------------------~----~~l~~~~~~-------~i-------------~~qi~~~l~~LH~- 140 (356)
.+.+.+... . ...+..... .+ ...+...+..+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433110 0 111211110 00 0011112222211
Q ss_pred --ccCCCeeeeccCccceEEcCC----CceEEeccCCccc
Q 047701 141 --ECQQRIIHYDIKPENVLLDAN----FSPKVADFGLAKL 174 (356)
Q Consensus 141 --~~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~~ 174 (356)
.....++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123689999999999999874 6789999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.6e-05 Score=66.13 Aligned_cols=71 Identities=8% Similarity=0.034 Sum_probs=42.7
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEec-CCC
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYM-ENG 106 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~~ 106 (356)
.+.|+.|....+|++ ..+++|+....... ......|+.+++.+...++ +++++++ ...-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 466888999999999 56888987643211 1122456666666532222 4555544 33347899999 665
Q ss_pred CH
Q 047701 107 SL 108 (356)
Q Consensus 107 sL 108 (356)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00014 Score=64.14 Aligned_cols=139 Identities=14% Similarity=0.112 Sum_probs=76.2
Q ss_pred ccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC--eeeEeee------EEcCCeeeEEEEe
Q 047701 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN--LVRLHGF------CHDQHMTALVYEY 102 (356)
Q Consensus 31 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~ 102 (356)
.|+.|....+|++...++ .+++|+..... ....+..|+.++..|...+ +++++.. ....+..++++++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 467788889999987555 68899886521 1223455666666553111 3333321 1223556899999
Q ss_pred cCCCCHhH-----------H---hcc--CC--CC----CC---HHHHHH------------HHHHHHHHHHHHHhc----
Q 047701 103 MENGSLDG-----------Y---LFG--KK--RA----LE---WEKLHE------------IAIGTAKGLVYLHEE---- 141 (356)
Q Consensus 103 ~~~~sL~~-----------~---l~~--~~--~~----l~---~~~~~~------------i~~qi~~~l~~LH~~---- 141 (356)
++|..+.. . +.. .. .. .. |..... +...+...+..++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865321 0 000 00 00 11 221110 011234455555532
Q ss_pred cCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 142 ~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
.+.+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23579999999999999887666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.79 E-value=5.1e-05 Score=69.94 Aligned_cols=72 Identities=18% Similarity=0.214 Sum_probs=48.6
Q ss_pred cccCcCCceEEEEEEcCC--------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEE
Q 047701 30 TRLGFGGFGQVYKGQFPN--------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVY 100 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 100 (356)
+.|+.|....+|++..++ ++.+++|+.... .....+..|..++..|...++ +++++.+.+ .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 457888889999998643 578999988432 111345578888888743333 566766543 3899
Q ss_pred EecCCCCH
Q 047701 101 EYMENGSL 108 (356)
Q Consensus 101 e~~~~~sL 108 (356)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=9e-05 Score=66.91 Aligned_cols=138 Identities=14% Similarity=0.162 Sum_probs=82.4
Q ss_pred cccCcCCceEEEEEEcC--------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEE
Q 047701 30 TRLGFGGFGQVYKGQFP--------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (356)
+.|..|-...+|++..+ +++.+++|+..... .....+.+|.++++.|. +.-.+++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 35677888899999874 24789999863321 23345668988888774 3223566666654 2999
Q ss_pred EecCCCCHhHH--------------h---ccC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 047701 101 EYMENGSLDGY--------------L---FGK----KRALE--WEKLHEIAIGTAK-------------------GLVYL 138 (356)
Q Consensus 101 e~~~~~sL~~~--------------l---~~~----~~~l~--~~~~~~i~~qi~~-------------------~l~~L 138 (356)
||++|.+|..- + ... ..... +.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655311 0 011 11222 4555556554422 23333
Q ss_pred Hhc-----cCCCeeeeccCccceEEcCC----CceEEeccCCcc
Q 047701 139 HEE-----CQQRIIHYDIKPENVLLDAN----FSPKVADFGLAK 173 (356)
Q Consensus 139 H~~-----~~~~ivH~Dlkp~Nill~~~----~~~kl~DfGla~ 173 (356)
... .+..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 321 13469999999999999876 789999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00025 Score=62.73 Aligned_cols=137 Identities=15% Similarity=0.148 Sum_probs=78.5
Q ss_pred cCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCC--CeeeEeee-----EEcCCeeeEEEEecC
Q 047701 32 LGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHI--NLVRLHGF-----CHDQHMTALVYEYME 104 (356)
Q Consensus 32 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~ 104 (356)
++ |....||++...+|+.+++|...... .....+..|..++..+... .+++++.. ....+..+++|++++
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 55 77789999987677789999986431 1234566677777766321 24444443 122445678999998
Q ss_pred CCCHh-----HH------h-------ccC----CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc--
Q 047701 105 NGSLD-----GY------L-------FGK----KRALEWEKL----HEI---------------AIGTAKGLVYLHEE-- 141 (356)
Q Consensus 105 ~~sL~-----~~------l-------~~~----~~~l~~~~~----~~i---------------~~qi~~~l~~LH~~-- 141 (356)
|..+. .. + ... ....++... ..+ ...+-..+..+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 10 0 000 011222211 001 00111122333221
Q ss_pred --cCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 142 --CQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 142 --~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
.+..++|+|+++.||+++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 235789999999999998 4 89999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00031 Score=65.05 Aligned_cols=73 Identities=15% Similarity=0.111 Sum_probs=46.4
Q ss_pred cccCcCCceEEEEEEcCC-CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe-eeEeeeEEcCCeeeEEEEecCCCC
Q 047701 30 TRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL-VRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
+.|+.|-...+|++...+ +..+++|+........ .....|..++..|...++ +++++++.. .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 457788889999998754 5788999875432111 112468888888754444 567776632 36999998754
Q ss_pred H
Q 047701 108 L 108 (356)
Q Consensus 108 L 108 (356)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0018 Score=57.50 Aligned_cols=31 Identities=29% Similarity=0.313 Sum_probs=27.4
Q ss_pred CCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999998878899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00033 Score=63.06 Aligned_cols=73 Identities=10% Similarity=0.132 Sum_probs=42.7
Q ss_pred cccCcCCceEEEEEEcCC---------CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC-eeeEeeeEEcCCeeeEE
Q 047701 30 TRLGFGGFGQVYKGQFPN---------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN-LVRLHGFCHDQHMTALV 99 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv 99 (356)
+.|+.|....+|++...+ ++.+++|+....... ......|..+++.+...+ ++++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 457788888999998643 268888987543211 112356777777664223 44566544 2 2689
Q ss_pred EEecCCCCH
Q 047701 100 YEYMENGSL 108 (356)
Q Consensus 100 ~e~~~~~sL 108 (356)
|+|++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0074 Score=55.19 Aligned_cols=137 Identities=12% Similarity=0.135 Sum_probs=81.2
Q ss_pred cccCcCCceEEEEEEcCC--------CcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEE
Q 047701 30 TRLGFGGFGQVYKGQFPN--------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (356)
+.|..|-...+|++...+ ++.+++++...... ......+|.++++.+. +.-.+++++.+. -++|+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 456778888999998753 57899998654321 1112346777777663 222455555332 27899
Q ss_pred EecCCCCHhH-------H-------h---c---c-----C---C-CCCCHHHHHHHHHHH-------------------H
Q 047701 101 EYMENGSLDG-------Y-------L---F---G-----K---K-RALEWEKLHEIAIGT-------------------A 132 (356)
Q Consensus 101 e~~~~~sL~~-------~-------l---~---~-----~---~-~~l~~~~~~~i~~qi-------------------~ 132 (356)
+|++|.+|.. . + . . . . .+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 0 0 0 0 1 111244444444332 1
Q ss_pred HHHHHHHh---------------------ccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 133 KGLVYLHE---------------------ECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 133 ~~l~~LH~---------------------~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
..+..|.. ..+..++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 11346999999999999 778899999998775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.0078 Score=54.73 Aligned_cols=29 Identities=24% Similarity=0.339 Sum_probs=24.2
Q ss_pred CeeeeccCccceEE------cCCCceEEeccCCcc
Q 047701 145 RIIHYDIKPENVLL------DANFSPKVADFGLAK 173 (356)
Q Consensus 145 ~ivH~Dlkp~Nill------~~~~~~kl~DfGla~ 173 (356)
.++|+|+.+.||++ +++..++++||-.|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36899999999999 345679999997764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=91.07 E-value=0.025 Score=52.38 Aligned_cols=63 Identities=5% Similarity=0.067 Sum_probs=19.3
Q ss_pred ccccccCcCCceEEEEEEcCC-CcEEEE------EEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc
Q 047701 27 NYSTRLGFGGFGQVYKGQFPN-GVKIAV------KVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD 92 (356)
Q Consensus 27 ~~~~~lg~G~fg~Vy~~~~~~-~~~vav------K~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 92 (356)
.+.++|| ||.||+|.+.. ..+||| |..... ........+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4556777 99999998853 467888 665542 222334568889999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.87 E-value=1.1 Score=36.52 Aligned_cols=81 Identities=11% Similarity=0.123 Sum_probs=58.8
Q ss_pred CCCCeeeEeeeEEcCCeeeEEEEecCC-CCHhHHhccCCCCCCHHHHHHHHHHHHHHHH-HHHhccCCCeeeeccCccce
Q 047701 79 YHINLVRLHGFCHDQHMTALVYEYMEN-GSLDGYLFGKKRALEWEKLHEIAIGTAKGLV-YLHEECQQRIIHYDIKPENV 156 (356)
Q Consensus 79 ~h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~Dlkp~Ni 156 (356)
.||++ -..+-.+.+.+.+.++.-++ -++.. + ..++...+++++.+|+.... +++. -+|--|.|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 47777 44444666666666666533 23433 2 46788999999999988777 6654 47778999999
Q ss_pred EEcCCCceEEeccCC
Q 047701 157 LLDANFSPKVADFGL 171 (356)
Q Consensus 157 ll~~~~~~kl~DfGl 171 (356)
+++.++.+++.-.|+
T Consensus 116 ~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 116 MFNRALEPFFLHVGV 130 (219)
T ss_dssp EECTTCCEEESCCEE
T ss_pred EEeCCCcEEEEEcCC
Confidence 999999999987765
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.98 E-value=1.1 Score=36.46 Aligned_cols=90 Identities=6% Similarity=0.046 Sum_probs=62.0
Q ss_pred HHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeec
Q 047701 71 EVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150 (356)
Q Consensus 71 e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 150 (356)
|+..|.. .||+.+.. .+-.+.+.+.+.++.-+ +...+- .-...+....++++.+|+....+++. -+|--
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~ 104 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFV 104 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence 3433333 57888876 45556666555555533 222221 12467889999999999988866654 37788
Q ss_pred cCccceEEcCCCceEEeccCC
Q 047701 151 IKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 151 lkp~Nill~~~~~~kl~DfGl 171 (356)
|.|+|++++.++.++++=.|+
T Consensus 105 L~P~NL~f~~~~~p~i~~RGi 125 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGL 125 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEE
T ss_pred EecceEEEcCCCCEEEEEccC
Confidence 999999999999999987665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 356 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-70 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 1e-70
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 20/278 (7%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
R+G G FG VYKG++ V AVK+LN + F EVG + +T H+N++ G+
Sbjct: 15 RIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ A+V ++ E SL +L + E KL +IA TA+G+ YLH + IIH
Sbjct: 73 STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG--NYPITH 207
D+K N+ L + + K+ DFGLA + R G+ + APE + P +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267
+ DVY+FG+V +E++ + + D V Y +L +
Sbjct: 189 QSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDL---------SKVRSN 237
Query: 268 KAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305
K + + C++ +RP ++ +E + LP
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-64
Identities = 61/268 (22%), Positives = 119/268 (44%), Gaps = 22/268 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G FG V G++ +A+K++ + G ++E++F+ E + H LV+L+G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
Q ++ EYM NG L YL + + ++L E+ + + YL ++ +H D
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
+ N L++ KV+DFGL++ + + G K +S PE L + + K D
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLMYS-KFSSKSD 183
Query: 211 VYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAK 270
+++FG++ +EI + +E + SE I + ++
Sbjct: 184 IWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASE 228
Query: 271 QLCMVALWCVQDSPADRPPMSAVVKMLE 298
++ + C + +RP ++ +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-63
Identities = 71/272 (26%), Positives = 127/272 (46%), Gaps = 22/272 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V+ G + N K+A+K + + G ++EE F+ E + + H LV+L+G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150
+Q LV+E+ME+G L YL ++ E L + + +G + + +IH D
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVIHRD 126
Query: 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCD 210
+ N L+ N KV+DFG+ + ++ + G K +++PE S + + K D
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSFS-RYSSKSD 184
Query: 211 VYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAK 270
V+SFG++ +E+ K +E SE+ I K + +
Sbjct: 185 VWSFGVLMWEVFSEG---------------KIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 271 QLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
+ + C ++ P DRP S +++ L + E
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-62
Identities = 69/294 (23%), Positives = 125/294 (42%), Gaps = 28/294 (9%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG+V++G++ G ++AVK+ + + AE+ H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAAD 66
Query: 91 HDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC---- 142
+ + T LV +Y E+GSL YL + + E + ++A+ TA GL +LH E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 143 -QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI--SGYKGTPGYSAPEFL 199
+ I H D+K +N+L+ N + +AD GLA D + I + GT Y APE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 200 SG-----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254
++ + D+Y+ G+V +EI R + + V + E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 255 MILACGI------EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
++ + + E + + + C + A R + K L + +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-61
Identities = 78/269 (28%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
RLG G FG+V+ G + K+AVK L + G ++ + F+AE + + H LVRL+
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKKRA-LEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ + ++ EYMENGSL +L L KL ++A A+G+ ++ E IH
Sbjct: 78 TQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D++ N+L+ S K+ADFGLA+L + N G K ++APE ++ T K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYG-TFTIKS 191
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269
DV+SFG++ EIV R + E+ + +
Sbjct: 192 DVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 270 KQLCMVALWCVQDSPADRPPMSAVVKMLE 298
++L + C ++ P DRP + +LE
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-61
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 24/279 (8%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+LG G FG+V+ G + ++A+K L ++ E F+ E + + H LV+L+
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 91 HDQHMTALVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
++ + +V EYM GSL +L G+ + L +L ++A A G+ Y+ + +H
Sbjct: 82 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D++ N+L+ N KVADFGLA+L + N G K ++APE T K
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG-RFTIKS 195
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269
DV+SFG++ E+ + R + E+ + E
Sbjct: 196 DVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 270 KQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPK 308
+ L + C + P +RP + LE P
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-60
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 24/271 (8%)
Query: 32 LGFGGFGQVYKGQF---PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
LG G FG V +G + + +A+KVL + K E+ M E + + + +VRL G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + + LV E G L +L GK+ + + E+ + G+ YL ++ +H
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 132
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI-SGYKGTPGYSAPEFLSGNYPITH 207
D+ NVLL K++DFGL+K + S+ T S K + APE ++ +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 191
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267
+ DV+S+G+ +E + + +++ + E+ A I E E
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 268 KAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+L + C DRP V + +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 5e-60
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 26/278 (9%)
Query: 32 LGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLH 87
+G G FG+V G + +A+K L + F++E +G+ H N++ L
Sbjct: 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G ++ E+MENGSLD +L +L + G A G+ YL +
Sbjct: 94 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYV 150
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS---GYKGTPGYSAPEFLSGNYP 204
H D+ N+L+++N KV+DFGL++ + + S T + G K ++APE +
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-K 209
Query: 205 ITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264
T DV+S+G+V +E++ + + + ++ I
Sbjct: 210 FTSASDVWSYGIVMWEVMSYG---------------ERPYWDMTNQDVINAIEQDYRLPP 254
Query: 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
+ L + L C Q RP +V L+ ++
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-58
Identities = 70/313 (22%), Positives = 123/313 (39%), Gaps = 29/313 (9%)
Query: 12 KPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQ 67
+ V+ + ++ +++ +G G FG VY G + + AVK LN+ Q
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74
Query: 68 FMAEVGTIGRTYHINLVRLHGFC-HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHE 126
F+ E + H N++ L G C + +V YM++G L ++ + + L
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN--RSHVTI 184
+ AKG+ ++ +H D+ N +LD F+ KVADFGLA+ S
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW 244
+G K + A E L T K DV+SFG++ +E++ R +
Sbjct: 192 TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPP---------------Y 235
Query: 245 EEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304
+ ++ +L + + L V L C RP S +V + +
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 305 PPPKPFRYLDLNK 317
Y+ +N
Sbjct: 296 IGE---HYVHVNA 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 6e-58
Identities = 63/301 (20%), Positives = 111/301 (36%), Gaps = 48/301 (15%)
Query: 31 RLGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
+G G FG+V++ + P +AVK+L + + F E + + N+V
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------------ALEW 121
+L G C L++EYM G L+ +L L
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
+ IA A G+ YL E ++ +H D+ N L+ N K+ADFGL++ +
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK 241
+ PE + T + DV+++G+V +EI
Sbjct: 197 KADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQP------------- 242
Query: 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301
+ E+ + I + +L + C PADRP ++ ++L+ +
Sbjct: 243 --YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300
Query: 302 E 302
E
Sbjct: 301 E 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 5e-57
Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 28/306 (9%)
Query: 32 LGFGGFGQVYKGQFPN-----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG VYKG + + +A+K L + A ++ + E + + ++ RL
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + L+ + M G L Y+ K + + L + AKG+ YL +R+
Sbjct: 77 LGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRL 132
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+ NVL+ K+ DFGLAKL G K + A E + T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYT 191
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
H+ DV+S+G+ +E++ ++ SE+ +++ +
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGERLPQPP 236
Query: 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPFRYLDLNKMTGLRSLES 326
+ M+ + C RP ++ ++ P+ + + ++ L S
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRYLVIQGDERMHLPSPTD 293
Query: 327 SDGSNS 332
S+ +
Sbjct: 294 SNFYRA 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 7e-57
Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 25/285 (8%)
Query: 32 LGFGGFGQVYKGQFPNG-----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G FG+VYKG V +A+K L + F+ E G +G+ H N++RL
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G ++ EYMENG+LD +L K +L + G A G+ YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNY 131
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGYSAPEFLSGNYPI 205
+H D+ N+L+++N KV+DFGL+++ + + T SG K ++APE +S
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KF 190
Query: 206 THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265
T DV+SFG+V +E++ + E E+ I
Sbjct: 191 TSASDVWSFGIVMWEVMTYGE---------------RPYWELSNHEVMKAINDGFRLPTP 235
Query: 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPF 310
+ + + + C Q A RP + +V +L+ ++ K
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-56
Identities = 68/299 (22%), Positives = 129/299 (43%), Gaps = 31/299 (10%)
Query: 19 LQLNNFTSNYST--RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTI 75
++L + ++ LG G G V+K P+G+ +A K+++ + Q + E+ +
Sbjct: 1 MELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGL 135
+V +G + ++ E+M+ GSLD L R + + L +++I KGL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
YL E+ +I+H D+KP N+L+++ K+ DFG++ + ++ + GT Y +
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMS 171
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255
PE L G + + D++S G+ E+ R P ++ +
Sbjct: 172 PERLQGT-HYSVQSDIWSMGLSLVEMAVGRY----------PIPPP-------DAKELEL 213
Query: 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPFRYLD 314
+ C +E E + RPPM A+ ++L+ +V PP P
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFS 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 67/297 (22%), Positives = 111/297 (37%), Gaps = 47/297 (15%)
Query: 31 RLGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINL 83
LG G FG+V +++AVK+L + E M+E+ + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKR----------------------ALEW 121
V L G C L++EY G L YL K+ L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 122 EKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181
E L A AKG+ +L + +H D+ NVL+ K+ DFGLA+ + ++
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK 241
V + + APE L T K DV+S+G++ +EI N G F K
Sbjct: 221 VVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-ANFYK 278
Query: 242 YVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ ++ ++ +++ ++ C RP + L
Sbjct: 279 LIQNGFK-------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-56
Identities = 67/275 (24%), Positives = 108/275 (39%), Gaps = 26/275 (9%)
Query: 31 RLGFGGFGQVYKGQFP----NGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLV 84
+LG G FG V +G++ V +AVK L ++ E + F+ EV + H NL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
RL+G M +V E GSL L + L A+ A+G+ YL +
Sbjct: 75 RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 145 RIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYP 204
R IH D+ N+LL K+ DFGL + +N H + ++ P
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 205 ITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE-E 263
+H D + FG+ +E+ + W S++ I G
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEP---------------WIGLNGSQILHKIDKEGERLP 235
Query: 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ ++ + + V + C P DRP A+ L
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-55
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 30/272 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG V G + G K+AVK + + F+AE + + H NLV+L G
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 91 -HDQHMTALVYEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
++ +V EYM GSL YL + R L + L + ++ + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+ NVL+ + KV+DFGL K + K ++APE L + K
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREK-KFSTK 180
Query: 209 CDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268
DV+SFG++ +EI R + ++ + +
Sbjct: 181 SDVWSFGILLWEIYSFGR---------------VPYPRIPLKDVVPRVEKGYKMDAPDGC 225
Query: 269 AKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300
+ V C A RP + + LE +
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-55
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 28/274 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G +G+ K + +G + K L+ ++ + ++ ++EV + H N+VR +
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 89 FCHDQHMTAL--VYEYMENGSLDGYLFGKKR---ALEWEKLHEIAIGTAKGLVYLHE--E 141
D+ T L V EY E G L + + L+ E + + L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 142 CQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
++H D+KP NV LD + K+ DFGLA++ + + S + GTP Y +PE ++
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQMNR 188
Query: 202 NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
K D++S G + +E+ + + + EL I
Sbjct: 189 M-SYNEKSDIWSLGCLLYEL----------------CALMPPFTAFSQKELAGKIREGKF 231
Query: 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+ +L + + RP + +++
Sbjct: 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-55
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 42/296 (14%)
Query: 31 RLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINL 83
LG G FG+V + + +AVK+L + E M+E+ + H+N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 84 VRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKR-----------------ALEWEKLHE 126
V L G C T ++ EY G L +L K+ AL+ E L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
+ AKG+ +L + IH D+ N+LL K+ DFGLA+ + ++V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246
+ + APE + T + DV+S+G+ +E+ + G F K + E
Sbjct: 207 ARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEG 264
Query: 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
+ + ++ + C P RP +V+++E +
Sbjct: 265 FR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-55
Identities = 67/309 (21%), Positives = 123/309 (39%), Gaps = 43/309 (13%)
Query: 13 PVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFPNG---VKIAVKVLNKNLGKIAEEQFM 69
P + L N+ + +G G FGQV K + + A+K + + K F
Sbjct: 1 PTIYPVLDWNDIK--FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58
Query: 70 AEVGTIGR-TYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGK------------- 115
E+ + + +H N++ L G C + L EY +G+L +L
Sbjct: 59 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118
Query: 116 --KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173
L ++L A A+G+ YL Q++ IH D+ N+L+ N+ K+ADFGL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 175
Query: 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS 233
+ + + A E L+ + T DV+S+G++ +EIV
Sbjct: 176 GQEVYVKKTMG---RLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP----- 226
Query: 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAV 293
+ +EL + EK ++ + C ++ P +RP + +
Sbjct: 227 ----------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276
Query: 294 VKMLEGVVE 302
+ L ++E
Sbjct: 277 LVSLNRMLE 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (456), Expect = 5e-55
Identities = 69/274 (25%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 31 RLGFGGFGQVYKGQFPN-GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG G +G+VY+G + + +AVK L ++ + E+F+ E + H NLV+L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKR-ALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + ++ E+M G+L YL R + L +A + + YL ++ IH
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+ N L+ N KVADFGL++L + +G K ++APE L+ N + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYN-KFSIK 196
Query: 209 CDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK 268
DV++FG++ +EI + + + S++ ++ E+ +
Sbjct: 197 SDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRMERPEGC 241
Query: 269 AKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
+++ + C Q +P+DRP + + + E + +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-55
Identities = 64/273 (23%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 31 RLGFGGFGQVYKGQFPN---GVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G FG V KG + +AVK+L +++ +AE + + + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G C + LV E E G L+ YL + R ++ + + E+ + G+ YL +
Sbjct: 74 IGICEAESW-MLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLE---ESNF 128
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTIS-GYKGTPGYSAPEFLSGNYPI 205
+H D+ NVLL K++DFGL+K + ++ K + APE ++
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KF 187
Query: 206 THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKD 265
+ K DV+SFG++ +E + + + SE+ AM+
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKP---------------YRGMKGSEVTAMLEKGERMGCP 232
Query: 266 KEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+++ + C +RP +AV L
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 4e-54
Identities = 65/282 (23%), Positives = 105/282 (37%), Gaps = 34/282 (12%)
Query: 22 NNFTSNYST--RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIG 76
++ +S +G G FG VY + N +A+K ++ + + + EV +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 77 RTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLV 136
+ H N ++ G +H LV EY + D KK L+ ++ + G +GL
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLA 129
Query: 137 YLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAP 196
YLH +IH D+K N+LL K+ DFG A + S V GTP + AP
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAP 180
Query: 197 EFLSGNY--PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254
E + K DV+S G+ E+ R+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP----------------LFNMNAMSALY 224
Query: 255 MILACGI-EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
I + ++ C+Q P DRP ++K
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-53
Identities = 61/272 (22%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G FG+VYK Q V A KV++ + E +M E+ + H N+V+L
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+ ++ ++ E+ G++D + +R L ++ + T L YLH+ +IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHR 134
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNY----PI 205
D+K N+L + K+ADFG++ R + GTP + APE + P
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKDRPY 192
Query: 206 THKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE--E 263
+K DV+S G+ E+ E + I
Sbjct: 193 DYKADVWSLGITLIEMAEIEPP----------------HHELNPMRVLLKIAKSEPPTLA 236
Query: 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+ + C++ + R S +++
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-53
Identities = 65/275 (23%), Positives = 108/275 (39%), Gaps = 29/275 (10%)
Query: 28 YSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVR 85
+ +G G F VYKG V++A L L K ++F E + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 86 LHGFCHD----QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEE 141
+ + LV E M +G+L YL + + ++ + L KGL +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 142 CQQRIIHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
IIH D+K +N+ + S K+ D GLA L + + I GTP + APE
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYE 186
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260
Y DVY+FGM E+ ++ + V + +
Sbjct: 187 EKY--DESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPASF-------- 234
Query: 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
DK ++ + C++ + +R + ++
Sbjct: 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 9e-53
Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 25/276 (9%)
Query: 31 RLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRL 86
+G G FG V++G + + + +A+K E+F+ E T+ + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
G + + ++ E G L +L +K +L+ L A + L YL +R
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H DI NVL+ +N K+ DFGL++ + + + G K + APE ++ T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINFR-RFT 187
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
DV+ FG+ +EI+ ++ + +++ I
Sbjct: 188 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 267 EKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
L + C P+ RP + + L ++E
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-52
Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 21/275 (7%)
Query: 24 FTSNYS--TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH 80
F ++ LG G +G+V +AVK+++ E E+ H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 81 INLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
N+V+ +G + ++ L EY G L + + G+VYLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
I H DIKPEN+LLD + K++DFGLA + N ++ GT Y APE L
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260
DV+S G+V ++ + + E S+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGEL-----------PWDQPSDSCQEYSDWKEKKTYLN 227
Query: 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+K L + ++P+ R + + K
Sbjct: 228 PWKKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-52
Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 34/301 (11%)
Query: 31 RLGFGGFGQVYKG------QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLV 84
LG G FG VY+G + ++A+K +N+ +F+ E + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRA---------LEWEKLHEIAIGTAKGL 135
RL G T ++ E M G L YL + A K+ ++A A G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
YL + +H D+ N ++ +F+ K+ DFG+ + + + +
Sbjct: 147 AYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255
PE L T DV+SFG+V +EI + ++ ++
Sbjct: 204 PESLKDG-VFTTYSDVWSFGVVLWEIA---------------TLAEQPYQGLSNEQVLRF 247
Query: 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLPPPKPFRYLDL 315
++ G+ +K L + C Q +P RP ++ ++ +E F Y +
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
Query: 316 N 316
N
Sbjct: 308 N 308
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-51
Identities = 71/270 (26%), Positives = 110/270 (40%), Gaps = 33/270 (12%)
Query: 31 RLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLH 87
LG G FG VY + + +A+KVL K E Q EV H N++RL+
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G+ HD L+ EY G++ L + + ++ A L Y H +R+I
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS---KRVI 128
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H DIKPEN+LL + K+ADFG + +R GT Y PE + G
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGR-MHDE 183
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK- 266
K D++S G++ +E + + +E E I D
Sbjct: 184 KVDLWSLGVLCYEFLVGKP----------------PFEANTYQETYKRISRVEFTFPDFV 227
Query: 267 -EKAKQLCMVALWCVQDSPADRPPMSAVVK 295
E A+ L ++ +P+ RP + V++
Sbjct: 228 TEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-51
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 43/297 (14%)
Query: 31 RLGFGGFGQVYKGQFP--------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHI 81
LG G FGQV + K+AVK+L + + ++E+ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHE 126
N++ L G C ++ EY G+L YL ++ L + L
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
A A+G+ YL ++ IH D+ NVL+ + K+ADFGLA+ + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246
+ + APE L TH+ DV+SFG++ +EI +
Sbjct: 197 GRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGG---------------SPYPG 240
Query: 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303
EL ++ +K +L M+ C P+ RP +V+ L+ +V +
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-48
Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 41/295 (13%)
Query: 31 RLGFGGFGQVYKG------QFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINL 83
LG G FGQV + + +AVK+L + M+E+ + +H+N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 84 VRLHGFC-HDQHMTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEI 127
V L G C ++ E+ + G+L YL K K L E L
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 128 AIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGY 187
+ AKG+ +L ++ IH D+ N+LL K+ DFGLA+ ++ +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 188 KGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEY 247
+ + APE + T + DV+SFG++ +EI + G + F + + E
Sbjct: 197 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT 254
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302
++ L C P+ RP S +V+ L +++
Sbjct: 255 R-------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (396), Expect = 2e-45
Identities = 67/330 (20%), Positives = 114/330 (34%), Gaps = 43/330 (13%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G FG V++ G A K + +E E+ T+ H LV LH
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
D + ++YE+M G L + + + ++ E KGL ++HE +H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHL 148
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
D+KPEN++ S K+ DFGL D +S GT ++APE G P+ +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK-PVGY 204
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK- 266
D++S G++S+ ++ + E + +C D
Sbjct: 205 YTDMWSVGVLSYILLSGLS----------------PFGGENDDETLRNVKSCDWNMDDSA 248
Query: 267 -----EKAKQLCMVALWCVQDSPADRPPMSAVVKM-------LEGVVEVLPPPKPFRYLD 314
E K + P R + ++ G +P + + D
Sbjct: 249 FSGISEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305
Query: 315 LNKMTGLRSLESSDGSNSSNQSRWYKETTP 344
K E + ++ P
Sbjct: 306 SIKTKYDAWPEPLPPLGRISNYSSLRKHRP 335
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-45
Identities = 51/268 (19%), Positives = 102/268 (38%), Gaps = 28/268 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G G VY G ++A++ +N + +E + E+ + + N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+V EY+ GSL + + ++ ++ + + L +LH ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
DIK +N+LL + S K+ DFG +S + GTP + APE ++ K
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRK-AYGPKV 197
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEK- 268
D++S G+++ E++ + +I G E +
Sbjct: 198 DIWSLGIMAIEMIEGEP----------------PYLNENPLRALYLIATNGTPELQNPEK 241
Query: 269 -AKQLCMVALWCVQDSPADRPPMSAVVK 295
+ C+ R +++
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-44
Identities = 54/273 (19%), Positives = 95/273 (34%), Gaps = 29/273 (10%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTYHINLVRLH 87
LG G F V + + A+K+L K + + E + R H V+L+
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
D Y +NG L Y+ E TA+ + L + II
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTAEIVSALEYLHGKGII 130
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
H D+KPEN+LL+ + ++ DFG AK+ + + GT Y +PE L+
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACK 189
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK- 266
D+++ G + +++V + + + I+ + +K
Sbjct: 190 SSDLWALGCIIYQLV----------------AGLPPFRAGNEYLIFQKIIKLEYDFPEKF 233
Query: 267 -EKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
KA+ L + R +
Sbjct: 234 FPKARDLVE---KLLVLDATKRLGCEEMEGYGP 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-43
Identities = 54/335 (16%), Positives = 111/335 (33%), Gaps = 40/335 (11%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G FG V++ + K + + E+ + H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHES 69
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
+++E++ + + L ++ + L +LH I H+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
DI+PEN++ S K+ +FG A+ + P Y APE + ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV-VST 182
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI---EEK 264
D++S G + + ++ + ++ I+ EE
Sbjct: 183 ATDMWSLGTLVYVLL----------------SGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVV------KMLEGV-VEVLPPPKPFRYLDLNK 317
KE + + + R S + + +E V +V+ K RY
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLI 286
Query: 318 MTGLRSLESSDGSNSSNQSRWYKETTPIMARHEIQ 352
L + S+ + R + +A+ ++
Sbjct: 287 KKDLNMVVSAARISCGGAIR--SQKGVSVAKVKVA 319
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 9e-43
Identities = 58/276 (21%), Positives = 110/276 (39%), Gaps = 30/276 (10%)
Query: 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTI 75
L +N+F+ +G GGFG+VY + G A+K L+K K E + E +
Sbjct: 1 LTMNDFS--VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 76 ---GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTA 132
+V + H + + + M G L +L E + + A
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-MRFYAAEII 117
Query: 133 KGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPG 192
GL ++H + +++ D+KP N+LLD + +++D GLA + + H ++ GT G
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHG 170
Query: 193 YSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252
Y APE L D +S G + F+++ F ++ ++ + +
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS-----------PFRQHKTKDKHEIDR 219
Query: 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP 288
+ +A + + + + L +Q R
Sbjct: 220 MTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRL 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (374), Expect = 3e-42
Identities = 50/271 (18%), Positives = 103/271 (38%), Gaps = 30/271 (11%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G FG V++ G K +N + + E+ + + +H L+ LH
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
D++ L+ E++ G L + + + ++ +GL ++HE I+H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 150 DIKPENVLLDANFSP--KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
DIKPEN++ + + K+ DFGLA + + T ++APE + P+
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDRE-PVGF 207
Query: 208 KCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKE 267
D+++ G++ + ++ + + E + C E +
Sbjct: 208 YTDMWAIGVLGYVLLSGLS----------------PFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 268 KAK---QLCMVALWCVQDSPADRPPMSAVVK 295
+ + +Q P R + ++
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-41
Identities = 57/299 (19%), Positives = 116/299 (38%), Gaps = 29/299 (9%)
Query: 20 QLNNFTSNYST--RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIG 76
Q+ + Y+ +G G +G V N V++A+K ++ + ++ + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 77 RTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFG--KKRALEWEKLHEIAIGTAKG 134
R H N++ ++ + + Y+ + L+ K + L + + +G
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV-TISGYKGTPGY 193
L Y+H ++H D+KP N+LL+ K+ DFGLA++ D + H ++ Y T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIVGRR--------RNAIVGASESLDWFPKYVWE 245
APE + + T D++S G + E++ R + + L +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 246 EYEKSELGAMILACGIEEKDK---------EKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+ +L+ + K KA L + +P R + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (362), Expect = 3e-41
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 43/292 (14%)
Query: 24 FTSNYST--RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--------KIAEEQFMAEV 72
F NY LG G V + P + AVK+++ G + E + EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 73 GTIGRT-YHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGT 131
+ + H N+++L LV++ M+ G L YL +K L ++ +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119
Query: 132 AKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTP 191
+ + LH+ I+H D+KPEN+LLD + + K+ DFG + D GTP
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173
Query: 192 GYSAPEFLSGNY-----PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEE 246
Y APE + + + D++S G++ + ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----------------PPFWH 217
Query: 247 YEKSELGAMILACGIEEKDKEKA---KQLCMVALWCVQDSPADRPPMSAVVK 295
++ + MI++ + E + + + P R +
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 3e-40
Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 19/266 (7%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
LG G F +V + +A+K + K + E E+ + + H N+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
L+ + + G L + K + + YLH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLK 134
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
LD + ++DFGL+K+ D +S GTPGY APE L+ P +
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQK-PYSKAV 190
Query: 210 DVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKA 269
D +S G++++ ++ ++ + + +E+ + + A
Sbjct: 191 DCWSIGVIAYILLCGYPP----------FYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 270 KQLCMVALWCVQDSPADRPPMSAVVK 295
K ++ P R ++
Sbjct: 241 KDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 140 bits (353), Expect = 6e-40
Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 33/282 (11%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLH 87
LGFGG +V+ + +AVKVL +L +F E H +V ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 88 GFCHDQHMTA----LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQ 143
+ +V EY++ +L + + + ++ E+ + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQ--- 129
Query: 144 QRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG-YKGTPGYSAPEFLSGN 202
IIH D+KP N+++ A + KV DFG+A+ + + VT + GT Y +PE G+
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 203 YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI- 261
+ + DVYS G V +E++ + + +
Sbjct: 190 -SVDARSDVYSLGCVLYEVLTGEP----------------PFTGDSPVSVAYQHVREDPI 232
Query: 262 --EEKDKEKAKQLCMVALWCVQDSPADRPP-MSAVVKMLEGV 300
+ + + L V L + +P +R + + L V
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-39
Identities = 65/284 (22%), Positives = 101/284 (35%), Gaps = 28/284 (9%)
Query: 32 LGFGGFGQVYKGQFPN-GVKIAVKVLNKN----LGKIAEEQFMAEVGTIGRTYHINLVRL 86
LG G F VYK + N +A+K + + E+ + H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ +LV+++ME + L + + T +GL YLH+ I
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 121
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
+H D+KP N+LLD N K+ADFGLAK T T Y APE L G
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGARMYG 179
Query: 207 HKCDVYSFGMVSFEIVGRRR--------------NAIVGASESLDWFPKYVWEEYEKSEL 252
D+++ G + E++ R +G W +Y +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296
I I + L +P R + +KM
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-39
Identities = 63/271 (23%), Positives = 106/271 (39%), Gaps = 32/271 (11%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTIGRTY-HINLVRL 86
LG G FG+V+ +F A+K L K+ L E M E + + H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 87 HGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
+ V EY+ G L ++ + + + A GL +LH + I
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHS---KGI 124
Query: 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPIT 206
++ D+K +N+LLD + K+ADFG+ K + + GTP Y APE L G
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEILLGQ-KYN 181
Query: 207 HKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDK 266
H D +SFG++ +E++ + + ++ EL I
Sbjct: 182 HSVDWWSFGVLLYEML----------------IGQSPFHGQDEEELFHSIRMDNPFYPRW 225
Query: 267 --EKAKQLCMVALWCVQDSPADRPPMSAVVK 295
++AK L + P R + ++
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 6e-39
Identities = 55/278 (19%), Positives = 104/278 (37%), Gaps = 19/278 (6%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G +G VYK Q G A+K + + + E+ + H N+V+L+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 90 CHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHY 149
H + LV+E+++ + LE + G+ Y H+ +R++H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD---RRVLHR 124
Query: 150 DIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKC 209
D+KP+N+L++ K+ADFGLA+ + T Y AP+ L G+ +
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 210 DVYSFGMVSFEIVGRR--------RNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
D++S G + E+V + ++ L W +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 262 EEKDKEKAKQLCMVAL----WCVQDSPADRPPMSAVVK 295
+ K L + ++ P R ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 58/274 (21%), Positives = 103/274 (37%), Gaps = 39/274 (14%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEE-----QFMAEVGTIGR--TYHIN 82
LG GGFG VY G + + +A+K + K+ E + EV + + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
++RL + L+ E E ++ AL+ E + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128
Query: 143 QQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
++H DIK EN+L+D N K+ DFG L + GT YS PE++
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRY 183
Query: 202 NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261
+ V+S G++ +++V P EE + ++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEIIRGQV-------FF 223
Query: 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
++ + + L WC+ P+DRP +
Sbjct: 224 RQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 3e-38
Identities = 46/280 (16%), Positives = 93/280 (33%), Gaps = 29/280 (10%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN-LVRLHG 88
R+G G FG +++G N ++A+K + + Q E T + ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR---RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
F + LV + + D L R + + A + +H ++ +++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124
Query: 149 YDIKPENVLLDANFSP-----KVADFGLAKLCDRNRSHVTI-----SGYKGTPGYSAPEF 198
DIKP+N L+ S V DFG+ K + I GT Y +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 199 LSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258
G + + D+ + G V + G+ ++YE+ +G +
Sbjct: 185 HLGR-EQSRRDDLEALGHVFMYF-------LRGSLPWQGLKAATNKQKYER--IGEKKQS 234
Query: 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
+ E ++ + + P + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 6e-38
Identities = 54/278 (19%), Positives = 97/278 (34%), Gaps = 27/278 (9%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
++G G FG +Y G G ++A+K+ K Q E + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 90 C-HDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
C + +V E + D + F ++ + + +A + Y+H + IH
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 149 YDIKPENVL---LDANFSPKVADFGLAKLCDRNRSHVTI-----SGYKGTPGYSAPEFLS 200
D+KP+N L + DFGLAK R+H I GT Y++
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260
G + + D+ S G V +G+ ++YE+ ++
Sbjct: 187 GI-EQSRRDDLESLGYVLMYF-------NLGSLPWQGLKAATKRQKYERIS--EKKMSTP 236
Query: 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298
IE K + +C D+P S + ++
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-38
Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 21/291 (7%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G +G VYK + G +A+K + + + + E+ + H N+V+L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
H ++ LV+E++ + + +GL + H ++H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLH 125
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+KP+N+L++ + K+ADFGLA+ T T Y APE L G +
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT--HEVVTLWYRAPEILLGCKYYSTA 183
Query: 209 CDVYSFGMVSFEIVGRRR--------NAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260
D++S G + E+V RR + + +L + VW
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 261 IEEKDKEKAKQLCMVAL----WCVQDSPADRPPMSAVVKM--LEGVVEVLP 305
+ + L + P R A + + V + +P
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 31/292 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G FG+V+K + G K+A+K + N + + E+ + H N+V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 89 FCHDQ--------HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHE 140
C + LV+++ E+ G L ++ + GL +
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGL---YY 132
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS--HVTISGYKGTPGYSAPEF 198
+ +I+H D+K NVL+ + K+ADFGLA+ ++ + T Y PE
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 199 LSGNYPITHKCDVYSFGMVSFEIVGRRR--------NAIVGASESLDWFPKYVWEE---Y 247
L G D++ G + E+ R + + S+ VW Y
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 248 EKSELGAMILACGIEEKDKEKAKQLCMVAL----WCVQDSPADRPPMSAVVK 295
E E ++ + KD+ KA AL + PA R +
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-37
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 39/282 (13%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
+G G FG VY+ + +G +A+K + ++ + E+ + + H N+VRL F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 91 H------DQHMTALVYEYMENGSLDGYLFG--KKRALEWEKLHEIAIGTAKGLVYLHEEC 142
+ D+ LV +Y+ K+ L + + L Y+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 139
Query: 143 QQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSG 201
I H DIKP+N+LLD + K+ DFG AK R +V+ Y + Y APE + G
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFG 196
Query: 202 NYPITHKCDVYSFGMVSFEIVGRRR---------------NAIVGASESLDWFPKYVWEE 246
T DV+S G V E++ + + + + E
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 247 YEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRP 288
++ ++ A + +A LC ++ +P R
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARL 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (336), Expect = 4e-37
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAE--EQFMAEVGTIGRTYHINLVRLH 87
LG G FG+V+ + NG A+KVL K + + E E + H ++R+
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 88 GFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRII 147
G D ++ +Y+E G L L +R A + L + II
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----CLALEYLHSKDII 126
Query: 148 HYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITH 207
+ D+KPEN+LLD N K+ DFG AK GTP Y APE +S P
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTK-PYNK 180
Query: 208 KCDVYSFGMVSFEIVGRRR 226
D +SFG++ +E++
Sbjct: 181 SIDWWSFGILIYEMLAGYT 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-37
Identities = 60/290 (20%), Positives = 117/290 (40%), Gaps = 36/290 (12%)
Query: 31 RLGFGGFGQVYKGQF--PNGVKIAVKVLNKNLGK----IAEEQFMAEVGTIGRTYHINLV 84
+G G +G+V+K + G +A+K + G+ ++ + +A + + H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 85 RLHGFCHDQH-----MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLH 139
RL C LV+E+++ + + E + ++ +GL +LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 140 EECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFL 199
R++H D+KP+N+L+ ++ K+ADFGLA++ + + T Y APE L
Sbjct: 134 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPEVL 187
Query: 200 SGNYPITHKCDVYSFGMVSFEIVGRRR--------------NAIVGASESLDWFPKYVWE 245
+ D++S G + E+ R+ ++G DW
Sbjct: 188 LQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 246 EYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
A + + + D+ K L + C+ +PA R + +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDEL-GKDLLL---KCLTFNPAKRISAYSALS 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 57/273 (20%), Positives = 99/273 (36%), Gaps = 30/273 (10%)
Query: 32 LGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFC 90
LG G G+V + K A+K+L E + ++VR+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-----CPHIVRIVDVY 74
Query: 91 HDQHMTA----LVYEYMENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQR 145
+ + +V E ++ G L + + +A + EI + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131
Query: 146 IIHYDIKPENVLLDANFSP---KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
I H D+KPEN+L + K+ DFG AK + S T TP Y APE L
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPE 188
Query: 203 YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIE 262
CD++S G++ + ++ ++ L P + +G
Sbjct: 189 -KYDKSCDMWSLGVIMYILLCGYP--PFYSNHGLAISPGM----KTRIRMGQYEFPNPEW 241
Query: 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295
+ E+ K L ++ P R ++ +
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-35
Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRTYHINLV 84
LG G F V K + G++ A K + K K ++ E EV + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 85 RLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQ 144
LH ++ L+ E + G L + +K +L E+ E G ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNG---VYYLHSL 132
Query: 145 RIIHYDIKPENVLLDANFSP----KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLS 200
+I H+D+KPEN++L P K+ DFGLA D GTP + APE ++
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 189
Query: 201 GNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260
P+ + D++S G++++ ++ + K E A + A
Sbjct: 190 YE-PLGLEADMWSIGVITYILL----------------SGASPFLGDTKQETLANVSAVN 232
Query: 261 IEEKDK------EKAKQLCMVALWCVQDSPADRPPMSAVVK 295
E +D+ AK + P R + ++
Sbjct: 233 YEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 7e-34
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 12/211 (5%)
Query: 19 LQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEEQFMAEVGTI 75
+ +N+F Y LG G FG+V + G A+K+L K + K + E +
Sbjct: 2 VTMNDFD--YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 76 GRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGL 135
T H L L V EY G L +L ++ E A+ +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAEIV 115
Query: 136 VYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSA 195
L + +++ DIK EN++LD + K+ DFGL K + + T+ + GTP Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA 173
Query: 196 PEFLSGNYPITHKCDVYSFGMVSFEIVGRRR 226
PE L N D + G+V +E++ R
Sbjct: 174 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-34
Identities = 50/280 (17%), Positives = 95/280 (33%), Gaps = 21/280 (7%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNK-NLGKIAEEQFMAEVGTIGRTYHINLVRLHG 88
++G G +G V+K + +A+K + + + + E+ + H N+VRLH
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIH 148
H LV+E+ + + + + L L + ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 149 YDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHK 208
D+KP+N+L++ N K+A+FGLA+ + T Y P+ L G +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182
Query: 209 CDVYSFGMVSFEIVGRRRNAIVGASES---------LDWFPKYVWEEYEKSELGAMILAC 259
D++S G + E+ R G L + W K
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 260 GIEEKDKEKAKQLCMVAL----WCVQDSPADRPPMSAVVK 295
+L ++ +P R ++
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 8e-33
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 15/220 (6%)
Query: 10 REKPVRFTSLQLNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKN--LGKIAEE 66
+ + + QL+ F LG G FG+V + +G A+K+L+K + E
Sbjct: 29 KWETPSQNTAQLDQFD--RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE 86
Query: 67 QFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHE 126
+ E + LV+L D +V EY+ G + +L +
Sbjct: 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARF 145
Query: 127 IAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISG 186
A YLH +I+ D+KPEN+L+D +V DFG AK
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 197
Query: 187 YKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRR 226
GTP APE + D ++ G++ +E+
Sbjct: 198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 4e-31
Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 19/201 (9%)
Query: 31 RLGFGGFGQVYKGQ-FPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGR-TYHINLVRLHG 88
+LG G + +V++ N K+ VK+L + +++ E+ + N++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLAD 97
Query: 89 FCHDQ--HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146
D ALV+E++ N + L + K L Y H I
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGI 150
Query: 147 IHYDIKPENVLLDA-NFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
+H D+KP NV++D + ++ D+GLA+ + + + + + PE L
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMY 207
Query: 206 THKCDVYSFGMVSFEIVGRRR 226
+ D++S G + ++ R+
Sbjct: 208 DYSLDMWSLGCMLASMIFRKE 228
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-31
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 13/200 (6%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G +G V G K+A+K L + ++ ++ E+ + H N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 89 FCHDQHMTALVYEY---MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
++ M D K L +++ + KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
IIH D+KP N+ ++ + K+ DFGLA+ D +GY T Y APE +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRY 196
Query: 206 THKCDVYSFGMVSFEIVGRR 225
T D++S G + E++ +
Sbjct: 197 TQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-30
Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 12/204 (5%)
Query: 31 RLGFGGFGQVYKGQ----FPNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRTYHI-N 82
LG G +G+V+ + G A+KVL K E E +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 83 LVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
LV LH + L+ +Y+ G L +L ++R E E + I + ++ L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHLH 146
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
+ II+ DIK EN+LLD+N + DFGL+K + + + G+
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 203 YPITHKCDVYSFGMVSFEIVGRRR 226
D +S G++ +E++
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-27
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 19/203 (9%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHG 88
+G G G V +A+K L++ + ++ E+ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 89 FCHDQHMT------ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC 142
Q LV E M+ + L+ E++ + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGN 202
IH D+KP N+++ ++ + K+ DFGLA+ + + Y T Y APE + G
Sbjct: 140 I---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILG- 192
Query: 203 YPITHKCDVYSFGMVSFEIVGRR 225
D++S G + E+V +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-27
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 13/200 (6%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAE-EQFMAEVGTIGRTYHINLVRLHG 88
+G G +G V G+++AVK L++ I ++ E+ + H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 89 FCHDQHMTA---LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR 145
VY D K + L + + + +GL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 146 IIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPI 205
IIH D+KP N+ ++ + K+ DFGLA+ D + Y T Y APE +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----YVATRWYRAPEIMLNWMHY 196
Query: 206 THKCDVYSFGMVSFEIVGRR 225
D++S G + E++ R
Sbjct: 197 NQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (260), Expect = 5e-26
Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 31 RLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89
+LG+G F V+ + N +A+K++ + K+ E E+ + R + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 90 CH---------------DQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKG 134
+ +V+E + L + R + + +I+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 135 LVYLHEECQQRIIHYDIKPENVLLDAN-FSPKVADFGLAKLCDRNRSHVTISGYKGTPGY 193
L Y+H + IIH DIKPENVL++ + +A L + + T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 194 SAPEFLSGNYPITHKCDVYSFGMVSFEIV 222
+PE L G P D++S + FE++
Sbjct: 196 RSPEVLLGA-PWGCGADIWSTACLIFELI 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 1e-21
Identities = 23/160 (14%), Positives = 42/160 (26%), Gaps = 19/160 (11%)
Query: 31 RLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG---------KIAEEQFMAEVGTIGRTYHI 81
+G G V+ + VK + F R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 82 NLVRLHGFCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLH-EIAIGTAKGLVYLHE 140
L +L G + Y + N L + K+ + E+ + + +
Sbjct: 67 ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 141 ECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180
I+H D+ NVL+ + DF +
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 356 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.03 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.2 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-60 Score=411.00 Aligned_cols=269 Identities=27% Similarity=0.432 Sum_probs=210.5
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
++....|.+.++||+|+||+||+|+++. .||||+++... .......+.+|+.++++++||||+++++++.+ ...++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 3445578889999999999999998743 59999997442 34556789999999999999999999999865 45799
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||||++|+|.+++......+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999997777789999999999999999999999 99999999999999999999999999999877654
Q ss_pred CCceeecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..........||+.|||||++.+. ..++.++|||||||++|||++|+.|+....... ...........
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~---- 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYL---- 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSC----
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----
Confidence 444444557799999999998753 247899999999999999999999874322210 01111111100
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCCC
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVLP 305 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~~ 305 (356)
.........++++++.+++.+||+.||.+|||+.+|++.|+.+.+..|
T Consensus 228 -~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 228 -SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp -CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 001122344567789999999999999999999999999998876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-60 Score=408.76 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=206.4
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.|++.++||+|+||+||+|.+.+++.||||+++... ...+++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 577889999999999999999888899999997643 334679999999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+|+|.+++......+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......... .
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-S 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee-e
Confidence 999999998777889999999999999999999999 999999999999999999999999999998765443322 2
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCch
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEK 264 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (356)
....||+.|+|||++.+. .++.++||||||+++|||++++.|+...... .++...+........
T Consensus 160 ~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---------------~~~~~~i~~~~~~~~ 223 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------------SEVVEDISTGFRLYK 223 (263)
T ss_dssp -----CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---------------HHHHHHHHHTCCCCC
T ss_pred cceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCH---------------HHHHHHHHhcCCCCC
Confidence 345689999999999887 7999999999999999999976665433221 111112222223334
Q ss_pred hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 265 DKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 265 ~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+..++.++.+++.+||+.||++|||+++|++.|+++.+
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 45567789999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-59 Score=403.34 Aligned_cols=253 Identities=23% Similarity=0.274 Sum_probs=206.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.++||+|+||+||+|.+ .+|+.||||++.........+.+.+|+.++++++||||+++++++.+++..|||||||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 477889999999999999986 4699999999976544444567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++|+|.+++. ....+++..+..++.||+.||+|||+ ++++||||||+|||+++++.+||+|||+|+..........
T Consensus 86 ~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 86 SGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999994 45679999999999999999999999 9999999999999999999999999999998765443333
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....+||+.|||||++.+...++.++|||||||++|||++|+.|+......... ..... .......
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~~~~--------~~~~~~~ 227 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWK--------EKKTYLN 227 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH------HHHHH--------TTCTTST
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH------HHHHh--------cCCCCCC
Confidence 455789999999999987744578899999999999999999998544332111 11111 1111112
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....+.++.+|+.+||+.||++|||++++++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23345678899999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-59 Score=409.67 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=205.8
Q ss_pred HhhccccccCcCCceEEEEEEcC-CC---cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NG---VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
..|++.++||+|+||+||+|.+. ++ ..||||.+...........|.+|+.++++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45666789999999999999874 23 368999988766666777899999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
||||++|+|.+++....+.+++..++.++.||+.||+|||+ ++++||||||+||||+.++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 99999999999997777789999999999999999999999 999999999999999999999999999998776543
Q ss_pred Ccee---ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 180 SHVT---ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 180 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.... .....||+.|||||++.+. .++.++|||||||++|||+| |+.|+..... .++...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----------------~~~~~~ 245 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTN----------------QDVINA 245 (299)
T ss_dssp -------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHH
T ss_pred CcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCH----------------HHHHHH
Confidence 3222 2335689999999999877 79999999999999999998 6777632211 112222
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+......+.+..++.++.+|+.+||+.||.+|||+.+|++.|+++.+
T Consensus 246 i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 246 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 33333444556678889999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-59 Score=410.49 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=224.7
Q ss_pred eeCHHHHHHHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC
Q 047701 15 RFTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ 93 (356)
Q Consensus 15 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 93 (356)
.+..|++....|++.++||+|+||+||+|.+. +++.||||+++.+. ...+++.+|++++++++|||||++++++.++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 56667777788999999999999999999874 58999999997653 3456799999999999999999999999999
Q ss_pred CeeeEEEEecCCCCHhHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCc
Q 047701 94 HMTALVYEYMENGSLDGYLFG-KKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLA 172 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla 172 (356)
+..++|||||++|+|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccce
Confidence 999999999999999999864 35679999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.|+..+... ..+
T Consensus 163 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---------------~~~ 225 (287)
T d1opja_ 163 RLMTGDTYT-AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQV 225 (287)
T ss_dssp TTCCSSSSE-EETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------HHH
T ss_pred eecCCCCce-eeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchH---------------HHH
Confidence 876654332 33455689999999999877 7999999999999999999988776543331 111
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
...+........+..++.++.+|+.+||+.||.+|||+++|++.|+.+..
T Consensus 226 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22233333444555677889999999999999999999999999987754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-59 Score=405.87 Aligned_cols=261 Identities=30% Similarity=0.456 Sum_probs=216.3
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
+|++....|++.++||+|+||+||+|.+++++.||||++.... ...+.+.+|+.++++++|||||++++++.+ +..+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 4556667888999999999999999999888899999997643 344679999999999999999999998866 4568
Q ss_pred EEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 98 LVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+||||+++|+|.+++... ...+++..++.++.||++||.|||+ ++++||||||+||||++++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEcc
Confidence 999999999999988543 3469999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.|+...... ..+...+
T Consensus 161 ~~~~~-~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~---------------~~~~~~i 223 (272)
T d1qpca_ 161 DNEYT-AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------------PEVIQNL 223 (272)
T ss_dssp SSCEE-CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHHH
T ss_pred CCccc-cccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH---------------HHHHHHH
Confidence 54322 23456799999999999877 6899999999999999999987665433221 1111222
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
........+..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 233334445567788999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-58 Score=403.42 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=215.0
Q ss_pred hhcccc-ccCcCCceEEEEEEcC---CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYST-RLGFGGFGQVYKGQFP---NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.+.+.+ +||+|+||+||+|.+. ++..||||+++........+.+.+|++++++++|||||++++++.++ ..||||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEE
Confidence 455566 4999999999999763 35679999998776667778899999999999999999999999764 578999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|||++|+|.+++......+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 9999999999987777889999999999999999999999 9999999999999999999999999999998765443
Q ss_pred cee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 181 HVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 181 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
... .....||+.|+|||++.+. .++.++|||||||++|||+| |..|+..... .++...+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----------------~~~~~~i~~ 227 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------------PEVMAFIEQ 227 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----------------HHHHHHHHT
T ss_pred ccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCH----------------HHHHHHHHc
Confidence 322 2345689999999999877 79999999999999999998 7887643221 112223333
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
+...+.+..++.++.+|+.+||+.||++|||+.+|++.|+...
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4445556677889999999999999999999999999998664
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=403.96 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=211.8
Q ss_pred HhhccccccCcCCceEEEEEEcCC-C----cEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPN-G----VKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
..+++.++||+|+||+||+|.+.+ + ..||||++...........+.+|+.++++++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 346778999999999999997643 2 47999999877666667789999999999999999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
||||+.++++.+++......+++..++.++.||+.||+|||+ ++++||||||+||||+.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999999987777889999999999999999999999 99999999999999999999999999999876544
Q ss_pred CCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 179 RSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 179 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
... .......||+.|+|||++.+. .++.++||||||+++|||++++.|+...... .++...+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---------------~~~~~~i~ 227 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------HEVMKAIN 227 (283)
T ss_dssp ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------HHHHHHHH
T ss_pred CccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCH---------------HHHHHHHh
Confidence 322 223445689999999999887 7999999999999999999987766443321 11222333
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.....+.+..++.++.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 334445556677889999999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=393.89 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=214.8
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYME 104 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (356)
.+++.++||+|+||+||+|++++++.||||+++... ...+++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 467889999999999999999888899999998653 345679999999999999999999999999999999999999
Q ss_pred CCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCceee
Q 047701 105 NGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTI 184 (356)
Q Consensus 105 ~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 184 (356)
+|+|..++......+++..+.+++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++........ ..
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence 999999987777889999999999999999999999 99999999999999999999999999999876554332 23
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....||+.|+|||++.+. .++.++||||||+++|||+| |+.|+..... .++...+.......
T Consensus 159 ~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----------------~~~~~~i~~~~~~~ 221 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------SETAEHIAQGLRLY 221 (258)
T ss_dssp CCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------------HHHHHHHHTTCCCC
T ss_pred cccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCH----------------HHHHHHHHhCCCCC
Confidence 456799999999999877 68999999999999999998 6766532211 12222233333344
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhh
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEG 299 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~ 299 (356)
.+..++.++.+++.+||+.||++|||+++|++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 455667889999999999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=407.18 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=212.2
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCC------CcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPN------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD 92 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 92 (356)
++....+.+.++||+|+||+||+|++.. ...||||.+...........+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4445678889999999999999997632 2369999987655555567889999999998 89999999999999
Q ss_pred CCeeeEEEEecCCCCHhHHhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeec
Q 047701 93 QHMTALVYEYMENGSLDGYLFGKK----------------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYD 150 (356)
Q Consensus 93 ~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~D 150 (356)
.+..++|||||++|+|.+++.... ..+++..++.++.||++||+|||+ ++|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecc
Confidence 999999999999999999996542 358999999999999999999999 9999999
Q ss_pred cCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccc
Q 047701 151 IKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAI 229 (356)
Q Consensus 151 lkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~ 229 (356)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+. .++.++|||||||++|||++ |..||.
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999887766555555566789999999999877 79999999999999999998 777764
Q ss_pred cCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhh
Q 047701 230 VGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLE 298 (356)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~ 298 (356)
...... .+...+......+.+..++.++.+|+.+||+.||++|||+++|+++|.
T Consensus 269 ~~~~~~---------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDA---------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSH---------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHH---------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 322211 111222233334455567788999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=395.61 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=203.7
Q ss_pred cccCcCCceEEEEEEcC---CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEecCC
Q 047701 30 TRLGFGGFGQVYKGQFP---NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYMEN 105 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (356)
++||+|+||+||+|.+. +++.||||+++... .....+.+.+|+.++++++|||||++++++.++ ..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999753 35789999997542 334557899999999999999999999999764 56899999999
Q ss_pred CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee-e
Q 047701 106 GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT-I 184 (356)
Q Consensus 106 ~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~ 184 (356)
|+|.+++. ....+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.......... .
T Consensus 92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999985 45679999999999999999999999 9999999999999999999999999999998765544332 2
Q ss_pred cCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCc
Q 047701 185 SGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEE 263 (356)
Q Consensus 185 ~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (356)
....||+.|+|||++.+. .++.++|||||||++|||++ |+.|+.... ..++...+..+...+
T Consensus 168 ~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----------------~~~~~~~i~~~~~~~ 230 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----------------GSEVTAMLEKGERMG 230 (277)
T ss_dssp ---CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHHHHHTTCCCC
T ss_pred cccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCC----------------HHHHHHHHHcCCCCC
Confidence 345689999999999877 68999999999999999998 787763221 112223333344455
Q ss_pred hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 264 KDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 264 ~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.+..++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 5667788999999999999999999999999988764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=393.68 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=195.2
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--CCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--QHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 100 (356)
.|++.+.||+|+||+||+|+. .+|+.||||++.... .+.....+.+|++++++++||||+++++++.+ +..+|+||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 578889999999999999976 469999999997553 44556778999999999999999999999965 45679999
Q ss_pred EecCCCCHhHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 101 EYMENGSLDGYLFG---KKRALEWEKLHEIAIGTAKGLVYLHEEC--QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 101 e~~~~~sL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
|||++|+|.+++.. ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999999853 3567999999999999999999999821 124999999999999999999999999999987
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... .....||+.|||||++.+. .++.++|||||||++|||++|+.|+..... . ++...
T Consensus 165 ~~~~~~--~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~---------~~~~~ 225 (269)
T d2java1 165 NHDTSF--AKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------K---------ELAGK 225 (269)
T ss_dssp -------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------H---------HHHHH
T ss_pred ccCCCc--cccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------H---------HHHHH
Confidence 643322 2346799999999999877 799999999999999999999998743211 1 11111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
+........+..++.++.+|+.+||+.||.+|||++++++
T Consensus 226 i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2222223344456778999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=391.25 Aligned_cols=247 Identities=20% Similarity=0.302 Sum_probs=206.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+|.+.++||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..|+|||||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 688899999999999999986 4699999999875432 34567899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
+||+|.+++.. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-- 172 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence 99999998843 469999999999999999999999 99999999999999999999999999999876543322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc-CCC
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC-GIE 262 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 262 (356)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..... ..... ...
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~---------~~~~~~~~~ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYL---------IATNGTPEL 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH---------HHHHCSCCC
T ss_pred ccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHH---------HHhCCCCCC
Confidence 2446799999999999987 7899999999999999999999998432211 00011 11111 112
Q ss_pred chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 263 EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 263 ~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..+..++.++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234456788999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=396.38 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=211.8
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
|++....+++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 445556889999999999999999998888889999997643 334679999999999999999999999965 45789
Q ss_pred EEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 99 VYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
||||+++|+|..++... ...+++..++.++.||+.||+|||+ ++++||||||+||||+.++.+||+|||+++....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999999998644 3569999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHh
Q 047701 178 NRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMIL 257 (356)
Q Consensus 178 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (356)
.... ......||+.|+|||++... .++.++||||||+++|||++|+.|+..+... .++...+.
T Consensus 166 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~---------------~~~~~~i~ 228 (285)
T d1fmka3 166 NEYT-ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------------REVLDQVE 228 (285)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------------HHHHHHHH
T ss_pred CCce-eeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH---------------HHHHHHHH
Confidence 3322 22445689999999999877 7899999999999999999987776544332 11112222
Q ss_pred hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccCC
Q 047701 258 ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEVL 304 (356)
Q Consensus 258 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~~ 304 (356)
.....+.+..++.++.+++.+||+.||++||++++|+++|+......
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 23334455667788999999999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=388.20 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=205.5
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||+||+|.+. +++.||||++.+.. .......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4788899999999999999874 68999999987432 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||++|+|.+++. ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 87 y~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 161 (263)
T d2j4za1 87 YAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR- 161 (263)
T ss_dssp CCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred ecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence 999999999995 34579999999999999999999999 9999999999999999999999999999986654322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|||||++.+. .++.++|||||||++|||++|+.||...... ..+...... .
T Consensus 162 ---~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~----------~ 220 (263)
T d2j4za1 162 ---TTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------ETYKRISRV----------E 220 (263)
T ss_dssp ---EETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTT----------C
T ss_pred ---cccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-------HHHHHHHcC----------C
Confidence 235699999999999987 6899999999999999999999998433211 111111111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+.++.+++.+||+.||++|||++++++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1223345678999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-57 Score=399.57 Aligned_cols=267 Identities=25% Similarity=0.382 Sum_probs=219.8
Q ss_pred eCHHHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeee
Q 047701 16 FTSLQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGF 89 (356)
Q Consensus 16 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 89 (356)
+..+|.....|++.+.||+|+||+||+|++. +++.||||++..........++.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3344445567888999999999999999753 3578999999876666667789999999999999999999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGK-----------------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRI 146 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 146 (356)
+.+....+++|||+.+|+|.+++... ...+++..++.++.|++.||+|||+ +++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence 99999999999999999999998532 1248999999999999999999999 999
Q ss_pred eeeccCccceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCC
Q 047701 147 IHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRR 226 (356)
Q Consensus 147 vH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~ 226 (356)
+||||||+|||++.++.+||+|||+++...........+...||+.|+|||.+.+. .++.++|||||||++|||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999876554433333456689999999999987 79999999999999999999975
Q ss_pred ccccCCCccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 227 NAIVGASESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
|++.+... .++...+........+..++.++.+|+.+||+.||++||||.+|++.|+++.
T Consensus 241 ~p~~~~~~---------------~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAH---------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSCH---------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCH---------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54333221 1122223333444455667788999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=392.14 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=206.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.++||+|+||+||+|.+ .+++.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++|||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 578889999999999999986 4699999999976532 44567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
++|+|.+++....+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 9999999987667789999999999999999999999 999999999999999999999999999997543221 11
Q ss_pred ecCCCCCCCCCCcccccC----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 184 ISGYKGTPGYSAPEFLSG----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||........ ........ .
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------~~~i~~~~-------~ 232 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSE-------P 232 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHHSC-------C
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCC-------C
Confidence 234679999999999852 23578999999999999999999998754322111 00000000 0
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.....+..++.++.+|+.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234456788999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-57 Score=393.67 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=203.9
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||+||+|.+ .+++.||||++.+.. .......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 588999999999999999986 469999999997532 22344678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||+||+|.+++. ..+.+++..+..++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+|+.+......
T Consensus 89 y~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 89 YAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred ccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999999884 44679999999999999999999999 99999999999999999999999999999987655444
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||...... ....... .. .
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~---------~~-~ 226 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQKII---------KL-E 226 (288)
T ss_dssp -----CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH---------TT-C
T ss_pred cccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHHHHH---------cC-C
Confidence 444556799999999999987 7999999999999999999999998543221 1111111 11 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
...+...+.++.+|+.+||+.||.+|||++|++.
T Consensus 227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1223345678999999999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=400.49 Aligned_cols=267 Identities=23% Similarity=0.319 Sum_probs=208.6
Q ss_pred HHHHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 21 LNNFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 21 ~~~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
+.+..|.+.++||+|+||+||+|.+ .+|+.||||+++..........+.+|+.++++++|||||++++++.+....|+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456788899999999999999986 479999999998765566677899999999999999999999999999999999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
|||++||+|.+++.+ .+.+++..+..++.|++.||.|||++ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 999999999999954 45799999999999999999999971 389999999999999999999999999998764322
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhH---------HHHHHH---
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK---------YVWEEY--- 247 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~---------~~~~~~--- 247 (356)
....+||+.|+|||++.+. .++.++||||+||++|||++|+.||............. .+....
T Consensus 160 ----~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----C---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----cccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 1335799999999999987 79999999999999999999999986544321100000 000000
Q ss_pred -----------hhh---chhhhHhhcCCCc-hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 248 -----------EKS---ELGAMILACGIEE-KDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 248 -----------~~~---~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... +............ .....+.++.+++.+||..||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 0000000000000 01123567999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=391.72 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=206.3
Q ss_pred HHHHHhhccccccCcCCceEEEEEEcCC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCe
Q 047701 20 QLNNFTSNYSTRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHM 95 (356)
Q Consensus 20 ~~~~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 95 (356)
++....|++.+.||+|+||.||+|.+.. +..||||.+...........+.+|+.++++++||||+++++++.+ +.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-Ce
Confidence 3445678899999999999999997632 456999998766666667789999999999999999999999965 56
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.++||||+++|+|.+++......+++..++.++.||++||+|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 899999999999999987777889999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
...... ......||+.|+|||++.+. .++.++|||||||++|||++ |.+|+..... .++..
T Consensus 159 ~~~~~~-~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----------------~~~~~ 220 (273)
T d1mp8a_ 159 EDSTYY-KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKN----------------NDVIG 220 (273)
T ss_dssp -------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----------------GGHHH
T ss_pred cCCcce-eccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCH----------------HHHHH
Confidence 543322 22345689999999999877 79999999999999999998 6666533222 11222
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.+..+...+.+.+++.++.+|+.+||..||++|||+.+|++.|+.+.+
T Consensus 221 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 233333444566678899999999999999999999999999987653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=381.66 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=198.6
Q ss_pred hccccccCcCCceEEEEEEcC-CCcEEEEEEeccc-CchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc----CCeeeEE
Q 047701 26 SNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKN-LGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD----QHMTALV 99 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 99 (356)
+++.++||+|+||+||+|.+. +++.||+|++... ........+.+|++++++++|||||++++++.+ +..+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 467889999999999999864 6899999998754 244556779999999999999999999999865 3567999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eeeeccCccceEEc-CCCceEEeccCCccccC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQR--IIHYDIKPENVLLD-ANFSPKVADFGLAKLCD 176 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~DfGla~~~~ 176 (356)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999953 4679999999999999999999998 77 99999999999996 57899999999998654
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhH
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMI 256 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (356)
.... ....||+.|||||++.+ .++.++|||||||++|||++|+.||...... ..........
T Consensus 167 ~~~~----~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~~~~~~i~~~------ 228 (270)
T d1t4ha_ 167 ASFA----KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSG------ 228 (270)
T ss_dssp TTSB----EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTT------
T ss_pred CCcc----CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------HHHHHHHHcC------
Confidence 3322 24579999999999976 4899999999999999999999997432221 1111111111
Q ss_pred hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 257 LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 257 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........++++.+++.+||+.||++|||++|+++
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 --VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111223334567999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-56 Score=391.74 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=191.2
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|++.+.||+|+||+||+|.+. +++.||||++...........+.+|+.++++++||||+++++++.+++..||||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45889999999999999999864 68999999998654444456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc---CCCceEEeccCCccccCCCC
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~~~~~ 179 (356)
|+||+|.+++. ..+.+++..+..++.||+.||+|||+ ++++||||||+||++. +++.+||+|||+++......
T Consensus 89 ~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999994 45679999999999999999999999 9999999999999994 57899999999998665433
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhc
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILAC 259 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (356)
. .....||+.|||||++.+. .++.++|||||||++|||++|..||...... ........... .
T Consensus 165 ~---~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~------~ 227 (307)
T d1a06a_ 165 V---LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEY------E 227 (307)
T ss_dssp -----------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHTTCC------C
T ss_pred e---eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCC------C
Confidence 2 2345699999999999887 7999999999999999999999998432211 11111111110 0
Q ss_pred CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 260 GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 260 ~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.........++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0112234567789999999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-56 Score=391.77 Aligned_cols=247 Identities=25% Similarity=0.335 Sum_probs=203.3
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
..|+..++||+|+||+||+|.+ .+++.||||++.... .......+.+|+.++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588889999999999999986 478999999997543 2344467899999999999999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
|||.+|+|..++ .....+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999997666 345679999999999999999999999 99999999999999999999999999999865432
Q ss_pred ceeecCCCCCCCCCCcccccCC--CCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 181 HVTISGYKGTPGYSAPEFLSGN--YPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
....||+.|||||++.+. ..++.++|||||||++|||++|..|+...... .. +......
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~~--------~~~i~~~ 229 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SA--------LYHIAQN 229 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HH--------HHHHHHS
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------HH--------HHHHHhC
Confidence 235699999999998643 25899999999999999999999987432211 00 1111111
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.........++.++.+++.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111223345678999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=393.89 Aligned_cols=268 Identities=25% Similarity=0.359 Sum_probs=208.9
Q ss_pred CHHHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeee
Q 047701 17 TSLQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGF 89 (356)
Q Consensus 17 ~~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 89 (356)
..|++....|++.++||+|+||.||+|.+. +++.||||++...........+..|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 455666678999999999999999999752 35789999998766656667788888888877 68999999999
Q ss_pred EEcC-CeeeEEEEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCc
Q 047701 90 CHDQ-HMTALVYEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153 (356)
Q Consensus 90 ~~~~-~~~~lv~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 153 (356)
+... ...++|||||++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCc
Confidence 8664 4689999999999999999543 2358999999999999999999999 9999999999
Q ss_pred cceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCC
Q 047701 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS 233 (356)
Q Consensus 154 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~ 233 (356)
+||||+.++.+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++|..++..+..
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999877655544444557799999999999887 799999999999999999998665433322
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... .+...+........+..+++++.+++.+||+.||++|||+++|+++|+++.+
T Consensus 242 ~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 IDE--------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CSH--------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 1111222233334445567789999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=393.45 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=208.2
Q ss_pred hhccccccCcCCceEEEEEEcC-CCc----EEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGV----KIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 99 (356)
.|++.++||+|+||+||+|.+. +|+ +||||.+.........+.+.+|+.++++++|||||++++++.++. .+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEE
Confidence 4788899999999999999763 444 688998876555556678999999999999999999999998754 5788
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
++++.+++|.+++......+++..+++++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 89999999999998888899999999999999999999999 999999999999999999999999999999877655
Q ss_pred CceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 180 SHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 180 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.........||+.|+|||++.+. .++.++|||||||++|||+| |..|+.... ..++...+..
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----------------~~~~~~~i~~ 228 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------ASEISSILEK 228 (317)
T ss_dssp C--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----------------GGGHHHHHHH
T ss_pred ccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCC----------------HHHHHHHHHc
Confidence 55444556799999999999887 79999999999999999998 555542221 1223333344
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
+.....+..++.++.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 44445556677889999999999999999999999999887643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=389.09 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=216.0
Q ss_pred HHhhccccccCcCCceEEEEEEcCC----CcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CCeee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFPN----GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QHMTA 97 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~ 97 (356)
..+++|.++||+|+||+||+|.+.+ ...||||+++.........++.+|++++++++||||++++|++.+ +...+
T Consensus 26 ~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred HceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 3456678899999999999998643 236899999866566677889999999999999999999999875 46789
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+|||||++|+|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999999999998888889999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 178 NRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 178 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
.... .......||+.|+|||++.+. .++.++||||||+++|||++|+.|+...... ..+...
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---------------~~~~~~ 246 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------------FDITVY 246 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC---------------------CHHH
T ss_pred cccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---------------HHHHHH
Confidence 4322 223346789999999999877 6999999999999999999988876433221 111222
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
+..+.....+..++.++.+|+.+||+.||++||++.+|++.|+++...
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 222333334455677899999999999999999999999999988754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-55 Score=394.11 Aligned_cols=252 Identities=19% Similarity=0.280 Sum_probs=209.7
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
..|++.++||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++.++...||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3688999999999999999986 479999999997653 24456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--CCCceEEeccCCccccCCCCC
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~~~~~~~~ 180 (356)
|+||+|.+++......+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999999887777789999999999999999999999 9999999999999997 678999999999998765443
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. ....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ........... ..
T Consensus 185 ~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~------~~ 247 (352)
T d1koba_ 185 V---KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDW------EF 247 (352)
T ss_dssp E---EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHHHHHCCC------CC
T ss_pred e---eeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CC
Confidence 3 235689999999999887 7999999999999999999999998432221 01111111100 01
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.......++.++.+|+.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334567889999999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-54 Score=390.41 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=209.1
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.|++.++||+|+||.||+|.+ .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..|||||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 688999999999999999986 469999999997653 345577899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc--CCCceEEeccCCccccCCCCCc
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD--ANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+||+|.+++....+.+++..+..++.||+.||+|||+ ++++||||||+|||++ .++.+||+|||+++........
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 9999999997677789999999999999999999999 9999999999999995 4678999999999877654433
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|||||++.+. .++.++|||||||++|+|++|..||...... ........... ...
T Consensus 183 ---~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~------~~~ 245 (350)
T d1koaa2 183 ---KVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDW------NMD 245 (350)
T ss_dssp ---EEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC------CSC
T ss_pred ---ceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CCC
Confidence 235689999999999987 7899999999999999999999998533211 11111111110 011
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......++.++.+|+.+||..||++|||++++++.
T Consensus 246 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22334566789999999999999999999999984
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=389.89 Aligned_cols=264 Identities=27% Similarity=0.376 Sum_probs=216.6
Q ss_pred HHHHHHhhccccccCcCCceEEEEEEcCC--------CcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeee
Q 047701 19 LQLNNFTSNYSTRLGFGGFGQVYKGQFPN--------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGF 89 (356)
Q Consensus 19 ~~~~~~~~~~~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 89 (356)
|++....|.+.+.||+|+||.||+|+... +..||||++..+........+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44556788999999999999999997521 3479999998877667778899999999888 79999999999
Q ss_pred EEcCCeeeEEEEecCCCCHhHHhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCcc
Q 047701 90 CHDQHMTALVYEYMENGSLDGYLFGKK---------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPE 154 (356)
Q Consensus 90 ~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 154 (356)
+.++...++||||+++|+|.+++..+. ..+++..++.++.||+.||+|||+ .+++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccc
Confidence 999999999999999999999996442 458999999999999999999999 99999999999
Q ss_pred ceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcC-CCccccCCC
Q 047701 155 NVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGR-RRNAIVGAS 233 (356)
Q Consensus 155 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g-~~~~~~~~~ 233 (356)
|||++.++.+||+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||+++ .+|+ .+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~-~~~~ 242 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 242 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS-TTCC
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCC-CCCC
Confidence 999999999999999999987765555445567789999999999877 799999999999999999985 5554 2222
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
. ..+...+..+.....+..++.++.+|+.+||+.||.+|||+.+|++.|+++.+
T Consensus 243 ~---------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 V---------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 11222333334445555677889999999999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=383.03 Aligned_cols=249 Identities=27% Similarity=0.369 Sum_probs=200.2
Q ss_pred HhhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc-CCeeeEEEEe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD-QHMTALVYEY 102 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 102 (356)
..+++.++||+|+||.||+|.+ .|+.||||+++.. ...+.+.+|+.++++++||||++++|++.+ .+..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 4577889999999999999998 5788999999754 344678999999999999999999999865 4568999999
Q ss_pred cCCCCHhHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 103 MENGSLDGYLFGKK-RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 103 ~~~~sL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
+++|+|.+++..+. ..+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 99999999996543 469999999999999999999999 999999999999999999999999999998654332
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcC-CCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGR-RRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
....+|..|+|||++.+. .++.++||||||+++|||+|+ ..|+..... ..+...+....
T Consensus 158 ---~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----------------~~~~~~i~~~~ 217 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------------KDVVPRVEKGY 217 (262)
T ss_dssp -------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----------------GGHHHHHTTTC
T ss_pred ---ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----------------HHHHHHHHcCC
Confidence 224578999999999877 799999999999999999984 555432211 11222233334
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcc
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVV 301 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~ 301 (356)
..+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 45556667788999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=390.67 Aligned_cols=266 Identities=23% Similarity=0.365 Sum_probs=223.0
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEcC------CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEE
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQFP------NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCH 91 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 91 (356)
.|++....+++.++||+|+||+||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 35566678889999999999999999762 357899999987666566678999999999999999999999999
Q ss_pred cCCeeeEEEEecCCCCHhHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC
Q 047701 92 DQHMTALVYEYMENGSLDGYLFGK---------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF 162 (356)
Q Consensus 92 ~~~~~~lv~e~~~~~sL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 162 (356)
.....++||||+.+|+|.+++... ...+++..+..++.|+++||.|||+ ++++||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCc
Confidence 999999999999999999998532 2457999999999999999999999 9999999999999999999
Q ss_pred ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH
Q 047701 163 SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY 242 (356)
Q Consensus 163 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~ 242 (356)
++||+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||++|..++..+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------- 240 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------- 240 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---------
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCC---------
Confidence 9999999999877665554444556789999999999887 789999999999999999999755432222
Q ss_pred HHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 243 VWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
..+....+.++...+.+..++..+.+++.+||+.||.+|||+.+|++.|++..+
T Consensus 241 ------~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 241 ------NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 112222333334445556677889999999999999999999999999987755
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=388.56 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=225.2
Q ss_pred HHHHHHHhhccccccCcCCceEEEEEEc------CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeE
Q 047701 18 SLQLNNFTSNYSTRLGFGGFGQVYKGQF------PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFC 90 (356)
Q Consensus 18 ~~~~~~~~~~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 90 (356)
.|++....+.+.++||+|+||.||+|++ .+++.||||+++..........+.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3566677899999999999999999974 346789999998766666777899999999999 799999999999
Q ss_pred EcCCeeeEEEEecCCCCHhHHhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCc
Q 047701 91 HDQHMTALVYEYMENGSLDGYLFGKK-----------------RALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKP 153 (356)
Q Consensus 91 ~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 153 (356)
.++...++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+ ++++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccc
Confidence 99999999999999999999985432 358999999999999999999999 9999999999
Q ss_pred cceEEcCCCceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCC
Q 047701 154 ENVLLDANFSPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGAS 233 (356)
Q Consensus 154 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~ 233 (356)
+||+++.++.+|++|||+++...............||+.|+|||++.+. .++.++||||||+++|||++++.|+.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999988766665555667899999999999877 689999999999999999996666544433
Q ss_pred ccccchhHHHHHHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 234 ESLDWFPKYVWEEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
... .+...+........+...+.++.+|+.+||+.||.+|||+++|+++|++...
T Consensus 253 ~~~--------------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 253 VDS--------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SSH--------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH--------------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 211 1122233333444445567889999999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=385.19 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=208.6
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCc--EEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEcCCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGV--KIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 99 (356)
..+++.++||+|+||+||+|.+. ++. .||||.+.........+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 46778899999999999999874 444 57888886554555667899999999998 799999999999999999999
Q ss_pred EEecCCCCHhHHhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCce
Q 047701 100 YEYMENGSLDGYLFGK---------------KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSP 164 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 164 (356)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999543 3679999999999999999999999 999999999999999999999
Q ss_pred EEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH
Q 047701 165 KVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW 244 (356)
Q Consensus 165 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~ 244 (356)
||+|||+++........ ....||..|+|||.+.+. .++.++||||||+++|||++|..++..+..
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~----------- 231 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------- 231 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCC-----------
Confidence 99999999765432222 234689999999999877 799999999999999999998765433222
Q ss_pred HHHhhhchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 245 EEYEKSELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
..++...+..+...+.+..++.++.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 232 ----~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 232 ----CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ----HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1112222233334445556778999999999999999999999999999988754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=378.05 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=206.4
Q ss_pred HHhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-----chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCee
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-----GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMT 96 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 96 (356)
+..|++.+.||+|+||+||+|.+ .+|+.||||++.+.. .....+.+.+|+.++++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35688999999999999999986 479999999996542 123457899999999999999999999999999999
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC----ceEEeccCCc
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----SPKVADFGLA 172 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~DfGla 172 (356)
|||||||++|+|.+++.. .+.+++..+..++.|++.||+|||+ ++++||||||+||+++.++ .+||+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999954 4579999999999999999999999 9999999999999998776 5999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhch
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSEL 252 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (356)
......... ....||+.|+|||++.+. .++.++|||||||++|||++|..||...... ...........
T Consensus 165 ~~~~~~~~~---~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~~i~~~~~ 233 (293)
T d1jksa_ 165 HKIDFGNEF---KNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNY 233 (293)
T ss_dssp EECTTSCBC---SCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHTTCC
T ss_pred hhcCCCccc---cccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------HHHHHHHhcCC
Confidence 877544322 345689999999999887 7899999999999999999999998533221 11111111100
Q ss_pred hhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 253 GAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..........+.++.+|+.+||+.||.+|||++++++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011122345678999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=378.11 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=200.4
Q ss_pred HhhccccccCcCCceEEEEEEcC--C--CcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP--N--GVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTA 97 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 97 (356)
..|++.+.||+|+||+||+|++. + ...||||++.+.. .....+.|.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 45788999999999999999752 2 3478999987542 234456899999999999999999999999764 568
Q ss_pred EEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCC
Q 047701 98 LVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDR 177 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~ 177 (356)
+||||+++|+|.+++..+...+++..++.++.||+.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999987777789999999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCcee-ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhc-CCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 178 NRSHVT-ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVG-RRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 178 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
...... .....||..|+|||++.+. .++.++||||||+++|||++ |..|+...... . ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~---------~~~~i 227 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------Q---------ILHKI 227 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H---------HHHHH
T ss_pred CCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------H---------HHHHH
Confidence 544433 2345688899999999987 79999999999999999998 77775321111 0 01111
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGV 300 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~ 300 (356)
.......+.+..++.++.+|+.+||+.||.+|||+.+|++.|.+.
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222233344556678899999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=381.31 Aligned_cols=247 Identities=26% Similarity=0.326 Sum_probs=206.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||.||+|+. .+|+.||||++.+.. .......+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 477889999999999999986 479999999997542 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||+||+|..++. ..+.+++..+..++.||+.||+|||+ ++++||||||+|||++.+|.+||+|||+|+........
T Consensus 86 y~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred ccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 999999999984 44678999999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....+||+.|+|||++.+. .++.++|||||||++|||++|..|+....... ... ..... .
T Consensus 162 --~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~---------~i~~~-~ 221 (337)
T d1o6la_ 162 --MKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFE---------LILME-E 221 (337)
T ss_dssp --BCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH---------HHHHC-C
T ss_pred --cccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHH---------HHhcC-C
Confidence 2346799999999999987 79999999999999999999999885443211 111 11111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
...+..++.++.+|+.+||+.||.+||+ ++++++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2234456778999999999999999995 778876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-53 Score=376.93 Aligned_cols=244 Identities=27% Similarity=0.323 Sum_probs=204.7
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.+.||+|+||+||+|++ .+|+.||||++.+.. .....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 477889999999999999986 469999999997542 22345678999999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
||.||+|..++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 85 ~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 85 YIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp CCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred ecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 999999998884 55678999999999999999999999 999999999999999999999999999998765432
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|||||++.+. .++.++|||||||++|+|++|+.||...... ..... +... .
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~---------i~~~-~ 217 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEK---------ILNA-E 217 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHH---------HHHC-C
T ss_pred ---ccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHH---------HHcC-C
Confidence 235799999999999887 6899999999999999999999998543221 01111 1111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
...+...+.++.+++.+||..||.+|| |++++++
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 223345667899999999999999996 8999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=374.76 Aligned_cols=272 Identities=25% Similarity=0.315 Sum_probs=201.7
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC----eeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----MTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 100 (356)
++.+.++||+|+||+||+|++ +|+.||||++.... ........|+..+.+++||||+++++++.+.+ ..++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 567789999999999999998 78999999996532 22222334555666789999999999998653 578999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC-----QQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. .++|+||||||+||||+.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999954 36899999999999999999999621 269999999999999999999999999999987
Q ss_pred CCCCCce--eecCCCCCCCCCCcccccCCC-----CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh
Q 047701 176 DRNRSHV--TISGYKGTPGYSAPEFLSGNY-----PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE 248 (356)
Q Consensus 176 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~ 248 (356)
....... ......||+.|+|||++.+.. .++.++|||||||++|||++|..|+.........+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~-~~~~ 237 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP-SDPS 237 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC-SSCC
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc-ccch
Confidence 6544332 234567999999999987542 2567899999999999999998877544333221110000 0000
Q ss_pred hhchhhhHhh-cCC-----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc
Q 047701 249 KSELGAMILA-CGI-----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE 302 (356)
Q Consensus 249 ~~~~~~~~~~-~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~ 302 (356)
.......... ... ..........+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000111111 111 11233456779999999999999999999999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=374.22 Aligned_cols=249 Identities=18% Similarity=0.235 Sum_probs=205.4
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+|.+.+.||+|+||+||+|.+. +++.||||+++... .....+.+|++++++++||||+++++++.+.+.+|||||||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 5788999999999999999864 68999999997643 34456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC--CCceEEeccCCccccCCCCCc
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA--NFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~DfGla~~~~~~~~~ 181 (356)
+||+|.+++...+..+++..+..++.||+.||+|||+ ++++||||||+|||++. ...+||+|||+++........
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999997666789999999999999999999999 99999999999999974 458999999999876544322
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|+|||.+.+. .++.++|||||||++|+|++|..||...... ........... ...
T Consensus 161 ---~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~~~~i~~~~~------~~~ 223 (321)
T d1tkia_ 161 ---RLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEY------TFD 223 (321)
T ss_dssp ---EEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCC------CCC
T ss_pred ---cccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCC------CCC
Confidence 234589999999999887 7999999999999999999999998543221 11111111100 000
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
......++.++.+|+.+||..||.+|||++++++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112245678999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.9e-53 Score=367.50 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=202.2
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC----ee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----MT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 96 (356)
.+|++.+.||+|+||+||+|.+ .+|+.||||+++.+. .......+.+|+.++++++||||+++++++.... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4688999999999999999986 579999999997653 2344567899999999999999999999997643 47
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
||||||++|++|..++. ..+.+++..+..++.||+.||+|||+ ++++||||||+|||++.++..+++|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 89999999999999884 34579999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhh
Q 047701 177 RNRSH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAM 255 (356)
Q Consensus 177 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (356)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~-- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP-- 233 (277)
T ss_dssp ----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC--
T ss_pred cccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCC--
Confidence 43322 223446799999999999877 7899999999999999999999998533221 1111111111100
Q ss_pred HhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhhhcc
Q 047701 256 ILACGIEEKDKEKAKQLCMVALWCVQDSPADRP-PMSAVVKMLEGVV 301 (356)
Q Consensus 256 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rp-s~~~v~~~L~~~~ 301 (356)
.......++.++.+++.+||+.||.+|| |++++.+.|.++.
T Consensus 234 -----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0112234567899999999999999999 8999999887663
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-52 Score=375.10 Aligned_cols=244 Identities=22% Similarity=0.234 Sum_probs=204.5
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC--chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL--GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 101 (356)
.|++.++||+|+||.||+|.+ .+|+.||||++.+.. .......+.+|+.++++++||||+++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 678889999999999999986 479999999987432 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCc
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSH 181 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~ 181 (356)
|+.+|+|..++.. .+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 122 ~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 9999999999854 3579999999999999999999999 999999999999999999999999999998765432
Q ss_pred eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcCC
Q 047701 182 VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACGI 261 (356)
Q Consensus 182 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (356)
....||+.|||||++.+. .++.++|||||||++|||++|..||...... ...... ... .
T Consensus 196 ---~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~i---------~~~-~ 254 (350)
T d1rdqe_ 196 ---WTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKI---------VSG-K 254 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHH---------HHC-C
T ss_pred ---ccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHH-------HHHHHH---------hcC-C
Confidence 235699999999999987 7899999999999999999999998533211 111111 111 1
Q ss_pred CchhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 047701 262 EEKDKEKAKQLCMVALWCVQDSPADRP-----PMSAVVK 295 (356)
Q Consensus 262 ~~~~~~~~~~l~~l~~~cl~~~p~~Rp-----s~~~v~~ 295 (356)
...+..++.++.+++.+||..||.+|+ +++++++
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 223345677899999999999999994 8999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-52 Score=377.48 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=200.7
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCc--hhHHHHH---HHHHHHHhcCCCCCeeeEeeeEEcCCeeeE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLG--KIAEEQF---MAEVGTIGRTYHINLVRLHGFCHDQHMTAL 98 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 98 (356)
.|++.+.||+|+||.||+|++. +|+.||||++.+... ......+ ..++.+++.++||||+++++++.+.+..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 4778899999999999999864 699999999864311 1112223 345778888899999999999999999999
Q ss_pred EEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCC
Q 047701 99 VYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 99 v~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~ 178 (356)
|||||+||+|.+++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.+|.+||+|||+|+.+...
T Consensus 85 vmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999954 4678999999999999999999999 99999999999999999999999999999877644
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhh
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILA 258 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (356)
.. ....||+.|+|||++.+...++.++|||||||++|||++|..||......... . +.....
T Consensus 161 ~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~------~~~~~~- 222 (364)
T d1omwa3 161 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------E------IDRMTL- 222 (364)
T ss_dssp CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-------H------HHHHSS-
T ss_pred cc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-------H------HHHhcc-
Confidence 32 34569999999999976546899999999999999999999998654332211 0 000000
Q ss_pred cCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 259 CGIEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 259 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
......+..+++++.+||.+||..||.+||+ ++++++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1112223346778999999999999999999 688876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-52 Score=364.79 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=205.5
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc--------hhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCC
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG--------KIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQH 94 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 94 (356)
.|++.+.||+|+||+||+|+. .+|+.||||++.+... ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 578899999999999999986 4799999999975421 123356889999999996 999999999999999
Q ss_pred eeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccc
Q 047701 95 MTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKL 174 (356)
Q Consensus 95 ~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~ 174 (356)
..|||||||++|+|.+++.. .+.+++..+..++.||++||+|||+ ++++||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999954 4579999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeecCCCCCCCCCCcccccC-----CCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh
Q 047701 175 CDRNRSHVTISGYKGTPGYSAPEFLSG-----NYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK 249 (356)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (356)
...... .....||+.|+|||++.+ ...++.++||||+||++|+|++|+.||...... ........
T Consensus 160 ~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------~~~~~i~~ 229 (277)
T d1phka_ 160 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMS 229 (277)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHH
T ss_pred ccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-------HHHHHHHh
Confidence 764332 234679999999999863 235788999999999999999999998543221 11111111
Q ss_pred hchhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 SELGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... ........++++++.+++.+||+.||.+|||+++|++
T Consensus 230 ~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 0112234467788999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=370.60 Aligned_cols=258 Identities=22% Similarity=0.253 Sum_probs=195.3
Q ss_pred ccccCcCCceEEEEEEcC-CCcEEEEEEecccCchh----HHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 29 STRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKI----AEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
.++||+|+||+||+|.+. +|+.||||+++...... ....+.+|+.++++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999874 69999999997543221 1246889999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.++++..+. .....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-- 156 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-- 156 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc--
Confidence 887666554 566789999999999999999999999 99999999999999999999999999999876544322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh---hhchh------h
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE---KSELG------A 254 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------~ 254 (356)
.....||+.|+|||++.+...++.++|||||||++|||++|..||........ +.. ..+... ..... .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~-i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR-IFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTTTSSSTTSSTT
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH--HHH-HHHhcCCCChhhccchhccch
Confidence 23457999999999997665689999999999999999999988743322110 000 000000 00000 0
Q ss_pred hHhhcCCC-----chhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MILACGIE-----EKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
........ ......+.++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000 011234577999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=372.70 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=202.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC--chhHHHHHHHHHHHHh-cCCCCCeeeEeeeEEcCCeeeEEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL--GKIAEEQFMAEVGTIG-RTYHINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~ 100 (356)
.|.+.+.||+|+||+||+|.+. +++.||||++.+.. .......+..|..++. .++||||+++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 4788999999999999999864 69999999997532 2233456677777765 689999999999999999999999
Q ss_pred EecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCC
Q 047701 101 EYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRS 180 (356)
Q Consensus 101 e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~ 180 (356)
||+++|+|..++. ....+++..+..++.||+.||+|||+ ++++||||||+|||+++++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp ECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999995 44578999999999999999999999 9999999999999999999999999999986654332
Q ss_pred ceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhhhHhhcC
Q 047701 181 HVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGAMILACG 260 (356)
Q Consensus 181 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (356)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+.... ..
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------~~~~~i~---------~~- 218 (320)
T d1xjda_ 159 K--TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIR---------MD- 218 (320)
T ss_dssp C--BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHH---------HC-
T ss_pred c--ccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-------HHHHHHH---------cC-
Confidence 2 2346799999999999987 7999999999999999999999998543221 1111111 11
Q ss_pred CCchhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 047701 261 IEEKDKEKAKQLCMVALWCVQDSPADRPPMS-AVVK 295 (356)
Q Consensus 261 ~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~-~v~~ 295 (356)
....+..++.++.+|+.+||..||.+||++. ++++
T Consensus 219 ~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1233345677899999999999999999995 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=366.48 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=201.0
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCc-hhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
.|.+.++||+|+||+||+|.+ .+|+.||||+++.... ......+.+|++++++++||||+++++++.++...|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 467789999999999999986 5799999999975432 22346789999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.++.+..........+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 97754544444556789999999999999999999999 9999999999999999999999999999987654332
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh--hhc-hhhhHh--
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE--KSE-LGAMIL-- 257 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~-- 257 (356)
......||+.|+|||++.....++.++|||||||++|+|++|+.||........ +.. ...... ... ......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHH-HHHhcCCCchhhcccccccc
Confidence 223457999999999988775678999999999999999999999854322110 000 000000 000 000000
Q ss_pred -------hcCC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 258 -------ACGI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 258 -------~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
.... .......+.++.+++.+||..||++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00112345778999999999999999999999984
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=367.25 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=197.2
Q ss_pred hhccc-cccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcC-CCCCeeeEeeeEEc----CCeee
Q 047701 25 TSNYS-TRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRT-YHINLVRLHGFCHD----QHMTA 97 (356)
Q Consensus 25 ~~~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~ 97 (356)
.|.+. +.||+|+||+||+|.+ .+++.||||++... ..+.+|+.++.++ +||||+++++++.+ ...+|
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46665 4699999999999976 57999999999642 3467899887654 89999999999875 46789
Q ss_pred EEEEecCCCCHhHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC---CCceEEeccCCcc
Q 047701 98 LVYEYMENGSLDGYLFGK-KRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA---NFSPKVADFGLAK 173 (356)
Q Consensus 98 lv~e~~~~~sL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~DfGla~ 173 (356)
||||||+||+|.+++... ...+++..+..++.||+.||+|||+ ++++||||||+|||++. .+.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 999999999999999655 3579999999999999999999999 99999999999999975 5679999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .........
T Consensus 163 ~~~~~~~~---~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~------~~~~~i~~~ 232 (335)
T d2ozaa1 163 ETTSHNSL---TTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKTRIRMG 232 (335)
T ss_dssp ECCCCCCC---CCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCCSC
T ss_pred eccCCCcc---ccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH------HHHHHHhcC
Confidence 77654332 345799999999999877 79999999999999999999999986543321100 000000000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ..........++.++.+|+.+||+.||++|||+.++++
T Consensus 233 ~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 Q---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00011223456788999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.7e-51 Score=359.30 Aligned_cols=262 Identities=21% Similarity=0.242 Sum_probs=201.5
Q ss_pred hhccccccCcCCceEEEEEEcCCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEec
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEYM 103 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 103 (356)
+|++.++||+|+||+||+|++++|+.||||++.... .......+.+|+.++++++||||+++++++.+.+..+++||++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 577889999999999999998889999999997543 2233467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCcee
Q 047701 104 ENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHVT 183 (356)
Q Consensus 104 ~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 183 (356)
.++.+..+. ...+.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 156 (286)
T d1ob3a_ 83 DQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (286)
T ss_dssp SEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence 876655554 566889999999999999999999999 99999999999999999999999999999876543322
Q ss_pred ecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh---h------chhh
Q 047701 184 ISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK---S------ELGA 254 (356)
Q Consensus 184 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~ 254 (356)
.....|++.|+|||.+.+...++.++|||||||++|||++|+.||........ +.. .+..... . ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCChhhccchhhhhh
Confidence 23346899999999998776789999999999999999999998743321110 000 0000000 0 0000
Q ss_pred hH------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 MI------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 ~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
.. ............+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000001122334577899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=361.30 Aligned_cols=241 Identities=23% Similarity=0.325 Sum_probs=196.5
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCch-----hHHHHHHHHHHHHhcCC--CCCeeeEeeeEEcCCe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGK-----IAEEQFMAEVGTIGRTY--HINLVRLHGFCHDQHM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 95 (356)
.+|++.+.||+|+||+||+|.+ .+|+.||||++.+.... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688999999999999999986 47999999998753211 11234668999999986 8999999999999999
Q ss_pred eeEEEEecCC-CCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-CCceEEeccCCcc
Q 047701 96 TALVYEYMEN-GSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-NFSPKVADFGLAK 173 (356)
Q Consensus 96 ~~lv~e~~~~-~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~DfGla~ 173 (356)
.++||||+.+ +++.+++. ....+++..+..++.||+.||+|||+ ++++||||||+|||++. ++.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 57777774 44679999999999999999999999 99999999999999985 5799999999998
Q ss_pred ccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 174 LCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
...... .+...||+.|+|||++.+...++.++|||||||++|||++|+.||.... ..
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i------ 216 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EI------ 216 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HH------
T ss_pred eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HH------
Confidence 755432 2346799999999999876445778999999999999999999873210 00
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
... ....+...+.++.+++.+||..||++|||++++++
T Consensus 217 --~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 --IRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --HHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 11122345678999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-50 Score=354.00 Aligned_cols=263 Identities=17% Similarity=0.180 Sum_probs=211.0
Q ss_pred HhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCC-CCeeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYH-INLVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 101 (356)
.+|.+.++||+|+||+||+|++. +|+.||||+++.... ...+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 47889999999999999999864 699999999865422 2346788899998865 899999999999999999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcC-----CCceEEeccCCccccC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDA-----NFSPKVADFGLAKLCD 176 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~DfGla~~~~ 176 (356)
|+ +++|.+++......++..++..++.|++.||+|||+ +|++||||||+|||++. ++.+||+|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 679999997777889999999999999999999999 99999999999999964 5789999999999876
Q ss_pred CCCCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhc
Q 047701 177 RNRSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSE 251 (356)
Q Consensus 177 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (356)
...... ......||+.|||||++.+. .++.++||||||+++|||++|..||........... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~----~~~i~~~~ 232 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----YERIGEKK 232 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH----HHHHHHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH----HHHHHhcc
Confidence 433221 22346799999999999987 799999999999999999999999864433322111 11111110
Q ss_pred hhhhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhcccC
Q 047701 252 LGAMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVEV 303 (356)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~~ 303 (356)
......+....+++++.+++..|+..+|++||+++.+.+.|+++...
T Consensus 233 -----~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 233 -----QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp -----HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 11111122334567899999999999999999999999999887654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-50 Score=356.12 Aligned_cols=273 Identities=18% Similarity=0.198 Sum_probs=208.8
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCC-eeeEeeeEEcCCeeeEEEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHIN-LVRLHGFCHDQHMTALVYE 101 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 101 (356)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++..... ...+..|++++++++|+| |+.+.+++.++...++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3688999999999999999986 4689999999875432 235788999999997665 5566677788889999999
Q ss_pred ecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEc---CCCceEEeccCCccccCCC
Q 047701 102 YMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLD---ANFSPKVADFGLAKLCDRN 178 (356)
Q Consensus 102 ~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~DfGla~~~~~~ 178 (356)
|+ +++|...+......+++..+..++.|++.||+|||+ ++++||||||+|||++ .+..+||+|||+|+.....
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99 558877776777889999999999999999999999 9999999999999985 3557999999999987654
Q ss_pred CCce-----eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchh
Q 047701 179 RSHV-----TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELG 253 (356)
Q Consensus 179 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (356)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............. ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~----~~~~---- 230 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----RISE---- 230 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH----HHHH----
T ss_pred ccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH----Hhhc----
Confidence 3321 22446799999999999987 69999999999999999999999986543332211110 0000
Q ss_pred hhHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhhhccc--CCCCCCCcccc
Q 047701 254 AMILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKMLEGVVE--VLPPPKPFRYL 313 (356)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~L~~~~~--~~~~~~p~~~~ 313 (356)
.............++.++.+++.+||+.||++||+++++.+.|+.+.. ......|++|.
T Consensus 231 -~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 231 -KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp -HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred -ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 000011112233456789999999999999999999999999887643 23344455443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=357.15 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=197.3
Q ss_pred HHhhccccccCcCCceEEEEEEc-CC-CcEEEEEEecccCc-hhHHHHHHHHHHHHhcC---CCCCeeeEeeeEEc----
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQF-PN-GVKIAVKVLNKNLG-KIAEEQFMAEVGTIGRT---YHINLVRLHGFCHD---- 92 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~-~~-~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 92 (356)
+.+|++.++||+|+||+||+|.+ .+ ++.||||++..... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35788899999999999999986 34 67799999864322 12223456677776655 79999999999853
Q ss_pred -CCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCC
Q 047701 93 -QHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGL 171 (356)
Q Consensus 93 -~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGl 171 (356)
....+++|||+.++++..........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 346789999999887776666667789999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh--
Q 047701 172 AKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK-- 249 (356)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (356)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ +... ......
T Consensus 163 ~~~~~~~~---~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i-~~~~~~~~ 235 (305)
T d1blxa_ 163 ARIYSFQM---ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKI-LDVIGLPG 235 (305)
T ss_dssp CCCCCGGG---GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH-HHHHCCCC
T ss_pred hhhhcccc---cCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHHH-HHhhCCCc
Confidence 87654332 22446799999999999887 799999999999999999999999854322110 0000 000000
Q ss_pred -h------chhhhHh----hcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 250 -S------ELGAMIL----ACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 250 -~------~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. ....... ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000000 00011122334567899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=355.69 Aligned_cols=267 Identities=19% Similarity=0.234 Sum_probs=198.2
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC----eeeEE
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH----MTALV 99 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv 99 (356)
+|++.++||+|+||+||+|.. .+|+.||||++...........+++|+.+|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 578889999999999999975 5799999999976555556678899999999999999999999997643 23455
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNR 179 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~ 179 (356)
++++.+|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 566678999999953 369999999999999999999999 999999999999999999999999999998765432
Q ss_pred Cc-eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHH-----HHHhh---h
Q 047701 180 SH-VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVW-----EEYEK---S 250 (356)
Q Consensus 180 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~-----~~~~~---~ 250 (356)
.. .......||+.|+|||++.....++.++||||+||++|+|++|..||................ ..... .
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 22 223446799999999998766578999999999999999999999985433211100000000 00000 0
Q ss_pred chhhhHhhc---CC---CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 251 ELGAMILAC---GI---EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 251 ~~~~~~~~~---~~---~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
......... .. ....+..+.++.+|+.+||..||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00 01112334678999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=356.12 Aligned_cols=262 Identities=20% Similarity=0.248 Sum_probs=196.1
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCC------e
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQH------M 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 95 (356)
.+|+..++||+|+||+||+|.+ .+|+.||||++++.. .......+.+|+.+|++++|||||++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4677889999999999999986 469999999997543 3345567899999999999999999999997654 4
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
+|+||||+ +.+|..+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+++..
T Consensus 98 ~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence 69999999 668887773 3579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccc--------hhHHHHHHH
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDW--------FPKYVWEEY 247 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~--------~~~~~~~~~ 247 (356)
.... +...||+.|+|||++.+...++.++||||+||++|+|++|+.|+.......... .+...+...
T Consensus 172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5432 345699999999999876568999999999999999999999885432211000 000000100
Q ss_pred hhhchhhhHhh------cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 248 EKSELGAMILA------CGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 248 ~~~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
........... ..........+.++.+|+.+||..||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000 00111223445678999999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=355.70 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=197.0
Q ss_pred HHhhccccccCcCCceEEEEEEcC-CCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc------CCe
Q 047701 23 NFTSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD------QHM 95 (356)
Q Consensus 23 ~~~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 95 (356)
..+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++.. ..+
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 347888899999999999999874 699999999976432 13469999999999999999999854 235
Q ss_pred eeEEEEecCCCCHhHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCc
Q 047701 96 TALVYEYMENGSLDGYLF--GKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLA 172 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla 172 (356)
.+||||||+++.+..+.. .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccch
Confidence 789999998754444332 345679999999999999999999999 9999999999999998765 8999999999
Q ss_pred cccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHH----------
Q 047701 173 KLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKY---------- 242 (356)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~---------- 242 (356)
+........ ....||..|+|||.+.+...++.++|||||||++|||++|..||........ +...
T Consensus 171 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 171 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTRE 245 (350)
T ss_dssp EECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred hhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHH
Confidence 877544322 2356899999999988766799999999999999999999998854332110 0000
Q ss_pred HHHHHhhhchhhhHhhc-----CCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--Hhhhc
Q 047701 243 VWEEYEKSELGAMILAC-----GIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK--MLEGV 300 (356)
Q Consensus 243 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~--~L~~~ 300 (356)
.+...... ........ .........++++.+|+.+||..||++|||+.|+++ .++.+
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 246 QIREMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000000 00000000 000112234667999999999999999999999997 34444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=349.76 Aligned_cols=266 Identities=20% Similarity=0.232 Sum_probs=196.0
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc--------C
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD--------Q 93 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~ 93 (356)
.+|++.++||+|+||+||+|.+ .+|+.||||++.... ......++.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 4788899999999999999986 479999999986442 23344678899999999999999999999865 3
Q ss_pred CeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 94 HMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 94 ~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...++||||+.++.+.. .......+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence 45789999998766554 43566789999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCc--eeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHh---
Q 047701 174 LCDRNRSH--VTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYE--- 248 (356)
Q Consensus 174 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~--- 248 (356)
........ .......||+.|+|||++.+...++.++|||||||++|||++|+.||........ .. .......
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~--~~-~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ--LA-LISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH--HH-HHHHhcCCCC
Confidence 76543322 1223456999999999998776789999999999999999999988743221110 00 0000000
Q ss_pred --------hhchhhhHhhcC-CCchh------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 249 --------KSELGAMILACG-IEEKD------KEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 249 --------~~~~~~~~~~~~-~~~~~------~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
............ ..... .....++.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000 00000 1124567899999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=344.03 Aligned_cols=263 Identities=19% Similarity=0.252 Sum_probs=207.4
Q ss_pred hhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcCCeeeEEEEe
Q 047701 25 TSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQHMTALVYEY 102 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 102 (356)
+|++.++||+|+||+||+|++ .+++.||||+++... ......++.+|+.++++++||||+++++++.+....++|+++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 578889999999999999986 478999999997543 335567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccCCCCCce
Q 047701 103 MENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCDRNRSHV 182 (356)
Q Consensus 103 ~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~~~~~~~ 182 (356)
+.+++|..++ ...+.+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.........
T Consensus 83 ~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 83 CDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred cccccccccc-ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9998888777 456788999999999999999999999 999999999999999999999999999998776543322
Q ss_pred eecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhh---hch---hh--
Q 047701 183 TISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEK---SEL---GA-- 254 (356)
Q Consensus 183 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~-- 254 (356)
....++..|+|||++.+...++.++|||||||++|||++|+.|+..+....... .. ....... ... ..
T Consensus 159 --~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KR-IFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HH-HHHHHCCCCTTTCTTGGGST
T ss_pred --eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HH-HHhhcCCCChhhhhhhhhcc
Confidence 234578889999999877567999999999999999999999976544322110 00 0000000 000 00
Q ss_pred -------hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 255 -------MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 255 -------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
..............+.++.+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001112223345677899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=349.57 Aligned_cols=258 Identities=18% Similarity=0.238 Sum_probs=199.4
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEc--CCeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHD--QHMTALV 99 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 99 (356)
..|++.++||+|+||+||+|++ .+|+.||||+++.. ...++.+|+.++++++ ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4688899999999999999986 47999999999753 2456889999999995 9999999999974 4568999
Q ss_pred EEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-ceEEeccCCccccCCC
Q 047701 100 YEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF-SPKVADFGLAKLCDRN 178 (356)
Q Consensus 100 ~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~DfGla~~~~~~ 178 (356)
||||.+++|..+. +.+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987654 569999999999999999999999 9999999999999998655 6999999999876544
Q ss_pred CCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhH-------HHHHHHhhhc
Q 047701 179 RSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK-------YVWEEYEKSE 251 (356)
Q Consensus 179 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 251 (356)
.. .....||+.|+|||.+.+...++.++||||+|+++|+|++|+.|+............. ..+.......
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 2345689999999999877568999999999999999999999986654432110000 0000000000
Q ss_pred h---hhhH-----------hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 252 L---GAMI-----------LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 252 ~---~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
. .... ............+.++.+|+.+||..||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000011122335678999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=346.66 Aligned_cols=254 Identities=22% Similarity=0.229 Sum_probs=202.2
Q ss_pred HhhccccccCcCCceEEEEEEc----CCCcEEEEEEecccC---chhHHHHHHHHHHHHhcCCC-CCeeeEeeeEEcCCe
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF----PNGVKIAVKVLNKNL---GKIAEEQFMAEVGTIGRTYH-INLVRLHGFCHDQHM 95 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 95 (356)
..|++.++||+|+||+||+|.. .+|+.||||++.+.. .......+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 3488899999999999999964 258899999986432 12234567889999999966 899999999999999
Q ss_pred eeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCcccc
Q 047701 96 TALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLC 175 (356)
Q Consensus 96 ~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~ 175 (356)
.+++|||+.+|+|.+++.. .+.+.+..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999853 4567889999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeecCCCCCCCCCCcccccCCC-CCCCCCceehhhHHHHHHhcCCCccccCCCccccchhHHHHHHHhhhchhh
Q 047701 176 DRNRSHVTISGYKGTPGYSAPEFLSGNY-PITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPKYVWEEYEKSELGA 254 (356)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (356)
....... .....|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.......... .......
T Consensus 180 ~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~------ 249 (322)
T d1vzoa_ 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRIL------ 249 (322)
T ss_dssp CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHH------
T ss_pred ccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcc------
Confidence 5433322 23356999999999997642 47889999999999999999999986554332211 1111110
Q ss_pred hHhhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 047701 255 MILACGIEEKDKEKAKQLCMVALWCVQDSPADRPP-----MSAVVK 295 (356)
Q Consensus 255 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps-----~~~v~~ 295 (356)
......+...+.++.+++.+||..||++||| ++|+++
T Consensus 250 ----~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ----KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1112233456788999999999999999995 788876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=339.35 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=189.9
Q ss_pred hhccccccCcCCceEEEEEEcC-CCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEc------CCee
Q 047701 25 TSNYSTRLGFGGFGQVYKGQFP-NGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHD------QHMT 96 (356)
Q Consensus 25 ~~~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~ 96 (356)
+|++.++||+|+||+||+|.+. +|+.||||++.+.. ......++.+|+.++++++||||+++++++.. ...+
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4778899999999999999864 69999999997653 33445678999999999999999999999964 3678
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
|+|||||.++.+. .+ ...+++..+..++.||+.||+|||+ +|++||||||+|||++.++.++++|||+++...
T Consensus 98 ~iv~Ey~~~~l~~-~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 98 YLVMELMDANLCQ-VI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEECCSEEHHH-HH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeccchHHHH-hh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccc
Confidence 9999999775444 44 2468999999999999999999999 999999999999999999999999999988665
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccch--------hHHHHHH--
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWF--------PKYVWEE-- 246 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~--------~~~~~~~-- 246 (356)
.... .....||+.|+|||++.+. .++.++||||+||++++|++|+.||........... ....|..
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 171 TSFM---MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc---cccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 4332 2345689999999999887 799999999999999999999988743321110000 0000000
Q ss_pred -----Hhhhc-------hhhhH---hhcCCCchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 047701 247 -----YEKSE-------LGAMI---LACGIEEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVKM 296 (356)
Q Consensus 247 -----~~~~~-------~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~~ 296 (356)
..... ..... ............+.++.+|+.+||..||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00000 0011122345567889999999999999999999999973
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=339.71 Aligned_cols=262 Identities=18% Similarity=0.231 Sum_probs=195.1
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccC-chhHHHHHHHHHHHHhcCCCCCeeeEeeeEEcC-----Cee
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNL-GKIAEEQFMAEVGTIGRTYHINLVRLHGFCHDQ-----HMT 96 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 96 (356)
.+|++.++||+|+||+||+|.+ .+|+.||||++.+.. ......++.+|+.++++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 3688889999999999999986 579999999997653 334456788999999999999999999998643 344
Q ss_pred eEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEeccCCccccC
Q 047701 97 ALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVADFGLAKLCD 176 (356)
Q Consensus 97 ~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~~~~ 176 (356)
+++++++.+|+|.+++. .+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+|++|||++....
T Consensus 98 ~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 67777888999999994 3579999999999999999999999 999999999999999999999999999987554
Q ss_pred CCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchh--------HHHHHHHh
Q 047701 177 RNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFP--------KYVWEEYE 248 (356)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~--------~~~~~~~~ 248 (356)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|..||............ ...+....
T Consensus 173 ~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 173 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp GG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred cc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 32 233568899999999887756799999999999999999999987543221100000 00000000
Q ss_pred hhchhhhHhhcC-C-----CchhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 047701 249 KSELGAMILACG-I-----EEKDKEKAKQLCMVALWCVQDSPADRPPMSAVVK 295 (356)
Q Consensus 249 ~~~~~~~~~~~~-~-----~~~~~~~~~~l~~l~~~cl~~~p~~Rps~~~v~~ 295 (356)
............ . .......+.++.+|+.+||..||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000000 0 0011234567899999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-41 Score=307.28 Aligned_cols=262 Identities=22% Similarity=0.250 Sum_probs=188.3
Q ss_pred HhhccccccCcCCceEEEEEEc-CCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-----------CCCeeeEeeeEE
Q 047701 24 FTSNYSTRLGFGGFGQVYKGQF-PNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-----------HINLVRLHGFCH 91 (356)
Q Consensus 24 ~~~~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 91 (356)
.+|.+.++||+|+||+||+|++ .+|+.||||++++. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 4689999999999999999986 47999999999764 233456778888888775 578999999886
Q ss_pred cC--CeeeEEEEecCCCCHh-H-HhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCC-----
Q 047701 92 DQ--HMTALVYEYMENGSLD-G-YLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANF----- 162 (356)
Q Consensus 92 ~~--~~~~lv~e~~~~~sL~-~-~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----- 162 (356)
.. ...+++++++..+... . ........+++..+..++.||+.||+|||+ ..||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence 53 4556666666544322 2 223445789999999999999999999996 27899999999999997654
Q ss_pred -ceEEeccCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHHHHHhcCCCccccCCCccccchhH
Q 047701 163 -SPKVADFGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVSFEIVGRRRNAIVGASESLDWFPK 241 (356)
Q Consensus 163 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il~ell~g~~~~~~~~~~~~~~~~~ 241 (356)
.++++|||.+....... ....||+.|+|||++.+. .++.++||||+||++++|++|+.||.............
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 38999999987654322 335699999999999877 68999999999999999999999976443321111000
Q ss_pred HHHHH-----------Hhhhchhh-hHh---------h----------cCCCchhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 047701 242 YVWEE-----------YEKSELGA-MIL---------A----------CGIEEKDKEKAKQLCMVALWCVQDSPADRPPM 290 (356)
Q Consensus 242 ~~~~~-----------~~~~~~~~-~~~---------~----------~~~~~~~~~~~~~l~~l~~~cl~~~p~~Rps~ 290 (356)
..... ........ ... . ..........+.++.+|+.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00000 00000000 000 0 00112245677899999999999999999999
Q ss_pred HHHHH
Q 047701 291 SAVVK 295 (356)
Q Consensus 291 ~~v~~ 295 (356)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4.8e-28 Score=198.41 Aligned_cols=171 Identities=13% Similarity=0.081 Sum_probs=122.1
Q ss_pred hccccccCcCCceEEEEEEcCCCcEEEEEEecccCc-----------------hhHHHHHHHHHHHHhcCCCCCeeeEee
Q 047701 26 SNYSTRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLG-----------------KIAEEQFMAEVGTIGRTYHINLVRLHG 88 (356)
Q Consensus 26 ~~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~niv~~~~ 88 (356)
+.++++||+|+||+||+|.+.+|+.||||++..+.. .........|+..+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999988899999998753211 111234456888999999999998876
Q ss_pred eEEcCCeeeEEEEecCCCCHhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeeeeccCccceEEcCCCceEEec
Q 047701 89 FCHDQHMTALVYEYMENGSLDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEECQQRIIHYDIKPENVLLDANFSPKVAD 168 (356)
Q Consensus 89 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 168 (356)
+.. .+++|||+++..+.. ++...+..++.|++.+|+|||+ ++++||||||+|||++++ .++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 642 379999998755433 3445567899999999999999 999999999999999865 589999
Q ss_pred cCCccccCCCCCceeecCCCCCCCCCCcccccCCCCCCCCCceehhhHHH
Q 047701 169 FGLAKLCDRNRSHVTISGYKGTPGYSAPEFLSGNYPITHKCDVYSFGMVS 218 (356)
Q Consensus 169 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv~slG~il 218 (356)
||+|...............+. .-.+.+. . .++.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~----~~~~~f~-r-~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVR----NIITYFS-R-TYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHH----HHHHHHH-H-HHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHH----HHHHHHc-C-CCCCcccHHHHHHHH
Confidence 999976553322110000000 0012222 2 478899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=3.1e-08 Score=83.18 Aligned_cols=137 Identities=11% Similarity=0.018 Sum_probs=90.8
Q ss_pred ccccCcCCceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 29 STRLGFGGFGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 29 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
.+..+-++.+.||+... +++.++||+...... .....+.+|...+..+. +--+.+++++..+++..++||++++|.+
T Consensus 19 ~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~ 96 (263)
T d1j7la_ 19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred EEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccc
Confidence 33333344568999976 566778888764321 22234667777777663 3336778888888888999999999988
Q ss_pred HhHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhcc---------------------------------------------
Q 047701 108 LDGYLFGKKRALEWEKLHEIAIGTAKGLVYLHEEC--------------------------------------------- 142 (356)
Q Consensus 108 L~~~l~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------- 142 (356)
+....... .....++.+++..+..||+..
T Consensus 97 ~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 97 CSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred cccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence 76554211 112334555555555565311
Q ss_pred -----------CCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 143 -----------QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 143 -----------~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.45 E-value=4.1e-07 Score=75.67 Aligned_cols=75 Identities=9% Similarity=0.004 Sum_probs=53.0
Q ss_pred ccCcCC-ceEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCC--CCCeeeEeeeEEcCCeeeEEEEecCCCC
Q 047701 31 RLGFGG-FGQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY--HINLVRLHGFCHDQHMTALVYEYMENGS 107 (356)
Q Consensus 31 ~lg~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~s 107 (356)
.+..|. -+.||+....++..+++|.-.... ...+..|...++.+. .-.+++++++..+++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344444 368999998778889999876432 123566777776653 2336778888888888999999998866
Q ss_pred Hh
Q 047701 108 LD 109 (356)
Q Consensus 108 L~ 109 (356)
+.
T Consensus 93 ~~ 94 (255)
T d1nd4a_ 93 LL 94 (255)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.03 E-value=8.8e-06 Score=71.97 Aligned_cols=76 Identities=14% Similarity=0.061 Sum_probs=48.1
Q ss_pred cccCcCCceEEEEEEcCC-CcEEEEEEecccC------chhHHHHHHHHHHHHhcCC-C--CCeeeEeeeEEcCCeeeEE
Q 047701 30 TRLGFGGFGQVYKGQFPN-GVKIAVKVLNKNL------GKIAEEQFMAEVGTIGRTY-H--INLVRLHGFCHDQHMTALV 99 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 99 (356)
+.||-|....||++...+ ++.|+||.-.... ......+...|.+.++.+. + ..+++++.+. ....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 468999999999998754 6789999753211 1122334556777777652 2 3466666554 4456799
Q ss_pred EEecCCCC
Q 047701 100 YEYMENGS 107 (356)
Q Consensus 100 ~e~~~~~s 107 (356)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.66 E-value=6.8e-05 Score=64.28 Aligned_cols=132 Identities=14% Similarity=0.125 Sum_probs=75.2
Q ss_pred eEEEEEEcCCCcEEEEEEecccCchhHHHHHHHHHHHHhcCCCCCe--eeEee-----eEEcCCeeeEEEEecCCCCHh-
Q 047701 38 GQVYKGQFPNGVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTYHINL--VRLHG-----FCHDQHMTALVYEYMENGSLD- 109 (356)
Q Consensus 38 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~~sL~- 109 (356)
-.||++...+|+.|++|+..... .+.+++..|.+.+..|...++ +.... .+......+.+++++.|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 47999998889999999986542 234567778887777642222 11111 223455678899998764321
Q ss_pred ----HH------h-------cc----CCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----ccCCC
Q 047701 110 ----GY------L-------FG----KKRALEWE-------------------KLHEIAIGTAKGLVYLHE----ECQQR 145 (356)
Q Consensus 110 ----~~------l-------~~----~~~~l~~~-------------------~~~~i~~qi~~~l~~LH~----~~~~~ 145 (356)
.+ + .. .....+.. ....+...+...+..+.. ..+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 0 00 00111111 111122222222333322 22457
Q ss_pred eeeeccCccceEEcCCCceEEeccCCcc
Q 047701 146 IIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 146 ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
+||+|+.+.|||++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 9999999999999743 4589998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.23 E-value=0.00066 Score=59.59 Aligned_cols=72 Identities=17% Similarity=0.149 Sum_probs=48.3
Q ss_pred cccCcCCceEEEEEEcCC--------CcEEEEEEecccCchhHHHHHHHHHHHHhcCC-CCCeeeEeeeEEcCCeeeEEE
Q 047701 30 TRLGFGGFGQVYKGQFPN--------GVKIAVKVLNKNLGKIAEEQFMAEVGTIGRTY-HINLVRLHGFCHDQHMTALVY 100 (356)
Q Consensus 30 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 100 (356)
+.|+-|-.=.+|++..++ .+.|.+++...... .....+|..+++.+. +.-.+++++++.+ .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 467888888999997643 35677777653222 234557888888774 4334577777754 6899
Q ss_pred EecCCCCH
Q 047701 101 EYMENGSL 108 (356)
Q Consensus 101 e~~~~~sL 108 (356)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.20 E-value=0.0018 Score=54.67 Aligned_cols=31 Identities=26% Similarity=0.321 Sum_probs=27.5
Q ss_pred CCCeeeeccCccceEEcCCCceEEeccCCcc
Q 047701 143 QQRIIHYDIKPENVLLDANFSPKVADFGLAK 173 (356)
Q Consensus 143 ~~~ivH~Dlkp~Nill~~~~~~kl~DfGla~ 173 (356)
+.++||+|+.++||+++++...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999988777899998864
|